<SEC-DOCUMENT>0000859737-21-000006.txt : 20210127
<SEC-HEADER>0000859737-21-000006.hdr.sgml : 20210127
<ACCEPTANCE-DATETIME>20210127161102
ACCESSION NUMBER:		0000859737-21-000006
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		96
CONFORMED PERIOD OF REPORT:	20201226
FILED AS OF DATE:		20210127
DATE AS OF CHANGE:		20210127

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		21559832

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx-20201226.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b,d:f042a09e5eee431a93fd100ba54df8e9--><html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:holx="http://www.hologic.com/20201226" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20201226</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV8yLTEtMS0xLTA_c5502e57-e133-4215-ba62-6a1d63af4d08">false</ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV8zLTEtMS0xLTA_438a80c0-4754-4c97-acd4-633af4934a31">2021</ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV80LTEtMS0xLTA_37e69a31-63b4-4adf-a8e5-4af843683bb0">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV81LTEtMS0xLTA_d7d37022-4acb-4fa4-947b-0ae79c80b1d4">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV82LTEtMS0xLTA_86055593-3d5f-467e-97a7-1e26ecced4f7">9-28</ix:nonNumeric><ix:nonNumeric contextRef="ife84c0d8763b4705a470b753572dd9ad_I20201226" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfMi0yLTEtMS0w_d672a544-62f0-40ad-8bcb-39531e0dce25">P6M</ix:nonNumeric><ix:nonNumeric contextRef="i08052409a9da48bd9c3023256acbffbf_I20201226" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfMy0yLTEtMS0w_ce5f6b08-7298-4673-b00a-9ec45db403fd">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="icf1c53d799a94ec78b381605622bd13b_I20201226" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNC0yLTEtMS0w_7d294249-8781-43de-b053-503efd8d57ec">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i605077a5590146648b817b54f0efeec3_I20201226" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNS0yLTEtMS0w_667f0eac-dc82-445f-b2ce-bdc7889fe3da">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i562f34e6727740619a5a1d16c97a58b4_I20201226" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNi0yLTEtMS0w_674ba7f0-7291-4bb3-893d-31f8bdb2c173">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20201226.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i77213d318a2b4d699ad623674cca6b4d_I20210121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-01-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b4dfc4a55634d5980988f0884ae4448_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idf5a202d41b64a3a9989f892adbc11d6_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2a33877be74a4bff826119edc7ed503d_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecfcaef9f54e46558440bc81f97e5eed_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5aebec3fb9bb4e4488a724c4d7743031_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b4184d7f35149b3b1f891cfb657efe0_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2bf21035b13f458a9644c6641ca45dc9_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia95de565187f45949e967d544a6d18d2_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a30acd7b78740cfbcd8e77c0e406bc5_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc8761797caf4a1ba7a00d4505018e6f_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia87ad826395149329bd9e8ac7b691cb4_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i583f922944894f7ea2b4213a2907b398_D20191229-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icef9871fe55a44bda919b0b0818f6106_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcc149ba496d4eb1af231a99ee58c7bc_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i911f42f14f9e440c9969b74a5fb822fc_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a6f08dec5bc465b9ee6f174df007570_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb4183da93954dc88904c56ed86abb2e_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i200f25ce96994bbbae7026819adf7b94_I20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibed5a407b01e495f8fcec834d617c870_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec58a1e4925447509af22498f07e082c_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie71ae6f99b084b4daf51a7a375e79bf6_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9581555522f04a0aae88d04d16ac8561_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic37dc7d6b73747eb8118aecf497797af_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ac726be9de04754acfb0c3ad2bbe977_I20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i127f35bc4ced488ea526b5c9709d9c78_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46f22b455cca46d8bf57b116a211d7e8_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0dbddd90f43449eb71f6e58600e75ca_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a34844d9d004ca59421077b20e85919_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8419f493c4f4d939c6a710aeda8796e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if770fda10e1f4568a769511e2cb46775_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84b132b519504c978ab69d88a3c921da_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda9918b12184a469461c064a31cda9e_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i61d28c68b4b044baa488a63597e4ba87_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice8e1c44566e46d7a9428b4c849cf075_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a1a2f2804d047f9be18b7470292b8f2_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2315ca24bb44334b2ede0aa904f5731_D20201230-20201230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-30</xbrli:startDate><xbrli:endDate>2020-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibaf5f2d2692346a88d7ae57bf6270cdc_D20210105-20210105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiothernosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-05</xbrli:startDate><xbrli:endDate>2021-01-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd718ddd1ed144e29f41973ee9eb875b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i807f1967ca0747168870227cdb5de282_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i814e82d01f554e07a70d51c7e0f6789c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24231c45c0e04b0cb463e368a4fa9819_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac260c17aab74a5aaad08d3c2e71c09f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85fe1c3197bf4160bde67b0e7b88e57e_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic11fbed77bea48e18a66f44359be8369_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb91856dc5f14d6e88d769b12a3553fc_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ca33f8b7647484d95b3e8825c8d1ae6_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida008df7022c4ec1b8fcdee5e84f1012_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d1862a2813f492184d07742064e2a0d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bfc0e0103f9487b965e824c2254203b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16374eee78494c719746d8b40c160941_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i20f4faff9e164fa29b72dc862bb814c1_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f918efa3d83476c9578e01f5704ea75_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i047e6064c2d441448b721d1506b755fa_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c48afb9a6cf4b619f1170a44995048b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3384fe463ec48f08c6f59ad68669d65_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f45f0b5e32942a5ba004547e2f18c70_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if63bac3956a34caaaf11ca4c0d481b3f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba06aba7b8a3482991a27db74984c2d2_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7744b72714974633840d43bd8f1c52aa_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifff05d29091f488093318a5c86a39998_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804f2e6f9b9c4c2dac795221463c7352_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i494de1667d6141d3a77fb81e098872d7_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i41fef6d46bcb4458936812aadb6a6eeb_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4e261e946c44e3289c0ec9dd139dd3e_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i53d2f9966d234c8f86709bf1c24480d9_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i425431777b7d4b3083ab8649a18e6394_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff1719f8bdb243f58136808bb4f920b6_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d6138445fc34f7b849cf1c4c1bd7b4c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibc90a64df06e44afad34c0fdb3d6acb0_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c1a753fd84741ea99c093f47887c09b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f39f8c1a58d4c0092f3c0f4a7e1145a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c80ddb3233741de8cb85ebe53044117_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08a1df1d86db4e5f98a13155567d6600_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a2a3bf74b34478e8fac81531d70102e_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0420bc7b903745a99eef56fe2d387c5d_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a381e87df3e4fd3881d975e6bf59018_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia848377d0119418c93ec23909f54ef88_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ed96c1bacd44799bde67d4474a21301_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08a1b32655d141b3827b070cb7dd8394_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ddb21f8026b4973b5e9cf9a186551ac_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f0f69550624497996276135c6bd77d_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171c9ca031bf4884816e7be4190b9db2_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86f98ab577e348f08c18b5ec1aa4c24f_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b9fa71bf4f54f2cb7e265c235983118_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9edfd07f43ea4110a087242c57d62661_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5896165fc6444c69a28f30d7622aab83_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf72943e74d14e5fbecf4403525ffeeb_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i894813c090864a3cb88eb86237b77caa_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64740b81a53c45249c05c34df962be4a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9475dc3a7d5487fbeab85f649c54044_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f217ab69c114d40a9a225677bf15b33_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i315641707d4c4fc39c5611d79f93f696_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0ba3144ce98484facbd98ad7ffb47dc_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67601f23ac8f42259e8935b9dc100943_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia48592e41d84415895cece1a0979daaf_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58584d59f7ca4ce8914046729ee0446b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2617de2ef6504c69af6d86624c6c1ae3_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ife84c0d8763b4705a470b753572dd9ad_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i08052409a9da48bd9c3023256acbffbf_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icf1c53d799a94ec78b381605622bd13b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i605077a5590146648b817b54f0efeec3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i562f34e6727740619a5a1d16c97a58b4_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b4b851aac0a434c82c8b786b613a366_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibda9057d843a4b73905a0ed943432150_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba6af4bb67bc4b93b0ef89a2863329bd_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3824626237124ce9828ecc11f78786df_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i126237eb247a4867bac37c6b2dea5699_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia393550942904ed09c042467d0645c37_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i589619851f164523acf1587d711fff2a_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50fa172708d24893990ba4c50d5437c5_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7323967dedcd49868eb4e102fb8b387e_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb7efed954b8455690ac3b12d64dcb4c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8c4bd4abad44e83aab53cec2dfaade1_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9712b4b8dc64000b015bfd132cfda2c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i69ec054955924207982fbd54d8a1cca2_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbcb67f917c48b39cc8cdf5e74c1d42_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i876dd7ede38d4edbae53824dea405212_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6a5fd7116579406fb4ab4e0c108de263_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i788bcb698408495ba16be99c3274b08c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i057ac10f806c4c558abf15ee4ec101cf_D20200329-20200627"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-06-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i241d11756be14078a3555bf86956ce71_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida2942dc56654504a3265279bdb12af9_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e700854ca8d480696bc4eb95d4ddb8a_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2f8bbd6225a46a59130b9953c661fca_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib945bc9d7dd74d23bef11fee1c766a86_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i445bb1bc12b94106bac10836061b786a_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34350e67e8944266b86f21311361cfa5_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0832db4cb8434084b9ee1801dd03071d_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ab367a0906d4115ae87e78dcc61bf59_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70d5bdf101354f3096ceb4018e2689fe_D20200203-20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-03</xbrli:startDate><xbrli:endDate>2020-02-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97f3b15a57f54d1388b8a487d385f489_I20200203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-02-03</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16b9bcb5f7f245b8844e041da365f4ca_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i371b6d6a17864bafad1d66b2594c1fd0_D20191230-20191230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-12-30</xbrli:startDate><xbrli:endDate>2019-12-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07707b0a4bc941daad3ff6db034e22c7_I20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia740bc8dc3ae4ebab5eaafc9d0d17247_D20190801-20190801"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic66d9c02f62b4399864f0fd8c7c03ef9_D20190901-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i819b181542894a318b23998e6b0d7876_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7760868627c74bd8909425527cd76d5f_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib444eb3971eb4078a9095005df6a2388_D20191101-20191130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-01</xbrli:startDate><xbrli:endDate>2019-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i723a995e7e6e469f93a43a1b15d07825_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-21</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0b7ae2b69c584c9bb1faea69bab3ce7d_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bcf08abaf134bbebc54968c5252645d_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaddf820f39534b4598834451cecb88ea_D20191121-20191121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-21</xbrli:startDate><xbrli:endDate>2019-11-21</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic22ee4e6996843b09dfab94a3c9ee000_I20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-11-20</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i263b950faa89407aa9ae0648ede3cbf6_D20191120-20191120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-11-20</xbrli:startDate><xbrli:endDate>2019-11-20</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i94e4cd78e2a64f9c8f35fa4309e98439_D20200628-20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-28</xbrli:startDate><xbrli:endDate>2020-09-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc6c143516c3424da5de0d0db2e91e98_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e1d2a8de8624ac59da8d9efd1fbaf86_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-31</xbrli:startDate><xbrli:endDate>2019-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b85682ab2d3455ca69df8563e60aa95_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb7f71fe3fdf45758b7a447848bff326_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bb87ee83878455d9a7b108c2fa2d672_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id6786a0492e547de9f464fbf0e844870_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67ca1e7d9cac43759262d127ccab005b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82e420f21c4c4b3f8b908f387378a7f2_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id33757ebc0984bec86c4ac09abcd3c10_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c6dd14c95ef47a7949124d127e36455_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2dbe00ac4547495f87d9491d8dd3581b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie68151a708294400b3d034999da20c0b_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i272b18cc7ba74e908f1067ae52fcdb03_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcd33ea87772405fa0aef1f0eddaef72_I20181217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3dfc408634648eb84ad199842d8c60c_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i266e0d14a55f4367b1cb47da87337f49_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ccd74dfac1940edb3766ae879c3f548_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i87a8917b112a432189d8acc8fa3c7c6b_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11457d1d34284cdd848e04fc6ade132e_I20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e7cc717b7744775a9beef49918787a7_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad667aadede54f53a73843991e84d978_I20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-15</xbrli:startDate><xbrli:endDate>2020-10-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c96bc19976644208f9a458ae4a150c3_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iacc119bc81e747be85919ea8b7a55a46_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie334e0aec6cd4cd1ab86db6fbbfaa551_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a8984669d744df49521703334b03d7e_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i96cd4aedc3204bf7bbe2a37df2b4ef1f_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6ebe4e0383e4fe69e44e515ac3c4504_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02a7dee3e67f41a097d797a6c9b2130e_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a15023472504c11938a4412d729c107_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if22e3b1bbb254fc0b22330dc8ee7c7bd_D20200928-20200928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-28</xbrli:startDate><xbrli:endDate>2020-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i946944c5847f4222b4d01aab1a2fa089_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97a53a8f47ba4871a7afa91c3b2b95ae_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5687e57173b24d598e070c83cda5ba64_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbfc7677b0624c36ad3fa92f1412ae0c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic040a340ce4f4e139d9aa05eac474e5c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4145415c8afb45a4bda97db9d2be27b8_D20171001-20180929"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2018-09-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb558ac27372440189b269e14d6cb9e9_D20180930-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2018-09-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia18821e25e654193b3722de96cae81e5_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i14c65c53cd0e4e41a8db5dd4fc6893ee_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5c79bf354ce4b21b4b0f50f1420f521_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99c9b14467904ef5b80860d433664aee_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaffcddff32544018920aee5d25e3c2ad_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9dfb8135d4b44625bbfd0c560825de11_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id06743973fb743b3bbaa0c0e4b84c26b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3146d8c6f2de426998db38b3743e8858_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia984d8ccc9314615a0c9a71d08c50377_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i840c202668e846e1a52fcd4ca8bc0961_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i969e4857b92749c69746b9416f9fdfa8_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46c4fddee0c14f81993ab3606eae7ab3_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i81a59afa7d3848bf9b91f17ca827426a_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i549ec774b12e4aa1a72a71662a06229e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3be9e57ba38f4e4eab5fb7b166680c7c_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib397c4180063456a85a4f4404a73c0ab_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7ced3c7b6bc347edb64064ea347792a1_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfed9d2d0c8c46be91e8f912672b894f_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6d9158bf57a4de4bb11c3ce2fbd34c8_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd61c3510e7e468085daf8a67ff23b49_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa0e515bd1224c0d899e4fcd02858289_I20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>holx:petition</xbrli:measure></xbrli:unit><xbrli:context id="i7c99293b0e714a19b40025886a612952_D20160304-20160304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-04</xbrli:startDate><xbrli:endDate>2016-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie80b72b0fb174e058cab363ca6b15048_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i32c95d4d9c584147982e6bb76f7f2f4d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i171272f0c8eb474abf7abd9bc10110a5_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55ee422e40ce4f768cceb979f540e79d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i476aabde140941c0aab31725a7ba549e_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafdc57909e694817a52781dc7898179f_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff6b7ab624354224947dce01c73a9d53_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5144cd88e48a4b849b044fdf0eba3d60_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9547059f414e4ec8bb5994e0b274a8e4_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if39c287645e74eff89da805fd540f295_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5e1cce238241218daf5e00d5bdb7b5_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b9c1bb1bfb5498d9c90a1947235bccf_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i855677b1eae843febb6235b904a536d4_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9aa17c0c19b24f93bc412700aea8fd05_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4bd4f87650894ee382525ad3d40a1b96_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a35e9e5b1784502b251b8e6485fc0ac_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="i10c0a8b3f4be439a89b84dd347cf9122_D20190929-20200328"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2020-03-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1a3cd78896644659e948a7690e47e54_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2cca350406704671a994c46fd4de1acd_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i189fd242f489432a9c8db82a5c7ffe1a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bd66551f9c242be97d7f7e5bf36f159_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53fdb57bb16f4ecd921dea40ee6810c9_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idea9543291624e5ababf4c314fce32dd_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida8674e08ddb40be8abf86e02713868e_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ce3ba4253a94d52bc59d8eee2d9a4bf_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b99c5a4675c4355b2ada4de33915985_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95f6c5d4cda44d798ae43baeb9d4c057_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f800d332c6b407198afce370a678a7d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a4363dfa5c645a0825be13c07abee4c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i58367c7ce8c54c989fc82c51b7e6dbcf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2b1fb47303fa4a959860825ff50f60af_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf46dd81205b47668902c1445ae9f97f_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic82c48e220f04e80a509c6a97393b47c_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-30</xbrli:startDate><xbrli:endDate>2019-09-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e60b8115b744ab191b4024f191eb8bf_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i243ea054fba6480fbcab7af21d6a4fce_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iafa5b970ae8547d5869dbb3f0236c428_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2252adf156645a6b718b3df114b1fad_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie951bc855db2428a86d3e005063b41ef_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e3d41a755af40568a3e504182462ce6_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c20b78ad72e4fe8a5420980636498f0_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i663bf06f259e40619f00b794ee8f3df4_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7f4ea0fd45f430abe0bc8838c398d85_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib64c67176ca34a27bd5311e672ebe881_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8aeb602620b040dbb06bd27522eabae8_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5e39d5d745b47fd991512768cc51329_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47fc0ea3fd504f739a98ccb1f8602c4d_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i012977a16707452184c540c1c42de324_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5ca4657cf4aa4a1883690d1eebc48675_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d9e66846015431a805ecdc7a2b07991_I20200926"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-09-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i691aa4e01085425ea916509572c8429b_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f3b88a636814103b52b8b03edd8eaad_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d6e7aa54b314ef6b6b0475e6c1109a8_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d75b63e30b04cf3a05528421174cf0f_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e77d8b4a000446c87e498c3fb63a20c_I20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcaee226383e4970803638e86e611e5f_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3896841cd53547aa9f241c9961480908_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63616236f1194463b9ef82bc0e35b837_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18a05642170e4a2eaba83cc4b9f1db63_I20190928"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-09-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-09-29</xbrli:startDate><xbrli:endDate>2019-12-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b08910f86f346c9b1270b470577d0b7_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5265c14bdf944ebeb3a15533c9c6b571_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i415e1540a94545748e7bb75e5b9e6db7_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if85ce9153c7c4628b53a745f295945de_I20191228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i570b9aef162a4a48b5ccb34ec6b061f8_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05539a83a04849449de905f6a9d13244_D20200927-20201226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-09-27</xbrli:startDate><xbrli:endDate>2020-12-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ace0144f6f4565a88544db9fa33ffb_I20191211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-11</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if042a09e5eee431a93fd100ba54df8e9_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgx_4e06dd93-5083-4b6f-bd85-1d21cf561ec8">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;__________________________________________________________&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6Nzk3NDhjZjI5OWY4NGJjZGEyN2VhNDQ0OGYyMjNkODMvdGFibGVyYW5nZTo3OTc0OGNmMjk5Zjg0YmNkYTI3ZWE0NDQ4ZjIyM2Q4M18wLTAtMS0xLTA_8772bf22-1969-49e1-94ea-8aa44fe446b7">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yNjA_9977bd42-ab80-4863-8d15-02647d5c7886">December&#160;26, 2020</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NjExMjUyN2EyZWI3NGM2MmI2MmFkM2U5ZDU1YzNiNGEvdGFibGVyYW5nZTo2MTEyNTI3YTJlYjc0YzYyYjYyYWQzZTlkNTVjM2I0YV8wLTAtMS0xLTA_8439ebda-d8ae-4200-a7d3-5b9ea0e59d67">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg0_0d649550-e597-4c68-93dc-bd7dcd942d7e">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgy_bd921888-5a20-4609-a9c8-6033111b22ea">HOLOGIC, INC</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8wLTAtMS0xLTA_756fe24f-ade7-42d0-afdc-8c33df24d5e6">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8wLTItMS0xLTA_5e582de5-48f7-46e1-bde7-eaab71daeb0c">04-2902449</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8yLTAtMS0xLTA_29872aa0-2f6c-43ae-a9eb-cf616579087b">250 Campus Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8zLTAtMS0xLTA_e7a5b694-8d71-42e2-b34c-54c8e14fa640">Marlborough,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF80LTAtMS0xLTA_05f4cd76-2e44-41b6-830e-19cc344e31bc">Massachusetts</ix:nonNumeric><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF80LTItMS0xLTA_a63e50f8-ece2-44ac-b57d-4459f85f5434">01752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg1_f2a55b69-09c9-437f-82d5-ad0fd47185ec">(508)</ix:nonNumeric> <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg2_40604b79-2848-407a-b801-8e71ebaad594">263-2900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">*Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTAtMS0xLTA_f074da4c-378c-405b-bd16-a8c031f5691a">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTEtMS0xLTA_5f20f167-6790-46dd-8b65-846b256b7854">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTItMS0xLTA_6836af9a-1a00-4c79-bea6-870d3ec02fd7">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg3_d6507e2b-52f8-4f0a-a0cf-88b59fb1b986">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg4_66d5533a-96ee-4a52-8c72-a1ec000a6754">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8wLTAtMS0xLTA_1c79aec6-a6eb-4565-b6ad-77c0c99f4800">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8xLTYtMS0xLTA_30b90ba9-9fd4-4f40-bc3b-6dedefcc4ff5">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8yLTYtMS0xLTA_98bff892-bac2-49ac-aed6-1a7f958de3a5">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgz_6e3fd441-bd0a-4335-b414-5ab5c477ea5a">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;21, 2021, <ix:nonFraction unitRef="shares" contextRef="i77213d318a2b4d699ad623674cca6b4d_I20210121" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjAx_11678690-9a89-4c99-899a-1805b7f2789c">257,661,792</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_13">Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">Consolidated Statements of </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">Inc</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">ome</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16"> for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_16">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">Consolidated Statements of Comprehensive Income</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19"> for the Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_19">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_22">Consolidated Balance Sheets as of December 26, 2020 and September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_22">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_25">Consolidated Statements of Stockholders' Equity for the Three Months Ended December 26, 2020 and Year Ended September 26, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_25">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">Consolidated Statements of Cash Flows for the </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">Three</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28"> Months Ended </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">6</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">, 2020 and </a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">December</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28"> 2</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">8</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">, 2019</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_28">9</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_31">10</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_100">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_100">31</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_121">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_121">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_124">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_124">48</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_127">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_130">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_130">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_133">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_133">49</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_136">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_136">50</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_139">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_139">51</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_142">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_142">52</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="if042a09e5eee431a93fd100ba54df8e9_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements (unaudited)</span></div><div id="if042a09e5eee431a93fd100ba54df8e9_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMy0xLTEtMS0w_50411307-c618-4877-a68f-bee8659307c9">1,455.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMy0zLTEtMS0w_26949bcf-583f-479e-93ff-b634671a70e0">699.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNC0xLTEtMS0w_539503fc-b68e-4830-8fd5-b17975b7d8a8">154.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNC0zLTEtMS0w_17184fd5-33a1-495e-9682-70f769d19e3d">151.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNS0xLTEtMS0w_18689044-1321-46d9-9caf-2b87d4ef44ad">1,609.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNS0zLTEtMS0w_f276b0c7-179a-43ab-b6a8-acfefa83b1e7">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNy0xLTEtMS0w_cd4e0a18-cc4a-4db7-87cd-075f6cca1dce">284.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNy0zLTEtMS0w_d709a2eb-b18a-4c1c-9197-18a5fa30f21a">237.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOC0xLTEtMS0w_73fcbbc0-d416-4e8c-9bd7-44bff89cc503">61.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOC0zLTEtMS0w_5e8bd00e-c71b-4738-bb38-87198bac7154">63.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOS0xLTEtMS0w_e777da0d-3beb-415c-a646-d4222135d8ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOS0zLTEtMS0w_4d3894ec-aca5-4cbd-b6b2-bf0437032495">25.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTAtMS0xLTEtMA_046f8c52-7bd4-4611-8c5e-55d4e1a6c7cd">83.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTAtMy0xLTEtMA_562493d4-a92f-449b-bb0e-0a826f079158">89.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTEtMS0xLTEtMA_41800b73-8ae8-4da3-84a8-c15e445a4fe8">1,180.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTEtMy0xLTEtMA_d0ff6e9c-a975-4900-9eaf-7bc256b7f8d5">433.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTMtMS0xLTEtMA_141226e9-15bf-424c-aadc-f0178012d90d">59.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTMtMy0xLTEtMA_d362d819-db68-4095-beba-251241c93514">61.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTQtMS0xLTEtMA_256dd2ee-4f38-4352-ba57-5d914d6e324f">128.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTQtMy0xLTEtMA_3d2678cf-24a5-498c-b0c3-1301d3564d71">144.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTUtMS0xLTEtMA_8e0204a0-c816-4231-9a47-7fb438b0c9b3">91.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTUtMy0xLTEtMA_fdc89509-85ad-4fe7-ba19-9981aa075d9e">87.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTYtMS0xLTEtMA_f3e2bb7d-a1a5-489e-9908-1b49b1b7102a">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTYtMy0xLTEtMA_d8b4b5ee-7b90-4a99-9a77-5ee2e07c34eb">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTctMS0xLTEtMA_58cbc858-4745-46bb-93f8-a6293a82f0a9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTctMy0xLTEtMA_4bd42ba6-1d79-47a3-ab75-ec324499f612">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTktMS0xLTEtMA_f77bcc8e-4d0a-4c81-bf0d-cfac61f24193">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTktMy0xLTEtMA_a0152b62-59cd-4458-8b79-b4b917eef44f">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring and divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjItMS0xLTEtMA_601b22a1-d18a-4580-8108-954f1b9b0a62">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjItMy0xLTEtMA_0a5837d9-d9b9-4791-b70d-17a533199ea2">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjMtMS0xLTEtMA_170e4315-01fb-4d6d-ab97-f842f3cc2b95">294.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjMtMy0xLTEtMA_e0445604-6bfd-4077-8cfb-a2ea5dc74be8">309.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjQtMS0xLTEtMA_4a8a39f1-37bd-445a-9ad8-4cf2dfe31e76">885.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjQtMy0xLTEtMA_661ec48f-94f1-4ef2-8cc8-53efbe1a283f">124.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjUtMS0xLTEtMA_3f05c943-10d4-4edd-904a-b0011f8e5f72">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjUtMy0xLTEtMA_109afdbc-2767-4d27-a76e-7f9a071d524e">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjYtMS0xLTEtMA_76c8d02e-88a4-422e-bff6-2252e1cc2c38">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjYtMy0xLTEtMA_b88cddbe-2ca8-4aba-a86a-e9d5c09d7415">32.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjctMS0xLTEtMA_ffed5704-ac20-4f9e-8fdf-c62b3002493a">21.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjctMy0xLTEtMA_729d3de3-f20f-4fe4-825b-07b2162c05a1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjgtMS0xLTEtMA_e5903018-a14b-40f3-aa74-e72a8d02b115">3.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjgtMy0xLTEtMA_dbe05392-e03d-4ea9-afa4-b8896e9bb8ec">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjktMS0xLTEtMA_4b87b0e6-3fd4-4220-b20b-883687861c8b">832.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjktMy0xLTEtMA_95a00f12-10b0-4222-807b-49f7aadf5a58">97.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision (benefit) for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzAtMS0xLTEtMA_4a7965f9-1fb3-4cce-b02d-41c387334644">179.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzAtMy0xLTEtMA_c4527185-8167-43be-9c66-c990fbe158e3">288.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzEtMS0xLTEtMA_bd948e41-d5cf-4a0b-9a73-42ea7ec1681b">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzEtMy0xLTEtMA_e1bc4dae-713c-4b14-b187-83a176c10ed6">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzItMS0xLTEtMA_4449d782-5351-49e1-8c5c-ce9abce30504">1.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzItMy0xLTEtMA_b0babe7b-491a-4bea-af5d-4ae7c9ec44ad">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Hologic</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzMtMS0xLTEtMA_db457d9a-a6de-4664-b880-d0cfa00ffae3">654.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzMtMy0xLTEtMA_6a006a8c-1d50-4443-b388-8821f4e08de8">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share attributable to Hologic:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzUtMS0xLTEtMA_bbbc3e06-d0c4-4b04-b521-76a3ae8a820f">2.53</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzUtMy0xLTEtMA_4c75c7d3-7f94-4eb4-8bff-5e77b3104364">1.44</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzYtMS0xLTEtMA_cf63fd61-2588-47e8-a640-a012ee9a7a8f">2.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzYtMy0xLTEtMA_a062fd03-15e8-4727-b99a-4d1c4a872700">1.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzgtMS0xLTEtMA_3e8546b2-b266-4aaa-88fa-de25ca2e78ef">258,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzgtMy0xLTEtMA_47bbf405-fa00-481a-98ee-d28b073ede19">267,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzktMS0xLTEtMA_9bedff84-7d01-4154-9c61-f57cf608ca61">261,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzktMy0xLTEtMA_34c0531b-5630-42d6-952c-a276f1bdd057">269,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMi01LTEtMS0w_bd948e41-d5cf-4a0b-9a73-42ea7ec1681b">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMi03LTEtMS0w_d3dd8e81-dc8c-4afc-b14a-6de328f45d17">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMy01LTEtMS0w_4c812235-2788-4a7b-8f61-774f87f689bf">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMy03LTEtMS0w_49dbf27a-26be-4e34-85bc-5e32c9152b58">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOC0wLTEtMS0wL3RleHRyZWdpb246OTFmMmJhNDQwOWI4NGY3ODk0MGI1NGE5ZjliYWY5NjFfODk_763736d8-b314-4489-8f82-fe4dfc2c2cb6">0.2</ix:nonFraction>) for the three months ended December 26, 2020 and $<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOC0wLTEtMS0wL3RleHRyZWdpb246OTFmMmJhNDQwOWI4NGY3ODk0MGI1NGE5ZjliYWY5NjFfMTUz_5c9b2ff8-fe02-498a-88f4-9f11b1f5766b">1.7</ix:nonFraction> for the three months ended December 28,2019.</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain recognized in other comprehensive income, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOS01LTEtMS0w_1c54c016-57f5-4b50-b5d7-c44d3443b7a4">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOS03LTEtMS0w_65df97df-6a65-48e9-aeeb-b2d117d4fa7a">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss reclassified from accumulated other comprehensive loss to the statements of income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTAtNS0xLTEtMA_b3d8bb9c-05ee-4c27-bbf1-99ecac28d6a9">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTAtNy0xLTEtMA_81e7222f-180d-487f-b61a-7cf21c00973a">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTEtNS0xLTEtMA_cda874a4-57da-4ccf-960d-b640b4c6662f">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTEtNy0xLTEtMA_e543c8a8-3e58-42de-b232-13b429ac8931">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTItNS0xLTEtMA_5549b75d-2deb-491a-aae1-a12f17abdbdc">672.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTItNy0xLTEtMA_54df3669-e1a7-4523-9343-30ebe9807606">399.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Components of comprehensive income attributable to noncontrolling interest:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTQtNS0xLTEtMA_9d2bfba2-13af-4451-8db5-0a8ebdc8ae86">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTQtNy0xLTEtMA_1899c26f-1cdc-4e67-a8c4-9b5d633462d7">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss attributable to noncontrolling interest</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTUtNS0xLTEtMA_8c2700a9-fde9-4d9c-82d3-40645d1cc607">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTUtNy0xLTEtMA_941b1f39-b157-43e9-98e5-8bd35bbf66e5">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income attributable to Hologic</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTYtNS0xLTEtMA_28936da6-b8ef-49f4-a7af-ceb30c0dcd01">673.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:ComprehensiveIncome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTYtNy0xLTEtMA_8c777895-67bf-446a-bb88-a729f49d5479">399.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMy0xLTEtMS0w_1dce3c6f-7fe9-4985-94d1-63e49d421030">868.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMy0zLTEtMS0w_3b06647d-fdf1-4039-8705-c1e368f22d22">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves of $<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0wLTEtMS0wL3RleHRyZWdpb246NjdiNTFiNGZhN2M3NDg4ZjlhNDFiMjRmYjY4ZGM5YWNfNDM_de7480a3-a757-47c7-9312-1ab542083d5b">39.4</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0wLTEtMS0wL3RleHRyZWdpb246NjdiNTFiNGZhN2M3NDg4ZjlhNDFiMjRmYjY4ZGM5YWNfNTE_840d9ec6-962d-404d-a96e-a6efb351ce75">31.6</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0xLTEtMS0w_2524f213-71a3-459d-86a9-e6f6fd6d559e">1,216.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0zLTEtMS0w_91582345-ff97-4311-b1ef-9454ab3ba5ae">1,028.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNy0xLTEtMS0w_cf527fbd-5bc5-4167-8139-a6f4f01d4cd7">420.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNy0zLTEtMS0w_1a853c1b-6c70-4c94-922b-ec92c3b26788">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOC0xLTEtMS0w_caebfe9d-b27c-40c6-aefe-dd95306bd84e">29.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOC0zLTEtMS0w_d395b388-bf63-48cd-9ce4-9cc8cf1344a8">38.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOS0xLTEtMS0w_37c9db50-d511-4f96-a810-afa075364f09">61.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOS0zLTEtMS0w_31862cb3-a114-4e84-8f08-32c2055bad32">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTItMS0xLTEtMA_1f1bbaf9-63bc-4c90-a19b-df46cc27ba65">2,596.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTItMy0xLTEtMA_aa49496d-3a64-463a-81db-57d666882025">2,222.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTMtMS0xLTEtMA_649b5162-3818-4db2-92d8-2af89a157c4f">514.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTMtMy0xLTEtMA_780a6456-ecbe-46eb-9150-c11e0cd90798">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTQtMS0xLTEtMA_20c01dd9-65f2-4de6-8f18-d335b6117446">1,244.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTQtMy0xLTEtMA_5738e062-f0a9-42bb-b571-ada4470054ea">1,307.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTUtMS0xLTEtMA_f73344f1-af91-48f3-87ad-89ca1fc8f1a5">2,663.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTUtMy0xLTEtMA_3d688d3e-ba84-4702-851c-1ef8296016ac">2,657.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTYtMS0xLTEtMA_d9350570-2c6d-4a6c-8ede-d3d32e1c0db6">531.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTYtMy0xLTEtMA_1db304a7-461a-4624-898c-b0f257d444ce">516.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTctMS0xLTEtMA_24bfe218-72c9-4ab2-adcc-efcea7b70bb7">7,550.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTctMy0xLTEtMA_b52ac5a7-110e-4dbd-a7c7-f695dbf7a4c2">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjAtMS0xLTEtMA_b47f6728-3a92-4c99-bee9-e10f467067e3">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjAtMy0xLTEtMA_e4d499c2-01ca-4d3b-88c0-65b2014fc950">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjEtMS0xLTEtMA_456fa77e-a6d5-4918-ba05-e9e800900e47">184.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjEtMy0xLTEtMA_376d2f3c-d862-4cb0-ab71-88e869bcae03">178.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjItMS0xLTEtMA_19e7effb-0cb2-4cdc-865b-62f70d5ca04d">611.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjItMy0xLTEtMA_41742b4e-3636-43a4-8c2b-f08da69bfee1">547.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjMtMS0xLTEtMA_64a353f3-41ff-4bec-a0d7-2752388ab68c">182.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjMtMy0xLTEtMA_99e466ed-fc16-4068-834a-f32629913169">186.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjQtMS0xLTEtMA_1b49cc36-23b1-40a4-8764-109afaa2a408">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjQtMy0xLTEtMA_6a25f7b0-52d6-402f-9abd-dea612e50f40">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjctMS0xLTEtMA_9153142a-e178-4723-9750-d21cce19deb9">1,056.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjctMy0xLTEtMA_89e2978d-d2a6-4d01-8ffe-6df0f8fef9fd">1,239.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjgtMS0xLTEtMA_4026cf35-8a2f-424e-8784-7a9505baef19">2,689.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjgtMy0xLTEtMA_71d4d342-dc9d-4cf8-b090-10ce8fa47f26">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligation - long term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjktMS0xLTEtMA_ee3510e8-405f-43f3-9f32-3a0b02ea249f">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:CapitalLeaseObligationsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjktMy0xLTEtMA_f1ca0978-ebb1-406a-a7df-186bac62f67f">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzAtMS0xLTEtMA_5b0cccee-91ae-4317-8a16-9c3621976cb9">189.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzAtMy0xLTEtMA_3e3f8e7f-902f-4edc-aa92-319550a49371">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzEtMS0xLTEtMA_c88ddb26-742c-4c19-98ff-f6ee6e913935">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzEtMy0xLTEtMA_bc520e96-b1e5-4777-991e-5e7f60fd13ba">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzItMS0xLTEtMA_6ef86676-4143-4770-96cc-0bade3c0b222">317.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzItMy0xLTEtMA_265f8259-c714-4d03-b816-5c8ae629acef">303.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzIx_2bfd89d3-63c4-4b86-b012-22b186fe4405"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzIx_9ae64d1c-d0b5-4026-9fb8-f408191c9a8e">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzM2_0bc51ee8-7730-4fae-87e0-40a8d546d8f2"><ix:nonFraction unitRef="shares" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzM2_fa63bcbc-f7a3-456b-8f36-10e717a6dfad">1,623</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzU4_17bcd0b1-4087-4ae4-b655-6eb404ceb878"><ix:nonFraction unitRef="shares" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzU4_c95d1ab1-efe2-4f66-9928-fc0fb016a4b1">0</ix:nonFraction></ix:nonFraction> shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMS0xLTEtMA_61b474af-e2cb-4c82-b0f8-9f489900e03a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMy0xLTEtMA_16019283-1148-4ebf-8bed-25322586f5a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzE4_5bdb000b-a934-49eb-a453-f3f283a42974"><ix:nonFraction unitRef="usdPerShare" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzE4_c5e2aaaa-1351-4e1d-982f-7514ba95cd07">0.01</ix:nonFraction></ix:nonFraction> par value &#8211;<ix:nonFraction unitRef="shares" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzMy_8f28decd-1721-4a10-aadf-ab59d92555fb"><ix:nonFraction unitRef="shares" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzMy_9cd052ab-aed6-4c7b-8f86-280300749a6d">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzU0_aece7599-8116-4c8f-8088-e0a732e35cf0">296,533</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzYx_e00d1c21-413d-42fc-89a2-61db5e6b2b38">295,107</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMS0xLTEtMA_57914eaf-cadd-4c79-8d1d-beaa0e697823">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMy0xLTEtMA_16bbb0ef-aff7-49fb-a502-6739ea18e4eb">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzYtMS0xLTEtMA_a5b13044-e2a5-4c0e-8e68-d4cb545219cd">5,895.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzYtMy0xLTEtMA_921d36ef-5742-4c3a-a057-4df915ca6de6">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzctMS0xLTEtMA_f0f2d2f1-527d-4c29-968b-de90f2303eda">918.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzctMy0xLTEtMA_0aee306d-9e08-4ed8-9c40-741d658803c0">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVjZGFmYmQ2OWNkMDQ3OTU4NWJjOWI4YTUzMGZmMWRiXzMw_c707a679-ded9-4507-b237-cddb93403e0d">39,078</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVjZGFmYmQ2OWNkMDQ3OTU4NWJjOWI4YTUzMGZmMWRiXzM3_b5b8b7cb-d485-4a24-87ab-1beb25d43f74">37,609</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMS0xLTEtMA_0561e8d6-a846-41cb-9635-8a8524762b45">1,680.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMy0xLTEtMA_8fce4d81-4ee9-401f-9f43-2e94dc836423">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzktMS0xLTEtMA_593d810a-357c-42e1-94e5-66dd645504e2">30.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzktMy0xLTEtMA_01184ac5-5e69-497f-ad01-71508e05a653">49.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Hologic's stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDAtMS0xLTEtMA_4b30f140-579f-4435-82f6-0efa8a0032e4">3,267.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDAtMy0xLTEtMA_37f6a07b-1f3a-46dc-943c-a3469b0cdcbd">2,705.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDEtMS0xLTEtMA_42b2e390-5b4b-40fc-8c75-6a0a9c6e5379">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:MinorityInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDEtMy0xLTEtMA_dbcc9b83-f2fb-4691-9527-9bb80c4c55f1">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDItMS0xLTEtMA_489b3cad-e2da-4d9c-b5f2-a22bbcff49bb">3,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDItMy0xLTEtMA_fc48f714-7374-42b9-a221-e46b1e7f0cd1">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDMtMS0xLTEtMA_93c211bf-6258-438b-a2c4-d9f1bdd83d43">7,550.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDMtMy0xLTEtMA_73f1de39-84ed-445b-9d00-0eef47f2e79a">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Noncontrolling Interest</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idf5a202d41b64a3a9989f892adbc11d6_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTItMS0xLTA_05901217-b51b-415d-8644-f240feb11f78">292,323</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf5a202d41b64a3a9989f892adbc11d6_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTQtMS0xLTA_b9502321-c7c8-4c6c-8ff9-cb241485aa45">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a33877be74a4bff826119edc7ed503d_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTYtMS0xLTA_7fc21bf2-f8c6-41a0-a36c-156a23ffb14b">5,769.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecfcaef9f54e46558440bc81f97e5eed_I20190928" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTgtMS0xLTA_6471ba18-2cc7-4561-9eeb-c92b55b0c5e3">2,688.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aebec3fb9bb4e4488a724c4d7743031_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTEwLTEtMS0w_cd8cea4e-ac12-4536-97d1-d787477b507d">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3b4184d7f35149b3b1f891cfb657efe0_I20190928" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTEyLTEtMS0w_e287f98c-5fa3-43f1-92f2-c78b3f992a5a">24,638</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3b4184d7f35149b3b1f891cfb657efe0_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE0LTEtMS0w_e0af9b1b-ec64-4c0f-bd8e-04776ca1d976">926.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" format="ixt:zerodash" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE2LTEtMS0w_96417f26-a8e4-48a7-8798-9a1561427721">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE4LTEtMS0w_5bf4a9da-07b7-4123-b098-25346dffceaf">2,115.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Noncontrolling interest created in acquisition</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE3LTE2LTEtMS0w_ea48ade9-6a5d-43e5-a48b-6b5c006bd6b0">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE3LTE4LTEtMS0w_b8e9ff0b-6a9d-49d7-b7f7-120a20685d09">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounting standard transition adjustment - ASC 842</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf21035b13f458a9644c6641ca45dc9_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE4LTgtMS0xLTA_0e90ae60-2f47-4107-81c1-02c2f7198df5">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bf21035b13f458a9644c6641ca45dc9_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE4LTE4LTEtMS0w_2fc7a96b-c3c2-40e6-ad92-4d0d7977a03f">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTItMS0xLTA_b1bbcd81-cf79-4689-a4e4-563b2018ea14">540</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTYtMS0xLTA_f9849c3d-72df-46bb-bb39-3c83cd41966b">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTE4LTEtMS0w_f7be76fb-ee86-4a7d-a64a-b02242cad6c4">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTItMS0xLTA_e7b2d35b-197d-4f0e-89d5-9f9fd869efd5">476</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTYtMS0xLTA_ad8c05dd-032a-4615-baec-6a4c8fe7a8f9">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTE4LTEtMS0w_5acfb9f8-1cc9-47dd-836e-8d8c5d9bd18e">10.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIyLTYtMS0xLTA_4fde4c03-40d3-4bcf-91be-60512bf69444">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIyLTE4LTEtMS0w_9d17baaa-859c-4dd1-8193-2ec6695e333f">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTgtMS0xLTA_03e3ffd7-e47b-48ed-9ac5-a4763e3536f6">386.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTE2LTEtMS0w_30e96eff-409a-411f-bca6-92b361558931">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTE4LTEtMS0w_330ef918-6038-4115-b5f2-fe88bf3d0f57">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI0LTEwLTEtMS0w_b995dcd2-1b6d-4a41-ae3a-061de79b887d">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI0LTE4LTEtMS0w_ded46be5-f9b0-4854-91e7-a08fb0145656">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTEyLTEtMS0w_b20e986f-3aa5-4b03-8957-2128db9fbd7f">1,545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTE0LTEtMS0w_5e2198cb-76da-4c4b-9c43-284654d5ecc7">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTE4LTEtMS0w_ca9416fd-9b52-462e-b903-f2802e799711">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTYtMS0xLTA_5e3394da-78c5-4382-ab71-99bc76781101">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTEyLTEtMS0w_b59e0106-501b-4f97-b47d-2c2b6faa0da5">3,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228" decimals="-3" sign="-" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTE0LTEtMS0w_c528ad65-b046-4089-b2b0-ed0e0dd03554">164.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTE4LTEtMS0w_38a4e2bf-582e-4f19-bc57-d8893dd1f658">205.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI3LTE2LTEtMS0w_0ba771a2-288b-4c0a-9c1c-eef891d88466">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI3LTE4LTEtMS0w_3b8fd6ed-f641-48f1-bed4-25a627765326">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 28, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia95de565187f45949e967d544a6d18d2_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTItMS0xLTA_4290e365-4631-4a39-aa8d-7fa2fd5387bb">293,339</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia95de565187f45949e967d544a6d18d2_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTQtMS0xLTA_be27062f-f0ad-4094-ae19-6e45f6594e85">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a30acd7b78740cfbcd8e77c0e406bc5_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTYtMS0xLTA_e36b9977-55f1-4e75-adf1-b3796a36e088">5,749.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifc8761797caf4a1ba7a00d4505018e6f_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTgtMS0xLTA_af917f79-60ee-4ded-8fad-27fbc05122a3">2,302.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTEwLTEtMS0w_2f6e3a73-1fbb-4569-8f84-b568dd7e12d9">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTEyLTEtMS0w_95a2bd25-bd32-4901-89b3-4af343f4aa9f">29,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE0LTEtMS0w_1acfd215-a2b1-4d57-a40a-9ffff086c97d">1,170.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE2LTEtMS0w_9f3410f2-6f81-450f-b98c-6a0683d64901">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE4LTEtMS0w_d9902caa-f95f-4213-8612-e8385d58a580">2,257.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTItMS0xLTA_e894e671-8568-4572-9046-c53a90168f07">503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTYtMS0xLTA_c89f32ac-b730-4d96-9c11-8c9f1f11b9aa">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTE4LTEtMS0w_d45a2e2d-043d-4304-8312-ebed75b79888">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTItMS0xLTA_9bb2d4e2-de01-4e58-8ba7-4b2ef92d2f2e">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTYtMS0xLTA_7beada1e-9c4e-4df1-9894-be9aa072569c">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTE4LTEtMS0w_4e751125-ec4a-45bb-ae52-03c5376cc1de">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTItMS0xLTA_077df3e0-6611-4466-a1cd-24a4e16ddb26">214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTYtMS0xLTA_63f0973c-a3f2-4d17-a969-ed3af749639b">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTE4LTEtMS0w_0eba04db-cf67-4e4e-a373-99f8157418c0">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM0LTYtMS0xLTA_4f96a50b-1bf6-4105-92a2-6e65063f27d0">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM0LTE4LTEtMS0w_101dfd09-7069-4339-9852-3ba8020218d4">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTgtMS0xLTA_b1b4765d-1d3f-4b2a-a35c-59c83d03ddf0">96.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTE2LTEtMS0w_21cf7287-7673-4922-9fd0-a7b54cde4304">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTE4LTEtMS0w_118e0963-ac85-4d4e-8ee9-f424b0251441">94.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM2LTEwLTEtMS0w_8a38498f-2a28-4e43-9338-6218f3dcb276">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM2LTE4LTEtMS0w_79fe0d03-f7a7-4965-96a4-d1841b668062">30.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTEyLTEtMS0w_32b7d31e-4da6-4fa4-9104-348cf84fc606">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTE0LTEtMS0w_ab3ed640-4491-40ef-9f75-450d15a240ea">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTE4LTEtMS0w_cb4cc041-dff9-4d51-9d16-21f33acd9928">267.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Completion of Accelerated share repurchase agreement</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328" decimals="-5" name="us-gaap:AcceleratedShareRepurchaseProgramAdjustment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTYtMS0xLTA_feaccc73-a900-4db0-b603-b77a0f8ed00e">41.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i583f922944894f7ea2b4213a2907b398_D20191229-20200328" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTEyLTEtMS0w_e7439f4b-5a38-491f-a8be-2671e1948710">628</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i583f922944894f7ea2b4213a2907b398_D20191229-20200328" decimals="-3" sign="-" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTE0LTEtMS0w_db8b0c50-2558-48d3-ab81-5b010409ae01">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" format="ixt:zerodash" name="holx:Acceleratedsharerepurchaseagreement" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTE4LTEtMS0w_44113ba7-1e88-4ae3-b95d-07cbb32885ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM5LTE2LTEtMS0w_568bc439-864f-43ed-a1fb-d1173d8766d2">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM5LTE4LTEtMS0w_ec1f5f64-788b-42ab-9d37-a8cd8968feaf">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 28, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icef9871fe55a44bda919b0b0818f6106_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTItMS0xLTA_c019d6b3-c3b1-49a1-be00-26b9603ee569">294,142</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icef9871fe55a44bda919b0b0818f6106_I20200328" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTQtMS0xLTA_38c2b29a-22e8-4718-825f-e028cc2566e9">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc149ba496d4eb1af231a99ee58c7bc_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTYtMS0xLTA_94c91208-5cf7-49c3-8cb4-16bb8267ef51">5,827.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i911f42f14f9e440c9969b74a5fb822fc_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTgtMS0xLTA_5d8bb98f-fdf9-40c5-8faf-38a7218a673b">2,206.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a6f08dec5bc465b9ee6f174df007570_I20200328" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTEwLTEtMS0w_3720714b-0290-4408-aa24-30c048b9fb98">58.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb4183da93954dc88904c56ed86abb2e_I20200328" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTEyLTEtMS0w_4dc4f525-c126-4df9-96eb-15df868f397a">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idb4183da93954dc88904c56ed86abb2e_I20200328" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE0LTEtMS0w_45e2c93d-ec7e-43a8-a968-95a97106ee09">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200f25ce96994bbbae7026819adf7b94_I20200328" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE2LTEtMS0w_adcb52ee-3ffd-4763-8329-4db510b79859">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i200f25ce96994bbbae7026819adf7b94_I20200328" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE4LTEtMS0w_567438e2-3bd4-4deb-8d77-de1662f97763">2,091.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTItMS0xLTA_12e03361-f543-459f-a2b8-c6d65dbad530">533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTYtMS0xLTA_96ae0610-1b5f-4b27-a548-d332fc82c16b">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTE4LTEtMS0w_ec63bd90-fbea-4c6e-bc4c-d92431adcf1c">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:15.517%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.988%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.488%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.694%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.958%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.047%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTItMS0xLTA_cf39ab70-0bc0-41b2-9fd2-5e9069de856b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTYtMS0xLTA_a0e7ec46-3cf1-417e-a8e0-d73a2b3e49d0">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTE4LTEtMS0w_65ab4a52-12a3-43f4-830e-faa8f5db7b02">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ0LTYtMS0xLTA_82f23dee-73c1-4bb0-9004-7e1620d9e167">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ0LTE4LTEtMS0w_bfe92442-6b12-4451-b02b-6f813d685952">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTgtMS0xLTA_0fb8d547-6dc0-4d95-888e-69318871fee2">137.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTE2LTEtMS0w_06e19174-c0d6-4fab-9fb0-68721a9e33d0">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTE4LTEtMS0w_65672884-9b25-49c0-80cb-d88813f9b715">136.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ2LTEwLTEtMS0w_63ca91c6-8d14-4568-9630-cdbe3210ab59">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ2LTE4LTEtMS0w_1d81c99a-6b39-4a92-a0da-2fa9d2098b12">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ5LTE2LTEtMS0w_5a8c966d-2550-4b02-86a6-6f83ac776fe2">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ5LTE4LTEtMS0w_6958bd32-279d-4291-a370-3f5ba810f907">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 27, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibed5a407b01e495f8fcec834d617c870_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTItMS0xLTA_4ab7a4a0-77bd-4c76-ae41-00c416d4c6f2">294,684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibed5a407b01e495f8fcec834d617c870_I20200627" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTQtMS0xLTA_5603d0ed-aa89-417f-88e2-2ad0cdc5456a">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iec58a1e4925447509af22498f07e082c_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTYtMS0xLTA_0d940965-44a6-4292-918a-d48e083468fd">5,861.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie71ae6f99b084b4daf51a7a375e79bf6_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTgtMS0xLTA_de411723-8fed-4352-bac0-a09aefc00476">2,068.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9581555522f04a0aae88d04d16ac8561_I20200627" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTEwLTEtMS0w_5f90d58a-f2ea-4a43-bfd1-bd403bfb4767">61.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic37dc7d6b73747eb8118aecf497797af_I20200627" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTEyLTEtMS0w_140a8fb1-51ae-44a6-a02b-707c18654b2a">35,941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic37dc7d6b73747eb8118aecf497797af_I20200627" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE0LTEtMS0w_6c3f4b08-7bd9-4001-8a20-1dd0961453b4">1,479.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac726be9de04754acfb0c3ad2bbe977_I20200627" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE2LTEtMS0w_e9178f14-25e9-41d6-bb09-65ef2b31f154">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ac726be9de04754acfb0c3ad2bbe977_I20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE4LTEtMS0w_7e2949df-7442-4f87-bb11-6687c64f07c1">2,258.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTItMS0xLTg3NDU_13db1557-c183-4589-a7c7-1f783447bd4d">185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTYtMS0xLTg4MDE_973077aa-eec1-4dab-bc6e-8222e4177958">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTE4LTEtMS04ODIx_456e365e-c912-4ff1-a3b1-65199f123292">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTItMS0xLTg3OTk_ee4fbee5-17ec-4229-9610-0b1383779737">40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTYtMS0xLTg4MDM_1e9f119c-2a70-46c3-aebe-6ad931d6b2a5">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTE4LTEtMS04ODIz_6b14b5bd-5b1e-4efe-9c89-6642e6add5b1">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTItMS0xLTg4MDQ_fda04b5d-ea9a-490a-9cce-91b9dcecc871">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTYtMS0xLTg4MDY_653fdd72-e275-4aa9-9ab8-7a15322c0693">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTE4LTEtMS04ODI0_d340bda7-f392-43ee-a7cd-06b2451f8161">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU0LTYtMS0xLTg4MDk_4645afd8-e4bb-49fb-99a2-c3a143243bf6">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU0LTE4LTEtMS04ODI3_62223bdb-07e4-4dce-9af6-30eaf4175d0e">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTgtMS0xLTg4MTE_0b75b6e3-0eeb-4cc8-941b-46b6a86977e3">494.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTE2LTEtMS04ODE5_feabbeb3-9004-4d8f-b3c1-c43d6edcbdc5">1.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTE4LTEtMS04ODI5_68751e3b-ba91-4b55-aaba-0765f58d7188">493.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU2LTEwLTEtMS04ODEz_6035516f-ba62-4c0f-b8d5-064c7e40dfb1">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU2LTE4LTEtMS04ODMx_5244db63-0470-403b-a2ba-c5e192f22aa2">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTEyLTEtMS04ODE1_598eec2e-ea7b-4221-acfe-4d28fc8bd047">1,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTE0LTEtMS04ODE3_6c305809-fba3-4117-989c-97c58ae5295f">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTE4LTEtMS04ODMz_049d82d2-64c8-4f31-825e-509f94a3380f">100.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 26, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i127f35bc4ced488ea526b5c9709d9c78_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTItMS0xLTg2MzQ_64aa1728-e1f0-4e18-899a-1f1efda830b4">295,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i127f35bc4ced488ea526b5c9709d9c78_I20200926" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTQtMS0xLTg2NDU_b4d9ae77-fff2-42b8-8a1a-beafae2a9bd2">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46f22b455cca46d8bf57b116a211d7e8_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTYtMS0xLTg2NDc_25681b62-953d-4c47-b068-ec67d144e0e4">5,904.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if0dbddd90f43449eb71f6e58600e75ca_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTgtMS0xLTg2NDk_131c428e-427b-4a91-95d7-b26ba521a96b">1,573.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a34844d9d004ca59421077b20e85919_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTEwLTEtMS04NjUx_f0c39ee1-e0a3-45ff-836d-90c45c481f33">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8419f493c4f4d939c6a710aeda8796e_I20200926" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTEyLTEtMS04NjUz_bb4069f4-696a-42f3-9916-af490e111e25">37,609</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8419f493c4f4d939c6a710aeda8796e_I20200926" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE0LTEtMS04NjU1_106b1ee3-e0b1-4950-94ec-c174de7b942d">1,579.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE2LTEtMS04NjU3_46477e83-e591-43fc-8e72-decc868fc3f6">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE4LTEtMS04NjU5_b6c63530-af62-4874-ac2d-5e8f30618abb">2,707.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTItMS0xLTg2NjE_d69a4b92-719f-4d5c-9ef1-b5e2e3c23743">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTYtMS0xLTUyNDY_3e141f5a-dfd6-4bc4-8c38-77d245251170">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTE4LTEtMS01NjYy_d7612e60-3715-43e6-bdf9-1ef6a963bb5a">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net of shares withheld for employee taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTItMS0xLTg3MTI_03a21b47-7938-4d90-b3d5-7394f1d8b5f3">936</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="5" name="holx:ChangeInParValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTQtMS0xLTg3MTg_5abc12ea-ace8-48e7-85c4-918dab764522">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTYtMS0xLTU1ODI_11456e48-7106-45ae-8c71-bc8ff3a8da70">46.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTE4LTEtMS01NTg2_5921beb6-daa7-4cfa-8025-5ea23c683896">46.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYyLTYtMS0xLTg3MjA_ce2d12e8-b653-4ac6-aebc-abbd6eddec6e">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYyLTE4LTEtMS04NzM3_461cc2e4-a8b7-4f53-852c-ee5538df78e5">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTgtMS0xLTU2MDI_ec8a60a8-6399-4de2-a8c3-06c55da65020"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTgtMS0xLTU2MDI_edec55f2-50ca-47ee-9339-1abb48f3031b">654.4</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTE2LTEtMS04NzMx_749080c7-7ee8-4b35-bf8a-dff151d699bb">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTE4LTEtMS04NzM5_2a3b6add-ebc5-4c15-bfb9-e8f92a840a68">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY0LTEwLTEtMS04NzI0_3683281b-67f3-4632-b4d6-ec96bf7beb61">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY0LTE4LTEtMS04NzQx_790e219e-fd0b-43d9-87e4-2f46d266898a">19.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockSharesAcquired" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTEyLTEtMS04NzI3_95cfc900-079f-42ce-923e-fa31c332e237">1,469</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTE0LTEtMS01NjEx_514d343f-9582-4327-9477-aa532c03e809">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTE4LTEtMS04NzQz_2d63540a-2475-4de4-8f10-d07119f30812">101.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84b132b519504c978ab69d88a3c921da_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTItMS0xLTg2MTY_8fd59634-3758-4ded-8077-c5c952018e97">296,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84b132b519504c978ab69d88a3c921da_I20201226" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTQtMS0xLTg2MTg_301b95e9-5f1b-452b-911f-f53bb6aa964d">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda9918b12184a469461c064a31cda9e_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTYtMS0xLTg2MjA_946a8cb8-a6e5-4ac2-9e72-ebd366abecab">5,895.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i61d28c68b4b044baa488a63597e4ba87_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTgtMS0xLTU2MTY_b701ac3f-8977-4400-afd4-82e38af1d71e">918.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice8e1c44566e46d7a9428b4c849cf075_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTEwLTEtMS04NjI0_46116d24-73bf-42e9-8d35-e9cbe0ba6a85">30.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0a1a2f2804d047f9be18b7470292b8f2_I20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTEyLTEtMS04NjI2_618363e2-4ebc-4ae4-8850-7fc3f09ab0fc">39,078</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0a1a2f2804d047f9be18b7470292b8f2_I20201226" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE0LTEtMS04NjI4_451f8bf6-32aa-4bf8-b788-19ed0c3655a4">1,680.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE2LTEtMS04NjMw_840bba71-186a-4d22-8888-596208c8dbd4">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE4LTEtMS01NjE0_532deb33-7bba-424b-a305-9179ba6cbadb">3,269.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMy0xLTEtMS0w_0f3698d1-e96f-48d6-b536-9e978cccd135">653.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMy0zLTEtMS0w_d3dd8e81-dc8c-4afc-b14a-6de328f45d17">385.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNS0xLTEtMS0w_15b22d57-f280-45f6-b18c-40be1f7668b4">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNS0zLTEtMS0w_0c63cf53-b92a-426e-90d6-ec55b277659f">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangibles</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNi0xLTEtMS0w_3710e6b9-45d6-4365-8469-090037fb35c0">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNi0zLTEtMS0w_900f538e-be60-43b8-ad7a-7a2537eb9727">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOC0xLTEtMS0w_875e3209-0ec6-4d73-8630-2f6afe104ee3">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOC0zLTEtMS0w_cae4e16e-5435-4751-bc41-fa7460e895d1">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOS0xLTEtMS0w_b081c851-1c40-46da-a5e3-21f5c62dbc22">12.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOS0zLTEtMS0w_73593780-bb74-465b-80b7-1b9ca1da414f">327.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Intangible asset and equipment impairment charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTEtMS0xLTEtMA_56ff8cb7-993d-459c-9d60-667ae3ac92b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTEtMy0xLTEtMA_42f93b23-6c1e-437d-b72f-9b2aca814bb1">30.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTMtMS0xLTEtMA_1d89c7c0-165a-4b9c-95aa-70c67f745e01">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="5" format="ixt:zerodash" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTMtMy0xLTEtMA_04909c86-1ecb-4450-85c9-45b8abb6002b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjAtMS0xLTEtMA_db0885b1-6a74-479c-bc83-2d06fd25bb58">29.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjAtMy0xLTEtMA_f732e783-425d-4eba-bb8b-1f5d2f2afcef">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjItMS0xLTEtMA_44647c24-dcc2-433a-b9e1-4d1080b6748b">175.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjItMy0xLTEtMA_0187f342-e5eb-46f4-bb79-ed3d6d91be10">17.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjMtMS0xLTEtMA_a96b309b-c7e5-473e-b472-7b2796995a02">21.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjMtMy0xLTEtMA_30d30f4b-842c-401d-a768-155ccc5202d7">14.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjQtMS0xLTEtMA_33534645-b84a-470d-83a6-1d80acd2c0d0">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjQtMy0xLTEtMA_0043eb78-f02c-4ca7-abb3-d395e5e3f618">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjUtMS0xLTEtMA_8d1d4799-3aba-4ef8-bb1b-4cbc022b27ac">18.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjUtMy0xLTEtMA_beb89d8b-4dc4-4f25-b3ac-544a615f29fe">2.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjYtMS0xLTEtMA_dbff52c4-bb88-4c66-87b2-19f604f2fe80">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjYtMy0xLTEtMA_b0efff65-393a-4b97-8f5e-a1f5aa2de1c9">55.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjctMS0xLTEtMA_55f13e41-b300-42ec-9afe-e7bd0c80281a">58.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjctMy0xLTEtMA_c36ba017-3d79-4d22-8b33-ab71641fdf27">22.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjgtMS0xLTEtMA_66fcf201-c083-452d-8aed-0a224d3c36fb">10.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjgtMy0xLTEtMA_d52e4d74-158f-48af-9cef-798305f42a2a">10.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjktMS0xLTEtMA_35f669d6-1451-4d4c-9ee1-f03ce01d7cf6">650.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjktMy0xLTEtMA_208051fb-9741-4f5c-9d36-a86d34ada089">113.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzEtMS0xLTEtMA_83c22fa2-e25a-4c41-b1ad-97b5b8bc248e">4.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzEtMy0xLTEtMA_85816510-02fc-45de-9755-322e74bbee6a">11.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzQtMS0xLTEtMA_33a74764-3034-4329-ac2a-43b9ac9a431b">32.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzQtMy0xLTEtMA_295dad43-54f7-42d6-98a9-bc226e733506">11.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzUtMS0xLTEtMA_72938f8e-9136-4280-b0c0-31a164c256b2">12.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzUtMy0xLTEtMA_46710460-e158-431e-a4df-9394fa1075dd">20.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of insurance contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDEtMS0xLTEtMA_1f258533-362b-4560-8bf0-3f9b51505ac4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDEtMy0xLTEtMA_58185696-4d98-40a5-a214-ffa4dc245993">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDUtMS0xLTEtMA_b2750ce0-fbd9-4425-951f-c5a67a217e8e">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDUtMy0xLTEtMA_445292a6-b1f0-4e60-a151-df80a982f188">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDYtMS0xLTEtMA_de9889c4-7dda-4d3e-bf48-5f975f03cb9a">49.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDYtMy0xLTEtMA_8d90225b-b7b2-4817-bea9-b5b307364332">45.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDktMS0xLTEtMA_845aa2c6-d551-4b6f-8ec7-a2a3aa791dd9">18.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDktMy0xLTEtMA_59c19e99-7c3e-4874-ad6d-4c4240633f1c">9.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from senior notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="5" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTAtMS0xLTEtMA_7cd36ee1-a0a4-4ec2-8b21-7d82126727ad">950.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="5" format="ixt:zerodash" name="holx:ProceedsFromSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTAtMy0xLTEtMA_05c03b38-46cf-4bbe-b3e7-38ab446af5d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of senior notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="5" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTEtMS0xLTEtMA_32a04b89-8ac0-4a2c-8759-9183ccb9d53e">970.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="5" format="ixt:zerodash" name="holx:RepaymentOfSeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTEtMy0xLTEtMA_159f8459-dcc9-4073-9464-a27086883660">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment under revolving credit line</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTQtMS0xLTEtMA_f3799b71-cf62-48ef-bce3-bf193af9bc32">250.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:RepaymentsOfLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTQtMy0xLTEtMA_77dc2131-2e20-4cf9-86a1-7617ed112ed6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from accounts receivable securitization agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTUtMS0xLTEtMA_00429a73-65ff-44dd-abef-85c423f7d4da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTUtMy0xLTEtMA_d5a4ec62-8fcd-4e1f-9ead-a44b6934a6f3">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTctMS0xLTEtMA_08a0c7a3-afaf-4af0-8516-a2f79b402708">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToMinorityShareholders" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTctMy0xLTEtMA_221a99c8-d63f-40f1-b038-a9b0bf9fe7cf">1.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTgtMS0xLTEtMA_d650ad8b-f16c-478b-9ea5-2004f3f1a0e3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTgtMy0xLTEtMA_09a908ba-b987-4fb5-b5a8-6e3acce883c1">16.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of debt issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjAtMS0xLTEtMA_1f10b28c-d483-49a1-832f-636a640b5c1b">13.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsOfDebtIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjAtMy0xLTEtMA_371f96f0-52ed-4e2a-a5f3-d6dcae11aa72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjMtMS0xLTEtMA_c7c18e01-3541-4bae-8f79-0593b6045646">101.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjMtMy0xLTEtMA_37663bbb-40b9-47f8-9260-e24249d3c81b">285.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjUtMS0xLTEtMA_2995e906-c8b4-457e-9c2c-439336ed55ac">23.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjUtMy0xLTEtMA_48c3272a-b837-4eaa-bd4d-28cad63604a8">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjYtMS0xLTEtMA_efa51d63-1a05-4120-9a93-8d113bbe1bfe">46.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjYtMy0xLTEtMA_517ab22c-7a1b-49ca-8607-f4f654535043">10.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjctMS0xLTEtMA_2a50aef8-ec36-434d-814a-d0f64812bdf1">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:RepaymentsOfLongTermCapitalLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjctMy0xLTEtMA_5e67db5a-757f-4130-832a-cd60b93cb8d8">0.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjgtMS0xLTEtMA_a883246d-8518-4fab-a0e9-83c335e21374">428.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjgtMy0xLTEtMA_56c64b0e-c8c0-45f0-be33-41d3097e9de8">289.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjktMS0xLTEtMA_8a989e06-6eb8-4725-84ef-0f74623ef9b5">4.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjktMy0xLTEtMA_4bbe2fb8-ecf2-4ca0-8fee-bb65bd25d775">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase (decrease) in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzAtMS0xLTEtMA_b9410b92-08dc-4fe3-9881-68dc3ca9efbe">167.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzAtMy0xLTEtMA_97f95c2d-4baa-4f83-99a0-cb22e1d14aa4">220.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzEtMS0xLTEtMA_3b06647d-fdf1-4039-8705-c1e368f22d22">701.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzEtMy0xLTEtMA_c5c7c699-aada-484b-a518-c28f7c6d03d0">601.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzItMS0xLTEtMA_3f4eaed8-3d7b-4c43-be5f-bc889d8fcb96">868.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzItMy0xLTEtMA_b038b904-34e3-4d0b-a9e7-b5ac26a8d937">381.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div id="if042a09e5eee431a93fd100ba54df8e9_34"></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(1) <ix:nonNumeric contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTI2NzU_447f4519-ca5d-4652-80bb-f5429191fe6b" continuedAt="i96fb0cc8e86244a38490fc1b69dc0bac" escape="true">Basis of Presentation</ix:nonNumeric></span></div><ix:continuation id="i96fb0cc8e86244a38490fc1b69dc0bac"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;26, 2020 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;26, 2020. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were two unrecognized subsequent events related to the acquisitions of Somatex Medical Technologies GmbH ("Somatex") and Biotheranostics, Inc. ("Biotheranostics"). On December 30, 2020, the Company completed the acquisition of Somatex for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ie2315ca24bb44334b2ede0aa904f5731_D20201230-20201230" decimals="5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTA5OTUxMTY3NDQyNA_8f6f225e-ca4b-4b22-a001-30d2c82230c9">64.0</ix:nonFraction>&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. On January 5, 2021, the Company announced that it had entered into an agreement to acquire Biotheranostics for a purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ibaf5f2d2692346a88d7ae57bf6270cdc_D20210105-20210105" decimals="5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTA5OTUxMTY3NDQzOQ_40b014b1-ebd2-43a2-af75-391b92edf541">230.0</ix:nonFraction>&#160;million. The closing is subject to certain regulatory approvals. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) Revenue</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC Update No. 2014-09, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation training and repairs. Prior to the Cynosure divestiture, the Company also generated revenue from the sale and service of medical aesthetic treatment systems. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNzY3NQ_56ca50e2-d09e-4035-b7a3-777287bf845a" continuedAt="id4890c0d7909495bac9c76b25eca5149" escape="true">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><ix:continuation id="id4890c0d7909495bac9c76b25eca5149" continuedAt="i8b2a4d6eed754677a186a5a2275f92ad"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:3.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.680%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd718ddd1ed144e29f41973ee9eb875b_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy0yLTEtMS0w_d340451d-92ee-48c3-a097-4f9192aab382">80.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i807f1967ca0747168870227cdb5de282_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy0zLTEtMS0w_f7163d40-293c-4712-a23c-94fbc3a7f832">44.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i814e82d01f554e07a70d51c7e0f6789c_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy00LTEtMS0w_098d4abd-2395-47ee-b496-4580a15f75da">124.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24231c45c0e04b0cb463e368a4fa9819_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC0yLTEtMS0w_9ff5f207-ae41-45c8-8d86-972782f156c0">675.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac260c17aab74a5aaad08d3c2e71c09f_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC0zLTEtMS0w_a36a8278-9306-4d5f-8442-f87509bc3e47">320.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85fe1c3197bf4160bde67b0e7b88e57e_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC00LTEtMS0w_52fceef7-9cce-4160-92e9-4d54570975cb">995.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic11fbed77bea48e18a66f44359be8369_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS0yLTEtMS0w_cf54d98e-30f8-46f7-9187-19867ecab3b6">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb91856dc5f14d6e88d769b12a3553fc_D20200927-20201226" decimals="-6" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS0zLTEtMS0w_b7d084bf-795d-41ce-a9f5-932deed28280">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ca33f8b7647484d95b3e8825c8d1ae6_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS00LTEtMS0w_c8bd146c-491f-4f06-8b20-158ff74c3469">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida008df7022c4ec1b8fcdee5e84f1012_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi0yLTEtMS0w_440edaa6-0217-4985-912f-40275c908b56">763.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d1862a2813f492184d07742064e2a0d_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi0zLTEtMS0w_e8660ec7-17c6-4d68-898b-27753c9b383f">364.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi00LTEtMS0w_54fa7b9e-3b91-4012-850d-c94da89cca95">1,128.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bfc0e0103f9487b965e824c2254203b_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS0yLTEtMS0w_e5e9bb0a-5ab4-484f-b920-da4cfae9de63">203.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16374eee78494c719746d8b40c160941_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS0zLTEtMS0w_31437852-9846-44ac-b0b8-0edd544defab">64.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i20f4faff9e164fa29b72dc862bb814c1_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS00LTEtMS0w_f9a474b4-4048-4279-881d-0cf1e3c391f4">267.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f918efa3d83476c9578e01f5704ea75_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtMi0xLTEtMA_396da2d6-258c-42de-a026-b3d7327dda12">55.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i047e6064c2d441448b721d1506b755fa_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtMy0xLTEtMA_a8c2d478-ec72-4d33-87ec-91f2eb70afcf">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c48afb9a6cf4b619f1170a44995048b_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtNC0xLTEtMA_a13857ae-723e-44ad-be07-4eafe3ee182c">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3384fe463ec48f08c6f59ad68669d65_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItMi0xLTEtMA_85cd792e-9fcc-4276-a33a-5aee7e7ca084">258.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f45f0b5e32942a5ba004547e2f18c70_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItMy0xLTEtMA_c1e7261a-b060-40de-95d0-ca3883e861d5">74.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItNC0xLTEtMA_e6119e24-2bdc-49f8-bc05-901994e30892">332.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if63bac3956a34caaaf11ca4c0d481b3f_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtMi0xLTEtMA_bba0f685-cec1-4390-844a-d807f95db1cc">101.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba06aba7b8a3482991a27db74984c2d2_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtMy0xLTEtMA_c9725f94-5d7e-4e75-9dec-e8f921f0b73f">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtNC0xLTEtMA_be4c3e7f-6f60-4456-bf9c-630e1a270037">124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7744b72714974633840d43bd8f1c52aa_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtMi0xLTEtMA_d37feaaa-590f-4b4e-bb9e-76d9caaf259c">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifff05d29091f488093318a5c86a39998_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtMy0xLTEtMA_272834cf-a3c1-4e8c-bde7-423980117bda">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtNC0xLTEtMA_d1848ecd-3c88-4c72-ba02-2fb9b65e1b2e">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktMi0xLTEtMA_25bb1d24-6498-42bc-81f9-d51a8d6b67d8">1,137.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804f2e6f9b9c4c2dac795221463c7352_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktMy0xLTEtMA_2ad52b35-5cc8-4c87-b12d-a1e5a00c3803">472.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktNC0xLTEtMA_33f6bf3b-22fe-4ae3-bf9b-4f66aaafac41">1,609.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:3.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.270%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.680%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i494de1667d6141d3a77fb81e098872d7_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy02LTEtMS0w_21683a05-8d25-45bc-b4c3-7b45565a3c09">77.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i41fef6d46bcb4458936812aadb6a6eeb_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy03LTEtMS0w_fd2c3117-85da-4719-994e-5327ab601e67">43.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4e261e946c44e3289c0ec9dd139dd3e_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy04LTEtMS0w_60e75427-25b5-4830-bd9d-f669495400e6">121.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53d2f9966d234c8f86709bf1c24480d9_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC02LTEtMS0w_cad8fbfd-5c76-4cfc-a38d-c58d17a759c3">142.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i425431777b7d4b3083ab8649a18e6394_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC03LTEtMS0w_49b47e9b-b146-485d-bbab-f2f32f11a592">36.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff1719f8bdb243f58136808bb4f920b6_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC04LTEtMS0w_3d5aa852-e3a9-4f86-8297-70c3a9597f8b">178.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d6138445fc34f7b849cf1c4c1bd7b4c_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS02LTEtMS0w_1fcc14fd-b7d7-4730-b4b9-e0ddaf67bc86">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc90a64df06e44afad34c0fdb3d6acb0_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS03LTEtMS0w_16766a7c-2e60-4b60-a85b-3dcdc1a47d7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c1a753fd84741ea99c093f47887c09b_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS04LTEtMS0w_c23bc5e4-30bb-4b24-9eba-c261cd9b77cb">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f39f8c1a58d4c0092f3c0f4a7e1145a_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi02LTEtMS0w_10a500fa-a236-4ddf-8c58-efa3243c2a57">231.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c80ddb3233741de8cb85ebe53044117_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi03LTEtMS0w_d7ada27d-1a02-4c61-a39d-48450f8c9173">79.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi04LTEtMS0w_ce71ccce-0201-43b1-9ae1-dfcef5d9c937">311.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08a1df1d86db4e5f98a13155567d6600_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS02LTEtMS0w_bd3936b2-81e9-4e8f-9bc9-74359f9b7892">209.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a2a3bf74b34478e8fac81531d70102e_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS03LTEtMS0w_2a53ba76-9140-4c5f-8eef-e6a4c77f5676">65.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0420bc7b903745a99eef56fe2d387c5d_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS04LTEtMS0w_b1034015-0560-4729-b9bf-321d4ef36f06">274.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a381e87df3e4fd3881d975e6bf59018_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtNi0xLTEtMA_4ef1b977-9e46-4e5c-a225-5bb42c63da9d">47.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia848377d0119418c93ec23909f54ef88_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtNy0xLTEtMA_8cebcf85-253a-4440-beef-ef204c691103">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ed96c1bacd44799bde67d4474a21301_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtOC0xLTEtMA_b8c88253-cf08-4b36-88a5-0e49bcc7dbfa">56.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08a1b32655d141b3827b070cb7dd8394_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItNi0xLTEtMA_71e150f0-fceb-4770-9b77-7ebb6b597273">256.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ddb21f8026b4973b5e9cf9a186551ac_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItNy0xLTEtMA_1960b583-35a4-4e18-8b0b-62f6b4c84224">74.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItOC0xLTEtMA_e4084096-609a-422b-bcaa-892c222b9c0e">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f0f69550624497996276135c6bd77d_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtNi0xLTEtMA_cbb60453-103d-4cf4-be5f-ae33dc869dc9">98.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i171c9ca031bf4884816e7be4190b9db2_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtNy0xLTEtMA_1da0e6ff-c1e5-4598-a2c4-8d5e7c67068d">20.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtOC0xLTEtMA_92b28849-5605-4441-bd53-cbe7f399d1e5">119.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86f98ab577e348f08c18b5ec1aa4c24f_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtNi0xLTEtMA_13f678a1-9404-42c8-b9c8-329c8e043779">30.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b9fa71bf4f54f2cb7e265c235983118_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtNy0xLTEtMA_2b98b674-a5c9-4eab-938b-b6e2426f937b">34.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtOC0xLTEtMA_e3f08cb8-4ab9-4810-a346-17ad43c9e00d">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9edfd07f43ea4110a087242c57d62661_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtNi0xLTEtMA_f7e7eac8-490d-417a-8eec-6a7e2a4c2dce">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5896165fc6444c69a28f30d7622aab83_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtNy0xLTEtMA_f0e6af2a-e4b3-4af4-9e24-3c752ee18f6f">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtOC0xLTEtMA_7534ea16-6b05-4cb9-8bee-414f38d82f74">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktNi0xLTEtMA_6b5c04ec-5b43-41b7-85b7-3f7c8b3e2955">632.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf72943e74d14e5fbecf4403525ffeeb_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktNy0xLTEtMA_f5e76fcf-3bd7-4c7c-a47f-e4f1fe6f3c9f">217.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktOC0xLTEtMA_cb7edd32-c188-433c-8583-3d4eacd40ade">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div><span><br/></span></div><ix:continuation id="i8b2a4d6eed754677a186a5a2275f92ad"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:60.790%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.956%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 29, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMi0yLTEtMS0w_9933a4f4-5440-4f97-9b9f-03a52da147ab">1,137.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMi0zLTEtMS0w_1840795c-1079-4adb-adf3-c7cc77fec199">632.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMy0yLTEtMS0w_a666c13e-e468-4c31-b2db-e20ca2cea322">338.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMy0zLTEtMS0w_c0cc2516-bf2f-488c-856f-574a380320bd">109.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNC0yLTEtMS0w_16d28b2f-df8e-495f-9d7e-baee627b5333">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNC0zLTEtMS0w_218bd918-55c9-4dfc-b288-e0a2b5937ba8">70.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i894813c090864a3cb88eb86237b77caa_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNS0yLTEtMS0w_599d6513-536d-4c44-89e6-7c2156cdb8da">45.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64740b81a53c45249c05c34df962be4a_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNS0zLTEtMS0w_34e11561-3cb5-4355-bd9f-def5e8f0dd08">38.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNi0yLTEtMS0w_de421beb-903f-4f89-83a4-b958498d7d07">1,609.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNi0zLTEtMS0w_cb805dc6-6799-4cc9-af72-42ce28290bc2">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:60.790%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.956%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9475dc3a7d5487fbeab85f649c54044_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0yLTEtMS02MjA1_c7af6b16-8c66-42a7-bf99-b89ecb4b32d8">1,263.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f217ab69c114d40a9a225677bf15b33_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0zLTEtMS02MjA1_88865193-a003-476f-bc03-8da7720291e9">466.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i315641707d4c4fc39c5611d79f93f696_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0yLTEtMS0w_09fe7ee5-ffa0-4a9e-a3cc-94b095b63b43">192.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0ba3144ce98484facbd98ad7ffb47dc_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0zLTEtMS0w_bb01863d-ea20-449c-bdb2-3b33e3244982">232.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67601f23ac8f42259e8935b9dc100943_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNC0yLTEtMS0w_e60139c3-6d1a-49ea-a5d0-e3f3abf2b2f9">137.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia48592e41d84415895cece1a0979daaf_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNC0zLTEtMS0w_ef174dc6-547d-4047-a5ca-70750dc5182e">145.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58584d59f7ca4ce8914046729ee0446b_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNS0yLTEtMS0w_3257196c-8feb-4d49-b0fc-e518dca179fd">17.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2617de2ef6504c69af6d86624c6c1ae3_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNS0zLTEtMS0w_4c0f2b7a-8c4f-44c9-8729-37aa3042da24">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNi0yLTEtMS0w_4fe6e9f8-b989-44f5-8a1b-478a1089d391">1,609.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNi0zLTEtMS0w_2b71e1a7-f5cd-45b8-b874-6cfd63d3fd99">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer, and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefit of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over three to twelve month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's contracts typically do not provide the right to return product. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 26, 2020, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueRemainingPerformanceObligation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNTg1Mw_c0baa3b0-e705-4d1a-9379-8b7ee9ee03ed">702.0</ix:nonFraction> million. These remaining performance obligations primarily relates to extended warranty and support and maintenance obligations in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="ife84c0d8763b4705a470b753572dd9ad_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjA5Mw_530cc710-096a-4229-98a9-d5c6f596e6d4">31</ix:nonFraction>% of this amount as revenue in 2021, <ix:nonFraction unitRef="number" contextRef="i08052409a9da48bd9c3023256acbffbf_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjEzMQ_6e3d6e35-eec3-48e2-8489-211569efd6eb">30</ix:nonFraction>% in 2022, <ix:nonFraction unitRef="number" contextRef="icf1c53d799a94ec78b381605622bd13b_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE0Mw_fcb707db-095e-40c5-86d3-5c9eba1c6896">21</ix:nonFraction>% in 2023, <ix:nonFraction unitRef="number" contextRef="i605077a5590146648b817b54f0efeec3_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE1NQ_8b7b0b30-a12a-420d-a277-7b9e369ca0e9">12</ix:nonFraction>% in 2024, and <ix:nonFraction unitRef="number" contextRef="i562f34e6727740619a5a1d16c97a58b4_I20201226" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE3MQ_8835d53b-4d94-41bd-aee0-c752ed0f206a">6</ix:nonFraction>% thereafter. The Company has applied the practical expedient to not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments and, until December 30, 2019, the divested Medical Aesthetics segment. Contract liabilities are classified as other current liabilities and other long-term liabilities on the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNzUzOA_c62040dd-8b31-409e-bfff-be32843b2b95">50.7</ix:nonFraction>&#160;million in the three months ended December 26, 2020 that was included in the contract liability balance at September 26, 2020. </span></div><div style="text-align:justify"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDM5ODA0NjUyNTE1Mw_867d9eeb-cd32-4c56-9f41-50d094415409" continuedAt="i932d57c168164eb5b328807834a3ba0f" escape="true"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDM5ODA0NjUyNTE1Mw_9679e1f1-8ce8-4486-9a5e-4c0bad4c15e0" continuedAt="if8f126f073fe4f09aee46c854247f2ef" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i932d57c168164eb5b328807834a3ba0f" continuedAt="i6f067884c0914502ab7451a0c8194831"><ix:continuation id="if8f126f073fe4f09aee46c854247f2ef" continuedAt="ie94b335318d046ff829609e20ec4da4c">Lessor Activity - Leases where Hologic is the Lessor</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6f067884c0914502ab7451a0c8194831"><ix:continuation id="ie94b335318d046ff829609e20ec4da4c">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are immaterial. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately <ix:nonFraction unitRef="number" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDMzMg_90ad58ab-cd53-462b-aebc-c1ab4f2f42e9">2</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="2" format="ixt:numdotdecimal" name="holx:LeaseRevenuePercentageOfTotalRevenue" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfMjE5OTAyMzI2ODQ5MA_d590cccd-ba8d-409f-af32-e497f273c495">3</ix:nonFraction>% of the Company&#8217;s consolidated revenue for the three months ended December&#160;26, 2020 and December 28, 2019, respectively.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_46"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(4) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzY1Mg_314dd62b-4770-4a21-852d-ff1879e5ad08" continuedAt="i4f268b8042734fc69cb541eea9db231f" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i4f268b8042734fc69cb541eea9db231f" continuedAt="ic015779419244187a25d62fa1a2f181f"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of interest rate caps, an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="ic015779419244187a25d62fa1a2f181f" continuedAt="idc47ad95fbea427fa38e31cfbfdac90c"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzY0Nw_31f8e382-63b5-48ba-8c14-2067d62bdbc3" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;26, 2020:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"></td><td style="width:37.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.130%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.569%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.288%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b4b851aac0a434c82c8b786b613a366_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS0xLTEtMS0w_65476946-3f67-46ae-9067-0b7c6656e8df">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda9057d843a4b73905a0ed943432150_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS0zLTEtMS0w_6a191dee-5ab0-4e04-9d72-04f97af3667c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba6af4bb67bc4b93b0ef89a2863329bd_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS01LTEtMS0w_b1ebe5ee-508e-4813-b3e4-bcf0a6457401">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3824626237124ce9828ecc11f78786df_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS03LTEtMS0w_7907f602-af74-4c2b-bf28-4c2ed59edf7f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy0xLTEtMS0w_a28f80cd-2c2f-4936-ae25-6b1dce92aa99">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy0zLTEtMS0w_4d656dac-c804-49df-92d7-073d974b82ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy01LTEtMS0w_ee2b647b-2233-4bb2-b6df-2d337c8692c9">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126237eb247a4867bac37c6b2dea5699_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy03LTEtMS0w_007968d5-dc9c-4c29-a2bc-80782ca331c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia393550942904ed09c042467d0645c37_I20201226" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS0xLTEtMS0w_756d2f4a-c0a3-45a4-a900-a63d5c2b4fd1">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i589619851f164523acf1587d711fff2a_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS0zLTEtMS0w_5ec0b369-1e09-443e-be5f-00f37fa88b8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50fa172708d24893990ba4c50d5437c5_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS01LTEtMS0w_4c68f044-b753-46da-88a0-4ee63675b54b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7323967dedcd49868eb4e102fb8b387e_I20201226" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS03LTEtMS0w_7377d96d-ad39-4dcd-8bf8-59819cb42920">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idb7efed954b8455690ac3b12d64dcb4c_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtMS0xLTEtMA_c95d868d-d2f6-4eac-9d45-4f8557fe1739">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8c4bd4abad44e83aab53cec2dfaade1_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtMy0xLTEtMA_babfc4cf-c4ca-46c9-ae23-773015c42698">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9712b4b8dc64000b015bfd132cfda2c_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtNS0xLTEtMA_8d804ea6-97bc-47e5-a0f5-3d4f10aa5c66">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69ec054955924207982fbd54d8a1cca2_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtNy0xLTEtMA_36f53625-8e83-426b-aa66-8e6f679e4b43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bbcb67f917c48b39cc8cdf5e74c1d42_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtMS0xLTEtMA_2b35803a-34c8-423b-83cf-575c49a1a93f">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i876dd7ede38d4edbae53824dea405212_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtMy0xLTEtMA_18a25925-cb8c-43b1-bffa-ce7fe8cf471f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a5fd7116579406fb4ab4e0c108de263_I20201226" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtNS0xLTEtMA_0d9e3ec3-3783-4fcd-ae86-62c5b99f8a5d">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i788bcb698408495ba16be99c3274b08c_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtNy0xLTEtMA_cc1bd17d-f862-4a6c-a61a-515681aff5df">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItMS0xLTEtMA_a1010c84-fd03-4548-afb3-691aa6674aef">123.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItMy0xLTEtMA_a22c53da-42ab-49dc-a7cd-4cad0847d27c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItNS0xLTEtMA_6f6f8ac6-a9c6-4388-9cbb-68656f36f706">36.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i126237eb247a4867bac37c6b2dea5699_I20201226" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItNy0xLTEtMA_fbe8106c-6910-4fdb-a4f7-3222b27a4a55">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 26, 2020 and December 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.795%"><tr><td style="width:1.0%"></td><td style="width:7.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:52.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.520%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.523%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMi0yLTEtMS05MDQ5_be865474-3574-4228-98ba-9b117d77fa88">81.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMi00LTEtMS05MDQ5_fb9736a2-eb5d-44c0-9a68-82c5aa11246d">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMy0yLTEtMS05MDQ5_c4e7a75a-3db5-4597-bb0f-e38bbd8ef55c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMy00LTEtMS05MDQ5_389b8dce-9f2d-452f-b9df-ae4c1c74b45d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNC0yLTEtMS05MDQ5_3afa0bc4-3fce-4074-833d-934c43c5e72c">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNC00LTEtMS05MDQ5_5d2dfc38-2909-4dc5-9c54-6c4960a2c8eb">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNS0yLTEtMS05MDQ5_130d55a9-49e5-46d9-85e9-324a6df7078a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNS00LTEtMS05MDQ5_2fb91b09-d239-4b73-b257-7d959bf69253">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNi0yLTEtMS05MDQ5_45891016-bb2e-4d90-9dcd-b1cf8dd2db0c">86.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNi00LTEtMS00MDU4_ab50cb26-d2b5-41bc-8b7c-3b480eb08e8b">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three months ended December&#160;26, 2020 and December&#160;28, 2019. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="i057ac10f806c4c558abf15ee4ec101cf_D20200329-20200627" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMTY4OA_19e0049b-1fd2-4335-89e7-eb3e42b72f4c">30.2</ix:nonFraction> million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate caps, interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idc47ad95fbea427fa38e31cfbfdac90c">Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $<ix:nonFraction unitRef="usd" contextRef="i241d11756be14078a3555bf86956ce71_I20201226" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzE1Nw_5a638f51-7dd9-4841-b4c9-ff80c78d2938">1.4</ix:nonFraction> billion aggregate principal as of December&#160;26, 2020 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $<ix:nonFraction unitRef="usd" contextRef="ida2942dc56654504a3265279bdb12af9_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzQ0Mw_e93e4b23-caf2-4f71-95fc-ef0c370865f4">427.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i6e700854ca8d480696bc4eb95d4ddb8a_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzQ1MA_ffda1270-5b2d-4abd-b249-ac5574e61dc1">974.0</ix:nonFraction> million, respectively, as of December&#160;26, 2020 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#8217;s debt.</ix:continuation></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_1202"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(5) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGV4dHJlZ2lvbjo5OWFlNjkyYzYyZjE0N2M1YjcxZDA3NzFjYzMwMmNiOV80Mzk4MDQ2NTE4MDE3_55f5427d-1612-433f-99b7-853519818af1" continuedAt="i2a7f7b0f2c694e3a847572762bb47e26" escape="true">Trade Receivables and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i2a7f7b0f2c694e3a847572762bb47e26"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGV4dHJlZ2lvbjo5OWFlNjkyYzYyZjE0N2M1YjcxZDA3NzFjYzMwMmNiOV80Mzk4MDQ2NTE4MDE4_fb78a947-d2ca-4ca4-8549-099a83431efa" escape="true">The following is a rollforward of the allowance for credit losses as of December 26, 2020, compared to December 28, 2019:</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:25.839%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.809%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.812%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified as Assets held for sale</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTItMS0xLTk2MDg_38c3ae8b-48c0-4402-baa2-da2db9d0a6d7">31.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTQtMS0xLTU4MTU_c93cb305-9f27-42f6-b312-b04b6ff76878">9.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTYtMS0xLTk2MDg_3eedb42b-be10-463d-8944-df307f01eb49">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTgtMS0xLTk2MDg_4f0e7c26-7d7a-4a9e-99eb-1ff292a73041">1.3</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTEwLTEtMS01OTQ3_2b018569-b7ee-49f6-a9e2-025178c18a5c">39.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTItMS0xLTk2MDg_740bdb8a-2e5c-4986-a971-288f99e2edfe">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTQtMS0xLTk2MDg_124b76d5-33ca-4a24-ba0e-c1f489c1901d">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="holx:AccountsReceivableAllowanceForCreditLossTransfers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTYtMS0xLTk2MDg_4f4c383c-d68f-494f-b6a3-877e3f7776c1">5.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTgtMS0xLTk2MDg_b5b415e6-77f5-4cc8-90ed-c60e47efd0a5">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTEwLTEtMS0zMTkx_9f38cd5e-3230-4c46-8616-c75a0ad666a6">11.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3OQ_122d0afe-946f-4921-a574-fee4a5caa2f6" continuedAt="ie963a1d1a279471fb9e1e2a1a3c824f3" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-indent:22.5pt"><span><br/></span></div><ix:continuation id="ie963a1d1a279471fb9e1e2a1a3c824f3" continuedAt="ia4df99be0af94242bbfada34030c91d5"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="ic2f8bbd6225a46a59130b9953c661fca_D20200928-20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAwMg_1551d452-ed51-4984-9d15-83eb007c8068">4.9</ix:nonFraction>&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="ib945bc9d7dd74d23bef11fee1c766a86_D20200928-20200928" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAyMA_cd912905-19dd-4faf-bb56-cf096e0e3ab0">5</ix:nonNumeric> years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAzMw_46c384cc-9e9e-4fb6-9082-f870cafab07e">161.3</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="i445bb1bc12b94106bac10836061b786a_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA0OQ_bdd93bbb-5b76-4d2a-94e1-e597d34abdc3">3.0</ix:nonFraction>&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $<ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA2Mw_fd27ef02-8dcf-4a68-9e55-6911db66261b">81.8</ix:nonFraction>&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a <ix:nonNumeric contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823" format="ixt-sec:durwordsen" name="holx:AnnualIncrementalRevenueGrowthPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA5Mg_cb1f34f0-f03b-4028-bffc-aa5ea202063d">three-year</ix:nonNumeric> period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="ia4df99be0af94242bbfada34030c91d5" continuedAt="ie4f940e695364a14a6346f6217306692"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. In the first quarter of fiscal 2021, the Company remeasured the contingent consideration liability and recorded a charge of $<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA5NA_83d95d7c-457a-4d90-b44b-31ff98da3b7f">4.6</ix:nonFraction>&#160;million to record the liability at fair value as of December 26, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA3Nw_b0d324ba-4a98-4daf-92d7-85a653cee6ef" continuedAt="ifc592d30bbd24b8faff940fb38c388c4" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"></td><td style="width:7.865%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:71.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.292%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMC0yLTEtMS04OTQ4_3e35d592-9482-4677-8eac-a1b5edb48810">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMS0yLTEtMS04OTQ4_c101cbb6-3626-4aea-9e7c-42d74ee16c7b">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMi0yLTEtMS04OTQ4_2a5861df-0188-4ca6-9b1b-f9ca390288aa">4.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNC0yLTEtMS04OTUw_a4fc2622-15d3-4505-8217-2f8ccda0a2d8">127.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNi0yLTEtMS04OTUw_89a6ef3d-8d88-4e1a-8765-8b465a68aaae">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNy0yLTEtMS04OTUw_18e14cac-c9e4-4ac4-bdd5-477cd20baae0">4.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfOC0yLTEtMS04OTUw_a6077b60-c869-4d8e-9d33-f9b03da0f8d5">20.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfOS0yLTEtMS04OTUw_2d39b67d-eab7-4336-8de4-c659b8ef3914">48.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34350e67e8944266b86f21311361cfa5_I20200823" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMTAtMi0xLTEtODk1MA_6d17685e-0ce0-4983-84a6-e5c961b953a4">161.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823" decimals="3" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEwOA_4b571acd-b307-459b-9814-75c84515f84a">18.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is <ix:nonNumeric contextRef="i0832db4cb8434084b9ee1801dd03071d_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEzMw_8223e98e-a2cd-42fb-8e29-6805630baace"><ix:nonNumeric contextRef="i0ab367a0906d4115ae87e78dcc61bf59_D20200823-20200823" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEzMw_dfdc0b43-6e00-4574-a31c-418394e3c9ff">10</ix:nonNumeric></ix:nonNumeric> years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i70d5bdf101354f3096ceb4018e2689fe_D20200203-20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk0Nw_a7f8a155-524f-46ab-9e2c-22c3f179b8e2">19.7</ix:nonFraction>&#160;million, which included hold-backs of $<ix:nonFraction unitRef="usd" contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk2Mg_61db0d75-929a-44f3-bb2e-181fd6741a70">2.3</ix:nonFraction>&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it allocated $<ix:nonFraction unitRef="usd" contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk5MA_8fac8414-20be-4bd4-8a3b-39bd07857c5e">10.7</ix:nonFraction>&#160;million of the purchase price to the preliminary value of developed technology and $<ix:nonFraction unitRef="usd" contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk3Ng_a9e651ae-56d7-4b13-9104-4f60492f708b">6.2</ix:nonFraction>&#160;million to goodwill. The remaining $<ix:nonFraction unitRef="usd" contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1ODAwNQ_c8b278ad-fdf6-47ee-b80a-460a9a00e655">2.8</ix:nonFraction>&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="i16b9bcb5f7f245b8844e041da365f4ca_D20191230-20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTgyOA_b7428965-3d66-470c-8367-8295c38dfd0a">18.0</ix:nonFraction>&#160;million, which included a hold-back of $<ix:nonFraction unitRef="usd" contextRef="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230" decimals="-5" format="ixt:numdotdecimal" name="holx:Holdback" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTg1Nw_327453b3-9381-4803-8b7f-2143d5376d77">1.0</ix:nonFraction>&#160;million and contingent consideration which the Company has estimated at $<ix:nonFraction unitRef="usd" contextRef="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationContingentConsiderationLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTg0Mw_02844ee6-8ec4-4956-ab2d-c85cf129be51">0.9</ix:nonFraction>&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="ie4f940e695364a14a6346f6217306692" continuedAt="i8206cae6343647588b2a505072bb5689"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of <ix:nonNumeric contextRef="i371b6d6a17864bafad1d66b2594c1fd0_D20191230-20191230" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTE1NA_bd0c5522-1e66-4da3-969a-3e512af8dfbf">5</ix:nonNumeric> years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased <ix:nonFraction unitRef="number" contextRef="i07707b0a4bc941daad3ff6db034e22c7_I20190801" decimals="2" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjMxNg_6748b1bf-7151-423a-bb35-b905cfde0876">46</ix:nonFraction>% of the outstanding shares of SuperSonic Imagine ("SSI") for $<ix:nonFraction unitRef="usd" contextRef="ia740bc8dc3ae4ebab5eaafc9d0d17247_D20190801-20190801" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjM3OQ_0b368fbd-1148-4d65-91f4-0a342455a519">18.2</ix:nonFraction> million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;<ix:nonFraction unitRef="usdPerShare" contextRef="ic66d9c02f62b4399864f0fd8c7c03ef9_D20190901-20190930" decimals="INF" name="holx:BusinessAcquisitionCashTenderOfferPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjYyOQ_a31c8cf3-775b-431e-af1f-154cecfbf6ca">1.50</ix:nonFraction> per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded <ix:nonFraction unitRef="number" contextRef="i819b181542894a318b23998e6b0d7876_I20191120" decimals="INF" name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjk0OQ_b8ce5eda-b2c8-4e50-8e1d-8b52f8d14cf1">50</ix:nonFraction>%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional <ix:nonFraction unitRef="shares" contextRef="i7760868627c74bd8909425527cd76d5f_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationSharesAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzI1Ng_6c33bc7e-a33b-460f-8311-1d8950192daf">7.6</ix:nonFraction> million shares of SSI for $<ix:nonFraction unitRef="usd" contextRef="i7760868627c74bd8909425527cd76d5f_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzI3Nw_fb84b08e-9779-43b2-a2fc-4a446a16fbe4">12.6</ix:nonFraction> million. As a result, the Company's ownership interest increased to approximately <ix:nonFraction unitRef="number" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="2" name="holx:BusinessCombinationOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzMyNg_c4a29d37-16ef-458c-939e-203529fa02ea">78</ix:nonFraction>% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of <ix:nonFraction unitRef="number" contextRef="i07707b0a4bc941daad3ff6db034e22c7_I20190801" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzY3Ng_6d01dff9-de2c-4d7f-b100-a00a5d4c9afd">46</ix:nonFraction>% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $<ix:nonFraction unitRef="usd" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzc3OA_910fb72a-331a-474a-a500-ec71f3fcc62c">3.2</ix:nonFraction> million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $<ix:nonFraction unitRef="usd" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:BusinessCombinationConsiderationTransferred1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzg2Nw_cb4422c2-13cc-445b-a1fc-726b967f63e7">69.3</ix:nonFraction> million, which consisted of $<ix:nonFraction unitRef="usd" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzg5MA_2c94f65d-c8b6-4d19-8dc9-8155a4120fad">17.9</ix:nonFraction> million for the equity method investment in SSI, $<ix:nonFraction unitRef="usd" contextRef="ib444eb3971eb4078a9095005df6a2388_D20191101-20191130" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzkzNA_f4e4a53f-5aad-48bb-bc1c-7a7327cab8cb">12.6</ix:nonFraction> million for shares acquired on November 21, 2019, $<ix:nonFraction unitRef="usd" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzk3OQ_dd8f16f9-5ab7-4f9c-901f-3ee3ba350482">30.2</ix:nonFraction> million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $<ix:nonFraction unitRef="usd" contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121" decimals="-5" format="ixt:numdotdecimal" name="holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDA3OQ_91b90329-aa91-4ce2-afa3-ab621ac4b4ff">8.6</ix:nonFraction> million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1 million outstanding shares in fiscal 2020 for $1.8 million, and as of December 26, 2020, the Company owned approximately <ix:nonFraction unitRef="number" contextRef="i723a995e7e6e469f93a43a1b15d07825_I20201226" decimals="2" name="us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDIxOQ_498a82b1-090b-4b96-aa0a-c0fda21c9b5a">81</ix:nonFraction>% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:continuation id="ifc592d30bbd24b8faff940fb38c388c4"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"></td><td style="width:78.849%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.951%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMC0xLTEtMS0w_b10a96d2-5d93-42c9-aac6-e28f9ab7084b">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMS0xLTEtMS0w_82f92295-8b7a-4642-910d-4b4959c5217e">7.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMi0xLTEtMS0w_66f9e42b-6dc4-4ed7-b5b9-f364b6a3d403">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMy0xLTEtMS0w_7dc19ac9-0726-4ea8-b2f3-7b0bac0ed7de">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNC0xLTEtMS0w_89567f93-1a96-47a4-9102-b3d5a9614a4b">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNS0xLTEtMS0w_cb8855be-1e15-4a30-b4e0-656127953c11">24.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNi0xLTEtMS0w_62ad90e3-9f22-475f-9b4e-e26b9894e65d">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNy0xLTEtMS0w_02a09f37-e146-4976-8fed-605a4854ab75">8.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfOC0xLTEtMS0w_27b4cd8c-1890-4050-80b6-b89039d2e8fa">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTAtMS0xLTEtMA_4c8461ce-6634-43c1-9732-3416de80cb80">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTEtMS0xLTEtMA_65d5a2aa-b1b6-4cc5-b9b8-30ab9f9ebcb1">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTItMS0xLTEtMA_733af71d-aed1-4d58-99e6-761d06fa1d9f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTMtMS0xLTEtMA_d2f33e6c-7dac-4cd0-bc0b-e6c1207626f3">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTQtMS0xLTEtMA_3f63ffb6-705a-4c14-8bde-616ad0221af1">34.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTUtMS0xLTEtMA_5071b59c-2716-4ea6-aa83-d025f2e957b3">69.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="3" name="holx:FairValueAssumptionDiscountRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNTM1MA_e5a315be-72a5-4170-a3ba-9e79a4840ec7">12.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is <ix:nonNumeric contextRef="i0b7ae2b69c584c9bb1faea69bab3ce7d_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3Ng_84c105df-6830-4e08-914d-851247867e79">9</ix:nonNumeric> years, customer relationships is <ix:nonNumeric contextRef="i3bcf08abaf134bbebc54968c5252645d_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3Nw_e093171e-78d0-48dc-b0e0-c89496ebae74">9</ix:nonNumeric> years and trade names is <ix:nonNumeric contextRef="iaddf820f39534b4598834451cecb88ea_D20191121-20191121" format="ixt-sec:duryear" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3OA_a25a54d2-aa15-45db-b118-14226ec7e8ad">8.6</ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-bottom:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8206cae6343647588b2a505072bb5689">amount of goodwill were based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</ix:continuation></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_55"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMzM2MQ_7e8ec53d-1102-41a2-8e5d-2fd3ee7052af" continuedAt="ie22657749d0b470da7ea7a1a6dcbc1dc" escape="true">Disposition</ix:nonNumeric></span></div><ix:continuation id="ie22657749d0b470da7ea7a1a6dcbc1dc"><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$<ix:nonFraction unitRef="usd" contextRef="ic22ee4e6996843b09dfab94a3c9ee000_I20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMjE2_b1ade86b-97f3-4638-a9ab-9d70abc6a150">205.0</ix:nonFraction> million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $<ix:nonFraction unitRef="usd" contextRef="i263b950faa89407aa9ae0648ede3cbf6_D20191120-20191120" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromDivestitureOfBusinesses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMzQx_4f573e85-e6fa-4a76-a44d-dc3a078db747">153.4</ix:nonFraction> million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $<ix:nonNumeric contextRef="i94e4cd78e2a64f9c8f35fa4309e98439_D20200628-20200926" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTA5OTUxMTYzNTI1Mw_afdd4cbe-5933-4971-8808-013f90138da5">150.0&#160;million</ix:nonNumeric> in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $<ix:nonFraction unitRef="usd" contextRef="icc6c143516c3424da5de0d0db2e91e98_I20201226" decimals="-5" format="ixt:numdotdecimal" name="holx:IndemnificationLiabily" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfNzg4_b2f3c59c-9b28-493f-8b6f-7ec9adb65976">10.9</ix:nonFraction>&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTc1OA_0d46d3f8-6aa6-41d9-9199-7a271e03f8a7">30.2</ix:nonFraction> million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $<ix:nonFraction unitRef="usd" contextRef="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTg4NA_3333f408-1190-4d7c-9c44-ca0da94997b4">25.8</ix:nonFraction> million was allocated to cost of product revenues and $<ix:nonFraction unitRef="usd" contextRef="i3e1d2a8de8624ac59da8d9efd1fbaf86_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTkzMw_1063f988-b6a7-47e0-a03a-9f6d9042937b">4.4</ix:nonFraction> million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="5" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTA5OTUxMTYzNTIzOA_ef1eca15-bd4b-4a12-b398-46a64bbd18a9">46.5</ix:nonFraction>&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first quarter of fiscal 2021.</span></div></ix:continuation><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTExMg_7c91b503-3f79-4299-9c0b-78ff16a059a7" continuedAt="i8d490808f4684793b3c1df64078ec089" escape="true">Borrowings and Credit Arrangements</ix:nonNumeric></span></div><ix:continuation id="i8d490808f4684793b3c1df64078ec089" continuedAt="i7a6575d9ad8c413aaa255155e93aa9bc"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTEwNg_c543e059-f8a7-4c79-b34f-0f4559470ead" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:73.386%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.216%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMi0xLTEtMS0w_5d6fad83-6764-4431-941a-adcef3fc6dbb">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7f71fe3fdf45758b7a447848bff326_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMi0zLTEtMS0w_feef9b36-1219-4d35-8120-6722380ac6b6">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bb87ee83878455d9a7b108c2fa2d672_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMy0xLTEtMS0w_006438a9-df86-4347-818b-6b82c1c4d271">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6786a0492e547de9f464fbf0e844870_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMy0zLTEtMS0w_ea7a8265-b456-4575-8640-51d414fcdf95">250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfNi0xLTEtMS0w_dadd12ec-3293-4bff-97ec-09bfc39d3f78">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfNi0zLTEtMS0w_e4d499c2-01ca-4d3b-88c0-65b2014fc950">324.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfOC0xLTEtMS0w_a33c372b-bee2-46fe-8fbe-6b9c854a2820">1,361.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb7f71fe3fdf45758b7a447848bff326_I20200926" decimals="-5" format="ixt:numdotdecimal" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfOC0zLTEtMS0w_d55a31f2-e61e-4669-a3b9-94e479fe9194">1,379.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67ca1e7d9cac43759262d127ccab005b_I20201226" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTAtMS0xLTEtMA_f864ce5c-4178-4802-ae70-ee74e8539344">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82e420f21c4c4b3f8b908f387378a7f2_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTAtMy0xLTEtMA_3ab81848-971f-420d-a897-782f20bc59f1">939.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id33757ebc0984bec86c4ac09abcd3c10_I20201226" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTEtMS0xLTEtMA_64d74e9c-a2e3-4414-af04-f2bc3efcb124">394.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c6dd14c95ef47a7949124d127e36455_I20200926" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTEtMy0xLTEtMA_dd60987b-da8c-4f16-9128-0d51e9120f70">394.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dbe00ac4547495f87d9491d8dd3581b_I20201226" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMS0xLTEtMTU3NA_0b88f573-e59a-408b-92eb-2bcc8caeb50a">932.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie68151a708294400b3d034999da20c0b_I20200926" decimals="-5" format="ixt:zerodash" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMy0xLTEtMTU3NA_937ab5d5-d982-4519-978d-fdd4bd357a30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMS0xLTEtMA_21985d8a-814f-428c-ac6d-bd030425c05e">2,689.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMy0xLTEtMA_71d4d342-dc9d-4cf8-b090-10ce8fa47f26">2,713.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTMtMS0xLTEtMA_5b19f3c6-2937-422e-b6a2-dda84295ce75">2,764.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTMtMy0xLTEtMA_672ee526-fc4b-45d3-8a7a-f89fd238c638">3,038.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="i7a6575d9ad8c413aaa255155e93aa9bc" continuedAt="i0a5904d593784679863ae201de56dae1"><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of December 26, 2020, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $<ix:nonFraction unitRef="usd" contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzg5NA_a77ee8b1-e3fd-408f-ae6d-d1cea9c1cac4">1.4</ix:nonFraction>&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was <ix:nonFraction unitRef="number" contextRef="i272b18cc7ba74e908f1067ae52fcdb03_D20200927-20201226" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfODUw_4687d82f-0123-4be0-bc66-e9683bba0da4">1.00</ix:nonFraction>% as of December 26, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $<ix:nonFraction unitRef="usd" contextRef="ifcd33ea87772405fa0aef1f0eddaef72_I20181217" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0NzkwOA_de396f72-7630-432f-87ac-c85097374712">1.5</ix:nonFraction>&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of December 26, 2020. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $<ix:nonFraction unitRef="usd" contextRef="if3dfc408634648eb84ad199842d8c60c_I20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjE5Ng_fb7e6a44-ec35-44dd-98b5-ad15864b7ee8">750.0</ix:nonFraction> million under the Revolver, $<ix:nonFraction unitRef="usd" contextRef="i266e0d14a55f4367b1cb47da87337f49_D20200927-20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjIxOQ_f4beeba1-834d-4ebb-8497-9a8352a8f491">250.0</ix:nonFraction> million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="i5ccd74dfac1940edb3766ae879c3f548_D20200927-20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:RepaymentsOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjQxNw_215080eb-06ab-4724-83c4-c2ddb2e348da">250.0</ix:nonFraction>&#160;million. As of December 26, 2020, the full amount of the Revolver ($<ix:nonFraction unitRef="usd" contextRef="i0bb87ee83878455d9a7b108c2fa2d672_I20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjUwOA_74d6693f-4eda-4f7f-b10e-f177289de86d">1.5</ix:nonFraction> billion) was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTA5OA_b7f8c5ba-185a-44dd-8ddc-495336ebdad7" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.591%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMi0xLTEtMS0w_94d0f3d6-349c-4b89-9444-e2e2b7898e49">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMi0zLTEtMS0w_0a6a86f5-edba-4f37-bbfa-99d5d761719d">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMy0xLTEtMS0w_b58fc4cf-40c4-4c2a-aa97-ed58d87c23af">1.23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMy0zLTEtMS0w_97ed3bc7-ebf1-48c2-9ca9-d58be90effbd">3.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i241d11756be14078a3555bf86956ce71_I20201226" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfNC0xLTEtMS0w_ffcbd7b1-9127-4d69-a9cc-9d7217c2f7dc">1.15</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i87a8917b112a432189d8acc8fa3c7c6b_I20191228" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfNC0zLTEtMS0w_e7bf1962-008c-43b9-9ce9-837e7f5a30bf">3.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of December 26, 2020, the Company was in compliance with these covenants.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $<ix:nonFraction unitRef="usd" contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMyOTg_36b30810-2226-45fd-a4c7-e73f814d4834">950</ix:nonFraction>&#160;million aggregate principal amount of its <ix:nonFraction unitRef="number" contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMTI_23756bbf-6e25-46d3-9819-6442c1691d9c">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of <ix:nonFraction unitRef="number" contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928" decimals="INF" name="holx:DebtInstrumentOfferingPricePercentOfFaceValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMjA_6574c6e6-2bcd-4036-b3ad-627a784c5d7d">100</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering in September 2020 and cash on hand to redeem in full its <ix:nonFraction unitRef="number" contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMjY_7940d557-f62f-4eb6-a8ed-6aa64a4a7cfc">4.375</ix:nonFraction>% Senior Notes due 2025 (the 2025 Senior Notes") in the aggregate principal amount of $<ix:nonFraction unitRef="usd" contextRef="iad667aadede54f53a73843991e84d978_I20201015" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk2NA_b40bebeb-e80e-4146-baec-be565b3f4530">950.0</ix:nonFraction>&#160;million on October 15, 2020 at an aggregate redemption price of $<ix:nonFraction unitRef="usd" contextRef="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ExtinguishmentOfDebtAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk2Ng_3a8d065d-fc26-4c4a-86b0-a75937c8c9d5">970.8</ix:nonFraction>&#160;million, including a premium payment $<ix:nonFraction unitRef="usd" contextRef="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015" decimals="-5" format="ixt:numdotdecimal" name="holx:DebtRedemptionPremiumPaid" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk4Mg_ad3d52a2-4984-4dcb-844d-9ec6b0a2608b">20.8</ix:nonFraction>&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the redemption, the total aggregate principal balance of 2025 Senior Notes was $<ix:nonFraction unitRef="usd" contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMzk3Mw_a272bf57-ceb9-4e15-a0b1-cb0b59673b4a">950.0</ix:nonFraction> million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $<ix:nonFraction unitRef="usd" contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzODE_1882978c-7054-4c99-81d4-c787017e6709">21.6</ix:nonFraction>&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $<ix:nonFraction unitRef="usd" contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzOTY_df422471-a0d3-47fc-b0ab-80c571c7d316">5.8</ix:nonFraction>&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $<ix:nonFraction unitRef="usd" contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0MTA_62fdf5a7-ae45-48d6-be24-74ab2a483025">7.9</ix:nonFraction>&#160;million and debt discount of $<ix:nonFraction unitRef="usd" contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0MjQ_9e81dfdf-675c-41d6-988e-452ad67d017b">6.4</ix:nonFraction>&#160;million related to the modified debt will be amortized over the term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="i0a5904d593784679863ae201de56dae1"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="number" contextRef="i8c96bc19976644208f9a458ae4a150c3_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NDU_2a183783-9b79-4ab9-afa9-94c92ddc131d">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="id33757ebc0984bec86c4ac09abcd3c10_I20201226" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDI0OA_239fce65-0fc3-4c3c-9981-0dc8d440fcd4">400</ix:nonFraction> million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTA5OQ_adf41605-da9e-4e42-a8cb-2435e637285b" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 2029 Senior Notes outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SeniorNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0NzkyMg_d04f3b89-7b77-4712-b9ab-22b979f61024">950</ix:nonFraction>&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of <ix:nonFraction unitRef="number" contextRef="iacc119bc81e747be85919ea8b7a55a46_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NTM_ad962898-9a1c-44ee-b852-1d00c968bd87">3.250</ix:nonFraction>%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to <ix:nonFraction unitRef="number" contextRef="ie334e0aec6cd4cd1ab86db6fbbfaa551_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NjE_280086ae-0826-4a3d-b629-91ea429fc349">100</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to <ix:nonFraction unitRef="number" contextRef="i9a8984669d744df49521703334b03d7e_D20200928-20200928" decimals="3" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0Njc_83b09c92-a9fd-4b31-82dc-029fc2f584fb">40</ix:nonFraction>% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to <ix:nonFraction unitRef="number" contextRef="i96cd4aedc3204bf7bbe2a37df2b4ef1f_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NzI_d4904858-6667-4602-be4e-1aba73b37f01">103.250</ix:nonFraction>% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at <ix:nonFraction unitRef="number" contextRef="if6ebe4e0383e4fe69e44e515ac3c4504_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0ODI_d190e1a8-d8ad-4819-8f39-3193a3a58117">101.625</ix:nonFraction>% of par; September 28, 2024 through September 27, 2025 at <ix:nonFraction unitRef="number" contextRef="i02a7dee3e67f41a097d797a6c9b2130e_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0OTI_79e732cc-6d47-4b66-b0ba-c78597518982">100.813</ix:nonFraction>% of par; and September 28, 2025 and thereafter at <ix:nonFraction unitRef="number" contextRef="i9a15023472504c11938a4412d729c107_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM1MDI_27338590-1ec0-4123-b946-823846ce6538">100</ix:nonFraction>% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to <ix:nonFraction unitRef="number" contextRef="if22e3b1bbb254fc0b22330dc8ee7c7bd_D20200928-20200928" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM1MDg_ce099bdb-f383-49b8-8e44-6db277fe132a">101</ix:nonFraction>% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.449%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c96bc19976644208f9a458ae4a150c3_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy0xLTEtMS0w_a3aa7ebb-d5fd-4006-a970-a2158013112a">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i946944c5847f4222b4d01aab1a2fa089_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy0zLTEtMS0w_92ebad29-fdfc-45d2-a193-d0134af47ec8">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i97a53a8f47ba4871a7afa91c3b2b95ae_D20190929-20191228" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy01LTEtMS0w_8d1aae8f-f664-4204-b0d7-f71aec9ac085">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC0xLTEtMS0w_f6fcd266-5d65-4caf-9aa2-d776b62acab5">4.375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC0zLTEtMS0w_71ccdd28-7a3e-4b87-8e85-f9378f9d62f1">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5687e57173b24d598e070c83cda5ba64_D20190929-20191228" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC01LTEtMS0w_da653a43-e6a0-4760-9a1b-d533b9fcf70a">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iacc119bc81e747be85919ea8b7a55a46_I20201226" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0xLTEtMS05MDg4_d5236f1c-5ff2-44f2-a27b-5f2dfd1d8016">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfc7677b0624c36ad3fa92f1412ae0c_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0zLTEtMS05MDkw_d6ec5a0b-fbbc-4a95-93da-2be7cabfe043">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic040a340ce4f4e139d9aa05eac474e5c_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS01LTEtMS05MDkw_87b4b23f-1aaf-4f4c-a200-12a5d4491b5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0zLTEtMS0w_b41a01f8-6617-4fe0-af62-46056b22b2db">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS01LTEtMS0w_f2680bc0-da4f-4dd6-8142-f68f4a8e46b5">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) Derivatives</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Cap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate caps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings. To the extent there is any hedge ineffectiveness, changes in fair value relating to the ineffective portion are immediately recognized in earnings in other income (expense), net in the Consolidated Statements of Income.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2018, the Company entered into separate interest rate cap agreements with multiple counter-parties to mitigate the interest rate volatility associated with the variable interest rate on amounts borrowed under the term loan feature of its credit facilities (see Note 8). Interest rate cap agreements provide the right to receive cash if the reference interest rate rises above a contractual rate. The aggregate premium paid for these interest rate cap agreements was $<ix:nonFraction unitRef="usd" contextRef="i4145415c8afb45a4bda97db9d2be27b8_D20171001-20180929" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMTM5Mw_aa1b64e8-2bde-466d-9ae6-22f69d1d3005">3.7</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company's financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal 2019, the Company entered into additional separate interest rate cap agreements with multiple counter-parties to extend the expiration date of its hedges by an additional year. The aggregate premium paid for these interest cap </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">agreements was $<ix:nonFraction unitRef="usd" contextRef="icb558ac27372440189b269e14d6cb9e9_D20180930-20190928" decimals="-5" format="ixt:numdotdecimal" name="holx:InterestRateCapAgreementsAggregatePremiumPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMTc1NA_cf36578c-56e3-4cd9-8236-981196e668df">1.5</ix:nonFraction> million, which was the initial fair value of the instruments recorded in the Company&#8217;s financial statements. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical terms of the interest rate caps were designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its Credit Agreement, that has been amended multiple times, and therefore are highly effective at offsetting the cash flows being hedged. The Company designated these derivatives as cash flow hedges of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-8" format="ixt:numdotdecimal" name="holx:PrincipalAmountOfBorrowings" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMjI0Mg_49be1d97-513a-4f37-b831-b66759a0d716">1.0</ix:nonFraction> billion of principal, which ended on December 27, 2019 for the contracts entered into in fiscal 2018, and on December 23, 2020 for the interest rate cap agreements entered into in fiscal 2019.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interest rate cap agreements matured as of December 26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt beyond the contracted period under interest cap agreements, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzU4Ng_896b0941-7ced-426c-84c1-859a21756bc9">1.0</ix:nonFraction> billion. The interest rate swap effectively fixes the LIBOR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzY4NA_1c2dd1ce-70b2-4ac5-9b94-2599c572a238">1.0</ix:nonFraction> billion of the notional amount under the 2018 Credit Agreement at <ix:nonFraction unitRef="number" contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzc0NQ_25b510a1-08bc-4298-88c7-104d25896bc9">1.23</ix:nonFraction>%. The critical terms of the interest rate swap are designed to mirror the terms of the Company&#8217;s LIBOR-based borrowings under its credit agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the LIBOR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226" decimals="-8" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDA5MQ_73b2724d-0d6d-45a3-84a8-40d31aae0dfc">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI and were losses of $<ix:nonFraction unitRef="usd" contextRef="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDE5Nw_35af0e84-8047-4426-8c4b-8b845e3d01c1">0.9</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDIwNA_2967ad08-40af-410f-b4e4-962e928c352e">4.3</ix:nonFraction>&#160;million for the three months ended December&#160;26, 2020 and December 28, 2019, respectively. The fair value of this derivative was in a liability position of $<ix:nonFraction unitRef="usd" contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDMxNA_317a5bbe-3045-4a57-8e07-579156387e2e">30.7</ix:nonFraction> million as of December&#160;26, 2020.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Contracts and Foreign Currency Option Contracts</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate a portion of our cash balances and certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency exchange contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts; however, the Company may seek to apply hedge accounting in future scenarios. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense), net. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts for the three months ended December 26, 2020 and December 28, 2019, respectively, were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5OQ_2c81e192-4c83-45f0-9cb8-e7b5856e0d75" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.227%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.297%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18821e25e654193b3722de96cae81e5_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMy0xLTEtMS0w_366f8a6f-0401-451d-a5dd-7033217552aa">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMy0zLTEtMS0w_3d1ddb1b-e1e3-4e40-81f2-0113c1c9f61b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNC0xLTEtMS0w_74220e69-2958-4de1-9ca9-a842ed834971">1.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNC0zLTEtMS0w_537c4473-be57-4f2e-b048-c63018c511c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNS0xLTEtMS0w_b145d87a-6df0-4a52-b4ad-775b12f3058c">4.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNS0zLTEtMS0w_d350db1d-31cf-46b0-a00e-9641f8cf6791">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia18821e25e654193b3722de96cae81e5_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOC0xLTEtMS0w_492c1f82-96f3-4686-9c14-f033b03d1f09">6.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOC0zLTEtMS0w_a01ad6c6-a6e0-4ca9-8e13-9558f2839a05">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOS0xLTEtMS0w_ca343b21-a12b-463b-9042-f9b008af815b">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOS0zLTEtMS0w_00a9fae2-a2b7-4718-88c7-4530a02326d0">1.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMTAtMS0xLTEtMA_e48d8260-c47a-4139-936c-f0b80db00178">14.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMTAtMy0xLTEtMA_c24720bc-31eb-4a18-8378-7f85a4aea194">3.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;26, 2020, the Company had outstanding forward foreign currency contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of certain of our cash balances denominated in the Euro and UK pound, as well as forecasted transactions denominated in the Euro, UK pound, Australian dollar, Canadian Dollar, Chinese Yuan and Japanese Yen with an aggregate notional amount of $<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="holx:NotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNTgyOA_82e6f475-fbaa-4495-8b9c-1a92622d4c40">299.5</ix:nonFraction> million. As of December&#160;26, 2020, the Company had outstanding foreign currency option contracts that were not designated for hedge accounting and were used to hedge fluctuations in the U.S. dollar of forecasted transactions denominated in the Euro and UK Pound with a notional amount of $<ix:nonFraction unitRef="usd" contextRef="i14c65c53cd0e4e41a8db5dd4fc6893ee_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DerivativeNotionalAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjA5NQ_904034e2-fda1-4758-be4a-a683e7c1db58">245.2</ix:nonFraction> million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5MQ_1226abc7-393e-47a0-ac24-9f12b1a8b194" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;26, 2020: </span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5c79bf354ce4b21b4b0f50f1420f521_I20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfOS0zLTEtMS0w_4b1aa307-68c8-491c-9199-b167f8e2f7f4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99c9b14467904ef5b80860d433664aee_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfOS01LTEtMS0w_39f09e45-4cd9-4c59-a5da-a1f29011a1db">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaffcddff32544018920aee5d25e3c2ad_I20201226" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTAtMy0xLTEtMA_06887e9e-bd00-48ce-a3c1-c9b12946da20">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dfb8135d4b44625bbfd0c560825de11_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTAtNS0xLTEtMA_2c6907fd-cb92-40b0-ad50-6b48a57a65ac">10.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id06743973fb743b3bbaa0c0e4b84c26b_I20201226" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTEtMy0xLTEtMA_daf0889e-fa9e-465a-9229-c18d8cab0cef">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3146d8c6f2de426998db38b3743e8858_I20200926" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTEtNS0xLTEtMA_f40cd30f-3af3-487f-8f2d-804b3a92071d">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia984d8ccc9314615a0c9a71d08c50377_I20201226" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTUtMy0xLTEtMA_b4edb5bf-7089-4130-85d8-9c5bb4c73c7b">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i840c202668e846e1a52fcd4ca8bc0961_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTUtNS0xLTEtMA_6ca58d84-bde1-4848-a2c6-320cd6a709bc">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i969e4857b92749c69746b9416f9fdfa8_I20201226" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTYtMy0xLTEtMA_ce7c54e4-7cf2-4840-94a2-b757a187938a">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46c4fddee0c14f81993ab3606eae7ab3_I20200926" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTYtNS0xLTEtMA_2a104647-d66f-4f29-9b22-dbd79404066c">23.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTctMy0xLTEtMA_3b53e0e2-f909-420d-84cf-67e0e041105a">30.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:DerivativeLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTctNS0xLTEtMA_2bb3883d-6113-4a44-ac4b-79cfa692bc04">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i81a59afa7d3848bf9b91f17ca827426a_I20201226" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTktMy0xLTEtMA_e7a16e28-4da5-4de2-8ac7-ebab24c7984f">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i549ec774b12e4aa1a72a71662a06229e_I20200926" decimals="-5" format="ixt:zerodash" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTktNS0xLTEtMA_0e171d15-87a5-4daa-9d18-6934e3a5c711">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5Mg_2c00f803-f418-4790-a529-8d5407222422" escape="true"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfMy0xLTEtMS0w_43e93605-6697-40c6-8f3a-f2b99ba3dbbd">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfMy0zLTEtMS0w_a11eeec1-46a7-444c-83c8-47de1073e908">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3be9e57ba38f4e4eab5fb7b166680c7c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNC0xLTEtMS0w_9e7548c4-f2db-4100-92f2-2434c59dc864">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib397c4180063456a85a4f4404a73c0ab_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNC0zLTEtMS0w_352fce23-a50c-4465-908a-8a75d9837871">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNS0xLTEtMS0w_38e7f208-6be9-4e8f-9a1c-ae6af77be48c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNS0zLTEtMS0w_71056a88-be5c-483b-a27f-075a1636b66d">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5Ng_75d36f35-afca-467a-b969-6a54f2fe4009" escape="true"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.432%"><tr><td style="width:1.0%"></td><td style="width:58.325%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.697%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.289%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.700%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss Recognized in Income</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7ced3c7b6bc347edb64064ea347792a1_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMi0xLTEtMS0w_d5ba894a-721c-47cb-b198-8d224ec36c25">9.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibfed9d2d0c8c46be91e8f912672b894f_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMi0zLTEtMS0w_1c4acee1-caa1-44f6-8664-7e64b5363875">1.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib6d9158bf57a4de4bb11c3ce2fbd34c8_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMy0xLTEtMS0w_fb0a26a7-9ccc-44ce-a50d-aa4acb7ede84">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idd61c3510e7e468085daf8a67ff23b49_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMy0zLTEtMS0w_0b46e156-28cb-4777-a365-cf4e60dfe687">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfNC0xLTEtMS0w_3f3f0284-a12c-4c1f-9830-d6dfeb2cedec">18.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfNC0zLTEtMS0w_47dce610-c726-4aab-948a-352dff7c7090">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_64"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfNzU0MA_30160de2-b9f1-4ab8-a534-2bcf0351e445" continuedAt="i44705c96ab804d3dac41a21967c601c5" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i44705c96ab804d3dac41a21967c601c5" continuedAt="i3fa5fc8401d8464495b210593f05ba7b"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="i3fa5fc8401d8464495b210593f05ba7b"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="ifa0e515bd1224c0d899e4fcd02858289_I20180727" decimals="-5" format="ixt:numdotdecimal" name="holx:AmountAssessedInDamages" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfMTk4MQ_801661b6-679c-4507-a540-d7f6e3f6a863">4.8</ix:nonFraction> million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed <ix:nonFraction unitRef="petition" contextRef="i7c99293b0e714a19b40025886a612952_D20160304-20160304" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfMjUyOQ_648b9976-6cd1-4659-a630-2eafca7f3820">two</ix:nonFraction> petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 7, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $<ix:nonFraction unitRef="usd" contextRef="ie80b72b0fb174e058cab363ca6b15048_I20201226" decimals="5" format="ixt:numdotdecimal" name="holx:LegalAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfNjc4MA_44c3458d-5616-43fc-a78e-d43354d6c09b">8.5</ix:nonFraction>&#160;million accrued for such matters as of December&#160;26, 2020. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_67"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RleHRyZWdpb246YmJlYTExN2Y0MGE3NDFhNmE4YjVkNjA1NDE2ZjAwMWRfNzg2_de933733-6322-40d7-af21-8b70a661aec9" continuedAt="iddab72e0f0e44bdb9827d4505940f3e9" escape="true">Net Income Per Share</ix:nonNumeric></span></div><ix:continuation id="iddab72e0f0e44bdb9827d4505940f3e9"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RleHRyZWdpb246YmJlYTExN2Y0MGE3NDFhNmE4YjVkNjA1NDE2ZjAwMWRfNzkz_374245a2-a8ef-4a96-9190-b39243f0bd63" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMi0xLTEtMS0w_3e8546b2-b266-4aaa-88fa-de25ca2e78ef">258,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMi0zLTEtMS0w_47bbf405-fa00-481a-98ee-d28b073ede19">267,893</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMy0xLTEtMS0w_104742e1-655c-48ae-8f03-a10d13b2e34b">3,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMy0zLTEtMS0w_9210579a-1f43-40b3-ba3e-75bd8d9d9d4a">1,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNS0xLTEtMS0w_7e6c6761-5ca0-491b-aa50-45e4ffc12cab">261,785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNS0zLTEtMS0w_d54bfce1-9211-4e3c-a667-8e3cfb299ed8">269,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i32c95d4d9c584147982e6bb76f7f2f4d_D20200927-20201226" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNy0xLTEtMS0w_341718f8-2551-430b-9636-2119c4de08ff">340</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i171272f0c8eb474abf7abd9bc10110a5_D20190929-20191228" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNy0zLTEtMS0w_7790708f-af27-4fd0-a32a-cca160e2cd53">1,290</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i55ee422e40ce4f768cceb979f540e79d_D20200927-20201226" decimals="-3" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfOC0xLTEtMS0w_8e42fdf4-a8cd-49c4-bc9a-4977ae291563">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i476aabde140941c0aab31725a7ba549e_D20190929-20191228" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfOC0zLTEtMS0w_9bea2fee-c9ee-4285-a7b3-e33503e60e50">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:9pt;text-indent:24.75pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk2Ng_3454cabc-4c4e-4671-86f4-8a41c077772b" continuedAt="if06770010c8442e2a1848e4107c1ce78" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="if06770010c8442e2a1848e4107c1ce78" continuedAt="iff0927576155457fb3170be32902be8e"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk0Nw_a09a51af-3b40-4754-bb53-05292c295557" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"></td><td style="width:63.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.336%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafdc57909e694817a52781dc7898179f_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMi0xLTEtMS0w_9453fd91-42db-4066-8d20-f409d60832ed">2.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMi0zLTEtMS0w_5c8f9096-dcca-4657-9fd6-a4ae28021464">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iff6b7ab624354224947dce01c73a9d53_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMy0xLTEtMS0w_74bb375f-6dc9-414d-9f8c-6df7eeb02a7e">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5144cd88e48a4b849b044fdf0eba3d60_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMy0zLTEtMS0w_06635fd4-9301-4790-917b-aa1fc81d1111">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9547059f414e4ec8bb5994e0b274a8e4_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNC0xLTEtMS0w_32249d8d-0d16-4cbd-8ac0-401588876197">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if39c287645e74eff89da805fd540f295_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNC0zLTEtMS0w_6986d8e8-8adf-4396-ad86-2ba6b0d0f2c5">2.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5e1cce238241218daf5e00d5bdb7b5_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNS0xLTEtMS0w_a0e79168-9e18-475e-a474-1df6f299d0ef">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9c1bb1bfb5498d9c90a1947235bccf_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNS0zLTEtMS0w_b9d06401-82ee-4a94-b0dc-1983360ad86e">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNy0xLTEtMS0w_9f08354b-3355-41e7-ba6d-c01e1065de0a">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNy0zLTEtMS0w_ce73c4eb-5466-4998-a9ff-9ea758e40cb7">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTg5_fdb7dec6-287e-4422-afb6-5c1f8c753bbb">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i855677b1eae843febb6235b904a536d4_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTk2_c5be212a-1e24-4ba8-a944-3aea88429380">0.8</ix:nonFraction> million shares of the Company's common stock during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzE2_1f609b19-0deb-4684-ad81-470a9ba3003a">68.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i855677b1eae843febb6235b904a536d4_D20190929-20191228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzIz_9a59be8f-f53e-437c-9c35-9e135d43ed7d">45.67</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzUy_e6cbb460-9cb4-4d98-b80a-f724f124b37b">4.6</ix:nonFraction> million options outstanding at December&#160;26, 2020 with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNDIz_51663cb6-6d2a-4fa0-be34-04f7b416fe7e">44.13</ix:nonFraction>.</span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk1Mg_22529c5a-2574-42e2-a71e-c5a95e56be6b" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"></td><td style="width:63.028%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.334%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.336%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMi0xLTEtMS0w_eea461b4-97d1-4f32-945d-48266157f8fe">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMi0zLTEtMS0w_630f4ed5-b941-4e7b-ba8a-2d615feea044">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMy0xLTEtMS0w_4271f1c2-ac50-4b83-88a7-ee515ca1cedd">35.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMy0zLTEtMS0w_0a5e3021-5af5-4453-b268-456dab3a479d">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNC0xLTEtMS0w_38ed0179-d129-4015-b120-1fa72618eee6">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNC0zLTEtMS0w_0af91594-2555-4886-a449-a08a0c3c2843">4.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNS0xLTEtMS0w_a35e530b-293a-4f1a-bc87-5fe377dc0b70">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNS0zLTEtMS0w_d7fba088-6696-40f9-899e-04df5e7ed99d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNi0xLTEtMS0w_5ca20235-1d17-4ea9-ae98-9c06cac318b1">19.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNi0zLTEtMS0w_d3a3c586-11be-4888-b689-a12f8e3000ed">13.83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNjQ0_72ad03ce-c2aa-417b-9900-5fe6298d6596">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNjUx_4d4b8ed8-f3da-4c77-91ef-404870028f02">0.7</ix:nonFraction> million restricted stock units (RSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNzg0_321a17e0-3808-4d83-aca6-231c2c6f8bbd">68.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNzkx_82b170e7-2604-4990-9fdd-64bd7e4d13d6">45.64</ix:nonFraction> per unit, respectively. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfODUx_a7f4e745-b9e4-4386-9a43-0d9792ea873e">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfODU4_f646eaf1-019e-431f-9b69-0fa7d42bbf3a">0.1</ix:nonFraction> million performance stock units (PSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTA0MQ_ab16967d-4b29-4168-b50c-8a86d14e0c0c">68.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTA0OA_fa4a8c83-4ef1-4cd8-b383-234af163152a">45.65</ix:nonFraction> per unit, respectively. Each recipient of PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTEyOQ_665cdfdb-a812-4b66-8783-91ce8614256c">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTEzNg_cc5cb3a3-80b3-478d-819c-8d6ff399ad90">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTIxNA_763f9c45-d64b-4b6f-896e-25c741c55566">three years</ix:nonNumeric> provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTMyMg_9fcccb0e-4959-4ece-ba8a-bf022e606fa1">0.1</ix:nonFraction> million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTQ1MA_dc468212-6046-4a13-b5a1-052758c0561d">68.35</ix:nonFraction> and $45.65 per unit during the three months ended December 26, 2020 and December 28, 2019, respectively. Each recipient of FCF PSUs is eligible to receive between zero and <ix:nonFraction unitRef="number" contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTUyMQ_196b2815-e187-427e-8e56-112fdb3c9393">200</ix:nonFraction>% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="iff0927576155457fb3170be32902be8e"><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">service period. The Company is recognizing compensation expense for PSUs and FCF PSUs ratably over the required service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjA5Mw_ee59a65c-b67b-44c1-b5ff-55b8db23bf9f">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjEwMA_aa438fb3-1ac3-4013-a631-4ea3bad92c08">0.1</ix:nonFraction> million market-based awards (MSUs) to its senior management team during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="INF" format="ixt-sec:numwordsen" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjI2OA_665cdfdb-a812-4b66-8783-91ce8614256c">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjI3NQ_cc5cb3a3-80b3-478d-819c-8d6ff399ad90">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of <ix:nonNumeric contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" format="ixt-sec:durwordsen" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjM1Mw_763f9c45-d64b-4b6f-896e-25c741c55566">three years</ix:nonNumeric> based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjQ3MA_eaa98c59-fc64-4fdd-b36b-4fde61fcb57b">82.31</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjQ3Nw_3ce81d29-11c5-4f7e-875d-8b2fb68b64bd">43.78</ix:nonFraction> per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;26, 2020, there was <ix:nonFraction unitRef="shares" contextRef="i4bd4f87650894ee382525ad3d40a1b96_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjY0MQ_581e2064-15b6-41be-af08-5910d850feef">3.1</ix:nonFraction> million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;26, 2020, there was $<ix:nonFraction unitRef="usd" contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjcxOA_b6fee9f7-57ba-4e04-abea-98e2b7dc45dd">26.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i5a35e9e5b1784502b251b8e6485fc0ac_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjcyNQ_e5a2b55c-bbd8-458b-a9ae-0076bcb69cef">83.2</ix:nonFraction> million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjkxNw_a39650f0-cba5-4f87-8f51-43a5b3a9646e">2.7</ix:nonNumeric> and <ix:nonNumeric contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjkyNA_8f572ad3-26e9-4600-974a-35bbb3086f54">2.3</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div id="if042a09e5eee431a93fd100ba54df8e9_73"></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="holx:DetailsOfCertainBalanceSheetAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTY_cfef6003-b451-4736-b19b-7151f595aaf3" continuedAt="i740622a314e4404aa26e83da479d4a3c" escape="true">Other Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="i740622a314e4404aa26e83da479d4a3c"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTE_8b0e47de-cc19-47eb-a94a-02211d35d227" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMi0xLTEtMS0w_897645f6-2f21-448f-94ff-09b99dfc28f5">152.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMi0zLTEtMS0w_d3725d16-fcb1-40a1-8f31-2ea2e7136fc8">152.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMy0xLTEtMS0w_864d1b1c-d172-4e34-aeb5-eb7041f53442">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMy0zLTEtMS0w_b0d06ed8-15d4-43f4-9ff4-dd468fcc3d28">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNC0xLTEtMS0w_565ba401-1d76-4f8e-85c6-343abf83927e">207.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNC0zLTEtMS0w_de250025-6729-4fd9-8f2f-ba4221c13f7e">196.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNS0xLTEtMS0w_16933ad7-c155-4026-96d9-800de4cc3a5f">420.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNS0zLTEtMS0w_1a853c1b-6c70-4c94-922b-ec92c3b26788">395.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:23pt;margin-top:5pt"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTM_c84a73f4-8efc-4228-9212-5eb043016390" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMS0xLTEtMS0w_038137da-0ee0-4b57-85ea-74be43792cc7">483.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMS0zLTEtMS0w_32e3eb79-1719-4f02-a549-be522c859178">460.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMi0xLTEtMS0w_068e183f-9ba3-4453-a089-849b389a85e1">478.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMi0zLTEtMS0w_379e0151-8479-49c5-84cc-9ab5e38a1016">456.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMy0xLTEtMS0w_447522c1-8cf2-4e24-af80-0fec0a5c9aa5">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMy0zLTEtMS0w_9da85f3a-e132-4d22-9f6a-443d3b35b176">167.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNC0xLTEtMS0w_0007d041-3a1f-4d03-a891-764dc349c44a">45.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNC0zLTEtMS0w_57e6355c-cf0f-4902-9bb3-af96220badfe">44.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNS0xLTEtMS0w_114d28c1-bc49-4dab-9deb-031abb31693a">40.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNS0zLTEtMS0w_8fcbce06-27ac-4aa1-9011-640bc98b9fb1">40.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNi0xLTEtMS0w_757f4243-0d29-41c1-bdab-abae6a358bb8">16.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNi0zLTEtMS0w_d7e1e795-0e80-45fb-a940-a8caf9e586b4">16.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNy0xLTEtMS0w_851ddeac-fa58-4d8a-a13f-ca39265cd4b9">1,237.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNy0zLTEtMS0w_ec8cd101-70c2-432a-a82d-0283cbbaaed3">1,185.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOC0xLTEtMS0w_e587eb8c-1b4b-4686-827a-89f61f1e1350">723.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOC0zLTEtMS0w_77946221-b8af-4a0b-8a0f-13fce2d5d8b4">694.4</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOS0xLTEtMS0w_74b78f39-7dfc-47ec-a19a-3260d86277b9">514.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOS0zLTEtMS0w_780a6456-ecbe-46eb-9150-c11e0cd90798">491.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div></ix:continuation><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAyNw_fa12ad44-71b4-4355-a39d-9afba34e34a5" continuedAt="ie2a4305e2fdf4152ba851178321d14bc" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie2a4305e2fdf4152ba851178321d14bc" continuedAt="i00d22eb0946a43a786452a3389fdeabd">During the first fiscal quarter of 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first fiscal quarter of 2020, the Company had <ix:nonFraction unitRef="segment" contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTI4_5c926c5b-f492-4623-9792-a67e5c6acdcf"><ix:nonFraction unitRef="segment" contextRef="i10c0a8b3f4be439a89b84dd347cf9122_D20190929-20200328" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTI4_908d00c6-6375-42d9-a0e3-d3d19ab0066f">five</ix:nonFraction></ix:nonFraction> reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="i00d22eb0946a43a786452a3389fdeabd" continuedAt="i8e8cbdbefa6848f5abd29f5fad5ea396"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_320138f3-01e0-4e64-b24c-b84be4e252da"><ix:nonFraction unitRef="usd" contextRef="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_4c15c0ac-dd27-4360-bb5c-424409574257"><ix:nonFraction unitRef="usd" contextRef="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_7c86c09a-8e31-461f-abb5-50b9feb68e66"><ix:nonFraction unitRef="usd" contextRef="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_e078eb44-bc96-41b8-ac8f-416bd7a9fc37">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> inter-segment revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019. S<ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAxNA_db51ee79-7f88-4f98-9320-17233ee41d84" continuedAt="i2a151c08add94e78916d78988f256098" escape="true">egment information is as follows:</ix:nonNumeric></span></div><ix:continuation id="i2a151c08add94e78916d78988f256098"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:69.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMy0xLTEtMS0w_718577ef-8674-4b83-9a68-95fb93b1875f">1,128.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMy0zLTEtMS0w_6154be60-69c3-4c47-9185-84bd40dec8fc">311.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNC0xLTEtMS0w_a91715d1-906c-4f4b-b645-d8bcb48c2db3">332.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNC0zLTEtMS0w_2b40cb6c-f23e-48ab-8c52-98398daac0fb">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNS0xLTEtMS0w_cda94c9f-5bc4-4204-8090-e5be6026ca19">124.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNS0zLTEtMS0w_798f59c9-6a5c-4f9c-9c1d-e7a53c983d70">119.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNy0xLTEtMS0w_e08210a4-a4b5-4d5f-9f99-4d9266e0e6d9">24.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNy0zLTEtMS0w_a934cf22-76cf-476a-a291-f1d95dab0a45">23.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0xLTEtMS0xNDk1_7ff305e3-6e8f-4cc9-9e13-0511f2f3f47f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0zLTEtMS0xNDk1_bdfc4002-657c-4bf7-90a9-f4e444907ea0">65.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0xLTEtMS0w_50fbd1f0-3937-420d-95d8-f54516b30665">1,609.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0zLTEtMS0w_44eaec13-b176-4778-8662-7111b6cf6dcc">850.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTAtMS0xLTEtMA_b6b82008-46af-4d3d-9f51-c9f1cf2a7614">784.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTAtMy0xLTEtMA_6200a856-05a7-41ac-8774-1450ad53f3b0">49.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTEtMS0xLTEtMA_5a443f25-4c17-4da2-9e46-7e4e0c550b3e">86.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTEtMy0xLTEtMA_a97a8cea-82c9-41f7-9341-a186e9574392">93.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTItMS0xLTEtMA_4a1cdb6d-7d54-41af-9b2e-592f5f2b4dd6">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTItMy0xLTEtMA_1d5b360c-ee49-4561-bb23-cebf601da95b">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTQtMS0xLTEtMA_f04a2995-4e9b-4a48-9ca8-067ccfa58b87">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTQtMy0xLTEtMA_887518be-aa52-437b-b1f5-f1f8a217c18e">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMS0xLTEtMTUwNQ_b2084beb-ce4d-4e40-ab1e-b5933a7fb896">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMy0xLTEtMTUwNQ_448b4981-341a-4670-8c77-4bc7a6cc8122">51.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMS0xLTEtMA_fdfef846-a073-4b35-8827-031aa0db1d09">885.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMy0xLTEtMA_ca371c1c-0a1e-4d4b-8447-847c42011cb9">124.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTctMS0xLTEtMA_43c4b37a-7a00-44d6-b8a5-235e3d3a8dae">56.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTctMy0xLTEtMA_2c42e4e9-cbe2-477e-8bbb-9214d837594a">59.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTgtMS0xLTEtMA_64ebeec9-8dec-4fa6-8fad-0e47cb32fd46">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTgtMy0xLTEtMA_45689ba2-6c7b-44cc-aff1-b143767774a6">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTktMS0xLTEtMA_feb38206-360d-4fcf-9925-25e0a01278a9">23.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTktMy0xLTEtMA_e147178d-e443-471c-8ffb-de95ff0abec5">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjEtMS0xLTEtMA_d580de23-7d6b-4fcf-981e-061dc52b1e62">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjEtMy0xLTEtMA_8b1a4962-87bb-404b-bd53-657ca2159731">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMS0xLTEtMTUxMw_8ab394c1-667d-4a27-9870-44b2163c334e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMy0xLTEtMTUxMw_511b0655-d636-4e55-8714-6bc7f193de5b">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMS0xLTEtMA_83693883-49c9-4be0-93a7-1ea1c3d4c222">92.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMy0xLTEtMA_93be640c-8727-4b5a-bc8f-c27601ef68c9">94.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjQtMS0xLTEtMA_39fa0c2b-89e7-4abe-bb1c-9a6a91238667">38.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjQtMy0xLTEtMA_b191bcdb-b873-4121-995d-d47e8571a9b1">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjUtMS0xLTEtMA_9a5fa893-2187-4665-bc0b-8228df1cee38">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjUtMy0xLTEtMA_87751700-3810-47b4-b08a-2ffb0adddd16">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjYtMS0xLTEtMA_d37945fd-0d1e-4566-a41d-c22098c3afb3">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjYtMy0xLTEtMA_7b24d16c-f280-405a-9046-0972d52e3e0d">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjgtMS0xLTEtMA_2c25fbf7-303b-4003-bc80-d1aff3a748a8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjgtMy0xLTEtMA_c2c03bd1-08f2-403d-bfb3-1baaf1518fbd">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMS0xLTEtMTUyMw_2111e841-382e-44b0-b823-88b6233041ab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMy0xLTEtMTUyMw_50e95a0b-62fd-4b9e-9707-0240c1309da9">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2cca350406704671a994c46fd4de1acd_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMS0xLTEtMA_70c6fb98-8a4f-4ea4-b10b-dc6f351a5b38">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i189fd242f489432a9c8db82a5c7ffe1a_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMy0xLTEtMA_b57ea9d8-d18c-4839-9ba8-c9dba349490e">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMzAtMS0xLTEtMA_bd905d62-3d70-41a2-b512-341dd6a1615c">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMzAtMy0xLTEtMA_f715ce58-0a1a-4361-8577-774c387ac3a0">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:69.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2bd66551f9c242be97d7f7e5bf36f159_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMi0xLTEtMS0w_472cde2f-5897-4a8e-a0bb-265495ef5f24">2,177.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53fdb57bb16f4ecd921dea40ee6810c9_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMi0zLTEtMS0w_d7f8314d-a6d9-458f-81a4-a856dff93d46">2,161.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idea9543291624e5ababf4c314fce32dd_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMy0xLTEtMS0w_e593836e-5ca6-43ce-ac4d-5ca4b2336126">1,203.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ida8674e08ddb40be8abf86e02713868e_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMy0zLTEtMS0w_113b9b58-4412-41de-b9f2-36b037f5ec7f">1,200.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ce3ba4253a94d52bc59d8eee2d9a4bf_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNC0xLTEtMS0w_f329972c-ea2e-4a92-ba12-2c995fd5eb37">1,418.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b99c5a4675c4355b2ada4de33915985_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNC0zLTEtMS0w_22aedefd-fad5-4449-884e-d9655951c394">1,438.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95f6c5d4cda44d798ae43baeb9d4c057_I20201226" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNi0xLTEtMS0w_8ea604a1-63fb-4f5d-9281-f8e1fa759b6b">31.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f800d332c6b407198afce370a678a7d_I20200926" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNi0zLTEtMS0w_dbc46953-3b6d-4e6c-b332-e8e9855b527a">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0a4363dfa5c645a0825be13c07abee4c_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNy0xLTEtMS0w_1f82da96-faec-4450-a841-ed3e00e6242f">2,719.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i58367c7ce8c54c989fc82c51b7e6dbcf_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNy0zLTEtMS0w_96ceeb01-f6c9-4daa-bd33-3c70bbdc34c7">2,355.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfOC0xLTEtMS0w_d35127b9-c694-42fe-b7a3-d7138a0ece04">7,550.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfOC0zLTEtMS0w_47af6666-6d07-4831-8208-c0948a39ada4">7,195.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><ix:continuation id="i8e8cbdbefa6848f5abd29f5fad5ea396"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAyNQ_140fe03b-4adc-416d-bd3e-fecabce5d343" escape="true"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"></td><td style="width:69.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.025%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMi0xLTEtMS0w_71ab76f5-b5c5-482e-91fc-7815a8e59465">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMi0zLTEtMS0w_8c840ce0-8a4c-4c7f-90f2-e0a69958411a">74.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMy0xLTEtMS0w_3116b18e-ed78-42d9-916c-680d89b1f60b">21.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMy0zLTEtMS0w_07629c50-a29a-4d2d-8b35-18a5becc9bf5">12.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNC0xLTEtMS0w_1f2fb654-ed0c-49b3-b388-57ff920b0419">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNC0zLTEtMS0w_11941ee4-85eb-465f-8198-bf5e898264f3">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2b1fb47303fa4a959860825ff50f60af_D20200927-20201226" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNS0xLTEtMS0w_0b18dc7d-e79e-4172-af19-709a867bebda">2.8</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iaf46dd81205b47668902c1445ae9f97f_D20190929-20191228" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNS0zLTEtMS0w_8e7fccad-4d2d-41ee-8bd0-8397230e91d1">4.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNi0xLTEtMS0w_4476e67d-aa58-48ba-a0cd-712ce1139de4">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNi0zLTEtMS0w_6c70b0fd-4cee-4e7e-9fbb-16579e7e0d57">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNTEyNw_2a935b1b-ee70-49c9-9ccc-a321e514035e" continuedAt="ie478c9d940f34bd5b26517c3a5418183" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="ie478c9d940f34bd5b26517c3a5418183"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three months ended December 26, 2020 was a provision of <ix:nonFraction unitRef="number" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNjEw_f8aeb6bf-7e6b-4818-a608-4331c1fbabca">21.5</ix:nonFraction>% compared to a net benefit of <ix:nonFraction unitRef="number" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNjk1_1c4a7ce0-33bc-41cb-a4b5-f457a8880049">296.1</ix:nonFraction>% for the corresponding period in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 26, 2020 differed from the U.S. statutory tax rate primarily due to state income taxes, the global intangible low-taxed income inclusion, and unbenefited foreign losses, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 28, 2019 differed from the U.S. statutory tax rate primarily due to a $<ix:nonFraction unitRef="usd" contextRef="ic82c48e220f04e80a509c6a97393b47c_I20191228" decimals="5" format="ixt:numdotdecimal" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfMTA5OTUxMTY0Mjc2NQ_9ca1a8ce-419a-4f6f-82da-f7a37997e5b1">312.2</ix:nonFraction>&#160;million discrete tax benefit related to the Medical Aesthetics business outside basis difference, partially offset by an increase in the Medical Aesthetics business valuation allowance. The outside basis difference is the difference between the carrying amount of an entity's investment for financial reporting purposes and the underlying tax basis in that investment. An outside tax-over-book basis difference for an investment in a subsidiary results in the recognition of a deferred tax asset only when it becomes apparent that the reversal of the temporary difference will occur in the foreseeable future. As the Medical Aesthetics business met the assets held for sale criteria during the three months ended December 28, 2019, the requirement for recognition of the deferred tax asset for the outside basis difference was also met. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) <ix:nonNumeric contextRef="i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTcxMw_ac2252c7-726c-40cf-912c-e89e8fb1654f" continuedAt="i83ae2407551a4c9e9fbacdd355f06bf3" escape="true">Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i83ae2407551a4c9e9fbacdd355f06bf3"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTcyOA_a3d477d5-0777-4248-9d31-7a0a89d6b02d" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy0xLTEtMS0w_ba12c12d-8b7d-4cd5-a4e6-4a7ae0a18770">4,056.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy0zLTEtMS0w_b6dc9dd5-9b22-46d8-9c9a-018dedcdaf9d">2,969.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e60b8115b744ab191b4024f191eb8bf_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy01LTEtMS0w_bcf50ccf-8e0e-4919-9ff9-3b57640498d7">4,054.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e60b8115b744ab191b4024f191eb8bf_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy03LTEtMS0w_978e3768-4e24-4a4b-a24f-66ce336a3d8a">2,907.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243ea054fba6480fbcab7af21d6a4fce_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS0xLTEtMS0w_5d160eae-644b-4dbb-932e-05924190e8a1">560.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i243ea054fba6480fbcab7af21d6a4fce_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS0zLTEtMS0w_4cbd7e1f-4c4b-4060-bf07-3706748854de">486.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS01LTEtMS0w_f216794a-76cd-42fc-aa48-9d4ef959605a">549.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS03LTEtMS0w_b62385e9-26d6-4b4e-a2a8-00eef85b5ef9">477.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa5b970ae8547d5869dbb3f0236c428_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi0xLTEtMS0w_5f19c8f2-4247-4ea0-a949-9d800fa6680d">245.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafa5b970ae8547d5869dbb3f0236c428_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi0zLTEtMS0w_4a8c1bf5-3636-41ab-afe2-0695acd2bd04">183.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2252adf156645a6b718b3df114b1fad_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi01LTEtMS0w_5e587aba-1157-408f-998e-e957ef612213">245.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2252adf156645a6b718b3df114b1fad_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi03LTEtMS0w_cde5c7d3-300c-483f-bd1b-1affee9922ac">181.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC0xLTEtMS0w_a2d5faf1-8d7f-426f-b9e8-5ece49ad734d">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC0zLTEtMS0w_fbd2ff6a-2e04-4eee-8507-91bd6da26ced">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie951bc855db2428a86d3e005063b41ef_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC01LTEtMS0w_9bb71200-0d64-4d6d-a483-9ba850e25803">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie951bc855db2428a86d3e005063b41ef_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC03LTEtMS0w_8eaa7ea5-88ef-4a04-a937-c5cd461d4eb5">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3d41a755af40568a3e504182462ce6_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS0xLTEtMS0w_684c96d7-49a6-4351-85fc-1ba1c34276a5">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e3d41a755af40568a3e504182462ce6_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS0zLTEtMS0w_6aad55ad-ba69-45b8-8228-6490b9f09561">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c20b78ad72e4fe8a5420980636498f0_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS01LTEtMS0w_039930ff-0e0a-42f5-bb89-30376feff0b7">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c20b78ad72e4fe8a5420980636498f0_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS03LTEtMS0w_491fe4fd-2d0f-4a48-ba71-5b0836580191">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663bf06f259e40619f00b794ee8f3df4_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtMS0xLTEtMA_9ce11d78-83d8-4124-824a-0beb54837aed">4,866.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i663bf06f259e40619f00b794ee8f3df4_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtMy0xLTEtMA_db89c94a-4cd3-4666-b173-6b5d0e9cc062">3,643.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtNS0xLTEtMA_dc75acef-a578-4550-acd4-30f949e307fe">4,852.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtNy0xLTEtMA_636820eb-5b78-43c0-b424-b84c286b9284">3,569.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f4ea0fd45f430abe0bc8838c398d85_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItMS0xLTEtMA_0826f6dc-d888-4e8b-8170-1f9e1b2106f5">51.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if7f4ea0fd45f430abe0bc8838c398d85_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItMy0xLTEtMA_d1d5317e-1d46-47e8-ae73-33a6d830810a">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64c67176ca34a27bd5311e672ebe881_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItNS0xLTEtMA_d5b5902b-0a7b-4d8a-bb4f-0dc5ee11b800">51.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib64c67176ca34a27bd5311e672ebe881_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItNy0xLTEtMA_6328e1fc-35d1-476b-b162-d4acb101fe06">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aeb602620b040dbb06bd27522eabae8_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtMS0xLTEtMA_a4c1e81a-5bdf-4348-bea0-651cb19e6a46">25.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8aeb602620b040dbb06bd27522eabae8_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtMy0xLTEtMA_ad804e70-77b1-48a4-9bcb-8b7febe6faaa">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e39d5d745b47fd991512768cc51329_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtNS0xLTEtMA_515f14cd-ab3d-4bcf-ae00-75536bd949a9">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5e39d5d745b47fd991512768cc51329_I20200926" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtNy0xLTEtMA_aa0a6bcc-f708-4712-9da7-1bc56d4ca2ba">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtMS0xLTEtMA_14e2a03a-ca40-4155-afd7-91875a8044c4">4,943.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtMy0xLTEtMA_a01cc3fc-adf1-422a-a633-b29a07adc773">3,699.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtNS0xLTEtMA_c12f33c8-a1e3-4594-8d90-c43c5b986f39">4,931.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtNy0xLTEtMA_365df42d-82ec-435c-b96a-93448025852b">3,623.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTczMQ_3df288c3-2916-4c6b-90af-d1959fa0a81e" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;26, 2020 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.766%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMC0xLTEtMS0w_44541d76-8ea3-4000-88d2-84ceac88306a">213.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMS0xLTEtMS0w_b5e4af39-bfca-4a4a-b499-ac07fd8be886">274.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMi0xLTEtMS0w_9c038c9f-2043-4a71-a78b-8705cdea881a">178.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMy0xLTEtMS0w_f515b770-d526-4665-ad5f-c81cec086989">166.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfNC0xLTEtMS0w_a26d7a7c-56aa-42ef-ad89-de99dbf3f4ed">153.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RleHRyZWdpb246OWFjNDAwZDcxZDE5NGM2Y2JiZTVkNjRkMTg4YjRmZmVfODE_695609fd-7d87-4e5a-ad7d-76f27a5716bd" continuedAt="if0c5b6c18b544625a4272fef4f4d6853" escape="true">Product Warranties</ix:nonNumeric></span></div><ix:continuation id="if0c5b6c18b544625a4272fef4f4d6853"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RleHRyZWdpb246OWFjNDAwZDcxZDE5NGM2Y2JiZTVkNjRkMTg4YjRmZmVfNzg_631a10e8-b28f-4032-a823-439780c8fbce" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.888%"><tr><td style="width:1.0%"></td><td style="width:34.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.248%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.951%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.235%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.622%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.240%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 26, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0xLTEtMS0w_dbb291e2-9ccd-4e77-88cf-b0f6651394d7">9.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0zLTEtMS0w_d98ed542-335f-4b87-b09c-a03d21680063">3.3</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi01LTEtMS0w_74c35ae0-6281-4f0b-9d25-441221edab7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi05LTEtMS0w_9f528230-0b0c-4ad5-83d7-b007c9cdc1d2">3.7</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0xMS0xLTEtMA_05b2a825-1ed0-4d3b-a9a4-010481b205f9">9.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 28, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0xLTEtMS0w_c0673bae-a891-4703-a676-743484d3a9b6">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0zLTEtMS0w_e69eb3f2-3545-4918-9332-625f607b70bb">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy01LTEtMS0w_d229d4c3-c581-4c46-aed8-dab81b01378f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy05LTEtMS0w_69936296-53e2-41bf-a2c2-c8ca26efbfc5">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0xMS0xLTEtMA_0c04741b-18f0-4edb-86c4-877b7fc6e44b">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_88"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RleHRyZWdpb246YjY3YmNhYWI4Y2RhNDc5MDhjMTJkZjQ0OGQzNTdjOTZfMTkz_fbddcbe6-b1a5-47fa-a895-f7a26938eb8e" continuedAt="ib815ae4f56ef4df48aab34f58e21d755" escape="true">Accumulated Other Comprehensive Income (Loss)</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ib815ae4f56ef4df48aab34f58e21d755"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RleHRyZWdpb246YjY3YmNhYWI4Y2RhNDc5MDhjMTJkZjQ0OGQzNTdjOTZfMTkx_58e969b9-a6dd-4ac2-b15c-a99738770f7f" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:49.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.195%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i47fc0ea3fd504f739a98ccb1f8602c4d_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi0xLTEtMS0w_9d8d422e-73b6-4113-a345-a8737d260e79">22.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i012977a16707452184c540c1c42de324_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi0zLTEtMS0w_ce41e250-ee19-4fec-ad73-7a523d3384dd">1.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5ca4657cf4aa4a1883690d1eebc48675_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi01LTEtMS0w_c4387037-8076-4f0d-9ab4-ee706a05594a">0.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d9e66846015431a805ecdc7a2b07991_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi03LTEtMS0w_109322a8-5783-4687-be9e-dd65d40b0731">24.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1a34844d9d004ca59421077b20e85919_I20200926" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi05LTEtMS0w_4bdf0807-fb64-48b1-875a-36238406dd24">49.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy0xLTEtMS0w_e073865c-019e-49e5-873b-11eb0a778dd3">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy0zLTEtMS0w_b944916a-d589-4951-8036-499110404cf1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy01LTEtMS0w_454225d2-55f1-4c33-a1e9-5b476b7c1e80">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i691aa4e01085425ea916509572c8429b_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy03LTEtMS0w_406ac204-1cc6-4b22-8e63-863b26a3e485">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy05LTEtMS0w_1eabfbf5-b08e-44f5-8466-a8ccced46a4e">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC0xLTEtMS0w_07e066f0-2b39-4654-8e87-422e6ab8332d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC0zLTEtMS0w_9f29ee7c-7031-4e76-9aa5-722b487a33de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC01LTEtMS0w_00d5ce32-9aeb-4d09-850e-8188400faba9">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i691aa4e01085425ea916509572c8429b_D20200927-20201226" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC03LTEtMS0w_7771f4e3-3bfe-48bb-9384-f04defc191cb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC05LTEtMS0w_bcbc6252-dabb-451e-b226-aff55ba0ce55">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8f3b88a636814103b52b8b03edd8eaad_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi0xLTEtMS0w_a11008c0-f543-4252-9927-358ab6fef7bc">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7d6e7aa54b314ef6b6b0475e6c1109a8_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi0zLTEtMS0w_8e6c117d-5254-4c9c-bedf-fe5cbeb67f30">1.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d75b63e30b04cf3a05528421174cf0f_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi01LTEtMS0w_504f4ad7-7b1f-4c6b-b1c2-27153e69f528">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3e77d8b4a000446c87e498c3fb63a20c_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi03LTEtMS0w_49cdc022-9fa6-49ba-bb72-a41a194433ea">23.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ice8e1c44566e46d7a9428b4c849cf075_I20201226" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi05LTEtMS0w_b6895bdf-9972-411e-9a66-8198feab7ff5">30.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:49.489%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.192%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.195%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibcaee226383e4970803638e86e611e5f_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi0xLTEtMS0w_7cd615d0-041c-4f33-8ff8-67d38c994f62">41.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3896841cd53547aa9f241c9961480908_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi01LTEtMS0w_2fae8177-0fef-4d4d-b4c4-f1ab05025244">1.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i63616236f1194463b9ef82bc0e35b837_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi03LTEtMS0w_f87aefc0-d0a5-476f-ad0c-08ad2c3ff60e">2.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18a05642170e4a2eaba83cc4b9f1db63_I20190928" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi05LTEtMS0xNDEz_91803bff-3290-4e6a-84f0-57c573795fe1">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5aebec3fb9bb4e4488a724c4d7743031_I20190928" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi05LTEtMS0w_32376a8b-1278-4d8f-ab1b-f99047300db4">42.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy0xLTEtMS0w_51136c26-566c-40a5-8303-55eb7d3e4aad">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy01LTEtMS0w_4ef6c77e-ce98-4a73-9b07-37965d0279ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy03LTEtMS0w_86b93f62-a1e9-471a-9d0f-b3a499e66d41">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy05LTEtMS0xNDEz_e7b44bcc-ba85-4150-b3ca-81e99e33b60d">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy05LTEtMS0w_e12fbe71-f794-4698-96d2-8a3b7ac4723e">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC0xLTEtMS0w_e2a90992-c50c-4ab3-98d6-110b5631c3aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC01LTEtMS0w_256d8c9e-adf8-46f9-8089-853f52b3f959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228" decimals="-5" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC03LTEtMS0w_0de3ee58-b675-43ef-8c6a-d02f6028eaf5">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228" decimals="-5" format="ixt:zerodash" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC05LTEtMS0xNDEz_97fc8e1c-c8d4-432c-9b1e-e433d0593a11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228" decimals="-5" sign="-" name="us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC05LTEtMS0w_527350ff-ee5e-42b9-a0c6-a6c2dd351350">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0b08910f86f346c9b1270b470577d0b7_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS0xLTEtMS0w_c7a5bd14-1c39-40f9-8855-c39e26755ad0">33.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5265c14bdf944ebeb3a15533c9c6b571_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS01LTEtMS0w_662e6169-f1a8-41a6-8d1e-e695a63a6cc2">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i415e1540a94545748e7bb75e5b9e6db7_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS03LTEtMS0w_8b845232-f959-42f9-9231-8c73b241f3fc">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if85ce9153c7c4628b53a745f295945de_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS04NTYz_5ddd027d-a4ec-4499-a482-8b2b715f3b32"><ix:nonFraction unitRef="usd" contextRef="if85ce9153c7c4628b53a745f295945de_I20191228" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS04NTYz_d0e503c7-91dc-4c14-be98-ca05270883d1">7.8</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS0w_2fd9ad69-1cf0-4cad-97e5-41b9c92c9f1f">28.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_94"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19) Share Repurchase</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a share repurchase plan to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i570b9aef162a4a48b5ccb34ec6b061f8_I20191211" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzNTI1NA_4c1e78d3-4bc3-4b98-8d6d-eca54427617c">500.0</ix:nonFraction>&#160;million of the Company's outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020 the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. During the first quarter of fiscal 2021, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="i05539a83a04849449de905f6a9d13244_D20200927-20201226" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchasedDuringPeriodShares" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzMDUxOQ_3bd83486-c20a-4cea-ba9f-ce26e06875a9">1.5</ix:nonFraction>&#160;million shares of its common stock for a total consideration of $<ix:nonFraction unitRef="usd" contextRef="i05539a83a04849449de905f6a9d13244_D20200927-20201226" decimals="5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromRepurchaseOfEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzMDY2MQ_1c390dce-23c2-41d4-b513-6f5c5b6a66a3">101.3</ix:nonFraction>&#160;million. On December 9, 2020, the Board of Directors authorized a new share repurchase plan, which is effective for five years, to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="ic5ace0144f6f4565a88544db9fa33ffb_I20191211" decimals="5" format="ixt:numdotdecimal" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzNTI3MA_4a607051-6101-457a-88ec-faf4cbae352a">1.0</ix:nonFraction>&#160;billion of the Company's outstanding common stock effective December 11, 2020. The prior plan was terminated in connection with this new authorization. As of December 26, 2020, the Company had not repurchased any shares under this new plan.</span></div><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_97"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(20) <ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85Ny9mcmFnOmNlYjZlYzVjMzIwMjQ0YTlhNGMwNTBjMjE1ZTUwN2Q2L3RleHRyZWdpb246Y2ViNmVjNWMzMjAyNDRhOWE0YzA1MGMyMTVlNTA3ZDZfNDA4NQ_9a5e3fbb-5c37-496b-b786-0d87fd32cb25" continuedAt="ia9f1377ff2404fa1a0fca32edc050836" escape="true"><ix:nonNumeric contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226" name="us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted" id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85Ny9mcmFnOmNlYjZlYzVjMzIwMjQ0YTlhNGMwNTBjMjE1ZTUwN2Q2L3RleHRyZWdpb246Y2ViNmVjNWMzMjAyNDRhOWE0YzA1MGMyMTVlNTA3ZDZfNDA4Ng_1ba05d17-bf63-47f5-973e-fdeb757f9879" continuedAt="ie284c2754f8445beae5e16aab7a848f9" escape="true">New Accounting Pronouncements</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="ia9f1377ff2404fa1a0fca32edc050836" continuedAt="id232e799ab6b4bb4ae6424520645d95b"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie284c2754f8445beae5e16aab7a848f9">See Note 1 for Recently Adopted Accounting Pronouncements.</ix:continuation></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id232e799ab6b4bb4ae6424520645d95b">only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</ix:continuation></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_100"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic and associated economic disruptions on our business, financial condition, results of operations and cash flows and our ability to further draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing and possible future effects of the global COVID-19 pandemic on our customers and suppliers;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manufacture, on a scale necessary to meet demand, our COVID-19 assays as well as the systems on which the assays run; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the continuing worldwide macroeconomic uncertainty, including the UK's decision to leave the European Union (known as Brexit), on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the current trade war between the U.S. and other nations, most notably China, and the impending impact of tariffs on the sale of our products in those countries and potential increased costs we may incur to purchase materials from our suppliers to manufacture our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the development of new competitive technologies and products, and the impact and anticipated benefits of completed acquisitions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the new European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">strategic alliances and the ability of the Company to realize anticipated benefits of those alliances;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business strategies;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">estimated asset and liability values;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conducting business internationally;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact and costs and expenses of any litigation we may be subject to now or in the future;</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our compliance with covenants contained in our debt agreements;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations, including the potential impact of the proposed phase out of LIBOR by the end of 2023; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our liquidity, capital resources and the adequacy thereof.</span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy." &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including those set forth under "Risk Factors" set forth in Part II, Item 1A of this Quarterly Report, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div id="if042a09e5eee431a93fd100ba54df8e9_103"></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:5pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. Until December 30, 2019, our product portfolio included aesthetic and medical treatments systems sold by our former Medical Aesthetic business. We completed the sale of our Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Diagnostics segment, we offer a wide range of diagnostics products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause the common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, certain high-risk strains of human papillomavirus, or HPV, and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Trichomonas vaginalis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the parasite that causes trichomoniasis. In addition, in 2017 and 2018 we introduced the Aptima quantitative viral load tests for HIV, Hepatitis C and Hepatitis B. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-Cov-2, as well as a test for the detection of Group B Streptococcus, or GBS, that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In 2020, in response to the COVID-19 global pandemic, we developed and launched the Aptima SARS-CoV-2 assay (which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). The Panther Fusion SARS-CoV-2 assay and the Aptima SARS-CoV-2 assay were launched at the end of our second quarter and in the third quarter of fiscal 2020, respectively. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care for radiology, pathology and surgery. These solutions include breast imaging and analytics, such as our 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, ultrasound and connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize a technology called tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam, as well as conventional 2D full field digital mammography images. With the acquisition of SuperSonic Imagine in the first quarter of fiscal 2020, we now offer premium ultrasound imaging, further connecting Hologic capabilities across the continuum of breast care from screening to diagnosis and treatment. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, and our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, as well as our Fluent Fluid Management system, or Fluent. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and involves a trans-cervical procedure for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan Insight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19 Considerations</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global COVID-19 pandemic has created significant volatility, uncertainty, and economic disruption in the markets we sell our products into, primarily the U.S., Europe and Asia-Pacific. Starting in the second quarter of fiscal 2020, the spread of COVID-19 negatively impacted business and healthcare activity globally. In particular, due to government measures, elective procedures and exams were delayed or cancelled, there were significant reductions in physician office visits, and hospitals postponed or canceled capital purchases as well as limited or eliminated services; however, in the second half of the third quarter of fiscal 2020, we started to see a recovery of elective procedures and exams as economies were opened back up and restrictions eased, which has continued through the first quarter of fiscal 2021. The reductions in testing and procedures had a negative impact on our operating results and cash flows in fiscal 2020, however, the impact of the commercial release of our COVID-19 assays more than offset those negative impacts as we generated significant revenue from the sales of these assays starting in the third quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our results of operations and cash flows since the third quarter of fiscal 2020 have been positively impacted by the sale of our COVID-19 assays as well the continued recovery of our other primary product lines and businesses to pre-COVID levels, the COVID-19 pandemic could have an adverse impact on our operating results, cash flows and financial condition in the future. The factors that could create such adverse impact include: the severity and duration of the COVID-19 pandemic; the emergence of new COVID strain variants; continued demand for COVID-19 testing; competition from existing and new COVID-19 testing technologies and products as well as the timing and effectiveness of distributing vaccines; the COVID-19 pandemic's impact on the U.S. and international healthcare systems, the U.S. economy and worldwide economy; and the timing, scope and effectiveness of U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and associated economic disruptions. We expect that, if and when the current COVID-19 pandemic subsides, there may be a significantly reduced demand for ongoing testing, and thus, for our COVID-19 assays. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the negative impact of COVID-19 on our business, in April 2020, we initiated cost-cutting measures, which included not only reducing discretionary and variable spend, such as travel, marketing programs and the use of contractors, consultants and temporary help, but we also implemented employee furloughs, salary cuts primarily in the U.S., reduced hours and in certain instances, employee terminations. Further in April 2020, we shut down certain manufacturing facilities temporarily and implemented reduced work-week schedules in response to lower near-term demand for many of our products. As of the end of the third quarter of fiscal 2020, substantially all of the Company's employee cost-cutting measures ceased, and the majority of the impacted manufacturing facilities were back to pre-COVID-19 pandemic levels. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also taken and continue to take measures to ensure the safety of our employees and to comply with governmental orders. These measures could require that our employees continue to work remotely or otherwise refrain from reporting to their normal workplace for extended periods of time, which in turn could result in a decrease in our commercial and marketing activities. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademark Notice</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, Acessa, Acessa Health, Acessa Pro Vu, Affirm, Affirm Prone, Alpha Imaging, Aptima, ATEC, Brevera, Clarity HD, Eviva, Fluent, Fluoroscan, Genius 3D, Genius 3D Mammography, Health Beacons, Hologic, Horizon DXA, Insight, Intelligent 2D, LOCalizer, MyoSure, NovaSure, Panther, Panther Fusion, Rapid fFN, Selenia, Selenia Dimensions, SmartCurve, SuperSonic Imagine, ThinPrep, Tigris, and Tumark. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective owners. Hologic's use or display of other parties' trademarks, trade dress or products in this offering circular does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_106"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following sets forth descriptions of acquisitions and dispositions we have completed in fiscal 2020 and the first quarter of fiscal 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, we completed the acquisition of assets from NXC Imaging, for a purchase price of $4.9 million. NXC Imaging was a long-standing distributor of our Breast and Skeletal products in the U.S. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, we completed the acquisition of Acessa Health, Inc., or Acessa, for a purchase price of $161.3 million, which included a hold-back of $3.0 million that was paid in January 2021, and contingent consideration, which we estimated at $81.8 million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its Acessa ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are included in our GYN Surgical segment. The contingent consideration is based on annual incremental revenue growth over a three-year period ending annually in December. The contingent consideration is payable after each annual measurement period. In the first quarter of fiscal 2021, we remeasured the contingent consideration liability and recorded a charge of $4.6 million to record the liability at fair value.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed the acquisition of Health Beacons, Inc., or Health Beacons, for a purchase price of $19.7 million, which included hold-backs of $2.3 million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Health Beacons results of operations are included in our Breast Health segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the acquisition of assets from Alpha Imaging, LLC, or Alpha Imaging, for a purchase price of $18.0 million, which included a hold-back of $1.0 million and contingent consideration, which we estimated at $0.9 million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of our Breast and Skeletal Health products in the U.S.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, we acquired approximately 46% of the outstanding shares of SuperSonic Imagine S. A., or SSI, which is headquartered in France. SSI specializes in ultrasound imaging and designs, and develops and markets an ultrasound platform used in the non-invasive care path for the characterization of breast, liver or prostate diseases. We initially accounted for this investment as an equity method investment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, we acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, we owned approximately 78% of the outstanding shares of SSI at November 21, 2019 and controlled SSI's voting interest and operations. We performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within our consolidated financial statements within our Breast Health segment. We remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded in Other income (expense), net in the first quarter of fiscal 2020.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 26, 2020, we owned approximately 81% of SSI, and accordingly we have recorded an adjustment to our net income for the non-controlling interest we do not own of $1.0 million and $0.3 million for the three months ended December 26, 2020 and December 28, 2019, respectively.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disposition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, we completed the sale of our Medical Aesthetics business. At the closing, we received cash proceeds of $153.4 million. The sales price was finalized in the fourth quarter of fiscal 2020, and we paid $3.4 million, resulting in a final sales price of $150.0 million. As a result of the sale, we recorded a $30.2 million impairment charge in the first quarter of fiscal 2020 to record the asset group at fair value less costs to dispose as it met the assets held-for-sale criteria. For additional </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">information, see Note 7 to our consolidated financial statements included herein. Following the sale of our Medical Aesthetics business, we have not received any further product revenue related to this business, although additional expenses will be incurred primarily in connection with the indemnification of legal and tax matters that existed as of the date of disposition. In addition, we agreed to provide transition services for a period of up to 15 months.</span></div><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_109"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts in tables are presented in millions.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:28.121%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.387%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,113.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,455.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generated an increase in product revenues of 108.1% compared to the corresponding period in the prior year primarily due to the significant increase in revenues in the Diagnostics business principally from sales of our two COVID-19 assays, one of which was launched near the end of the second quarter of fiscal 2020 and the other in the third quarter of fiscal 2020, partially offset by no revenues from the Medical Aesthetics business as we disposed of this business segment on December 30, 2019, the beginning of our second quarter of fiscal 2020. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues increased $806.5 million or 263.1% in the current quarter compared to the corresponding period in the prior year primarily due to increases in Molecular Diagnostics of $805.6 million and Cytology &amp; Perinatal of $3.5 million, partially offset by a decrease of $2.6 million in blood screening. While we divested our blood screening business in the second quarter of fiscal 2017, we continue to provide long-term access to Panther instrumentation and certain supplies to the purchaser of that business. Molecular Diagnostics product revenue was $982.2 million in the current quarter compared to $176.6 million in the corresponding period in the prior year. The increase was primarily attributable to revenues of $745.3 million from our two SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay), an increase in collection kits primarily related to our SARS-CoV-2 assays and an increase in Panther and Panther Fusion instrument sales due to demand for increased testing capacity for COVID-19. We are actively working to increase capacity production to meet worldwide demand of these assays. Our Aptima assays (exclusive of our Aptima SARS-CoV-2 assay) increased $4.9 million in the current quarter compared to the corresponding period in the prior year primarily due to an increase in HPV assays driven by co-testing in Germany and to a lesser extent in the UK. In addition, we had an increase in our Fusion flu assays. Cytology &amp; Perinatal product revenue increased in the current quarter compared to the corresponding period in the prior year primarily due to higher ThinPrep test volumes in the U.S., which we primarily attribute to the recovery of wellness office visits that had previously been delayed or cancelled in response to the COVID-19 pandemic, partially offset by lower Perinatal product volumes. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues decreased $7.8 million or 3.8%, respectively, in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in sales volume and average selling prices of our digital mammography systems and related workflow products (primarily Intelligent 2D, Clarity HD and SmartCurve) and Affirm Prone breast biopsy tables. While these sales have declined moderately compared to the prior year comparable period, they have increased sequentially from the fourth quarter of fiscal 2020 as we believe many of our customers were purchasing to fulfill their budgets and demand has increased in the sequential quarters, which we primarily attribute to a recovery of elective procedures and exams as elective procedures and wellness visits have begun to recover from the initial cancellation and deferrals due to the COVID-19 pandemic earlier in fiscal 2020. However, we continue to believe that such visits continue to be adversely affect by the ongoing pandemic. These decreases in revenue were partially offset by increases in our interventional breast solutions products, primarily our Brevera system and disposables as we relaunched this product line in the fourth quarter </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of fiscal 2020 as well as our ATEC and Eviva devices, and our breast conserving surgery products in the current quarter compared to the corresponding period in the prior year primarily due to increased biopsy procedures, which we attribute to recovery of elective procedures and exams that had been previously delayed or cancelled in response to the COVID-19 pandemic. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased $5.3 million or 4.5%, respectively, in the current quarter compared to the corresponding period in the prior year primarily due to increases in the volume of MyoSure systems and Fluent Fluid Management systems. We primarily attribute the increases in the current quarter to recovery of elective medical procedures that had previously been delayed or cancelled in response to the COVID-19 pandemic. These increases were partially offset by decreases in NovaSure system sales in the current quarter compared to the corresponding period in the prior year. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues increased $1.8 million or 10.9% in the current quarter compared to the corresponding period in the prior year primarily due to an increase in sales volume of our Insight FD mini C-arm system. We also experienced an increase in revenue from the favorable foreign currency exchange impact of the weakened U.S. dollar against a number of currencies.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total product revenues were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:64.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.848%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current quarter compared to the corresponding period in the prior year, the percentage of product revenue derived from the U.S. decreased while Europe increased which we primarily attributed to strong sales of our SARS-CoV-2 assays in Europe and growth in our Aptima assays in Europe as we expanded our customer base and increased sales from the adoption of co-testing for cervical cancer screening in Germany. Asia-Pacific product revenue as a percentage of total product revenue decreased primarily due to lower sales of our SARS-CoV-2 assays in the Asia-Pacific region compared to the U.S. and Europe. Rest of world decline due to lower sales in Latin America.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.257%"><tr><td style="width:1.0%"></td><td style="width:36.018%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.561%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.481%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">154.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">151.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation and repair of our products. The majority of these revenues are generated within our Breast Health segment, and to a lesser extent, the Medical Aesthetics business prior to its disposition in the beginning of the second quarter of fiscal 2020. The increase in service and other revenue in the current quarter compared to the corresponding period in the prior year is primarily due to an increase in Breast Health service contract revenue as the Breast Health business continues to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period, an increase in spare parts revenue in the current quarter for services that had previously been delayed or cancelled due to the COVID-19 pandemic and additional royalty revenue from Grifols related to licensing intellectual property related to our COVID-19 assays for their sale in Spain. These increases were partially offset by the disposition of Medical Aesthetics which contributed $15.6 million of revenue in the prior year quarter.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:86.988%"><tr><td style="width:1.0%"></td><td style="width:36.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.311%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.479%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.647%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">237.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">34.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">47.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Impairment of Intangible Assets and Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">25.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">346.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">326.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">46.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 19.5% in the current quarter compared to 34.0% in the corresponding period in the prior year. Cost of product revenues as a percentage of revenue decreased in the current quarter primarily due to sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 51.2% of total product revenue in the current quarter. Also benefiting the gross margin was the disposition of Medical Aesthetics, which had lower gross margins compared to our remaining businesses. Partially offsetting these decreases was higher field service costs for the instrument installed base for the Diagnostics business and higher freight costs.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue decreased in the current quarter compared to the corresponding period in the prior year primarily due to sales of our SARS-CoV-2 assays and higher overall production reducing fixed overhead on a unit basis, and increased volumes of our ThinPrep Pap Test, partially offset by higher field service costs for the instrument installed base and freight charges internationally.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue decreased slightly in the current quarter compared to the corresponding period in the prior year primarily due an increase in sales volume of our breast biopsy and breast conserving surgery disposable products and favorable manufacturing variances, partially offset by a decline in average selling prices of our 3D systems and related components.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue increased in the current quarter compared to the corresponding period in the prior year primarily due to the product mix of higher volumes of MyoSure devices and lower volumes of NovaSure devices, which have higher margins compared to MyoSure, higher sales of Fluent fluid management systems, which is a lower-margin product.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue increased in the current quarter compared to the corresponding period in the prior year due to unfavorable manufacturing variances.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We divested the Medical Aesthetics segment on December 30, 2019, the beginning of our second quarter of fiscal 2020.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense decreased in the current quarter compared to the corresponding period in the prior year primarily due to no amortization from intangible assets acquired in the Cynosure acquisition in the current quarter as a result of the disposition of Cynosure on December 30, 2019 and lower amortization of intangible assets acquired in the Cytyc acquisition which reduce over time. These decreases were partially offset by amortization expense in the current quarter related to intangible assets acquired in the Acessa and SSI acquisitions.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets and Equipment. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Note 7 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets, of which $25.8 million was allocated to developed technology assets and written off to cost of revenues. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.526%"><tr><td style="width:1.0%"></td><td style="width:35.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">83.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin increased to 46.1% in the current quarter compared to 40.6% in the corresponding period in the prior year. The increase in the current quarter compared to the corresponding period in the prior year is primarily due to the disposition of Medical Aesthetics as service margins for Medical Aesthetics were lower compared to the Breast Health business, which generates the majority of our service revenues. In addition, in the current quarter the Breast Health business had an increase in service contract revenue which benefited gross margin as service contract revenue has higher margins compared to revenue from spare parts, installation and training. In addition, Diagnostics had higher royalty revenue.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.526%"><tr><td style="width:1.0%"></td><td style="width:35.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.654%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.662%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">59.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">61.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">144.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(16.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">87.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Impairment of intangible assets and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">411.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and Divestiture charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">294.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">309.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">36.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(14.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses decreased 3.1% in the current quarter compared to the corresponding period in the prior year primarily due to the disposition of the Medical Aesthetics business which contributed $7.3 million of expense in the prior year quarter. In addition, during the current quarter, we recorded a reduction to research and development expenses of $6.4 million from the Biomedical Advanced Research and Development Authority (BARDA) in connection with a grant to expand manufacturing capacity and obtain FDA approval of our SARS-CoV-2 assays. Partially offsetting these decreases was higher R&amp;D project spend in Surgical, higher compensation and benefits, the inclusion of expenses from the Acessa acquisition, a full quarter of SSI expenses and increased spending to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements. At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses decreased 11.7% in the current quarter compared to the corresponding period in the prior year primarily due to the disposition of the Medical Aesthetics which contributed $23.7 million of expense in the prior year quarter and to decreases related to our national sales meeting, travel and trade shows primarily in response to the COVID pandemic. Partially offsetting these decreases was an increase in commissions in the Breast Health, Surgical and Diagnostics from higher revenues, an increase in marketing initiatives spending, and the inclusion of expenses from the Acessa acquisition and a full quarter of SSI expenses.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses increased 4.5% in the current quarter compared to the corresponding period in the prior year primarily due to a charitable donation of $5.0 million, higher compensation and benefits, primarily from our deferred compensation plan, an increase in bad debt expense, higher consulting spend primarily from information system implementation projects, and the inclusion of expenses from the Acessa acquisition and a full quarter of SSI expenses. Partially offsetting these increases was the disposition of the Medical Aesthetics business </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which contributed $5.5 million of expenses in the prior year quarter, and in the current quarter we recorded a credit related to services provided under the transition services agreement with Cynosure and lower travel.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets results from customer relationships, trade names, distributor relationships and business licenses related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 2 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense increased $1.0 million in the current quarter compared to the corresponding period in the prior year primarily due to the Alpha Imaging acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa, we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December. As of the acquisition date for Acessa, we recorded a contingent consideration liability for the estimated fair value of the amount we expect to pay to the former shareholders of the acquired business. This liability is not contingent on future employment and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liabilities can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;As discussed in Note 7 to the consolidated financial statements, we recorded an aggregate impairment charge of $30.2 million during the first quarter of fiscal 2020. The impairment charge was allocated to the Medical Aesthetics long-lived assets of which $4.4 million was written off to operating expenses. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring and Divestiture Charges.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have implemented various cost reduction initiatives to align our cost structure with our operations and related integration activities. These actions have primarily resulted in the termination of employees. As a result, we recorded charges of $1.4 million in the current quarter, respectively, and $0.9 million in the prior year period, respectively, primarily related to severance benefits. </span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:35.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense in the current quarter decreased primarily due to a decrease in LIBOR year over year, the basis for determining interest expense under our 2018 Credit Agreement, and lower interest rates on our Senior Notes due to issuing our 2029 Senior Notes and paying off our 2025 Senior Notes, partially offset by issuance costs expensed from the issuance of the 2029 Senior Notes.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:35.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current quarter, we completed private placement of $950 million aggregate principal amount of the 2029 Senior Notes. The proceeds under the 2029 Senior Notes offering, together with available cash, were used to redeem the 2025 Senior Notes in the same principal amount. In connection with this transaction, we recorded a debt extinguishment loss of $21.6 million in the current quarter.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:79.824%"><tr><td style="width:1.0%"></td><td style="width:35.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.284%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.715%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.368%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.721%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(215.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current quarter, this account primarily consisted of net foreign currency exchange losses of $9.9 million, primarily from the mark-to-market of outstanding forward foreign currency exchange and foreign currency option contracts, partially offset by a gain of $6.2 million on the cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains. The first quarter of fiscal 2020, this account primarily consisted of a gain of $2.9 million on the cash surrender value of life insurance contracts related to our deferred compensation plan and a net gain of $3.2 million to reflect an adjustment to remeasure our initial investment in SSI in connection with purchase accounting, partially offset by net foreign currency exchange losses of $1.7 million primarily from mark-to-market of outstanding forward foreign currency exchange contracts, which were partially offset by realized gains from settling forward foreign currency contracts.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision (Benefit) for Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:80.847%"><tr><td style="width:1.0%"></td><td style="width:36.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.704%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.185%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.708%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision (Benefit) for Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">179.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(288.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(162.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended December 26, 2020 was a provision of 21.5% compared to a net benefit of 296.1% for the corresponding period in the prior year. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 26, 2020, the effective tax rate differed from the U.S. statutory tax rate primarily due to state income taxes, the global intangible low-taxed income inclusion, and unbenefited foreign losses, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended December 28, 2019, the effective tax rate differed from the U.S. statutory tax rate primarily due to a $312.2 million discrete tax benefit related to the Medical Aesthetics business outside basis difference, partially offset by an increase in the Medical Aesthetics business valuation allowance. The outside basis difference is the difference between the carrying amount of an entity's investment for financial reporting purposes, and the underlying tax basis in that investment. An outside tax-over-book basis difference for an investment in a subsidiary results in the recognition of a deferred tax asset only when it becomes apparent that the reversal of the temporary difference will occur in the foreseeable future. As the Medical Aesthetics business met the assets held for sale criteria during the three months ended December 28, 2019, the requirement for recognition of the deferred tax asset for the outside basis difference was also met.</span></div><div style="text-indent:24pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_112"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Until the divestiture of our Medical Aesthetics segment, we reported our business as five segments: Diagnostics, Breast Health, GYN Surgical, Skeletal Health and Medical Aesthetics. We completed the disposition of the Medical Aesthetics segment on December 30, 2019 (the first day of the second quarter of fiscal 2020). The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. We measure segment performance based on total revenues and operating income (loss). Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:36.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.685%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,128.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">816.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">262.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">784.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">735.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,484.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to the increase in product revenues associated with the introduction of our SARS-CoV-2 assays discussed above and an increase in royalty revenue from Grifols related to licensing intellectual property related to our COVID-19 assays for their sale in Spain.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current quarter compared to the corresponding period in the prior year due to an increase in gross profit from higher revenues with higher gross margins, partially offset by an increase in operating expenses. Gross margin was 79.9% in the current quarter compared to 49.0% in the corresponding period in the prior year. The increase in gross profit was primarily due to sales of our SARS-CoV-2 assays partially offset by an increase in freight costs to ship product internationally. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to higher compensation and benefits driven by an increase in headcount in the operations and sales departments, an increase in marketing initiatives, an increase in bad debt expense and an allocated portion of the charitable donation. These increases were partially offset by the BARDA $6.4 million credit and a decrease in spending for travel, consulting and trade shows. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.040%"><tr><td style="width:1.0%"></td><td style="width:36.223%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.688%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.685%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">332.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.6)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8.1)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to an increase of $9.5 million in service revenue, partially offset by a decrease of $7.8 million in product revenue, discussed above. The increase in service revenue in the current quarter is primarily due to an increase in service contract revenue as the Breast Health business continues to convert a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period and an increase in spare parts revenue.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current quarter compared to the corresponding period in the prior year primarily due to an increase in operating expenses partially offset by an increase in gross profit from higher service revenues. Gross margin was 57.8% in the current quarter compared to 57.4% in the corresponding period in the prior year. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to higher third-party commissions, an increase in bad debt expense, an allocated portion of the charitable donation and an increase in the current quarter of SSI expenses of $2.8 million. These increases were partially offset by a decrease in travel expenses, trade show expenses and R&amp;D project spend. The increase in the current quarter is also a result of the prior year period including a benefit from the reversal of acquisition related accruals and a holdback.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:85.818%"><tr><td style="width:1.0%"></td><td style="width:38.422%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.210%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.651%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.039%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.656%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(17.8)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(56.5)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current quarter compared to the corresponding period in the prior year due to an increase in operating expenses and a decrease in gross profit. Gross margin was 62.7% in the current quarter compared to 66.3% in the corresponding period in the prior year. The decrease in gross margin was primarily due to a decrease in product margins related to product mix discussed above, higher amortization expense from intangible assets due to the Acessa acquisition and a charge of $1.0 million related to the impact of stepping-up the acquired inventory to fair value in purchase accounting for the Acessa acquisition.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to inclusion in the current quarter of Acessa expenses of $4.2 million, recording a charge of $4.6 million in the current quarter to record the Acessa contingent consideration liability at fair value, increased spending on research and development projects, higher marketing initiative spend, higher consulting spend, higher commissions from the increase in sales and an allocated portion of the charitable donation, partially offset by a decrease in travel and trade show expenses.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"></td><td style="width:36.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in operating expenses, partially offset by a decrease in gross profit from lower gross margins. Gross margin was 35.6% in the current quarter compared to 42.0% in the corresponding period in the prior year. The decrease in gross margin was primarily due to unfavorable manufacturing variances and lower service margins.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current quarter compared to the corresponding period in the prior year primarily due to lower research and development expenses due to lower headcount and lower commission, partially offset by higher marketing initiative spend.</span></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medical Aesthetics</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:83.187%"><tr><td style="width:1.0%"></td><td style="width:36.334%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.678%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.662%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.684%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(65.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">51.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Loss as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(78.1)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical Aesthetics revenue and operating loss decreased in the current quarter compared to the corresponding period in the prior year due to the divestiture of the Medical Aesthetics segment on December 30, 2019, the first day of our second quarter of fiscal 2020. We will continue to incur expenses related to legal and tax matters that we have agreed to retain. These expenses were not significant in the first quarter of fiscal 2021. The operating loss in the first quarter of fiscal 2020 included an intangible assets and equipment impairment charges of $30.2 million.</span></div><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;26, 2020, we had $1,540.3 million of working capital and our cash and cash equivalents totaled $868.7 million. Our cash and cash equivalents balance increased by $167.7 million during the first three months of fiscal 2021 primarily due to cash generated from operating activities, partially offset by cash used in investing and financing activities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2021, our operating activities provided cash of $650.0 million, primarily due to net income of $653.4 million, non-cash charges for depreciation and amortization aggregating $92.8 million, stock-based compensation expense of $18.6 million, and a debt extinguishment loss of $21.6 million. Cash provided by operations was negatively impacted by a net cash outflow of $153.9 million from changes in our operating assets and liabilities. The net cash outflow was primarily driven by a $175.5 million increase in accounts receivable primarily due to an increase in our COVID-19 assay sales in our Diagnostics division and an increase in inventory of $21.2 million primarily due to an increase in Diagnostics inventory to support the SARS-CoV-2 assay demand and production. These cash outflows were partially offset by an increase in accrued expenses of $58.1 primarily due to an increase in accrued income taxes as a result of higher profits, partially offset by a decrease in accrued compensation due to the payment of the annual bonuses.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2021, our investing activities used cash of $49.9 million primarily related to capital expenditures of $44.8 million, which primarily consisted of the placement of equipment under customer usage agreements and purchases of manufacturing equipment to expand capacity of our molecular diagnostics manufacturing facilities.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2021, our financing activities used cash of $428.2 million primarily related to $970.8 million for the repayment of our 2025 Senior Notes, $250.0 million for the net repayment of amounts borrowed under the revolving credit line, payment of $101.3 million for repurchases of our common stock, $46.4 million for the payment of employee taxes withheld for the net share settlement of vested restricted stock units and $18.8 million for scheduled principal payments under our 2018 Credit Agreement. Partially offsetting these uses of cash were net proceeds of $950.0 million under our 2029 Senior Notes and $23.3 million from our equity plans, primarily from the exercise of stock options.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $2.76 billion at December&#160;26, 2020, which was comprised of amounts outstanding under our 2018 Credit Agreement of $1.44 billion (principal of $1.44 billion), 2029 Senior Notes of $932.9 million (principal of $950.0 million), and 2028 Senior Notes of $394.8 million (principal of $400.0 million).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, we refinanced our term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement, amended and restated as of October 3, 2017 ("2017 Credit Agreement"). </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The credit facilities under the 2018 Credit Agreement consisted of:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A $1.5 billion secured term loan ("2018 Amended Term Loan") with a maturity date of December 17, 2023; and</span></div><div style="text-align:justify;text-indent:4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28pt">A secured revolving credit facility (the "2018 Amended Revolver") under which the Company may borrow up to $1.5 </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">billion, subject to certain sublimits, with a maturity date of December 17, 2023.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The borrowings of the 2018 Amended Term Loan bear interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was equal to 1.0% as of December 26, 2020. The borrowings of the 2018 Amended Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate equal to 1.0% as of December 26, 2020. At December 26, 2020, borrowings under the 2018 Amended Term Loan were subject to an interest rate of 1.15%.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2018 Amended Term Loan in increasing amounts ranging from $9.375 million per three-month period commencing with the three-month period ending on December&#160;27, 2019 to $28.125 million per three-month period commencing with the three-month period ending on December&#160;29, 2022 and ending on September 29, 2023. The remaining balance of the 2018 Amended Term Loan after the scheduled principal payments, which was $1.4 billion as of December 26, 2020, and any amount outstanding under the 2018 Amended Revolver, which was $0.0 million at December 26, 2020, are due at maturity. In addition, subject to the terms and conditions set forth in the 2018 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances and insurance recoveries (subject to certain reinvestment rights). These mandatory prepayments are required to be applied by us,&#160;first, to the 2018 Amended Term Loan,&#160;second, to any outstanding amount under any Swing Line Loans,&#160;third,&#160;to the 2018 Amended Revolver,&#160;fourth&#160;to prepay any outstanding reimbursement obligations with respect to Letters of Credit and&#160;fifth, to cash collateralize any Letters of Credit. Subject to certain limitations, the Company may voluntarily prepay any of the 2018 Credit Facilities without premium or penalty.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Borrowings are secured by first-priority liens on, and a first-priority security interest in, substantially all of the assets of</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company and its U.S. subsidiaries, with certain exceptions. For example, borrowings under the 2018 Credit Agreement are not secured by those accounts receivable that are transferred to the special purpose entity under the Company's Accounts Receivable Securitization program (discussed below).</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including covenants restricting our ability, subject to negotiated exceptions, to incur additional indebtedness and grant additional liens on its assets, engage in mergers or acquisitions or dispose of assets, enter into sale-leaseback transactions, pay dividends or make other distributions, voluntarily prepay other indebtedness, enter into transactions with affiliated persons, make investments, and change the nature of their businesses. In addition, the 2018 Credit Agreement requires us to maintain certain financial ratios. The 2018 Credit Agreement also contains customary representations and warranties and events of default, including payment defaults, breach of representations and warranties, covenant defaults, cross defaults and an event of default upon a change of control of the company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants (a total net leverage ratio and an interest coverage ratio) measured as of the last day of each fiscal quarter. As of December 26, 2020, we were in compliance with these covenants.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which has been extended to the end of 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2028 Senior Notes is $400.0 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries. The 2028 Senior Notes were issued pursuant to an indenture, dated as of January 19, 2018, among the Company, the guarantors and Wells Fargo Bank, National Association, as trustee. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to&#160;35%&#160;of the aggregate principal amount of the 2028 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before February&#160;1, 2021, at a redemption price equal to&#160;104.625%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February 15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February 15, 2021. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acquisitions</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the end of our first fiscal quarter of 2021, on December 30, 2020, we completed the acquisition of Somatex Medical Technologies GmbH, or Somatex, for a purchase price of approximately $64.0 million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, on January 5, 2021, we announced that we entered into an agreement to acquire Biotheranostics, Inc., or Biotheranostics, for a purchase price of approximately $230.0 million. The closing is subject to certain regulatory approvals. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with certain of our acquisitions, we have incurred the obligation to make contingent earn-out payments tied to performance criteria, principally revenue growth of the acquired business over a specified period. In addition, contractual provisions relating to these contingent earn-out obligations may result in the risk of litigation relating to the calculation of the amount due or our operation of the acquired business. Such litigation could be expensive and divert management attention and resources. Our obligation to make contingent payments may also result in significant operating expenses.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contingent consideration arrangements are recorded as either additional purchase price or compensation expense if continuing employment is required to receive such payments. Pursuant to ASC 805, contingent consideration that is deemed to be part of the purchase price is recorded as a liability based on the estimated fair value of the consideration we expect to pay to the former shareholders of the acquired business as of the acquisition date. This liability is re-measured each reporting period with the change in fair value recorded through a separate line item within our Consolidated Statements of Income. Increases or decreases in the fair value of contingent consideration liabilities can result from changes in discount rates, changes in the timing, probabilities and amount of revenue estimates, and accretion of the liability for the passage of time. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary contingent consideration liability is from our acquisition of Acessa. We have an obligation to the former Acessa shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. At December 26, 2020 this liability was $86.4 million and no contingent payments have been earned or made.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 11, 2019, the Board of Directors authorized a new share repurchase plan to repurchase up to $500.0 million of our outstanding common stock, effective at the beginning of the third quarter of fiscal 2020. On March 2, 2020, the Board of Directors approved accelerating the effective date of the new share repurchase plan from March 27, 2020 to March 2, 2020. During the first quarter of fiscal 2021, we repurchased 1.5 million shares of our common stock for a total consideration of $101.3 million.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 9, 2020, the Board of Directors authorized a new share repurchase plan, which is effective to five years, to repurchase up to $1.0 billion of our outstanding common stock effective December 11, 2020. In connection with this authorization, the prior plan was terminated. As of December 26, 2020, we had not repurchased any shares under this new plan.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions and alliances that we believe will complement our current or future business. Subject to the &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report, if any, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports, and the general disclaimers set forth in our Special Note Regarding Forward-Looking Statements at the outset of this MD&amp;A, we believe that our cash and cash equivalents, cash flows from operations, and the cash available under our 2018 Amended Revolver will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2018 Credit Agreement, 2028 Senior Notes, and 2029 Senior Notes. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see &#8220;Risk Factors&#8221; in Part I, Item&#160;1A in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; above and &#8220;Risk Factors&#8221; set forth in Part II, Item 1A of this Quarterly Report as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020 or any other of our subsequently filed reports.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency contracts, interest rate swap agreements, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 Senior Notes and 2029 Senior Notes, the fair value of these financial instruments approximates their carrying amount. The fair value of our 2028 Senior Notes and 2029 Senior Notes as of December&#160;26, 2020 was $427.0 million and $974.0 million, respectively. Amounts outstanding under our 2018 Credit Agreement of $1.4 billion as of December&#160;26, 2020 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 Senior Notes, 2029 Senior Notes and 2018 Credit Agreement. The 2028 Senior Notes and 2029 Senior Notes have fixed interest rates. Borrowings under our 2018 Credit Agreement currently bear interest at the Eurocurrency Rate (i.e., LIBOR) plus the applicable margin of 1.0% per annum.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above, as of December&#160;26, 2020, there was $1.4 billion of aggregate principal outstanding under the 2018 Credit Agreement. Since these debt obligations are variable rate instruments, our interest expense associated with these instruments is subject to change. A hypothetical 10% adverse movement (increase in LIBOR rate) would increase annual interest expense by approximately $0.2 million. We entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding. The critical terms of the interest rate swap were designed to mirror the terms of our LIBOR-based borrowings under the 2018 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the LIBOR-based interest payments on $1.0 billion of principal. These interest rate swap contract expires on December 17, 2023.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The UK Financial Conduct Authority announced in 2017 that it intended to phase out LIBOR by the end of 2021, which was recently extended to the end of 2023. If changes are made to the method of calculating LIBOR or LIBOR ceases to exist, we may need to amend certain contracts, including our 2018 Credit Agreement and related interest rate swap agreements, and we cannot predict what alternative rate or benchmark would be negotiated or the extent to which this would adversely affect our interest rate and the effectiveness of our interest rate hedging activity.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the United States as well as manufacturing facilities in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Renminbi. The majority of our foreign subsidiaries' functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely affected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen, Chinese Yuan and Canadian dollar. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Operations due to (i) the impact of unrealized gains and losses reported in other income, net from the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">strengthens against them and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. A hypothetical 10% increase or decrease in foreign currencies in which we transact would not have a material adverse impact on our business, financial condition or results of operations.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_124"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 26, 2020, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of December&#160;26, 2020. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="if042a09e5eee431a93fd100ba54df8e9_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="if042a09e5eee431a93fd100ba54df8e9_133"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended September&#160;26, 2020 or any of our subsequently filed reports.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-top:6pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs  <br/>(in millions)      ($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 27, 2020 &#8211; October 24, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.35&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 25, 2020 &#8211; November 21, 2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,834&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468,622&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.95&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2020 &#8211; December 26, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">526,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">666,100&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.70&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,468,622&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.95&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,000.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On December 9, 2020, the Board of Directors authorized a new share repurchase plan to repurchase up to $1.0 billion of the Company's outstanding common stock, effective December 11, 2020. In connection with this authorization, the prior plan was terminated. As of December 26, 2020, the Company had not repurchased any shares under this new plan.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Exhibits </span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2021xex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2021xex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2021xex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2021xex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101verstreken-ukcontract.htm">Amended Contract of Employment between Jan Verstreken and Hologic dated December 11, 2020</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*             Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="if042a09e5eee431a93fd100ba54df8e9_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#if042a09e5eee431a93fd100ba54df8e9_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 27, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan<br/>Chairman, President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 27, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Karleen M. Oberton&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101verstreken-ukcontract.htm
<DESCRIPTION>EX-10.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i7049b528636b4b91bb7d14958758f6be_1"></div><div style="min-height:93.6pt;width:100%"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ex. 10.1</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%">AMENDED CONTRACT OF EMPLOYMENT </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Statement of Main Terms and Conditions of Employment, pursuant to the</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Rights Act 1996</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PARTIES TO THE CONTRACT OF EMPLOYMENT</font></div><div style="padding-left:68.1pt;text-align:justify;text-indent:-68.1pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer&#58; &#160;&#160;&#160;&#160;Hologic Limited, Heron House, Oaks Business Park, Crewe Road, Wythenshawe, Manchester M23 9HZ. Hereinafter called &#8220;the Company&#8221;</font></div><div style="padding-left:68.1pt;text-align:justify;text-indent:-68.1pt"><font><br></font></div><div style="padding-right:-2.25pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employee&#58; &#160;&#160;&#160;&#160;Jan Verstreken</font></div><div style="padding-right:-2.25pt;text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOB TITLE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be employed as Group President, International. You may be asked to perform additional duties or other roles from time to time during your employment with the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLACE OF WORK</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">You may be required to travel and work on behalf of the Company within the United Kingdom and globally for the proper discharge of your duties. You will be entitled to reimbursement of such expenses as detailed in the company&#8217;s Expense Claim procedure.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RELEVANT DATES</font></div><div style="padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">For continuous service purposes, your start date with the company will continue as 3rd January 2017</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REMUNERATION    </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Your remuneration is at the basic rate of &#163;425,600 per annum.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">You are eligible to participate in the Company&#8217;s Short-term Incentive Plan (STIP) with annual target of 75% base pay, subject to the rules that are from time to time in place alongside objectives set.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">You will be paid monthly into a personal bank account or building society account by credit transfer on or about the 20th day of the month in which salary is earned.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Salaries are normally reviewed annually in October. Reviews are at the total discretion of the Directors.  Increases are not automatic and take into account a number of variables, including performance, market value, qualifications and future potential.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">In accordance with the Employment Rights Act 1996 you hereby consent to the deduction of any sum owing by you to the Company from your salary or any other payment or payments due from the Company to you hereunder or otherwise. You also agree to make any payment of sums owing by you to the Company as requested. Such payments are likely to arise from but are not limited to remuneration&#47;expenses under&#47;overpayments etc.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOUSING SUPPORT</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">You will be entitled to receive a monthly payment of &#163;2,193.00 for housing support.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOURS OF WORK</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) Your normal hours of work will be 37.5 hours per week (Monday to Friday), which may vary according to the requirements of the business due to changing economic conditions and any &#160;&#160;&#160;&#160;future reorganization of the business. </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) The Company allows for each member of staff to take unpaid break(s) totaling one hour each &#160;&#160;&#160;&#160;day normally between 12.00 noon and 2.00pm.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that these hours fall well below the maximum hours allowed under the Working Time Regulations 1998.                           </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c ) The employee acknowledges that the limit under Regulation 4 (1) of the Working Time &#160;&#160;&#160;&#160;Regulations 1998 shall not apply to him&#47;her and accordingly agrees to work longer than 48 hours </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a week on average whenever necessary for the proper discharge of his&#47;her duties, or in any event as may be required by the company.  The employee is entitled to withdraw such agreement by providing three months&#8217; notice in writing to their manager.  </font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that &#34;working time&#34; for the purposes of the Working Time Regulations 1998 is defined as time at which you are at the Company's disposal, ready and willing to perform your duties.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPANY CAR &#47; CAR ALLOWANCE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will receive a car or car allowance as part of your compensation package, with a monthly value &#163;1,315.00</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GLOBAL HEALTH PLAN &#47; ALLOWANCE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will receive access to a Global Health Plan or receive a Global Health Plan allowance as part of your compensation package, with a monthly value of &#163;1,096.00</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLIDAYS</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Your annual paid holiday entitlement is 25 days plus English statutory public holidays. Holiday requests should be made to your manager as far in advance as is practical. Managers will make every effort to accommodate leave requests, but may not be able to approve all requests based on business need. You therefore should not make any financial commitments to a holiday before receiving approval.  </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (d) The Company&#8217;s Holiday Year runs from January to December and employees should make every effort to ensure that holidays are taken within that period. Outstanding holidays may not be carried over without prior authorisation from your manager.  If granted, carried-over days they must be taken during the first quarter of the following calendar year.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) In some locations it may be the company practice to close for one week at Christmas.  If this is the case, you will be required to allocate part of your annual holiday entitlement to facilitate this. Christmas or other arrangements will be notified to you in advance.</font></div><div style="padding-left:18pt;padding-right:-1.1pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Holiday pay may also be withheld in whole or in part should you fail to give proper notice of termination of your employment or should you leave prior to the end of your notice period. In such a case your holiday pay will be reduced by the number of days&#8217; notice not worked. Any overtaken pro-rata holiday entitlement will be deducted from your final salary.</font></div><div style="padding-right:-1.1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PENSION ARRANGEMENTS</font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company grants access to its Group Pension Scheme, or will make an equivalent allowance for payment into your personal pension vehicle.</font></div><div style="padding-right:-1.1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIFE ASSURANCE</font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides Life Assurance Cover for all permanent employees at the rate of 2 years gross remuneration.  You will be eligible for this benefit from your first day of employment.  Further details are available in the Employee Handbook.</font></div><div style="padding-right:-1.1pt;text-align:justify"><font><br></font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INCOME PROTECTION</font></div><div style="padding-right:-1.1pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will automatically be enrolled on the Company&#8217;s UK Income Protection scheme, subject to the rules of that scheme.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SICK PAY&#47;COMPANY SICK PAY ENTITLEMENT</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">You will be entitled to Company Sick Pay providing you comply with the Company Sick Pay procedures as detailed in the Employee Handbook.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">Sickness absence is calculated on a rolling 12 month basis and details of entitlements are available in the Employee Handbook.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">In accordance with legislation, the Company reserves the right to withhold company and&#47;or statutory sick pay in exceptional circumstances. </font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">You are required to notify the Company of any absence caused by the negligence of a third party.  Full details of the circumstances and particulars of any claims&#47;settlements awarded</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan Verstreken</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">2 of 5 Pages</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="padding-left:22.5pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">must be provided by you.  The Company reserves the right to request a refund of some or all of the sick payments paid to you.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MEDICAL REPORTS</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reserves the right to require employees to undergo medical examinations&#47;reports in respect of either sickness&#47;absence (regardless of duration) or in respect of the Access to Medical Reports Act 1988 or otherwise. Costs will be borne by the company and by signing this agreement you acknowledge that you have given your consent to the aforesaid.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHANGE TO PERSONAL CIRCUMSTANCES</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are required to notify your Manager in writing of any change of address or personal circumstances (including health conditions) as soon as is practicable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISCIPLINARY PROCEDURE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Details of the Company Disciplinary Procedure are available from your Manager or can be found in the Employee Handbook. Please note that this procedure is non-contractual and does not form part of your contract of employment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRIEVANCE PROCEDURE</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You have a right to express a grievance relating to your employment which in the first instance should be raised informally with your Manager who will make every effort to resolve the issue as soon as possible.  Please refer to the Employee Handbook for further information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> WHOLE TIME AND ATTENTION</font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) During your employment you shall be obliged to faithfully and diligently carry out the careful instructions of the Company and at all times use your best endeavours to promote the best interests of the Company.</font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:1.98pt">You may not work in a self-employed capacity or for anyone other than the Company without the prior written express permission of your manager. </font></div><div style="padding-left:14.2pt;text-align:justify;text-indent:-14.2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.77pt">You are not permitted to sell or attempt to sell goods or services for personal gain from or on the premises of the Company without</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> prior </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">express permission from your Manager.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONFIDENTIALITY </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">You shall not make use of, divulge or communicate to any person (save in the proper performance of your duties under this contract) any of the trade secrets or other confidential information of or relating to the Company or any Group Company, which you may have received or obtained while in the service of the Company or any Group Company.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">This restriction shall continue to apply after the termination of your employment without limit in point of time but shall cease to apply to information ordered to be disclosed by a Court of competent jurisdiction or otherwise required to be disclosed by law.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the purposes of this contract confidential information shall include, but shall not be limited to the secrets, dealings, details of customers, suppliers or employees and any details relating to the marketing or pricing of products or financial information of any kind.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATA PROTECTION</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">The Company retains and processes personal data concerning employees for the purpose of efficient human resource management.  You agree to the Company doing so and acknowledge that such data may be disclosed to employees and the Company&#8217;s professional advisors, in accordance with the principles of the Data Protection Act 1998. </font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">The Company has established proper safeguards to prevent misuse of such data and takes all reasonable steps to ensure that data is accurate, complete, current and relevant.  If you consider your data may be inaccurate or if you simply wish to have access to it to satisfy yourself, you may do so by contacting your Manager.</font></div><div style="padding-left:22.5pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan Verstreken</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">3 of 5 Pages</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DATA SECURITY</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">You must not at any time remove any documents or tangible items from the Company&#8217;s premises which belong to the Company or which contain any confidential information without the prior written consent of your Manager.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.28pt">You must not use computer hardware&#47;software without proper authorisation or licence   (including the copying of software outside the terms of the licence). You must not use your own hardware and&#47;or software on Company business, whether on Company premises or not, unless approval has been given in writing by your Manager. If such permission is given, the ownership of all Company data remains with the Company for all time and must not be divulged to any unauthorised person either during or after your employment with the Company.</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">You must return to the Company upon request and, in any event, upon the termination of your employment, all documents and computer files and discs, and tangible items which belong to the Company or which contain or refer to any confidential information which are in the your possession or under your control. </font></div><div style="padding-left:21.3pt;text-align:justify;text-indent:-21.3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)   You must, if requested by the Company, delete all confidential information from any reusable material and destroy all other documents and tangible items which contain or refer to any confidential information and which are in your possession or under your control.</font></div><div style="padding-left:21.3pt;text-align:justify;text-indent:-21.3pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TERMINATION OF EMPLOYMENT</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">In the event of resignation, you are required to give the Company 3 months of notice of your intention to resign. The right to waive all or part of the notice period may be exercised by either party by mutual consent.</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">In the event that your employment is terminated by the Company for any reason other than change in control (i.e., the Company being acquired), you will receive 24 months of total compensation including base pay, bonus, allowances and benefits (or cash equivalent). In the event your employment is terminated by the Company for change in control, you will receive   accrued obligations (includes pro-rated bonus), 2.99x annual base salary, 2.99x bonus and full vesting of equity.  The change in control period extends for 3 years after the change in control occurs.  Any payments under this provision are subject to local taxes and deductions.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NON-COMPETITION &#38; NON-SOLICITATION</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">In the event of termination via resignation or termination for any reason (including change in control), you are expressly prevented from soliciting employees who currently work for the Company, or who did so in the 12 months prior to leaving.</font></div><div style="padding-left:17.85pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">In the event of termination via resignation or termination for any reason (including change in control), you expressly refrain from entering the service of a company manufacturing or selling products or services likely to compete with those of the Company, to create on its own account a similar company or to participate directly or indirectly, in any capacity whatsoever. As such, you are prohibited from prospecting, for any product or service likely to compete with the products or services of the Company, the customers of the Company and to deal with any natural or legal person who has been the client of the Company at any time during the two (2) years preceding his effective departure from the Company. The territory concerned by this non-compete obligation is the United Kingdom.</font></div><div style="padding-left:17.85pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore it is expressly agreed that the execution of this clause is limited to a period of twelve (12) months from the date of the effective departure from the Company. During this non-compete period, the Company will pay an indemnity equal to the remuneration received by the employee on the basis of the previous 12 months, representing full compensation for the wages, bonuses and benefits received by the employee.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is understood that in all circumstances the Company will be able either to reduce the duration of the period of application of the non-competition clause, or to give up the latter.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:18pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan Verstreken</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">4 of 5 Pages</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INVENTIONS AND OTHER INDUSTRIAL AND&#47;OR INTELLECTUAL PROPERTY</font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">The parties foresee that you may create intellectual property in the course of your duties hereunder and agree that in this respect you have a special responsibility to further the interests of the Company. </font></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.78pt">Any Intellectual Property created by you during the continuance of your employment whether normal working hours or otherwise hereunder (whether capable of being patented or registered or not made or discovered in the course of your employment hereunder) and whether using the Company&#8217;s offices and facilities or otherwise in conjunction with or in any way affecting or relating to the business of any Company in the Group or capable of being used or adapted for use therein or in connection therewith shall forthwith be disclosed to the Company and shall (subject to sections 39 to 43 Patents Act 1977) belong to and be the absolute property of the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HEALTH AND SAFETY</font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)    Whilst employed by the Company you must take care for your own health and safety and &#160;&#160;&#160;&#160;that of fellow employees or other people who may be affected by your actions at work. You are expected to co-operate with management and&#47;or other employees in observing statutory duties as well as company policies relating to health and safety, as defined in the company's Health and Safety Policy.</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)  You must advise your Manager as soon as possible if you believe the design of your workplace is adversely affecting your health, or if you experience problems, headaches, eyestrain or muscular aches or pains, which you believe, may be attributable to your working conditions. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VARIATION</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be notified in writing of any variations to your Particulars of Employment in so far as those variations are not significant. You will be consulted prior to the introduction of significant variations.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Copies of documents referred to in this Statement are available from your Manager.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">You should regularly read the notice board in your workplace to ensure that you are aware of changes regarding your employment with the Company.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan Verstreken</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">5 of 5 Pages</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:93.6pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This agreement contains the written particulars of employment required to be given to you pursuant to the Employment Rights Act 1996 and the Working Time Regulations 1998 (as amended from time to time). For these statutory purposes it is confirmed that it is correct as at the date shown.</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMPLOYEE&#58;</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I have received a copy of these Particulars of Employment as required by S1. ERA 1996 and the attached documents, all of which I have read, understood and agree to be bound by the rules contained within them.</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signed&#58; &#160;&#160;&#160;&#160;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">By&#58; &#47;s&#47; Jan Verstreken</font></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt dashed #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Name&#58; Jan Verstreken</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt dashed #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EMPLOYER&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Signed on behalf of the Company &#58;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">  </font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Carmel O&#8217;Kane</font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt dashed #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Name&#58; Carmel O'Kane</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">VP Human Resources EMEAC                </font></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt dashed #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Date&#58; December 11, 2020</font></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt dashed #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Jan Verstreken</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">December 11, 2020</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:8pt;font-weight:400;line-height:120%">6 of 5 Pages</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>holx_q1-2021xex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if65c54c1bdf94dfa8c44de8f8e8beda6_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; January&#160;27, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>holx_q1-2021xex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ifd8d063343964a8d86a0394419921cec_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; January&#160;27, 2021 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>holx_q1-2021xex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia46de1995bed4fba8e11186e1f807389_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended December 26, 2020 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; January 27, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>holx_q1-2021xex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ideba2c9d84e2417d956c74b4ab1a0fcc_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended December 26, 2020 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; January 27, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>holx-20201226.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20201226" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20201226">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20201226_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20201226_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20201226_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20201226_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>1001002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>1002003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>1004005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>1006007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>1007008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.hologic.com/role/BasisofPresentation">
        <link:definition>2101101 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentationDetailsDetails" roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails">
        <link:definition>2402401 - Disclosure - Basis of Presentation Details (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.hologic.com/role/Revenue">
        <link:definition>2103102 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>2304301 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>2405402 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>2406403 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>2407404 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>2408405 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails">
        <link:definition>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1">
        <link:definition>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>2110103 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>2411407 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>2112104 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>2313302 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollForwardDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails">
        <link:definition>2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>2117105 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>2318303 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>2419411 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLosses" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses">
        <link:definition>2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesTables" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables">
        <link:definition>2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesDetails" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails">
        <link:definition>2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Disposition" roleURI="http://www.hologic.com/role/Disposition">
        <link:definition>2124107 - Disclosure - Disposition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DispositionDetails" roleURI="http://www.hologic.com/role/DispositionDetails">
        <link:definition>2425414 - Disclosure - Disposition (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>2126108 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>2132109 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.hologic.com/role/DerivativesTables">
        <link:definition>2333306 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>2434419 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
        <link:definition>2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueofDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
        <link:definition>2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>2437422 - Disclosure - Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails">
        <link:definition>2438423 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>2139110 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetail" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail">
        <link:definition>2440424 - Disclosure - Commitments and Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.hologic.com/role/NetIncomeLossPerShare">
        <link:definition>2141111 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables">
        <link:definition>2342307 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>2443425 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>2144112 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>2345308 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
        <link:definition>2446426 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>2447427 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail">
        <link:definition>2448428 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>2149113 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>2350309 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail">
        <link:definition>2451429 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail">
        <link:definition>2452430 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>2153114 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>2354310 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>2455431 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>2456432 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>2457433 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>2158115 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>2459434 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill">
        <link:definition>2160116 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>2361311 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
        <link:definition>2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>2463436 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>2164117 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>2365312 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>2466437 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>2167118 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>2368313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>2469438 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchaseSharerepurchaseDetails" roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails">
        <link:definition>2470439 - Disclosure - Share Repurchase Share repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncements" roleURI="http://www.hologic.com/role/NewAccountingPronouncements">
        <link:definition>2171119 - Disclosure - New Accounting Pronouncements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NewAccountingPronouncementsPolicies" roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies">
        <link:definition>2272201 - Disclosure - New Accounting Pronouncements (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_IndemnificationLiabily" abstract="false" name="IndemnificationLiabily" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmountAssessedInDamages" abstract="false" name="AmountAssessedInDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_PercentageAddedtoEurodollarRateMember" abstract="true" name="PercentageAddedtoEurodollarRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_ChangeInParValue" abstract="false" name="ChangeInParValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LegalAccrual" abstract="false" name="LegalAccrual" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DebtRedemptionPremiumPaid" abstract="false" name="DebtRedemptionPremiumPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AnnualIncrementalRevenueGrowthPeriod" abstract="false" name="AnnualIncrementalRevenueGrowthPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" abstract="false" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Netincome" abstract="false" name="Netincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BasisofPresentationAbstract" abstract="true" name="BasisofPresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_AssetsofBusinessHeldforSaleAbstract" abstract="true" name="AssetsofBusinessHeldforSaleAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_BusinessCombinationSharesAcquired" abstract="false" name="BusinessCombinationSharesAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_BusinessCombinationOwnershipPercentage" abstract="false" name="BusinessCombinationOwnershipPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AlphaImagingMember" abstract="true" name="AlphaImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MarketBasedAwardsMember" abstract="true" name="MarketBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_HealthBeaconsMember" abstract="true" name="HealthBeaconsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DebtInstrumentOfferingPricePercentOfFaceValue" abstract="false" name="DebtInstrumentOfferingPricePercentOfFaceValue" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_December112019Member" abstract="true" name="December112019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_A2025SeniorNotesMember" abstract="true" name="A2025SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" abstract="false" name="CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AmendedTermLoanMember" abstract="true" name="AmendedTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_December112020Member" abstract="true" name="December112020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_NotionalAmount" abstract="false" name="NotionalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Holdback" abstract="false" name="Holdback" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_RepaymentOfSeniorNotes" abstract="false" name="RepaymentOfSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessLicensesMember" abstract="true" name="BusinessLicensesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_FairValueAssumptionDiscountRate" abstract="false" name="FairValueAssumptionDiscountRate" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_MedicalAestheticsMember" abstract="true" name="MedicalAestheticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveIncomeAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ServiceRevenue" abstract="false" name="ServiceRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ComprehensiveIncome" abstract="false" name="ComprehensiveIncome" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MinervaMember" abstract="true" name="MinervaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BiothernosticsMember" abstract="true" name="BiothernosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SomatexMember" abstract="true" name="SomatexMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AmortizationCostofGoodsSold" abstract="false" name="AmortizationCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_AccountsReceivableSecuritizationMember" abstract="true" name="AccountsReceivableSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SharerepurchaseplanLineItems" abstract="true" name="SharerepurchaseplanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_AccountsReceivableAllowanceForCreditLossTransfers" abstract="false" name="AccountsReceivableAllowanceForCreditLossTransfers" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_NXCImagingMember" abstract="true" name="NXCImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_InterestRateCapAgreementsAggregatePremiumPayable" abstract="false" name="InterestRateCapAgreementsAggregatePremiumPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ProceedsFromSeniorNotes" abstract="false" name="ProceedsFromSeniorNotes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ContingentHoldbackMember" abstract="true" name="ContingentHoldbackMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Purchaseofinsurancecontracts" abstract="false" name="Purchaseofinsurancecontracts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_Costofservice" abstract="false" name="Costofservice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_SharerepurchaseplanTable" abstract="true" name="SharerepurchaseplanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_SuperSonicImagineMember" abstract="true" name="SuperSonicImagineMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessAcquisitionCashTenderOfferPricePerShare" abstract="false" name="BusinessAcquisitionCashTenderOfferPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="holx_Acceleratedsharerepurchaseagreement" abstract="false" name="Acceleratedsharerepurchaseagreement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PrepaidIncomeTaxesCurrent" abstract="false" name="PrepaidIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" abstract="false" name="BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RSUPSUMSUMember" abstract="true" name="RSUPSUMSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" abstract="false" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>holx-20201226_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20201226.xsd#CoverPage"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_75ad47e3-afe7-4f4b-a846-56847baa92ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:to="loc_us-gaap_OperatingIncomeLoss_75ad47e3-afe7-4f4b-a846-56847baa92ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_cc6f4978-9e0b-4fb7-89d5-6e1547d465f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:to="loc_us-gaap_InvestmentIncomeInterest_cc6f4978-9e0b-4fb7-89d5-6e1547d465f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_2146fd2e-f256-4385-bb6e-2fd84eb2cdf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:to="loc_us-gaap_InterestExpense_2146fd2e-f256-4385-bb6e-2fd84eb2cdf7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844e858a-35b6-4db3-a826-d7a07c36e95b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_844e858a-35b6-4db3-a826-d7a07c36e95b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_9a6a59f1-4e93-400b-ae4d-d5b50e744afe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_ffc301ef-46aa-4744-a643-8c5cf10f776b" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_9a6a59f1-4e93-400b-ae4d-d5b50e744afe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_f916573f-ae71-4df2-acb2-a2d1658fad9a" xlink:href="holx-20201226.xsd#holx_Netincome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_249c758f-38f4-4d78-8156-67f38c4da300" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_f916573f-ae71-4df2-acb2-a2d1658fad9a" xlink:to="loc_us-gaap_NetIncomeLoss_249c758f-38f4-4d78-8156-67f38c4da300" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_f8b5f6c5-0dfa-4388-940c-a98b95e22ff8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_Netincome_f916573f-ae71-4df2-acb2-a2d1658fad9a" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_f8b5f6c5-0dfa-4388-940c-a98b95e22ff8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_ac900401-c078-4e36-81f3-b1327e41b0cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:to="loc_us-gaap_Revenues_ac900401-c078-4e36-81f3-b1327e41b0cd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3f4f25a0-4d48-4f47-bb65-99e96a673037" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3f4f25a0-4d48-4f47-bb65-99e96a673037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_779dc02c-b25f-4d2d-b7a0-baaa3748a05d" xlink:href="holx-20201226.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:to="loc_holx_AmortizationCostofGoodsSold_779dc02c-b25f-4d2d-b7a0-baaa3748a05d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_d3f181ef-11d2-4c86-aa80-a36584b14dde" xlink:href="holx-20201226.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_d3f181ef-11d2-4c86-aa80-a36584b14dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_201d8642-0dbe-4e65-9a09-ef5e0ff0b8d6" xlink:href="holx-20201226.xsd#holx_Costofservice"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_4879d59a-3a70-4894-a8e8-06693b2a5559" xlink:to="loc_holx_Costofservice_201d8642-0dbe-4e65-9a09-ef5e0ff0b8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_c109541a-be8e-4ff6-a364-ce7f10e83946" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_d0230d47-168a-442a-bef7-65316e36b942" xlink:href="holx-20201226.xsd#holx_ProductRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c109541a-be8e-4ff6-a364-ce7f10e83946" xlink:to="loc_holx_ProductRevenue_d0230d47-168a-442a-bef7-65316e36b942" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_59b0cf41-657d-4a3a-ac8f-c7841de454b9" xlink:href="holx-20201226.xsd#holx_ServiceRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_c109541a-be8e-4ff6-a364-ce7f10e83946" xlink:to="loc_holx_ServiceRevenue_59b0cf41-657d-4a3a-ac8f-c7841de454b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bd75fd41-41e1-419b-a323-e5a54dbd328f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3f626c4d-1ca9-48c8-ad54-57f37e2ea1f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bd75fd41-41e1-419b-a323-e5a54dbd328f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_3f626c4d-1ca9-48c8-ad54-57f37e2ea1f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_167babc9-8a4d-4a31-a39f-cba2a3f8cf1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_bd75fd41-41e1-419b-a323-e5a54dbd328f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_167babc9-8a4d-4a31-a39f-cba2a3f8cf1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fbe35ab1-17d9-4752-b7b7-41f810476f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a9e8d81e-aa4a-477e-a9a0-52677110e8d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fbe35ab1-17d9-4752-b7b7-41f810476f7e" xlink:to="loc_us-gaap_GrossProfit_a9e8d81e-aa4a-477e-a9a0-52677110e8d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e704ff71-831a-4bcf-bace-a492181c2acd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fbe35ab1-17d9-4752-b7b7-41f810476f7e" xlink:to="loc_us-gaap_OperatingExpenses_e704ff71-831a-4bcf-bace-a492181c2acd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_8f75bb3a-c0dc-4549-9eed-8a80a3cef563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_8f75bb3a-c0dc-4549-9eed-8a80a3cef563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d5b8c888-aa0f-4e55-9f49-d79208a102bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d5b8c888-aa0f-4e55-9f49-d79208a102bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_ed241d5f-4897-464d-b27b-055de0b3541a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_SellingAndMarketingExpense_ed241d5f-4897-464d-b27b-055de0b3541a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_25d08291-bd1a-4eb2-9ff1-faefd5559ee8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_25d08291-bd1a-4eb2-9ff1-faefd5559ee8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_4ae1570b-dd77-4dff-9bcb-d7ea1217d696" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_RestructuringCharges_4ae1570b-dd77-4dff-9bcb-d7ea1217d696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_e849b625-9e9f-458d-a70e-5f860d04c898" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_e849b625-9e9f-458d-a70e-5f860d04c898" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_09ced024-82f2-4fe6-8976-c2ecead1b225" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_7d54c38c-1909-4760-a801-22eaf1727804" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_09ced024-82f2-4fe6-8976-c2ecead1b225" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_8551411c-2d52-4a50-ba82-737e86e8ee94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_72bdbf2d-b845-4d82-8465-08ee9d1ec66b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8551411c-2d52-4a50-ba82-737e86e8ee94" xlink:to="loc_us-gaap_NetIncomeLoss_72bdbf2d-b845-4d82-8465-08ee9d1ec66b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9403637c-69fa-4c25-81e1-2467819d8bff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_8551411c-2d52-4a50-ba82-737e86e8ee94" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9403637c-69fa-4c25-81e1-2467819d8bff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd379593-b1bc-454f-bfaa-ca7bde6a2eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d58e9c4e-bca6-4471-b6e9-71d803529a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd379593-b1bc-454f-bfaa-ca7bde6a2eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_d58e9c4e-bca6-4471-b6e9-71d803529a5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f72a2c97-911c-420d-ae89-1e109ce45bf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd379593-b1bc-454f-bfaa-ca7bde6a2eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_f72a2c97-911c-420d-ae89-1e109ce45bf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_7639eb04-adf3-4380-ab17-d5c7e317e597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_dd379593-b1bc-454f-bfaa-ca7bde6a2eda" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_7639eb04-adf3-4380-ab17-d5c7e317e597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_f6cc1983-e09d-414d-83e6-372f3c001191" xlink:href="holx-20201226.xsd#holx_ComprehensiveIncome"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_29254f11-6f98-41d2-93f4-ac5deb00c6b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_f6cc1983-e09d-414d-83e6-372f3c001191" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_29254f11-6f98-41d2-93f4-ac5deb00c6b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_05cdc462-71d7-40fc-bd68-713a4625f7ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_holx_ComprehensiveIncome_f6cc1983-e09d-414d-83e6-372f3c001191" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_05cdc462-71d7-40fc-bd68-713a4625f7ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_ad4bf29f-27b1-443f-8217-9a796bc11c66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:to="loc_us-gaap_LongTermDebtCurrent_ad4bf29f-27b1-443f-8217-9a796bc11c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_b7ebd66f-b7fa-42c0-9498-6f8afeb20747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:to="loc_us-gaap_AccountsPayableCurrent_b7ebd66f-b7fa-42c0-9498-6f8afeb20747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1e46b746-4864-4294-97fe-305c6de2bb11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1e46b746-4864-4294-97fe-305c6de2bb11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_0763d50c-125b-4fdb-8de4-3ed6c323b26c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:to="loc_us-gaap_DeferredRevenueCurrent_0763d50c-125b-4fdb-8de4-3ed6c323b26c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_c1ea6742-167d-4080-b457-6bac507a31ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_ca23e208-6c75-4f6d-a82d-4cc71fd4e819" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_c1ea6742-167d-4080-b457-6bac507a31ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0043bb81-5cb8-4026-8792-eb0a89d59566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:to="loc_us-gaap_AssetsCurrent_0043bb81-5cb8-4026-8792-eb0a89d59566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3c175d-5ba9-4457-a813-6f8f9a71bdcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_ff3c175d-5ba9-4457-a813-6f8f9a71bdcb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_04aedc33-7362-4503-8e07-5830a219af62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_04aedc33-7362-4503-8e07-5830a219af62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6b6d7de1-6308-429d-8779-7f6175bdb6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:to="loc_us-gaap_Goodwill_6b6d7de1-6308-429d-8779-7f6175bdb6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_4fe89047-01de-49c8-9318-c06c19d9b059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_f459c378-ffce-473c-b1a6-42ee7b7a9edc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_4fe89047-01de-49c8-9318-c06c19d9b059" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_92a1d55f-9067-4bde-9a8f-a74fcaee15cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d43d7ffd-13bf-469f-8aaf-a5d941309fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_92a1d55f-9067-4bde-9a8f-a74fcaee15cb" xlink:to="loc_us-gaap_StockholdersEquity_d43d7ffd-13bf-469f-8aaf-a5d941309fc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c53ea31b-9626-4b30-b8e0-44007d160eef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_92a1d55f-9067-4bde-9a8f-a74fcaee15cb" xlink:to="loc_us-gaap_MinorityInterest_c53ea31b-9626-4b30-b8e0-44007d160eef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_52d8c3b4-16de-4d43-bddf-0a3fe8818f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_PreferredStockValue_52d8c3b4-16de-4d43-bddf-0a3fe8818f07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_07a53a76-7e23-45cf-a973-a11a2a26c79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_CommonStockValue_07a53a76-7e23-45cf-a973-a11a2a26c79f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_98fe1bcf-071e-4a87-b060-ce8e2a5eb280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_98fe1bcf-071e-4a87-b060-ce8e2a5eb280" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_114a9840-fb13-4491-929c-fa6633c5a7c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_114a9840-fb13-4491-929c-fa6633c5a7c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7a15ffe4-3426-4f1a-a8ac-629287d5b3dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_TreasuryStockValue_7a15ffe4-3426-4f1a-a8ac-629287d5b3dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7972a74c-53ba-4eca-9dc9-e305b5897ad2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bc4b9c3-75eb-405e-af2c-eeae3a3ac35d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7972a74c-53ba-4eca-9dc9-e305b5897ad2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_415ff34e-4983-4b69-aa92-77b4c4782b1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_LiabilitiesCurrent_415ff34e-4983-4b69-aa92-77b4c4782b1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_688f7348-5a86-4f5d-b2d2-02eb67dbf563" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_688f7348-5a86-4f5d-b2d2-02eb67dbf563" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_7d7c9f44-7e64-4d4d-b7a9-3e9de6045c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_7d7c9f44-7e64-4d4d-b7a9-3e9de6045c6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bfaa7330-a058-446f-9fcc-1372f8ec3177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_bfaa7330-a058-446f-9fcc-1372f8ec3177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_e4ced75f-ac13-44ac-88c7-83c2f0e4b56e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_e4ced75f-ac13-44ac-88c7-83c2f0e4b56e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_a71d79e2-a57a-4c9f-b6a8-19f4334d3e0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_a71d79e2-a57a-4c9f-b6a8-19f4334d3e0f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ed22de4d-df8d-4383-8b55-ee6d2ad570dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_eabb6a06-3b52-47cc-a5fe-8b42bf9beec2" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ed22de4d-df8d-4383-8b55-ee6d2ad570dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_14af99db-f687-4f7a-9fcf-436e6fba665d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_14af99db-f687-4f7a-9fcf-436e6fba665d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_88640787-8286-4d46-93d3-750e13c10701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_88640787-8286-4d46-93d3-750e13c10701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_60d3168f-c403-46cb-aacf-7d4461666af3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:to="loc_us-gaap_InventoryNet_60d3168f-c403-46cb-aacf-7d4461666af3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_ee3be290-bc0d-49d5-850d-08324002aa09" xlink:href="holx-20201226.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_ee3be290-bc0d-49d5-850d-08324002aa09" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_4d3c9d2f-b018-4987-89ba-822f02e6a27b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_63ed54f4-3bac-4a38-99e9-c04efc8640df" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_4d3c9d2f-b018-4987-89ba-822f02e6a27b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73cb275b-0b95-4125-a286-b07584551cfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_73cb275b-0b95-4125-a286-b07584551cfa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b4c61ea5-1b74-4506-aab0-e4b4ab1f7398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_b4c61ea5-1b74-4506-aab0-e4b4ab1f7398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_5128101f-a92d-4f2b-9ac2-0b1ba46ede65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_5128101f-a92d-4f2b-9ac2-0b1ba46ede65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_c5e21402-cc21-49d3-aa8d-85de2b00ee17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_c5e21402-cc21-49d3-aa8d-85de2b00ee17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_53cdb895-c8ce-42d6-a862-b3cd045cadad" xlink:href="holx-20201226.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_53cdb895-c8ce-42d6-a862-b3cd045cadad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_83eaf2f4-cf8c-472f-9928-b106d706a94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_83eaf2f4-cf8c-472f-9928-b106d706a94b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ed3b8464-067e-44d5-9935-a9af492859af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_ed3b8464-067e-44d5-9935-a9af492859af" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_4161b5f7-164d-42b6-b341-a7fd2e43d70e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_4161b5f7-164d-42b6-b341-a7fd2e43d70e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_6e1b7da1-12d1-47df-9ee9-b76767ffad6a" xlink:href="holx-20201226.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_holx_ProceedsFromSeniorNotes_6e1b7da1-12d1-47df-9ee9-b76767ffad6a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_7ce520d0-9a14-40ac-9ce3-4af68a367be5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_7ce520d0-9a14-40ac-9ce3-4af68a367be5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e7fd34ff-9846-4fe7-9fc0-e04ac528ffd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_e7fd34ff-9846-4fe7-9fc0-e04ac528ffd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_3cfa2dc5-7f64-4822-b0cf-56fc999aae1d" xlink:href="holx-20201226.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_052348d4-0082-4046-9063-5b99f77e3856" xlink:to="loc_holx_RepaymentOfSeniorNotes_3cfa2dc5-7f64-4822-b0cf-56fc999aae1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_c969b572-edfb-4871-9f51-6ee85bf98ed2" xlink:href="holx-20201226.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_c969b572-edfb-4871-9f51-6ee85bf98ed2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_97d2750b-9878-4c21-8e62-9aaef8a746a1" xlink:href="holx-20201226.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:to="loc_holx_Purchaseofinsurancecontracts_97d2750b-9878-4c21-8e62-9aaef8a746a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9fbd639c-33ab-49b9-91b5-8d3f399d7842" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9fbd639c-33ab-49b9-91b5-8d3f399d7842" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_55eb893d-03fb-479f-a8f6-63cac493c025" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_55eb893d-03fb-479f-a8f6-63cac493c025" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d9c4ff48-2081-4cd4-95fb-64d55b46d333" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_907961ba-25c0-4909-b147-cc6014ee7f3c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d9c4ff48-2081-4cd4-95fb-64d55b46d333" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b305567c-42e6-4f0b-8367-5b107227401b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a994486-981c-4167-9665-95ac82573c67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b305567c-42e6-4f0b-8367-5b107227401b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_3a994486-981c-4167-9665-95ac82573c67" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ddd5d18a-6da9-4052-b2cf-1138415f84f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b305567c-42e6-4f0b-8367-5b107227401b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_ddd5d18a-6da9-4052-b2cf-1138415f84f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f73bd4cf-17c9-4825-8bca-a174aa05bae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b305567c-42e6-4f0b-8367-5b107227401b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_f73bd4cf-17c9-4825-8bca-a174aa05bae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ded2cee7-b97a-4399-9e42-8da2b96726fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b305567c-42e6-4f0b-8367-5b107227401b" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_ded2cee7-b97a-4399-9e42-8da2b96726fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e96e27b9-0b81-4399-89b1-96a9bec9035d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_ShareBasedCompensation_e96e27b9-0b81-4399-89b1-96a9bec9035d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_51c17009-837b-499f-8e90-53ebbbabc0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_51c17009-837b-499f-8e90-53ebbbabc0df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1350c1b1-b380-4377-b98a-e00d0d3c0c42" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1350c1b1-b380-4377-b98a-e00d0d3c0c42" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_36a5ef0a-7e64-4a03-b03a-e949c527303f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_NetIncomeLoss_36a5ef0a-7e64-4a03-b03a-e949c527303f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_014ba85c-adca-4466-b8cb-169392ba0561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_AdjustmentForAmortization_014ba85c-adca-4466-b8cb-169392ba0561" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_e2cffb11-a668-4ddc-8428-14a0da2556dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_e2cffb11-a668-4ddc-8428-14a0da2556dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_cbafac68-54d2-4f46-a5a9-6c1c8fdb1ebb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_Depreciation_cbafac68-54d2-4f46-a5a9-6c1c8fdb1ebb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_30b2de1c-d11e-4275-b5e8-cf05581e6597" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_30b2de1c-d11e-4275-b5e8-cf05581e6597" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_70186fca-6b0d-49a8-80c8-c7b53226d504" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_AssetImpairmentCharges_70186fca-6b0d-49a8-80c8-c7b53226d504" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9fe2559e-613e-4b6f-a6fb-9dd2673cbdf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9fe2559e-613e-4b6f-a6fb-9dd2673cbdf0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_be513f28-a621-40aa-9b00-0402756313e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_be513f28-a621-40aa-9b00-0402756313e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8b072cb-6ffe-43f4-bb8b-26cad41ba0c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_e8b072cb-6ffe-43f4-bb8b-26cad41ba0c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_29b00ee0-2033-41a5-8bd5-160a734d770f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_29b00ee0-2033-41a5-8bd5-160a734d770f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23d81cf8-6f10-4df3-914d-adf8d3f6f5da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_23d81cf8-6f10-4df3-914d-adf8d3f6f5da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_dc6d7e0f-425a-4c92-b334-afcf9761145f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_98eedde0-a4fe-4cbc-94f7-ba2310381308" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_dc6d7e0f-425a-4c92-b334-afcf9761145f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentationDetailsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20201226.xsd#Revenue"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueBusinessRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueGeographicalRevenueDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRevenuebyTypeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20201226.xsd#Leases"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinations"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3044d594-8992-45b0-a468-4d623eac346b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_3044d594-8992-45b0-a468-4d623eac346b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_223969d9-db82-40d0-a8c9-1fceb7fd62c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_223969d9-db82-40d0-a8c9-1fceb7fd62c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a0b0c5e2-d108-4609-ba0c-a20cf6073fb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_a0b0c5e2-d108-4609-ba0c-a20cf6073fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b4b7706a-d897-4b10-8e26-df878aa3dce8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b4b7706a-d897-4b10-8e26-df878aa3dce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1dfaea41-ce8b-4c22-931e-183ead19fb97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1dfaea41-ce8b-4c22-931e-183ead19fb97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_01b52c38-39ec-473b-b69b-42b2e104982c" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_01b52c38-39ec-473b-b69b-42b2e104982c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4f262f20-eeb4-49ec-b1b6-30918c952ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_4f262f20-eeb4-49ec-b1b6-30918c952ec4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e6dbd9da-a802-460b-b148-c101e7b4e56f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_e6dbd9da-a802-460b-b148-c101e7b4e56f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_519d402d-08fa-4859-86cb-da026077789e" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_519d402d-08fa-4859-86cb-da026077789e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_c3e8dfd5-be05-49ad-b688-eb0b9930a056" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_c3e8dfd5-be05-49ad-b688-eb0b9930a056" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_43d04dd7-61ea-430d-b6fe-9a21f269a7da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_Goodwill_43d04dd7-61ea-430d-b6fe-9a21f269a7da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cbbc4a01-9c63-4421-89a7-9cdaf9ba9659" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_cbbc4a01-9c63-4421-89a7-9cdaf9ba9659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_ab52a29b-b70c-4341-b35d-c704eac0e218" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_ab52a29b-b70c-4341-b35d-c704eac0e218" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dfdb81ef-bf7e-4a4c-ac26-dbe8d817d10f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_2dc7f310-98a2-4109-9818-5be6e423fad9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_dfdb81ef-bf7e-4a4c-ac26-dbe8d817d10f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20201226.xsd#Disposition"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DispositionDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_4d9b5652-ce38-4b2f-b24c-11a864aa4e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_22ad018c-3bbf-4975-92ec-afaa9ee7d3ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d9b5652-ce38-4b2f-b24c-11a864aa4e5a" xlink:to="loc_us-gaap_LongTermDebtCurrent_22ad018c-3bbf-4975-92ec-afaa9ee7d3ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_5cae6061-0eaa-4e39-9fea-1ea6bd59bd53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d9b5652-ce38-4b2f-b24c-11a864aa4e5a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_5cae6061-0eaa-4e39-9fea-1ea6bd59bd53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_3eefc25b-3133-477f-8ed9-61575b78f7ec" xlink:href="holx-20201226.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_4d9b5652-ce38-4b2f-b24c-11a864aa4e5a" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_3eefc25b-3133-477f-8ed9-61575b78f7ec" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20201226.xsd#Derivatives"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesAdditionalInformationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingenciesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShare"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_78f821f1-1183-4608-a306-6b1128e1c571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5316bccc-49ec-4e4c-b6a0-57f55bfeaff2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_78f821f1-1183-4608-a306-6b1128e1c571" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5316bccc-49ec-4e4c-b6a0-57f55bfeaff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a049af54-177c-4feb-ba03-6c5d17446a3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_78f821f1-1183-4608-a306-6b1128e1c571" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a049af54-177c-4feb-ba03-6c5d17446a3a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_bda4e635-3620-463a-b5c3-8dc3228aa7b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f0d84a01-8801-4116-a0e2-984fbeaac679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bda4e635-3620-463a-b5c3-8dc3228aa7b4" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_f0d84a01-8801-4116-a0e2-984fbeaac679" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c8c3256a-6ac2-4506-9d8d-e98d08d90ba4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bda4e635-3620-463a-b5c3-8dc3228aa7b4" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_c8c3256a-6ac2-4506-9d8d-e98d08d90ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_776836c2-fd44-4680-a774-7993bf82d9e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_bda4e635-3620-463a-b5c3-8dc3228aa7b4" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_776836c2-fd44-4680-a774-7993bf82d9e3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d0d00e2c-fb6e-4aac-8c28-7b1df37c1a87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_f4150634-f3bf-4b4c-aa2f-d9b401db71f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d0d00e2c-fb6e-4aac-8c28-7b1df37c1a87" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_f4150634-f3bf-4b4c-aa2f-d9b401db71f6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2cc243a2-7661-4ee4-b1cb-f7fde548c6d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d0d00e2c-fb6e-4aac-8c28-7b1df37c1a87" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2cc243a2-7661-4ee4-b1cb-f7fde548c6d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_c17b50ff-0ca6-4d5d-8922-9e3e2403ec92" xlink:href="holx-20201226.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_c17b50ff-0ca6-4d5d-8922-9e3e2403ec92" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_45261b6f-85e8-4677-8d9d-936e368e7f84" xlink:href="holx-20201226.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_45261b6f-85e8-4677-8d9d-936e368e7f84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_eb1b9253-afea-491b-90e7-f158776d8350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_eb1b9253-afea-491b-90e7-f158776d8350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_fea106a1-78c3-4397-b3dd-f882bd7489d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_fea106a1-78c3-4397-b3dd-f882bd7489d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_6428b1ea-2e8c-41d3-98b1-7814f00342c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_us-gaap_Land_6428b1ea-2e8c-41d3-98b1-7814f00342c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_d80aea30-9063-4933-8409-0894a4594a48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_4ad395de-88c7-44fa-8198-d9b7558e3ce7" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_d80aea30-9063-4933-8409-0894a4594a48" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxes"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwill"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarranties"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8a978d91-30f8-4308-9fbd-361efd1f2ab2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3a9bf772-72bc-4a9b-8dc6-f2535e86c9d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8a978d91-30f8-4308-9fbd-361efd1f2ab2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_3a9bf772-72bc-4a9b-8dc6-f2535e86c9d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_590b1f62-dd6f-4447-bee3-b6da7d5af7fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8a978d91-30f8-4308-9fbd-361efd1f2ab2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_590b1f62-dd6f-4447-bee3-b6da7d5af7fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a62fe523-0295-49a1-ac86-f08394355240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8a978d91-30f8-4308-9fbd-361efd1f2ab2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_a62fe523-0295-49a1-ac86-f08394355240" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0a73a0bd-1d81-492b-9b6c-ba48fa1cb4b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_8a978d91-30f8-4308-9fbd-361efd1f2ab2" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_0a73a0bd-1d81-492b-9b6c-ba48fa1cb4b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncements"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncementsPolicies"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>holx-20201226_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20201226.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended" id="ie60c7598629e45c7a5b86c683d13b5b6_CoverPage"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofIncome"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended" id="i0884b577aa0641898e029c1c03fa577b_ConsolidatedStatementsofIncome"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended" id="i2cf5f5fa1f6f499693070e7fccc9868e_ConsolidatedStatementsofComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended" id="i170925c3db264e9996a04102392c56e0_ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended" id="ib4c597a90ec14aec872b6336a23b3b02_ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="ic76747b2ea364be492b04f9720dc9613_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i3d48bcd408ac4eb08910da41be811520_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_7b7a9172-d8b0-413e-9d4d-5aebd2add428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_7b7a9172-d8b0-413e-9d4d-5aebd2add428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4edee5a6-6416-40e8-8e7a-d1c1c25b39b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4edee5a6-6416-40e8-8e7a-d1c1c25b39b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_398bde50-97cf-4f8c-845b-ba24b3b6b2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_SharesIssued_398bde50-97cf-4f8c-845b-ba24b3b6b2f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f276f7e-329c-4507-b96f-5de2623c639c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockholdersEquity_6f276f7e-329c-4507-b96f-5de2623c639c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ec58eb9-8c5b-4db3-b32d-1950dea1e90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ec58eb9-8c5b-4db3-b32d-1950dea1e90c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9334a44a-94cf-42c1-8239-a0dc0e73a847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9334a44a-94cf-42c1-8239-a0dc0e73a847" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_5c0b1d33-791a-4766-9efc-0a8a77c32efd" xlink:href="holx-20201226.xsd#holx_ChangeInParValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_ChangeInParValue_5c0b1d33-791a-4766-9efc-0a8a77c32efd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_e7005c8f-a6f8-45f9-be63-09ac6ecdbdd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_e7005c8f-a6f8-45f9-be63-09ac6ecdbdd8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_aad6ea1f-bc5b-4325-a686-01ee76ac773a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_aad6ea1f-bc5b-4325-a686-01ee76ac773a" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fa03a802-b3be-4a07-b050-31fe8ccbc4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fa03a802-b3be-4a07-b050-31fe8ccbc4f3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_16058932-c9b6-4643-91e9-0a90d7af3bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_16058932-c9b6-4643-91e9-0a90d7af3bf4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a998631d-4ea2-45ec-9c1a-4965dcb55a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a998631d-4ea2-45ec-9c1a-4965dcb55a9c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5035fec9-1995-4fc3-8bf9-01860f78c856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_NetIncomeLoss_5035fec9-1995-4fc3-8bf9-01860f78c856" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca4642aa-3d67-411a-b9a1-bd06ffc308e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca4642aa-3d67-411a-b9a1-bd06ffc308e1" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7a719402-cb55-404e-b2d1-16250acdc24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7a719402-cb55-404e-b2d1-16250acdc24b" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_6538254f-29ec-4275-9f21-d8de3c6b4b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_6538254f-29ec-4275-9f21-d8de3c6b4b52" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_3d5abc2a-7587-4f28-b0fa-3278c66d3975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_3d5abc2a-7587-4f28-b0fa-3278c66d3975" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_36284c00-2f1d-4e7e-9c1c-740371ed2e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_70c7ed82-90f8-4c53-b216-181481220c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_0ea01414-dfff-4471-b56e-539787c80c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_0ea01414-dfff-4471-b56e-539787c80c33" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_e22cc64c-c53d-4141-b046-d3e4bad964c2" xlink:href="holx-20201226.xsd#holx_Netincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_Netincome_e22cc64c-c53d-4141-b046-d3e4bad964c2" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_96fd8024-f08b-42dc-9f72-d4aafd089587" xlink:href="holx-20201226.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_96fd8024-f08b-42dc-9f72-d4aafd089587" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_5fdcbe5c-21db-473a-a651-533e1b1ef3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_5fdcbe5c-21db-473a-a651-533e1b1ef3fd" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3b90f61-1722-4b95-9e36-027162897241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3b90f61-1722-4b95-9e36-027162897241" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_98aff9cc-531a-48a1-9994-10981eb83db9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_98aff9cc-531a-48a1-9994-10981eb83db9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_e164bf16-99f0-4789-8f59-c640d34f95bd" xlink:href="holx-20201226.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:to="loc_holx_ShareRepurchaseProgramMember_e164bf16-99f0-4789-8f59-c640d34f95bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:to="loc_us-gaap_EquityComponentDomain_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:to="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a4883a16-c1d4-41d3-8543-a32a1f6962bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_CommonStockMember_a4883a16-c1d4-41d3-8543-a32a1f6962bc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a09ad1ed-1fb5-4225-9984-ce83d9e99f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a09ad1ed-1fb5-4225-9984-ce83d9e99f54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e528b82d-0923-4bfa-a895-9656be3855b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_RetainedEarningsMember_e528b82d-0923-4bfa-a895-9656be3855b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17436aa2-6550-44df-9ef3-9cf03499b848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17436aa2-6550-44df-9ef3-9cf03499b848" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_aa01f17d-72ad-4006-aada-566c07f25410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_TreasuryStockMember_aa01f17d-72ad-4006-aada-566c07f25410" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_935bd642-20b2-40c9-b5a5-408082309a1f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_935bd642-20b2-40c9-b5a5-408082309a1f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_ebeb2266-e238-45ee-8605-4cee54ca7a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_ebeb2266-e238-45ee-8605-4cee54ca7a12" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended" id="i1618502eedcd464cb30bb276b228749c_ConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended" id="i06cf595ce6cb4119aabd8b30b83cd22b_BasisofPresentation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentationDetailsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended" id="ide1dc28465ac41859b7a13965d350176_BasisofPresentationDetailsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_42b0592e-15ea-4ace-b503-4236e50b2cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_42b0592e-15ea-4ace-b503-4236e50b2cb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:to="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab9d3020-933b-4c75-aee6-fe7d9eeac33e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_ab9d3020-933b-4c75-aee6-fe7d9eeac33e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_67483acf-593e-4047-a4e9-617d47ffb044" xlink:href="holx-20201226.xsd#holx_SomatexMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:to="loc_holx_SomatexMember_67483acf-593e-4047-a4e9-617d47ffb044" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiothernosticsMember_dd427c58-54a2-417c-bb82-b33f6d300d4c" xlink:href="holx-20201226.xsd#holx_BiothernosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:to="loc_holx_BiothernosticsMember_dd427c58-54a2-417c-bb82-b33f6d300d4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_40e952f6-c186-4178-a5f5-951d7a2a065d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_40e952f6-c186-4178-a5f5-951d7a2a065d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ddc13d71-26d4-403f-af8b-fed874b4ee4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:to="loc_us-gaap_SubsequentEventMember_ddc13d71-26d4-403f-af8b-fed874b4ee4c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20201226.xsd#Revenue"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended" id="iffeba1577da749e9a93dd26c7f0ef0dc_Revenue"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended" id="if3b83abd0c44464b820482916e208a3d_RevenueTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="i73be1fd17593418b97efe7181518567b_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f6e2dee3-598c-4bf4-bfc7-ab30aebbdd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:to="loc_us-gaap_Revenues_f6e2dee3-598c-4bf4-bfc7-ab30aebbdd41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_dbdb9423-93af-4592-a06e-eff57fdde8c9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:to="loc_us-gaap_SegmentDomain_dbdb9423-93af-4592-a06e-eff57fdde8c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:to="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_8715bf99-b941-4fc1-8d92-12ceca6ea04e" xlink:href="holx-20201226.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_DiagnosticsMember_8715bf99-b941-4fc1-8d92-12ceca6ea04e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_3f96361c-7aa3-4380-bcf3-1d174cd55b23" xlink:href="holx-20201226.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_BreastHealthMember_3f96361c-7aa3-4380-bcf3-1d174cd55b23" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_a02bcc73-0865-4d90-9038-3eb36ca8e2cf" xlink:href="holx-20201226.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_GynSurgicalMember_a02bcc73-0865-4d90-9038-3eb36ca8e2cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_8af4cb13-325f-4ab7-bdd5-7183fe6b4154" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_MedicalAestheticsMember_8af4cb13-325f-4ab7-bdd5-7183fe6b4154" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_9eb9be9f-f518-4c7a-939d-521054d63c7a" xlink:href="holx-20201226.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_SkeletalHealthMember_9eb9be9f-f518-4c7a-939d-521054d63c7a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_1a6bc635-e65f-4e08-b5db-55b8c750919d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:to="loc_srt_ProductsAndServicesDomain_1a6bc635-e65f-4e08-b5db-55b8c750919d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:to="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_1e7cfe18-b0af-4717-bf67-8927d7c4f5c9" xlink:href="holx-20201226.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_CytologyPerinatalMember_1e7cfe18-b0af-4717-bf67-8927d7c4f5c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_0e71359c-5897-40b9-8f7e-54d9f1938e27" xlink:href="holx-20201226.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_MolecularDiagnosticsMember_0e71359c-5897-40b9-8f7e-54d9f1938e27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_db88b896-3b6f-4404-9c2b-d76c793a9dbe" xlink:href="holx-20201226.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_BloodScreeningMember_db88b896-3b6f-4404-9c2b-d76c793a9dbe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_7ffb5034-bd53-4232-a00e-43a08e3287e4" xlink:href="holx-20201226.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_BreastImagingMember_7ffb5034-bd53-4232-a00e-43a08e3287e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_f7cd5d63-c40d-4588-8e48-61a69ef1e518" xlink:href="holx-20201226.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_InterventionalBreastSolutionsMember_f7cd5d63-c40d-4588-8e48-61a69ef1e518" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9d41cf47-a62a-43ab-9465-22b71f3d24fc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:to="loc_srt_SegmentGeographicalDomain_9d41cf47-a62a-43ab-9465-22b71f3d24fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:to="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ac985acf-fae2-43dc-88e4-9373332855f3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:to="loc_country_US_ac985acf-fae2-43dc-88e4-9373332855f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_abd9b4c0-4e00-49d2-8464-471e1d5f4098" xlink:href="holx-20201226.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:to="loc_holx_InternationalMember_abd9b4c0-4e00-49d2-8464-471e1d5f4098" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="ib754d4b01cab4be29e7015305aea50b8_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6a986762-fa89-4228-a15a-f74479f6499a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:to="loc_us-gaap_Revenues_6a986762-fa89-4228-a15a-f74479f6499a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:to="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:to="loc_srt_SegmentGeographicalDomain_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:to="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0770c5de-7a3e-40c8-b210-143c841cbb97" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_country_US_0770c5de-7a3e-40c8-b210-143c841cbb97" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2a03df2b-6dec-4b59-8621-942453d0df11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_srt_EuropeMember_2a03df2b-6dec-4b59-8621-942453d0df11" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a7c69698-a034-4c7a-9ba7-1ee272a5b3ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_srt_AsiaPacificMember_a7c69698-a034-4c7a-9ba7-1ee272a5b3ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_ff42a067-b362-455e-949f-62259cb8f95c" xlink:href="holx-20201226.xsd#holx_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_holx_RestofWorldMember_ff42a067-b362-455e-949f-62259cb8f95c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="idd6fe3f19d694395bee51f13e2e9d004_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e99d479-1b7f-463c-8e90-22fc7bd7fa22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:to="loc_us-gaap_Revenues_2e99d479-1b7f-463c-8e90-22fc7bd7fa22" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:to="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:to="loc_srt_ProductsAndServicesDomain_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:to="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_4223451f-d4a9-4bfb-91bc-43fb98efc6d9" xlink:href="holx-20201226.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_ConsumablesMember_4223451f-d4a9-4bfb-91bc-43fb98efc6d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_40bf27b8-31f3-4c7b-8c75-7772222b5a3a" xlink:href="holx-20201226.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_40bf27b8-31f3-4c7b-8c75-7772222b5a3a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_964346f7-4833-4548-af65-a64cdef71480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_us-gaap_ServiceMember_964346f7-4833-4548-af65-a64cdef71480" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_53332b60-fc75-4686-8df6-3179622cac91" xlink:href="holx-20201226.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_OtherTypeofRevenueMember_53332b60-fc75-4686-8df6-3179622cac91" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i4e36cfbbf5224418990d0edd9b1c8c44_RevenueNarrativeDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="i3dc4a93cba514353bfb7164893c11bf6_RevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_df8d684b-a59e-469f-92b0-7a7de130c7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_df8d684b-a59e-469f-92b0-7a7de130c7b7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i50557a331a784cd2a835841c4c7902d5_RevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20201226.xsd#Leases"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended" id="ic5985f6f29cb476e86fcb83c401665e0_Leases"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended" id="i403afc1391e1461bb0fcd7ca8291083f_LeasesAdditionalLeaseInformationDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended" id="i84f2179403d94dcdb4f4166be9bef7f0_FairValueMeasurements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i368017ae132c44b6becfbed038bbf8c3_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="ibf436bcfd9384678ba28a8d1cd1bc72a_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_04fc8a65-2c34-4f8c-a2b3-dbfd4cd1e3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_04fc8a65-2c34-4f8c-a2b3-dbfd4cd1e3a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_242146e1-20c6-4354-8b69-3a9ea06ee31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_242146e1-20c6-4354-8b69-3a9ea06ee31b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9d00205e-9ec0-4735-952f-596273ac833f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9d00205e-9ec0-4735-952f-596273ac833f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ee6d075-bf4e-441a-9399-17f2e7e54add_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8ee6d075-bf4e-441a-9399-17f2e7e54add_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39b4a2b3-9a5b-436c-a7d9-9ea4e7294d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39b4a2b3-9a5b-436c-a7d9-9ea4e7294d91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_372f91e5-f06b-463d-921d-567a944a6399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_372f91e5-f06b-463d-921d-567a944a6399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_628699ea-53d5-4418-9a54-640718ead74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_628699ea-53d5-4418-9a54-640718ead74e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05e10a37-a1f6-47ad-8613-d5b01b9ff352_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_05e10a37-a1f6-47ad-8613-d5b01b9ff352_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_2d7ae8bf-b958-4619-8c72-84ddf9fe53ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_2d7ae8bf-b958-4619-8c72-84ddf9fe53ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9fb17b59-f600-41d8-9324-e42eb7524fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9fb17b59-f600-41d8-9324-e42eb7524fa2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4a894fee-4f7b-4eea-a780-a770acda60a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4a894fee-4f7b-4eea-a780-a770acda60a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_82b23f1e-e249-46ee-a4ae-caa687274431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_InterestRateSwapMember_82b23f1e-e249-46ee-a4ae-caa687274431" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e311384a-169e-4ff7-b27a-53fd6e27c914_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e311384a-169e-4ff7-b27a-53fd6e27c914_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_097c376c-3bd0-44d2-bc7a-b341e00fdace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:to="loc_us-gaap_LiabilityMember_097c376c-3bd0-44d2-bc7a-b341e00fdace" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="i914831812d6f47eea4cc2a965a330139_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_77ff0cd4-4d5d-4e4e-9053-88ba538094e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_us-gaap_AssetImpairmentCharges_77ff0cd4-4d5d-4e4e-9053-88ba538094e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_79a03ed1-4c7f-4223-b5f5-2b3b925409ee" xlink:href="holx-20201226.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_holx_PrincipalAmountOfBorrowings_79a03ed1-4c7f-4223-b5f5-2b3b925409ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5420ac50-3ded-4c5e-9100-2c16318ce99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5420ac50-3ded-4c5e-9100-2c16318ce99c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_90e91eda-399b-4818-91c7-e2dafd04bbcc_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:to="loc_us-gaap_SegmentDomain_90e91eda-399b-4818-91c7-e2dafd04bbcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:to="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_e16437c4-fb27-43ce-823a-fe2b33eb4c53" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:to="loc_holx_MedicalAestheticsMember_e16437c4-fb27-43ce-823a-fe2b33eb4c53" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fd685a84-5456-411e-8ca0-d438159d1efe_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fd685a84-5456-411e-8ca0-d438159d1efe_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_241b200c-fe8b-4004-8a15-6dafafcf81fc" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_CreditAgreementMember_241b200c-fe8b-4004-8a15-6dafafcf81fc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_b0a844a4-e1d5-4311-86c4-72924d99ddaa" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_A2025SeniorNotesMember_b0a844a4-e1d5-4311-86c4-72924d99ddaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_87f5961e-11cc-48a3-93e3-bee674434ea0" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_A2028SeniorNotesMember_87f5961e-11cc-48a3-93e3-bee674434ea0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended" id="i45df7d3d648d4266945202722b5bd678_FairValueMeasurementsRollForwardDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinations"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended" id="i599f83adc0914cf4824c70cf6331c510_BusinessCombinations"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended" id="ie3efd8cbd32146c9a8b807b7dfed1fd0_BusinessCombinationsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="i5516955566fa400888df245dd935689f_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87d24782-62b1-4134-9359-c7ebe31289d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87d24782-62b1-4134-9359-c7ebe31289d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_5efb3dda-52a3-4b8a-8ba2-c160ccf0d3be" xlink:href="holx-20201226.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_5efb3dda-52a3-4b8a-8ba2-c160ccf0d3be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_549dbdc3-016c-457a-89c9-a8cb5f7d9856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_549dbdc3-016c-457a-89c9-a8cb5f7d9856" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a049f89f-7263-441f-977c-2c810f7be3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_Goodwill_a049f89f-7263-441f-977c-2c810f7be3ba" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ade7a6b8-0dd8-459d-bcfa-bda445ad2b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ade7a6b8-0dd8-459d-bcfa-bda445ad2b61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_7b783754-8474-4dd1-a501-630748f1b28a" xlink:href="holx-20201226.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_7b783754-8474-4dd1-a501-630748f1b28a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_7d9cce8f-08dc-4bf5-b3e2-dbc340044bbe" xlink:href="holx-20201226.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationSharesAcquired_7d9cce8f-08dc-4bf5-b3e2-dbc340044bbe" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_020783f9-cc1a-4f97-a7bd-fda55e7b51ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_020783f9-cc1a-4f97-a7bd-fda55e7b51ce" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_d0b20502-61ba-4f9c-999f-c71eda598368" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_d0b20502-61ba-4f9c-999f-c71eda598368" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_9dc0e875-4e83-43d1-97e4-4205cd814bde" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_9dc0e875-4e83-43d1-97e4-4205cd814bde" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_8fccd2d0-0dc0-4df0-ae9a-8c9bba61c856" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_8fccd2d0-0dc0-4df0-ae9a-8c9bba61c856" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_4410943c-1830-4f34-96c4-ce00d196d13d" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_4410943c-1830-4f34-96c4-ce00d196d13d" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_8c981734-4fe2-4541-a8c9-7daffae04fca" xlink:href="holx-20201226.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_FairValueAssumptionDiscountRate_8c981734-4fe2-4541-a8c9-7daffae04fca" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_16990c6f-7b9d-4b38-ba24-35b82aeae903" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_16990c6f-7b9d-4b38-ba24-35b82aeae903" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bcc65cf1-0002-47e7-a009-f3c9880362ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bcc65cf1-0002-47e7-a009-f3c9880362ec" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d48dd77-8e97-4cde-a367-5795998ec40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d48dd77-8e97-4cde-a367-5795998ec40a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_91feb257-29f4-4932-9301-818da79bcdf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_91feb257-29f4-4932-9301-818da79bcdf0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c3b9ac9-0f61-44a4-8819-37d02234e273" xlink:href="holx-20201226.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c3b9ac9-0f61-44a4-8819-37d02234e273" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_8bf0327a-eb55-4676-81eb-3a70d7426bb5" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_8bf0327a-eb55-4676-81eb-3a70d7426bb5" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c25e3de5-3411-4cd2-a470-d84ae6f819d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c25e3de5-3411-4cd2-a470-d84ae6f819d6" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_d15a3810-aa5b-4e98-8383-febfc03e8b0e" xlink:href="holx-20201226.xsd#holx_Holdback"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_Holdback_d15a3810-aa5b-4e98-8383-febfc03e8b0e" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6ab6896f-032a-419e-816e-e0f3faf337a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6ab6896f-032a-419e-816e-e0f3faf337a2" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b264572c-ced1-452b-9cc0-099f1f0c4d3f_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_b264572c-ced1-452b-9cc0-099f1f0c4d3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_f3cbe077-8545-4ec9-9042-c850d516f720" xlink:href="holx-20201226.xsd#holx_NXCImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_NXCImagingMember_f3cbe077-8545-4ec9-9042-c850d516f720" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_252ca810-10e5-476c-b507-f7083666d025" xlink:href="holx-20201226.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_AcessaHealthMember_252ca810-10e5-476c-b507-f7083666d025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_ec0e8a5c-4fa2-4c36-b48c-793df93c8dd3" xlink:href="holx-20201226.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_SuperSonicImagineMember_ec0e8a5c-4fa2-4c36-b48c-793df93c8dd3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_7693b834-1fe1-4232-b1d0-9d3fd3de32e0" xlink:href="holx-20201226.xsd#holx_HealthBeaconsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_HealthBeaconsMember_7693b834-1fe1-4232-b1d0-9d3fd3de32e0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_97984349-0f8f-4e30-b3e7-b2a109bbcc34" xlink:href="holx-20201226.xsd#holx_AlphaImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_AlphaImagingMember_97984349-0f8f-4e30-b3e7-b2a109bbcc34" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4a3bc9cb-f05d-48e9-b561-743a40071184_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4a3bc9cb-f05d-48e9-b561-743a40071184_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_8425edde-5104-4d97-a1ca-1b99027daa8c" xlink:href="holx-20201226.xsd#holx_ContingentHoldbackMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:to="loc_holx_ContingentHoldbackMember_8425edde-5104-4d97-a1ca-1b99027daa8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e05233a-e782-4ad5-84a7-3ea7e4345d0a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_2e05233a-e782-4ad5-84a7-3ea7e4345d0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c471490-9ec8-4981-8290-b4ba0ab52116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c471490-9ec8-4981-8290-b4ba0ab52116" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_24d419d0-5e17-4a57-b1e0-ccfec7972540" xlink:href="holx-20201226.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_holx_DevelopedTechnologyMember_24d419d0-5e17-4a57-b1e0-ccfec7972540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_46f6cae2-6e9e-4d35-9623-d2d71267d75e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_us-gaap_TradeNamesMember_46f6cae2-6e9e-4d35-9623-d2d71267d75e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i2e89599e8480486c80d00a33e1e18f02_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b59aac28-ba34-4516-9a19-4aeca437ede2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b59aac28-ba34-4516-9a19-4aeca437ede2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1e2666fd-d583-4f14-95a4-2a68c97eecaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1e2666fd-d583-4f14-95a4-2a68c97eecaa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_af50d53f-e330-40b3-a738-edf24597f3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_af50d53f-e330-40b3-a738-edf24597f3c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94d02399-11f9-4c20-86b1-543aba28fa4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94d02399-11f9-4c20-86b1-543aba28fa4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e042018-df94-4d8f-a2b1-08a0a5a9022b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e042018-df94-4d8f-a2b1-08a0a5a9022b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_064a1f7a-9b80-4915-9ffe-bf3993c4e131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_064a1f7a-9b80-4915-9ffe-bf3993c4e131" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_fb7f9f1d-b027-4049-9300-4ed2c9461d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_fb7f9f1d-b027-4049-9300-4ed2c9461d15" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_14ccbe05-ba12-448b-9886-c5407fe2aa1b" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_14ccbe05-ba12-448b-9886-c5407fe2aa1b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b763e7cd-7ed3-427d-9791-f0e3d018af96" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b763e7cd-7ed3-427d-9791-f0e3d018af96" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_6a0fed3b-a1bf-4bb4-a93f-e24729dbbc3a" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_6a0fed3b-a1bf-4bb4-a93f-e24729dbbc3a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_a13b5f1c-7bff-4b6a-abc8-990a2760fd0c" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_a13b5f1c-7bff-4b6a-abc8-990a2760fd0c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_327299f2-cab0-4965-8102-6ba260888d5c" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_327299f2-cab0-4965-8102-6ba260888d5c" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1b367466-68bc-4971-87e1-ae82ecc8346c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1b367466-68bc-4971-87e1-ae82ecc8346c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4433f892-a173-4b16-bdca-23d359da769f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_Goodwill_4433f892-a173-4b16-bdca-23d359da769f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7b81c5a-73f9-450b-bb10-5945f0e3ec01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7b81c5a-73f9-450b-bb10-5945f0e3ec01" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_8affb3ee-7846-49b0-a278-89a825ef6633" xlink:href="holx-20201226.xsd#holx_SuperSonicImagineMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:to="loc_holx_SuperSonicImagineMember_8affb3ee-7846-49b0-a278-89a825ef6633" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_e7d6ff60-e900-4c0f-9011-062ce99536cb" xlink:href="holx-20201226.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:to="loc_holx_AcessaHealthMember_e7d6ff60-e900-4c0f-9011-062ce99536cb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended" id="i8f16c0ecf5564cc2a023f192b5b79180_TradeReceivablesandAllowanceforCreditLosses"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended" id="i5a959d887cb54aff95c165c099663eab_TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended" id="ie2327061540048c1ab914b03b3a34b68_TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20201226.xsd#Disposition"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended" id="i889d037555984457acf10fb38b8acd14_Disposition"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DispositionDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended" id="ia589ce5247dd4abb9610d8e249fbaed5_DispositionDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_dd323d9f-a025-4103-a9e5-6c57cc145174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_dd323d9f-a025-4103-a9e5-6c57cc145174" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_15fe606c-c99a-470a-9a58-6cb5ad20194f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_15fe606c-c99a-470a-9a58-6cb5ad20194f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_3e259c34-9250-4ad7-ab70-7f01e41b7b8b" xlink:href="holx-20201226.xsd#holx_IndemnificationLiabily"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_holx_IndemnificationLiabily_3e259c34-9250-4ad7-ab70-7f01e41b7b8b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_f37287ba-9e7f-41cf-b240-7f23956e3948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_AssetImpairmentCharges_f37287ba-9e7f-41cf-b240-7f23956e3948" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5dd72f67-107f-4e8d-a29d-b935738b767b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5dd72f67-107f-4e8d-a29d-b935738b767b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_1a074ffa-37c5-4d39-960d-128af56615f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_1a074ffa-37c5-4d39-960d-128af56615f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_972ce775-0c12-4353-b063-53ff2253efde_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_972ce775-0c12-4353-b063-53ff2253efde_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_89989e46-d3bf-4aac-8ee4-e5e4ce32e192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:to="loc_us-gaap_CostOfSalesMember_89989e46-d3bf-4aac-8ee4-e5e4ce32e192" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_d6ed932c-ec79-4ef3-9741-6e5cda8536b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:to="loc_us-gaap_OperatingExpenseMember_d6ed932c-ec79-4ef3-9741-6e5cda8536b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_a3d38643-2201-4e44-935e-08eb986a1319_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_a3d38643-2201-4e44-935e-08eb986a1319_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_828577c5-d81e-4186-9963-cfecf5793e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_828577c5-d81e-4186-9963-cfecf5793e6b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_adf67808-1cc7-4602-bdee-ff23eb48fa7a" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:to="loc_holx_MedicalAestheticsMember_adf67808-1cc7-4602-bdee-ff23eb48fa7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended" id="i843882f9537e4cf3bff0e2930dee426c_BorrowingsandCreditArrangements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended" id="i7cee84d0a98d416c9c2844e8ff0a17c2_BorrowingsandCreditArrangementsTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="iac80acf0c52d44d8b1e1de235c8478f3_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_52e00dd1-91a6-408d-99df-750deac97aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebtCurrent_52e00dd1-91a6-408d-99df-750deac97aca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_f2fe8618-f4c8-468e-bb0e-988f453b980c" xlink:href="holx-20201226.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_f2fe8618-f4c8-468e-bb0e-988f453b980c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6c6c4afd-60be-47a8-bc32-dbc97ae3121c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6c6c4afd-60be-47a8-bc32-dbc97ae3121c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0089cdb5-cc09-4140-a47c-e92ccf15fbda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebt_0089cdb5-cc09-4140-a47c-e92ccf15fbda" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2cce571c-bf5b-4ba7-ac29-39fd4b398821_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2cce571c-bf5b-4ba7-ac29-39fd4b398821_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_4982f462-47ed-4d37-8af5-70c0e6086389" xlink:href="holx-20201226.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_TermLoanMember_4982f462-47ed-4d37-8af5-70c0e6086389" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_e7425a3e-c676-44f0-bc89-6246528e2d27" xlink:href="holx-20201226.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_RevolverMember_e7425a3e-c676-44f0-bc89-6246528e2d27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_46ba4875-c855-4a59-a21b-68c6fd85d79d" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2025SeniorNotesMember_46ba4875-c855-4a59-a21b-68c6fd85d79d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_d02ff3b2-d4f6-4e62-844c-bf3746be43dc" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2028SeniorNotesMember_d02ff3b2-d4f6-4e62-844c-bf3746be43dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_045416f2-b60b-4496-8fe9-54777d23b20b" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2029SeniorNotesMember_045416f2-b60b-4496-8fe9-54777d23b20b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="i3402e65963f74a6186ae596c3f1d95f0_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4df68557-415e-44b0-a987-9664d5ad339b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4df68557-415e-44b0-a987-9664d5ad339b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5424ca36-6762-42e3-9752-e6d4d8939873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LongTermDebt_5424ca36-6762-42e3-9752-e6d4d8939873" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db868600-056f-4621-90d0-b58c5f1d990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db868600-056f-4621-90d0-b58c5f1d990b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7ea36313-d387-4acf-beca-11256544813e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7ea36313-d387-4acf-beca-11256544813e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f4582da7-5d97-4d8e-ba2a-ab6e0054fb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f4582da7-5d97-4d8e-ba2a-ab6e0054fb2b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_306a415d-f514-45c0-91b4-39f5870493e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LongTermDebtCurrent_306a415d-f514-45c0-91b4-39f5870493e3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_5f96aa8f-1065-4b4a-ad85-58d8309c16d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_RepaymentsOfDebt_5f96aa8f-1065-4b4a-ad85-58d8309c16d5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_c4a2b812-3dfe-42aa-aaa8-668de5fdc90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_c4a2b812-3dfe-42aa-aaa8-668de5fdc90c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_304ac154-6db9-4f5f-ba68-9f7f5daa3bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_SeniorNotes_304ac154-6db9-4f5f-ba68-9f7f5daa3bdf" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e6d4860d-9cbe-4d00-8279-e05665879b78" xlink:href="holx-20201226.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e6d4860d-9cbe-4d00-8279-e05665879b78" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b3e2a627-3f24-4d35-9296-0ceb291b524e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b3e2a627-3f24-4d35-9296-0ceb291b524e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e058578d-dcb4-4bed-a1d5-c37bd1a2be6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_InterestExpenseDebt_e058578d-dcb4-4bed-a1d5-c37bd1a2be6e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9421018d-1521-408e-8644-3c8490518599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9421018d-1521-408e-8644-3c8490518599" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1e160720-90a3-439a-801c-3fd5bdcf8070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1e160720-90a3-439a-801c-3fd5bdcf8070" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_89adfed7-a1b6-4d3a-91ac-6b329689cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_89adfed7-a1b6-4d3a-91ac-6b329689cddf" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_2b1268c5-184e-4907-b092-4bb7823d888d" xlink:href="holx-20201226.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_holx_DebtRedemptionPremiumPaid_2b1268c5-184e-4907-b092-4bb7823d888d" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_c2cecc45-58e4-433b-85cc-32548eec7783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_c2cecc45-58e4-433b-85cc-32548eec7783" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_31f0aa96-4da5-4036-b023-b23afde719d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_31f0aa96-4da5-4036-b023-b23afde719d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_1f731070-12f5-4251-9674-5914cf02626e" xlink:href="holx-20201226.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_RevolverMember_1f731070-12f5-4251-9674-5914cf02626e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_ea67b471-70a3-437e-bf51-cb71a08847ae" xlink:href="holx-20201226.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_ea67b471-70a3-437e-bf51-cb71a08847ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_d3f05dad-cb19-4c1a-8735-a3100887b082" xlink:href="holx-20201226.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_AmendedTermLoanMember_d3f05dad-cb19-4c1a-8735-a3100887b082" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_96589e07-a2f1-4d4f-ab7a-51fb5229ef6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_us-gaap_SeniorNotesMember_96589e07-a2f1-4d4f-ab7a-51fb5229ef6a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_12abfedf-567f-49fb-b0f5-2243fad916d0" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_A2025SeniorNotesMember_12abfedf-567f-49fb-b0f5-2243fad916d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_79eec940-832b-41bb-9bf1-3391bc94b264" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_A2028SeniorNotesMember_79eec940-832b-41bb-9bf1-3391bc94b264" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3756d238-a2da-4821-a00a-cf3009568b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3756d238-a2da-4821-a00a-cf3009568b99" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7bf5ee71-820a-4aba-8a34-5ffa5c429005" xlink:href="holx-20201226.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_TermLoanMember_7bf5ee71-820a-4aba-8a34-5ffa5c429005" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e15667e7-21d1-40e2-9561-30860516ed93_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e15667e7-21d1-40e2-9561-30860516ed93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_40a85167-d446-47e5-8566-79428817fd59" xlink:href="holx-20201226.xsd#holx_AmendedTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_AmendedTermLoanMember_40a85167-d446-47e5-8566-79428817fd59" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_7e81d08e-d44d-4673-8f53-c1d02d4dcebf" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_CreditAgreementMember_7e81d08e-d44d-4673-8f53-c1d02d4dcebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_de6f15e1-aff8-498e-97d6-be3e961e589d" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2025SeniorNotesMember_de6f15e1-aff8-498e-97d6-be3e961e589d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_012757c0-2f4a-40b0-9007-112981622a42" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2028SeniorNotesMember_012757c0-2f4a-40b0-9007-112981622a42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_93387739-37b6-4081-b623-314a0d9d640c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_us-gaap_SeniorNotesMember_93387739-37b6-4081-b623-314a0d9d640c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_0fb011f3-e449-43f6-a7ac-2c6850813f9b" xlink:href="holx-20201226.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_0fb011f3-e449-43f6-a7ac-2c6850813f9b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b1daf38a-75c7-408c-8161-f31f06665c2c" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2029SeniorNotesMember_b1daf38a-75c7-408c-8161-f31f06665c2c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_368942ac-0f3f-42de-8a47-32f53444f52a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_368942ac-0f3f-42de-8a47-32f53444f52a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_c1e0ec8c-7473-4030-bc50-5e2c77ec0453" xlink:href="holx-20201226.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_c1e0ec8c-7473-4030-bc50-5e2c77ec0453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2d57a3ad-1460-430b-bba1-94109e7c48fb_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_2d57a3ad-1460-430b-bba1-94109e7c48fb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a3f53aef-5aec-46f6-b727-56270d99b908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a3f53aef-5aec-46f6-b727-56270d99b908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_1c2f76bc-96e4-435a-91e2-f1a4629d2327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_1c2f76bc-96e4-435a-91e2-f1a4629d2327" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_09a29d9a-e04f-4693-a8ce-7aeb7c198b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_09a29d9a-e04f-4693-a8ce-7aeb7c198b09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_1729a546-a23c-43d9-b435-819a0c9a10d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_1729a546-a23c-43d9-b435-819a0c9a10d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_b34b7fbb-632a-437f-a22c-f7c8eefc2571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_b34b7fbb-632a-437f-a22c-f7c8eefc2571" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="i122167cd9d42409a8763a402e64d70bb_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b6e9a4ca-5cc0-491f-ac62-e064292c7c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b6e9a4ca-5cc0-491f-ac62-e064292c7c4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_4f086c04-227f-4008-a25b-3a848c805545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_4f086c04-227f-4008-a25b-3a848c805545" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_451dfc53-c043-402a-a360-98939884b5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_451dfc53-c043-402a-a360-98939884b5a4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ef4494a4-4b09-4149-b580-0a8ab901d350_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ef4494a4-4b09-4149-b580-0a8ab901d350_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f0cc6f17-a560-4c2b-ae69-a704b825f0fa" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:to="loc_holx_CreditAgreementMember_f0cc6f17-a560-4c2b-ae69-a704b825f0fa" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i494cdf4088ca419f8cd4743668232fd7_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a9fbc1b6-545a-4973-9749-e841a2011cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a9fbc1b6-545a-4973-9749-e841a2011cd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_7acfbedd-7915-4c5d-8e53-c9a9124f2ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:to="loc_us-gaap_InterestExpenseBorrowings_7acfbedd-7915-4c5d-8e53-c9a9124f2ee3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ce9fa9b8-3dee-46fe-8cce-cb298dfed055_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ce9fa9b8-3dee-46fe-8cce-cb298dfed055_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_976b1004-5663-4113-a557-ecdf31bf4c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:to="loc_us-gaap_SeniorNotesMember_976b1004-5663-4113-a557-ecdf31bf4c1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:to="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_f778be24-bf89-42f9-ad17-b23f076298ba_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_f778be24-bf89-42f9-ad17-b23f076298ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f013e18f-01ba-47a4-b3bf-97ed4de62971" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2028SeniorNotesMember_f013e18f-01ba-47a4-b3bf-97ed4de62971" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_2651b222-42ad-4629-b1d7-a966e45618e3" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2025SeniorNotesMember_2651b222-42ad-4629-b1d7-a966e45618e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_4d26246f-a4ca-4ce7-b78c-c7b63c8b2d08" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2029SeniorNotesMember_4d26246f-a4ca-4ce7-b78c-c7b63c8b2d08" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20201226.xsd#Derivatives"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended" id="i19ac68ad981f4d0ba90b10b1ee9c7c3b_Derivatives"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended" id="i4eeb0674616a4d48a409f90133a51a32_DerivativesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" id="ie47076c654f544e2ab2a898cb56cbc46_DerivativesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48374877-8a6d-49ef-929e-837b0fe2eaca" xlink:href="holx-20201226.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48374877-8a6d-49ef-929e-837b0fe2eaca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_773e2ac8-d471-4fad-b114-a231f36f7249" xlink:href="holx-20201226.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_PrincipalAmountOfBorrowings_773e2ac8-d471-4fad-b114-a231f36f7249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ef6995d1-ec30-44e6-968d-e3d304c29d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ef6995d1-ec30-44e6-968d-e3d304c29d8e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_a0d8d29e-c3a0-4749-80e5-7baf1670b02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_a0d8d29e-c3a0-4749-80e5-7baf1670b02d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_d8ba1b25-5832-4efb-b61d-a3237a88b0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_d8ba1b25-5832-4efb-b61d-a3237a88b0a5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_859ea64c-0f15-4635-b2cd-c3546ecff55c" xlink:href="holx-20201226.xsd#holx_NotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_NotionalAmount_859ea64c-0f15-4635-b2cd-c3546ecff55c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_0f2b4d64-f524-479c-ac6b-2a05fa7aaae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_0f2b4d64-f524-479c-ac6b-2a05fa7aaae1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b5bc3476-c0b2-480b-b328-51492e184c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:to="loc_us-gaap_InterestRateSwapMember_b5bc3476-c0b2-480b-b328-51492e184c9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_5917a572-e073-435d-84bc-76ca07988888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_5917a572-e073-435d-84bc-76ca07988888" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7e2dc1bc-9327-43b6-a78a-b6a85f402a66_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_7e2dc1bc-9327-43b6-a78a-b6a85f402a66_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_79bddb36-f81e-469b-8593-28ba2b420ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:to="loc_us-gaap_InterestRateCapMember_79bddb36-f81e-469b-8593-28ba2b420ab5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended" id="i8f97d85387e14b3692f750efb3c914cc_DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a43d495-95df-40aa-8f09-928c99369318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a43d495-95df-40aa-8f09-928c99369318" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_92ede41f-891b-4c5f-8472-5b38af6caa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_92ede41f-891b-4c5f-8472-5b38af6caa9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_7ed089aa-207f-4b96-ac05-ab0381e67556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_7ed089aa-207f-4b96-ac05-ab0381e67556" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bfaba2ad-45dd-459c-8b13-38e3fd57da04_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bfaba2ad-45dd-459c-8b13-38e3fd57da04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_08b9a97b-813a-4596-99b8-3193ae9b8282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_08b9a97b-813a-4596-99b8-3193ae9b8282" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_6270b58d-b5fd-4bc4-8e36-f52a1da23a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_6270b58d-b5fd-4bc4-8e36-f52a1da23a70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce4c1338-b20e-4bf7-8ce6-dd1df241897e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_InterestRateSwapMember_ce4c1338-b20e-4bf7-8ce6-dd1df241897e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_2cb20c2b-0875-48b4-9152-1c376b246874_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:to="loc_us-gaap_HedgingDesignationDomain_2cb20c2b-0875-48b4-9152-1c376b246874_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:to="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8031e42-24f9-4de6-814c-556a79936f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:to="loc_us-gaap_NondesignatedMember_e8031e42-24f9-4de6-814c-556a79936f71" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_747d7293-4463-444d-b725-3d08c21a636e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_747d7293-4463-444d-b725-3d08c21a636e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ab328316-5cfe-45ea-b277-ae9409d0a2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ab328316-5cfe-45ea-b277-ae9409d0a2b4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_93b34c0d-478b-4e95-86dc-eb868a1602c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_93b34c0d-478b-4e95-86dc-eb868a1602c1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="if0f9b0bb3b2d496cab639d697e629fe1_DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_821c00f0-b140-47ee-9ea7-7d12730e4809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_821c00f0-b140-47ee-9ea7-7d12730e4809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5f5b3db8-ce67-40da-9782-37000637004e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_DerivativeLiabilities_5f5b3db8-ce67-40da-9782-37000637004e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7c625caf-23f6-4707-9cc3-0f94a09b91cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7c625caf-23f6-4707-9cc3-0f94a09b91cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_24b8b4c4-a14c-42f6-8ec1-f6795af45852_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:to="loc_us-gaap_HedgingDesignationDomain_24b8b4c4-a14c-42f6-8ec1-f6795af45852_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:to="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4566d7d4-2494-49b8-8416-569a185c3549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:to="loc_us-gaap_NondesignatedMember_4566d7d4-2494-49b8-8416-569a185c3549" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_0209f539-24e4-4593-ac81-8e0949b4c997_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_0209f539-24e4-4593-ac81-8e0949b4c997_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_9160a510-68d7-44bb-98ef-c118baeca62d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_InterestRateCapMember_9160a510-68d7-44bb-98ef-c118baeca62d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40de9580-8a5e-49b7-91f6-35454c51aab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_InterestRateSwapMember_40de9580-8a5e-49b7-91f6-35454c51aab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_80e49d52-2bbf-4100-ac9d-cd17af73ccd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_80e49d52-2bbf-4100-ac9d-cd17af73ccd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_c58a1fa8-080e-4990-bbc1-d3bbc8c1943c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_c58a1fa8-080e-4990-bbc1-d3bbc8c1943c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6880ad59-25a0-4334-b49e-3f4370e7189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6880ad59-25a0-4334-b49e-3f4370e7189b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3befd24-5604-4cdf-b596-5d52609c9a16_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3befd24-5604-4cdf-b596-5d52609c9a16_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0359aa43-b24f-4878-b81c-c47c69eaebf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0359aa43-b24f-4878-b81c-c47c69eaebf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_bee6e991-4a3f-4b0c-bff0-7729c6141052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_bee6e991-4a3f-4b0c-bff0-7729c6141052" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended" id="ifc23e3e648984edcaf045334f765d23a_DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ee6f9d5f-41f9-4fc6-9cd3-62445b43247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ee6f9d5f-41f9-4fc6-9cd3-62445b43247f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5142ffb8-5f43-4535-9ea6-2cb4b81da25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5142ffb8-5f43-4535-9ea6-2cb4b81da25f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_108ae909-dcc2-40d2-952c-2b076f1d05ee_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_108ae909-dcc2-40d2-952c-2b076f1d05ee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fc8ee3ee-4adf-4855-b5fc-b540ea6dbaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:to="loc_us-gaap_InterestRateSwapMember_fc8ee3ee-4adf-4855-b5fc-b540ea6dbaf1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_7bc88e7f-0f1b-4083-8ce0-6870f2122a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:to="loc_us-gaap_InterestRateCapMember_7bc88e7f-0f1b-4083-8ce0-6870f2122a66" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended" id="i5c975e54c15448e29b5ba65ead30f5ce_DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_6efd98c4-a75a-4c0f-ae55-a471f614fe99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_6efd98c4-a75a-4c0f-ae55-a471f614fe99" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_07e0171e-44c5-41dd-9f3b-54cd8e5059e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_07e0171e-44c5-41dd-9f3b-54cd8e5059e9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_aa58bd5c-6500-432a-b6f5-99373c508fce_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_aa58bd5c-6500-432a-b6f5-99373c508fce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b143e22c-10ed-496b-88b2-51014b593ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b143e22c-10ed-496b-88b2-51014b593ae4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_498dcd39-6224-4c73-be92-2faf6b1dd882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_498dcd39-6224-4c73-be92-2faf6b1dd882" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended" id="i3f36bffa281b4cb1867be903a217a1e9_CommitmentsandContingencies"/>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended" id="ie887565435ed4f128b07f53200d0ed6d_CommitmentsandContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_d9b21827-dd87-47ec-8718-9a6d18a94e6c" xlink:href="holx-20201226.xsd#holx_AmountAssessedInDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_holx_AmountAssessedInDamages_d9b21827-dd87-47ec-8718-9a6d18a94e6c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5fbc253b-99da-4744-b19d-d5300e5ec04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5fbc253b-99da-4744-b19d-d5300e5ec04f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_c9105119-75af-4e4a-85ff-f8c979a965c9" xlink:href="holx-20201226.xsd#holx_LegalAccrual"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_holx_LegalAccrual_c9105119-75af-4e4a-85ff-f8c979a965c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:to="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_5f11aa53-32c5-4a14-a818-d3d269d04cdd_default" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:to="loc_dei_EntityDomain_5f11aa53-32c5-4a14-a818-d3d269d04cdd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:to="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_0fde8b2a-0a60-4e45-ab2b-f74e8394b1a6" xlink:href="holx-20201226.xsd#holx_MinervaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:to="loc_holx_MinervaMember_0fde8b2a-0a60-4e45-ab2b-f74e8394b1a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_4c2921a8-6f70-44df-9890-fd7895b2182f" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:to="loc_holx_MedicalAestheticsMember_4c2921a8-6f70-44df-9890-fd7895b2182f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShare"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended" id="ia082d99d42e74d62bb257fac5d28e03a_NetIncomeLossPerShare"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended" id="i0794c66a15e3460dbb72406613ea4d29_NetIncomeLossPerShareTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="i102b042b212f4508b21c4e5947682400_NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:href="holx-20201226.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3208f8f5-aa2a-4d33-8a64-bdd1f90f50f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3208f8f5-aa2a-4d33-8a64-bdd1f90f50f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f3c3f1d5-01cb-4c60-88db-4653e5c1470f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f3c3f1d5-01cb-4c60-88db-4653e5c1470f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2fa8d79b-6f57-4958-96aa-c9dae8aca3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2fa8d79b-6f57-4958-96aa-c9dae8aca3c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a49742c-d5c0-429a-86f4-e4119bf66fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a49742c-d5c0-429a-86f4-e4119bf66fb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:href="holx-20201226.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82d54fa8-8cff-4c22-9092-e54c02c9784d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_82d54fa8-8cff-4c22-9092-e54c02c9784d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_1b7faea4-8e40-4224-9e78-ffaca7dd612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:to="loc_us-gaap_StockCompensationPlanMember_1b7faea4-8e40-4224-9e78-ffaca7dd612b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f9bc6eeb-513a-495e-a448-6f4eac3bec0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f9bc6eeb-513a-495e-a448-6f4eac3bec0d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended" id="i4c601d5a43b946bba6a2d8507d43ceeb_StockBasedCompensation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended" id="i2fbd5aee7ae64371bba88920c3d70d35_StockBasedCompensationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended" id="i0f2ed953db15412c89b527d49cd7f118_StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bac4512f-baf6-4ca5-a3cb-b3844d593004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:to="loc_us-gaap_ShareBasedCompensation_bac4512f-baf6-4ca5-a3cb-b3844d593004" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4a4e2108-6ef1-4072-b874-5c1779b3b02d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4a4e2108-6ef1-4072-b874-5c1779b3b02d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_979bf6b9-13ca-4ca5-90bf-68845582bfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_CostOfSalesMember_979bf6b9-13ca-4ca5-90bf-68845582bfd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1381341f-e801-48da-b9ee-07870d483944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1381341f-e801-48da-b9ee-07870d483944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_918fc7c5-f9a2-4647-9e9a-76bfbb0fddf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_918fc7c5-f9a2-4647-9e9a-76bfbb0fddf2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d1327e0-7346-4589-aee2-fc0462a20857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d1327e0-7346-4589-aee2-fc0462a20857" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="ie3f24ef67a5b4f71aab0fba177b3ca52_StockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b96de1a4-0b45-43f6-80c3-8ee1672a5cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b96de1a4-0b45-43f6-80c3-8ee1672a5cd9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b27d43a2-6c5a-4cd2-a8a7-03bcc6b453ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b27d43a2-6c5a-4cd2-a8a7-03bcc6b453ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d393f7c7-2fbd-47e5-9d27-1c05b0c6aeef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d393f7c7-2fbd-47e5-9d27-1c05b0c6aeef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6c8a7be-0668-466c-87a7-c51f480c091d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6c8a7be-0668-466c-87a7-c51f480c091d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_121d9c94-c368-4878-8730-700c9128242c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_121d9c94-c368-4878-8730-700c9128242c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1bbc28b6-544e-48a9-b41d-3ea2b3d5d0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1bbc28b6-544e-48a9-b41d-3ea2b3d5d0a6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e16ef872-ff26-418d-abce-fcd7106ca507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e16ef872-ff26-418d-abce-fcd7106ca507" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_3397177a-bf2c-4fdb-b409-426830423266" xlink:href="holx-20201226.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_3397177a-bf2c-4fdb-b409-426830423266" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2db0425e-1acf-4a15-bd40-45639db4bcd6" xlink:href="holx-20201226.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2db0425e-1acf-4a15-bd40-45639db4bcd6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_96942123-888d-4410-84dd-ac1ae2000f9b" xlink:href="holx-20201226.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_96942123-888d-4410-84dd-ac1ae2000f9b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_491de45f-6791-4adf-a4e5-cc99ae966f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_491de45f-6791-4adf-a4e5-cc99ae966f66" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_aa2b3dd8-af92-400a-b4b9-f1b222c59a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_aa2b3dd8-af92-400a-b4b9-f1b222c59a61" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:to="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f3c7da17-50c4-49f7-bf40-3421750d3c91_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f3c7da17-50c4-49f7-bf40-3421750d3c91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d86d2d97-7070-4af2-b2ae-64754483c91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d86d2d97-7070-4af2-b2ae-64754483c91e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_11175631-18c6-43d9-9a98-e8bf6d88e78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_11175631-18c6-43d9-9a98-e8bf6d88e78d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_16565370-7a09-4816-ba63-5e0ead49fefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_PerformanceSharesMember_16565370-7a09-4816-ba63-5e0ead49fefd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_7526cafc-34f6-4da4-a9c1-ac9a0f7538ab" xlink:href="holx-20201226.xsd#holx_MarketBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_MarketBasedAwardsMember_7526cafc-34f6-4da4-a9c1-ac9a0f7538ab" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_4b059161-efd4-4120-bc24-4bc3b4ef7241" xlink:href="holx-20201226.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_PSUFreeCashFlowMember_4b059161-efd4-4120-bc24-4bc3b4ef7241" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_eb59af73-d012-4cf9-9135-31c9a9865158" xlink:href="holx-20201226.xsd#holx_RSUPSUMSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_RSUPSUMSUMember_eb59af73-d012-4cf9-9135-31c9a9865158" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended" id="i427758bf9e574fafb2858a3127901d7e_StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended" id="i0f087715170a4e498cefd501b32ef5fe_OtherBalanceSheetInformation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended" id="i552111b4fa0b4e4f9c84ca0e353b8e6d_OtherBalanceSheetInformationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended" id="i3f6c30f2beb14780824591acfda86b9c_OtherBalanceSheetInformationInventoriesDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended" id="i3e213f2867944d848df44558d347b16a_OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended" id="i4c0e10f0eb3c485db7cf73ef90a2e7f1_BusinessSegmentsandGeographicInformation"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended" id="i824c72f914ca4335b6dd8b942264fffb_BusinessSegmentsandGeographicInformationTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="ifd43dbca937244589218766b29d0ece6_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:href="holx-20201226.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f80b87d7-31e9-4977-9095-756640591ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:to="loc_us-gaap_NumberOfReportableSegments_f80b87d7-31e9-4977-9095-756640591ed1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_79ab9e5b-a5b3-46ca-ad16-f6216e9c5619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:to="loc_us-gaap_Revenues_79ab9e5b-a5b3-46ca-ad16-f6216e9c5619" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:to="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_4ebfb254-33ca-40f0-9d25-97ab764d65fa_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:to="loc_srt_ConsolidationItemsDomain_4ebfb254-33ca-40f0-9d25-97ab764d65fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:to="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_04782b56-6e6e-4166-91f5-8b7b9e31df7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:to="loc_us-gaap_IntersegmentEliminationMember_04782b56-6e6e-4166-91f5-8b7b9e31df7d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i3c58eb398b3e4d7bb3b0a141983795bb_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_17d90d06-0e2b-4ff7-820c-b42500415f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_Revenues_17d90d06-0e2b-4ff7-820c-b42500415f54" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_40a50ad3-a322-4ed9-b36f-0265f4c1e1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_OperatingIncomeLoss_40a50ad3-a322-4ed9-b36f-0265f4c1e1bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_8a178b8d-7e27-43dd-b072-976732de5627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_8a178b8d-7e27-43dd-b072-976732de5627" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_c262277c-9242-4d06-8a04-ba2a6c5445b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_c262277c-9242-4d06-8a04-ba2a6c5445b2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9d58a047-8888-43e2-99fc-c4c9f5a0fb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_Assets_9d58a047-8888-43e2-99fc-c4c9f5a0fb3d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_38c8204b-b20c-4e54-ba08-59d2dfd700ac_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:to="loc_us-gaap_SegmentDomain_38c8204b-b20c-4e54-ba08-59d2dfd700ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:to="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_13d9804c-6408-4f48-a0b8-3b7c760d7a06" xlink:href="holx-20201226.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_DiagnosticsMember_13d9804c-6408-4f48-a0b8-3b7c760d7a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_afedfceb-e0ba-4b32-aaa3-45ff1e4f0969" xlink:href="holx-20201226.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_BreastHealthMember_afedfceb-e0ba-4b32-aaa3-45ff1e4f0969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9222a3c4-dafd-406c-b67e-da174617a512" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_MedicalAestheticsMember_9222a3c4-dafd-406c-b67e-da174617a512" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_949f4b0c-6d72-4932-bd2e-f2479d8cc682" xlink:href="holx-20201226.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_GynSurgicalMember_949f4b0c-6d72-4932-bd2e-f2479d8cc682" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_3bf16a02-9e1d-4cc9-801b-a1f9307dcdc9" xlink:href="holx-20201226.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_SkeletalHealthMember_3bf16a02-9e1d-4cc9-801b-a1f9307dcdc9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_05910576-1f72-43fa-af73-a3108456c530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_us-gaap_CorporateMember_05910576-1f72-43fa-af73-a3108456c530" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="ibd744d5ec0254fb1b62646a9c9700b72_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_9e425fa2-b144-4f78-b846-3cd737d66428" xlink:href="holx-20201226.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:to="loc_holx_PercentageOfRevenues_9e425fa2-b144-4f78-b846-3cd737d66428" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:to="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_78125292-30c1-462f-acaa-ea789247cc91_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:to="loc_srt_SegmentGeographicalDomain_78125292-30c1-462f-acaa-ea789247cc91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:to="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b75604c-33ad-4b05-9c8c-5eff88b6289d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_country_US_8b75604c-33ad-4b05-9c8c-5eff88b6289d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c5bf9524-06d9-407d-a9b4-c7c6e5dd1f48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_srt_EuropeMember_c5bf9524-06d9-407d-a9b4-c7c6e5dd1f48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_612b779b-4743-43e1-841b-97fa8f0b4c05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_srt_AsiaPacificMember_612b779b-4743-43e1-841b-97fa8f0b4c05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_8ce5df74-f968-41f0-8bff-d85825f49789" xlink:href="holx-20201226.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_holx_AllOtherCountriesMember_8ce5df74-f968-41f0-8bff-d85825f49789" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxes"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended" id="i4fc73d1edc0a4f3ea0a682ffaf98e372_IncomeTaxes"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended" id="i7a49453df8444ae89d5b83d0edefb8f1_IncomeTaxesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_797b92a6-ef76-4cd5-8a86-7588e4d47a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_797b92a6-ef76-4cd5-8a86-7588e4d47a8f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_89de45f1-100f-4c5c-bda7-95437bf85790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_89de45f1-100f-4c5c-bda7-95437bf85790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0436f1ce-5aba-4737-b5b8-1f6dadf67585_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:to="loc_us-gaap_SegmentDomain_0436f1ce-5aba-4737-b5b8-1f6dadf67585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:to="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_7c00c303-a3ce-44db-950c-465a18ce44ab" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:to="loc_holx_MedicalAestheticsMember_7c00c303-a3ce-44db-950c-465a18ce44ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwill"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended" id="i323e6265ddee40e4baef9a3aaaa171fc_IntangibleAssetsandGoodwill"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended" id="i86e168cfbdb2498799c009fc371bcb3d_IntangibleAssetsandGoodwillTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended" id="i007d96c66f164b9f892e7b000df89f7b_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_479f98cd-8d11-43a8-984b-253816da76b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_479f98cd-8d11-43a8-984b-253816da76b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0a2d0356-2fb9-4ba6-80fa-b111678b2d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0a2d0356-2fb9-4ba6-80fa-b111678b2d2f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f45581e3-54b1-4b38-8bd8-2f534fb15968_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_f45581e3-54b1-4b38-8bd8-2f534fb15968_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_604da83a-de47-46f4-b615-1e06df941e78" xlink:href="holx-20201226.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_DevelopedTechnologyMember_604da83a-de47-46f4-b615-1e06df941e78" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_dd47183c-62a5-43fc-a92b-4bb3170188af" xlink:href="holx-20201226.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_CustomerRelationshipsContractsMember_dd47183c-62a5-43fc-a92b-4bb3170188af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a953f5ce-b84d-4173-8033-5203bba77dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_us-gaap_TradeNamesMember_a953f5ce-b84d-4173-8033-5203bba77dd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e398a080-d3ab-4da7-95cc-0798b15d65b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e398a080-d3ab-4da7-95cc-0798b15d65b7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_b19659e1-70a7-4e2e-a5ad-998d2b74e568" xlink:href="holx-20201226.xsd#holx_BusinessLicensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_BusinessLicensesMember_b19659e1-70a7-4e2e-a5ad-998d2b74e568" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_92135ce8-b1ab-44bd-accf-bb1be33390f8" xlink:href="holx-20201226.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_AcquiredintangibleassetsMember_92135ce8-b1ab-44bd-accf-bb1be33390f8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_e314858e-bcfb-4ac6-bdf0-19953241a151" xlink:href="holx-20201226.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_InternalusesoftwareMember_e314858e-bcfb-4ac6-bdf0-19953241a151" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_9c33b1fc-a63a-4393-bca5-05a80196c9da" xlink:href="holx-20201226.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_CapitalizedsoftwareMember_9c33b1fc-a63a-4393-bca5-05a80196c9da" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended" id="i723a4dcb593b454ea8db94e51f4b4e7b_IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarranties"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended" id="ie198db98590d4ef29b878bffdddaf30c_ProductWarranties"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended" id="ie053c86ad8184a6a8e47226da1a85276_ProductWarrantiesTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended" id="i4d87b961da5d46abb0862121989dd017_ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended" id="ia1c1b61cb0474513a103eb02c99265bc_AccumulatedOtherComprehensiveLoss"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended" id="ia86553fa2d22469cbda01626ebe1feb8_AccumulatedOtherComprehensiveLossTables"/>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended" id="ie9b27f71f1e74d1098ad82380c4ccc8f_AccumulatedOtherComprehensiveIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff25aef4-7934-4438-b9a5-1f6fa9f9e02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_StockholdersEquity_ff25aef4-7934-4438-b9a5-1f6fa9f9e02f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e7a722c6-86ab-4f8e-91e1-4e20d400c319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e7a722c6-86ab-4f8e-91e1-4e20d400c319" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_408f6c6d-4393-4538-9051-0ce2bc891bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_408f6c6d-4393-4538-9051-0ce2bc891bf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_07cd723d-69b8-453e-93ad-846bed5c5d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_07cd723d-69b8-453e-93ad-846bed5c5d8c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9aa7f10a-d130-4c9a-858b-96d284d9819e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9aa7f10a-d130-4c9a-858b-96d284d9819e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_95fee8b7-75e0-4ca1-a7f2-0ebb53d47656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_95fee8b7-75e0-4ca1-a7f2-0ebb53d47656" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a0391e2f-5810-48c9-9e9a-889465e38a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a0391e2f-5810-48c9-9e9a-889465e38a62" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_71f7c9d7-133c-4865-9c63-61e6dae6ce97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4858b81e-3a7e-43d8-ad70-0695095609c7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_4858b81e-3a7e-43d8-ad70-0695095609c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4bac3ea4-68b4-4fc2-a0bb-fa22967ed1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:to="loc_us-gaap_InterestRateCapMember_4bac3ea4-68b4-4fc2-a0bb-fa22967ed1de" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bf6685bf-8abb-421b-b367-9e3add457bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:to="loc_us-gaap_InterestRateSwapMember_bf6685bf-8abb-421b-b367-9e3add457bdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_342c6901-7518-4ee9-9d95-06678723a4f3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:to="loc_us-gaap_EquityComponentDomain_342c6901-7518-4ee9-9d95-06678723a4f3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:to="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e05869e1-397d-4d9a-a599-832e8e30a1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e05869e1-397d-4d9a-a599-832e8e30a1a0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_09851545-3c02-4273-b6e2-7380c5e2af72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_09851545-3c02-4273-b6e2-7380c5e2af72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a1fbae5a-b4bc-4668-84fd-f003936ed411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a1fbae5a-b4bc-4668-84fd-f003936ed411" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_860fbb33-d9d0-4400-bf6f-7ff0fd75ede1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_860fbb33-d9d0-4400-bf6f-7ff0fd75ede1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended" id="i8b87568cf40e41948b5f6cc3b6e10143_ShareRepurchaseSharerepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_54e9d326-8551-44e4-93bb-c470308a6a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_54e9d326-8551-44e4-93bb-c470308a6a62" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9a7c0b6d-841c-46af-88ca-27d75ac1044f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9a7c0b6d-841c-46af-88ca-27d75ac1044f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7173cbb6-1312-43bf-9648-ac0520da8f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7173cbb6-1312-43bf-9648-ac0520da8f60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_eda8bb65-9f8e-4635-9cd5-3e93a984599a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_eda8bb65-9f8e-4635-9cd5-3e93a984599a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_566099ee-9f47-4eab-883c-99a20f773bca" xlink:href="holx-20201226.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:to="loc_holx_December112019Member_566099ee-9f47-4eab-883c-99a20f773bca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_d378a54a-18e9-4760-83eb-097c49150ec7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_d378a54a-18e9-4760-83eb-097c49150ec7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_03dfe2ce-6cab-49f6-9bda-9a9362869574" xlink:href="holx-20201226.xsd#holx_December112019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:to="loc_holx_December112019Member_03dfe2ce-6cab-49f6-9bda-9a9362869574" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_71beb313-9080-4c30-a862-b9ffdf618acb" xlink:href="holx-20201226.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:to="loc_holx_December112020Member_71beb313-9080-4c30-a862-b9ffdf618acb" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncements"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended" id="i6d6a23ae0d60429d9875a11bc1d89b90_NewAccountingPronouncements"/>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncementsPolicies"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended" id="ia4a825c8a9214b8a9f86a63269fbb6c9_NewAccountingPronouncementsPolicies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>holx-20201226_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_72601e2c-dbc2-4021-9a33-723eb239a5f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_2108c10e-4789-4256-9711-127f49d2490b_terseLabel_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium payment</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_label_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:label id="lab_holx_DebtRedemptionPremiumPaid_documentation_en-US" xlink:label="lab_holx_DebtRedemptionPremiumPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Redemption, Premium Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid" xlink:href="holx-20201226.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtRedemptionPremiumPaid" xlink:to="lab_holx_DebtRedemptionPremiumPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_218e94b2-bd3f-4f9f-911d-b4cefeb6cdd9_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_971aaf82-27a3-4dab-97c7-2f5919f7986e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_65a54e4f-8e8f-4b86-9e01-d3e376e3bd3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_ca405f15-b256-4582-a66a-7a86a75980fe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments/Accruals</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_7b7da02e-8e35-41d8-b9d0-5132b4ad3a76_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotionalAmount_1f072cfe-5c5c-460e-ae98-94a750eece46_terseLabel_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_label_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:label id="lab_holx_NotionalAmount_documentation_en-US" xlink:label="lab_holx_NotionalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount" xlink:href="holx-20201226.xsd#holx_NotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotionalAmount" xlink:to="lab_holx_NotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_989942f2-c38a-45d2-ae4b-1078a28585eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, Percentage</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_3af0547e-e1b9-430a-a419-167860cf0abc_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_0878843d-69db-4602-8fd6-0cc623f2cc6b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_e463898a-18fb-47bf-b64f-ac63724f068a_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_ff7a9f4a-17a6-4d61-af5b-1dac895f63b2_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20201226.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_e36ee5bd-81d5-41d8-9aa9-36493792c9d8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8ab5f59f-a13f-46c1-accb-e90a9f9fe64a_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_0341cf67-b7ab-4770-9f26-5a1c62e2569d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_b88d4b90-f9e3-483f-a0db-758aa73c7e68_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_7b1bcd8a-bf72-4a87-a803-86e6334d02f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_e3efe770-4e0e-44cc-ba92-6d17602632de_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20201226.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_f4e7e481-e0b7-444b-b196-382ce9da8ffd_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3f53a0b4-6a54-41de-91cf-08410dbbad35_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_3d936814-16ef-4cfd-ab6a-a77c281a12e7_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_7df27cad-2eb3-4dbc-9d22-2cc5abd999fa_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_f592b402-3bb9-4541-8f74-92e955c632e6_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b9ccbb01-f020-4f25-a539-67f7053cbbf8_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_467e4043-dada-43dd-bf3d-0cb34e958d24_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unused Borrowing Capacity, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:to="lab_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_370b6bc8-0526-48f2-bf43-9a162b1ddbb4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_e35a3453-cdf0-4487-87cd-5bb2b335d259_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_8ef617ba-020e-4993-a21f-0bc898fe1f78_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_5d62c550-66cf-48eb-8bc6-0633450e2fbd_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_9d78008c-fa3e-4a9b-ae07-d5dd35cf6e68_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDebtIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfDebtIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_d363c535-4725-40ca-87de-a00de06e063e_verboseLabel_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_label_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap Agreements Aggregate Premium Payable</link:label>
    <link:label id="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable_documentation_en-US" xlink:label="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements aggregate premium payable.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:href="holx-20201226.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:to="lab_holx_InterestRateCapAgreementsAggregatePremiumPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_80dc71f0-d75b-45f7-97f6-cf4e6b33fd2b_negatedTerseLabel_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_label_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_holx_Acceleratedsharerepurchaseagreement_documentation_en-US" xlink:label="lab_holx_Acceleratedsharerepurchaseagreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement" xlink:href="holx-20201226.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Acceleratedsharerepurchaseagreement" xlink:to="lab_holx_Acceleratedsharerepurchaseagreement" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_10ef5383-5f00-450a-9c39-cbe62121bbcc_negatedTerseLabel_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Senior Debt</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_label_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:label id="lab_holx_RepaymentOfSeniorNotes_documentation_en-US" xlink:label="lab_holx_RepaymentOfSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes" xlink:href="holx-20201226.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RepaymentOfSeniorNotes" xlink:to="lab_holx_RepaymentOfSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_ecf323f8-f176-4833-8409-6b9f6149ff51_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_98f1807c-7980-435e-b31f-5f109a5aebcb_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_7fc3f8b0-187a-4ab4-88be-e375fc9c6477_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity interest in acquiree, remeasurement gain</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:to="lab_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_df54171b-cf43-40e7-9bc1-f12860a48f88_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_de48980c-fb10-4c3f-b0fa-f42cccdcb16c_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_01db9328-c7b7-4795-a8e8-0d6ad865a12d_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20201226.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_89b69d53-35c9-4339-b709-d31c2c99ef01_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_5fffd5c8-aa8a-43fb-bd4c-96a398b0f957_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_8b34e922-296b-493c-8337-1c0549fd78b6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_10b0cd7f-67d1-4a1b-abec-9e247837fcbc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_b721dc53-90c5-4144-b43e-65a582244260_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_36b6730f-9e12-40df-a8e6-874f4e35282d_terseLabel_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_label_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_documentation_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:href="holx-20201226.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:to="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_7699f394-886e-4fe0-8944-86860ecda408_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AlphaImagingMember_d71479fb-3db9-4470-8875-0edaa9287d6b_terseLabel_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging</link:label>
    <link:label id="lab_holx_AlphaImagingMember_label_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:label id="lab_holx_AlphaImagingMember_documentation_en-US" xlink:label="lab_holx_AlphaImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Alpha Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember" xlink:href="holx-20201226.xsd#holx_AlphaImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AlphaImagingMember" xlink:to="lab_holx_AlphaImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessLicensesMember_5369db2f-8f7b-4982-9a84-e4a4a852c9df_terseLabel_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_label_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Licenses [Member]</link:label>
    <link:label id="lab_holx_BusinessLicensesMember_documentation_en-US" xlink:label="lab_holx_BusinessLicensesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business licenses.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember" xlink:href="holx-20201226.xsd#holx_BusinessLicensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessLicensesMember" xlink:to="lab_holx_BusinessLicensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_e6d30ade-afb1-4c4c-9ab7-1ec1c507fa46_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_b2974b4f-86d1-43f1-9037-8d478bdb431a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_2954ffa8-0c3c-455a-b3eb-58e1673f719d_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment under revolving credit line</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_d3f0773f-0e52-493e-99dc-e08778367f1a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_63a3861c-0f68-4caa-80f6-9b6052d66e59_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_93094fe7-83b3-4e3c-8079-6b3622062c80_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_1f2c2264-705d-4d8f-88de-547dd5de4245_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d7636d21-fe1f-4d5d-98ad-12d1507f5afe_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_95797822-e437-4eef-9dd5-5ec4d8d41d2f_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_d6eae609-fae8-48cb-961b-0af43e617f2e_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_7fa17157-2158-41b2-ab18-e5db3d69436f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, stock option outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_ed93bd41-7a88-4a4c-82f0-788313ca917a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_028067f1-50ba-4082-bc80-46fad889497f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b15c04a7-de19-4178-a337-3ac5c2de5156_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_3d51550c-fe44-4efb-b712-d2361cc18169_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments not designated as hedges, gain (loss)</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_60980cc3-49d3-46fc-9109-3b8e0b6e5dbb_negatedTerseLabel_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassified as Assets held for sale</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_label_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:label id="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers_documentation_en-US" xlink:label="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Transfers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:href="holx-20201226.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:to="lab_holx_AccountsReceivableAllowanceForCreditLossTransfers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_ced53bf1-6dab-424a-935c-670099f0a0e7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_b4f3fd77-7db9-44be-bffb-3a09415df531_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_fefadc17-6a91-4c38-ba47-240155b5a6e4_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20201226.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_e40bf797-a4f5-4bb9-90ca-f279171a4c29_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_bcc50948-3c54-4ffa-a371-d28b5c17cd01_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_0cfcf19a-3b73-463b-be37-fcbb30b0ab9f_terseLabel_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_label_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:label id="lab_holx_AssetsofBusinessHeldforSaleAbstract_documentation_en-US" xlink:label="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets of Business Held-for-Sale [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:href="holx-20201226.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract" xlink:to="lab_holx_AssetsofBusinessHeldforSaleAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_17b1021d-c7df-4dda-b437-86e339b187e1_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_727da1f2-6724-4315-a780-bcd80c814bb1_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_722dc1f8-5ed6-4bff-b7d6-19ee5db3c320_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_f80e7233-5a1e-46e8-8980-620f4b6ff212_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_422349eb-3da8-4f84-8acd-8b4aa53c00f2_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_9ddcdb7b-8f56-44e1-9bcc-bea35fd7cff9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_121d81de-44c4-4677-ab4d-84fbeac7c154_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_438ebbba-3b77-4264-97ce-29667b2dc43a_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateDomain_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_4a3cf35c-a7a7-497f-98fb-8d8a907de6de_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_cd46d3cf-1066-4fb4-b5fa-e7a6771f3c10_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_68302624-3d53-485c-b4d5-3204804d92bd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_bc9de82b-d13d-4e4c-9442-019e6a150e2d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_11eacef6-f3ec-4907-b85a-4819f179fbc4_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_a27699aa-445b-4a9c-939e-5ac571cd7e72_verboseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20201226.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_a687e097-e642-4f4a-894b-42c06127d4f8_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20201226.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_313a6249-80d2-488a-b3f9-1710d07028cd_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_326bc63d-5f7a-40f9-9a7d-4d6bef124045_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20201226.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_3c03015e-dabe-4e74-9e1a-5857724c2c8b_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, fair value (percentage)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_89f5aeca-d779-4a3b-80e5-0d6847c6fe41_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_fe4afce0-f642-4437-aa16-de4bbee09a77_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20201226.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_030afc98-f4e6-4f5f-ab80-c885765513ce_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_2650f8b5-2652-493c-b595-b1450e9eed94_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write- offs and Payments</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_0ad47d16-e401-402f-8d58-0aa19c97102a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Costofservice_403dc9f0-83b2-46b9-86fb-aee34d915080_terseLabel_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_Costofservice_label_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_holx_Costofservice_documentation_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice" xlink:href="holx-20201226.xsd#holx_Costofservice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Costofservice" xlink:to="lab_holx_Costofservice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_8f2aeea7-d7e3-45d3-96d8-e5c59a46584a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_7f733481-039c-491a-baa5-36bb84be9b39_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_5fb35c07-ab54-4b44-8ce2-27adc3e4d539_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_3ae5f849-8f95-450e-a60f-5fb162887c20_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_9f4279d6-2fcd-4480-b15f-03dfc3504ba2_terseLabel_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_label_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:label id="lab_holx_AccountsReceivableSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AccountsReceivableSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable Securitization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember" xlink:href="holx-20201226.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccountsReceivableSecuritizationMember" xlink:to="lab_holx_AccountsReceivableSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_3529f1c0-24a6-4b14-8778-120d4f554e5b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_5b4e0dc9-f851-489a-98e2-487782710369_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:to="lab_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_e7800245-6c53-4a59-9fcf-8e2854bd26ee_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20201226.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9f8f4813-1c48-4001-b8d1-ad95b4f86d23_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_816cfe64-80c9-4dbd-8bbf-699440251594_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_dd3da7da-3211-4aec-9445-49a93654d40f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_95cdfc86-d245-410f-ad45-5e6225161ef3_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_fd0ec31a-ae2b-4b90-994d-afafee3e603b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedAwardsMember_708404d2-5221-4f07-8892-857e261722f2_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember" xlink:href="holx-20201226.xsd#holx_MarketBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember" xlink:to="lab_holx_MarketBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_a0cbc070-e7a0-4e14-bb5d-e41b0dd683bd_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_fba7d148-893f-4f22-afbf-c6a0f25d6b2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_2e221c75-95ab-4493-95e1-043708f7a1a5_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a76ee29-4667-4ff7-8488-0b4a7fab6a09_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1d7d07c5-4932-42a7-be82-6a38cca889ad_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_530c51d9-bdee-4d87-89ae-5ab58f0b5d1b_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_f71f0bfc-91fa-43bd-8676-4cf097567039_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationTypeDomain_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain" xlink:to="lab_us-gaap_ContingentConsiderationTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BiothernosticsMember_8661e19d-3a65-482e-9b6a-bdc57b9e8010_terseLabel_en-US" xlink:label="lab_holx_BiothernosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biothernostics [Member]</link:label>
    <link:label id="lab_holx_BiothernosticsMember_label_en-US" xlink:label="lab_holx_BiothernosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biothernostics [Member]</link:label>
    <link:label id="lab_holx_BiothernosticsMember_documentation_en-US" xlink:label="lab_holx_BiothernosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Biothernostics</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiothernosticsMember" xlink:href="holx-20201226.xsd#holx_BiothernosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BiothernosticsMember" xlink:to="lab_holx_BiothernosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_03d5ff71-f7bc-4674-b73a-2c6bf37804cc_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_42d36524-203a-4397-9cc1-0256a695caba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_bab530a8-1947-4f2a-b0e9-6fe57955b571_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_1f6249f2-9cfd-4fbc-8a76-220b8c5b19cb_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20201226.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_e3c082af-ff7e-4aa7-8f09-a66461a341e2_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_2ef68c79-7ad9-4732-9e00-d0389cdd58fa_verboseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_85775da0-e6d4-4b83-badc-96e7b101af96_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20201226.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_67b601c0-1fc2-45cf-8ae6-2388c80b05c3_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20201226.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_3661f1d6-302b-40f5-a43c-12a982e675b0_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfDebt" xlink:to="lab_us-gaap_RepaymentsOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_839364e8-bc2c-48f1-9ec1-37d4f69c85a4_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_378a4482-3326-4faa-b9c8-e2021dabbd7d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_55e73649-5dfc-47fb-ba4c-0fc7a3ab6821_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0477addb-bcdd-4d6f-bcd2-44c52a768dd9_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_27f1d5e8-af65-4ff5-80ee-80b905e20ce2_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_42ff7123-221a-421b-9e34-c03cf0cfc973_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f18f74dc-d691-46f9-9ccb-4beed2f9659c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_d7eb4726-76cb-4971-9cbf-2596cf22c2b6_terseLabel_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_label_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_documentation_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold" xlink:href="holx-20201226.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationCostofGoodsSold" xlink:to="lab_holx_AmortizationCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_0c4af50f-1ed0-4f5e-9923-932c4f1a762e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_10561717-98d8-469f-9b79-86da52e3063b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0abe2170-4614-4168-9aaf-cf0d6f6eda1a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_ae45c542-c29f-40d3-8ea8-e6751f03f95c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_3396e201-02d4-4c65-aea5-5f07c5356afe_terseLabel_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_label_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:label id="lab_holx_PercentageAddedtoEurodollarRateMember_documentation_en-US" xlink:label="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Added to Eurodollar Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:href="holx-20201226.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageAddedtoEurodollarRateMember" xlink:to="lab_holx_PercentageAddedtoEurodollarRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_bb6a0e65-5aa9-4ccf-a4a2-25798780b45c_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20201226.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_227996fd-80cc-4106-8b88-7f1d3bc59ae6_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_cd01f293-0157-41ff-a97b-5cf6a05aaa7d_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ComprehensiveIncome_cc2f6a1d-057f-43b8-81f8-8f7ce9345954_totalLabel_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_label_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_holx_ComprehensiveIncome_documentation_en-US" xlink:label="lab_holx_ComprehensiveIncome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome" xlink:href="holx-20201226.xsd#holx_ComprehensiveIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ComprehensiveIncome" xlink:to="lab_holx_ComprehensiveIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_ab028046-ccca-4d86-804c-2bdddef94446_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_label_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanLineItems" xlink:to="lab_holx_SharerepurchaseplanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_2d978874-bd09-49b3-b21f-759204d23018_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_12c8b66d-bca9-4868-9c80-7a01ac88ffe9_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to newly acquired shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_05883d7b-e412-4fd5-a1f2-a5c24b79e03c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_d0705641-39b1-43fa-b15c-cedbfa5538fb_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_bd976d25-0504-4d9e-8aa0-0ab7d85663ef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_a1af2d10-ed90-401f-98b5-6cca1b9e8d11_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20201226.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_43f939ee-38d7-4017-910c-a6edb20fe2ac_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_d006e3db-9148-40ed-ac2c-41dfd2cbd6d9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_b25f6674-7f13-444d-9dac-f274fb115209_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_bc48687f-e5b9-4bf0-8197-81dcfe718eee_terseLabel_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_label_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_documentation_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts" xlink:href="holx-20201226.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseofinsurancecontracts" xlink:to="lab_holx_Purchaseofinsurancecontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_82d8e578-2bad-484f-adf7-fd202c344736_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, reserves</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2d253e13-6130-4c28-8c5c-c0f8bcc9be1d_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d09a5950-136a-460b-9c00-94c90deae004_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7a02cba4-1c4f-4078-bb2a-17fd56b2180a_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_632715a4-cc08-4b32-b1cf-b9f461cccfa1_terseLabel_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_label_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:label id="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue_documentation_en-US" xlink:label="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Offering Price, Percent Of Face Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:href="holx-20201226.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:to="lab_holx_DebtInstrumentOfferingPricePercentOfFaceValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_40a08475-0067-4612-b1c4-fec41b428dcb_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_a0759534-b14d-46a6-81f2-20dccc96e3e9_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:href="holx-20201226.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_2b1ecd51-5bbb-4066-9193-ebad666f4219_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_e3039ddb-efd1-4134-9a4d-f726bdcdc6e7_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_42cd331a-d604-4459-b6cc-991452920ea5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_acf026ff-9af3-4f08-9b0e-a3d2e606bfd5_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_3e3c150a-7d39-4e37-b757-8d90c681122b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_dd29f43c-2be0-4661-8186-cf99b188fffb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_2e6e48fb-cc57-416e-b40d-606da8dcb9dc_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_08b56dd3-27ae-4e61-a347-44be72efe778_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:to="lab_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_b6b2b1de-40c8-47e1-a6b1-b4b00d3144d1_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_020d4f7c-a56e-457d-87d9-a4cdfaed6052_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquired intangible assets</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20201226.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b66ac917-5405-4e7e-9321-d27936363915_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_43b9b712-b9f9-4575-951b-a648c3d7f2b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_2ecf3600-ec46-4753-a19e-d8dd747681c1_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_40a598be-13b5-4937-9d8a-7356fb0a2527_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_82b03424-00cb-4849-aa9f-364342a21e57_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_1a4d68da-06de-4876-a9e1-3f3d0de5c310_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20201226.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_a465031f-c54d-4e94-8b74-cb679decdeaf_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20201226.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_61370436-345c-4c92-8606-57d78b7da2d2_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_26ea08a2-48a3-4b68-a128-4c7b96f79080_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_56727ae2-0af5-43d8-9b70-2c3d9096ffbc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_85137ca3-6480-4b9f-ad82-aa5e74a42dd6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_7c95de84-1ffe-47c9-a97f-6f0518e23409_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a470b153-08dd-4eb6-b175-23f77dbcac86_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_a6a351a3-f77f-4e59-b424-de59817bef45_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_6196c09b-3480-4618-8fea-1ed9c94a73c5_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b7c0c27b-e3d9-4bb1-befe-602d1f9c0c9c_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_90f2b76d-edec-4090-b394-e513d1e7cec6_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20201226.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_be4171cb-5590-4353-9f1c-9e9121ca9288_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligation - long term</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_6225332a-cc60-4b67-96de-edcb4012b01a_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_30862ac5-27dc-4baa-8b76-849fa705d5ab_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20201226.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_b042c039-edca-461f-820f-ef58f73b6d01_terseLabel_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dispositions</link:label>
    <link:label id="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mergers, Acquisitions and Dispositions Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:to="lab_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_243db5c5-4819-4c37-89a9-0c0de7b96dcc_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_4a678511-2b74-4323-bf8a-8a390f1c5d9b_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_c92361d0-5430-4596-a714-d5a6805a3620_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:href="holx-20201226.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_3dc00147-523a-4b51-bd37-5e753e65b812_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_b19d25b1-41de-4739-ae3c-5e94210f7a91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_9bf3a73a-8e50-49fe-967f-c6716015d084_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchasesDateAxis_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchases, Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:to="lab_us-gaap_AcceleratedShareRepurchasesDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_7c16af83-6abc-4e05-971a-ac9d3739506d_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_ef38b8e2-ba12-4d3a-a1c1-503babab757d_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9593fc8e-13df-479f-ab54-2630e6bb9bee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_6b307ba2-e65c-45d5-8d8f-59c9745656f9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration fair value adjustments</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_8817cd9e-88ac-4210-810a-a2a2b56e0b6f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_8a851d62-2f7e-4c03-bb89-811ad38b300d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_bf85bc8d-e955-46de-92ee-bd591eafa7b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e9d1d66c-0888-4ed0-bad5-5edaee78a42f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_3864663a-ee14-472d-9c92-fb76c1ba9b92_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_14e25db7-52a5-420c-bef7-a7c4d38f422a_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_e42abe05-a7c8-47bc-b58d-8dc6db5261de_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_c189bd06-0a7e-47c8-9d75-c34154c23d26_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of capital lease obligations</link:label>
    <link:label id="lab_us-gaap_CapitalLeaseObligationsCurrent_label_en-US" xlink:label="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Lease Obligations, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalLeaseObligationsCurrent" xlink:to="lab_us-gaap_CapitalLeaseObligationsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_9aa402a7-2b36-42a6-ad78-931b4933e525_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20201226.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_bfe62521-72d2-4739-8c72-d4ff0aee28af_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_de203ace-0832-442d-9c54-742eb784e7dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_c152fe3e-4088-46fb-a3af-db83ef053fab_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20201226.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_4e340dc1-b437-4d28-b73e-269754c65f72_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_d0f08065-c068-45b7-95ec-1e70e7d02353_terseLabel_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_label_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost Of Goods Sold Impairment Of Intangible Assets and equipment</link:label>
    <link:label id="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_documentation_en-US" xlink:label="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:href="holx-20201226.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:to="lab_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountAssessedInDamages_d441a299-5f1c-4465-a489-557c00a9fe8b_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages" xlink:href="holx-20201226.xsd#holx_AmountAssessedInDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages" xlink:to="lab_holx_AmountAssessedInDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_9216b76b-fe82-4a0d-822e-13275af384da_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration by Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis" xlink:to="lab_us-gaap_ContingentConsiderationByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_59f98096-28c3-43ad-a873-1e6b5aa6c00d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_cd834876-9526-45fc-a4d9-36dcef53358e_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_836ca381-433f-44b6-acb5-ce5f594f6239_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss reclassified from accumulated other comprehensive loss to the statements of income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_1b6ef70d-705b-49f5-a930-822860d0a704_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_a0a63b5b-91ed-495e-8f27-4fd1e0bbe7c9_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20201226.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_bd6fc9de-6332-4c7f-9018-59faa5401186_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_72f40ee0-f5ff-4b6d-947d-8731d2b73373_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_a9a46cb6-6687-4934-a299-3ba9288826d4_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_4a6524cc-df86-41f6-8e00-acdf5042f53e_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_a6656841-d209-489b-967a-ac2a7e2888e7_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_81d81831-f7fc-4f4c-8082-d2e6151cfb9a_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from accounts receivable securitization agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Accounts Receivable Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_0dcd52b7-bcbc-4dc6-90f0-06d4230014d8_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20201226.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112020Member_ef44fbe9-a39a-4bb0-aea9-62c4ad23f273_terseLabel_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:label id="lab_holx_December112020Member_label_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020 [Member]</link:label>
    <link:label id="lab_holx_December112020Member_documentation_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member" xlink:href="holx-20201226.xsd#holx_December112020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112020Member" xlink:to="lab_holx_December112020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_efffaac2-a46b-433d-afd6-3352956deec2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_1ef50ef0-69e5-4376-8225-63c133bd6687_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total (percentage)</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20201226.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_34ae1902-78c3-4c4e-a119-da2232630162_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_3478e765-8318-47ed-bf45-3c90e4533e14_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20201226.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1aef0af8-0c79-4a9b-9147-bf5ff1d11392_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_00fc27c1-209b-4733-be19-f38abd23ab1c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_203b77ce-20e3-4bf0-8ae0-4848e9a73a3e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price of options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_095b891e-041c-4c2f-9980-0bd8d9277ee9_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20201226.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_b0f8f6a1-aeb7-4fcb-b8c3-3a3bd08b198e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_9320ebc4-c9fb-4da1-908f-626e7d5a9afb_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_29b65c77-379d-44b9-bb4e-fcd4877500eb_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of outstanding shares acquired</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Percentage of Voting Interests Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:to="lab_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_ad62d093-8ce0-4f0d-a33c-e48171837419_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_9e171c23-6b5c-476e-96d5-5cd800c7e21b_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_b32b319f-40a9-45a6-88b2-29741ca2888a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenseMember_746e50f8-03f8-427c-af49-ef7dd27ad284_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense</link:label>
    <link:label id="lab_us-gaap_OperatingExpenseMember_label_en-US" xlink:label="lab_us-gaap_OperatingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenseMember" xlink:to="lab_us-gaap_OperatingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_8aa98411-fbf4-41b3-9fca-cad42a127e2a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_aace700b-06d8-4104-a1ce-17bd11f716a1_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MedicalAestheticsMember_a8cef8bd-cf1c-4083-910b-7af33711a2b4_verboseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_de9ab3e6-d834-4a6a-9eaf-fbd8f460adfb_terseLabel_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_label_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetics [Member]</link:label>
    <link:label id="lab_holx_MedicalAestheticsMember_documentation_en-US" xlink:label="lab_holx_MedicalAestheticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medical Aesthetic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MedicalAestheticsMember" xlink:to="lab_holx_MedicalAestheticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasisofPresentationAbstract_0bd2f5f1-2980-436b-9f3e-6173a18cff08_terseLabel_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_label_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_documentation_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract" xlink:href="holx-20201226.xsd#holx_BasisofPresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasisofPresentationAbstract" xlink:to="lab_holx_BasisofPresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_636b637f-3fde-4d40-aad0-9f6631079c17_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_9487b2bc-866f-42a4-aca7-dbcc15c97a08_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_68cbccdf-8659-49b0-97db-d91351d2eb4c_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_f6232a6a-1dd2-4630-8427-c1c1fdb90d0d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_0a842a17-d884-4ac3-a1a4-8b5344ee80f5_terseLabel_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated share repurchase agreement</link:label>
    <link:label id="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_label_en-US" xlink:label="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accelerated Share Repurchase Program, Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:to="lab_us-gaap_AcceleratedShareRepurchaseProgramAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_05dc5fb2-6e39-4dbd-a812-87eb4be7da7b_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_9a2cff4b-7d8f-41eb-b22b-621711061f03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_00536b46-80b9-4afb-8dd3-20955deea3f8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(0.2) for the three months ended December 26, 2020 and $1.7 for the three months ended December 28,2019.</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_1fc6935f-56a0-4c18-abf1-740966732ddd_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_07684f31-2fa4-4699-819a-c6d8542d39e2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_084b6c3f-a628-416c-a225-620afaf8d99c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_35b10c11-c07a-41b7-9f9d-9d22b25fc2b1_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_597df77d-9b2a-4874-93a4-0ef011812b20_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_853a11f5-47eb-40e7-a793-f09b5ca3bbdd_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_33382ccd-7316-4509-a3e0-01a84b33ef97_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangibles</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_7291ba58-52fb-4d3a-a59e-d4875b66b22e_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_e941cd3f-46b0-41d3-bd90-34c612fe5b3a_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_eb9aa203-5101-43c3-9a2c-de9c78816828_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_8fa6ca3d-fbb2-4457-b347-ac19b0c940c9_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20201226.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_c781b5ab-142e-4e6f-ad25-2a556e57e3bc_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20201226.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateCapMember_47ca5ef9-1176-437d-973d-d47053c8e3fc_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate caps - derivative</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_0553c61d-e1ae-4b0e-9ca7-09d08535b43d_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate cap agreements</link:label>
    <link:label id="lab_us-gaap_InterestRateCapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateCapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Cap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateCapMember" xlink:to="lab_us-gaap_InterestRateCapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_8bd96832-5066-4a16-9629-16b1163b046f_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_fa015b0e-db95-48c8-b6fb-9880662a4307_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_62293ddf-920c-4de1-8500-158c5d9ec377_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_dfca60e6-5178-49ec-acf2-1ec00a9bebbf_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_a6f9f311-0050-4ab3-a162-ace1dd36b58b_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_ce8299e8-4209-44b3-99d4-c7aa7904197d_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_40a4dc3f-770f-40ae-b0a0-8dd4c96b61f9_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_73aff9d4-0d13-407c-aa73-9d0e52c93edb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_9f512447-2a53-4dec-8245-2afc04e4f7b5_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase price withheld</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112019Member_ddfc8a33-532e-4b35-9c3a-19f735184344_terseLabel_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:label id="lab_holx_December112019Member_label_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019 [Member]</link:label>
    <link:label id="lab_holx_December112019Member_documentation_en-US" xlink:label="lab_holx_December112019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2019</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member" xlink:href="holx-20201226.xsd#holx_December112019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112019Member" xlink:to="lab_holx_December112019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Holdback_7d6c1009-e1dd-41a5-a255-ad858b0d37c4_terseLabel_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_label_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:label id="lab_holx_Holdback_documentation_en-US" xlink:label="lab_holx_Holdback" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback" xlink:href="holx-20201226.xsd#holx_Holdback"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Holdback" xlink:to="lab_holx_Holdback" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_f81029e9-0171-4f4a-9e73-aaa0777ff9e9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_7dac0984-54a8-4252-b1cb-af7421ac02c2_terseLabel_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Notes Payable</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_label_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:label id="lab_holx_ProceedsFromSeniorNotes_documentation_en-US" xlink:label="lab_holx_ProceedsFromSeniorNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes" xlink:href="holx-20201226.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsFromSeniorNotes" xlink:to="lab_holx_ProceedsFromSeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_9f8c9b3f-5424-48b8-94a5-05439cfd718e_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_b35575d8-9fc2-4e01-8fbf-2bca4f59bd08_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_5c883f0e-219c-403f-b714-b23051855722_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_8ef46022-1c6e-4058-bd79-c7ec08c5f4f7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts reclassified to statement of income</link:label>
    <link:label id="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:to="lab_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_bd8840ee-0730-44b7-aabd-651d85cb6836_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_f01282dc-8c97-4dc3-ae26-a5faa3b86a2e_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20201226.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_2546b2cb-3a3f-4611-8050-170d708ea247_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmendedTermLoanMember_bac2a74e-d036-4adf-afc7-d4f1dfba4dde_terseLabel_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_label_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:label id="lab_holx_AmendedTermLoanMember_documentation_en-US" xlink:label="lab_holx_AmendedTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember" xlink:href="holx-20201226.xsd#holx_AmendedTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmendedTermLoanMember" xlink:to="lab_holx_AmendedTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_3bdf332e-5ffc-4796-ba14-f064862fc431_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_7e75c601-6552-4de5-9adc-19cfb91f44e3_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss) before Reclassifications, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_c320b6fd-8051-4b93-86ed-f8ce23a9fc9f_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a2e999d0-9dec-4cca-adae-2853d3e0f587_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_c9292823-06e0-4cc6-baeb-2801ba7e4403_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_74c4cba8-1dc7-4677-ad51-bcbd8a5b1e74_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LegalAccrual_2c75e220-2256-47fa-8861-d3a0d0c2e079_terseLabel_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_label_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:label id="lab_holx_LegalAccrual_documentation_en-US" xlink:label="lab_holx_LegalAccrual" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual" xlink:href="holx-20201226.xsd#holx_LegalAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LegalAccrual" xlink:to="lab_holx_LegalAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_01aa7689-590b-4a3f-a8ce-91b41f14c62b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_fef8944d-4fa9-415c-90bb-46f94c45e99b_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_ad57f080-7055-45df-9671-8043aede6999_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_0d97f611-614b-4cfa-a5a6-374e05f98488_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_4add57bf-f64d-4554-8990-b00b286422e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Adjustment to Fair Value within the Consolidated Statements of Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives Not Designated as Hedging Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_764f98b2-8623-4306-a7d1-8aec38ed679a_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f4ea09cb-e77c-4456-836f-67d9d5b9a8cd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_627f2839-9207-4dc6-be9c-5386787c2e8a_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_label_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:label id="lab_holx_BusinessCombinationSharesAcquired_documentation_en-US" xlink:label="lab_holx_BusinessCombinationSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Shares Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired" xlink:href="holx-20201226.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationSharesAcquired" xlink:to="lab_holx_BusinessCombinationSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SuperSonicImagineMember_a028fdba-aa3a-497e-9b92-471fde4f55ab_terseLabel_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_label_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:label id="lab_holx_SuperSonicImagineMember_documentation_en-US" xlink:label="lab_holx_SuperSonicImagineMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SuperSonic Imagine [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember" xlink:href="holx-20201226.xsd#holx_SuperSonicImagineMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SuperSonicImagineMember" xlink:to="lab_holx_SuperSonicImagineMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_7673d580-50ba-4251-9f5d-ac807cf3eb1a_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_f10d95cd-cd29-442d-b5c6-33e7e3cd529c_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_a27f0750-f8ca-47c9-b3c8-ec7ac2975e9b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_fb6ac865-3844-4de0-8c88-d8401331208d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_03cdb086-b522-4a28-af02-b367cb733994_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentHoldbackMember_38ff5b9e-9736-49bf-b522-9e6bd735f3a5_terseLabel_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_label_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback [Member]</link:label>
    <link:label id="lab_holx_ContingentHoldbackMember_documentation_en-US" xlink:label="lab_holx_ContingentHoldbackMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Holdback</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember" xlink:href="holx-20201226.xsd#holx_ContingentHoldbackMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentHoldbackMember" xlink:to="lab_holx_ContingentHoldbackMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_bf9f213e-75e3-4aa5-ae1d-ac4db914dde3_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration, portion related to loan repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_555c0622-7d97-4220-9d65-ab2f4da3c8e2_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_3ee778f5-3f2b-476e-9407-326d8bef8842_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_95ebd2b9-c60f-4b68-96b9-bbe50088f58d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_90838acd-f326-44ab-9aa6-cf1c6c563ddc_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_a807d8d4-7191-4d02-b4f7-0e7bda85048d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_7b166ebe-257e-4585-a041-be202cc5407c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f564a8e9-d22f-4eb1-9a43-da32960f8ade_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_95c679af-ca17-4c6b-9a09-2c434f6e9803_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_HealthBeaconsMember_3b645de9-0d5e-4509-a0f4-9822a3e16dc1_terseLabel_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_label_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:label id="lab_holx_HealthBeaconsMember_documentation_en-US" xlink:label="lab_holx_HealthBeaconsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Health Beacons [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember" xlink:href="holx-20201226.xsd#holx_HealthBeaconsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_HealthBeaconsMember" xlink:to="lab_holx_HealthBeaconsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_28940f94-7cb9-4846-94ce-162b93821918_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_000376ae-6798-4b2f-bcef-edf84b4531ba_terseLabel_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount rate percentage</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_label_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:label id="lab_holx_FairValueAssumptionDiscountRate_documentation_en-US" xlink:label="lab_holx_FairValueAssumptionDiscountRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assumption, Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate" xlink:href="holx-20201226.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_FairValueAssumptionDiscountRate" xlink:to="lab_holx_FairValueAssumptionDiscountRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_edb53bb0-9b1c-43cf-aca4-fd1048196cbc_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_4212742e-8045-48ba-a8bd-f1b5a895d981_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_e40a4dd7-29e5-4531-b0ec-d9c96ced2d83_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_679b46a8-9af8-434c-b817-3820de302b9c_terseLabel_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:label id="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_label_en-US" xlink:label="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:to="lab_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_262d9549-b698-45bb-ad1e-8095764bb542_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_a9833997-d215-4773-8212-08a031d7ed24_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_ed951542-8dbd-4d01-9fe8-8f9107d090f3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e5652920-fb68-4794-83fd-1026d96cd321_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_db9c826f-1d74-49b7-89a4-b5a041089c32_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_89817773-f485-45d0-a7ef-dafe0f17c478_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ad599c73-58f1-4959-8749-61fd12e1e642_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ServiceRevenue_c164d60c-3562-4839-883a-2c2645f75cb0_terseLabel_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_ServiceRevenue_label_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_holx_ServiceRevenue_documentation_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue" xlink:href="holx-20201226.xsd#holx_ServiceRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ServiceRevenue" xlink:to="lab_holx_ServiceRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_62fc37e9-3d6f-4e2c-957c-79fe88040838_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of Fiscal 2021</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_5b41c19f-0122-422e-bf0f-324d1f0ccf9e_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_48e41391-a4ec-4800-82f9-569c53177600_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_67e0bf60-ba73-4290-b514-9167ac588123_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_3f243a87-cb5d-4e4d-bc4f-e21acd2bed42_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f9b563e6-4347-4774-a06c-6c9e4def58ca_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_5522ece5-0346-4de0-a2b4-ced1a10a4c86_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_1459f16a-5fb2-48d7-a04c-7cd67c01e4be_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_df3d4e9e-3914-4a4e-ad00-5fd4e4389898_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_37d132f6-4121-4fef-a633-5ec36e320b07_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_4ad9c377-7906-4628-9517-fc25df9a6a4a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_5668bfc7-2d25-49cc-94b7-7bb642114143_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset and equipment impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_1b56279b-c5f3-409d-8078-f1560bc9402f_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f7989021-194c-4015-9e9d-799095185bc7_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_2f24b69b-daca-41b9-96d0-8fc1b57d4dd5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_21f0c9b5-f04c-49aa-a424-70f5f76727a5_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20201226.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_9fc003e8-a60a-40a6-bc9a-ddb3c987f08b_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_e405c242-7cf4-4753-995f-a3b54b1ed788_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_e7fcba71-a742-49b9-b4aa-44114e9dbddb_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_0e67668c-a0a6-48ff-8800-bc7ba0082627_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_19a00ac5-48d7-4c31-b5c0-839bd17b6717_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_3543a9a0-ba46-43c1-be0d-40a6889e951a_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_0faaea56-0a72-44c2-8710-4d276a778cf4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_6566f389-a616-4b67-ab68-1c7baab75397_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_c4523e7e-5510-4e88-a9a5-4fc889c48cbc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves of $39.4 and $31.6, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_d962c047-be32-4594-8bc8-dca60bd3e1cd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_b068a08e-bb50-40de-9c88-d712cb042b32_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_b81f672d-aece-4ffe-8dfc-40ea6e6befc4_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20201226.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_d2a23346-7d6b-40d2-a7c8-e443096dddc8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_78f81ee2-3c6c-42c0-9dcf-ea839ab2e00e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_af2c2bb2-14f6-45d2-a1e4-fce16ba9fd93_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_83e52004-0a4c-40d9-b932-68cad2e89014_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_960670ca-9471-40df-bbac-538c23947379_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_8dbad03c-1096-4390-bb3a-6660ebeb1682_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_ad327915-0d2b-412e-9eee-ddda61f77139_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_16fd019c-60b4-4212-8f3b-1953ba29b391_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_260a90cf-79d1-4572-a440-1c516def0ed5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_ce23207f-239f-4e62-9ac8-e1f4665dffbd_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20201226.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_0d18d4df-f744-4ebb-b9e7-1ea1f9381643_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Fair Value, Gross Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ChangeInParValue_afcbb122-10b8-4148-a746-28048fc97a61_terseLabel_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_label_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:label id="lab_holx_ChangeInParValue_documentation_en-US" xlink:label="lab_holx_ChangeInParValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in par value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue" xlink:href="holx-20201226.xsd#holx_ChangeInParValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ChangeInParValue" xlink:to="lab_holx_ChangeInParValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_9eefc958-2c9d-4141-b315-dba88cca470b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_a99dd8c4-054f-4266-8d6b-bfd486a9bcd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_c53c4d8f-b66a-4267-bf6e-3ed0dd872a7d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_c614ee0a-3377-44a0-822f-37e86aca097d_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_16a85eb0-e6ae-47f6-ad88-0374c2f5631b_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_299dbe80-8228-4112-b7a1-c72e4689de8a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_51e9889a-2aa0-413e-ac64-f5f7d0e9fdbe_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_f779f136-7077-4070-b79f-b06dcff90ec1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of equity</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepurchaseOfEquity_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repurchase of) Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:to="lab_us-gaap_ProceedsFromRepurchaseOfEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_5c784699-32d1-4b8d-bd47-ed6a7ddb66d5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise prices</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_e2a002c5-3d11-413a-8950-ae019469019c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_c6602e9a-5c5f-49c1-ab8d-436a5d151a95_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ad0c65e0-b99a-4519-a00b-f26277c13b6d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c40bf2c1-45e9-45a2-a783-a6d13aec2705_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_3cade365-17a7-4b14-a70b-70c67050f7d2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_e3ff0002-e671-4288-a883-f2d0cee98c8d_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_3e65bf49-9d7b-462c-9d12-e898c9284075_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Five [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFiveMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_16809f03-b7b8-4ecc-b584-11efbee60c30_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_f386a2b5-8bbd-4785-a77f-7e70e051afe1_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_e2d9ab4b-c254-4c86-b8e6-7232a39db4b8_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_2fcb081e-785e-4b16-b79a-74e2b275faca_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_ae1e2557-2078-4954-9e94-3d38302a87cb_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_366d5cb6-f723-4e8d-acbe-6ebb657bf9f1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_79afe6ff-671a-47a8-9936-442e5084cb66_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_345a1db0-1d85-422f-83ad-4729ba093526_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_8d20cb5f-b9d4-4347-9a02-7d6c3c072eb3_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_30428a4f-7524-4fb2-8d5d-584883825b57_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,533 and 295,107 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_69449348-df09-4d9b-856f-156710118fea_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_4ed54f43-907a-4ff5-a77e-f34e69c457ce_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_1b584943-d6c9-4229-a508-e68349368630_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_6cd929fd-6230-4a68-b8d3-5b188181804b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_1dd8fdb0-0e61-4677-ac5d-e9c2249c1be5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_a45ba26f-a4ee-49fc-87d5-81251f601d21_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_94413ca3-3c97-4a53-ad8d-b3f02ac2ba55_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_b80f61d2-d601-4290-ad50-a1123bcfe7c3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_dd97ae94-8e79-4680-a96d-5944dafda7bb_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_a65a8abf-7210-43df-ad30-c8c9851bb530_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_dcf253c5-5601-4a39-9754-5994a7b6eb08_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201801Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2018-01 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201801Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201801Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinervaMember_41a23001-ded5-4106-aa97-fc4c81a9eda1_terseLabel_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva</link:label>
    <link:label id="lab_holx_MinervaMember_label_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:label id="lab_holx_MinervaMember_documentation_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember" xlink:href="holx-20201226.xsd#holx_MinervaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinervaMember" xlink:to="lab_holx_MinervaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_b1d02353-d2d2-48af-9b94-7c8d9a8de066_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Capital Lease Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:to="lab_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0b9b023e-5595-490a-bb1c-c70915624e52_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_5fa8452a-49ed-4a4f-83a3-74c3c983d33b_terseLabel_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_holx_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_holx_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember" xlink:href="holx-20201226.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ShareRepurchaseProgramMember" xlink:to="lab_holx_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_20f8672b-0f82-42d7-9c78-5df6e61a2fd3_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c795913a-968f-4c9a-a365-c4fb7b5c725e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_785b50eb-1dc1-4042-9f9e-d542ffaee940_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_525b7a5d-8332-461c-a478-dfc5e02c2a02_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_b539fefb-74ec-4453-8000-e6406fe711cc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_cb90f4b7-60af-4436-b033-6e3b26e1454c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash less assets held for sale</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_ea1db2f6-de8e-4562-8349-0509b885866e_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_02b2a296-a9cf-4e55-9cf7-51c17e6802b5_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_9d3936a7-c148-418d-8cc3-0d1318a5a0c9_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_c9420d77-8734-43e8-8bab-ec6c1505a7b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_9a603c6b-7645-40e1-8a94-939c9524903f_terseLabel_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:label id="lab_us-gaap_ExtinguishmentOfDebtAmount_label_en-US" xlink:label="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Extinguishment of Debt, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExtinguishmentOfDebtAmount" xlink:to="lab_us-gaap_ExtinguishmentOfDebtAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_78632ff5-8d6d-4655-b37f-01a38df39c17_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_655ce969-36a8-4f97-b148-10089254d50d_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_22a2a073-a251-41c3-bbf3-a786d7a03d95_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_1f69ab62-e8b8-4290-b1d3-f8585045e560_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_b1d39554-6c59-41b8-ad95-54619fbd7f4c_terseLabel_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash tender offer price (per share)</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_label_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:label id="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare_documentation_en-US" xlink:label="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Cash Tender Offer Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:href="holx-20201226.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:to="lab_holx_BusinessAcquisitionCashTenderOfferPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_cf08ddba-1ccc-4798-94e5-a55de3ad96d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_3daa7b3f-fa8e-43a6-89d5-7dbc4541469a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b74c7ee2-988f-4728-94ae-cbc3f11622c0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Hologic's stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_7e21298a-4ede-4c2f-af59-dec2047c1fb8_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f927e6e3-01d9-4b98-ad9c-de618b73e180_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_2a183685-b5a8-43eb-933f-d0ada419a6af_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_92c23a52-5155-4c75-91bb-7af987b9ae69_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_c1891348-ec49-4bdd-8f5e-0c6ea5727c2c_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_label_en-US" xlink:label="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Fair Value Hedges Recognized in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:to="lab_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_67629b72-9a6e-47a1-afde-e8aa0654640e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_1f42eae8-37a4-4580-adb8-2b38e17db923_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_46928fea-71d5-4a92-ba34-c91a9bf92637_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_f9acb74e-386c-4277-be3b-e077369a2b2b_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_8dd24194-5626-4c4b-a9bf-2726a72fd8a0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_293e5e03-fe82-4377-909d-02863eac4903_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_63b4a4f9-4d33-4a68-af90-8c92f851225e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_04b46ad3-c991-46a4-bc22-a8f006d5169e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_9716330e-5017-425c-8717-7a7b3b3fed92_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestofWorldMember_a55d74d3-35af-4ea1-adf2-f3e3265f7963_terseLabel_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_RestofWorldMember_label_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_holx_RestofWorldMember_documentation_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember" xlink:href="holx-20201226.xsd#holx_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestofWorldMember" xlink:to="lab_holx_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_374edb9d-7b4d-40c7-8462-78919ba2ba39_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6aad2f0c-5f2d-400d-8977-386f48724bfd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_ae29bed9-4d24-47d9-9a6c-266935acdccf_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_IndemnificationLiabily_ebd3db00-6d69-4312-ad63-8a8598e5e402_terseLabel_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_label_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:label id="lab_holx_IndemnificationLiabily_documentation_en-US" xlink:label="lab_holx_IndemnificationLiabily" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indemnification liabily</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily" xlink:href="holx-20201226.xsd#holx_IndemnificationLiabily"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_IndemnificationLiabily" xlink:to="lab_holx_IndemnificationLiabily" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_35b575c8-ef79-48fc-b57a-96db421f6ea2_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_f69837da-c5e0-475f-a6d9-c7ef2f8ecc94_verboseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_cc2f509d-af63-4c84-bc51-a8a9393858f5_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20201226.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_b7c154b6-c0fc-47ab-a6f9-f9904e9ce5d5_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_920f2ca8-75fd-4e78-8e58-6f788ec1b29f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_e9d87597-1211-47c7-afcf-8e0e2d60214d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_7c12ddfd-8247-413f-96e2-bd34f0f10be3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_b7b30c0c-ad8e-4d6e-8b14-0b5c24e7f7f4_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_3a1eece2-3d08-42ee-9321-0a20c22876b2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_c42f0d36-dc6e-4c3a-b6a7-7123ba55354d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_79693b4a-3a2b-42d6-9da7-3ca8268f8fd3_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9391770b-b944-4228-81ea-e85f3259ac98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other activity</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_f6405fea-81c3-49b0-b2cf-467d87e1a1c3_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_49f58ecb-8fdb-41c1-b329-3e14a94c53d8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b84e0b82-8eab-4daf-adcc-190023de1d95_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_60fcfb99-ef92-4677-8bd7-ee1e3155dbba_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2025SeniorNotesMember_861c85ac-cdef-4dcf-a386-e4c924e75163_terseLabel_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2025SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2025SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2025SeniorNotesMember" xlink:to="lab_holx_A2025SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_048b0a80-dbec-4e4e-94e8-932e37fcc197_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20201226.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_580eb6e3-a088-4a4d-82c6-2206ff4ce5f0_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_b03068ff-c8e2-4d30-b33b-b3cad7b58450_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_05f41a3c-4f6b-44ce-bc60-d5730b272d49_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_1bf08011-d585-4c10-a3b9-f164aba22dab_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ff0d7cb2-a56d-43b7-8ec9-d77fe8a9faf7_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_add7a77d-09c5-4f0e-ac71-b34defd069e1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_34f43adb-8cbe-42db-bdf7-62eabeec4952_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_5514239f-ca8b-4614-a055-6d4847c8745b_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_3ec9c9d1-b794-49d3-86aa-c25187224901_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_8db3507f-04f0-4035-8d29-ed59f970ee1d_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_23eee252-339d-4033-bb24-debc00afdd10_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_1cd84600-2f13-4213-8c52-9cf53893c706_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2089265f-1b92-49a9-ad49-a181f64d1f84_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_4858270f-4e7d-405b-8b8e-559e5252fb75_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_9344c10b-6064-451f-b617-0225f7d1d167_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_f477e354-5bcd-40df-82d6-a8811eace87d_terseLabel_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_label_en-US" xlink:label="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Description of New Accounting Pronouncements Not yet Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:to="lab_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_0848d737-8167-4d17-895a-fe8bcb73cedc_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share attributable to Hologic:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProductRevenue_50517b1a-244e-420c-a245-fdc9f6d7cdde_terseLabel_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_holx_ProductRevenue_label_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_holx_ProductRevenue_documentation_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue" xlink:href="holx-20201226.xsd#holx_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductRevenue" xlink:to="lab_holx_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_7af48c55-0150-4876-93b0-444484b16bcd_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and divestiture charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RSUPSUMSUMember_37f48aa5-263d-44ba-8b79-682fa08e572d_terseLabel_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_label_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_documentation_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember" xlink:href="holx-20201226.xsd#holx_RSUPSUMSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RSUPSUMSUMember" xlink:to="lab_holx_RSUPSUMSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_f9fb5d88-0593-46ed-a488-e8c1b798fc5c_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SomatexMember_e226f8c6-ad4e-496a-9405-55bdf0b06f0a_terseLabel_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex [Member]</link:label>
    <link:label id="lab_holx_SomatexMember_label_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex [Member]</link:label>
    <link:label id="lab_holx_SomatexMember_documentation_en-US" xlink:label="lab_holx_SomatexMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Somatex</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember" xlink:href="holx-20201226.xsd#holx_SomatexMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SomatexMember" xlink:to="lab_holx_SomatexMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_ab36b649-937e-4b12-9d60-35b6ab700f1f_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NXCImagingMember_a79e8477-e0bb-4d6b-9620-49b877598833_terseLabel_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:label id="lab_holx_NXCImagingMember_label_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging [Member]</link:label>
    <link:label id="lab_holx_NXCImagingMember_documentation_en-US" xlink:label="lab_holx_NXCImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NXC Imaging</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember" xlink:href="holx-20201226.xsd#holx_NXCImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NXCImagingMember" xlink:to="lab_holx_NXCImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_b4c82b67-1d86-43d4-aa0b-94da9939a43d_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_9ad35353-e0de-4e67-b028-a2ebe2338e11_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:href="holx-20201226.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_83bf3855-3f1a-4d42-a8fa-1542d17f7286_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20201226.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_b8e08dce-981b-48a5-9e3a-4290e811a312_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_28b8caeb-85bd-44d5-bf88-2a25ea6fa320_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_afcfd48b-9698-4653-bef7-dad74d4357ec_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_dd55ea60-8532-47c0-a973-4a5c10f79d4e_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_79c11fbf-2fd7-410e-9749-2667f6024b78_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_71388251-900b-423c-88fe-1fc6101a66d3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_51310c62-6693-4341-948f-447f4da51d7d_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_439518ae-b775-424b-b352-84d87a1a2829_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_0fba5362-eca2-426f-b7fc-49997296fa75_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_98f89088-0831-4c8c-94b5-61ea91561909_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_f01fbca4-fd76-4cd8-814c-d3c3cf36afff_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_e8e68c81-ef23-4ba4-98b0-a5f56d31eda7_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_8462b7b3-e27f-497f-86e9-685c4832023a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_c96b773a-39c2-4a03-8194-2b8fc0d22354_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_3c71f180-a829-4ddd-b6c6-031f5573546e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_38983877-16ec-4226-b3ba-ee7737553200_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20201226.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_10a42ff7-118a-42ab-9622-eadfa0d56f08_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Netincome_0a1eace9-590e-4cb9-a9fe-b0c416d28b8d_totalLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:label id="lab_holx_Netincome_41023369-df73-4841-9988-f128bde8285f_terseLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_label_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_documentation_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome" xlink:href="holx-20201226.xsd#holx_Netincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Netincome" xlink:to="lab_holx_Netincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_b6c6044f-db99-415e-bd70-28148eb5ff9a_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_330106d9-14d1-478b-a6d4-cb374cb0dc6a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a725c04a-4308-42e4-97cc-0879db0190f2_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_b10aca38-1e24-4352-a966-b7b9378e89cc_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration related to fair value of noncontrolling interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_51ce652f-7035-431f-9058-4758f99a8433_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_dd3cc89c-8567-4a95-82fe-93c1ce39b23d_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_59d6d359-5e37-4ed9-9be9-e351816779ad_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanTable_5d31390a-c217-4957-ab5a-cc9fd7deddf0_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_label_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanTable" xlink:to="lab_holx_SharerepurchaseplanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_fa712c25-5372-4e5e-bd13-2b3eedb98356_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0bb16d7c-e3ad-4116-a34a-598117788980_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1872b4db-153f-4975-9a95-e8a3c23ea045_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_b6a43657-6a70-4618-bce3-d9b37e523d7a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_5c176c7f-b410-46ab-a7e1-0fce7c0b4afd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_4a095a88-ca20-46e8-899d-29767a3fcbda_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_047c0906-9d2a-4134-a7b8-fd51a0008cac_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_14d3d81a-dbcb-4d9a-aadc-036c7ac7642d_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_ef4375c3-72b4-41d1-8624-5f0d64954256_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis spread on variable rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_02533590-7727-4b90-88e1-504ad884555e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_8d2a71ec-8b19-4f2f-94f9-1f8e5383b964_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_a931ee67-6536-4324-bc54-f840eac195ec_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_00dea663-2b42-43ef-a45c-8af8c41f8738_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_313852dd-fef7-4b4c-bf94-cde55fed17a5_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_3485ce55-eddb-453b-95ff-3aebd2e481c1_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_78f8266b-293e-423f-82a2-4c50015b8725_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6b599d22-8a69-4f61-a7a0-04987770a54a_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_34a64ce0-00e4-4a52-963a-8158575b42c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_71f047b3-17e8-4a31-8751-491028b9deb7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_44d3cac2-83a7-4223-ad63-12b0bfc423fd_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_3df31221-44ab-4a8c-b655-a438d0c178df_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_916604ef-1458-40b4-8f1c-33ae994b6b27_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_bac8a1eb-102d-4ce2-93dd-b9047de54c37_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_d2fd3670-adeb-49a5-9479-17cd9d853f9c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision (benefit) for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_152c2ddb-8962-45de-933e-99012f479801_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_32973ca1-62e7-4c67-856b-135bf34909bc_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfBusinesses_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Businesses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfBusinesses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_ea6025ba-6f26-4bc9-9da2-f53ac6364931_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d1b4fc88-65c8-4566-8a77-c20f7aef8303_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_3d34e169-1a05-4d51-95a3-566e25af16ee_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_bc4860bb-1222-44cc-8b9b-caddcc8af78b_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_84464867-08a4-4275-b4f6-2984620ae823_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_a6b047a4-a1bb-4ab7-94cf-a1c9a4bf64f2_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_86b6f2f8-4063-4abc-b305-cff43af19610_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_555aa002-c8d7-4a54-a8c6-b826eb73c114_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in value of hedged interest rate swap and interest rate cap, tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_6772b2d1-5d09-4904-9bdb-2c03547df066_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_34eaa97c-e2dd-4a2a-8d53-8815f8db122e_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_f037d639-f498-4fe3-b79d-20f0cf2dc743_terseLabel_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_label_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent" xlink:href="holx-20201226.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrepaidIncomeTaxesCurrent" xlink:to="lab_holx_PrepaidIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_908afe83-2914-4e5d-8048-0a09b590e91d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_11463312-a892-4e40-a656-7c089c6c2776_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-competition agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_d2bbbccd-c87a-4d3f-a287-cd261e9af324_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_34799016-6bc8-4eef-920d-37ac6e42e66d_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20201226.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6274554f-28cc-43ea-8119-d61fad5527c6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_50e3c9d5-a7b4-4d9c-8126-a79f2c59c95c_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_198be18f-7e2f-4c3a-b59c-bff473072c16_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_119ed1ef-5113-4d05-9413-f593504d5d72_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_6e1a83bc-e59a-4367-99d1-d6937a5637cf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Redemption, Period Four [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPeriodFourMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_abbca566-dc63-4525-8b52-f0f50906403d_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software embedded in products</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20201226.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_d6a19b3a-2f54-4448-92d8-620554952e1c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c1d55688-3add-44c0-8c8e-45adff11af27_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_bcdde2e3-a3d4-4285-ab30-a5e09aaafa9c_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b42a827e-3018-4155-865e-7d7fbb3bd8cb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_39f1bb8a-3feb-4877-8f73-0fa251d1268f_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_1174f757-299e-48f4-85d3-7523014bba16_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_d58ec3a7-4985-4cf1-8f81-91a5c06bac8a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_976c6cea-a002-4f55-839b-882ec1407678_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_f690cd74-7db4-4297-9c85-682929811333_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_cced22ec-7886-4549-932d-84eb7c8c8cd1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6aa1e406-c5d1-4f9f-8475-10e361b5ebb5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_20e61dd0-41c6-4cd0-a918-e7e37e3eed12_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Petitions filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_a8e8f384-93b0-4236-8195-34a3f23f3c66_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_746a0731-f28a-4bbf-a5a8-df3c5a7d0d8a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_9032171a-bf91-4f68-b107-a1d0a73725a2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e58fc2aa-d0ba-43fa-86e3-4f2a126086ab_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_63ba6fe5-ddde-4cdb-bb29-d54eb5cea21e_negatedTerseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short and long-term debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_647257a4-484a-4904-8bc4-bcc1127d2fd2_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_d7f5211f-5203-405c-b1e5-c0da3115cec7_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_88983ed1-17ce-4245-a411-2a43b74c1243_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_47f42815-df93-4719-8def-e3d9d2e8bd8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_f6423c65-51d2-4d67-bb2f-79a1ca8a5515_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_db57e4aa-8312-4332-8021-12b98e4e5471_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap at fair value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_f942fd72-5fb8-4b06-bba5-1724c5229958_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 39,078 and 37,609 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_19da7353-d605-4e7d-aa95-919bd57d83b2_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_5f629e9d-86ed-403b-b5b6-bf5c376e138b_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration related to equity method investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_label_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:label id="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_documentation_en-US" xlink:label="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:to="lab_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_7449b4ba-e7f9-4fdf-9a3f-d0bb00f265da_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_label_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:label id="lab_holx_BusinessCombinationOwnershipPercentage_documentation_en-US" xlink:label="lab_holx_BusinessCombinationOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage" xlink:href="holx-20201226.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationOwnershipPercentage" xlink:to="lab_holx_BusinessCombinationOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_d0933e98-ee46-4ced-b335-6e5421d1a143_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_f72fea91-a023-43c1-837a-f64d1341e783_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_8eec8b57-be47-47e9-862c-4d459389962f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_afedad5c-5f77-41bc-93dd-6147b8f8c37a_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_703ac1ad-4bed-4782-b44d-40deba9159de_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>holx-20201226_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:c943252c-cccd-40db-8528-0a30c8529578,g:a16a1f02-5004-4ac1-a6e4-d507bf0abb0b-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20201226.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_cdd9414f-6920-434f-b250-55ca9e3f6243" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_Security12bTitle_cdd9414f-6920-434f-b250-55ca9e3f6243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_55e1d28c-4946-43e2-860b-7b4f3a94692c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentTransitionReport_55e1d28c-4946-43e2-860b-7b4f3a94692c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_37e5e2cf-606d-4e38-9a06-eb0968426bca" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentQuarterlyReport_37e5e2cf-606d-4e38-9a06-eb0968426bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_101fd491-b07e-4b05-b2dd-ad15b78511e4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityIncorporationStateCountryCode_101fd491-b07e-4b05-b2dd-ad15b78511e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_62117814-2eda-4493-90c6-1e5001f23a5d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityAddressPostalZipCode_62117814-2eda-4493-90c6-1e5001f23a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_9c1605b7-0cdd-42d0-8b66-8d42dc0bcd0f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityFileNumber_9c1605b7-0cdd-42d0-8b66-8d42dc0bcd0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_8647d5bf-c4c6-4493-aed5-eea21cce3753" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentType_8647d5bf-c4c6-4493-aed5-eea21cce3753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f650d6b5-8708-41c4-9cbe-16847353f71d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_AmendmentFlag_f650d6b5-8708-41c4-9cbe-16847353f71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_77b9aee6-80e7-4169-823c-f3ebcdde31d7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentPeriodEndDate_77b9aee6-80e7-4169-823c-f3ebcdde31d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_b799fa75-03e7-4af4-a9bb-c093ee5c0c36" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentFiscalYearFocus_b799fa75-03e7-4af4-a9bb-c093ee5c0c36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_757d772a-f8f9-4e3b-b1cf-9cf12fd4c7e9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_DocumentFiscalPeriodFocus_757d772a-f8f9-4e3b-b1cf-9cf12fd4c7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_6bfb1ce8-a237-4057-b7a9-637c45656d01" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityRegistrantName_6bfb1ce8-a237-4057-b7a9-637c45656d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_55db0b48-2fe3-4cc8-9f53-c912c4695e75" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityCentralIndexKey_55db0b48-2fe3-4cc8-9f53-c912c4695e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_4acd05eb-4635-4742-8a7d-20bad197a939" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_CurrentFiscalYearEndDate_4acd05eb-4635-4742-8a7d-20bad197a939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_d5b3629c-c81d-4a17-a78d-130e55ee169e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityFilerCategory_d5b3629c-c81d-4a17-a78d-130e55ee169e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_d3de09ea-e164-4046-b257-accc3d9a94e1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityEmergingGrowthCompany_d3de09ea-e164-4046-b257-accc3d9a94e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_652ad096-5c13-42ba-a9c3-f93581f5ccf0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntitySmallBusiness_652ad096-5c13-42ba-a9c3-f93581f5ccf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_edb43db3-fe81-451e-b6d6-a1f38a9af1aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_edb43db3-fe81-451e-b6d6-a1f38a9af1aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_7f302922-8ae9-4a77-a0e8-6640779a7873" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityShellCompany_7f302922-8ae9-4a77-a0e8-6640779a7873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4b080e28-a3bb-4dd8-b41a-a5578c42f70e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityCurrentReportingStatus_4b080e28-a3bb-4dd8-b41a-a5578c42f70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_53bd1564-b221-4d6e-8511-3c96fe258282" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityInteractiveDataCurrent_53bd1564-b221-4d6e-8511-3c96fe258282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_0d83eeca-d3ed-4a25-ba3e-fa615839ca64" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_CityAreaCode_0d83eeca-d3ed-4a25-ba3e-fa615839ca64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_8a82c319-fab5-4232-b7cf-b771cc66631f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_LocalPhoneNumber_8a82c319-fab5-4232-b7cf-b771cc66631f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_fefd949d-9f05-471a-839d-ee193d47148c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityTaxIdentificationNumber_fefd949d-9f05-471a-839d-ee193d47148c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_8066b3b7-5a61-4d2d-9b06-e0dc6fd37f6a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityAddressAddressLine1_8066b3b7-5a61-4d2d-9b06-e0dc6fd37f6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a1f43172-b636-4b09-914f-a6f7dcbcde4f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityAddressCityOrTown_a1f43172-b636-4b09-914f-a6f7dcbcde4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e046bb83-019b-47fc-bb98-8a3a85782e0b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_EntityAddressStateOrProvince_e046bb83-019b-47fc-bb98-8a3a85782e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_80937d53-bfcb-486d-a8d3-fc531d1a8117" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_TradingSymbol_80937d53-bfcb-486d-a8d3-fc531d1a8117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_b0a5c587-8a9b-4ca5-a892-a5e1630f2f66" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56986464-b624-44f8-acab-165b2cd377b2" xlink:to="loc_dei_SecurityExchangeName_b0a5c587-8a9b-4ca5-a892-a5e1630f2f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_d6e30bc3-edfe-4cc3-9550-c1deae9495d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:to="loc_us-gaap_RevenuesAbstract_d6e30bc3-edfe-4cc3-9550-c1deae9495d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_11ee2c7e-47d0-4b5e-856c-897b9099aa97" xlink:href="holx-20201226.xsd#holx_ProductRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d6e30bc3-edfe-4cc3-9550-c1deae9495d3" xlink:to="loc_holx_ProductRevenue_11ee2c7e-47d0-4b5e-856c-897b9099aa97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_e272375a-ac5f-4b89-b139-71afb7c880d4" xlink:href="holx-20201226.xsd#holx_ServiceRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d6e30bc3-edfe-4cc3-9550-c1deae9495d3" xlink:to="loc_holx_ServiceRevenue_e272375a-ac5f-4b89-b139-71afb7c880d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_81041eff-2368-41fe-8fe5-7c3efd8d0cca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_d6e30bc3-edfe-4cc3-9550-c1deae9495d3" xlink:to="loc_us-gaap_Revenues_81041eff-2368-41fe-8fe5-7c3efd8d0cca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:to="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_3887b450-d382-4957-922e-24c8b0a562e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_3887b450-d382-4957-922e-24c8b0a562e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_8799c339-82bb-4ab4-a71a-d339953a92b1" xlink:href="holx-20201226.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:to="loc_holx_AmortizationCostofGoodsSold_8799c339-82bb-4ab4-a71a-d339953a92b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_da71456c-eb0f-4d92-8888-86775a2f0698" xlink:href="holx-20201226.xsd#holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:to="loc_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment_da71456c-eb0f-4d92-8888-86775a2f0698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_e330b9c3-2844-4f6e-8e8f-c560bb6fa9e5" xlink:href="holx-20201226.xsd#holx_Costofservice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:to="loc_holx_Costofservice_e330b9c3-2844-4f6e-8e8f-c560bb6fa9e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d6dda6dc-824c-45b8-a99b-1303e0ea7269" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_72388302-aebf-431c-9c99-f64a5b4e2806" xlink:to="loc_us-gaap_GrossProfit_d6dda6dc-824c-45b8-a99b-1303e0ea7269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:to="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_95ae9c22-c756-482a-97e1-e21228dcc2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_95ae9c22-c756-482a-97e1-e21228dcc2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_26545767-01d4-4acc-abd7-a6c809bb54e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_SellingAndMarketingExpense_26545767-01d4-4acc-abd7-a6c809bb54e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_877320ea-3296-420f-8997-e91f4d9adac8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_877320ea-3296-420f-8997-e91f4d9adac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_dfb8a3ff-aca0-4f10-92f6-1ce153daadbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_dfb8a3ff-aca0-4f10-92f6-1ce153daadbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b31b3432-888a-4d5f-bfe0-713cf6348d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_b31b3432-888a-4d5f-bfe0-713cf6348d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_64ab07cc-9b6a-4d94-9103-2617ff0002bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_64ab07cc-9b6a-4d94-9103-2617ff0002bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_e0cd644f-587c-4e79-9f64-3612e5bd060f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_RestructuringCharges_e0cd644f-587c-4e79-9f64-3612e5bd060f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_e232581d-0108-4065-b3ed-45a4048c6cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_OperatingExpenses_e232581d-0108-4065-b3ed-45a4048c6cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_24c19424-e2d3-4296-b137-53a47eb7b516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_OperatingIncomeLoss_24c19424-e2d3-4296-b137-53a47eb7b516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_99786a99-9b8e-4997-9062-1ef997a57d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_InvestmentIncomeInterest_99786a99-9b8e-4997-9062-1ef997a57d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d1087d8b-6e32-4ab4-9313-9d07cfad89c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_InterestExpense_d1087d8b-6e32-4ab4-9313-9d07cfad89c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c8cfed2f-0189-47d2-9b0e-64f6033f7ded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_c8cfed2f-0189-47d2-9b0e-64f6033f7ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_42fb205d-6295-401f-9aa9-3f4f1e028323" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_42fb205d-6295-401f-9aa9-3f4f1e028323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fc1642c3-adcb-4191-8c9e-17114aa250b8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_fc1642c3-adcb-4191-8c9e-17114aa250b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_9a835819-18c1-4610-90e9-fda10f64922b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_9a835819-18c1-4610-90e9-fda10f64922b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dc7a452e-8043-487e-b8c5-0acfeca8da46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_NetIncomeLoss_dc7a452e-8043-487e-b8c5-0acfeca8da46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_e77ced5b-1ba5-47f5-b734-9277728a06ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_e77ced5b-1ba5-47f5-b734-9277728a06ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_9a3a5cfa-f50d-4c4c-9736-3b96983a5a59" xlink:href="holx-20201226.xsd#holx_Netincome"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_1b8c0912-819f-4787-9f88-f3ecdabd94c5" xlink:to="loc_holx_Netincome_9a3a5cfa-f50d-4c4c-9736-3b96983a5a59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2b3739d8-c882-48aa-b780-8bf80d8b8acb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:to="loc_us-gaap_EarningsPerShareAbstract_2b3739d8-c882-48aa-b780-8bf80d8b8acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a135eefd-2a65-4996-9545-c924dce07790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2b3739d8-c882-48aa-b780-8bf80d8b8acb" xlink:to="loc_us-gaap_EarningsPerShareBasic_a135eefd-2a65-4996-9545-c924dce07790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_31e69c8e-3283-4686-847f-9302cb2c5c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2b3739d8-c882-48aa-b780-8bf80d8b8acb" xlink:to="loc_us-gaap_EarningsPerShareDiluted_31e69c8e-3283-4686-847f-9302cb2c5c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d33c1edb-c8a9-477f-8e32-75560218711b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e727aef4-7488-4a8f-a541-b9070f5b8661" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d33c1edb-c8a9-477f-8e32-75560218711b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1ec29523-84f8-4d59-bb56-034484a5291c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d33c1edb-c8a9-477f-8e32-75560218711b" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_1ec29523-84f8-4d59-bb56-034484a5291c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0832dced-b17b-43dc-bcea-38b474cedac3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_d33c1edb-c8a9-477f-8e32-75560218711b" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_0832dced-b17b-43dc-bcea-38b474cedac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_12bad4eb-7bca-46f2-9e79-f9ae4710c193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_NetIncomeLoss_12bad4eb-7bca-46f2-9e79-f9ae4710c193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f3a26ded-f6e3-44ff-95ba-0c367b9d48ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_f3a26ded-f6e3-44ff-95ba-0c367b9d48ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_86de5e71-cbb3-436b-9de1-05140ff6fc5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_86de5e71-cbb3-436b-9de1-05140ff6fc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_e55b6ae0-ef66-47fa-94ef-b4e1f3df05de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax_e55b6ae0-ef66-47fa-94ef-b4e1f3df05de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c91a10a8-4ab2-46d5-8c1c-074d8c334340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c91a10a8-4ab2-46d5-8c1c-074d8c334340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_fa6b22ce-dbba-4a9f-87b4-b2ab2b98eccb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_fa6b22ce-dbba-4a9f-87b4-b2ab2b98eccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_4dc29e70-e3fd-4c8f-99ae-11f27b6a4a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest_4dc29e70-e3fd-4c8f-99ae-11f27b6a4a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ComprehensiveIncome_3f5f4170-dd97-4f04-9495-a80f34e7bf14" xlink:href="holx-20201226.xsd#holx_ComprehensiveIncome"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_c3d61aa9-26bc-4506-9165-92ac42147cbd" xlink:to="loc_holx_ComprehensiveIncome_3f5f4170-dd97-4f04-9495-a80f34e7bf14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e6e1aac3-13cf-4473-b989-8f1942b1a577" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_4420dfd9-2318-4099-a54c-438a3bf3fc94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e6e1aac3-13cf-4473-b989-8f1942b1a577" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax_4420dfd9-2318-4099-a54c-438a3bf3fc94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d2e6ca30-896c-4870-80a1-a6da5f77c144" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2e6ca30-896c-4870-80a1-a6da5f77c144" xlink:to="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f8f7d95-2191-46c3-8fc5-321ca8532c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_4f8f7d95-2191-46c3-8fc5-321ca8532c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_11696ce9-9c7d-4ee7-9944-57109a1f6d33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_11696ce9-9c7d-4ee7-9944-57109a1f6d33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c5d95bb4-68c7-4627-87f5-b7b898b17cd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_us-gaap_InventoryNet_c5d95bb4-68c7-4627-87f5-b7b898b17cd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_3f735f5e-2d1c-403c-98e9-e10f5629a987" xlink:href="holx-20201226.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_3f735f5e-2d1c-403c-98e9-e10f5629a987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_0484bb9c-ee17-4830-828a-8ed6af8dfdb3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_0484bb9c-ee17-4830-828a-8ed6af8dfdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_615653ae-0340-4456-9808-d9be481c2280" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e7197efa-1316-4b45-807e-5fbed83bd0df" xlink:to="loc_us-gaap_AssetsCurrent_615653ae-0340-4456-9808-d9be481c2280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8de55724-2be9-483a-9ff1-b0ef3b2db2de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_8de55724-2be9-483a-9ff1-b0ef3b2db2de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_26e933e5-ab42-4098-8e6b-1a814b9d4d54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_26e933e5-ab42-4098-8e6b-1a814b9d4d54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6f541b60-7264-4c4e-ab0f-94bde434a488" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_Goodwill_6f541b60-7264-4c4e-ab0f-94bde434a488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_ea6ecfd8-cfcf-4768-bdc3-058df95dedbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_ea6ecfd8-cfcf-4768-bdc3-058df95dedbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_95598ae3-4774-4b15-acec-52758335b0d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_352352a5-6cd6-416d-bd6b-45e94b677faf" xlink:to="loc_us-gaap_Assets_95598ae3-4774-4b15-acec-52758335b0d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2e6ca30-896c-4870-80a1-a6da5f77c144" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_df5cd2eb-593e-40d5-98f9-e6e3c3d6a677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_LongTermDebtCurrent_df5cd2eb-593e-40d5-98f9-e6e3c3d6a677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_721046d8-c045-4549-a7e4-7eb9fb7092ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_AccountsPayableCurrent_721046d8-c045-4549-a7e4-7eb9fb7092ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_022c36e0-d9d8-47c3-b766-09899febe6c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_022c36e0-d9d8-47c3-b766-09899febe6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_7f2d5e25-b295-4c92-8230-1af0ec7758a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_DeferredRevenueCurrent_7f2d5e25-b295-4c92-8230-1af0ec7758a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsCurrent_9ac66b99-5be0-4d82-9e42-922e7dd16e04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_CapitalLeaseObligationsCurrent_9ac66b99-5be0-4d82-9e42-922e7dd16e04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_266c6b53-3dc1-42d1-8d7f-433153421ef1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_b9b01a2b-42b9-4ff1-86fd-391c9959af97" xlink:to="loc_us-gaap_LiabilitiesCurrent_266c6b53-3dc1-42d1-8d7f-433153421ef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_b9ff23c9-f3de-4fd9-b87f-6aa4187b8553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_b9ff23c9-f3de-4fd9-b87f-6aa4187b8553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalLeaseObligationsNoncurrent_6f475a12-df34-4c59-b65e-e1429bdf5b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalLeaseObligationsNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_CapitalLeaseObligationsNoncurrent_6f475a12-df34-4c59-b65e-e1429bdf5b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b95aa06e-add6-4ccc-9165-fa4ae3295305" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_b95aa06e-add6-4ccc-9165-fa4ae3295305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_b8b4a5ef-4c38-4004-a903-0528fd56dc86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_b8b4a5ef-4c38-4004-a903-0528fd56dc86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ab040586-9965-41b0-a79d-7ed231428bee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ab040586-9965-41b0-a79d-7ed231428bee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_81d77d70-f246-4c3b-b86e-5bfd22e7cf68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_PreferredStockValue_81d77d70-f246-4c3b-b86e-5bfd22e7cf68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_cd017b92-d0dc-4b3e-aff4-0554eb476cbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_CommonStockValue_cd017b92-d0dc-4b3e-aff4-0554eb476cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ab8187dd-0b07-4a89-99cd-1baae708b7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ab8187dd-0b07-4a89-99cd-1baae708b7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ed32b06-0fb7-4252-b9b9-950cfb51a9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2ed32b06-0fb7-4252-b9b9-950cfb51a9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_8fd5a083-594a-4632-b39f-ddbeb635c347" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_TreasuryStockValue_8fd5a083-594a-4632-b39f-ddbeb635c347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_894df5d7-8ea3-4b19-ae77-ca0d545b1b7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_894df5d7-8ea3-4b19-ae77-ca0d545b1b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_c462b027-cb7a-4a44-99be-c07e9297c4f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_e27dc5bf-ec9e-478a-ab50-0b5f7828ce40" xlink:to="loc_us-gaap_StockholdersEquity_c462b027-cb7a-4a44-99be-c07e9297c4f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_71f4e5ed-133f-4d64-8ba6-7c0c5f209575" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_MinorityInterest_71f4e5ed-133f-4d64-8ba6-7c0c5f209575" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_219e5ad2-e6ea-4a5e-bf58-fb610bea39fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_219e5ad2-e6ea-4a5e-bf58-fb610bea39fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_209a684d-7dd8-4281-a151-0ec502972ada" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_284c7c83-6b56-4f24-8847-90cefff78bee" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_209a684d-7dd8-4281-a151-0ec502972ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bf8e1a39-d2cf-41de-b3a1-61d177852a29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_bf8e1a39-d2cf-41de-b3a1-61d177852a29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3a8279a4-2fdd-465b-b535-1718b71fbff6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_3a8279a4-2fdd-465b-b535-1718b71fbff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_9d64529f-539a-4a7b-827a-f6745c0b2c26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_9d64529f-539a-4a7b-827a-f6745c0b2c26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f4554aa5-8610-42ea-8e0a-da82f38b75a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f4554aa5-8610-42ea-8e0a-da82f38b75a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_d2b0b105-9d85-499d-b2d1-193685f76d66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_d2b0b105-9d85-499d-b2d1-193685f76d66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_ec842689-0bc1-4487-861f-99068484210e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_ec842689-0bc1-4487-861f-99068484210e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_1b0d6733-30a3-41cd-8445-e2bd999843b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_CommonStockSharesIssued_1b0d6733-30a3-41cd-8445-e2bd999843b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_e79ba0b6-00ad-49b1-996c-32a67939d074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0bd0a478-dea6-4843-921a-5a93cf52a1ec" xlink:to="loc_us-gaap_TreasuryStockShares_e79ba0b6-00ad-49b1-996c-32a67939d074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ff98204-0df1-464f-85e7-d2e41144479b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_3ff98204-0df1-464f-85e7-d2e41144479b" xlink:to="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_98aff9cc-531a-48a1-9994-10981eb83db9" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ShareRepurchaseProgramMember_e164bf16-99f0-4789-8f59-c640d34f95bd" xlink:href="holx-20201226.xsd#holx_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_64c6985a-b252-4207-8368-5997cb7fe5e2" xlink:to="loc_holx_ShareRepurchaseProgramMember_e164bf16-99f0-4789-8f59-c640d34f95bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b8fcbd48-75ab-42cf-bcd2-cb499c7480ae" xlink:to="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_a4883a16-c1d4-41d3-8543-a32a1f6962bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_CommonStockMember_a4883a16-c1d4-41d3-8543-a32a1f6962bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_a09ad1ed-1fb5-4225-9984-ce83d9e99f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_a09ad1ed-1fb5-4225-9984-ce83d9e99f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_e528b82d-0923-4bfa-a895-9656be3855b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_RetainedEarningsMember_e528b82d-0923-4bfa-a895-9656be3855b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17436aa2-6550-44df-9ef3-9cf03499b848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_17436aa2-6550-44df-9ef3-9cf03499b848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_aa01f17d-72ad-4006-aada-566c07f25410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_dadefdb4-d2ae-4878-bf57-834c2171a79f" xlink:to="loc_us-gaap_TreasuryStockMember_aa01f17d-72ad-4006-aada-566c07f25410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_935bd642-20b2-40c9-b5a5-408082309a1f" xlink:to="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201801Member_ebeb2266-e238-45ee-8605-4cee54ca7a12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingStandardsUpdate201801Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfAdoptionMember_cee9fc04-e3bc-4952-889f-2b82a41043d9" xlink:to="loc_us-gaap_AccountingStandardsUpdate201801Member_ebeb2266-e238-45ee-8605-4cee54ca7a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_707f42ad-16c5-4823-99f2-204d57d66fcb" xlink:to="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_7b7a9172-d8b0-413e-9d4d-5aebd2add428" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount_7b7a9172-d8b0-413e-9d4d-5aebd2add428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4edee5a6-6416-40e8-8e7a-d1c1c25b39b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_4edee5a6-6416-40e8-8e7a-d1c1c25b39b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_398bde50-97cf-4f8c-845b-ba24b3b6b2f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_SharesIssued_398bde50-97cf-4f8c-845b-ba24b3b6b2f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6f276f7e-329c-4507-b96f-5de2623c639c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockholdersEquity_6f276f7e-329c-4507-b96f-5de2623c639c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ec58eb9-8c5b-4db3-b32d-1950dea1e90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ec58eb9-8c5b-4db3-b32d-1950dea1e90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9334a44a-94cf-42c1-8239-a0dc0e73a847" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_9334a44a-94cf-42c1-8239-a0dc0e73a847" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ChangeInParValue_5c0b1d33-791a-4766-9efc-0a8a77c32efd" xlink:href="holx-20201226.xsd#holx_ChangeInParValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_ChangeInParValue_5c0b1d33-791a-4766-9efc-0a8a77c32efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_e7005c8f-a6f8-45f9-be63-09ac6ecdbdd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_e7005c8f-a6f8-45f9-be63-09ac6ecdbdd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_aad6ea1f-bc5b-4325-a686-01ee76ac773a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_aad6ea1f-bc5b-4325-a686-01ee76ac773a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fa03a802-b3be-4a07-b050-31fe8ccbc4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_fa03a802-b3be-4a07-b050-31fe8ccbc4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_16058932-c9b6-4643-91e9-0a90d7af3bf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_16058932-c9b6-4643-91e9-0a90d7af3bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a998631d-4ea2-45ec-9c1a-4965dcb55a9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_a998631d-4ea2-45ec-9c1a-4965dcb55a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_5035fec9-1995-4fc3-8bf9-01860f78c856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_NetIncomeLoss_5035fec9-1995-4fc3-8bf9-01860f78c856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca4642aa-3d67-411a-b9a1-bd06ffc308e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ca4642aa-3d67-411a-b9a1-bd06ffc308e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_7a719402-cb55-404e-b2d1-16250acdc24b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_7a719402-cb55-404e-b2d1-16250acdc24b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_6538254f-29ec-4275-9f21-d8de3c6b4b52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_6538254f-29ec-4275-9f21-d8de3c6b4b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_3d5abc2a-7587-4f28-b0fa-3278c66d3975" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchaseProgramAdjustment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_AcceleratedShareRepurchaseProgramAdjustment_3d5abc2a-7587-4f28-b0fa-3278c66d3975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_36284c00-2f1d-4e7e-9c1c-740371ed2e99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_SharesIssued_36284c00-2f1d-4e7e-9c1c-740371ed2e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_70c7ed82-90f8-4c53-b216-181481220c13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_StockholdersEquity_70c7ed82-90f8-4c53-b216-181481220c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_0ea01414-dfff-4471-b56e-539787c80c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable_0ea01414-dfff-4471-b56e-539787c80c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_e22cc64c-c53d-4141-b046-d3e4bad964c2" xlink:href="holx-20201226.xsd#holx_Netincome"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_Netincome_e22cc64c-c53d-4141-b046-d3e4bad964c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Acceleratedsharerepurchaseagreement_96fd8024-f08b-42dc-9f72-d4aafd089587" xlink:href="holx-20201226.xsd#holx_Acceleratedsharerepurchaseagreement"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_holx_Acceleratedsharerepurchaseagreement_96fd8024-f08b-42dc-9f72-d4aafd089587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_5fdcbe5c-21db-473a-a651-533e1b1ef3fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d628dc8a-39df-4ae0-bf4b-18cdea02069f" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_5fdcbe5c-21db-473a-a651-533e1b1ef3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3b90f61-1722-4b95-9e36-027162897241" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6e1336bb-fa3c-4fa7-9c48-86422d290eda" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d3b90f61-1722-4b95-9e36-027162897241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20201226.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c77be12c-fe32-4992-b391-c1aa96edd6d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:to="loc_us-gaap_NetIncomeLoss_c77be12c-fe32-4992-b391-c1aa96edd6d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_c8b0538d-b733-4939-b983-27c82bf3ad80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_Depreciation_c8b0538d-b733-4939-b983-27c82bf3ad80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_54170dd7-85ff-4204-9302-65e6f332cf72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_AdjustmentForAmortization_54170dd7-85ff-4204-9302-65e6f332cf72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_6e0eebfa-f6e0-40bc-9629-b43139b82e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_ShareBasedCompensation_6e0eebfa-f6e0-40bc-9629-b43139b82e7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e5faf9a4-3f8a-4292-9f77-a6c1596cd7e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_e5faf9a4-3f8a-4292-9f77-a6c1596cd7e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_8a6b4050-5d76-4241-85a4-813860655c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_AssetImpairmentCharges_8a6b4050-5d76-4241-85a4-813860655c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6244b458-dd92-4ad2-af12-f8c1c6a5d3a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6244b458-dd92-4ad2-af12-f8c1c6a5d3a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_41f822be-237a-4085-b334-3649d0672ec4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ee2dc9c8-731f-4d6c-812b-364e770563c4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_41f822be-237a-4085-b334-3649d0672ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f0d21458-428a-4e29-9b09-65c06b771e2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f0d21458-428a-4e29-9b09-65c06b771e2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_6cb33d52-7c36-44c0-912c-84b879dd77cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_6cb33d52-7c36-44c0-912c-84b879dd77cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_234564af-4eed-4095-837a-99cda282a17b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_234564af-4eed-4095-837a-99cda282a17b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4af519f2-3805-458b-82d5-de6774298feb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_4af519f2-3805-458b-82d5-de6774298feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3dd10c18-2c8b-4fb6-a355-87802cf4ce04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3dd10c18-2c8b-4fb6-a355-87802cf4ce04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_bba92095-2182-45e9-b9f9-8cd8f7d93f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_bba92095-2182-45e9-b9f9-8cd8f7d93f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_16182d9c-b3b8-45ec-8681-a7c220002835" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f4f09ed7-e947-4f71-b68f-a26028890cb2" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_16182d9c-b3b8-45ec-8681-a7c220002835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_994a598d-1f56-4380-b3d5-c32815c43558" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_645c8d0a-c418-44ed-a8cb-81ab8245314a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_994a598d-1f56-4380-b3d5-c32815c43558" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9654a850-e2d8-4187-8763-b4129c9d21a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_9654a850-e2d8-4187-8763-b4129c9d21a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8327c309-b305-43e4-a7cc-1c3201f6e924" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_8327c309-b305-43e4-a7cc-1c3201f6e924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_006137d6-bf1a-44ad-960a-92bfc4136600" xlink:href="holx-20201226.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_006137d6-bf1a-44ad-960a-92bfc4136600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_c59809b2-28b8-46de-b937-1031f2c015c2" xlink:href="holx-20201226.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_holx_Purchaseofinsurancecontracts_c59809b2-28b8-46de-b937-1031f2c015c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_70e20718-a5c3-44b4-a793-c10116e918e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_70e20718-a5c3-44b4-a793-c10116e918e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75828d2a-46d2-402d-984a-ce2af40028a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f8014134-46d8-41ca-a843-3fe093bfb20d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_75828d2a-46d2-402d-984a-ce2af40028a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_554edbde-cc34-4c9d-8f77-3e1fa9fc96ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_554edbde-cc34-4c9d-8f77-3e1fa9fc96ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsFromSeniorNotes_9218a89e-4a9d-4072-a327-ab07b65ba3a3" xlink:href="holx-20201226.xsd#holx_ProceedsFromSeniorNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_holx_ProceedsFromSeniorNotes_9218a89e-4a9d-4072-a327-ab07b65ba3a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RepaymentOfSeniorNotes_33711285-08f7-4418-aaa5-8bf841b744ef" xlink:href="holx-20201226.xsd#holx_RepaymentOfSeniorNotes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_holx_RepaymentOfSeniorNotes_33711285-08f7-4418-aaa5-8bf841b744ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLinesOfCredit_d817d418-af7c-4414-b9ee-45f0feb6714b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLinesOfCredit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_RepaymentsOfLinesOfCredit_d817d418-af7c-4414-b9ee-45f0feb6714b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_b671a22e-b844-4528-bad8-16b77111d4a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization_b671a22e-b844-4528-bad8-16b77111d4a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_e9a2a41a-a683-4863-bfd0-90e8007df67b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_e9a2a41a-a683-4863-bfd0-90e8007df67b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_36a3f24a-75eb-4c26-bc34-fd6fe1da3982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_36a3f24a-75eb-4c26-bc34-fd6fe1da3982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06987c02-af7d-400d-9697-e6cafbe17e95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_06987c02-af7d-400d-9697-e6cafbe17e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8b896973-1688-4b26-861c-9355b34ba1e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_8b896973-1688-4b26-861c-9355b34ba1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fed85d59-e94b-4e04-9993-b99bec76687c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_fed85d59-e94b-4e04-9993-b99bec76687c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_ea2c7eab-3229-4f88-a411-c7b0c6fa824f" xlink:href="holx-20201226.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_ea2c7eab-3229-4f88-a411-c7b0c6fa824f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_b5ce771f-bbd3-4f3e-ae34-d75fb6b62c69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfLongTermCapitalLeaseObligations"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations_b5ce771f-bbd3-4f3e-ae34-d75fb6b62c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc46f494-cba1-41bd-a291-74b7c1b643a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9d55212c-a2ec-4c31-b408-04dbaf3d54bc" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_bc46f494-cba1-41bd-a291-74b7c1b643a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_15479077-2bad-4ecc-a228-02350d0c60d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_15479077-2bad-4ecc-a228-02350d0c60d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_051212d3-8468-4ddc-a1a5-6bf7ad851c71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_051212d3-8468-4ddc-a1a5-6bf7ad851c71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f608f8f-7e5b-4d86-8dc9-715928827d88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_3f608f8f-7e5b-4d86-8dc9-715928827d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_be5fe433-f4a8-478f-aff1-6182dcffe67a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_cb1551ab-48d2-428c-82fa-2649a8905d1c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_be5fe433-f4a8-478f-aff1-6182dcffe67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_13ed48c1-56d2-4585-9646-ac930aa47f88" xlink:href="holx-20201226.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a1bd153-ca3c-4ff6-a982-ffe3adf0f370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_13ed48c1-56d2-4585-9646-ac930aa47f88" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8a1bd153-ca3c-4ff6-a982-ffe3adf0f370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BasisofPresentationDetailsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentationDetailsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_d24f45b4-6f86-489e-a3a8-d3deed4d2544" xlink:href="holx-20201226.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_d24f45b4-6f86-489e-a3a8-d3deed4d2544" xlink:to="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_ab9d3020-933b-4c75-aee6-fe7d9eeac33e" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SomatexMember_67483acf-593e-4047-a4e9-617d47ffb044" xlink:href="holx-20201226.xsd#holx_SomatexMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:to="loc_holx_SomatexMember_67483acf-593e-4047-a4e9-617d47ffb044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BiothernosticsMember_dd427c58-54a2-417c-bb82-b33f6d300d4c" xlink:href="holx-20201226.xsd#holx_BiothernosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_48da596c-d0ce-467e-8ff2-c87be4757eb8" xlink:to="loc_holx_BiothernosticsMember_dd427c58-54a2-417c-bb82-b33f6d300d4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_40e952f6-c186-4178-a5f5-951d7a2a065d" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_ddc13d71-26d4-403f-af8b-fed874b4ee4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_092bc4c2-4756-4ed7-bd02-9d7d02cd0362" xlink:to="loc_us-gaap_SubsequentEventMember_ddc13d71-26d4-403f-af8b-fed874b4ee4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_2cc88235-55cc-4925-90a0-e0bc083aaf57" xlink:to="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_42b0592e-15ea-4ace-b503-4236e50b2cb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_13a8634c-a003-427f-9468-454573732fe9" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_42b0592e-15ea-4ace-b503-4236e50b2cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20201226.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ede7792f-a5b1-4880-9e3b-225eef95c53e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c988bd99-659c-4bdf-86e0-f1193b564d22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_ede7792f-a5b1-4880-9e3b-225eef95c53e" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c988bd99-659c-4bdf-86e0-f1193b564d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b224b65-6292-426f-8905-4e4ca6be2484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b224b65-6292-426f-8905-4e4ca6be2484" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_dbdb9423-93af-4592-a06e-eff57fdde8c9" xlink:to="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_8715bf99-b941-4fc1-8d92-12ceca6ea04e" xlink:href="holx-20201226.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_DiagnosticsMember_8715bf99-b941-4fc1-8d92-12ceca6ea04e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_3f96361c-7aa3-4380-bcf3-1d174cd55b23" xlink:href="holx-20201226.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_BreastHealthMember_3f96361c-7aa3-4380-bcf3-1d174cd55b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_a02bcc73-0865-4d90-9038-3eb36ca8e2cf" xlink:href="holx-20201226.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_GynSurgicalMember_a02bcc73-0865-4d90-9038-3eb36ca8e2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_8af4cb13-325f-4ab7-bdd5-7183fe6b4154" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_MedicalAestheticsMember_8af4cb13-325f-4ab7-bdd5-7183fe6b4154" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_9eb9be9f-f518-4c7a-939d-521054d63c7a" xlink:href="holx-20201226.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c6d1990f-457b-4dd7-80f6-10080d52f28e" xlink:to="loc_holx_SkeletalHealthMember_9eb9be9f-f518-4c7a-939d-521054d63c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_1a6bc635-e65f-4e08-b5db-55b8c750919d" xlink:to="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_1e7cfe18-b0af-4717-bf67-8927d7c4f5c9" xlink:href="holx-20201226.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_CytologyPerinatalMember_1e7cfe18-b0af-4717-bf67-8927d7c4f5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_0e71359c-5897-40b9-8f7e-54d9f1938e27" xlink:href="holx-20201226.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_MolecularDiagnosticsMember_0e71359c-5897-40b9-8f7e-54d9f1938e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_db88b896-3b6f-4404-9c2b-d76c793a9dbe" xlink:href="holx-20201226.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_BloodScreeningMember_db88b896-3b6f-4404-9c2b-d76c793a9dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_7ffb5034-bd53-4232-a00e-43a08e3287e4" xlink:href="holx-20201226.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_BreastImagingMember_7ffb5034-bd53-4232-a00e-43a08e3287e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_f7cd5d63-c40d-4588-8e48-61a69ef1e518" xlink:href="holx-20201226.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_80397869-4f94-4365-bc71-460d6717a2b8" xlink:to="loc_holx_InterventionalBreastSolutionsMember_f7cd5d63-c40d-4588-8e48-61a69ef1e518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9d41cf47-a62a-43ab-9465-22b71f3d24fc" xlink:to="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_ac985acf-fae2-43dc-88e4-9373332855f3" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:to="loc_country_US_ac985acf-fae2-43dc-88e4-9373332855f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_abd9b4c0-4e00-49d2-8464-471e1d5f4098" xlink:href="holx-20201226.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6b88f404-0a14-4776-b73c-d68f1bd8918f" xlink:to="loc_holx_InternationalMember_abd9b4c0-4e00-49d2-8464-471e1d5f4098" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_f5e08797-5d06-4e2e-9928-fc119d518bdd" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_f6e2dee3-598c-4bf4-bfc7-ab30aebbdd41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_0bf41874-53f1-4488-8400-2802bf4f49c2" xlink:to="loc_us-gaap_Revenues_f6e2dee3-598c-4bf4-bfc7-ab30aebbdd41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c38d1fde-1b66-4964-a8ff-700a59d6e583" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_1b224b65-6292-426f-8905-4e4ca6be2484" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c38d1fde-1b66-4964-a8ff-700a59d6e583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_621c90ca-d29d-49b9-afa3-f7f9acf3871a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_621c90ca-d29d-49b9-afa3-f7f9acf3871a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:to="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6f9fd5c9-f1b9-48c6-b10e-bf7810939b01" xlink:to="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_0770c5de-7a3e-40c8-b210-143c841cbb97" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_country_US_0770c5de-7a3e-40c8-b210-143c841cbb97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_2a03df2b-6dec-4b59-8621-942453d0df11" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_srt_EuropeMember_2a03df2b-6dec-4b59-8621-942453d0df11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_a7c69698-a034-4c7a-9ba7-1ee272a5b3ae" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_srt_AsiaPacificMember_a7c69698-a034-4c7a-9ba7-1ee272a5b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_ff42a067-b362-455e-949f-62259cb8f95c" xlink:href="holx-20201226.xsd#holx_RestofWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_2c647c6e-d5d8-4872-9ac1-78be5e105e1c" xlink:to="loc_holx_RestofWorldMember_ff42a067-b362-455e-949f-62259cb8f95c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d600c352-f287-4dae-8711-82685ad15aca" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_6a986762-fa89-4228-a15a-f74479f6499a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_c5cd47d9-ff5c-43e2-b969-deb01098655c" xlink:to="loc_us-gaap_Revenues_6a986762-fa89-4228-a15a-f74479f6499a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_368603d3-351a-4218-a61d-fbca3eff74e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_368603d3-351a-4218-a61d-fbca3eff74e3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:to="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_4b3f0b4e-d31b-48c6-99eb-65d53ff7d319" xlink:to="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_4223451f-d4a9-4bfb-91bc-43fb98efc6d9" xlink:href="holx-20201226.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_ConsumablesMember_4223451f-d4a9-4bfb-91bc-43fb98efc6d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_40bf27b8-31f3-4c7b-8c75-7772222b5a3a" xlink:href="holx-20201226.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_40bf27b8-31f3-4c7b-8c75-7772222b5a3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_964346f7-4833-4548-af65-a64cdef71480" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_us-gaap_ServiceMember_964346f7-4833-4548-af65-a64cdef71480" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_53332b60-fc75-4686-8df6-3179622cac91" xlink:href="holx-20201226.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b2bd3d5f-4e79-4f83-bb05-7156926dc174" xlink:to="loc_holx_OtherTypeofRevenueMember_53332b60-fc75-4686-8df6-3179622cac91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_c9a9a883-ab67-42a8-bbb3-99245420d1e9" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_2e99d479-1b7f-463c-8e90-22fc7bd7fa22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_32381153-6800-4dc2-b6e7-349a3b4f3724" xlink:to="loc_us-gaap_Revenues_2e99d479-1b7f-463c-8e90-22fc7bd7fa22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_223e46a7-be40-4d8f-91d1-ab2c289a7131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_368603d3-351a-4218-a61d-fbca3eff74e3" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_223e46a7-be40-4d8f-91d1-ab2c289a7131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9f89760b-9aef-4f62-b668-64e6fdeba38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_3d610da2-fa74-4ec9-97c3-d91739431636" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_9f89760b-9aef-4f62-b668-64e6fdeba38d" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_3d610da2-fa74-4ec9-97c3-d91739431636" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b2c52d21-132c-4893-849e-f0466f86a5e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b2c52d21-132c-4893-849e-f0466f86a5e4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_df8d684b-a59e-469f-92b0-7a7de130c7b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_df8d684b-a59e-469f-92b0-7a7de130c7b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_02c99527-783f-4d9f-9fe0-fbed2b75bf1e" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_55b3383a-d26e-46e8-a339-a84acebeb582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_71c6cc77-24dd-4361-a5f1-2931fedc193c" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_28965a34-ea2d-454b-af06-15fb74ddf6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20201226.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20201226.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_52ecc29f-f365-48fb-b5cd-5613a6ee3e06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_9da04001-3fa6-47a6-a1ba-506316dd0470" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_52ecc29f-f365-48fb-b5cd-5613a6ee3e06" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_9da04001-3fa6-47a6-a1ba-506316dd0470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_036a2ebf-8e38-41ad-9ff4-e53d0bdb0e28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_52ecc29f-f365-48fb-b5cd-5613a6ee3e06" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_036a2ebf-8e38-41ad-9ff4-e53d0bdb0e28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_9c688f1f-3de2-43c1-a0a2-53fcb8c3cf6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_6fe4c927-694a-4407-91f8-ee1fdd8938ab" xlink:href="holx-20201226.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_9c688f1f-3de2-43c1-a0a2-53fcb8c3cf6a" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_6fe4c927-694a-4407-91f8-ee1fdd8938ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_39044607-65d1-48a4-ba30-c7fff76f95fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_af615ab1-a5cf-40eb-98cb-0eba25cd5e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_39044607-65d1-48a4-ba30-c7fff76f95fb" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_af615ab1-a5cf-40eb-98cb-0eba25cd5e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_145c43f1-7b62-44b8-b1f0-78c4c033738c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_112b7b74-ff6c-491a-bad0-aff654ad3de7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_145c43f1-7b62-44b8-b1f0-78c4c033738c" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_112b7b74-ff6c-491a-bad0-aff654ad3de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_f5f85d7a-da27-410f-b42d-dc2f3464182d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_f5f85d7a-da27-410f-b42d-dc2f3464182d" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_8ee6d075-bf4e-441a-9399-17f2e7e54add" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_39b4a2b3-9a5b-436c-a7d9-9ea4e7294d91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_39b4a2b3-9a5b-436c-a7d9-9ea4e7294d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_372f91e5-f06b-463d-921d-567a944a6399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_372f91e5-f06b-463d-921d-567a944a6399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_628699ea-53d5-4418-9a54-640718ead74e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2f92db93-3c32-484a-9e4c-0940872791fe" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_628699ea-53d5-4418-9a54-640718ead74e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_05e10a37-a1f6-47ad-8613-d5b01b9ff352" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_2d7ae8bf-b958-4619-8c72-84ddf9fe53ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_2d7ae8bf-b958-4619-8c72-84ddf9fe53ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_9fb17b59-f600-41d8-9324-e42eb7524fa2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ForeignExchangeContractMember_9fb17b59-f600-41d8-9324-e42eb7524fa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_4a894fee-4f7b-4eea-a780-a770acda60a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_4a894fee-4f7b-4eea-a780-a770acda60a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_82b23f1e-e249-46ee-a4ae-caa687274431" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_cd053edd-d00b-4468-9e09-4c7ab09bc72c" xlink:to="loc_us-gaap_InterestRateSwapMember_82b23f1e-e249-46ee-a4ae-caa687274431" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e311384a-169e-4ff7-b27a-53fd6e27c914" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_097c376c-3bd0-44d2-bc7a-b341e00fdace" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_a4a87ff8-5235-48ad-bf6d-d66bed6064fd" xlink:to="loc_us-gaap_LiabilityMember_097c376c-3bd0-44d2-bc7a-b341e00fdace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_1799442c-9799-4d4e-aef7-070190d0f0fe" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_04fc8a65-2c34-4f8c-a2b3-dbfd4cd1e3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_8e2e8210-87ae-493f-b709-164db74e40c9" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_04fc8a65-2c34-4f8c-a2b3-dbfd4cd1e3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_2dab496d-edc0-459b-866e-7871a3f85873" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_242146e1-20c6-4354-8b69-3a9ea06ee31b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_242146e1-20c6-4354-8b69-3a9ea06ee31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9d00205e-9ec0-4735-952f-596273ac833f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_17473ea1-a5b8-4e2f-848a-c6a9a56c22f0" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_9d00205e-9ec0-4735-952f-596273ac833f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_d414bc72-131a-4451-9730-8d7ae09a456a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_d414bc72-131a-4451-9730-8d7ae09a456a" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_90e91eda-399b-4818-91c7-e2dafd04bbcc" xlink:to="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_e16437c4-fb27-43ce-823a-fe2b33eb4c53" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9856ef21-2333-4ba5-8064-f901ab97837f" xlink:to="loc_holx_MedicalAestheticsMember_e16437c4-fb27-43ce-823a-fe2b33eb4c53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:to="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_fd685a84-5456-411e-8ca0-d438159d1efe" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_241b200c-fe8b-4004-8a15-6dafafcf81fc" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_CreditAgreementMember_241b200c-fe8b-4004-8a15-6dafafcf81fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_b0a844a4-e1d5-4311-86c4-72924d99ddaa" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_A2025SeniorNotesMember_b0a844a4-e1d5-4311-86c4-72924d99ddaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_87f5961e-11cc-48a3-93e3-bee674434ea0" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_3a3a1c18-56be-4afd-bd81-731e7570b375" xlink:to="loc_holx_A2028SeniorNotesMember_87f5961e-11cc-48a3-93e3-bee674434ea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_ad25fcf1-d074-4dd7-9052-1bbb2f6ce4bc" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_77ff0cd4-4d5d-4e4e-9053-88ba538094e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_us-gaap_AssetImpairmentCharges_77ff0cd4-4d5d-4e4e-9053-88ba538094e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_79a03ed1-4c7f-4223-b5f5-2b3b925409ee" xlink:href="holx-20201226.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_holx_PrincipalAmountOfBorrowings_79a03ed1-4c7f-4223-b5f5-2b3b925409ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_5420ac50-3ded-4c5e-9100-2c16318ce99c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_73aa6900-68f6-4ac9-811b-09a9e622b509" xlink:to="loc_us-gaap_DebtInstrumentFairValue_5420ac50-3ded-4c5e-9100-2c16318ce99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9c2941f0-931c-4a66-993f-5c4e19f46a47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_9c2941f0-931c-4a66-993f-5c4e19f46a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_6ceb2ae4-35d9-41cf-ac7c-d7a4d6c150fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_6ceb2ae4-35d9-41cf-ac7c-d7a4d6c150fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3e615b77-6da1-4129-a68a-37901ba3c78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_3e615b77-6da1-4129-a68a-37901ba3c78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_aff26135-e9fc-4fb2-a93f-b5e2bdaf5a22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_aff26135-e9fc-4fb2-a93f-b5e2bdaf5a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1d22a333-5a2f-4f82-96f9-adf934133e08" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a8d2f626-f4f0-46ac-bd9b-03bfef2ebe15" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_1d22a333-5a2f-4f82-96f9-adf934133e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_369b8d93-becf-41b1-b0b8-ce4643d48939" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_13e73eef-d21e-41bf-9bd0-392a86bc5efb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_369b8d93-becf-41b1-b0b8-ce4643d48939" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_13e73eef-d21e-41bf-9bd0-392a86bc5efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_bde53a24-e0ca-4e90-8a9c-9a37c15ffe0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_aaa38d38-43b0-4486-ac0c-1cfd40ac100e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_bde53a24-e0ca-4e90-8a9c-9a37c15ffe0e" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_aaa38d38-43b0-4486-ac0c-1cfd40ac100e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5e44c58f-6954-4be1-9000-d76506921455" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5e44c58f-6954-4be1-9000-d76506921455" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_b264572c-ced1-452b-9cc0-099f1f0c4d3f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NXCImagingMember_f3cbe077-8545-4ec9-9042-c850d516f720" xlink:href="holx-20201226.xsd#holx_NXCImagingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_NXCImagingMember_f3cbe077-8545-4ec9-9042-c850d516f720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_252ca810-10e5-476c-b507-f7083666d025" xlink:href="holx-20201226.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_AcessaHealthMember_252ca810-10e5-476c-b507-f7083666d025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_ec0e8a5c-4fa2-4c36-b48c-793df93c8dd3" xlink:href="holx-20201226.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_SuperSonicImagineMember_ec0e8a5c-4fa2-4c36-b48c-793df93c8dd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_HealthBeaconsMember_7693b834-1fe1-4232-b1d0-9d3fd3de32e0" xlink:href="holx-20201226.xsd#holx_HealthBeaconsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_HealthBeaconsMember_7693b834-1fe1-4232-b1d0-9d3fd3de32e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AlphaImagingMember_97984349-0f8f-4e30-b3e7-b2a109bbcc34" xlink:href="holx-20201226.xsd#holx_AlphaImagingMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_743cd53b-e79a-4444-aefe-67b85f299079" xlink:to="loc_holx_AlphaImagingMember_97984349-0f8f-4e30-b3e7-b2a109bbcc34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContingentConsiderationTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationByTypeAxis_4a3bc9cb-f05d-48e9-b561-743a40071184" xlink:to="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentHoldbackMember_8425edde-5104-4d97-a1ca-1b99027daa8c" xlink:href="holx-20201226.xsd#holx_ContingentHoldbackMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContingentConsiderationTypeDomain_e98f6b5b-400e-444c-a407-ef4f223e16de" xlink:to="loc_holx_ContingentHoldbackMember_8425edde-5104-4d97-a1ca-1b99027daa8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_2e05233a-e782-4ad5-84a7-3ea7e4345d0a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_3c471490-9ec8-4981-8290-b4ba0ab52116" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_us-gaap_CustomerRelationshipsMember_3c471490-9ec8-4981-8290-b4ba0ab52116" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_24d419d0-5e17-4a57-b1e0-ccfec7972540" xlink:href="holx-20201226.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_holx_DevelopedTechnologyMember_24d419d0-5e17-4a57-b1e0-ccfec7972540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_46f6cae2-6e9e-4d35-9623-d2d71267d75e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_357159ef-d106-4c0f-ae3b-9134829003c4" xlink:to="loc_us-gaap_TradeNamesMember_46f6cae2-6e9e-4d35-9623-d2d71267d75e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_716eb223-338b-4aba-9609-6afe89f3c2b0" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87d24782-62b1-4134-9359-c7ebe31289d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_87d24782-62b1-4134-9359-c7ebe31289d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationOwnershipPercentage_5efb3dda-52a3-4b8a-8ba2-c160ccf0d3be" xlink:href="holx-20201226.xsd#holx_BusinessCombinationOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationOwnershipPercentage_5efb3dda-52a3-4b8a-8ba2-c160ccf0d3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_549dbdc3-016c-457a-89c9-a8cb5f7d9856" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage_549dbdc3-016c-457a-89c9-a8cb5f7d9856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_a049f89f-7263-441f-977c-2c810f7be3ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_Goodwill_a049f89f-7263-441f-977c-2c810f7be3ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ade7a6b8-0dd8-459d-bcfa-bda445ad2b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired_ade7a6b8-0dd8-459d-bcfa-bda445ad2b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_7b783754-8474-4dd1-a501-630748f1b28a" xlink:href="holx-20201226.xsd#holx_BusinessAcquisitionCashTenderOfferPricePerShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessAcquisitionCashTenderOfferPricePerShare_7b783754-8474-4dd1-a501-630748f1b28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationSharesAcquired_7d9cce8f-08dc-4bf5-b3e2-dbc340044bbe" xlink:href="holx-20201226.xsd#holx_BusinessCombinationSharesAcquired"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationSharesAcquired_7d9cce8f-08dc-4bf5-b3e2-dbc340044bbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_020783f9-cc1a-4f97-a7bd-fda55e7b51ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain_020783f9-cc1a-4f97-a7bd-fda55e7b51ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_d0b20502-61ba-4f9c-999f-c71eda598368" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment_d0b20502-61ba-4f9c-999f-c71eda598368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_9dc0e875-4e83-43d1-97e4-4205cd814bde" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares_9dc0e875-4e83-43d1-97e4-4205cd814bde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_8fccd2d0-0dc0-4df0-ae9a-8c9bba61c856" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment_8fccd2d0-0dc0-4df0-ae9a-8c9bba61c856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_4410943c-1830-4f34-96c4-ce00d196d13d" xlink:href="holx-20201226.xsd#holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest_4410943c-1830-4f34-96c4-ce00d196d13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_FairValueAssumptionDiscountRate_8c981734-4fe2-4541-a8c9-7daffae04fca" xlink:href="holx-20201226.xsd#holx_FairValueAssumptionDiscountRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_FairValueAssumptionDiscountRate_8c981734-4fe2-4541-a8c9-7daffae04fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_16990c6f-7b9d-4b38-ba24-35b82aeae903" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_16990c6f-7b9d-4b38-ba24-35b82aeae903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bcc65cf1-0002-47e7-a009-f3c9880362ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_bcc65cf1-0002-47e7-a009-f3c9880362ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d48dd77-8e97-4cde-a367-5795998ec40a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_3d48dd77-8e97-4cde-a367-5795998ec40a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_91feb257-29f4-4932-9301-818da79bcdf0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_91feb257-29f4-4932-9301-818da79bcdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c3b9ac9-0f61-44a4-8819-37d02234e273" xlink:href="holx-20201226.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_1c3b9ac9-0f61-44a4-8819-37d02234e273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_8bf0327a-eb55-4676-81eb-3a70d7426bb5" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_8bf0327a-eb55-4676-81eb-3a70d7426bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c25e3de5-3411-4cd2-a470-d84ae6f819d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_c25e3de5-3411-4cd2-a470-d84ae6f819d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Holdback_d15a3810-aa5b-4e98-8383-febfc03e8b0e" xlink:href="holx-20201226.xsd#holx_Holdback"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_holx_Holdback_d15a3810-aa5b-4e98-8383-febfc03e8b0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6ab6896f-032a-419e-816e-e0f3faf337a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_c77f2acb-6cc9-4635-a859-62e9f0f6ab9e" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_6ab6896f-032a-419e-816e-e0f3faf337a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_5f7c7ab3-5f9a-42bb-82d2-e7945a8bf065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_5f7c7ab3-5f9a-42bb-82d2-e7945a8bf065" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_4ad85e4d-8ac1-4eba-aa28-d7be4e2ab3b1" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SuperSonicImagineMember_8affb3ee-7846-49b0-a278-89a825ef6633" xlink:href="holx-20201226.xsd#holx_SuperSonicImagineMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:to="loc_holx_SuperSonicImagineMember_8affb3ee-7846-49b0-a278-89a825ef6633" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_e7d6ff60-e900-4c0f-9011-062ce99536cb" xlink:href="holx-20201226.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_2b8ed117-92b6-4845-a25f-bd75500ba404" xlink:to="loc_holx_AcessaHealthMember_e7d6ff60-e900-4c0f-9011-062ce99536cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_e5c99af8-7480-420b-9b0b-0ab1258a7878" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b59aac28-ba34-4516-9a19-4aeca437ede2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_b59aac28-ba34-4516-9a19-4aeca437ede2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1e2666fd-d583-4f14-95a4-2a68c97eecaa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_1e2666fd-d583-4f14-95a4-2a68c97eecaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_af50d53f-e330-40b3-a738-edf24597f3c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_af50d53f-e330-40b3-a738-edf24597f3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94d02399-11f9-4c20-86b1-543aba28fa4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_94d02399-11f9-4c20-86b1-543aba28fa4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e042018-df94-4d8f-a2b1-08a0a5a9022b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_8e042018-df94-4d8f-a2b1-08a0a5a9022b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_064a1f7a-9b80-4915-9ffe-bf3993c4e131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_064a1f7a-9b80-4915-9ffe-bf3993c4e131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_fb7f9f1d-b027-4049-9300-4ed2c9461d15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_fb7f9f1d-b027-4049-9300-4ed2c9461d15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_14ccbe05-ba12-448b-9886-c5407fe2aa1b" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt_14ccbe05-ba12-448b-9886-c5407fe2aa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b763e7cd-7ed3-427d-9791-f0e3d018af96" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities_b763e7cd-7ed3-427d-9791-f0e3d018af96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_6a0fed3b-a1bf-4bb4-a93f-e24729dbbc3a" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_6a0fed3b-a1bf-4bb4-a93f-e24729dbbc3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_a13b5f1c-7bff-4b6a-abc8-990a2760fd0c" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_a13b5f1c-7bff-4b6a-abc8-990a2760fd0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_327299f2-cab0-4965-8102-6ba260888d5c" xlink:href="holx-20201226.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_327299f2-cab0-4965-8102-6ba260888d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1b367466-68bc-4971-87e1-ae82ecc8346c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_1b367466-68bc-4971-87e1-ae82ecc8346c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_4433f892-a173-4b16-bdca-23d359da769f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_Goodwill_4433f892-a173-4b16-bdca-23d359da769f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7b81c5a-73f9-450b-bb10-5945f0e3ec01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_90a0b1c9-2d09-476e-8582-9c54ab4b3585" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_a7b81c5a-73f9-450b-bb10-5945f0e3ec01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_5987ea85-e553-4990-8b5b-c9cc3c810408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0cd47c17-7845-46b4-b5c5-c6cafc1de33c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_5987ea85-e553-4990-8b5b-c9cc3c810408" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_0cd47c17-7845-46b4-b5c5-c6cafc1de33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ebee6578-f6ce-491f-9350-89366cf7440e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_9d647c34-e994-49e9-9b2c-612c2d3db80d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ebee6578-f6ce-491f-9350-89366cf7440e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_9d647c34-e994-49e9-9b2c-612c2d3db80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ef2e1ddd-9794-4c3e-ae29-033cfb420cab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ef2e1ddd-9794-4c3e-ae29-033cfb420cab" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a2dd0463-ea95-4ed9-9350-d9ab68bfda30" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_a2dd0463-ea95-4ed9-9350-d9ab68bfda30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_004ca293-3550-476e-b810-7d552a3da2df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_004ca293-3550-476e-b810-7d552a3da2df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_a999c6f5-ec95-4635-b51d-e2b97979e08d" xlink:href="holx-20201226.xsd#holx_AccountsReceivableAllowanceForCreditLossTransfers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:to="loc_holx_AccountsReceivableAllowanceForCreditLossTransfers_a999c6f5-ec95-4635-b51d-e2b97979e08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7487ea01-102e-4cd6-9c1c-1a060c1ab758" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_7487ea01-102e-4cd6-9c1c-1a060c1ab758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_25ab2312-90d2-4e29-92f9-7211de4b21a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_c40df9ec-1f72-4861-b6b7-01441cb28c93" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_25ab2312-90d2-4e29-92f9-7211de4b21a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Disposition" xlink:type="simple" xlink:href="holx-20201226.xsd#Disposition"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Disposition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_454ec27f-31cd-4d77-997a-fdf5e6d98c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_39d0ce9f-0f5c-4508-92de-b903d58d867b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_454ec27f-31cd-4d77-997a-fdf5e6d98c11" xlink:to="loc_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock_39d0ce9f-0f5c-4508-92de-b903d58d867b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DispositionDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DispositionDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DispositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0091ad53-c4f5-420f-946d-ed1e8c4ece8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetsofBusinessHeldforSaleAbstract_85c1573c-1394-4933-829c-8deba40628a5" xlink:href="holx-20201226.xsd#holx_AssetsofBusinessHeldforSaleAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_0091ad53-c4f5-420f-946d-ed1e8c4ece8e" xlink:to="loc_holx_AssetsofBusinessHeldforSaleAbstract_85c1573c-1394-4933-829c-8deba40628a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AssetsofBusinessHeldforSaleAbstract_85c1573c-1394-4933-829c-8deba40628a5" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_972ce775-0c12-4353-b063-53ff2253efde" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_89989e46-d3bf-4aac-8ee4-e5e4ce32e192" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:to="loc_us-gaap_CostOfSalesMember_89989e46-d3bf-4aac-8ee4-e5e4ce32e192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenseMember_d6ed932c-ec79-4ef3-9741-6e5cda8536b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_101f6a28-5db7-4d2a-b1a0-4eb3fafdd18b" xlink:to="loc_us-gaap_OperatingExpenseMember_d6ed932c-ec79-4ef3-9741-6e5cda8536b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_a3d38643-2201-4e44-935e-08eb986a1319" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_828577c5-d81e-4186-9963-cfecf5793e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_33d91666-1797-4c1b-96a0-5de62677e4a0" xlink:to="loc_us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember_828577c5-d81e-4186-9963-cfecf5793e6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_454d8d44-d1c9-44ab-ac8d-b4d2e0a9592d" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_adf67808-1cc7-4602-bdee-ff23eb48fa7a" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_5e2f43a7-2f31-4c72-bda1-faf09a9e7b61" xlink:to="loc_holx_MedicalAestheticsMember_adf67808-1cc7-4602-bdee-ff23eb48fa7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_c64d2edd-521f-40c3-877f-61559e5602db" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_dd323d9f-a025-4103-a9e5-6c57cc145174" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration_dd323d9f-a025-4103-a9e5-6c57cc145174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_15fe606c-c99a-470a-9a58-6cb5ad20194f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromDivestitureOfBusinesses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfBusinesses_15fe606c-c99a-470a-9a58-6cb5ad20194f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_IndemnificationLiabily_3e259c34-9250-4ad7-ab70-7f01e41b7b8b" xlink:href="holx-20201226.xsd#holx_IndemnificationLiabily"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_holx_IndemnificationLiabily_3e259c34-9250-4ad7-ab70-7f01e41b7b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_f37287ba-9e7f-41cf-b240-7f23956e3948" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_AssetImpairmentCharges_f37287ba-9e7f-41cf-b240-7f23956e3948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5dd72f67-107f-4e8d-a29d-b935738b767b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_5dd72f67-107f-4e8d-a29d-b935738b767b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_1a074ffa-37c5-4d39-960d-128af56615f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_26868f8c-ee89-4e2c-b655-e70f53193fc6" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup_1a074ffa-37c5-4d39-960d-128af56615f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_f1f8393b-8591-44ff-97cc-2732b5f44ffa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_aa002061-8493-4c6b-8182-c8440d17f660" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_f1f8393b-8591-44ff-97cc-2732b5f44ffa" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_aa002061-8493-4c6b-8182-c8440d17f660" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e2d14f73-5a42-4113-bbed-72977d87b14f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_45d99cea-91b3-45b8-9f67-94413ed31b4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e2d14f73-5a42-4113-bbed-72977d87b14f" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_45d99cea-91b3-45b8-9f67-94413ed31b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_c2833754-7be6-49cc-acd8-5ff8424430cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e2d14f73-5a42-4113-bbed-72977d87b14f" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_c2833754-7be6-49cc-acd8-5ff8424430cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_3b5f761e-5d5a-4b34-a71d-d0365ede9eb9" xlink:href="holx-20201226.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e2d14f73-5a42-4113-bbed-72977d87b14f" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_3b5f761e-5d5a-4b34-a71d-d0365ede9eb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c4e80239-1331-4fbc-81c6-75960581c994" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c4e80239-1331-4fbc-81c6-75960581c994" xlink:to="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2cce571c-bf5b-4ba7-ac29-39fd4b398821" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_4982f462-47ed-4d37-8af5-70c0e6086389" xlink:href="holx-20201226.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_TermLoanMember_4982f462-47ed-4d37-8af5-70c0e6086389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_e7425a3e-c676-44f0-bc89-6246528e2d27" xlink:href="holx-20201226.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_RevolverMember_e7425a3e-c676-44f0-bc89-6246528e2d27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_46ba4875-c855-4a59-a21b-68c6fd85d79d" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2025SeniorNotesMember_46ba4875-c855-4a59-a21b-68c6fd85d79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_d02ff3b2-d4f6-4e62-844c-bf3746be43dc" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2028SeniorNotesMember_d02ff3b2-d4f6-4e62-844c-bf3746be43dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_045416f2-b60b-4496-8fe9-54777d23b20b" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_98000710-30e0-428a-992c-5386f6d383b3" xlink:to="loc_holx_A2029SeniorNotesMember_045416f2-b60b-4496-8fe9-54777d23b20b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_379082a9-c4d9-4134-acaa-2c82dcc87426" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_52e00dd1-91a6-408d-99df-750deac97aca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebtCurrent_52e00dd1-91a6-408d-99df-750deac97aca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_f2fe8618-f4c8-468e-bb0e-988f453b980c" xlink:href="holx-20201226.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_f2fe8618-f4c8-468e-bb0e-988f453b980c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_6c6c4afd-60be-47a8-bc32-dbc97ae3121c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_6c6c4afd-60be-47a8-bc32-dbc97ae3121c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0089cdb5-cc09-4140-a47c-e92ccf15fbda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f83a5427-6129-40ae-9886-e2c91b4fbfb1" xlink:to="loc_us-gaap_LongTermDebt_0089cdb5-cc09-4140-a47c-e92ccf15fbda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_9526de00-2140-4039-807a-9eb7c02d2239" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_9526de00-2140-4039-807a-9eb7c02d2239" xlink:to="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_31f0aa96-4da5-4036-b023-b23afde719d9" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_1f731070-12f5-4251-9674-5914cf02626e" xlink:href="holx-20201226.xsd#holx_RevolverMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_RevolverMember_1f731070-12f5-4251-9674-5914cf02626e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_ea67b471-70a3-437e-bf51-cb71a08847ae" xlink:href="holx-20201226.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_ea67b471-70a3-437e-bf51-cb71a08847ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_d3f05dad-cb19-4c1a-8735-a3100887b082" xlink:href="holx-20201226.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_AmendedTermLoanMember_d3f05dad-cb19-4c1a-8735-a3100887b082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_96589e07-a2f1-4d4f-ab7a-51fb5229ef6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_us-gaap_SeniorNotesMember_96589e07-a2f1-4d4f-ab7a-51fb5229ef6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_12abfedf-567f-49fb-b0f5-2243fad916d0" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_A2025SeniorNotesMember_12abfedf-567f-49fb-b0f5-2243fad916d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_79eec940-832b-41bb-9bf1-3391bc94b264" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_A2028SeniorNotesMember_79eec940-832b-41bb-9bf1-3391bc94b264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_3756d238-a2da-4821-a00a-cf3009568b99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_3756d238-a2da-4821-a00a-cf3009568b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7bf5ee71-820a-4aba-8a34-5ffa5c429005" xlink:href="holx-20201226.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_787c94dd-07ed-4e33-9768-cfa45c6bb05f" xlink:to="loc_holx_TermLoanMember_7bf5ee71-820a-4aba-8a34-5ffa5c429005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e15667e7-21d1-40e2-9561-30860516ed93" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmendedTermLoanMember_40a85167-d446-47e5-8566-79428817fd59" xlink:href="holx-20201226.xsd#holx_AmendedTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_AmendedTermLoanMember_40a85167-d446-47e5-8566-79428817fd59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_7e81d08e-d44d-4673-8f53-c1d02d4dcebf" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_CreditAgreementMember_7e81d08e-d44d-4673-8f53-c1d02d4dcebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_de6f15e1-aff8-498e-97d6-be3e961e589d" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2025SeniorNotesMember_de6f15e1-aff8-498e-97d6-be3e961e589d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_012757c0-2f4a-40b0-9007-112981622a42" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2028SeniorNotesMember_012757c0-2f4a-40b0-9007-112981622a42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_93387739-37b6-4081-b623-314a0d9d640c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_us-gaap_SeniorNotesMember_93387739-37b6-4081-b623-314a0d9d640c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccountsReceivableSecuritizationMember_0fb011f3-e449-43f6-a7ac-2c6850813f9b" xlink:href="holx-20201226.xsd#holx_AccountsReceivableSecuritizationMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_AccountsReceivableSecuritizationMember_0fb011f3-e449-43f6-a7ac-2c6850813f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_b1daf38a-75c7-408c-8161-f31f06665c2c" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a8948ad6-c7af-4cab-8ece-48be7219fff3" xlink:to="loc_holx_A2029SeniorNotesMember_b1daf38a-75c7-408c-8161-f31f06665c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_368942ac-0f3f-42de-8a47-32f53444f52a" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageAddedtoEurodollarRateMember_c1e0ec8c-7473-4030-bc50-5e2c77ec0453" xlink:href="holx-20201226.xsd#holx_PercentageAddedtoEurodollarRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_61b4f67f-cbd3-44ff-bc1f-a1758acc0e4e" xlink:to="loc_holx_PercentageAddedtoEurodollarRateMember_c1e0ec8c-7473-4030-bc50-5e2c77ec0453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodAxis_2d57a3ad-1460-430b-bba1-94109e7c48fb" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a3f53aef-5aec-46f6-b727-56270d99b908" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodOneMember_a3f53aef-5aec-46f6-b727-56270d99b908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_1c2f76bc-96e4-435a-91e2-f1a4629d2327" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodTwoMember_1c2f76bc-96e4-435a-91e2-f1a4629d2327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_09a29d9a-e04f-4693-a8ce-7aeb7c198b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodThreeMember_09a29d9a-e04f-4693-a8ce-7aeb7c198b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_1729a546-a23c-43d9-b435-819a0c9a10d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFourMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFourMember_1729a546-a23c-43d9-b435-819a0c9a10d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_b34b7fbb-632a-437f-a22c-f7c8eefc2571" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPeriodFiveMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPeriodDomain_bce6675c-2489-41db-900f-4215c8873029" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPeriodFiveMember_b34b7fbb-632a-437f-a22c-f7c8eefc2571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9d2706ca-198b-4a91-ab34-aed757d9f7de" xlink:to="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4df68557-415e-44b0-a987-9664d5ad339b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4df68557-415e-44b0-a987-9664d5ad339b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_5424ca36-6762-42e3-9752-e6d4d8939873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LongTermDebt_5424ca36-6762-42e3-9752-e6d4d8939873" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db868600-056f-4621-90d0-b58c5f1d990b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_db868600-056f-4621-90d0-b58c5f1d990b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7ea36313-d387-4acf-beca-11256544813e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_7ea36313-d387-4acf-beca-11256544813e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_f4582da7-5d97-4d8e-ba2a-ab6e0054fb2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_f4582da7-5d97-4d8e-ba2a-ab6e0054fb2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_306a415d-f514-45c0-91b4-39f5870493e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LongTermDebtCurrent_306a415d-f514-45c0-91b4-39f5870493e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfDebt_5f96aa8f-1065-4b4a-ad85-58d8309c16d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_RepaymentsOfDebt_5f96aa8f-1065-4b4a-ad85-58d8309c16d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_c4a2b812-3dfe-42aa-aaa8-668de5fdc90c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount_c4a2b812-3dfe-42aa-aaa8-668de5fdc90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_304ac154-6db9-4f5f-ba68-9f7f5daa3bdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_SeniorNotes_304ac154-6db9-4f5f-ba68-9f7f5daa3bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e6d4860d-9cbe-4d00-8279-e05665879b78" xlink:href="holx-20201226.xsd#holx_DebtInstrumentOfferingPricePercentOfFaceValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_holx_DebtInstrumentOfferingPricePercentOfFaceValue_e6d4860d-9cbe-4d00-8279-e05665879b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b3e2a627-3f24-4d35-9296-0ceb291b524e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_b3e2a627-3f24-4d35-9296-0ceb291b524e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_e058578d-dcb4-4bed-a1d5-c37bd1a2be6e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_InterestExpenseDebt_e058578d-dcb4-4bed-a1d5-c37bd1a2be6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9421018d-1521-408e-8644-3c8490518599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9421018d-1521-408e-8644-3c8490518599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1e160720-90a3-439a-801c-3fd5bdcf8070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_1e160720-90a3-439a-801c-3fd5bdcf8070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_89adfed7-a1b6-4d3a-91ac-6b329689cddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_89adfed7-a1b6-4d3a-91ac-6b329689cddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DebtRedemptionPremiumPaid_2b1268c5-184e-4907-b092-4bb7823d888d" xlink:href="holx-20201226.xsd#holx_DebtRedemptionPremiumPaid"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_holx_DebtRedemptionPremiumPaid_2b1268c5-184e-4907-b092-4bb7823d888d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExtinguishmentOfDebtAmount_c2cecc45-58e4-433b-85cc-32548eec7783" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ExtinguishmentOfDebtAmount"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_02d6f6bf-a1c0-4b23-a499-3252dc299b43" xlink:to="loc_us-gaap_ExtinguishmentOfDebtAmount_c2cecc45-58e4-433b-85cc-32548eec7783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_eead4711-87eb-4efa-a9c2-cc5ccd8526d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_eead4711-87eb-4efa-a9c2-cc5ccd8526d6" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:to="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ef4494a4-4b09-4149-b580-0a8ab901d350" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f0cc6f17-a560-4c2b-ae69-a704b825f0fa" xlink:href="holx-20201226.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_79e8f33b-93d0-4edd-9a06-9bd1fdbcfc16" xlink:to="loc_holx_CreditAgreementMember_f0cc6f17-a560-4c2b-ae69-a704b825f0fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_bfbccb32-83c3-4b3a-9188-174dc49447df" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b6e9a4ca-5cc0-491f-ac62-e064292c7c4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b6e9a4ca-5cc0-491f-ac62-e064292c7c4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_4f086c04-227f-4008-a25b-3a848c805545" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_4f086c04-227f-4008-a25b-3a848c805545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_451dfc53-c043-402a-a360-98939884b5a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_46cc5431-50f3-4a4d-ab33-285ff16428a4" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_451dfc53-c043-402a-a360-98939884b5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_16678a22-7975-4399-a4cb-8e78846dae2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_16678a22-7975-4399-a4cb-8e78846dae2c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ce9fa9b8-3dee-46fe-8cce-cb298dfed055" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_976b1004-5663-4113-a557-ecdf31bf4c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_fed5bd3e-c55f-48ac-a947-6c7e665096a3" xlink:to="loc_us-gaap_SeniorNotesMember_976b1004-5663-4113-a557-ecdf31bf4c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:to="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_f778be24-bf89-42f9-ad17-b23f076298ba" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_f013e18f-01ba-47a4-b3bf-97ed4de62971" xlink:href="holx-20201226.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2028SeniorNotesMember_f013e18f-01ba-47a4-b3bf-97ed4de62971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2025SeniorNotesMember_2651b222-42ad-4629-b1d7-a966e45618e3" xlink:href="holx-20201226.xsd#holx_A2025SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2025SeniorNotesMember_2651b222-42ad-4629-b1d7-a966e45618e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_4d26246f-a4ca-4ce7-b78c-c7b63c8b2d08" xlink:href="holx-20201226.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_4a22dc62-5742-4d83-aa72-ca82e91e9264" xlink:to="loc_holx_A2029SeniorNotesMember_4d26246f-a4ca-4ce7-b78c-c7b63c8b2d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_818f2c14-d509-4dc0-80e6-9591a3d1cc59" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a9fbc1b6-545a-4973-9749-e841a2011cd5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_a9fbc1b6-545a-4973-9749-e841a2011cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_7acfbedd-7915-4c5d-8e53-c9a9124f2ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_8edea829-7276-4791-9202-3218dfd7e2ac" xlink:to="loc_us-gaap_InterestExpenseBorrowings_7acfbedd-7915-4c5d-8e53-c9a9124f2ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20201226.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a5e8098-bdcb-4503-9178-11dff66d0ae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_50a4d648-6313-4b5c-aeae-d2e62f162c65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a5e8098-bdcb-4503-9178-11dff66d0ae2" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_50a4d648-6313-4b5c-aeae-d2e62f162c65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_bae6116b-b369-4efd-a646-acf086c5ccf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a5e8098-bdcb-4503-9178-11dff66d0ae2" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_bae6116b-b369-4efd-a646-acf086c5ccf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c086b716-0fd5-437e-8c45-cfab87ce8096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a5e8098-bdcb-4503-9178-11dff66d0ae2" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c086b716-0fd5-437e-8c45-cfab87ce8096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5f128478-c88e-4191-8c26-5245b74cdfad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_1a5e8098-bdcb-4503-9178-11dff66d0ae2" xlink:to="loc_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock_5f128478-c88e-4191-8c26-5245b74cdfad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d5cc0ddc-5738-4396-a1d9-c7da7010ffed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_d5cc0ddc-5738-4396-a1d9-c7da7010ffed" xlink:to="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_da4cf143-dcf8-47fc-bdaf-fc5417ca58dd" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_b5bc3476-c0b2-480b-b328-51492e184c9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:to="loc_us-gaap_InterestRateSwapMember_b5bc3476-c0b2-480b-b328-51492e184c9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_5917a572-e073-435d-84bc-76ca07988888" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_6fc467a2-fc2c-45ff-801c-735390c84efd" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_5917a572-e073-435d-84bc-76ca07988888" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:to="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_7e2dc1bc-9327-43b6-a78a-b6a85f402a66" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_79bddb36-f81e-469b-8593-28ba2b420ab5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5c226cf4-974b-4251-b467-f4ee1492d1cb" xlink:to="loc_us-gaap_InterestRateCapMember_79bddb36-f81e-469b-8593-28ba2b420ab5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_7d7253bf-da12-4425-b0c2-d26736658c43" xlink:to="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48374877-8a6d-49ef-929e-837b0fe2eaca" xlink:href="holx-20201226.xsd#holx_InterestRateCapAgreementsAggregatePremiumPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_InterestRateCapAgreementsAggregatePremiumPayable_48374877-8a6d-49ef-929e-837b0fe2eaca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_773e2ac8-d471-4fad-b114-a231f36f7249" xlink:href="holx-20201226.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_PrincipalAmountOfBorrowings_773e2ac8-d471-4fad-b114-a231f36f7249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_ef6995d1-ec30-44e6-968d-e3d304c29d8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_DerivativeNotionalAmount_ef6995d1-ec30-44e6-968d-e3d304c29d8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_a0d8d29e-c3a0-4749-80e5-7baf1670b02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_a0d8d29e-c3a0-4749-80e5-7baf1670b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_d8ba1b25-5832-4efb-b61d-a3237a88b0a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_d8ba1b25-5832-4efb-b61d-a3237a88b0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotionalAmount_859ea64c-0f15-4635-b2cd-c3546ecff55c" xlink:href="holx-20201226.xsd#holx_NotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_holx_NotionalAmount_859ea64c-0f15-4635-b2cd-c3546ecff55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_0f2b4d64-f524-479c-ac6b-2a05fa7aaae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_1313a164-4f64-4a34-8b8e-50109a0ebe5b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_0f2b4d64-f524-479c-ac6b-2a05fa7aaae1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_41c52f72-2247-458a-b356-48cc0b4aed50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_41c52f72-2247-458a-b356-48cc0b4aed50" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bfaba2ad-45dd-459c-8b13-38e3fd57da04" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_08b9a97b-813a-4596-99b8-3193ae9b8282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_08b9a97b-813a-4596-99b8-3193ae9b8282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_6270b58d-b5fd-4bc4-8e36-f52a1da23a70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_6270b58d-b5fd-4bc4-8e36-f52a1da23a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_ce4c1338-b20e-4bf7-8ce6-dd1df241897e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_20d5ac5b-3338-425a-ad0b-3620e128e809" xlink:to="loc_us-gaap_InterestRateSwapMember_ce4c1338-b20e-4bf7-8ce6-dd1df241897e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_2cb20c2b-0875-48b4-9152-1c376b246874" xlink:to="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_e8031e42-24f9-4de6-814c-556a79936f71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_75e305bf-0059-4fb4-91ad-54801d18fa89" xlink:to="loc_us-gaap_NondesignatedMember_e8031e42-24f9-4de6-814c-556a79936f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_747d7293-4463-444d-b725-3d08c21a636e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_ab328316-5cfe-45ea-b277-ae9409d0a2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_ab328316-5cfe-45ea-b277-ae9409d0a2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_93b34c0d-478b-4e95-86dc-eb868a1602c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_e7ccc1b8-1eac-4f39-8680-4a6c742fa6b7" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_93b34c0d-478b-4e95-86dc-eb868a1602c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_f786c15a-06db-43d8-b4ed-7b2ca34b29f4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a43d495-95df-40aa-8f09-928c99369318" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6a43d495-95df-40aa-8f09-928c99369318" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_92ede41f-891b-4c5f-8472-5b38af6caa9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_92ede41f-891b-4c5f-8472-5b38af6caa9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_7ed089aa-207f-4b96-ac05-ab0381e67556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1fca371f-0d19-47b8-ac25-cd0bbeab2f2e" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_7ed089aa-207f-4b96-ac05-ab0381e67556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2fa00814-4e0a-47f2-b2a7-93019efc47f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2fa00814-4e0a-47f2-b2a7-93019efc47f1" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_24b8b4c4-a14c-42f6-8ec1-f6795af45852" xlink:to="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_4566d7d4-2494-49b8-8416-569a185c3549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c2cf16f0-df03-4726-8946-b177d1dbf67e" xlink:to="loc_us-gaap_NondesignatedMember_4566d7d4-2494-49b8-8416-569a185c3549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_0209f539-24e4-4593-ac81-8e0949b4c997" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_9160a510-68d7-44bb-98ef-c118baeca62d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_InterestRateCapMember_9160a510-68d7-44bb-98ef-c118baeca62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_40de9580-8a5e-49b7-91f6-35454c51aab3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_InterestRateSwapMember_40de9580-8a5e-49b7-91f6-35454c51aab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_80e49d52-2bbf-4100-ac9d-cd17af73ccd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_80e49d52-2bbf-4100-ac9d-cd17af73ccd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_c58a1fa8-080e-4990-bbc1-d3bbc8c1943c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_c58a1fa8-080e-4990-bbc1-d3bbc8c1943c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6880ad59-25a0-4334-b49e-3f4370e7189b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9a70025c-c1aa-44a8-ab58-9d0dc2862973" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_6880ad59-25a0-4334-b49e-3f4370e7189b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d3befd24-5604-4cdf-b596-5d52609c9a16" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0359aa43-b24f-4878-b81c-c47c69eaebf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_0359aa43-b24f-4878-b81c-c47c69eaebf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_bee6e991-4a3f-4b0c-bff0-7729c6141052" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_b0f67cef-fb21-467a-9b02-9d2a54eac1c3" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_bee6e991-4a3f-4b0c-bff0-7729c6141052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_c78b25c6-6716-4c10-a144-7256c498c63e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_821c00f0-b140-47ee-9ea7-7d12730e4809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_821c00f0-b140-47ee-9ea7-7d12730e4809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_5f5b3db8-ce67-40da-9782-37000637004e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_DerivativeLiabilities_5f5b3db8-ce67-40da-9782-37000637004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7c625caf-23f6-4707-9cc3-0f94a09b91cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_aa048727-609b-4a5d-8498-afe6a101b05c" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_7c625caf-23f6-4707-9cc3-0f94a09b91cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9a520c60-ee4f-48d8-a16f-f2937d10332a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9a520c60-ee4f-48d8-a16f-f2937d10332a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_108ae909-dcc2-40d2-952c-2b076f1d05ee" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_fc8ee3ee-4adf-4855-b5fc-b540ea6dbaf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:to="loc_us-gaap_InterestRateSwapMember_fc8ee3ee-4adf-4855-b5fc-b540ea6dbaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_7bc88e7f-0f1b-4083-8ce0-6870f2122a66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_11a1b2d3-1da7-4b69-ad7b-d33e60f74ce7" xlink:to="loc_us-gaap_InterestRateCapMember_7bc88e7f-0f1b-4083-8ce0-6870f2122a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_c930a591-4d7f-44ea-9c40-64d9fb2b34fc" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ee6f9d5f-41f9-4fc6-9cd3-62445b43247f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ee6f9d5f-41f9-4fc6-9cd3-62445b43247f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5142ffb8-5f43-4535-9ea6-2cb4b81da25f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d5210548-783d-489f-b97d-825b2abc254f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_5142ffb8-5f43-4535-9ea6-2cb4b81da25f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f1690fef-e1f0-4378-ae50-109e97e899b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f1690fef-e1f0-4378-ae50-109e97e899b4" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_aa58bd5c-6500-432a-b6f5-99373c508fce" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b143e22c-10ed-496b-88b2-51014b593ae4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b143e22c-10ed-496b-88b2-51014b593ae4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_498dcd39-6224-4c73-be92-2faf6b1dd882" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_e34732e3-c5fa-477d-8cb5-dc1f7891b251" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_498dcd39-6224-4c73-be92-2faf6b1dd882" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_d1ee5a58-10fc-4aac-aaa1-61226d9aed10" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_6efd98c4-a75a-4c0f-ae55-a471f614fe99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:to="loc_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings_6efd98c4-a75a-4c0f-ae55-a471f614fe99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_07e0171e-44c5-41dd-9f3b-54cd8e5059e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_d8c5e1c3-a845-4d8c-970f-5827c72e74b6" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_07e0171e-44c5-41dd-9f3b-54cd8e5059e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf716b34-6c55-4fe4-bd48-08a4a4cd590c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f95cae91-6103-4174-b95d-f9dfdb5eb2fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_cf716b34-6c55-4fe4-bd48-08a4a4cd590c" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_f95cae91-6103-4174-b95d-f9dfdb5eb2fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#CommitmentsandContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_986707b7-bb44-4811-afdd-cbd17e0d1ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_986707b7-bb44-4811-afdd-cbd17e0d1ec3" xlink:to="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:to="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_5f11aa53-32c5-4a14-a818-d3d269d04cdd" xlink:to="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_0fde8b2a-0a60-4e45-ab2b-f74e8394b1a6" xlink:href="holx-20201226.xsd#holx_MinervaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:to="loc_holx_MinervaMember_0fde8b2a-0a60-4e45-ab2b-f74e8394b1a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_4c2921a8-6f70-44df-9890-fd7895b2182f" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ab3b0b41-f8dd-43b0-81cc-b5d30ad9f2f4" xlink:to="loc_holx_MedicalAestheticsMember_4c2921a8-6f70-44df-9890-fd7895b2182f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_3aa9f40e-808a-457f-827c-abda333e24b3" xlink:to="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_d9b21827-dd87-47ec-8718-9a6d18a94e6c" xlink:href="holx-20201226.xsd#holx_AmountAssessedInDamages"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_holx_AmountAssessedInDamages_d9b21827-dd87-47ec-8718-9a6d18a94e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5fbc253b-99da-4744-b19d-d5300e5ec04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_5fbc253b-99da-4744-b19d-d5300e5ec04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LegalAccrual_c9105119-75af-4e4a-85ff-f8c979a965c9" xlink:href="holx-20201226.xsd#holx_LegalAccrual"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_5330790c-1805-4132-9ed0-75cafe915482" xlink:to="loc_holx_LegalAccrual_c9105119-75af-4e4a-85ff-f8c979a965c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_eca1d79b-b6b4-410c-9f18-513f81fe3222" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_00ffb1e2-7b79-4e77-9865-3befce43a6d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_eca1d79b-b6b4-410c-9f18-513f81fe3222" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_00ffb1e2-7b79-4e77-9865-3befce43a6d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e291a1fe-7421-4f4e-9372-ab21601ecec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1b574bdb-7d3e-43c3-bbb3-f27fa7089056" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e291a1fe-7421-4f4e-9372-ab21601ecec3" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_1b574bdb-7d3e-43c3-bbb3-f27fa7089056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_59d22c22-47c9-419a-823b-66a462b712c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:href="holx-20201226.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_59d22c22-47c9-419a-823b-66a462b712c8" xlink:to="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_82d54fa8-8cff-4c22-9092-e54c02c9784d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_1b7faea4-8e40-4224-9e78-ffaca7dd612b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:to="loc_us-gaap_StockCompensationPlanMember_1b7faea4-8e40-4224-9e78-ffaca7dd612b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f9bc6eeb-513a-495e-a448-6f4eac3bec0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_a28b4569-a136-4650-b002-9bdebb4bfe39" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f9bc6eeb-513a-495e-a448-6f4eac3bec0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:href="holx-20201226.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_ded17312-7631-4ab0-ae27-d62f0e333772" xlink:to="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3208f8f5-aa2a-4d33-8a64-bdd1f90f50f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3208f8f5-aa2a-4d33-8a64-bdd1f90f50f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f3c3f1d5-01cb-4c60-88db-4653e5c1470f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_f3c3f1d5-01cb-4c60-88db-4653e5c1470f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2fa8d79b-6f57-4958-96aa-c9dae8aca3c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2fa8d79b-6f57-4958-96aa-c9dae8aca3c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_737ce343-1ccf-46a1-a307-343b9f11397d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a49742c-d5c0-429a-86f4-e4119bf66fb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a9051a46-d211-41e4-ab67-d0fd00b0115a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_8a49742c-d5c0-429a-86f4-e4119bf66fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afc2ff2c-8385-4428-a897-fb3071506944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_99f1042c-999a-42a7-ad07-a0fdc86b2c59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_afc2ff2c-8385-4428-a897-fb3071506944" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_99f1042c-999a-42a7-ad07-a0fdc86b2c59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e9ba794-a337-4b13-a950-91715e9c2f23" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5db5dc4f-720a-4581-8684-ba9968ab2edd" xlink:href="holx-20201226.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e9ba794-a337-4b13-a950-91715e9c2f23" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_5db5dc4f-720a-4581-8684-ba9968ab2edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b7c08326-4f86-4840-bd05-6522673cf4ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e9ba794-a337-4b13-a950-91715e9c2f23" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_b7c08326-4f86-4840-bd05-6522673cf4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2cbad3e-34c1-4014-ab46-50a9465168c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b2cbad3e-34c1-4014-ab46-50a9465168c3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_4a4e2108-6ef1-4072-b874-5c1779b3b02d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_979bf6b9-13ca-4ca5-90bf-68845582bfd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_CostOfSalesMember_979bf6b9-13ca-4ca5-90bf-68845582bfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1381341f-e801-48da-b9ee-07870d483944" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_1381341f-e801-48da-b9ee-07870d483944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_918fc7c5-f9a2-4647-9e9a-76bfbb0fddf2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_918fc7c5-f9a2-4647-9e9a-76bfbb0fddf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d1327e0-7346-4589-aee2-fc0462a20857" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b01aed5d-0b09-40bb-836f-21dc8631c332" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1d1327e0-7346-4589-aee2-fc0462a20857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9c1caadd-259c-440d-830a-e766baad3459" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_bac4512f-baf6-4ca5-a3cb-b3844d593004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ff78df1c-3123-4482-a5b4-f19556b5669c" xlink:to="loc_us-gaap_ShareBasedCompensation_bac4512f-baf6-4ca5-a3cb-b3844d593004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_746d1d0c-e232-46ca-95b5-1f08988e9d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_746d1d0c-e232-46ca-95b5-1f08988e9d63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:to="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f3c7da17-50c4-49f7-bf40-3421750d3c91" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d86d2d97-7070-4af2-b2ae-64754483c91e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d86d2d97-7070-4af2-b2ae-64754483c91e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_11175631-18c6-43d9-9a98-e8bf6d88e78d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_11175631-18c6-43d9-9a98-e8bf6d88e78d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_16565370-7a09-4816-ba63-5e0ead49fefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_us-gaap_PerformanceSharesMember_16565370-7a09-4816-ba63-5e0ead49fefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_7526cafc-34f6-4da4-a9c1-ac9a0f7538ab" xlink:href="holx-20201226.xsd#holx_MarketBasedAwardsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_MarketBasedAwardsMember_7526cafc-34f6-4da4-a9c1-ac9a0f7538ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_4b059161-efd4-4120-bc24-4bc3b4ef7241" xlink:href="holx-20201226.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_PSUFreeCashFlowMember_4b059161-efd4-4120-bc24-4bc3b4ef7241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_eb59af73-d012-4cf9-9135-31c9a9865158" xlink:href="holx-20201226.xsd#holx_RSUPSUMSUMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0522f18e-9c0f-480b-a15d-24ba0e97da4c" xlink:to="loc_holx_RSUPSUMSUMember_eb59af73-d012-4cf9-9135-31c9a9865158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_35f1af41-cc50-4160-ad69-905dfb6a2f89" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b96de1a4-0b45-43f6-80c3-8ee1672a5cd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_b96de1a4-0b45-43f6-80c3-8ee1672a5cd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b27d43a2-6c5a-4cd2-a8a7-03bcc6b453ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_b27d43a2-6c5a-4cd2-a8a7-03bcc6b453ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d393f7c7-2fbd-47e5-9d27-1c05b0c6aeef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d393f7c7-2fbd-47e5-9d27-1c05b0c6aeef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6c8a7be-0668-466c-87a7-c51f480c091d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b6c8a7be-0668-466c-87a7-c51f480c091d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_121d9c94-c368-4878-8730-700c9128242c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_121d9c94-c368-4878-8730-700c9128242c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1bbc28b6-544e-48a9-b41d-3ea2b3d5d0a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1bbc28b6-544e-48a9-b41d-3ea2b3d5d0a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e16ef872-ff26-418d-abce-fcd7106ca507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e16ef872-ff26-418d-abce-fcd7106ca507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_3397177a-bf2c-4fdb-b409-426830423266" xlink:href="holx-20201226.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_3397177a-bf2c-4fdb-b409-426830423266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2db0425e-1acf-4a15-bd40-45639db4bcd6" xlink:href="holx-20201226.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_2db0425e-1acf-4a15-bd40-45639db4bcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_96942123-888d-4410-84dd-ac1ae2000f9b" xlink:href="holx-20201226.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_96942123-888d-4410-84dd-ac1ae2000f9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_491de45f-6791-4adf-a4e5-cc99ae966f66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_491de45f-6791-4adf-a4e5-cc99ae966f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_aa2b3dd8-af92-400a-b4b9-f1b222c59a61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_260c3fbd-88a4-4446-920d-f3bb8af4918f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_aa2b3dd8-af92-400a-b4b9-f1b222c59a61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c6ee9a94-7f53-4395-9ca9-350110347832" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c6ee9a94-7f53-4395-9ca9-350110347832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2931f576-fd05-47cb-9309-ecc38e1f56db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_2931f576-fd05-47cb-9309-ecc38e1f56db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d21f53ba-ef24-4d04-80f3-32246eda3d8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d21f53ba-ef24-4d04-80f3-32246eda3d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_b2ed7ef4-eb34-4134-9334-ab04c2296eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_b2ed7ef4-eb34-4134-9334-ab04c2296eed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab082815-eef8-40b0-bbf6-68925e04a0db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bfd18a0c-1ace-4e3a-a76b-478ddfe6eb2a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab082815-eef8-40b0-bbf6-68925e04a0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_38c5671b-3637-4ecf-a36a-04caf2b14486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_032360fa-d57a-48a5-8acc-e79746cdc189" xlink:href="holx-20201226.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_38c5671b-3637-4ecf-a36a-04caf2b14486" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_032360fa-d57a-48a5-8acc-e79746cdc189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c5dc8d56-e20b-4260-b1ae-bb1bf0e32f1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_26db8b1c-6ca0-4c3d-b845-2be2345b671b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c5dc8d56-e20b-4260-b1ae-bb1bf0e32f1a" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_26db8b1c-6ca0-4c3d-b845-2be2345b671b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a4fc877c-7dcb-4579-81a9-c88698d18177" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_c5dc8d56-e20b-4260-b1ae-bb1bf0e32f1a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a4fc877c-7dcb-4579-81a9-c88698d18177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4975f311-57eb-4822-b414-b82713a1db6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5d61950f-5e3d-41be-9c5e-1a03c6c6cabe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4975f311-57eb-4822-b414-b82713a1db6d" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_5d61950f-5e3d-41be-9c5e-1a03c6c6cabe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bb9c5d3e-26f7-40c8-8534-292e3a999422" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4975f311-57eb-4822-b414-b82713a1db6d" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bb9c5d3e-26f7-40c8-8534-292e3a999422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3163fe2b-e9a9-4fe6-8ba6-a531b27ed9ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4975f311-57eb-4822-b414-b82713a1db6d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_3163fe2b-e9a9-4fe6-8ba6-a531b27ed9ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e37f76a0-9a52-4b80-bc8a-fbd8381bf891" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4975f311-57eb-4822-b414-b82713a1db6d" xlink:to="loc_us-gaap_InventoryNet_e37f76a0-9a52-4b80-bc8a-fbd8381bf891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_6d9d15a7-f552-4ced-8cbf-d62b20950482" xlink:href="holx-20201226.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_6d9d15a7-f552-4ced-8cbf-d62b20950482" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_e4d1a7aa-6e7f-4559-84fe-36cbbff211e0" xlink:href="holx-20201226.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_e4d1a7aa-6e7f-4559-84fe-36cbbff211e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_6e8cda42-b61e-40b9-a4f3-a8ce855618cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_6e8cda42-b61e-40b9-a4f3-a8ce855618cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_6a188a0d-164e-460d-a24a-a86a9ba2669f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_6a188a0d-164e-460d-a24a-a86a9ba2669f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_11744bce-30f9-4c3d-a545-3e09c0c6ce0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_Land_11744bce-30f9-4c3d-a545-3e09c0c6ce0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_967a41e0-ea3b-4183-8e82-f2f1c697984b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_967a41e0-ea3b-4183-8e82-f2f1c697984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_b726da63-83cf-4ec4-9d9d-9e22d199d448" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_b726da63-83cf-4ec4-9d9d-9e22d199d448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4869f7ba-fb6a-4411-9f85-be2a6bc7e13b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_4869f7ba-fb6a-4411-9f85-be2a6bc7e13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_bee2a849-e141-4f9f-9c61-2ebaba1fe8c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_49b62f63-4659-4627-9cd7-c5ed71ef661c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_bee2a849-e141-4f9f-9c61-2ebaba1fe8c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_457b05ec-e1cc-4d5f-b0a7-d6a205a094a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_a9156a64-a270-4a84-bdd7-03b9926a6bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_457b05ec-e1cc-4d5f-b0a7-d6a205a094a7" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_a9156a64-a270-4a84-bdd7-03b9926a6bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4f64e264-acbc-4e8f-9d68-b9cea775f07f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_83431b26-65b6-42a2-8628-c874bac002e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f64e264-acbc-4e8f-9d68-b9cea775f07f" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_83431b26-65b6-42a2-8628-c874bac002e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_89e23814-d2f6-493a-818b-eef8b716def4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4f64e264-acbc-4e8f-9d68-b9cea775f07f" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_89e23814-d2f6-493a-818b-eef8b716def4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_469f7d99-0e39-43d4-a845-58d5f8dd3a4c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_469f7d99-0e39-43d4-a845-58d5f8dd3a4c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:to="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_4ebfb254-33ca-40f0-9d25-97ab764d65fa" xlink:to="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_04782b56-6e6e-4166-91f5-8b7b9e31df7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_474071a8-88f3-4baf-9c72-e5cc46197999" xlink:to="loc_us-gaap_IntersegmentEliminationMember_04782b56-6e6e-4166-91f5-8b7b9e31df7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:href="holx-20201226.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0a30d181-dc91-4421-9ec2-97d7f9d4f75c" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_f80b87d7-31e9-4977-9095-756640591ed1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:to="loc_us-gaap_NumberOfReportableSegments_f80b87d7-31e9-4977-9095-756640591ed1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_79ab9e5b-a5b3-46ca-ad16-f6216e9c5619" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_216cec4f-4639-434c-ab90-c143e8c17f81" xlink:to="loc_us-gaap_Revenues_79ab9e5b-a5b3-46ca-ad16-f6216e9c5619" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cfccf41b-43fb-4407-99e5-4b7a1e7c9638" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cfccf41b-43fb-4407-99e5-4b7a1e7c9638" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_38c8204b-b20c-4e54-ba08-59d2dfd700ac" xlink:to="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_13d9804c-6408-4f48-a0b8-3b7c760d7a06" xlink:href="holx-20201226.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_DiagnosticsMember_13d9804c-6408-4f48-a0b8-3b7c760d7a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_afedfceb-e0ba-4b32-aaa3-45ff1e4f0969" xlink:href="holx-20201226.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_BreastHealthMember_afedfceb-e0ba-4b32-aaa3-45ff1e4f0969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_9222a3c4-dafd-406c-b67e-da174617a512" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_MedicalAestheticsMember_9222a3c4-dafd-406c-b67e-da174617a512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_949f4b0c-6d72-4932-bd2e-f2479d8cc682" xlink:href="holx-20201226.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_GynSurgicalMember_949f4b0c-6d72-4932-bd2e-f2479d8cc682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_3bf16a02-9e1d-4cc9-801b-a1f9307dcdc9" xlink:href="holx-20201226.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_holx_SkeletalHealthMember_3bf16a02-9e1d-4cc9-801b-a1f9307dcdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_05910576-1f72-43fa-af73-a3108456c530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_c9ff6416-aa25-4a6b-9af8-c37e56033fae" xlink:to="loc_us-gaap_CorporateMember_05910576-1f72-43fa-af73-a3108456c530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_4d412179-77c9-47af-b995-30ed0bf1c2af" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_17d90d06-0e2b-4ff7-820c-b42500415f54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_Revenues_17d90d06-0e2b-4ff7-820c-b42500415f54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_40a50ad3-a322-4ed9-b36f-0265f4c1e1bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_OperatingIncomeLoss_40a50ad3-a322-4ed9-b36f-0265f4c1e1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_8a178b8d-7e27-43dd-b072-976732de5627" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_8a178b8d-7e27-43dd-b072-976732de5627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_c262277c-9242-4d06-8a04-ba2a6c5445b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_c262277c-9242-4d06-8a04-ba2a6c5445b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_9d58a047-8888-43e2-99fc-c4c9f5a0fb3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_6a5184ba-c529-43bb-af6a-76522ccdb1a0" xlink:to="loc_us-gaap_Assets_9d58a047-8888-43e2-99fc-c4c9f5a0fb3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_945a15fe-e98d-440e-a9b3-af1b0ec69019" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_945a15fe-e98d-440e-a9b3-af1b0ec69019" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:to="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_78125292-30c1-462f-acaa-ea789247cc91" xlink:to="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_8b75604c-33ad-4b05-9c8c-5eff88b6289d" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_country_US_8b75604c-33ad-4b05-9c8c-5eff88b6289d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_c5bf9524-06d9-407d-a9b4-c7c6e5dd1f48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_srt_EuropeMember_c5bf9524-06d9-407d-a9b4-c7c6e5dd1f48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_612b779b-4743-43e1-841b-97fa8f0b4c05" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_srt_AsiaPacificMember_612b779b-4743-43e1-841b-97fa8f0b4c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_8ce5df74-f968-41f0-8bff-d85825f49789" xlink:href="holx-20201226.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_b219db02-122f-4e09-9e5b-9ceb3a0194df" xlink:to="loc_holx_AllOtherCountriesMember_8ce5df74-f968-41f0-8bff-d85825f49789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:href="holx-20201226.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_d0912187-ff93-4cd5-9d46-32e2d807ab4b" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_9e425fa2-b144-4f78-b846-3cd737d66428" xlink:href="holx-20201226.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_1da757e8-c71e-4fc6-a17e-3eab92da5948" xlink:to="loc_holx_PercentageOfRevenues_9e425fa2-b144-4f78-b846-3cd737d66428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9d8e7bc0-f824-477a-aa13-b083db77bfd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_be8fbef9-40e0-4371-b8a8-a3c45e2506b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9d8e7bc0-f824-477a-aa13-b083db77bfd1" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_be8fbef9-40e0-4371-b8a8-a3c45e2506b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_effd3eef-963d-4a09-a7f8-a15778ac5997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_effd3eef-963d-4a09-a7f8-a15778ac5997" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_0436f1ce-5aba-4737-b5b8-1f6dadf67585" xlink:to="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MedicalAestheticsMember_7c00c303-a3ce-44db-950c-465a18ce44ab" xlink:href="holx-20201226.xsd#holx_MedicalAestheticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e703ed7b-721f-4431-a846-9b9f86c3aa4b" xlink:to="loc_holx_MedicalAestheticsMember_7c00c303-a3ce-44db-950c-465a18ce44ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_c91135d5-8e3d-4784-99a5-7b21c98525c7" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_797b92a6-ef76-4cd5-8a86-7588e4d47a8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_797b92a6-ef76-4cd5-8a86-7588e4d47a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_89de45f1-100f-4c5c-bda7-95437bf85790" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_fd880dac-d77f-45bf-b734-49685f5f2c5f" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_89de45f1-100f-4c5c-bda7-95437bf85790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ca6ee6f-5beb-45fa-b619-494a68545ce5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a7cb47bd-9b2b-4f89-b1c0-b38f04c102c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_2ca6ee6f-5beb-45fa-b619-494a68545ce5" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a7cb47bd-9b2b-4f89-b1c0-b38f04c102c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7f953a4-2eca-48d2-b6fb-4f0b21cc5b89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e619aa07-4a2d-40a0-82ae-16e1fb168691" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7f953a4-2eca-48d2-b6fb-4f0b21cc5b89" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_e619aa07-4a2d-40a0-82ae-16e1fb168691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_53306a06-8af4-4342-a989-74c46c6a705d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_b7f953a4-2eca-48d2-b6fb-4f0b21cc5b89" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_53306a06-8af4-4342-a989-74c46c6a705d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8afa006a-1bd7-4502-a02f-db2c3685ae95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8afa006a-1bd7-4502-a02f-db2c3685ae95" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_f45581e3-54b1-4b38-8bd8-2f534fb15968" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_604da83a-de47-46f4-b615-1e06df941e78" xlink:href="holx-20201226.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_DevelopedTechnologyMember_604da83a-de47-46f4-b615-1e06df941e78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_dd47183c-62a5-43fc-a92b-4bb3170188af" xlink:href="holx-20201226.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_CustomerRelationshipsContractsMember_dd47183c-62a5-43fc-a92b-4bb3170188af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a953f5ce-b84d-4173-8033-5203bba77dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_us-gaap_TradeNamesMember_a953f5ce-b84d-4173-8033-5203bba77dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_e398a080-d3ab-4da7-95cc-0798b15d65b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_e398a080-d3ab-4da7-95cc-0798b15d65b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessLicensesMember_b19659e1-70a7-4e2e-a5ad-998d2b74e568" xlink:href="holx-20201226.xsd#holx_BusinessLicensesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_BusinessLicensesMember_b19659e1-70a7-4e2e-a5ad-998d2b74e568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_92135ce8-b1ab-44bd-accf-bb1be33390f8" xlink:href="holx-20201226.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_AcquiredintangibleassetsMember_92135ce8-b1ab-44bd-accf-bb1be33390f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_e314858e-bcfb-4ac6-bdf0-19953241a151" xlink:href="holx-20201226.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_InternalusesoftwareMember_e314858e-bcfb-4ac6-bdf0-19953241a151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_9c33b1fc-a63a-4393-bca5-05a80196c9da" xlink:href="holx-20201226.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_dded54e5-25b3-405a-bf3d-383675af6201" xlink:to="loc_holx_CapitalizedsoftwareMember_9c33b1fc-a63a-4393-bca5-05a80196c9da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_3a344040-d37b-4dd6-b80b-48fd83757207" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_479f98cd-8d11-43a8-984b-253816da76b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_479f98cd-8d11-43a8-984b-253816da76b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0a2d0356-2fb9-4ba6-80fa-b111678b2d2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_a4658584-b6f0-4a6a-b007-9ba195e8195a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0a2d0356-2fb9-4ba6-80fa-b111678b2d2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9e05c955-2de3-4c32-bc6f-391ffc3246f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_9e05c955-2de3-4c32-bc6f-391ffc3246f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3b9c3f9e-7ae3-4809-9c48-55f9bf0762b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_3b9c3f9e-7ae3-4809-9c48-55f9bf0762b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_654d9074-b859-477e-9cc5-e53c554eb4a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_654d9074-b859-477e-9cc5-e53c554eb4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_38b74fa7-df5d-430a-8ca1-b66220ecce72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_38b74fa7-df5d-430a-8ca1-b66220ecce72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a1b9cc7-586f-4db7-bf15-151ae01cc7bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_efc85337-4228-4e44-9c6c-a3e5da5929e7" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0a1b9cc7-586f-4db7-bf15-151ae01cc7bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_23fa62d7-c3ca-4c9a-8218-262a7c2b9c10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_2a5c9be5-a526-4a7b-bafb-a0d9d64e69d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_23fa62d7-c3ca-4c9a-8218-262a7c2b9c10" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_2a5c9be5-a526-4a7b-bafb-a0d9d64e69d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_030e8206-86cb-4384-bdfb-d205202a9024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_9c9e3111-c66c-4ab3-a3bd-003b6beb10bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_030e8206-86cb-4384-bdfb-d205202a9024" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_9c9e3111-c66c-4ab3-a3bd-003b6beb10bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_9f37e258-592a-4d72-906d-e9a2934498a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_9f37e258-592a-4d72-906d-e9a2934498a2" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_aa183fbc-e9f4-4be1-b1df-611b7e059972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:to="loc_us-gaap_ProductWarrantyAccrual_aa183fbc-e9f4-4be1-b1df-611b7e059972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5e2130be-ca6e-472d-bce4-bd612dac349d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_5e2130be-ca6e-472d-bce4-bd612dac349d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_7ff9949a-dddd-42d0-8100-198a551ab33d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:to="loc_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition_7ff9949a-dddd-42d0-8100-198a551ab33d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_ff678ab8-3876-4e77-be4d-54462c7598f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_ff678ab8-3876-4e77-be4d-54462c7598f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_a3314546-8187-4f27-8c4a-88ec7745e0ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_d6550a56-707d-4bff-a586-bb30818e9291" xlink:to="loc_us-gaap_ProductWarrantyAccrual_a3314546-8187-4f27-8c4a-88ec7745e0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_af919913-8b5d-45f5-975a-8b2ab40ea875" xlink:href="holx-20201226.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bab8a45a-9de7-4f07-acbb-08af1d3c41a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_af919913-8b5d-45f5-975a-8b2ab40ea875" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_bab8a45a-9de7-4f07-acbb-08af1d3c41a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_583d221c-0286-4148-a6b3-fd9d970024e0" xlink:href="holx-20201226.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e9f27f0-a51a-4e9a-89db-ac313a75b10c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_583d221c-0286-4148-a6b3-fd9d970024e0" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_8e9f27f0-a51a-4e9a-89db-ac313a75b10c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20201226.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_46b9f7f4-3090-446d-ba77-458d7d323de7" xlink:href="holx-20201226.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_46b9f7f4-3090-446d-ba77-458d7d323de7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:to="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_4858b81e-3a7e-43d8-ad70-0695095609c7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateCapMember_4bac3ea4-68b4-4fc2-a0bb-fa22967ed1de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateCapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:to="loc_us-gaap_InterestRateCapMember_4bac3ea4-68b4-4fc2-a0bb-fa22967ed1de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_bf6685bf-8abb-421b-b367-9e3add457bdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_c06800d4-ba71-4515-b0eb-a979766dd609" xlink:to="loc_us-gaap_InterestRateSwapMember_bf6685bf-8abb-421b-b367-9e3add457bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_342c6901-7518-4ee9-9d95-06678723a4f3" xlink:to="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e05869e1-397d-4d9a-a599-832e8e30a1a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_e05869e1-397d-4d9a-a599-832e8e30a1a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_09851545-3c02-4273-b6e2-7380c5e2af72" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_09851545-3c02-4273-b6e2-7380c5e2af72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a1fbae5a-b4bc-4668-84fd-f003936ed411" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_a1fbae5a-b4bc-4668-84fd-f003936ed411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_860fbb33-d9d0-4400-bf6f-7ff0fd75ede1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_c66ee219-d74c-4eb3-9793-93f0403788e6" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_860fbb33-d9d0-4400-bf6f-7ff0fd75ede1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_1e3b69c2-36a2-4795-9e5a-54e34004366b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ff25aef4-7934-4438-b9a5-1f6fa9f9e02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_StockholdersEquity_ff25aef4-7934-4438-b9a5-1f6fa9f9e02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e7a722c6-86ab-4f8e-91e1-4e20d400c319" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_e7a722c6-86ab-4f8e-91e1-4e20d400c319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_408f6c6d-4393-4538-9051-0ce2bc891bf3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_408f6c6d-4393-4538-9051-0ce2bc891bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_07cd723d-69b8-453e-93ad-846bed5c5d8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_07cd723d-69b8-453e-93ad-846bed5c5d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9aa7f10a-d130-4c9a-858b-96d284d9819e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax_9aa7f10a-d130-4c9a-858b-96d284d9819e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_95fee8b7-75e0-4ca1-a7f2-0ebb53d47656" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_95fee8b7-75e0-4ca1-a7f2-0ebb53d47656" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a0391e2f-5810-48c9-9e9a-889465e38a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax_a0391e2f-5810-48c9-9e9a-889465e38a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_71f7c9d7-133c-4865-9c63-61e6dae6ce97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_deb8302c-b515-4c8b-a8c2-2d5097992437" xlink:to="loc_us-gaap_StockholdersEquity_71f7c9d7-133c-4865-9c63-61e6dae6ce97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20201226.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ac653ea9-d45c-41f7-90cf-04c00a9fdfe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ac653ea9-d45c-41f7-90cf-04c00a9fdfe8" xlink:to="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_eda8bb65-9f8e-4635-9cd5-3e93a984599a" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_566099ee-9f47-4eab-883c-99a20f773bca" xlink:href="holx-20201226.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_79749aec-47f7-4adb-a59d-3cbbd35e27a2" xlink:to="loc_holx_December112019Member_566099ee-9f47-4eab-883c-99a20f773bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AcceleratedShareRepurchasesDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateAxis_d378a54a-18e9-4760-83eb-097c49150ec7" xlink:to="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112019Member_03dfe2ce-6cab-49f6-9bda-9a9362869574" xlink:href="holx-20201226.xsd#holx_December112019Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:to="loc_holx_December112019Member_03dfe2ce-6cab-49f6-9bda-9a9362869574" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_71beb313-9080-4c30-a862-b9ffdf618acb" xlink:href="holx-20201226.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AcceleratedShareRepurchasesDateDomain_e0b2fef2-0308-41e9-8068-b924e901d073" xlink:to="loc_holx_December112020Member_71beb313-9080-4c30-a862-b9ffdf618acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:href="holx-20201226.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_94998483-719c-471f-8529-c84cffa17c3a" xlink:to="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_54e9d326-8551-44e4-93bb-c470308a6a62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_54e9d326-8551-44e4-93bb-c470308a6a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_9a7c0b6d-841c-46af-88ca-27d75ac1044f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_9a7c0b6d-841c-46af-88ca-27d75ac1044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7173cbb6-1312-43bf-9648-ac0520da8f60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromRepurchaseOfEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_af221f1a-0576-4fda-a692-3490c5e907c8" xlink:to="loc_us-gaap_ProceedsFromRepurchaseOfEquity_7173cbb6-1312-43bf-9648-ac0520da8f60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1ef0fff0-31dd-4e64-99c5-eb893bacd5ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_200e0190-6975-4bbd-bea3-4e6744a53684" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1ef0fff0-31dd-4e64-99c5-eb893bacd5ee" xlink:to="loc_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted_200e0190-6975-4bbd-bea3-4e6744a53684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="simple" xlink:href="holx-20201226.xsd#NewAccountingPronouncementsPolicies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NewAccountingPronouncementsPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6fcd8080-b4cd-473d-adeb-8dafcce2fc16" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f0e61d8f-f8e1-4537-9b5a-43fbdbf7e284" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6fcd8080-b4cd-473d-adeb-8dafcce2fc16" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f0e61d8f-f8e1-4537-9b5a-43fbdbf7e284" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>holx-20201226_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:holx="http://www.hologic.com/20201226"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="holx-20201226.xsd" xlink:type="simple"/>
    <context id="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i77213d318a2b4d699ad623674cca6b4d_I20210121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-01-21</instant>
        </period>
    </context>
    <context id="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i573838e4ead64367a1cf3a3e4674ffd2_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i2b4dfc4a55634d5980988f0884ae4448_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="idf5a202d41b64a3a9989f892adbc11d6_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2a33877be74a4bff826119edc7ed503d_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="iecfcaef9f54e46558440bc81f97e5eed_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i5aebec3fb9bb4e4488a724c4d7743031_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i3b4184d7f35149b3b1f891cfb657efe0_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="if86ea7db4fd24e63b6e2c24f3290f064_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i2bf21035b13f458a9644c6641ca45dc9_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AdjustmentsForNewAccountingPronouncementsAxis">us-gaap:AccountingStandardsUpdate201801Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia95de565187f45949e967d544a6d18d2_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i4a30acd7b78740cfbcd8e77c0e406bc5_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ifc8761797caf4a1ba7a00d4505018e6f_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="ia87ad826395149329bd9e8ac7b691cb4_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i583f922944894f7ea2b4213a2907b398_D20191229-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="icef9871fe55a44bda919b0b0818f6106_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="ifcc149ba496d4eb1af231a99ee58c7bc_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i911f42f14f9e440c9969b74a5fb822fc_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i4a6f08dec5bc465b9ee6f174df007570_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="idb4183da93954dc88904c56ed86abb2e_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="i200f25ce96994bbbae7026819adf7b94_I20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-03-28</instant>
        </period>
    </context>
    <context id="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="ibed5a407b01e495f8fcec834d617c870_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="iec58a1e4925447509af22498f07e082c_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="ie71ae6f99b084b4daf51a7a375e79bf6_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i9581555522f04a0aae88d04d16ac8561_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="ic37dc7d6b73747eb8118aecf497797af_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i4ac726be9de04754acfb0c3ad2bbe977_I20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2020-06-27</instant>
        </period>
    </context>
    <context id="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="i127f35bc4ced488ea526b5c9709d9c78_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i46f22b455cca46d8bf57b116a211d7e8_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if0dbddd90f43449eb71f6e58600e75ca_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i1a34844d9d004ca59421077b20e85919_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia8419f493c4f4d939c6a710aeda8796e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if770fda10e1f4568a769511e2cb46775_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i84b132b519504c978ab69d88a3c921da_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ibda9918b12184a469461c064a31cda9e_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i61d28c68b4b044baa488a63597e4ba87_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ice8e1c44566e46d7a9428b4c849cf075_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i0a1a2f2804d047f9be18b7470292b8f2_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie2315ca24bb44334b2ede0aa904f5731_D20201230-20201230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SomatexMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-30</startDate>
            <endDate>2020-12-30</endDate>
        </period>
    </context>
    <context id="ibaf5f2d2692346a88d7ae57bf6270cdc_D20210105-20210105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BiothernosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-05</startDate>
            <endDate>2021-01-05</endDate>
        </period>
    </context>
    <context id="idd718ddd1ed144e29f41973ee9eb875b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i807f1967ca0747168870227cdb5de282_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i814e82d01f554e07a70d51c7e0f6789c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i24231c45c0e04b0cb463e368a4fa9819_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iac260c17aab74a5aaad08d3c2e71c09f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i85fe1c3197bf4160bde67b0e7b88e57e_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic11fbed77bea48e18a66f44359be8369_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="icb91856dc5f14d6e88d769b12a3553fc_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1ca33f8b7647484d95b3e8825c8d1ae6_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ida008df7022c4ec1b8fcdee5e84f1012_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1d1862a2813f492184d07742064e2a0d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i8bfc0e0103f9487b965e824c2254203b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i16374eee78494c719746d8b40c160941_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i20f4faff9e164fa29b72dc862bb814c1_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2f918efa3d83476c9578e01f5704ea75_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i047e6064c2d441448b721d1506b755fa_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1c48afb9a6cf4b619f1170a44995048b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic3384fe463ec48f08c6f59ad68669d65_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i8f45f0b5e32942a5ba004547e2f18c70_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if63bac3956a34caaaf11ca4c0d481b3f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iba06aba7b8a3482991a27db74984c2d2_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i7744b72714974633840d43bd8f1c52aa_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ifff05d29091f488093318a5c86a39998_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i804f2e6f9b9c4c2dac795221463c7352_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i494de1667d6141d3a77fb81e098872d7_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i41fef6d46bcb4458936812aadb6a6eeb_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="if4e261e946c44e3289c0ec9dd139dd3e_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i53d2f9966d234c8f86709bf1c24480d9_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i425431777b7d4b3083ab8649a18e6394_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="iff1719f8bdb243f58136808bb4f920b6_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2d6138445fc34f7b849cf1c4c1bd7b4c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ibc90a64df06e44afad34c0fdb3d6acb0_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0c1a753fd84741ea99c093f47887c09b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2f39f8c1a58d4c0092f3c0f4a7e1145a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3c80ddb3233741de8cb85ebe53044117_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i08a1df1d86db4e5f98a13155567d6600_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i6a2a3bf74b34478e8fac81531d70102e_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0420bc7b903745a99eef56fe2d387c5d_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4a381e87df3e4fd3881d975e6bf59018_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia848377d0119418c93ec23909f54ef88_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i1ed96c1bacd44799bde67d4474a21301_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i08a1b32655d141b3827b070cb7dd8394_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3ddb21f8026b4973b5e9cf9a186551ac_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia1f0f69550624497996276135c6bd77d_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i171c9ca031bf4884816e7be4190b9db2_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i86f98ab577e348f08c18b5ec1aa4c24f_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0b9fa71bf4f54f2cb7e265c235983118_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="iae70212752be41b28bd54fda1cba672b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i9edfd07f43ea4110a087242c57d62661_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5896165fc6444c69a28f30d7622aab83_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="iaf72943e74d14e5fbecf4403525ffeeb_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i894813c090864a3cb88eb86237b77caa_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i64740b81a53c45249c05c34df962be4a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib9475dc3a7d5487fbeab85f649c54044_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i7f217ab69c114d40a9a225677bf15b33_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i315641707d4c4fc39c5611d79f93f696_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie0ba3144ce98484facbd98ad7ffb47dc_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i67601f23ac8f42259e8935b9dc100943_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ia48592e41d84415895cece1a0979daaf_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i58584d59f7ca4ce8914046729ee0446b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2617de2ef6504c69af6d86624c6c1ae3_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ife84c0d8763b4705a470b753572dd9ad_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2020-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i08052409a9da48bd9c3023256acbffbf_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2021-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="icf1c53d799a94ec78b381605622bd13b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i605077a5590146648b817b54f0efeec3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i562f34e6727740619a5a1d16c97a58b4_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9b4b851aac0a434c82c8b786b613a366_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ibda9057d843a4b73905a0ed943432150_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iba6af4bb67bc4b93b0ef89a2863329bd_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3824626237124ce9828ecc11f78786df_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i126237eb247a4867bac37c6b2dea5699_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ia393550942904ed09c042467d0645c37_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i589619851f164523acf1587d711fff2a_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i50fa172708d24893990ba4c50d5437c5_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7323967dedcd49868eb4e102fb8b387e_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ContingentConsiderationTypeDomain</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="idb7efed954b8455690ac3b12d64dcb4c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ia8c4bd4abad44e83aab53cec2dfaade1_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic9712b4b8dc64000b015bfd132cfda2c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i69ec054955924207982fbd54d8a1cca2_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i0bbcb67f917c48b39cc8cdf5e74c1d42_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i876dd7ede38d4edbae53824dea405212_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6a5fd7116579406fb4ab4e0c108de263_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i788bcb698408495ba16be99c3274b08c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i057ac10f806c4c558abf15ee4ec101cf_D20200329-20200627">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-06-27</endDate>
        </period>
    </context>
    <context id="i241d11756be14078a3555bf86956ce71_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ida2942dc56654504a3265279bdb12af9_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6e700854ca8d480696bc4eb95d4ddb8a_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic2f8bbd6225a46a59130b9953c661fca_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ib945bc9d7dd74d23bef11fee1c766a86_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:NXCImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i445bb1bc12b94106bac10836061b786a_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ContingentConsiderationByTypeAxis">holx:ContingentHoldbackMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i34350e67e8944266b86f21311361cfa5_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="i0832db4cb8434084b9ee1801dd03071d_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i0ab367a0906d4115ae87e78dcc61bf59_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i70d5bdf101354f3096ceb4018e2689fe_D20200203-20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-03</startDate>
            <endDate>2020-02-03</endDate>
        </period>
    </context>
    <context id="i97f3b15a57f54d1388b8a487d385f489_I20200203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:HealthBeaconsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-03</instant>
        </period>
    </context>
    <context id="i16b9bcb5f7f245b8844e041da365f4ca_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-30</instant>
        </period>
    </context>
    <context id="i371b6d6a17864bafad1d66b2594c1fd0_D20191230-20191230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AlphaImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-12-30</startDate>
            <endDate>2019-12-30</endDate>
        </period>
    </context>
    <context id="i07707b0a4bc941daad3ff6db034e22c7_I20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-01</instant>
        </period>
    </context>
    <context id="ia740bc8dc3ae4ebab5eaafc9d0d17247_D20190801-20190801">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-01</endDate>
        </period>
    </context>
    <context id="ic66d9c02f62b4399864f0fd8c7c03ef9_D20190901-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i819b181542894a318b23998e6b0d7876_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="i7760868627c74bd8909425527cd76d5f_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ib444eb3971eb4078a9095005df6a2388_D20191101-20191130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-11-01</startDate>
            <endDate>2019-11-30</endDate>
        </period>
    </context>
    <context id="i723a995e7e6e469f93a43a1b15d07825_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-21</instant>
        </period>
    </context>
    <context id="i0b7ae2b69c584c9bb1faea69bab3ce7d_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="i3bcf08abaf134bbebc54968c5252645d_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="iaddf820f39534b4598834451cecb88ea_D20191121-20191121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:SuperSonicImagineMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-21</startDate>
            <endDate>2019-11-21</endDate>
        </period>
    </context>
    <context id="ic22ee4e6996843b09dfab94a3c9ee000_I20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-11-20</instant>
        </period>
    </context>
    <context id="i263b950faa89407aa9ae0648ede3cbf6_D20191120-20191120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-11-20</startDate>
            <endDate>2019-11-20</endDate>
        </period>
    </context>
    <context id="i94e4cd78e2a64f9c8f35fa4309e98439_D20200628-20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-28</startDate>
            <endDate>2020-09-26</endDate>
        </period>
    </context>
    <context id="icc6c143516c3424da5de0d0db2e91e98_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i3e1d2a8de8624ac59da8d9efd1fbaf86_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-03-31</startDate>
            <endDate>2019-06-29</endDate>
        </period>
    </context>
    <context id="i6b85682ab2d3455ca69df8563e60aa95_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ieb7f71fe3fdf45758b7a447848bff326_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0bb87ee83878455d9a7b108c2fa2d672_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="id6786a0492e547de9f464fbf0e844870_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i67ca1e7d9cac43759262d127ccab005b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i82e420f21c4c4b3f8b908f387378a7f2_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id33757ebc0984bec86c4ac09abcd3c10_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3c6dd14c95ef47a7949124d127e36455_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2dbe00ac4547495f87d9491d8dd3581b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie68151a708294400b3d034999da20c0b_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i272b18cc7ba74e908f1067ae52fcdb03_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:AmendedTermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:PercentageAddedtoEurodollarRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ifcd33ea87772405fa0aef1f0eddaef72_I20181217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-17</instant>
        </period>
    </context>
    <context id="if3dfc408634648eb84ad199842d8c60c_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i266e0d14a55f4367b1cb47da87337f49_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AccountsReceivableSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i5ccd74dfac1940edb3766ae879c3f548_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i87a8917b112a432189d8acc8fa3c7c6b_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i11457d1d34284cdd848e04fc6ade132e_I20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-28</instant>
        </period>
    </context>
    <context id="i0e7cc717b7744775a9beef49918787a7_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iad667aadede54f53a73843991e84d978_I20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-15</instant>
        </period>
    </context>
    <context id="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-15</startDate>
            <endDate>2020-10-15</endDate>
        </period>
    </context>
    <context id="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i8c96bc19976644208f9a458ae4a150c3_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="iacc119bc81e747be85919ea8b7a55a46_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie334e0aec6cd4cd1ab86db6fbbfaa551_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i9a8984669d744df49521703334b03d7e_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i96cd4aedc3204bf7bbe2a37df2b4ef1f_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="if6ebe4e0383e4fe69e44e515ac3c4504_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i02a7dee3e67f41a097d797a6c9b2130e_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i9a15023472504c11938a4412d729c107_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="if22e3b1bbb254fc0b22330dc8ee7c7bd_D20200928-20200928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentRedemptionPeriodAxis">us-gaap:DebtInstrumentRedemptionPeriodFiveMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-09-28</endDate>
        </period>
    </context>
    <context id="i946944c5847f4222b4d01aab1a2fa089_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i97a53a8f47ba4871a7afa91c3b2b95ae_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5687e57173b24d598e070c83cda5ba64_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2025SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ibbfc7677b0624c36ad3fa92f1412ae0c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic040a340ce4f4e139d9aa05eac474e5c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4145415c8afb45a4bda97db9d2be27b8_D20171001-20180929">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2018-09-29</endDate>
        </period>
    </context>
    <context id="icb558ac27372440189b269e14d6cb9e9_D20180930-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2018-09-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i2b87642439d147ca81c80ca1dfb67dc5_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ia18821e25e654193b3722de96cae81e5_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i14c65c53cd0e4e41a8db5dd4fc6893ee_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic5c79bf354ce4b21b4b0f50f1420f521_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i99c9b14467904ef5b80860d433664aee_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iaffcddff32544018920aee5d25e3c2ad_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9dfb8135d4b44625bbfd0c560825de11_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="id06743973fb743b3bbaa0c0e4b84c26b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3146d8c6f2de426998db38b3743e8858_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ia984d8ccc9314615a0c9a71d08c50377_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i840c202668e846e1a52fcd4ca8bc0961_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i969e4857b92749c69746b9416f9fdfa8_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i46c4fddee0c14f81993ab3606eae7ab3_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i81a59afa7d3848bf9b91f17ca827426a_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i549ec774b12e4aa1a72a71662a06229e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i3be9e57ba38f4e4eab5fb7b166680c7c_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib397c4180063456a85a4f4404a73c0ab_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7ced3c7b6bc347edb64064ea347792a1_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ibfed9d2d0c8c46be91e8f912672b894f_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ib6d9158bf57a4de4bb11c3ce2fbd34c8_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="idd61c3510e7e468085daf8a67ff23b49_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ifa0e515bd1224c0d899e4fcd02858289_I20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="i7c99293b0e714a19b40025886a612952_D20160304-20160304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-04</startDate>
            <endDate>2016-03-04</endDate>
        </period>
    </context>
    <context id="ie80b72b0fb174e058cab363ca6b15048_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i32c95d4d9c584147982e6bb76f7f2f4d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i171272f0c8eb474abf7abd9bc10110a5_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i55ee422e40ce4f768cceb979f540e79d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i476aabde140941c0aab31725a7ba549e_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="iafdc57909e694817a52781dc7898179f_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iff6b7ab624354224947dce01c73a9d53_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i5144cd88e48a4b849b044fdf0eba3d60_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i9547059f414e4ec8bb5994e0b274a8e4_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if39c287645e74eff89da805fd540f295_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i9b5e1cce238241218daf5e00d5bdb7b5_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i1b9c1bb1bfb5498d9c90a1947235bccf_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i855677b1eae843febb6235b904a536d4_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i9aa17c0c19b24f93bc412700aea8fd05_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i4bd4f87650894ee382525ad3d40a1b96_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i5a35e9e5b1784502b251b8e6485fc0ac_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i10c0a8b3f4be439a89b84dd347cf9122_D20190929-20200328">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2020-03-28</endDate>
        </period>
    </context>
    <context id="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="if1a3cd78896644659e948a7690e47e54_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i2cca350406704671a994c46fd4de1acd_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i189fd242f489432a9c8db82a5c7ffe1a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i2bd66551f9c242be97d7f7e5bf36f159_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i53fdb57bb16f4ecd921dea40ee6810c9_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="idea9543291624e5ababf4c314fce32dd_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ida8674e08ddb40be8abf86e02713868e_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0ce3ba4253a94d52bc59d8eee2d9a4bf_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9b99c5a4675c4355b2ada4de33915985_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i95f6c5d4cda44d798ae43baeb9d4c057_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i4f800d332c6b407198afce370a678a7d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i0a4363dfa5c645a0825be13c07abee4c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i58367c7ce8c54c989fc82c51b7e6dbcf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i2b1fb47303fa4a959860825ff50f60af_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="iaf46dd81205b47668902c1445ae9f97f_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="ic82c48e220f04e80a509c6a97393b47c_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:MedicalAestheticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2019-06-30</startDate>
            <endDate>2019-09-28</endDate>
        </period>
    </context>
    <context id="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i9e60b8115b744ab191b4024f191eb8bf_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i243ea054fba6480fbcab7af21d6a4fce_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="iafa5b970ae8547d5869dbb3f0236c428_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ic2252adf156645a6b718b3df114b1fad_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ie951bc855db2428a86d3e005063b41ef_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i4e3d41a755af40568a3e504182462ce6_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6c20b78ad72e4fe8a5420980636498f0_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:BusinessLicensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i663bf06f259e40619f00b794ee8f3df4_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="if7f4ea0fd45f430abe0bc8838c398d85_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ib64c67176ca34a27bd5311e672ebe881_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8aeb602620b040dbb06bd27522eabae8_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ib5e39d5d745b47fd991512768cc51329_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i47fc0ea3fd504f739a98ccb1f8602c4d_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i012977a16707452184c540c1c42de324_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i5ca4657cf4aa4a1883690d1eebc48675_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i8d9e66846015431a805ecdc7a2b07991_I20200926">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-09-26</instant>
        </period>
    </context>
    <context id="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i691aa4e01085425ea916509572c8429b_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="i8f3b88a636814103b52b8b03edd8eaad_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i7d6e7aa54b314ef6b6b0475e6c1109a8_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i6d75b63e30b04cf3a05528421174cf0f_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="i3e77d8b4a000446c87e498c3fb63a20c_I20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-26</instant>
        </period>
    </context>
    <context id="ibcaee226383e4970803638e86e611e5f_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i3896841cd53547aa9f241c9961480908_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i63616236f1194463b9ef82bc0e35b837_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="i18a05642170e4a2eaba83cc4b9f1db63_I20190928">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-09-28</instant>
        </period>
    </context>
    <context id="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-09-29</startDate>
            <endDate>2019-12-28</endDate>
        </period>
    </context>
    <context id="i0b08910f86f346c9b1270b470577d0b7_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i5265c14bdf944ebeb3a15533c9c6b571_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i415e1540a94545748e7bb75e5b9e6db7_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateCapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="if85ce9153c7c4628b53a745f295945de_I20191228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-28</instant>
        </period>
    </context>
    <context id="i570b9aef162a4a48b5ccb34ec6b061f8_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <context id="i05539a83a04849449de905f6a9d13244_D20200927-20201226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-27</startDate>
            <endDate>2020-12-26</endDate>
        </period>
    </context>
    <context id="ic5ace0144f6f4565a88544db9fa33ffb_I20191211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AcceleratedShareRepurchasesDateAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-11</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="petition">
        <measure>holx:petition</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV8yLTEtMS0xLTA_c5502e57-e133-4215-ba62-6a1d63af4d08">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV8zLTEtMS0xLTA_438a80c0-4754-4c97-acd4-633af4934a31">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV80LTEtMS0xLTA_37e69a31-63b4-4adf-a8e5-4af843683bb0">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV81LTEtMS0xLTA_d7d37022-4acb-4fa4-947b-0ae79c80b1d4">0000859737</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80L2ZyYWc6MjZlODE4NTUxNDM3NGM4OWEwOGU3OWFiNWRmYTM2YzIvdGFibGU6NzRkMWRkOTJjZjE3NGZmODg1NTUwOTQzZjMyMjQ1ZGEvdGFibGVyYW5nZTo3NGQxZGQ5MmNmMTc0ZmY4ODU1NTA5NDNmMzIyNDVkYV82LTEtMS0xLTA_86055593-3d5f-467e-97a7-1e26ecced4f7">--09-28</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ife84c0d8763b4705a470b753572dd9ad_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfMi0yLTEtMS0w_d672a544-62f0-40ad-8bcb-39531e0dce25">P6M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i08052409a9da48bd9c3023256acbffbf_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfMy0yLTEtMS0w_ce5f6b08-7298-4673-b00a-9ec45db403fd">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="icf1c53d799a94ec78b381605622bd13b_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNC0yLTEtMS0w_7d294249-8781-43de-b053-503efd8d57ec">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i605077a5590146648b817b54f0efeec3_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNS0yLTEtMS0w_667f0eac-dc82-445f-b2ce-bdc7889fe3da">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i562f34e6727740619a5a1d16c97a58b4_I20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80MC9mcmFnOjc3NjQwYmY5YTlkOTRkNGM5MDMyMjA3MjA3YzEzMzY1L3RhYmxlOjk3ZTE2Y2YwODcwMzRkNmVhMmVmNWE1YmNjZGU4MTEzL3RhYmxlcmFuZ2U6OTdlMTZjZjA4NzAzNGQ2ZWEyZWY1YTViY2NkZTgxMTNfNi0yLTEtMS0w_674ba7f0-7291-4bb3-893d-31f8bdb2c173">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgx_4e06dd93-5083-4b6f-bd85-1d21cf561ec8">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6Nzk3NDhjZjI5OWY4NGJjZGEyN2VhNDQ0OGYyMjNkODMvdGFibGVyYW5nZTo3OTc0OGNmMjk5Zjg0YmNkYTI3ZWE0NDQ4ZjIyM2Q4M18wLTAtMS0xLTA_8772bf22-1969-49e1-94ea-8aa44fe446b7">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yNjA_9977bd42-ab80-4863-8d15-02647d5c7886">2020-12-26</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NjExMjUyN2EyZWI3NGM2MmI2MmFkM2U5ZDU1YzNiNGEvdGFibGVyYW5nZTo2MTEyNTI3YTJlYjc0YzYyYjYyYWQzZTlkNTVjM2I0YV8wLTAtMS0xLTA_8439ebda-d8ae-4200-a7d3-5b9ea0e59d67">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg0_0d649550-e597-4c68-93dc-bd7dcd942d7e">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgy_bd921888-5a20-4609-a9c8-6033111b22ea">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8wLTAtMS0xLTA_756fe24f-ade7-42d0-afdc-8c33df24d5e6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8wLTItMS0xLTA_5e582de5-48f7-46e1-bde7-eaab71daeb0c">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8yLTAtMS0xLTA_29872aa0-2f6c-43ae-a9eb-cf616579087b">250 Campus Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF8zLTAtMS0xLTA_e7a5b694-8d71-42e2-b34c-54c8e14fa640">Marlborough,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF80LTAtMS0xLTA_05f4cd76-2e44-41b6-830e-19cc344e31bc">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6ZDY2NTZkYWU2MjQ3NGZlN2EyMzkzNzE4ZWMwMTJjZTQvdGFibGVyYW5nZTpkNjY1NmRhZTYyNDc0ZmU3YTIzOTM3MThlYzAxMmNlNF80LTItMS0xLTA_a63e50f8-ece2-44ac-b57d-4459f85f5434">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg1_f2a55b69-09c9-437f-82d5-ad0fd47185ec">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg2_40604b79-2848-407a-b801-8e71ebaad594">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTAtMS0xLTA_f074da4c-378c-405b-bd16-a8c031f5691a">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTEtMS0xLTA_5f20f167-6790-46dd-8b65-846b256b7854">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6M2UwYmEwZDNlMzU3NGJlNThlMmMxYTFkNDMwMjYyNjUvdGFibGVyYW5nZTozZTBiYTBkM2UzNTc0YmU1OGUyYzFhMWQ0MzAyNjI2NV8xLTItMS0xLTA_6836af9a-1a00-4c79-bea6-870d3ec02fd7">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg3_d6507e2b-52f8-4f0a-a0cf-88b59fb1b986">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjg4_66d5533a-96ee-4a52-8c72-a1ec000a6754">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8wLTAtMS0xLTA_1c79aec6-a6eb-4565-b6ad-77c0c99f4800">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8xLTYtMS0xLTA_30b90ba9-9fd4-4f40-bc3b-6dedefcc4ff5">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGFibGU6NGY5NTk1NmRlOGIyNDNkMjgzNDIzY2M4YzFiZDI4YjAvdGFibGVyYW5nZTo0Zjk1OTU2ZGU4YjI0M2QyODM0MjNjYzhjMWJkMjhiMF8yLTYtMS0xLTA_98bff892-bac2-49ac-aed6-1a7f958de3a5">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjgz_6e3fd441-bd0a-4335-b414-5ab5c477ea5a">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i77213d318a2b4d699ad623674cca6b4d_I20210121"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xL2ZyYWc6ZDE1ZTE1NmQ3MDZiNGI3ODg5ZDc1NDBmYzYwNTRkYTAvdGV4dHJlZ2lvbjpkMTVlMTU2ZDcwNmI0Yjc4ODlkNzU0MGZjNjA1NGRhMF8yMjAx_11678690-9a89-4c99-899a-1805b7f2789c"
      unitRef="shares">257661792</dei:EntityCommonStockSharesOutstanding>
    <holx:ProductRevenue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMy0xLTEtMS0w_50411307-c618-4877-a68f-bee8659307c9"
      unitRef="usd">1455400000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMy0zLTEtMS0w_26949bcf-583f-479e-93ff-b634671a70e0"
      unitRef="usd">699300000</holx:ProductRevenue>
    <holx:ServiceRevenue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNC0xLTEtMS0w_539503fc-b68e-4830-8fd5-b17975b7d8a8"
      unitRef="usd">154400000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNC0zLTEtMS0w_17184fd5-33a1-495e-9682-70f769d19e3d"
      unitRef="usd">151200000</holx:ServiceRevenue>
    <us-gaap:Revenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNS0xLTEtMS0w_18689044-1321-46d9-9caf-2b87d4ef44ad"
      unitRef="usd">1609800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNS0zLTEtMS0w_f276b0c7-179a-43ab-b6a8-acfefa83b1e7"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNy0xLTEtMS0w_cd4e0a18-cc4a-4db7-87cd-075f6cca1dce"
      unitRef="usd">284500000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfNy0zLTEtMS0w_d709a2eb-b18a-4c1c-9197-18a5fa30f21a"
      unitRef="usd">237500000</us-gaap:CostOfGoodsAndServicesSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOC0xLTEtMS0w_73fcbbc0-d416-4e8c-9bd7-44bff89cc503"
      unitRef="usd">61600000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOC0zLTEtMS0w_5e8bd00e-c71b-4738-bb38-87198bac7154"
      unitRef="usd">63600000</holx:AmortizationCostofGoodsSold>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOS0xLTEtMS0w_e777da0d-3beb-415c-a646-d4222135d8ae"
      unitRef="usd">0</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfOS0zLTEtMS0w_4d3894ec-aca5-4cbd-b6b2-bf0437032495"
      unitRef="usd">25800000</holx:CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment>
    <holx:Costofservice
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTAtMS0xLTEtMA_046f8c52-7bd4-4611-8c5e-55d4e1a6c7cd"
      unitRef="usd">83300000</holx:Costofservice>
    <holx:Costofservice
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTAtMy0xLTEtMA_562493d4-a92f-449b-bb0e-0a826f079158"
      unitRef="usd">89800000</holx:Costofservice>
    <us-gaap:GrossProfit
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTEtMS0xLTEtMA_41800b73-8ae8-4da3-84a8-c15e445a4fe8"
      unitRef="usd">1180400000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTEtMy0xLTEtMA_d0ff6e9c-a975-4900-9eaf-7bc256b7f8d5"
      unitRef="usd">433800000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTMtMS0xLTEtMA_141226e9-15bf-424c-aadc-f0178012d90d"
      unitRef="usd">59300000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTMtMy0xLTEtMA_d362d819-db68-4095-beba-251241c93514"
      unitRef="usd">61200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTQtMS0xLTEtMA_256dd2ee-4f38-4352-ba57-5d914d6e324f"
      unitRef="usd">128000000.0</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTQtMy0xLTEtMA_3d2678cf-24a5-498c-b0c3-1301d3564d71"
      unitRef="usd">144900000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTUtMS0xLTEtMA_8e0204a0-c816-4231-9a47-7fb438b0c9b3"
      unitRef="usd">91500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTUtMy0xLTEtMA_fdc89509-85ad-4fe7-ba19-9981aa075d9e"
      unitRef="usd">87600000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTYtMS0xLTEtMA_f3e2bb7d-a1a5-489e-9908-1b49b1b7102a"
      unitRef="usd">10100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTYtMy0xLTEtMA_d8b4b5ee-7b90-4a99-9a77-5ee2e07c34eb"
      unitRef="usd">9100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTctMS0xLTEtMA_58cbc858-4745-46bb-93f8-a6293a82f0a9"
      unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTctMy0xLTEtMA_4bd42ba6-1d79-47a3-ab75-ec324499f612"
      unitRef="usd">4400000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTktMS0xLTEtMA_f77bcc8e-4d0a-4c81-bf0d-cfac61f24193"
      unitRef="usd">-4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMTktMy0xLTEtMA_a0152b62-59cd-4458-8b79-b4b917eef44f"
      unitRef="usd">-900000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjItMS0xLTEtMA_601b22a1-d18a-4580-8108-954f1b9b0a62"
      unitRef="usd">1400000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjItMy0xLTEtMA_0a5837d9-d9b9-4791-b70d-17a533199ea2"
      unitRef="usd">900000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjMtMS0xLTEtMA_170e4315-01fb-4d6d-ab97-f842f3cc2b95"
      unitRef="usd">294900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjMtMy0xLTEtMA_e0445604-6bfd-4077-8cfb-a2ea5dc74be8"
      unitRef="usd">309000000.0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjQtMS0xLTEtMA_4a8a39f1-37bd-445a-9ad8-4cf2dfe31e76"
      unitRef="usd">885500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjQtMy0xLTEtMA_661ec48f-94f1-4ef2-8cc8-53efbe1a283f"
      unitRef="usd">124800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjUtMS0xLTEtMA_3f05c943-10d4-4edd-904a-b0011f8e5f72"
      unitRef="usd">400000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjUtMy0xLTEtMA_109afdbc-2767-4d27-a76e-7f9a071d524e"
      unitRef="usd">2100000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjYtMS0xLTEtMA_76c8d02e-88a4-422e-bff6-2252e1cc2c38"
      unitRef="usd">28100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjYtMy0xLTEtMA_b88cddbe-2ca8-4aba-a86a-e9d5c09d7415"
      unitRef="usd">32800000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjctMS0xLTEtMA_ffed5704-ac20-4f9e-8fdf-c62b3002493a"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjctMy0xLTEtMA_729d3de3-f20f-4fe4-825b-07b2162c05a1"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjgtMS0xLTEtMA_e5903018-a14b-40f3-aa74-e72a8d02b115"
      unitRef="usd">-3800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjgtMy0xLTEtMA_dbe05392-e03d-4ea9-afa4-b8896e9bb8ec"
      unitRef="usd">3300000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjktMS0xLTEtMA_4b87b0e6-3fd4-4220-b20b-883687861c8b"
      unitRef="usd">832400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMjktMy0xLTEtMA_95a00f12-10b0-4222-807b-49f7aadf5a58"
      unitRef="usd">97400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzAtMS0xLTEtMA_4a7965f9-1fb3-4cce-b02d-41c387334644"
      unitRef="usd">179000000.0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzAtMy0xLTEtMA_c4527185-8167-43be-9c66-c990fbe158e3"
      unitRef="usd">-288400000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzEtMS0xLTEtMA_bd948e41-d5cf-4a0b-9a73-42ea7ec1681b"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzEtMy0xLTEtMA_e1bc4dae-713c-4b14-b187-83a176c10ed6"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzItMS0xLTEtMA_4449d782-5351-49e1-8c5c-ce9abce30504"
      unitRef="usd">-1000000.0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzItMy0xLTEtMA_b0babe7b-491a-4bea-af5d-4ae7c9ec44ad"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <holx:Netincome
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzMtMS0xLTEtMA_db457d9a-a6de-4664-b880-d0cfa00ffae3"
      unitRef="usd">654400000</holx:Netincome>
    <holx:Netincome
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzMtMy0xLTEtMA_6a006a8c-1d50-4443-b388-8821f4e08de8"
      unitRef="usd">386100000</holx:Netincome>
    <us-gaap:EarningsPerShareBasic
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzUtMS0xLTEtMA_bbbc3e06-d0c4-4b04-b521-76a3ae8a820f"
      unitRef="usdPerShare">2.53</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzUtMy0xLTEtMA_4c75c7d3-7f94-4eb4-8bff-5e77b3104364"
      unitRef="usdPerShare">1.44</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzYtMS0xLTEtMA_cf63fd61-2588-47e8-a640-a012ee9a7a8f"
      unitRef="usdPerShare">2.50</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzYtMy0xLTEtMA_a062fd03-15e8-4727-b99a-4d1c4a872700"
      unitRef="usdPerShare">1.43</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzgtMS0xLTEtMA_3e8546b2-b266-4aaa-88fa-de25ca2e78ef"
      unitRef="shares">258605000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzgtMy0xLTEtMA_47bbf405-fa00-481a-98ee-d28b073ede19"
      unitRef="shares">267893000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzktMS0xLTEtMA_9bedff84-7d01-4154-9c61-f57cf608ca61"
      unitRef="shares">261785000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xNi9mcmFnOjM5YzI3OWQ1MmI1ZTQ5ZjRhMTQzMTUyNzQ2MDQ4ZjJjL3RhYmxlOjBiMTJiMjUwNjY0OTQyOWZhNjU0OWUwNWZhZWU3ZjU0L3RhYmxlcmFuZ2U6MGIxMmIyNTA2NjQ5NDI5ZmE2NTQ5ZTA1ZmFlZTdmNTRfMzktMy0xLTEtMA_34c0531b-5630-42d6-952c-a276f1bdd057"
      unitRef="shares">269721000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMi01LTEtMS0w_bd948e41-d5cf-4a0b-9a73-42ea7ec1681b"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMi03LTEtMS0w_d3dd8e81-dc8c-4afc-b14a-6de328f45d17"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMy01LTEtMS0w_4c812235-2788-4a7b-8f61-774f87f689bf"
      unitRef="usd">17800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMy03LTEtMS0w_49dbf27a-26be-4e34-85bc-5e32c9152b58"
      unitRef="usd">8300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOC0wLTEtMS0wL3RleHRyZWdpb246OTFmMmJhNDQwOWI4NGY3ODk0MGI1NGE5ZjliYWY5NjFfODk_763736d8-b314-4489-8f82-fe4dfc2c2cb6"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOC0wLTEtMS0wL3RleHRyZWdpb246OTFmMmJhNDQwOWI4NGY3ODk0MGI1NGE5ZjliYWY5NjFfMTUz_5c9b2ff8-fe02-498a-88f4-9f11b1f5766b"
      unitRef="usd">1700000</us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOS01LTEtMS0w_1c54c016-57f5-4b50-b5d7-c44d3443b7a4"
      unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfOS03LTEtMS0w_65df97df-6a65-48e9-aeeb-b2d117d4fa7a"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTAtNS0xLTEtMA_b3d8bb9c-05ee-4c27-bbf1-99ecac28d6a9"
      unitRef="usd">-500000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTAtNy0xLTEtMA_81e7222f-180d-487f-b61a-7cf21c00973a"
      unitRef="usd">-1300000</us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTEtNS0xLTEtMA_cda874a4-57da-4ccf-960d-b640b4c6662f"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTEtNy0xLTEtMA_e543c8a8-3e58-42de-b232-13b429ac8931"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTItNS0xLTEtMA_5549b75d-2deb-491a-aae1-a12f17abdbdc"
      unitRef="usd">672400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTItNy0xLTEtMA_54df3669-e1a7-4523-9343-30ebe9807606"
      unitRef="usd">399400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTQtNS0xLTEtMA_9d2bfba2-13af-4451-8db5-0a8ebdc8ae86"
      unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTQtNy0xLTEtMA_1899c26f-1cdc-4e67-a8c4-9b5d633462d7"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTUtNS0xLTEtMA_8c2700a9-fde9-4d9c-82d3-40645d1cc607"
      unitRef="usd">1000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTUtNy0xLTEtMA_941b1f39-b157-43e9-98e5-8bd35bbf66e5"
      unitRef="usd">300000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest>
    <holx:ComprehensiveIncome
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTYtNS0xLTEtMA_28936da6-b8ef-49f4-a7af-ceb30c0dcd01"
      unitRef="usd">673400000</holx:ComprehensiveIncome>
    <holx:ComprehensiveIncome
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xOS9mcmFnOjQyMmE3ZmNlZGIxZDQ0NTNhY2JkOGJiMmM2MzhiM2RkL3RhYmxlOmQzODEyOWNhM2EzNzQyMzZiYmQ2OWViMjczY2U1NTFjL3RhYmxlcmFuZ2U6ZDM4MTI5Y2EzYTM3NDIzNmJiZDY5ZWIyNzNjZTU1MWNfMTYtNy0xLTEtMA_8c777895-67bf-446a-bb88-a729f49d5479"
      unitRef="usd">399700000</holx:ComprehensiveIncome>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMy0xLTEtMS0w_1dce3c6f-7fe9-4985-94d1-63e49d421030"
      unitRef="usd">868700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMy0zLTEtMS0w_3b06647d-fdf1-4039-8705-c1e368f22d22"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0wLTEtMS0wL3RleHRyZWdpb246NjdiNTFiNGZhN2M3NDg4ZjlhNDFiMjRmYjY4ZGM5YWNfNDM_de7480a3-a757-47c7-9312-1ab542083d5b"
      unitRef="usd">39400000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0wLTEtMS0wL3RleHRyZWdpb246NjdiNTFiNGZhN2M3NDg4ZjlhNDFiMjRmYjY4ZGM5YWNfNTE_840d9ec6-962d-404d-a96e-a6efb351ce75"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0xLTEtMS0w_2524f213-71a3-459d-86a9-e6f6fd6d559e"
      unitRef="usd">1216100000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNi0zLTEtMS0w_91582345-ff97-4311-b1ef-9454ab3ba5ae"
      unitRef="usd">1028900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNy0xLTEtMS0w_cf527fbd-5bc5-4167-8139-a6f4f01d4cd7"
      unitRef="usd">420200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNy0zLTEtMS0w_1a853c1b-6c70-4c94-922b-ec92c3b26788"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOC0xLTEtMS0w_caebfe9d-b27c-40c6-aefe-dd95306bd84e"
      unitRef="usd">29900000</holx:PrepaidIncomeTaxesCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOC0zLTEtMS0w_d395b388-bf63-48cd-9ce4-9cc8cf1344a8"
      unitRef="usd">38800000</holx:PrepaidIncomeTaxesCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOS0xLTEtMS0w_37c9db50-d511-4f96-a810-afa075364f09"
      unitRef="usd">61400000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfOS0zLTEtMS0w_31862cb3-a114-4e84-8f08-32c2055bad32"
      unitRef="usd">58500000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTItMS0xLTEtMA_1f1bbaf9-63bc-4c90-a19b-df46cc27ba65"
      unitRef="usd">2596300000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTItMy0xLTEtMA_aa49496d-3a64-463a-81db-57d666882025"
      unitRef="usd">2222300000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTMtMS0xLTEtMA_649b5162-3818-4db2-92d8-2af89a157c4f"
      unitRef="usd">514500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTMtMy0xLTEtMA_780a6456-ecbe-46eb-9150-c11e0cd90798"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTQtMS0xLTEtMA_20c01dd9-65f2-4de6-8f18-d335b6117446"
      unitRef="usd">1244800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTQtMy0xLTEtMA_5738e062-f0a9-42bb-b571-ada4470054ea"
      unitRef="usd">1307500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTUtMS0xLTEtMA_f73344f1-af91-48f3-87ad-89ca1fc8f1a5"
      unitRef="usd">2663300000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTUtMy0xLTEtMA_3d688d3e-ba84-4702-851c-1ef8296016ac"
      unitRef="usd">2657900000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTYtMS0xLTEtMA_d9350570-2c6d-4a6c-8ede-d3d32e1c0db6"
      unitRef="usd">531800000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTYtMy0xLTEtMA_1db304a7-461a-4624-898c-b0f257d444ce"
      unitRef="usd">516600000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTctMS0xLTEtMA_24bfe218-72c9-4ab2-adcc-efcea7b70bb7"
      unitRef="usd">7550700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMTctMy0xLTEtMA_b52ac5a7-110e-4dbd-a7c7-f695dbf7a4c2"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjAtMS0xLTEtMA_b47f6728-3a92-4c99-bee9-e10f467067e3"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjAtMy0xLTEtMA_e4d499c2-01ca-4d3b-88c0-65b2014fc950"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjEtMS0xLTEtMA_456fa77e-a6d5-4918-ba05-e9e800900e47"
      unitRef="usd">184300000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjEtMy0xLTEtMA_376d2f3c-d862-4cb0-ab71-88e869bcae03"
      unitRef="usd">178800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjItMS0xLTEtMA_19e7effb-0cb2-4cdc-865b-62f70d5ca04d"
      unitRef="usd">611900000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjItMy0xLTEtMA_41742b4e-3636-43a4-8c2b-f08da69bfee1"
      unitRef="usd">547600000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjMtMS0xLTEtMA_64a353f3-41ff-4bec-a0d7-2752388ab68c"
      unitRef="usd">182900000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjMtMy0xLTEtMA_99e466ed-fc16-4068-834a-f32629913169"
      unitRef="usd">186100000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjQtMS0xLTEtMA_1b49cc36-23b1-40a4-8764-109afaa2a408"
      unitRef="usd">2000000.0</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:CapitalLeaseObligationsCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjQtMy0xLTEtMA_6a25f7b0-52d6-402f-9abd-dea612e50f40"
      unitRef="usd">1900000</us-gaap:CapitalLeaseObligationsCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjctMS0xLTEtMA_9153142a-e178-4723-9750-d21cce19deb9"
      unitRef="usd">1056000000.0</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjctMy0xLTEtMA_89e2978d-d2a6-4d01-8ffe-6df0f8fef9fd"
      unitRef="usd">1239300000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjgtMS0xLTEtMA_4026cf35-8a2f-424e-8784-7a9505baef19"
      unitRef="usd">2689500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjgtMy0xLTEtMA_71d4d342-dc9d-4cf8-b090-10ce8fa47f26"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjktMS0xLTEtMA_ee3510e8-405f-43f3-9f32-3a0b02ea249f"
      unitRef="usd">16800000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:CapitalLeaseObligationsNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMjktMy0xLTEtMA_f1ca0978-ebb1-406a-a7df-186bac62f67f"
      unitRef="usd">17400000</us-gaap:CapitalLeaseObligationsNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzAtMS0xLTEtMA_5b0cccee-91ae-4317-8a16-9c3621976cb9"
      unitRef="usd">189400000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzAtMy0xLTEtMA_3e3f8e7f-902f-4edc-aa92-319550a49371"
      unitRef="usd">201800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzEtMS0xLTEtMA_c88ddb26-742c-4c19-98ff-f6ee6e913935"
      unitRef="usd">12500000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzEtMy0xLTEtMA_bc520e96-b1e5-4777-991e-5e7f60fd13ba"
      unitRef="usd">12900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzItMS0xLTEtMA_6ef86676-4143-4770-96cc-0bade3c0b222"
      unitRef="usd">317500000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzItMy0xLTEtMA_265f8259-c714-4d03-b816-5c8ae629acef"
      unitRef="usd">303200000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzIx_2bfd89d3-63c4-4b86-b012-22b186fe4405"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzIx_9ae64d1c-d0b5-4026-9fb8-f408191c9a8e"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzM2_0bc51ee8-7730-4fae-87e0-40a8d546d8f2"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzM2_fa63bcbc-f7a3-456b-8f36-10e717a6dfad"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzU4_17bcd0b1-4087-4ae4-b655-6eb404ceb878"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMC0xLTEtMC90ZXh0cmVnaW9uOjk0MTY4MWMyYzI1NDQ0OGM5MGI3MjAwODlhNTZlNGI4XzU4_c95d1ab1-efe2-4f66-9928-fc0fb016a4b1"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMS0xLTEtMA_61b474af-e2cb-4c82-b0f8-9f489900e03a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzQtMy0xLTEtMA_16019283-1148-4ebf-8bed-25322586f5a6"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzE4_5bdb000b-a934-49eb-a453-f3f283a42974"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzE4_c5e2aaaa-1351-4e1d-982f-7514ba95cd07"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzMy_8f28decd-1721-4a10-aadf-ab59d92555fb"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzMy_9cd052ab-aed6-4c7b-8f86-280300749a6d"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzU0_aece7599-8116-4c8f-8088-e0a732e35cf0"
      unitRef="shares">296533000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMC0xLTEtMC90ZXh0cmVnaW9uOjVkYWUxZjFlYzAxZDQ4MzI5ZDJmMzkxMDVlNDUxNjBlXzYx_e00d1c21-413d-42fc-89a2-61db5e6b2b38"
      unitRef="shares">295107000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMS0xLTEtMA_57914eaf-cadd-4c79-8d1d-beaa0e697823"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzUtMy0xLTEtMA_16bbb0ef-aff7-49fb-a502-6739ea18e4eb"
      unitRef="usd">2900000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzYtMS0xLTEtMA_a5b13044-e2a5-4c0e-8e68-d4cb545219cd"
      unitRef="usd">5895300000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzYtMy0xLTEtMA_921d36ef-5742-4c3a-a057-4df915ca6de6"
      unitRef="usd">5904800000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzctMS0xLTEtMA_f0f2d2f1-527d-4c29-968b-de90f2303eda"
      unitRef="usd">-918800000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzctMy0xLTEtMA_0aee306d-9e08-4ed8-9c40-741d658803c0"
      unitRef="usd">-1573200000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVjZGFmYmQ2OWNkMDQ3OTU4NWJjOWI4YTUzMGZmMWRiXzMw_c707a679-ded9-4507-b237-cddb93403e0d"
      unitRef="shares">39078000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMC0xLTEtMC90ZXh0cmVnaW9uOjVjZGFmYmQ2OWNkMDQ3OTU4NWJjOWI4YTUzMGZmMWRiXzM3_b5b8b7cb-d485-4a24-87ab-1beb25d43f74"
      unitRef="shares">37609000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMS0xLTEtMA_0561e8d6-a846-41cb-9635-8a8524762b45"
      unitRef="usd">1680900000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzgtMy0xLTEtMA_8fce4d81-4ee9-401f-9f43-2e94dc836423"
      unitRef="usd">1579600000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzktMS0xLTEtMA_593d810a-357c-42e1-94e5-66dd645504e2"
      unitRef="usd">-30700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfMzktMy0xLTEtMA_01184ac5-5e69-497f-ad01-71508e05a653"
      unitRef="usd">-49700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDAtMS0xLTEtMA_4b30f140-579f-4435-82f6-0efa8a0032e4"
      unitRef="usd">3267900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDAtMy0xLTEtMA_37f6a07b-1f3a-46dc-943c-a3469b0cdcbd"
      unitRef="usd">2705200000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDEtMS0xLTEtMA_42b2e390-5b4b-40fc-8c75-6a0a9c6e5379"
      unitRef="usd">1100000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDEtMy0xLTEtMA_dbcc9b83-f2fb-4691-9527-9bb80c4c55f1"
      unitRef="usd">2100000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDItMS0xLTEtMA_489b3cad-e2da-4d9c-b5f2-a22bbcff49bb"
      unitRef="usd">3269000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDItMy0xLTEtMA_fc48f714-7374-42b9-a221-e46b1e7f0cd1"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDMtMS0xLTEtMA_93c211bf-6258-438b-a2c4-d9f1bdd83d43"
      unitRef="usd">7550700000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yMi9mcmFnOjc5ZmY5NzY5MGZkMTQ1YTc4ZDUyNTg0MDU3YjNiNzk0L3RhYmxlOmVlZjJlYzA2Zjk0ZDQ3Nzc4N2ZlN2RkYzk0ZTQyYWUyL3RhYmxlcmFuZ2U6ZWVmMmVjMDZmOTRkNDc3Nzg3ZmU3ZGRjOTRlNDJhZTJfNDMtMy0xLTEtMA_73f1de39-84ed-445b-9d00-0eef47f2e79a"
      unitRef="usd">7195800000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="idf5a202d41b64a3a9989f892adbc11d6_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTItMS0xLTA_05901217-b51b-415d-8644-f240feb11f78"
      unitRef="shares">292323000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idf5a202d41b64a3a9989f892adbc11d6_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTQtMS0xLTA_b9502321-c7c8-4c6c-8ff9-cb241485aa45"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2a33877be74a4bff826119edc7ed503d_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTYtMS0xLTA_7fc21bf2-f8c6-41a0-a36c-156a23ffb14b"
      unitRef="usd">5769800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iecfcaef9f54e46558440bc81f97e5eed_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTgtMS0xLTA_6471ba18-2cc7-4561-9eeb-c92b55b0c5e3"
      unitRef="usd">-2688700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5aebec3fb9bb4e4488a724c4d7743031_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTEwLTEtMS0w_cd8cea4e-ac12-4536-97d1-d787477b507d"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i3b4184d7f35149b3b1f891cfb657efe0_I20190928"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTEyLTEtMS0w_e287f98c-5fa3-43f1-92f2-c78b3f992a5a"
      unitRef="shares">24638000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3b4184d7f35149b3b1f891cfb657efe0_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE0LTEtMS0w_e0af9b1b-ec64-4c0f-bd8e-04776ca1d976"
      unitRef="usd">-926000000.0</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE2LTEtMS0w_96417f26-a8e4-48a7-8798-9a1561427721"
      unitRef="usd">0</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquity
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE2LTE4LTEtMS0w_5bf4a9da-07b7-4123-b098-25346dffceaf"
      unitRef="usd">2115700000</us-gaap:StockholdersEquity>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE3LTE2LTEtMS0w_ea48ade9-6a5d-43e5-a48b-6b5c006bd6b0"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE3LTE4LTEtMS0w_b8e9ff0b-6a9d-49d7-b7f7-120a20685d09"
      unitRef="usd">8600000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:StockholdersEquity
      contextRef="i2bf21035b13f458a9644c6641ca45dc9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE4LTgtMS0xLTA_0e90ae60-2f47-4107-81c1-02c2f7198df5"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2bf21035b13f458a9644c6641ca45dc9_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE4LTE4LTEtMS0w_2fc7a96b-c3c2-40e6-ad92-4d0d7977a03f"
      unitRef="usd">300000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTItMS0xLTA_b1bbcd81-cf79-4689-a4e4-563b2018ea14"
      unitRef="shares">540000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTYtMS0xLTA_f9849c3d-72df-46bb-bb39-3c83cd41966b"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTE5LTE4LTEtMS0w_f7be76fb-ee86-4a7d-a64a-b02242cad6c4"
      unitRef="usd">13800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i9cb26f36d3be423fb70fb4ae94e076e1_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTItMS0xLTA_e7b2d35b-197d-4f0e-89d5-9f9fd869efd5"
      unitRef="shares">476000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTYtMS0xLTA_ad8c05dd-032a-4615-baec-6a4c8fe7a8f9"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIwLTE4LTEtMS0w_5acfb9f8-1cc9-47dd-836e-8d8c5d9bd18e"
      unitRef="usd">10900000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIyLTYtMS0xLTA_4fde4c03-40d3-4bcf-91be-60512bf69444"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i4fe814bf528e4654a9bd419776b8137e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIyLTE4LTEtMS0w_9d17baaa-859c-4dd1-8193-2ec6695e333f"
      unitRef="usd">18100000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTgtMS0xLTA_03e3ffd7-e47b-48ed-9ac5-a4763e3536f6"
      unitRef="usd">386100000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTE2LTEtMS0w_30e96eff-409a-411f-bca6-92b361558931"
      unitRef="usd">-300000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTIzLTE4LTEtMS0w_330ef918-6038-4115-b5f2-fe88bf3d0f57"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI0LTEwLTEtMS0w_b995dcd2-1b6d-4a41-ae3a-061de79b887d"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI0LTE4LTEtMS0w_ded46be5-f9b0-4854-91e7-a08fb0145656"
      unitRef="usd">13600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTEyLTEtMS0w_b20e986f-3aa5-4b03-8957-2128db9fbd7f"
      unitRef="shares">1545000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTE0LTEtMS0w_5e2198cb-76da-4c4b-9c43-284654d5ecc7"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI1LTE4LTEtMS0w_ca9416fd-9b52-462e-b903-f2802e799711"
      unitRef="usd">80900000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="id61a52f83e6d451da705354f15a0eff6_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTYtMS0xLTA_5e3394da-78c5-4382-ab71-99bc76781101"
      unitRef="usd">-41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTEyLTEtMS0w_b59e0106-501b-4f97-b47d-2c2b6faa0da5"
      unitRef="shares">3279000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i191a7a656bdb466a9b9eb8e3e69be5ed_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTE0LTEtMS0w_c528ad65-b046-4089-b2b0-ed0e0dd03554"
      unitRef="usd">-164000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI2LTE4LTEtMS0w_38a4e2bf-582e-4f19-bc57-d8893dd1f658"
      unitRef="usd">205000000.0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI3LTE2LTEtMS0w_0ba771a2-288b-4c0a-9c1c-eef891d88466"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI3LTE4LTEtMS0w_3b8fd6ed-f641-48f1-bed4-25a627765326"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="ia95de565187f45949e967d544a6d18d2_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTItMS0xLTA_4290e365-4631-4a39-aa8d-7fa2fd5387bb"
      unitRef="shares">293339000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia95de565187f45949e967d544a6d18d2_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTQtMS0xLTA_be27062f-f0ad-4094-ae19-6e45f6594e85"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a30acd7b78740cfbcd8e77c0e406bc5_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTYtMS0xLTA_e36b9977-55f1-4e75-adf1-b3796a36e088"
      unitRef="usd">5749800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc8761797caf4a1ba7a00d4505018e6f_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTgtMS0xLTA_af917f79-60ee-4ded-8fad-27fbc05122a3"
      unitRef="usd">-2302300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTEwLTEtMS0w_2f6e3a73-1fbb-4569-8f84-b568dd7e12d9"
      unitRef="usd">-28700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTEyLTEtMS0w_95a2bd25-bd32-4901-89b3-4af343f4aa9f"
      unitRef="shares">29462000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i3ff6db4fae1946a1b794fa7b4132dfb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE0LTEtMS0w_1acfd215-a2b1-4d57-a40a-9ffff086c97d"
      unitRef="usd">-1170900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE2LTEtMS0w_9f3410f2-6f81-450f-b98c-6a0683d64901"
      unitRef="usd">6900000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTI4LTE4LTEtMS0w_d9902caa-f95f-4213-8612-e8385d58a580"
      unitRef="usd">2257700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTItMS0xLTA_e894e671-8568-4572-9046-c53a90168f07"
      unitRef="shares">503000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTYtMS0xLTA_c89f32ac-b730-4d96-9c11-8c9f1f11b9aa"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMxLTE4LTEtMS0w_d45a2e2d-043d-4304-8312-ebed75b79888"
      unitRef="usd">13900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTItMS0xLTA_9bb2d4e2-de01-4e58-8ba7-4b2ef92d2f2e"
      unitRef="shares">86000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTYtMS0xLTA_7beada1e-9c4e-4df1-9894-be9aa072569c"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMyLTE4LTEtMS0w_4e751125-ec4a-45bb-ae52-03c5376cc1de"
      unitRef="usd">1600000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i971ee20e9caa45d88c2a0ca0ddfe09d5_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTItMS0xLTA_077df3e0-6611-4466-a1cd-24a4e16ddb26"
      unitRef="shares">214000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTYtMS0xLTA_63f0973c-a3f2-4d17-a969-ed3af749639b"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTMzLTE4LTEtMS0w_0eba04db-cf67-4e4e-a373-99f8157418c0"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM0LTYtMS0xLTA_4f96a50b-1bf6-4105-92a2-6e65063f27d0"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i197c2fe7ac584f0d81b966dd80d4dcad_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM0LTE4LTEtMS0w_101dfd09-7069-4339-9852-3ba8020218d4"
      unitRef="usd">15700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTgtMS0xLTA_b1b4765d-1d3f-4b2a-a35c-59c83d03ddf0"
      unitRef="usd">96300000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTE2LTEtMS0w_21cf7287-7673-4922-9fd0-a7b54cde4304"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM1LTE4LTEtMS0w_118e0963-ac85-4d4e-8ee9-f424b0251441"
      unitRef="usd">94800000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM2LTEwLTEtMS0w_8a38498f-2a28-4e43-9338-6218f3dcb276"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ia3dcde46cdd64e80a626b5468b7ba8a0_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM2LTE4LTEtMS0w_79fe0d03-f7a7-4965-96a4-d1841b668062"
      unitRef="usd">-30200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTEyLTEtMS0w_32b7d31e-4da6-4fa4-9104-348cf84fc606"
      unitRef="shares">5851000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTE0LTEtMS0w_ab3ed640-4491-40ef-9f75-450d15a240ea"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM3LTE4LTEtMS0w_cb4cc041-dff9-4d51-9d16-21f33acd9928"
      unitRef="usd">267600000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:AcceleratedShareRepurchaseProgramAdjustment
      contextRef="i6f6a29664fb844619d4fd22ee899d18a_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTYtMS0xLTA_feaccc73-a900-4db0-b603-b77a0f8ed00e"
      unitRef="usd">41000000.0</us-gaap:AcceleratedShareRepurchaseProgramAdjustment>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i583f922944894f7ea2b4213a2907b398_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTEyLTEtMS0w_e7439f4b-5a38-491f-a8be-2671e1948710"
      unitRef="shares">628000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i583f922944894f7ea2b4213a2907b398_D20191229-20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTE0LTEtMS0w_db8b0c50-2558-48d3-ab81-5b010409ae01"
      unitRef="usd">-41000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <holx:Acceleratedsharerepurchaseagreement
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM4LTE4LTEtMS0w_44113ba7-1e88-4ae3-b95d-07cbb32885ff"
      unitRef="usd">0</holx:Acceleratedsharerepurchaseagreement>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM5LTE2LTEtMS0w_568bc439-864f-43ed-a1fb-d1173d8766d2"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i6b0f1fdaff1641fb9fba07081252089b_D20191229-20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTM5LTE4LTEtMS0w_ec1f5f64-788b-42ab-9d37-a8cd8968feaf"
      unitRef="usd">300000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="icef9871fe55a44bda919b0b0818f6106_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTItMS0xLTA_c019d6b3-c3b1-49a1-be00-26b9603ee569"
      unitRef="shares">294142000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icef9871fe55a44bda919b0b0818f6106_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTQtMS0xLTA_38c2b29a-22e8-4718-825f-e028cc2566e9"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifcc149ba496d4eb1af231a99ee58c7bc_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTYtMS0xLTA_94c91208-5cf7-49c3-8cb4-16bb8267ef51"
      unitRef="usd">5827600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i911f42f14f9e440c9969b74a5fb822fc_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTgtMS0xLTA_5d8bb98f-fdf9-40c5-8faf-38a7218a673b"
      unitRef="usd">-2206000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4a6f08dec5bc465b9ee6f174df007570_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTEwLTEtMS0w_3720714b-0290-4408-aa24-30c048b9fb98"
      unitRef="usd">-58900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="idb4183da93954dc88904c56ed86abb2e_I20200328"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTEyLTEtMS0w_4dc4f525-c126-4df9-96eb-15df868f397a"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idb4183da93954dc88904c56ed86abb2e_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE0LTEtMS0w_45e2c93d-ec7e-43a8-a968-95a97106ee09"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i200f25ce96994bbbae7026819adf7b94_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE2LTEtMS0w_adcb52ee-3ffd-4763-8329-4db510b79859"
      unitRef="usd">5100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i200f25ce96994bbbae7026819adf7b94_I20200328"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQwLTE4LTEtMS0w_567438e2-3bd4-4deb-8d77-de1662f97763"
      unitRef="usd">2091200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTItMS0xLTA_12e03361-f543-459f-a2b8-c6d65dbad530"
      unitRef="shares">533000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTYtMS0xLTA_96ae0610-1b5f-4b27-a548-d332fc82c16b"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQxLTE4LTEtMS0w_ec63bd90-fbea-4c6e-bc4c-d92431adcf1c"
      unitRef="usd">14400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="if0fa23fd561f4eacb3b8969d08e23ed4_D20200329-20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTItMS0xLTA_cf39ab70-0bc0-41b2-9fd2-5e9069de856b"
      unitRef="shares">9000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTYtMS0xLTA_a0e7ec46-3cf1-417e-a8e0-d73a2b3e49d0"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQyLTE4LTEtMS0w_65ab4a52-12a3-43f4-830e-faa8f5db7b02"
      unitRef="usd">200000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ0LTYtMS0xLTA_82f23dee-73c1-4bb0-9004-7e1620d9e167"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i6ed40771b656461b9bc71cc3d09f708b_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ0LTE4LTEtMS0w_bfe92442-6b12-4451-b02b-6f813d685952"
      unitRef="usd">19900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTgtMS0xLTA_0fb8d547-6dc0-4d95-888e-69318871fee2"
      unitRef="usd">137900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTE2LTEtMS0w_06e19174-c0d6-4fab-9fb0-68721a9e33d0"
      unitRef="usd">-1500000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ1LTE4LTEtMS0w_65672884-9b25-49c0-80cb-d88813f9b715"
      unitRef="usd">136400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ2LTEwLTEtMS0w_63ca91c6-8d14-4568-9630-cdbe3210ab59"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i0cf6a96011a348989c37cfb3fc6014e1_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ2LTE4LTEtMS0w_1d81c99a-6b39-4a92-a0da-2fa9d2098b12"
      unitRef="usd">-3000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ5LTE2LTEtMS0w_5a8c966d-2550-4b02-86a6-6f83ac776fe2"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTQ5LTE4LTEtMS0w_6958bd32-279d-4291-a370-3f5ba810f907"
      unitRef="usd">100000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:SharesIssued
      contextRef="ibed5a407b01e495f8fcec834d617c870_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTItMS0xLTA_4ab7a4a0-77bd-4c76-ae41-00c416d4c6f2"
      unitRef="shares">294684000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ibed5a407b01e495f8fcec834d617c870_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTQtMS0xLTA_5603d0ed-aa89-417f-88e2-2ad0cdc5456a"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="iec58a1e4925447509af22498f07e082c_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTYtMS0xLTA_0d940965-44a6-4292-918a-d48e083468fd"
      unitRef="usd">5861700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie71ae6f99b084b4daf51a7a375e79bf6_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTgtMS0xLTA_de411723-8fed-4352-bac0-a09aefc00476"
      unitRef="usd">-2068100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i9581555522f04a0aae88d04d16ac8561_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTEwLTEtMS0w_5f90d58a-f2ea-4a43-bfd1-bd403bfb4767"
      unitRef="usd">-61900000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ic37dc7d6b73747eb8118aecf497797af_I20200627"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTEyLTEtMS0w_140a8fb1-51ae-44a6-a02b-707c18654b2a"
      unitRef="shares">35941000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic37dc7d6b73747eb8118aecf497797af_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE0LTEtMS0w_6c3f4b08-7bd9-4001-8a20-1dd0961453b4"
      unitRef="usd">-1479500000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i4ac726be9de04754acfb0c3ad2bbe977_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE2LTEtMS0w_e9178f14-25e9-41d6-bb09-65ef2b31f154"
      unitRef="usd">3500000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4ac726be9de04754acfb0c3ad2bbe977_I20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUwLTE4LTEtMS0w_7e2949df-7442-4f87-bb11-6687c64f07c1"
      unitRef="usd">2258600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTItMS0xLTg3NDU_13db1557-c183-4589-a7c7-1f783447bd4d"
      unitRef="shares">185000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTYtMS0xLTg4MDE_973077aa-eec1-4dab-bc6e-8222e4177958"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUxLTE4LTEtMS04ODIx_456e365e-c912-4ff1-a3b1-65199f123292"
      unitRef="usd">6200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTItMS0xLTg3OTk_ee4fbee5-17ec-4229-9610-0b1383779737"
      unitRef="shares">40000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTYtMS0xLTg4MDM_1e9f119c-2a70-46c3-aebe-6ad931d6b2a5"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUyLTE4LTEtMS04ODIz_6b14b5bd-5b1e-4efe-9c89-6642e6add5b1"
      unitRef="usd">1500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i225f3511db15450a9dbc8105e0e76d3a_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTItMS0xLTg4MDQ_fda04b5d-ea9a-490a-9cce-91b9dcecc871"
      unitRef="shares">198000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTYtMS0xLTg4MDY_653fdd72-e275-4aa9-9ab8-7a15322c0693"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTUzLTE4LTEtMS04ODI0_d340bda7-f392-43ee-a7cd-06b2451f8161"
      unitRef="usd">8800000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU0LTYtMS0xLTg4MDk_4645afd8-e4bb-49fb-99a2-c3a143243bf6"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic0c4a7a5fe4c405c8cd2193bba3d2749_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU0LTE4LTEtMS04ODI3_62223bdb-07e4-4dce-9af6-30eaf4175d0e"
      unitRef="usd">29600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTgtMS0xLTg4MTE_0b75b6e3-0eeb-4cc8-941b-46b6a86977e3"
      unitRef="usd">494900000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTE2LTEtMS04ODE5_feabbeb3-9004-4d8f-b3c1-c43d6edcbdc5"
      unitRef="usd">-1400000</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU1LTE4LTEtMS04ODI5_68751e3b-ba91-4b55-aaba-0765f58d7188"
      unitRef="usd">493500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU2LTEwLTEtMS04ODEz_6035516f-ba62-4c0f-b8d5-064c7e40dfb1"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i8174c3ec0a144f2e947d0eb37f58113a_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU2LTE4LTEtMS04ODMx_5244db63-0470-403b-a2ba-c5e192f22aa2"
      unitRef="usd">12200000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTEyLTEtMS04ODE1_598eec2e-ea7b-4221-acfe-4d28fc8bd047"
      unitRef="shares">1668000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTE0LTEtMS04ODE3_6c305809-fba3-4117-989c-97c58ae5295f"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i1c8d36c5b7114fec909a27d045aab3d4_D20200628-20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU3LTE4LTEtMS04ODMz_049d82d2-64c8-4f31-825e-509f94a3380f"
      unitRef="usd">100100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i127f35bc4ced488ea526b5c9709d9c78_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTItMS0xLTg2MzQ_64aa1728-e1f0-4e18-899a-1f1efda830b4"
      unitRef="shares">295107000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i127f35bc4ced488ea526b5c9709d9c78_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTQtMS0xLTg2NDU_b4d9ae77-fff2-42b8-8a1a-beafae2a9bd2"
      unitRef="usd">2900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i46f22b455cca46d8bf57b116a211d7e8_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTYtMS0xLTg2NDc_25681b62-953d-4c47-b068-ec67d144e0e4"
      unitRef="usd">5904800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if0dbddd90f43449eb71f6e58600e75ca_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTgtMS0xLTg2NDk_131c428e-427b-4a91-95d7-b26ba521a96b"
      unitRef="usd">-1573200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a34844d9d004ca59421077b20e85919_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTEwLTEtMS04NjUx_f0c39ee1-e0a3-45ff-836d-90c45c481f33"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="ia8419f493c4f4d939c6a710aeda8796e_I20200926"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTEyLTEtMS04NjUz_bb4069f4-696a-42f3-9916-af490e111e25"
      unitRef="shares">37609000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ia8419f493c4f4d939c6a710aeda8796e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE0LTEtMS04NjU1_106b1ee3-e0b1-4950-94ec-c174de7b942d"
      unitRef="usd">-1579600000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE2LTEtMS04NjU3_46477e83-e591-43fc-8e72-decc868fc3f6"
      unitRef="usd">2100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU4LTE4LTEtMS04NjU5_b6c63530-af62-4874-ac2d-5e8f30618abb"
      unitRef="usd">2707300000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTItMS0xLTg2NjE_d69a4b92-719f-4d5c-9ef1-b5e2e3c23743"
      unitRef="shares">490000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTYtMS0xLTUyNDY_3e141f5a-dfd6-4bc4-8c38-77d245251170"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTU5LTE4LTEtMS01NjYy_d7612e60-3715-43e6-bdf9-1ef6a963bb5a"
      unitRef="usd">18400000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="id8098d1eacac4ebe9accf46fdfe369f4_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTItMS0xLTg3MTI_03a21b47-7938-4d90-b3d5-7394f1d8b5f3"
      unitRef="shares">936000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <holx:ChangeInParValue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTQtMS0xLTg3MTg_5abc12ea-ace8-48e7-85c4-918dab764522"
      unitRef="usd">100000</holx:ChangeInParValue>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTYtMS0xLTU1ODI_11456e48-7106-45ae-8c71-bc8ff3a8da70"
      unitRef="usd">46500000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYwLTE4LTEtMS01NTg2_5921beb6-daa7-4cfa-8025-5ea23c683896"
      unitRef="usd">46400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYyLTYtMS0xLTg3MjA_ce2d12e8-b653-4ac6-aebc-abbd6eddec6e"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i480d37db2ce74e90bfb4fb3c43c149a6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYyLTE4LTEtMS04NzM3_461cc2e4-a8b7-4f53-852c-ee5538df78e5"
      unitRef="usd">18600000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTgtMS0xLTU2MDI_ec8a60a8-6399-4de2-a8c3-06c55da65020"
      unitRef="usd">654400000</holx:Netincome>
    <holx:Netincome
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTgtMS0xLTU2MDI_edec55f2-50ca-47ee-9339-1abb48f3031b"
      unitRef="usd">654400000</holx:Netincome>
    <us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTE2LTEtMS04NzMx_749080c7-7ee8-4b35-bf8a-dff151d699bb"
      unitRef="usd">-1000000.0</us-gaap:NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable>
    <us-gaap:NetIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTYzLTE4LTEtMS04NzM5_2a3b6add-ebc5-4c15-bfb9-e8f92a840a68"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY0LTEwLTEtMS04NzI0_3683281b-67f3-4632-b4d6-ec96bf7beb61"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY0LTE4LTEtMS04NzQx_790e219e-fd0b-43d9-87e4-2f46d266898a"
      unitRef="usd">19000000.0</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTEyLTEtMS04NzI3_95cfc900-079f-42ce-923e-fa31c332e237"
      unitRef="shares">1469000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i5b6ee52ea11440bb80edb93b908696b3_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTE0LTEtMS01NjEx_514d343f-9582-4327-9477-aa532c03e809"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY1LTE4LTEtMS04NzQz_2d63540a-2475-4de4-8f10-d07119f30812"
      unitRef="usd">101300000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i84b132b519504c978ab69d88a3c921da_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTItMS0xLTg2MTY_8fd59634-3758-4ded-8077-c5c952018e97"
      unitRef="shares">296533000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i84b132b519504c978ab69d88a3c921da_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTQtMS0xLTg2MTg_301b95e9-5f1b-452b-911f-f53bb6aa964d"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibda9918b12184a469461c064a31cda9e_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTYtMS0xLTg2MjA_946a8cb8-a6e5-4ac2-9e72-ebd366abecab"
      unitRef="usd">5895300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i61d28c68b4b044baa488a63597e4ba87_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTgtMS0xLTU2MTY_b701ac3f-8977-4400-afd4-82e38af1d71e"
      unitRef="usd">-918800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice8e1c44566e46d7a9428b4c849cf075_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTEwLTEtMS04NjI0_46116d24-73bf-42e9-8d35-e9cbe0ba6a85"
      unitRef="usd">-30700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i0a1a2f2804d047f9be18b7470292b8f2_I20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTEyLTEtMS04NjI2_618363e2-4ebc-4ae4-8850-7fc3f09ab0fc"
      unitRef="shares">39078000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i0a1a2f2804d047f9be18b7470292b8f2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE0LTEtMS04NjI4_451f8bf6-32aa-4bf8-b788-19ed0c3655a4"
      unitRef="usd">-1680900000</us-gaap:StockholdersEquity>
    <us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE2LTEtMS04NjMw_840bba71-186a-4d22-8888-596208c8dbd4"
      unitRef="usd">1100000</us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yNS9mcmFnOjVkNmI1OTVkZGZmNTRjNjJhZDBiODk0MTJkZTllMGFiL3RhYmxlOjUwMjE4NmRlOTFkYjQ1ZjBhNmRjNTM0ZTMzYzIwZjVlL3RhYmxlcmFuZ2U6NTAyMTg2ZGU5MWRiNDVmMGE2ZGM1MzRlMzNjMjBmNWVfMTY2LTE4LTEtMS01NjE0_532deb33-7bba-424b-a305-9179ba6cbadb"
      unitRef="usd">3269000000.0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMy0xLTEtMS0w_0f3698d1-e96f-48d6-b536-9e978cccd135"
      unitRef="usd">653400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMy0zLTEtMS0w_d3dd8e81-dc8c-4afc-b14a-6de328f45d17"
      unitRef="usd">385800000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNS0xLTEtMS0w_15b22d57-f280-45f6-b18c-40be1f7668b4"
      unitRef="usd">21100000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNS0zLTEtMS0w_0c63cf53-b92a-426e-90d6-ec55b277659f"
      unitRef="usd">21600000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNi0xLTEtMS0w_3710e6b9-45d6-4365-8469-090037fb35c0"
      unitRef="usd">71700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNi0zLTEtMS0w_900f538e-be60-43b8-ad7a-7a2537eb9727"
      unitRef="usd">72800000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOC0xLTEtMS0w_875e3209-0ec6-4d73-8630-2f6afe104ee3"
      unitRef="usd">18600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOC0zLTEtMS0w_cae4e16e-5435-4751-bc41-fa7460e895d1"
      unitRef="usd">18100000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOS0xLTEtMS0w_b081c851-1c40-46da-a5e3-21f5c62dbc22"
      unitRef="usd">-12000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfOS0zLTEtMS0w_73593780-bb74-465b-80b7-1b9ca1da414f"
      unitRef="usd">-327900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:AssetImpairmentCharges
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTEtMS0xLTEtMA_56ff8cb7-993d-459c-9d60-667ae3ac92b6"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTEtMy0xLTEtMA_42f93b23-6c1e-437d-b72f-9b2aca814bb1"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTMtMS0xLTEtMA_1d89c7c0-165a-4b9c-95aa-70c67f745e01"
      unitRef="usd">-21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMTMtMy0xLTEtMA_04909c86-1ecb-4450-85c9-45b8abb6002b"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjAtMS0xLTEtMA_db0885b1-6a74-479c-bc83-2d06fd25bb58"
      unitRef="usd">-29500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjAtMy0xLTEtMA_f732e783-425d-4eba-bb8b-1f5d2f2afcef"
      unitRef="usd">-500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjItMS0xLTEtMA_44647c24-dcc2-433a-b9e1-4d1080b6748b"
      unitRef="usd">175500000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjItMy0xLTEtMA_0187f342-e5eb-46f4-bb79-ed3d6d91be10"
      unitRef="usd">-17600000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjMtMS0xLTEtMA_a96b309b-c7e5-473e-b472-7b2796995a02"
      unitRef="usd">21200000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjMtMy0xLTEtMA_30d30f4b-842c-401d-a768-155ccc5202d7"
      unitRef="usd">14900000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjQtMS0xLTEtMA_33534645-b84a-470d-83a6-1d80acd2c0d0"
      unitRef="usd">-8900000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjQtMy0xLTEtMA_0043eb78-f02c-4ca7-abb3-d395e5e3f618"
      unitRef="usd">-1000000.0</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjUtMS0xLTEtMA_8d1d4799-3aba-4ef8-bb1b-4cbc022b27ac"
      unitRef="usd">18300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjUtMy0xLTEtMA_beb89d8b-4dc4-4f25-b3ac-544a615f29fe"
      unitRef="usd">2600000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjYtMS0xLTEtMA_dbff52c4-bb88-4c66-87b2-19f604f2fe80"
      unitRef="usd">4600000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjYtMy0xLTEtMA_b0efff65-393a-4b97-8f5e-a1f5aa2de1c9"
      unitRef="usd">-55400000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjctMS0xLTEtMA_55f13e41-b300-42ec-9afe-e7bd0c80281a"
      unitRef="usd">58100000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjctMy0xLTEtMA_c36ba017-3d79-4d22-8b33-ab71641fdf27"
      unitRef="usd">-22600000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjgtMS0xLTEtMA_66fcf201-c083-452d-8aed-0a224d3c36fb"
      unitRef="usd">-10500000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjgtMy0xLTEtMA_d52e4d74-158f-48af-9cef-798305f42a2a"
      unitRef="usd">-10300000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjktMS0xLTEtMA_35f669d6-1451-4d4c-9ee1-f03ce01d7cf6"
      unitRef="usd">650000000.0</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMjktMy0xLTEtMA_208051fb-9741-4f5c-9d36-a86d34ada089"
      unitRef="usd">113900000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzEtMS0xLTEtMA_83c22fa2-e25a-4c41-b1ad-97b5b8bc248e"
      unitRef="usd">4900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzEtMy0xLTEtMA_85816510-02fc-45de-9755-322e74bbee6a"
      unitRef="usd">11800000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzQtMS0xLTEtMA_33a74764-3034-4329-ac2a-43b9ac9a431b"
      unitRef="usd">32400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzQtMy0xLTEtMA_295dad43-54f7-42d6-98a9-bc226e733506"
      unitRef="usd">11400000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzUtMS0xLTEtMA_72938f8e-9136-4280-b0c0-31a164c256b2"
      unitRef="usd">12400000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfMzUtMy0xLTEtMA_46710460-e158-431e-a4df-9394fa1075dd"
      unitRef="usd">20100000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:Purchaseofinsurancecontracts
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDEtMS0xLTEtMA_1f258533-362b-4560-8bf0-3f9b51505ac4"
      unitRef="usd">0</holx:Purchaseofinsurancecontracts>
    <holx:Purchaseofinsurancecontracts
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDEtMy0xLTEtMA_58185696-4d98-40a5-a214-ffa4dc245993"
      unitRef="usd">2400000</holx:Purchaseofinsurancecontracts>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDUtMS0xLTEtMA_b2750ce0-fbd9-4425-951f-c5a67a217e8e"
      unitRef="usd">200000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDUtMy0xLTEtMA_445292a6-b1f0-4e60-a151-df80a982f188"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDYtMS0xLTEtMA_de9889c4-7dda-4d3e-bf48-5f975f03cb9a"
      unitRef="usd">-49900000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDYtMy0xLTEtMA_8d90225b-b7b2-4817-bea9-b5b307364332"
      unitRef="usd">-45700000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDktMS0xLTEtMA_845aa2c6-d551-4b6f-8ec7-a2a3aa791dd9"
      unitRef="usd">18800000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNDktMy0xLTEtMA_59c19e99-7c3e-4874-ad6d-4c4240633f1c"
      unitRef="usd">9400000</us-gaap:RepaymentsOfLongTermDebt>
    <holx:ProceedsFromSeniorNotes
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTAtMS0xLTEtMA_7cd36ee1-a0a4-4ec2-8b21-7d82126727ad"
      unitRef="usd">950000000.0</holx:ProceedsFromSeniorNotes>
    <holx:ProceedsFromSeniorNotes
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTAtMy0xLTEtMA_05c03b38-46cf-4bbe-b3e7-38ab446af5d3"
      unitRef="usd">0</holx:ProceedsFromSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTEtMS0xLTEtMA_32a04b89-8ac0-4a2c-8759-9183ccb9d53e"
      unitRef="usd">970800000</holx:RepaymentOfSeniorNotes>
    <holx:RepaymentOfSeniorNotes
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTEtMy0xLTEtMA_159f8459-dcc9-4073-9464-a27086883660"
      unitRef="usd">0</holx:RepaymentOfSeniorNotes>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTQtMS0xLTEtMA_f3799b71-cf62-48ef-bce3-bf193af9bc32"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:RepaymentsOfLinesOfCredit
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTQtMy0xLTEtMA_77dc2131-2e20-4cf9-86a1-7617ed112ed6"
      unitRef="usd">0</us-gaap:RepaymentsOfLinesOfCredit>
    <us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTUtMS0xLTEtMA_00429a73-65ff-44dd-abef-85c423f7d4da"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTUtMy0xLTEtMA_d5a4ec62-8fcd-4e1f-9ead-a44b6934a6f3"
      unitRef="usd">16000000.0</us-gaap:ProceedsFromRepaymentsOfAccountsReceivableSecuritization>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTctMS0xLTEtMA_08a0c7a3-afaf-4af0-8516-a2f79b402708"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTctMy0xLTEtMA_221a99c8-d63f-40f1-b038-a9b0bf9fe7cf"
      unitRef="usd">1400000</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTgtMS0xLTEtMA_d650ad8b-f16c-478b-9ea5-2004f3f1a0e3"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNTgtMy0xLTEtMA_09a908ba-b987-4fb5-b5a8-6e3acce883c1"
      unitRef="usd">16600000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjAtMS0xLTEtMA_1f10b28c-d483-49a1-832f-636a640b5c1b"
      unitRef="usd">13700000</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsOfDebtIssuanceCosts
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjAtMy0xLTEtMA_371f96f0-52ed-4e2a-a5f3-d6dcae11aa72"
      unitRef="usd">0</us-gaap:PaymentsOfDebtIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjMtMS0xLTEtMA_c7c18e01-3541-4bae-8f79-0593b6045646"
      unitRef="usd">101300000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjMtMy0xLTEtMA_37663bbb-40b9-47f8-9260-e24249d3c81b"
      unitRef="usd">285900000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjUtMS0xLTEtMA_2995e906-c8b4-457e-9c2c-439336ed55ac"
      unitRef="usd">23300000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjUtMy0xLTEtMA_48c3272a-b837-4eaa-bd4d-28cad63604a8"
      unitRef="usd">18700000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjYtMS0xLTEtMA_efa51d63-1a05-4120-9a93-8d113bbe1bfe"
      unitRef="usd">46400000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjYtMy0xLTEtMA_517ab22c-7a1b-49ca-8607-f4f654535043"
      unitRef="usd">10900000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjctMS0xLTEtMA_2a50aef8-ec36-434d-814a-d0f64812bdf1"
      unitRef="usd">500000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:RepaymentsOfLongTermCapitalLeaseObligations
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjctMy0xLTEtMA_5e67db5a-757f-4130-832a-cd60b93cb8d8"
      unitRef="usd">400000</us-gaap:RepaymentsOfLongTermCapitalLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjgtMS0xLTEtMA_a883246d-8518-4fab-a0e9-83c335e21374"
      unitRef="usd">-428200000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjgtMy0xLTEtMA_56c64b0e-c8c0-45f0-be33-41d3097e9de8"
      unitRef="usd">-289900000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjktMS0xLTEtMA_8a989e06-6eb8-4725-84ef-0f74623ef9b5"
      unitRef="usd">-4200000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNjktMy0xLTEtMA_4bbe2fb8-ecf2-4ca0-8fee-bb65bd25d775"
      unitRef="usd">1400000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzAtMS0xLTEtMA_b9410b92-08dc-4fe3-9881-68dc3ca9efbe"
      unitRef="usd">167700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzAtMy0xLTEtMA_97f95c2d-4baa-4f83-99a0-cb22e1d14aa4"
      unitRef="usd">-220300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzEtMS0xLTEtMA_3b06647d-fdf1-4039-8705-c1e368f22d22"
      unitRef="usd">701000000.0</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzEtMy0xLTEtMA_c5c7c699-aada-484b-a518-c28f7c6d03d0"
      unitRef="usd">601800000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzItMS0xLTEtMA_3f4eaed8-3d7b-4c43-be5f-bc889d8fcb96"
      unitRef="usd">868700000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8yOC9mcmFnOmNmZjQ5NTBmM2IwMjQ0NjY4N2U1YmY3ZmNjYjAxMjdlL3RhYmxlOjBkZDkzODliYjQ4ZjQ1M2FhYjdlNDgxYWYyZDBjM2M3L3RhYmxlcmFuZ2U6MGRkOTM4OWJiNDhmNDUzYWFiN2U0ODFhZjJkMGMzYzdfNzItMy0xLTEtMA_b038b904-34e3-4d0b-a9e7-b5ac26a8d937"
      unitRef="usd">381500000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i8659049ec61c4559b26d2dde9021937c_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTI2NzU_447f4519-ca5d-4652-80bb-f5429191fe6b">Basis of Presentation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements of Hologic, Inc. (&#x201c;Hologic&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#x2019;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;26, 2020 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2019, the FASB issued ASU No. 2019-08, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:8pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;26, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were two unrecognized subsequent events related to the acquisitions of Somatex Medical Technologies GmbH ("Somatex") and Biotheranostics, Inc. ("Biotheranostics"). On December 30, 2020, the Company completed the acquisition of Somatex for a purchase price of approximately $64.0&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. On January 5, 2021, the Company announced that it had entered into an agreement to acquire Biotheranostics for a purchase price of approximately $230.0&#160;million. The closing is subject to certain regulatory approvals. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ie2315ca24bb44334b2ede0aa904f5731_D20201230-20201230"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTA5OTUxMTY3NDQyNA_8f6f225e-ca4b-4b22-a001-30d2c82230c9"
      unitRef="usd">64000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ibaf5f2d2692346a88d7ae57bf6270cdc_D20210105-20210105"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNC9mcmFnOmVhODhjMGY0MGFkNjQzNzdhY2EyNjVkYmY3ZTE3NDYzL3RleHRyZWdpb246ZWE4OGMwZjQwYWQ2NDM3N2FjYTI2NWRiZjdlMTc0NjNfMTA5OTUxMTY3NDQzOQ_40b014b1-ebd2-43a2-af75-391b92edf541"
      unitRef="usd">230000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNzY3NQ_56ca50e2-d09e-4035-b7a3-777287bf845a">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;675.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;995.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;763.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;101.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;472.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;142.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;231.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;217.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 29, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,137.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;632.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,263.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;192.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;232.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="idd718ddd1ed144e29f41973ee9eb875b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy0yLTEtMS0w_d340451d-92ee-48c3-a097-4f9192aab382"
      unitRef="usd">80100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i807f1967ca0747168870227cdb5de282_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy0zLTEtMS0w_f7163d40-293c-4712-a23c-94fbc3a7f832"
      unitRef="usd">44700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i814e82d01f554e07a70d51c7e0f6789c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMy00LTEtMS0w_098d4abd-2395-47ee-b496-4580a15f75da"
      unitRef="usd">124800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24231c45c0e04b0cb463e368a4fa9819_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC0yLTEtMS0w_9ff5f207-ae41-45c8-8d86-972782f156c0"
      unitRef="usd">675300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iac260c17aab74a5aaad08d3c2e71c09f_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC0zLTEtMS0w_a36a8278-9306-4d5f-8442-f87509bc3e47"
      unitRef="usd">320000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i85fe1c3197bf4160bde67b0e7b88e57e_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNC00LTEtMS0w_52fceef7-9cce-4160-92e9-4d54570975cb"
      unitRef="usd">995300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic11fbed77bea48e18a66f44359be8369_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS0yLTEtMS0w_cf54d98e-30f8-46f7-9187-19867ecab3b6"
      unitRef="usd">8100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icb91856dc5f14d6e88d769b12a3553fc_D20200927-20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS0zLTEtMS0w_b7d084bf-795d-41ce-a9f5-932deed28280"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1ca33f8b7647484d95b3e8825c8d1ae6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNS00LTEtMS0w_c8bd146c-491f-4f06-8b20-158ff74c3469"
      unitRef="usd">8100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ida008df7022c4ec1b8fcdee5e84f1012_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi0yLTEtMS0w_440edaa6-0217-4985-912f-40275c908b56"
      unitRef="usd">763500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d1862a2813f492184d07742064e2a0d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi0zLTEtMS0w_e8660ec7-17c6-4d68-898b-27753c9b383f"
      unitRef="usd">364700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfNi00LTEtMS0w_54fa7b9e-3b91-4012-850d-c94da89cca95"
      unitRef="usd">1128200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8bfc0e0103f9487b965e824c2254203b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS0yLTEtMS0w_e5e9bb0a-5ab4-484f-b920-da4cfae9de63"
      unitRef="usd">203000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i16374eee78494c719746d8b40c160941_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS0zLTEtMS0w_31437852-9846-44ac-b0b8-0edd544defab"
      unitRef="usd">64700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i20f4faff9e164fa29b72dc862bb814c1_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfOS00LTEtMS0w_f9a474b4-4048-4279-881d-0cf1e3c391f4"
      unitRef="usd">267700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f918efa3d83476c9578e01f5704ea75_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtMi0xLTEtMA_396da2d6-258c-42de-a026-b3d7327dda12"
      unitRef="usd">55200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i047e6064c2d441448b721d1506b755fa_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtMy0xLTEtMA_a8c2d478-ec72-4d33-87ec-91f2eb70afcf"
      unitRef="usd">9800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1c48afb9a6cf4b619f1170a44995048b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTAtNC0xLTEtMA_a13857ae-723e-44ad-be07-4eafe3ee182c"
      unitRef="usd">65000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3384fe463ec48f08c6f59ad68669d65_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItMi0xLTEtMA_85cd792e-9fcc-4276-a33a-5aee7e7ca084"
      unitRef="usd">258200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8f45f0b5e32942a5ba004547e2f18c70_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItMy0xLTEtMA_c1e7261a-b060-40de-95d0-ca3883e861d5"
      unitRef="usd">74500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTItNC0xLTEtMA_e6119e24-2bdc-49f8-bc05-901994e30892"
      unitRef="usd">332700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if63bac3956a34caaaf11ca4c0d481b3f_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtMi0xLTEtMA_bba0f685-cec1-4390-844a-d807f95db1cc"
      unitRef="usd">101000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba06aba7b8a3482991a27db74984c2d2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtMy0xLTEtMA_c9725f94-5d7e-4e75-9dec-e8f921f0b73f"
      unitRef="usd">23000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTQtNC0xLTEtMA_be4c3e7f-6f60-4456-bf9c-630e1a270037"
      unitRef="usd">124000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7744b72714974633840d43bd8f1c52aa_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtMi0xLTEtMA_d37feaaa-590f-4b4e-bb9e-76d9caaf259c"
      unitRef="usd">15100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ifff05d29091f488093318a5c86a39998_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtMy0xLTEtMA_272834cf-a3c1-4e8c-bde7-423980117bda"
      unitRef="usd">9800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTgtNC0xLTEtMA_d1848ecd-3c88-4c72-ba02-2fb9b65e1b2e"
      unitRef="usd">24900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktMi0xLTEtMA_25bb1d24-6498-42bc-81f9-d51a8d6b67d8"
      unitRef="usd">1137800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i804f2e6f9b9c4c2dac795221463c7352_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktMy0xLTEtMA_2ad52b35-5cc8-4c87-b12d-a1e5a00c3803"
      unitRef="usd">472000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjI4YmNlMTM5OGI5YjQ0Y2JhNGZjN2ZlZGRmMGQ4ZGJjL3RhYmxlcmFuZ2U6MjhiY2UxMzk4YjliNDRjYmE0ZmM3ZmVkZGYwZDhkYmNfMTktNC0xLTEtMA_33f6bf3b-22fe-4ae3-bf9b-4f66aaafac41"
      unitRef="usd">1609800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i494de1667d6141d3a77fb81e098872d7_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy02LTEtMS0w_21683a05-8d25-45bc-b4c3-7b45565a3c09"
      unitRef="usd">77500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i41fef6d46bcb4458936812aadb6a6eeb_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy03LTEtMS0w_fd2c3117-85da-4719-994e-5327ab601e67"
      unitRef="usd">43500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if4e261e946c44e3289c0ec9dd139dd3e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMy04LTEtMS0w_60e75427-25b5-4830-bd9d-f669495400e6"
      unitRef="usd">121000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i53d2f9966d234c8f86709bf1c24480d9_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC02LTEtMS0w_cad8fbfd-5c76-4cfc-a38d-c58d17a759c3"
      unitRef="usd">142100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i425431777b7d4b3083ab8649a18e6394_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC03LTEtMS0w_49b47e9b-b146-485d-bbab-f2f32f11a592"
      unitRef="usd">36400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iff1719f8bdb243f58136808bb4f920b6_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNC04LTEtMS0w_3d5aa852-e3a9-4f86-8297-70c3a9597f8b"
      unitRef="usd">178500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2d6138445fc34f7b849cf1c4c1bd7b4c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS02LTEtMS0w_1fcc14fd-b7d7-4730-b4b9-e0ddaf67bc86"
      unitRef="usd">12000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibc90a64df06e44afad34c0fdb3d6acb0_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS03LTEtMS0w_16766a7c-2e60-4b60-a85b-3dcdc1a47d7c"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0c1a753fd84741ea99c093f47887c09b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNS04LTEtMS0w_c23bc5e4-30bb-4b24-9eba-c261cd9b77cb"
      unitRef="usd">12000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f39f8c1a58d4c0092f3c0f4a7e1145a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi02LTEtMS0w_10a500fa-a236-4ddf-8c58-efa3243c2a57"
      unitRef="usd">231600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3c80ddb3233741de8cb85ebe53044117_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi03LTEtMS0w_d7ada27d-1a02-4c61-a39d-48450f8c9173"
      unitRef="usd">79900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfNi04LTEtMS0w_ce71ccce-0201-43b1-9ae1-dfcef5d9c937"
      unitRef="usd">311500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08a1df1d86db4e5f98a13155567d6600_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS02LTEtMS0w_bd3936b2-81e9-4e8f-9bc9-74359f9b7892"
      unitRef="usd">209400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a2a3bf74b34478e8fac81531d70102e_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS03LTEtMS0w_2a53ba76-9140-4c5f-8eef-e6a4c77f5676"
      unitRef="usd">65400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0420bc7b903745a99eef56fe2d387c5d_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfOS04LTEtMS0w_b1034015-0560-4729-b9bf-321d4ef36f06"
      unitRef="usd">274800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4a381e87df3e4fd3881d975e6bf59018_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtNi0xLTEtMA_4ef1b977-9e46-4e5c-a225-5bb42c63da9d"
      unitRef="usd">47100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia848377d0119418c93ec23909f54ef88_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtNy0xLTEtMA_8cebcf85-253a-4440-beef-ef204c691103"
      unitRef="usd">9200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1ed96c1bacd44799bde67d4474a21301_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTAtOC0xLTEtMA_b8c88253-cf08-4b36-88a5-0e49bcc7dbfa"
      unitRef="usd">56300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08a1b32655d141b3827b070cb7dd8394_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItNi0xLTEtMA_71e150f0-fceb-4770-9b77-7ebb6b597273"
      unitRef="usd">256500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ddb21f8026b4973b5e9cf9a186551ac_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItNy0xLTEtMA_1960b583-35a4-4e18-8b0b-62f6b4c84224"
      unitRef="usd">74600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTItOC0xLTEtMA_e4084096-609a-422b-bcaa-892c222b9c0e"
      unitRef="usd">331100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1f0f69550624497996276135c6bd77d_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtNi0xLTEtMA_cbb60453-103d-4cf4-be5f-ae33dc869dc9"
      unitRef="usd">98800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i171c9ca031bf4884816e7be4190b9db2_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtNy0xLTEtMA_1da0e6ff-c1e5-4598-a2c4-8d5e7c67068d"
      unitRef="usd">20300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTQtOC0xLTEtMA_92b28849-5605-4441-bd53-cbe7f399d1e5"
      unitRef="usd">119100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i86f98ab577e348f08c18b5ec1aa4c24f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtNi0xLTEtMA_13f678a1-9404-42c8-b9c8-329c8e043779"
      unitRef="usd">30900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0b9fa71bf4f54f2cb7e265c235983118_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtNy0xLTEtMA_2b98b674-a5c9-4eab-938b-b6e2426f937b"
      unitRef="usd">34400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTYtOC0xLTEtMA_e3f08cb8-4ab9-4810-a346-17ad43c9e00d"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9edfd07f43ea4110a087242c57d62661_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtNi0xLTEtMA_f7e7eac8-490d-417a-8eec-6a7e2a4c2dce"
      unitRef="usd">14900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5896165fc6444c69a28f30d7622aab83_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtNy0xLTEtMA_f0e6af2a-e4b3-4af4-9e24-3c752ee18f6f"
      unitRef="usd">8600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTgtOC0xLTEtMA_7534ea16-6b05-4cb9-8bee-414f38d82f74"
      unitRef="usd">23500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktNi0xLTEtMA_6b5c04ec-5b43-41b7-85b7-3f7c8b3e2955"
      unitRef="usd">632700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaf72943e74d14e5fbecf4403525ffeeb_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktNy0xLTEtMA_f5e76fcf-3bd7-4c7c-a47f-e4f1fe6f3c9f"
      unitRef="usd">217800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjJkNGE5ZTAzNTdlMzQ1MTNhOWFlODYyNTk5YzBmMmRjL3RhYmxlcmFuZ2U6MmQ0YTllMDM1N2UzNDUxM2E5YWU4NjI1OTljMGYyZGNfMTktOC0xLTEtMA_cb7edd32-c188-433c-8583-3d4eacd40ade"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMi0yLTEtMS0w_9933a4f4-5440-4f97-9b9f-03a52da147ab"
      unitRef="usd">1137800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMi0zLTEtMS0w_1840795c-1079-4adb-adf3-c7cc77fec199"
      unitRef="usd">632700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMy0yLTEtMS0w_a666c13e-e468-4c31-b2db-e20ca2cea322"
      unitRef="usd">338200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfMy0zLTEtMS0w_c0cc2516-bf2f-488c-856f-574a380320bd"
      unitRef="usd">109400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNC0yLTEtMS0w_16d28b2f-df8e-495f-9d7e-baee627b5333"
      unitRef="usd">88300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNC0zLTEtMS0w_218bd918-55c9-4dfc-b288-e0a2b5937ba8"
      unitRef="usd">70200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i894813c090864a3cb88eb86237b77caa_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNS0yLTEtMS0w_599d6513-536d-4c44-89e6-7c2156cdb8da"
      unitRef="usd">45500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i64740b81a53c45249c05c34df962be4a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNS0zLTEtMS0w_34e11561-3cb5-4355-bd9f-def5e8f0dd08"
      unitRef="usd">38200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNi0yLTEtMS0w_de421beb-903f-4f89-83a4-b958498d7d07"
      unitRef="usd">1609800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOmI1ZjM5ZjlmZTZjMjRmYjg5NGM2OWJjNGU1NDRkMzg2L3RhYmxlcmFuZ2U6YjVmMzlmOWZlNmMyNGZiODk0YzY5YmM0ZTU0NGQzODZfNi0zLTEtMS0w_cb805dc6-6799-4cc9-af72-42ce28290bc2"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib9475dc3a7d5487fbeab85f649c54044_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0yLTEtMS02MjA1_c7af6b16-8c66-42a7-bf99-b89ecb4b32d8"
      unitRef="usd">1263400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f217ab69c114d40a9a225677bf15b33_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0zLTEtMS02MjA1_88865193-a003-476f-bc03-8da7720291e9"
      unitRef="usd">466400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i315641707d4c4fc39c5611d79f93f696_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0yLTEtMS0w_09fe7ee5-ffa0-4a9e-a3cc-94b095b63b43"
      unitRef="usd">192000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie0ba3144ce98484facbd98ad7ffb47dc_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfMi0zLTEtMS0w_bb01863d-ea20-449c-bdb2-3b33e3244982"
      unitRef="usd">232900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67601f23ac8f42259e8935b9dc100943_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNC0yLTEtMS0w_e60139c3-6d1a-49ea-a5d0-e3f3abf2b2f9"
      unitRef="usd">137100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia48592e41d84415895cece1a0979daaf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNC0zLTEtMS0w_ef174dc6-547d-4047-a5ca-70750dc5182e"
      unitRef="usd">145000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i58584d59f7ca4ce8914046729ee0446b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNS0yLTEtMS0w_3257196c-8feb-4d49-b0fc-e518dca179fd"
      unitRef="usd">17300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2617de2ef6504c69af6d86624c6c1ae3_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNS0zLTEtMS0w_4c0f2b7a-8c4f-44c9-8729-37aa3042da24"
      unitRef="usd">6200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNi0yLTEtMS0w_4fe6e9f8-b989-44f5-8a1b-478a1089d391"
      unitRef="usd">1609800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RhYmxlOjBiNTE2ZmIwODNkMDRhYWE5MTI1ZTc5MDBhYzQwZjkyL3RhYmxlcmFuZ2U6MGI1MTZmYjA4M2QwNGFhYTkxMjVlNzkwMGFjNDBmOTJfNi0zLTEtMS0w_2b71e1a7-f5cd-45b8-b874-6cfd63d3fd99"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNTg1Mw_c0baa3b0-e705-4d1a-9379-8b7ee9ee03ed"
      unitRef="usd">702000000.0</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ife84c0d8763b4705a470b753572dd9ad_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjA5Mw_530cc710-096a-4229-98a9-d5c6f596e6d4"
      unitRef="number">0.31</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i08052409a9da48bd9c3023256acbffbf_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjEzMQ_6e3d6e35-eec3-48e2-8489-211569efd6eb"
      unitRef="number">0.30</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="icf1c53d799a94ec78b381605622bd13b_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE0Mw_fcb707db-095e-40c5-86d3-5c9eba1c6896"
      unitRef="number">0.21</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i605077a5590146648b817b54f0efeec3_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE1NQ_8b7b0b30-a12a-420d-a277-7b9e369ca0e9"
      unitRef="number">0.12</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i562f34e6727740619a5a1d16c97a58b4_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNjE3MQ_8835d53b-4d94-41bd-aee0-c752ed0f206a"
      unitRef="number">0.06</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8zNy9mcmFnOjlkNDA2NDkyNGQ5NTQyNTlhMTk3NmI4NTJhOWNkMTk2L3RleHRyZWdpb246OWQ0MDY0OTI0ZDk1NDI1OWExOTc2Yjg1MmE5Y2QxOTZfNzUzOA_c62040dd-8b31-409e-bfff-be32843b2b95"
      unitRef="usd">50700000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDM5ODA0NjUyNTE1Mw_867d9eeb-cd32-4c56-9f41-50d094415409">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are immaterial. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 2% and 3% of the Company&#x2019;s consolidated revenue for the three months ended December&#160;26, 2020 and December 28, 2019, respectively.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDM5ODA0NjUyNTE1Mw_9679e1f1-8ce8-4486-9a5e-4c0bad4c15e0">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are immaterial. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 2% and 3% of the Company&#x2019;s consolidated revenue for the three months ended December&#160;26, 2020 and December 28, 2019, respectively.</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfNDMzMg_90ad58ab-cd53-462b-aebc-c1ab4f2f42e9"
      unitRef="number">0.02</holx:LeaseRevenuePercentageOfTotalRevenue>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80My9mcmFnOjhlNmU0MWFiNjc4ZTRhODhhZmUzODA3NzZjMDdlNDM1L3RleHRyZWdpb246OGU2ZTQxYWI2NzhlNGE4OGFmZTM4MDc3NmMwN2U0MzVfMjE5OTAyMzI2ODQ5MA_d590cccd-ba8d-409f-af32-e497f273c495"
      unitRef="number">3</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzY1Mg_314dd62b-4770-4a21-852d-ff1879e5ad08">Fair Value Measurements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in derivative instruments comprised of interest rate caps, an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;26, 2020:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 26, 2020 and December 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three months ended December&#160;26, 2020 and December&#160;28, 2019. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure of Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#x2019;s interest rate caps, interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.&lt;/span&gt;&lt;/div&gt;Amounts outstanding under the Company&#x2019;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of December&#160;26, 2020 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#x2019;s 2028 Senior Notes and 2029 Senior Notes had fair values of $427.0 million and $974.0 million, respectively, as of December&#160;26, 2020 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#x2019;s debt.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzY0Nw_31f8e382-63b5-48ba-8c14-2067d62bdbc3">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;26, 2020:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:37.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.130%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.569%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 26, 2020 and December 28, 2019 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:18pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.795%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.348%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.523%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments/Accruals&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9b4b851aac0a434c82c8b786b613a366_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS0xLTEtMS0w_65476946-3f67-46ae-9067-0b7c6656e8df"
      unitRef="usd">800000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibda9057d843a4b73905a0ed943432150_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS0zLTEtMS0w_6a191dee-5ab0-4e04-9d72-04f97af3667c"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="iba6af4bb67bc4b93b0ef89a2863329bd_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS01LTEtMS0w_b1ebe5ee-508e-4813-b3e4-bcf0a6457401"
      unitRef="usd">800000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i3824626237124ce9828ecc11f78786df_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNS03LTEtMS0w_7907f602-af74-4c2b-bf28-4c2ed59edf7f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy0xLTEtMS0w_a28f80cd-2c2f-4936-ae25-6b1dce92aa99"
      unitRef="usd">800000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy0zLTEtMS0w_4d656dac-c804-49df-92d7-073d974b82ba"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy01LTEtMS0w_ee2b647b-2233-4bb2-b6df-2d337c8692c9"
      unitRef="usd">800000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i126237eb247a4867bac37c6b2dea5699_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfNy03LTEtMS0w_007968d5-dc9c-4c29-a2bc-80782ca331c6"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ia393550942904ed09c042467d0645c37_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS0xLTEtMS0w_756d2f4a-c0a3-45a4-a900-a63d5c2b4fd1"
      unitRef="usd">86400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i589619851f164523acf1587d711fff2a_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS0zLTEtMS0w_5ec0b369-1e09-443e-be5f-00f37fa88b8e"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i50fa172708d24893990ba4c50d5437c5_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS01LTEtMS0w_4c68f044-b753-46da-88a0-4ee63675b54b"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i7323967dedcd49868eb4e102fb8b387e_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfOS03LTEtMS0w_7377d96d-ad39-4dcd-8bf8-59819cb42920"
      unitRef="usd">86400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idb7efed954b8455690ac3b12d64dcb4c_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtMS0xLTEtMA_c95d868d-d2f6-4eac-9d45-4f8557fe1739"
      unitRef="usd">30700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ia8c4bd4abad44e83aab53cec2dfaade1_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtMy0xLTEtMA_babfc4cf-c4ca-46c9-ae23-773015c42698"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ic9712b4b8dc64000b015bfd132cfda2c_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtNS0xLTEtMA_8d804ea6-97bc-47e5-a0f5-3d4f10aa5c66"
      unitRef="usd">30700000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i69ec054955924207982fbd54d8a1cca2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTAtNy0xLTEtMA_36f53625-8e83-426b-aa66-8e6f679e4b43"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i0bbcb67f917c48b39cc8cdf5e74c1d42_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtMS0xLTEtMA_2b35803a-34c8-423b-83cf-575c49a1a93f"
      unitRef="usd">6000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i876dd7ede38d4edbae53824dea405212_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtMy0xLTEtMA_18a25925-cb8c-43b1-bffa-ce7fe8cf471f"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6a5fd7116579406fb4ab4e0c108de263_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtNS0xLTEtMA_0d9e3ec3-3783-4fcd-ae86-62c5b99f8a5d"
      unitRef="usd">6000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i788bcb698408495ba16be99c3274b08c_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTEtNy0xLTEtMA_cc1bd17d-f862-4a6c-a61a-515681aff5df"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItMS0xLTEtMA_a1010c84-fd03-4548-afb3-691aa6674aef"
      unitRef="usd">123100000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i17a6a8a05ff7405bbd8cdf7c67d24796_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItMy0xLTEtMA_a22c53da-42ab-49dc-a7cd-4cad0847d27c"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i6fcbd8920ee14be99d3661ce0de4f2b3_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItNS0xLTEtMA_6f6f8ac6-a9c6-4388-9cbb-68656f36f706"
      unitRef="usd">36700000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i126237eb247a4867bac37c6b2dea5699_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOjhhOGY0OWJkNWYyYTQyOGRiNTdiOWNjNzgwMzU4NzgxL3RhYmxlcmFuZ2U6OGE4ZjQ5YmQ1ZjJhNDI4ZGI1N2I5Y2M3ODAzNTg3ODFfMTItNy0xLTEtMA_fbe8106c-6910-4fdb-a4f7-3222b27a4a55"
      unitRef="usd">86400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMi0yLTEtMS05MDQ5_be865474-3574-4228-98ba-9b117d77fa88"
      unitRef="usd">81800000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMi00LTEtMS05MDQ5_fb9736a2-eb5d-44c0-9a68-82c5aa11246d"
      unitRef="usd">9100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMy0yLTEtMS05MDQ5_c4e7a75a-3db5-4597-bb0f-e38bbd8ef55c"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfMy00LTEtMS05MDQ5_389b8dce-9f2d-452f-b9df-ae4c1c74b45d"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNC0yLTEtMS05MDQ5_3afa0bc4-3fce-4074-833d-934c43c5e72c"
      unitRef="usd">4600000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNC00LTEtMS05MDQ5_5d2dfc38-2909-4dc5-9c54-6c4960a2c8eb"
      unitRef="usd">900000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNS0yLTEtMS05MDQ5_130d55a9-49e5-46d9-85e9-324a6df7078a"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNS00LTEtMS05MDQ5_2fb91b09-d239-4b73-b257-7d959bf69253"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNi0yLTEtMS05MDQ5_45891016-bb2e-4d90-9dcd-b1cf8dd2db0c"
      unitRef="usd">86400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RhYmxlOmVlNmJkOTgwMDFkZDQwZmE5ZGNmYWQ5OWJjYjU2NTZkL3RhYmxlcmFuZ2U6ZWU2YmQ5ODAwMWRkNDBmYTlkY2ZhZDk5YmNiNTY1NmRfNi00LTEtMS00MDU4_ab50cb26-d2b5-41bc-8b7c-3b480eb08e8b"
      unitRef="usd">10000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:AssetImpairmentCharges
      contextRef="i057ac10f806c4c558abf15ee4ec101cf_D20200329-20200627"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMTY4OA_19e0049b-1fd2-4335-89e7-eb3e42b72f4c"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i241d11756be14078a3555bf86956ce71_I20201226"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzE1Nw_5a638f51-7dd9-4841-b4c9-ff80c78d2938"
      unitRef="usd">1400000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ida2942dc56654504a3265279bdb12af9_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzQ0Mw_e93e4b23-caf2-4f71-95fc-ef0c370865f4"
      unitRef="usd">427000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i6e700854ca8d480696bc4eb95d4ddb8a_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80Ni9mcmFnOjkyOTliMjNlYTQ4YzRlOWM4NmJmYjIyNzA0NjNiZTQwL3RleHRyZWdpb246OTI5OWIyM2VhNDhjNGU5Yzg2YmZiMjI3MDQ2M2JlNDBfMzQ1MA_ffda1270-5b2d-4abd-b249-ac5574e61dc1"
      unitRef="usd">974000000.0</us-gaap:DebtInstrumentFairValue>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGV4dHJlZ2lvbjo5OWFlNjkyYzYyZjE0N2M1YjcxZDA3NzFjYzMwMmNiOV80Mzk4MDQ2NTE4MDE3_55f5427d-1612-433f-99b7-853519818af1">Trade Receivables and Allowance for Credit Losses&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses as of December 26, 2020, compared to December 28, 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.839%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.662%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.809%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.532%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.812%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Reclassified as Assets held for sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-&lt;br/&gt;offs and&lt;br/&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGV4dHJlZ2lvbjo5OWFlNjkyYzYyZjE0N2M1YjcxZDA3NzFjYzMwMmNiOV80Mzk4MDQ2NTE4MDE4_fb78a947-d2ca-4ca4-8549-099a83431efa">The following is a rollforward of the allowance for credit losses as of December 26, 2020, compared to December 28, 2019:</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTItMS0xLTk2MDg_38c3ae8b-48c0-4402-baa2-da2db9d0a6d7"
      unitRef="usd">31600000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTQtMS0xLTU4MTU_c93cb305-9f27-42f6-b312-b04b6ff76878"
      unitRef="usd">9100000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTYtMS0xLTk2MDg_3eedb42b-be10-463d-8944-df307f01eb49"
      unitRef="usd">0</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTgtMS0xLTk2MDg_4f0e7c26-7d7a-4a9e-99eb-1ff292a73041"
      unitRef="usd">1300000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18yLTEwLTEtMS01OTQ3_2b018569-b7ee-49f6-a9e2-025178c18a5c"
      unitRef="usd">39400000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTItMS0xLTk2MDg_740bdb8a-2e5c-4986-a971-288f99e2edfe"
      unitRef="usd">17800000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTQtMS0xLTk2MDg_124b76d5-33ca-4a24-ba0e-c1f489c1901d"
      unitRef="usd">300000</us-gaap:ProvisionForDoubtfulAccounts>
    <holx:AccountsReceivableAllowanceForCreditLossTransfers
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTYtMS0xLTk2MDg_4f4c383c-d68f-494f-b6a3-877e3f7776c1"
      unitRef="usd">5900000</holx:AccountsReceivableAllowanceForCreditLossTransfers>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTgtMS0xLTk2MDg_b5b415e6-77f5-4cc8-90ed-c60e47efd0a5"
      unitRef="usd">500000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV8xMjAyL2ZyYWc6OTlhZTY5MmM2MmYxNDdjNWI3MWQwNzcxY2MzMDJjYjkvdGFibGU6MGIxMThlM2I1Mjg3NDYyZGE2NTIxMTk4ODE1ZjUxYTMvdGFibGVyYW5nZTowYjExOGUzYjUyODc0NjJkYTY1MjExOTg4MTVmNTFhM18zLTEwLTEtMS0zMTkx_9f38cd5e-3230-4c46-8616-c75a0ad666a6"
      unitRef="usd">11700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3OQ_122d0afe-946f-4921-a574-fee4a5caa2f6">Business Combinations&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;NXC Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $4.9&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Acessa Health&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. In the first quarter of fiscal 2021, the Company remeasured the contingent consideration liability and recorded a charge of $4.6&#160;million to record the liability at fair value as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Health Beacons&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it allocated $10.7&#160;million of the purchase price to the preliminary value of developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Alpha Imaging&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;SuperSonic Imagine&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#x20ac;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#x201c;VIE&#x201d;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1 million outstanding shares in fiscal 2020 for $1.8 million, and as of December 26, 2020, the Company owned approximately 81% of the outstanding shares of SSI.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the &lt;/span&gt;&lt;/div&gt;amount of goodwill were based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ic2f8bbd6225a46a59130b9953c661fca_D20200928-20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAwMg_1551d452-ed51-4984-9d15-83eb007c8068"
      unitRef="usd">4900000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="ib945bc9d7dd74d23bef11fee1c766a86_D20200928-20200928"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAyMA_cd912905-19dd-4faf-bb56-cf096e0e3ab0">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTAzMw_46c384cc-9e9e-4fb6-9082-f870cafab07e"
      unitRef="usd">161300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i445bb1bc12b94106bac10836061b786a_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA0OQ_bdd93bbb-5b76-4d2a-94e1-e597d34abdc3"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA2Mw_fd27ef02-8dcf-4a68-9e55-6911db66261b"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:AnnualIncrementalRevenueGrowthPeriod
      contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA5Mg_cb1f34f0-f03b-4028-bffc-aa5ea202063d">P3Y</holx:AnnualIncrementalRevenueGrowthPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA5NA_83d95d7c-457a-4d90-b44b-31ff98da3b7f"
      unitRef="usd">4600000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTA3Nw_b0d324ba-4a98-4daf-92d7-85a653cee6ef">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.865%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.543%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.292%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;127.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;161.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:78.849%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short and long-term debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMC0yLTEtMS04OTQ4_3e35d592-9482-4677-8eac-a1b5edb48810"
      unitRef="usd">1200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMS0yLTEtMS04OTQ4_c101cbb6-3626-4aea-9e7c-42d74ee16c7b"
      unitRef="usd">4000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMi0yLTEtMS04OTQ4_2a5861df-0188-4ca6-9b1b-f9ca390288aa"
      unitRef="usd">4400000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNC0yLTEtMS04OTUw_a4fc2622-15d3-4505-8217-2f8ccda0a2d8"
      unitRef="usd">127000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNi0yLTEtMS04OTUw_89a6ef3d-8d88-4e1a-8765-8b465a68aaae"
      unitRef="usd">1200000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfNy0yLTEtMS04OTUw_18e14cac-c9e4-4ac4-bdd5-477cd20baae0"
      unitRef="usd">4700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfOC0yLTEtMS04OTUw_a6077b60-c869-4d8e-9d33-f9b03da0f8d5"
      unitRef="usd">20200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfOS0yLTEtMS04OTUw_2d39b67d-eab7-4336-8de4-c659b8ef3914"
      unitRef="usd">48400000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i34350e67e8944266b86f21311361cfa5_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOjhkMTdkMWFkNDczMTRlODc5ZmNkNjZjMzc3YTMyYjY0L3RhYmxlcmFuZ2U6OGQxN2QxYWQ0NzMxNGU4NzlmY2Q2NmMzNzdhMzJiNjRfMTAtMi0xLTEtODk1MA_6d17685e-0ce0-4983-84a6-e5c961b953a4"
      unitRef="usd">161300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="ia3974df6ea77454a8411e06ddd223e40_D20200823-20200823"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEwOA_4b571acd-b307-459b-9814-75c84515f84a"
      unitRef="number">0.180</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0832db4cb8434084b9ee1801dd03071d_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEzMw_8223e98e-a2cd-42fb-8e29-6805630baace">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0ab367a0906d4115ae87e78dcc61bf59_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTEzMw_dfdc0b43-6e00-4574-a31c-418394e3c9ff">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i70d5bdf101354f3096ceb4018e2689fe_D20200203-20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk0Nw_a7f8a155-524f-46ab-9e2c-22c3f179b8e2"
      unitRef="usd">19700000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk2Mg_61db0d75-929a-44f3-bb2e-181fd6741a70"
      unitRef="usd">2300000</holx:Holdback>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk5MA_8fac8414-20be-4bd4-8a3b-39bd07857c5e"
      unitRef="usd">10700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1Nzk3Ng_a9e651ae-56d7-4b13-9104-4f60492f708b"
      unitRef="usd">6200000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i97f3b15a57f54d1388b8a487d385f489_I20200203"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1ODAwNQ_c8b278ad-fdf6-47ee-b80a-460a9a00e655"
      unitRef="usd">2800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i16b9bcb5f7f245b8844e041da365f4ca_D20191230-20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTgyOA_b7428965-3d66-470c-8367-8295c38dfd0a"
      unitRef="usd">18000000.0</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:Holdback
      contextRef="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTg1Nw_327453b3-9381-4803-8b7f-2143d5376d77"
      unitRef="usd">1000000.0</holx:Holdback>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iea05e70abbce44ee8d8a57f4ff5f67de_I20191230"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMTA5OTUxMTY1OTg0Mw_02844ee6-8ec4-4956-ab2d-c85cf129be51"
      unitRef="usd">900000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i371b6d6a17864bafad1d66b2594c1fd0_D20191230-20191230"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDM5ODA0NjU1OTE1NA_bd0c5522-1e66-4da3-969a-3e512af8dfbf">P5Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i07707b0a4bc941daad3ff6db034e22c7_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjMxNg_6748b1bf-7151-423a-bb35-b905cfde0876"
      unitRef="number">0.46</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ia740bc8dc3ae4ebab5eaafc9d0d17247_D20190801-20190801"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjM3OQ_0b368fbd-1148-4d65-91f4-0a342455a519"
      unitRef="usd">18200000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessAcquisitionCashTenderOfferPricePerShare
      contextRef="ic66d9c02f62b4399864f0fd8c7c03ef9_D20190901-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjYyOQ_a31c8cf3-775b-431e-af1f-154cecfbf6ca"
      unitRef="usdPerShare">1.50</holx:BusinessAcquisitionCashTenderOfferPricePerShare>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="i819b181542894a318b23998e6b0d7876_I20191120"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMjk0OQ_b8ce5eda-b2c8-4e50-8e1d-8b52f8d14cf1"
      unitRef="number">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <holx:BusinessCombinationSharesAcquired
      contextRef="i7760868627c74bd8909425527cd76d5f_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzI1Ng_6c33bc7e-a33b-460f-8311-1d8950192daf"
      unitRef="shares">7600000</holx:BusinessCombinationSharesAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i7760868627c74bd8909425527cd76d5f_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzI3Nw_fb84b08e-9779-43b2-a2fc-4a446a16fbe4"
      unitRef="usd">12600000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationOwnershipPercentage
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzMyNg_c4a29d37-16ef-458c-939e-203529fa02ea"
      unitRef="number">0.78</holx:BusinessCombinationOwnershipPercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i07707b0a4bc941daad3ff6db034e22c7_I20190801"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzY3Ng_6d01dff9-de2c-4d7f-b100-a00a5d4c9afd"
      unitRef="number">0.46</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzc3OA_910fb72a-331a-474a-a500-ec71f3fcc62c"
      unitRef="usd">3200000</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzg2Nw_cb4422c2-13cc-445b-a1fc-726b967f63e7"
      unitRef="usd">69300000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzg5MA_2c94f65d-c8b6-4d19-8dc9-8155a4120fad"
      unitRef="usd">17900000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares
      contextRef="ib444eb3971eb4078a9095005df6a2388_D20191101-20191130"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzkzNA_f4e4a53f-5aad-48bb-bc1c-7a7327cab8cb"
      unitRef="usd">12600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfMzk3OQ_dd8f16f9-5ab7-4f9c-901f-3ee3ba350482"
      unitRef="usd">30200000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment>
    <holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest
      contextRef="i9a899c4bae794d06842003a1fa6af944_D20191121-20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDA3OQ_91b90329-aa91-4ce2-afa3-ab621ac4b4ff"
      unitRef="usd">8600000</holx:BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest>
    <us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage
      contextRef="i723a995e7e6e469f93a43a1b15d07825_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNDIxOQ_498a82b1-090b-4b96-aa0a-c0fda21c9b5a"
      unitRef="number">0.81</us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMC0xLTEtMS0w_b10a96d2-5d93-42c9-aac6-e28f9ab7084b"
      unitRef="usd">2600000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMS0xLTEtMS0w_82f92295-8b7a-4642-910d-4b4959c5217e"
      unitRef="usd">7100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMi0xLTEtMS0w_66f9e42b-6dc4-4ed7-b5b9-f364b6a3d403"
      unitRef="usd">10000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMy0xLTEtMS0w_7dc19ac9-0726-4ea8-b2f3-7b0bac0ed7de"
      unitRef="usd">6500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNC0xLTEtMS0w_89567f93-1a96-47a4-9102-b3d5a9614a4b"
      unitRef="usd">4300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNS0xLTEtMS0w_cb8855be-1e15-4a30-b4e0-656127953c11"
      unitRef="usd">24500000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNi0xLTEtMS0w_62ad90e3-9f22-475f-9b4e-e26b9894e65d"
      unitRef="usd">1800000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfNy0xLTEtMS0w_02a09f37-e146-4976-8fed-605a4854ab75"
      unitRef="usd">8800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfOC0xLTEtMS0w_27b4cd8c-1890-4050-80b6-b89039d2e8fa"
      unitRef="usd">3800000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTAtMS0xLTEtMA_4c8461ce-6634-43c1-9732-3416de80cb80"
      unitRef="usd">38300000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTEtMS0xLTEtMA_65d5a2aa-b1b6-4cc5-b9b8-30ab9f9ebcb1"
      unitRef="usd">4000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTItMS0xLTEtMA_733af71d-aed1-4d58-99e6-761d06fa1d9f"
      unitRef="usd">3000000.0</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTMtMS0xLTEtMA_d2f33e6c-7dac-4cd0-bc0b-e6c1207626f3"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTQtMS0xLTEtMA_3f63ffb6-705a-4c14-8bde-616ad0221af1"
      unitRef="usd">34300000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i0abfc60aa15d4a8bade3170d8c3c2954_I20191121"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RhYmxlOmIwZWE5NTZiYjc2ZDQ0Yzk4NzM0ZDkxOTlmN2Y2Y2I4L3RhYmxlcmFuZ2U6YjBlYTk1NmJiNzZkNDRjOTg3MzRkOTE5OWY3ZjZjYjhfMTUtMS0xLTEtMA_5071b59c-2716-4ea6-aa83-d025f2e957b3"
      unitRef="usd">69300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:FairValueAssumptionDiscountRate
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNTM1MA_e5a315be-72a5-4170-a3ba-9e79a4840ec7"
      unitRef="number">0.120</holx:FairValueAssumptionDiscountRate>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i0b7ae2b69c584c9bb1faea69bab3ce7d_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3Ng_84c105df-6830-4e08-914d-851247867e79">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i3bcf08abaf134bbebc54968c5252645d_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3Nw_e093171e-78d0-48dc-b0e0-c89496ebae74">P9Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iaddf820f39534b4598834451cecb88ea_D20191121-20191121"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV80OS9mcmFnOjdkOWUyOTI2MWU0NjQyNjU5ZGNlZWQzNWUzNDBjZjM3L3RleHRyZWdpb246N2Q5ZTI5MjYxZTQ2NDI2NTlkY2VlZDM1ZTM0MGNmMzdfNzc3OA_a25a54d2-aa15-45db-b118-14226ec7e8ad">P8Y7M6D</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMzM2MQ_7e8ec53d-1102-41a2-8e5d-2fd3ee7052af">Disposition&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Sale of Medical Aesthetics&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp;amp; Rice ("CD&amp;amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first quarter of fiscal 2021.&lt;/span&gt;&lt;/div&gt;</us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration
      contextRef="ic22ee4e6996843b09dfab94a3c9ee000_I20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMjE2_b1ade86b-97f3-4638-a9ab-9d70abc6a150"
      unitRef="usd">205000000.0</us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration>
    <us-gaap:ProceedsFromDivestitureOfBusinesses
      contextRef="i263b950faa89407aa9ae0648ede3cbf6_D20191120-20191120"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMzQx_4f573e85-e6fa-4a76-a44d-dc3a078db747"
      unitRef="usd">153400000</us-gaap:ProceedsFromDivestitureOfBusinesses>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup
      contextRef="i94e4cd78e2a64f9c8f35fa4309e98439_D20200628-20200926"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTA5OTUxMTYzNTI1Mw_afdd4cbe-5933-4971-8808-013f90138da5">150.0&#160;million</us-gaap:DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup>
    <holx:IndemnificationLiabily
      contextRef="icc6c143516c3424da5de0d0db2e91e98_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfNzg4_b2f3c59c-9b28-493f-8b6f-7ec9adb65976"
      unitRef="usd">10900000</holx:IndemnificationLiabily>
    <us-gaap:AssetImpairmentCharges
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTc1OA_0d46d3f8-6aa6-41d9-9199-7a271e03f8a7"
      unitRef="usd">30200000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTg4NA_3333f408-1190-4d7c-9c44-ca0da94997b4"
      unitRef="usd">25800000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i3e1d2a8de8624ac59da8d9efd1fbaf86_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTkzMw_1063f988-b6a7-47e0-a03a-9f6d9042937b"
      unitRef="usd">4400000</us-gaap:AssetImpairmentCharges>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81NS9mcmFnOmY3MmJlYjBiNzkyNjQ4YTBhZDI3MmFmMTMwM2E0NGE2L3RleHRyZWdpb246ZjcyYmViMGI3OTI2NDhhMGFkMjcyYWYxMzAzYTQ0YTZfMTA5OTUxMTYzNTIzOA_ef1eca15-bd4b-4a12-b398-46a64bbd18a9"
      unitRef="usd">46500000</us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTExMg_7c91b503-3f79-4299-9c0b-78ff16a059a7">Borrowings and Credit Arrangements&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2018 Amended and Restated Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of December 26, 2020, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of December 26, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of December 26, 2020. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of December 26, 2020, the full amount of the Revolver ($1.5 billion) was available to borrow by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of December 26, 2020, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:72pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering in September 2020 and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the 2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, including a premium payment $20.8&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to the redemption, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the term of the 2029 Senior Notes using the effective interest method.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTEwNg_c543e059-f8a7-4c79-b34f-0f4559470ead">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.386%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.216%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.365%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolver&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;324.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,361.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,379.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;939.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;932.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,689.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,713.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,764.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,038.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMi0xLTEtMS0w_5d6fad83-6764-4431-941a-adcef3fc6dbb"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="ieb7f71fe3fdf45758b7a447848bff326_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMi0zLTEtMS0w_feef9b36-1219-4d35-8120-6722380ac6b6"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i0bb87ee83878455d9a7b108c2fa2d672_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMy0xLTEtMS0w_006438a9-df86-4347-818b-6b82c1c4d271"
      unitRef="usd">0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="id6786a0492e547de9f464fbf0e844870_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMy0zLTEtMS0w_ea7a8265-b456-4575-8640-51d414fcdf95"
      unitRef="usd">250000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfNi0xLTEtMS0w_dadd12ec-3293-4bff-97ec-09bfc39d3f78"
      unitRef="usd">74900000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfNi0zLTEtMS0w_e4d499c2-01ca-4d3b-88c0-65b2014fc950"
      unitRef="usd">324900000</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfOC0xLTEtMS0w_a33c372b-bee2-46fe-8fbe-6b9c854a2820"
      unitRef="usd">1361800000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ieb7f71fe3fdf45758b7a447848bff326_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfOC0zLTEtMS0w_d55a31f2-e61e-4669-a3b9-94e479fe9194"
      unitRef="usd">1379900000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i67ca1e7d9cac43759262d127ccab005b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTAtMS0xLTEtMA_f864ce5c-4178-4802-ae70-ee74e8539344"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i82e420f21c4c4b3f8b908f387378a7f2_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTAtMy0xLTEtMA_3ab81848-971f-420d-a897-782f20bc59f1"
      unitRef="usd">939400000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="id33757ebc0984bec86c4ac09abcd3c10_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTEtMS0xLTEtMA_64d74e9c-a2e3-4414-af04-f2bc3efcb124"
      unitRef="usd">394800000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i3c6dd14c95ef47a7949124d127e36455_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTEtMy0xLTEtMA_dd60987b-da8c-4f16-9128-0d51e9120f70"
      unitRef="usd">394600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i2dbe00ac4547495f87d9491d8dd3581b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMS0xLTEtMTU3NA_0b88f573-e59a-408b-92eb-2bcc8caeb50a"
      unitRef="usd">932900000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ie68151a708294400b3d034999da20c0b_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMy0xLTEtMTU3NA_937ab5d5-d982-4519-978d-fdd4bd357a30"
      unitRef="usd">0</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMS0xLTEtMA_21985d8a-814f-428c-ac6d-bd030425c05e"
      unitRef="usd">2689500000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTItMy0xLTEtMA_71d4d342-dc9d-4cf8-b090-10ce8fa47f26"
      unitRef="usd">2713900000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTMtMS0xLTEtMA_5b19f3c6-2937-422e-b6a2-dda84295ce75"
      unitRef="usd">2764400000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmM1OWM3M2ZiMDIzOTQ4YTViOTI1Yzg3ZTE4YzY2NTIzL3RhYmxlcmFuZ2U6YzU5YzczZmIwMjM5NDhhNWI5MjVjODdlMThjNjY1MjNfMTMtMy0xLTEtMA_672ee526-fc4b-45d3-8a7a-f89fd238c638"
      unitRef="usd">3038800000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="i6b85682ab2d3455ca69df8563e60aa95_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzg5NA_a77ee8b1-e3fd-408f-ae6d-d1cea9c1cac4"
      unitRef="usd">1400000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i272b18cc7ba74e908f1067ae52fcdb03_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfODUw_4687d82f-0123-4be0-bc66-e9683bba0da4"
      unitRef="number">0.0100</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ifcd33ea87772405fa0aef1f0eddaef72_I20181217"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0NzkwOA_de396f72-7630-432f-87ac-c85097374712"
      unitRef="usd">1500000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LongTermDebtCurrent
      contextRef="if3dfc408634648eb84ad199842d8c60c_I20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjE5Ng_fb7e6a44-ec35-44dd-98b5-ad15864b7ee8"
      unitRef="usd">750000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:RepaymentsOfDebt
      contextRef="i266e0d14a55f4367b1cb47da87337f49_D20200927-20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjIxOQ_f4beeba1-834d-4ebb-8497-9a8352a8f491"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:RepaymentsOfDebt
      contextRef="i5ccd74dfac1940edb3766ae879c3f548_D20200927-20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjQxNw_215080eb-06ab-4724-83c4-c2ddb2e348da"
      unitRef="usd">250000000.0</us-gaap:RepaymentsOfDebt>
    <us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount
      contextRef="i0bb87ee83878455d9a7b108c2fa2d672_I20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMjUwOA_74d6693f-4eda-4f7f-b10e-f177289de86d"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTA5OA_b7f8c5ba-185a-44dd-8ddc-495336ebdad7">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.591%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMi0xLTEtMS0w_94d0f3d6-349c-4b89-9444-e2e2b7898e49"
      unitRef="usd">6500000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMi0zLTEtMS0w_0a6a86f5-edba-4f37-bbfa-99d5d761719d"
      unitRef="usd">13600000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMy0xLTEtMS0w_b58fc4cf-40c4-4c2a-aa97-ed58d87c23af"
      unitRef="number">0.0123</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i1026a35d60fb43afa85e0ab069c4bc92_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfMy0zLTEtMS0w_97ed3bc7-ebf1-48c2-9ca9-d58be90effbd"
      unitRef="number">0.0311</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i241d11756be14078a3555bf86956ce71_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfNC0xLTEtMS0w_ffcbd7b1-9127-4d69-a9cc-9d7217c2f7dc"
      unitRef="number">0.0115</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i87a8917b112a432189d8acc8fa3c7c6b_I20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOjc2N2EwM2ZhOTgwMjQwODU5Yjg2Nzg4MzRlOTNjYzZkL3RhYmxlcmFuZ2U6NzY3YTAzZmE5ODAyNDA4NTliODY3ODgzNGU5M2NjNmRfNC0zLTEtMS0w_e7bf1962-008c-43b9-9ce9-837e7f5a30bf"
      unitRef="number">0.0304</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:SeniorNotes
      contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMyOTg_36b30810-2226-45fd-a4c7-e73f814d4834"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMTI_23756bbf-6e25-46d3-9819-6442c1691d9c"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <holx:DebtInstrumentOfferingPricePercentOfFaceValue
      contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMjA_6574c6e6-2bcd-4036-b3ad-627a784c5d7d"
      unitRef="number">1</holx:DebtInstrumentOfferingPricePercentOfFaceValue>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzMjY_7940d557-f62f-4eb6-a8ed-6aa64a4a7cfc"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="iad667aadede54f53a73843991e84d978_I20201015"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk2NA_b40bebeb-e80e-4146-baec-be565b3f4530"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ExtinguishmentOfDebtAmount
      contextRef="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk2Ng_3a8d065d-fc26-4c4a-86b0-a75937c8c9d5"
      unitRef="usd">970800000</us-gaap:ExtinguishmentOfDebtAmount>
    <holx:DebtRedemptionPremiumPaid
      contextRef="i00c2d29b22fb45e38c99aa09af3fd764_D20201015-20201015"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0Nzk4Mg_ad3d52a2-4984-4dcb-844d-9ec6b0a2608b"
      unitRef="usd">20800000</holx:DebtRedemptionPremiumPaid>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMzk3Mw_a272bf57-ceb9-4e15-a0b1-cb0b59673b4a"
      unitRef="usd">950000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzODE_1882978c-7054-4c99-81d4-c787017e6709"
      unitRef="usd">21600000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzMzOTY_df422471-a0d3-47fc-b0ab-80c571c7d316"
      unitRef="usd">5800000</us-gaap:InterestExpenseDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0MTA_62fdf5a7-ae45-48d6-be24-74ab2a483025"
      unitRef="usd">7900000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0MjQ_9e81dfdf-675c-41d6-988e-452ad67d017b"
      unitRef="usd">6400000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c96bc19976644208f9a458ae4a150c3_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NDU_2a183783-9b79-4ab9-afa9-94c92ddc131d"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="id33757ebc0984bec86c4ac09abcd3c10_I20201226"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDI0OA_239fce65-0fc3-4c3c-9981-0dc8d440fcd4"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNTA5OQ_adf41605-da9e-4e42-a8cb-2435e637285b">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#x2019;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:17pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.449%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:SeniorNotes
      contextRef="i11457d1d34284cdd848e04fc6ade132e_I20200928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfNDM5ODA0NjU0NzkyMg_d04f3b89-7b77-4712-b9ab-22b979f61024"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacc119bc81e747be85919ea8b7a55a46_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NTM_ad962898-9a1c-44ee-b852-1d00c968bd87"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="ie334e0aec6cd4cd1ab86db6fbbfaa551_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NjE_280086ae-0826-4a3d-b629-91ea429fc349"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9a8984669d744df49521703334b03d7e_D20200928-20200928"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0Njc_83b09c92-a9fd-4b31-82dc-029fc2f584fb"
      unitRef="number">0.40</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i96cd4aedc3204bf7bbe2a37df2b4ef1f_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0NzI_d4904858-6667-4602-be4e-1aba73b37f01"
      unitRef="number">1.03250</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="if6ebe4e0383e4fe69e44e515ac3c4504_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0ODI_d190e1a8-d8ad-4819-8f39-3193a3a58117"
      unitRef="number">1.01625</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i02a7dee3e67f41a097d797a6c9b2130e_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM0OTI_79e732cc-6d47-4b66-b0ba-c78597518982"
      unitRef="number">1.00813</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="i9a15023472504c11938a4412d729c107_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM1MDI_27338590-1ec0-4123-b946-823846ce6538"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="if22e3b1bbb254fc0b22330dc8ee7c7bd_D20200928-20200928"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RleHRyZWdpb246ODBkOGE1MjIwMzRjNDQ2YWIxNDA4NjJjMTEzNDA4NjZfMTM3NDM4OTUzNzM1MDg_ce099bdb-f383-49b8-8e44-6db277fe132a"
      unitRef="number">1.01</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8c96bc19976644208f9a458ae4a150c3_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy0xLTEtMS0w_a3aa7ebb-d5fd-4006-a970-a2158013112a"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i946944c5847f4222b4d01aab1a2fa089_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy0zLTEtMS0w_92ebad29-fdfc-45d2-a193-d0134af47ec8"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i97a53a8f47ba4871a7afa91c3b2b95ae_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfMy01LTEtMS0w_8d1aae8f-f664-4204-b0d7-f71aec9ac085"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0e7cc717b7744775a9beef49918787a7_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC0xLTEtMS0w_f6fcd266-5d65-4caf-9aa2-d776b62acab5"
      unitRef="number">0.04375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i2dce7b9053fa40d3b4c1cf61d95b2bb0_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC0zLTEtMS0w_71ccdd28-7a3e-4b87-8e85-f9378f9d62f1"
      unitRef="usd">2300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i5687e57173b24d598e070c83cda5ba64_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNC01LTEtMS0w_da653a43-e6a0-4760-9a1b-d533b9fcf70a"
      unitRef="usd">10900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="iacc119bc81e747be85919ea8b7a55a46_I20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0xLTEtMS05MDg4_d5236f1c-5ff2-44f2-a27b-5f2dfd1d8016"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ibbfc7677b0624c36ad3fa92f1412ae0c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0zLTEtMS05MDkw_d6ec5a0b-fbbc-4a95-93da-2be7cabfe043"
      unitRef="usd">8000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic040a340ce4f4e139d9aa05eac474e5c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS01LTEtMS05MDkw_87b4b23f-1aaf-4f4c-a200-12a5d4491b5c"
      unitRef="usd">0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS0zLTEtMS0w_b41a01f8-6617-4fe0-af62-46056b22b2db"
      unitRef="usd">15100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV81OC9mcmFnOjgwZDhhNTIyMDM0YzQ0NmFiMTQwODYyYzExMzQwODY2L3RhYmxlOmJmZTlhNmE2MDQ3MDQ1OGViZGRmZDg1NTM0OWNlOGJmL3RhYmxlcmFuZ2U6YmZlOWE2YTYwNDcwNDU4ZWJkZGZkODU1MzQ5Y2U4YmZfNS01LTEtMS0w_f2680bc0-da4f-4dd6-8142-f68f4a8e46b5"
      unitRef="usd">15700000</us-gaap:InterestExpenseBorrowings>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="i4145415c8afb45a4bda97db9d2be27b8_D20171001-20180929"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMTM5Mw_aa1b64e8-2bde-466d-9ae6-22f69d1d3005"
      unitRef="usd">3700000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:InterestRateCapAgreementsAggregatePremiumPayable
      contextRef="icb558ac27372440189b269e14d6cb9e9_D20180930-20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMTc1NA_cf36578c-56e3-4cd9-8236-981196e668df"
      unitRef="usd">1500000</holx:InterestRateCapAgreementsAggregatePremiumPayable>
    <holx:PrincipalAmountOfBorrowings
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMjI0Mg_49be1d97-513a-4f37-b831-b66759a0d716"
      unitRef="usd">1000000000.0</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzU4Ng_896b0941-7ced-426c-84c1-859a21756bc9"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzY4NA_1c2dd1ce-70b2-4ac5-9b94-2599c572a238"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfMzc0NQ_25b510a1-08bc-4298-88c7-104d25896bc9"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDA5MQ_73b2724d-0d6d-45a3-84a8-40d31aae0dfc"
      unitRef="usd">1000000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDE5Nw_35af0e84-8047-4426-8c4b-8b845e3d01c1"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDIwNA_2967ad08-40af-410f-b4e4-962e928c352e"
      unitRef="usd">-4300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i2b87642439d147ca81c80ca1dfb67dc5_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNDMxNA_317a5bbe-3045-4a57-8e07-579156387e2e"
      unitRef="usd">30700000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5OQ_2c81e192-4c83-45f0-9cb8-e7b5856e0d75">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.227%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.712%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.297%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized (loss) gain recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ia18821e25e654193b3722de96cae81e5_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMy0xLTEtMS0w_366f8a6f-0401-451d-a5dd-7033217552aa"
      unitRef="usd">-2900000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMy0zLTEtMS0w_3d1ddb1b-e1e3-4e40-81f2-0113c1c9f61b"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNC0xLTEtMS0w_74220e69-2958-4de1-9ca9-a842ed834971"
      unitRef="usd">-1200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNC0zLTEtMS0w_537c4473-be57-4f2e-b048-c63018c511c6"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNS0xLTEtMS0w_b145d87a-6df0-4a52-b4ad-775b12f3058c"
      unitRef="usd">-4100000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfNS0zLTEtMS0w_d350db1d-31cf-46b0-a00e-9641f8cf6791"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ia18821e25e654193b3722de96cae81e5_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOC0xLTEtMS0w_492c1f82-96f3-4686-9c14-f033b03d1f09"
      unitRef="usd">-6600000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i85349d2ad2684342b1cff7983bf06ebf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOC0zLTEtMS0w_a01ad6c6-a6e0-4ca9-8e13-9558f2839a05"
      unitRef="usd">-1500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i286d7ebed78a4fadb035fc0966ea6a7d_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOS0xLTEtMS0w_ca343b21-a12b-463b-9042-f9b008af815b"
      unitRef="usd">-8000000.0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i4bb25a429d4c413181ab8ab623f72f21_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfOS0zLTEtMS0w_00a9fae2-a2b7-4718-88c7-4530a02326d0"
      unitRef="usd">-1500000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMTAtMS0xLTEtMA_e48d8260-c47a-4139-936c-f0b80db00178"
      unitRef="usd">-14600000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ida3f73cab4204b379ced9f87d3ef3f8c_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjQyMDdkMjA0MjI0NzRhOWZiYjY4NGQzNzNkY2IwYjVjL3RhYmxlcmFuZ2U6NDIwN2QyMDQyMjQ3NGE5ZmJiNjg0ZDM3M2RjYjBiNWNfMTAtMy0xLTEtMA_c24720bc-31eb-4a18-8378-7f85a4aea194"
      unitRef="usd">-3000000.0</us-gaap:UnrealizedGainLossOnDerivatives>
    <holx:NotionalAmount
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNTgyOA_82e6f475-fbaa-4495-8b9c-1a92622d4c40"
      unitRef="usd">299500000</holx:NotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i14c65c53cd0e4e41a8db5dd4fc6893ee_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjA5NQ_904034e2-fda1-4758-be4a-a683e7c1db58"
      unitRef="usd">245200000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5MQ_1226abc7-393e-47a0-ac24-9f12b1a8b194">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;26, 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ic5c79bf354ce4b21b4b0f50f1420f521_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfOS0zLTEtMS0w_4b1aa307-68c8-491c-9199-b167f8e2f7f4"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i99c9b14467904ef5b80860d433664aee_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfOS01LTEtMS0w_39f09e45-4cd9-4c59-a5da-a1f29011a1db"
      unitRef="usd">1100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="iaffcddff32544018920aee5d25e3c2ad_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTAtMy0xLTEtMA_06887e9e-bd00-48ce-a3c1-c9b12946da20"
      unitRef="usd">800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9dfb8135d4b44625bbfd0c560825de11_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTAtNS0xLTEtMA_2c6907fd-cb92-40b0-ad50-6b48a57a65ac"
      unitRef="usd">10100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="id06743973fb743b3bbaa0c0e4b84c26b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTEtMy0xLTEtMA_daf0889e-fa9e-465a-9229-c18d8cab0cef"
      unitRef="usd">800000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i3146d8c6f2de426998db38b3743e8858_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTEtNS0xLTEtMA_f40cd30f-3af3-487f-8f2d-804b3a92071d"
      unitRef="usd">11200000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="ia984d8ccc9314615a0c9a71d08c50377_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTUtMy0xLTEtMA_b4edb5bf-7089-4130-85d8-9c5bb4c73c7b"
      unitRef="usd">11100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i840c202668e846e1a52fcd4ca8bc0961_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTUtNS0xLTEtMA_6ca58d84-bde1-4848-a2c6-320cd6a709bc"
      unitRef="usd">8200000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i969e4857b92749c69746b9416f9fdfa8_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTYtMy0xLTEtMA_ce7c54e4-7cf2-4840-94a2-b757a187938a"
      unitRef="usd">19600000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i46c4fddee0c14f81993ab3606eae7ab3_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTYtNS0xLTEtMA_2a104647-d66f-4f29-9b22-dbd79404066c"
      unitRef="usd">23000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeLiabilities
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTctMy0xLTEtMA_3b53e0e2-f909-420d-84cf-67e0e041105a"
      unitRef="usd">30700000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTctNS0xLTEtMA_2bb3883d-6113-4a44-ac4b-79cfa692bc04"
      unitRef="usd">31200000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i81a59afa7d3848bf9b91f17ca827426a_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTktMy0xLTEtMA_e7a16e28-4da5-4de2-8ac7-ebab24c7984f"
      unitRef="usd">6000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i549ec774b12e4aa1a72a71662a06229e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjNlYmJhMjliYzEzZTQ4Y2Y4ZWZmODNlZTdjOTlhNWYzL3RhYmxlcmFuZ2U6M2ViYmEyOWJjMTNlNDhjZjhlZmY4M2VlN2M5OWE1ZjNfMTktNS0xLTEtMA_0e171d15-87a5-4daa-9d18-6934e3a5c711"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5Mg_2c00f803-f418-4790-a529-8d5407222422">&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.905%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of gain (loss) recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate cap agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i9b526325470e4851899ddde2dfebb8f0_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfMy0xLTEtMS0w_43e93605-6697-40c6-8f3a-f2b99ba3dbbd"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ib4ed328b143e46f393e178fe3e3ca611_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfMy0zLTEtMS0w_a11eeec1-46a7-444c-83c8-47de1073e908"
      unitRef="usd">-4300000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="i3be9e57ba38f4e4eab5fb7b166680c7c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNC0xLTEtMS0w_9e7548c4-f2db-4100-92f2-2434c59dc864"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ib397c4180063456a85a4f4404a73c0ab_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNC0zLTEtMS0w_352fce23-a50c-4465-908a-8a75d9837871"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNS0xLTEtMS0w_38e7f208-6be9-4e8f-9a1c-ae6af77be48c"
      unitRef="usd">700000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjM2YTRjZDI0NTNiZTRiZWZhMmMyYTAyOWY1ZTBlMmE3L3RhYmxlcmFuZ2U6MzZhNGNkMjQ1M2JlNGJlZmEyYzJhMDI5ZjVlMGUyYTdfNS0zLTEtMS0w_71056a88-be5c-483b-a27f-075a1636b66d"
      unitRef="usd">4000000.0</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RleHRyZWdpb246MjBjNGI1ODNmNzhmNDZlYTk4N2E1YmI2Y2FhMjEzODRfNjY5Ng_75d36f35-afca-467a-b969-6a54f2fe4009">&lt;div style="margin-top:18pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:11pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.432%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.325%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.697%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.289%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.700%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives not classified as hedging instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of Loss Recognized in Income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="i7ced3c7b6bc347edb64064ea347792a1_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMi0xLTEtMS0w_d5ba894a-721c-47cb-b198-8d224ec36c25"
      unitRef="usd">-9500000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings
      contextRef="ibfed9d2d0c8c46be91e8f912672b894f_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMi0zLTEtMS0w_1c4acee1-caa1-44f6-8664-7e64b5363875"
      unitRef="usd">-1500000</us-gaap:GainLossOnFairValueHedgesRecognizedInEarnings>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ib6d9158bf57a4de4bb11c3ce2fbd34c8_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMy0xLTEtMS0w_fb0a26a7-9ccc-44ce-a50d-aa4acb7ede84"
      unitRef="usd">-9200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="idd61c3510e7e468085daf8a67ff23b49_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfMy0zLTEtMS0w_0b46e156-28cb-4777-a365-cf4e60dfe687"
      unitRef="usd">-1700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfNC0xLTEtMS0w_3f3f0284-a12c-4c1f-9830-d6dfeb2cedec"
      unitRef="usd">-18700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82MS9mcmFnOjIwYzRiNTgzZjc4ZjQ2ZWE5ODdhNWJiNmNhYTIxMzg0L3RhYmxlOjYzYzY1MTE0N2NmMTRhODdhYmNlM2Q2OWYwMDg1OTEwL3RhYmxlcmFuZ2U6NjNjNjUxMTQ3Y2YxNGE4N2FiY2UzZDY5ZjAwODU5MTBfNC0zLTEtMS0w_47dce610-c726-4aab-948a-352dff7c7090"
      unitRef="usd">-3200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfNzU0MA_30160de2-b9f1-4ab8-a534-2bcf0351e445">Commitments and Contingencies&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses or any reliance on collateral findings regarding invalidity from &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review proceedings. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#x2019;s petition to address the issue of assignor estoppel.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As described in Note 7, the Company has agreed to indemnify CD&amp;amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of December&#160;26, 2020. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <holx:AmountAssessedInDamages
      contextRef="ifa0e515bd1224c0d899e4fcd02858289_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfMTk4MQ_801661b6-679c-4507-a540-d7f6e3f6a863"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="i7c99293b0e714a19b40025886a612952_D20160304-20160304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfMjUyOQ_648b9976-6cd1-4659-a630-2eafca7f3820"
      unitRef="petition">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <holx:LegalAccrual
      contextRef="ie80b72b0fb174e058cab363ca6b15048_I20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82NC9mcmFnOjkyYjc3MTQ1YTcwMjRlOWRhNDA2MWQ1ZDQ1YjYxYzgzL3RleHRyZWdpb246OTJiNzcxNDVhNzAyNGU5ZGE0MDYxZDVkNDViNjFjODNfNjc4MA_44c3458d-5616-43fc-a78e-d43354d6c09b"
      unitRef="usd">8500000</holx:LegalAccrual>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RleHRyZWdpb246YmJlYTExN2Y0MGE3NDFhNmE4YjVkNjA1NDE2ZjAwMWRfNzg2_de933733-6322-40d7-af21-8b70a661aec9">Net Income Per Share&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RleHRyZWdpb246YmJlYTExN2Y0MGE3NDFhNmE4YjVkNjA1NDE2ZjAwMWRfNzkz_374245a2-a8ef-4a96-9190-b39243f0bd63">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;258,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267,893&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;269,721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;340&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,290&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock Units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMi0xLTEtMS0w_3e8546b2-b266-4aaa-88fa-de25ca2e78ef"
      unitRef="shares">258605000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMi0zLTEtMS0w_47bbf405-fa00-481a-98ee-d28b073ede19"
      unitRef="shares">267893000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMy0xLTEtMS0w_104742e1-655c-48ae-8f03-a10d13b2e34b"
      unitRef="shares">3180000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfMy0zLTEtMS0w_9210579a-1f43-40b3-ba3e-75bd8d9d9d4a"
      unitRef="shares">1828000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNS0xLTEtMS0w_7e6c6761-5ca0-491b-aa50-45e4ffc12cab"
      unitRef="shares">261785000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNS0zLTEtMS0w_d54bfce1-9211-4e3c-a667-8e3cfb299ed8"
      unitRef="shares">269721000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i32c95d4d9c584147982e6bb76f7f2f4d_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNy0xLTEtMS0w_341718f8-2551-430b-9636-2119c4de08ff"
      unitRef="shares">340000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i171272f0c8eb474abf7abd9bc10110a5_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfNy0zLTEtMS0w_7790708f-af27-4fd0-a32a-cca160e2cd53"
      unitRef="shares">1290000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i55ee422e40ce4f768cceb979f540e79d_D20200927-20201226"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfOC0xLTEtMS0w_8e42fdf4-a8cd-49c4-bc9a-4977ae291563"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i476aabde140941c0aab31725a7ba549e_D20190929-20191228"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV82Ny9mcmFnOmJiZWExMTdmNDBhNzQxYTZhOGI1ZDYwNTQxNmYwMDFkL3RhYmxlOjZmYzMwMTE3MTAzYzQ5ZDViNGMxMWE4OTgxMTQxZGZlL3RhYmxlcmFuZ2U6NmZjMzAxMTcxMDNjNDlkNWI0YzExYTg5ODExNDFkZmVfOC0zLTEtMS0w_9bea2fee-c9ee-4285-a7b3-e33503e60e50"
      unitRef="shares">1000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk2Ng_3454cabc-4c4e-4671-86f4-8a41c077772b">Stock-Based Compensation&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted options to purchase 0.6 million and 0.8 million shares of the Company's common stock during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average exercise prices of $68.35 and $45.67, respectively. There were 4.6 million options outstanding at December&#160;26, 2020 with a weighted-average exercise price of $44.13.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.5 million and 0.7 million restricted stock units (RSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average grant date fair values of $68.35 and $45.64 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.35 and $45.65 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years provided the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $68.35 and $45.65 per unit during the three months ended December 26, 2020 and December 28, 2019, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;service period. The Company is recognizing compensation expense for PSUs and FCF PSUs ratably over the required service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31 and $43.78 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;26, 2020, there was 3.1 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;26, 2020, there was $26.0 million and $83.2 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.7 and 2.3 years, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk0Nw_a09a51af-3b40-4754-bb53-05292c295557">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="iafdc57909e694817a52781dc7898179f_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMi0xLTEtMS0w_9453fd91-42db-4066-8d20-f409d60832ed"
      unitRef="usd">2200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="id040eddf67924e3ab672053d4e6b5f72_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMi0zLTEtMS0w_5c8f9096-dcca-4657-9fd6-a4ae28021464"
      unitRef="usd">2000000.0</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iff6b7ab624354224947dce01c73a9d53_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMy0xLTEtMS0w_74bb375f-6dc9-414d-9f8c-6df7eeb02a7e"
      unitRef="usd">2500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5144cd88e48a4b849b044fdf0eba3d60_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfMy0zLTEtMS0w_06635fd4-9301-4790-917b-aa1fc81d1111"
      unitRef="usd">2400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9547059f414e4ec8bb5994e0b274a8e4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNC0xLTEtMS0w_32249d8d-0d16-4cbd-8ac0-401588876197"
      unitRef="usd">2700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if39c287645e74eff89da805fd540f295_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNC0zLTEtMS0w_6986d8e8-8adf-4396-ad86-2ba6b0d0f2c5"
      unitRef="usd">2800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i9b5e1cce238241218daf5e00d5bdb7b5_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNS0xLTEtMS0w_a0e79168-9e18-475e-a474-1df6f299d0ef"
      unitRef="usd">11200000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i1b9c1bb1bfb5498d9c90a1947235bccf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNS0zLTEtMS0w_b9d06401-82ee-4a94-b0dc-1983360ad86e"
      unitRef="usd">10900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNy0xLTEtMS0w_9f08354b-3355-41e7-ba6d-c01e1065de0a"
      unitRef="usd">18600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmIwNjdlMmQwMjMxNTQzZjdhN2JiNjhhNTFjNTE1YWE0L3RhYmxlcmFuZ2U6YjA2N2UyZDAyMzE1NDNmN2E3YmI2OGE1MWM1MTVhYTRfNy0zLTEtMS0w_ce73c4eb-5466-4998-a9ff-9ea758e40cb7"
      unitRef="usd">18100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTg5_fdb7dec6-287e-4422-afb6-5c1f8c753bbb"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i855677b1eae843febb6235b904a536d4_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTk2_c5be212a-1e24-4ba8-a944-3aea88429380"
      unitRef="shares">800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzE2_1f609b19-0deb-4684-ad81-470a9ba3003a"
      unitRef="usdPerShare">68.35</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i855677b1eae843febb6235b904a536d4_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzIz_9a59be8f-f53e-437c-9c35-9e135d43ed7d"
      unitRef="usdPerShare">45.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMzUy_e6cbb460-9cb4-4d98-b80a-f724f124b37b"
      unitRef="shares">4600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNDIz_51663cb6-6d2a-4fa0-be34-04f7b416fe7e"
      unitRef="usdPerShare">44.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjk1Mg_22529c5a-2574-42e2-a71e-c5a95e56be6b">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.028%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.334%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.336%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMi0xLTEtMS0w_eea461b4-97d1-4f32-945d-48266157f8fe"
      unitRef="number">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMi0zLTEtMS0w_630f4ed5-b941-4e7b-ba8a-2d615feea044"
      unitRef="number">0.017</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMy0xLTEtMS0w_4271f1c2-ac50-4b83-88a7-ee515ca1cedd"
      unitRef="number">0.350</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfMy0zLTEtMS0w_0a5e3021-5af5-4453-b268-456dab3a479d"
      unitRef="number">0.336</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNC0xLTEtMS0w_38ed0179-d129-4015-b120-1fa72618eee6">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNC0zLTEtMS0w_0af91594-2555-4886-a449-a08a0c3c2843">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNS0xLTEtMS0w_a35e530b-293a-4f1a-bc87-5fe377dc0b70"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNS0zLTEtMS0w_d7fba088-6696-40f9-899e-04df5e7ed99d"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNi0xLTEtMS0w_5ca20235-1d17-4ea9-ae98-9c06cac318b1"
      unitRef="usdPerShare">19.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RhYmxlOmI0MzVkNmQzMTI4ZjRlN2RhYzc3Y2RmZWE2MjJkZjJmL3RhYmxlcmFuZ2U6YjQzNWQ2ZDMxMjhmNGU3ZGFjNzdjZGZlYTYyMmRmMmZfNi0zLTEtMS0w_d3a3c586-11be-4888-b689-a12f8e3000ed"
      unitRef="usdPerShare">13.83</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNjQ0_72ad03ce-c2aa-417b-9900-5fe6298d6596"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNjUx_4d4b8ed8-f3da-4c77-91ef-404870028f02"
      unitRef="shares">700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNzg0_321a17e0-3808-4d83-aca6-231c2c6f8bbd"
      unitRef="usdPerShare">68.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i879142dd35b944c0bf34fbf230d98f39_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfNzkx_82b170e7-2604-4990-9fdd-64bd7e4d13d6"
      unitRef="usdPerShare">45.64</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfODUx_a7f4e745-b9e4-4386-9a43-0d9792ea873e"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfODU4_f646eaf1-019e-431f-9b69-0fa7d42bbf3a"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0b544f93ef4a4012b32cdfa464e07b04_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTA0MQ_ab16967d-4b29-4168-b50c-8a86d14e0c0c"
      unitRef="usdPerShare">68.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2a908337b56a45fbbfb5fb878e070e5b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTA0OA_fa4a8c83-4ef1-4cd8-b383-234af163152a"
      unitRef="usdPerShare">45.65</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTEyOQ_665cdfdb-a812-4b66-8783-91ce8614256c"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTEzNg_cc5cb3a3-80b3-478d-819c-8d6ff399ad90"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTIxNA_763f9c45-d64b-4b6f-896e-25c741c55566">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTMyMg_9fcccb0e-4959-4ece-ba8a-bf022e606fa1"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTQ1MA_dc468212-6046-4a13-b5a1-052758c0561d"
      unitRef="usdPerShare">68.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i222c1fb4f1a2414e9946da61a536f902_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMTUyMQ_196b2815-e187-427e-8e56-112fdb3c9393"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjA5Mw_ee59a65c-b67b-44c1-b5ff-55b8db23bf9f"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjEwMA_aa438fb3-1ac3-4013-a631-4ea3bad92c08"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjI2OA_665cdfdb-a812-4b66-8783-91ce8614256c"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjI3NQ_cc5cb3a3-80b3-478d-819c-8d6ff399ad90"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjM1Mw_763f9c45-d64b-4b6f-896e-25c741c55566">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i7889ac0b05d744c7a8ddbe1eac4f0256_D20200927-20201226"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjQ3MA_eaa98c59-fc64-4fdd-b36b-4fde61fcb57b"
      unitRef="usdPerShare">82.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie39e5a3d8a444ec799d352096a1e8e8b_D20190929-20191228"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjQ3Nw_3ce81d29-11c5-4f7e-875d-8b2fb68b64bd"
      unitRef="usdPerShare">43.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i4bd4f87650894ee382525ad3d40a1b96_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjY0MQ_581e2064-15b6-41be-af08-5910d850feef"
      unitRef="shares">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i9aa17c0c19b24f93bc412700aea8fd05_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjcxOA_b6fee9f7-57ba-4e04-abea-98e2b7dc45dd"
      unitRef="usd">26000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i5a35e9e5b1784502b251b8e6485fc0ac_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjcyNQ_e5a2b55c-bbd8-458b-a9ae-0076bcb69cef"
      unitRef="usd">83200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjkxNw_a39650f0-cba5-4f87-8f51-43a5b3a9646e">P2Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ie47b0c5f5621402f84839a5d5501cb97_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83MC9mcmFnOjEwNmQyOTZlOGEyNTQ4YmJhOTY5YjM4YmU1ZmM5YzkzL3RleHRyZWdpb246MTA2ZDI5NmU4YTI1NDhiYmE5NjliMzhiZTVmYzljOTNfMjkyNA_8f572ad3-26e9-4600-974a-35bbb3086f54">P2Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <holx:DetailsOfCertainBalanceSheetAccountsTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTY_cfef6003-b451-4736-b19b-7151f595aaf3">Other Balance Sheet Information&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTE_8b0e47de-cc19-47eb-a94a-02211d35d227">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;420.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMi0xLTEtMS0w_897645f6-2f21-448f-94ff-09b99dfc28f5"
      unitRef="usd">152600000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMi0zLTEtMS0w_d3725d16-fcb1-40a1-8f31-2ea2e7136fc8"
      unitRef="usd">152300000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMy0xLTEtMS0w_864d1b1c-d172-4e34-aeb5-eb7041f53442"
      unitRef="usd">60100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfMy0zLTEtMS0w_b0d06ed8-15d4-43f4-9ff4-dd468fcc3d28"
      unitRef="usd">46500000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNC0xLTEtMS0w_565ba401-1d76-4f8e-85c6-343abf83927e"
      unitRef="usd">207500000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNC0zLTEtMS0w_de250025-6729-4fd9-8f2f-ba4221c13f7e"
      unitRef="usd">196300000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNS0xLTEtMS0w_16933ad7-c155-4026-96d9-800de4cc3a5f"
      unitRef="usd">420200000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjU2ZTZhMDRmZDliMDQ4NGQ4ZDFlMTIyMTBlMzA1NGRjL3RhYmxlcmFuZ2U6NTZlNmEwNGZkOWIwNDg0ZDhkMWUxMjIxMGUzMDU0ZGNfNS0zLTEtMS0w_1a853c1b-6c70-4c94-922b-ec92c3b26788"
      unitRef="usd">395100000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RleHRyZWdpb246NDY4ZGQ1YzBkMzZmNDZlMDlhY2QxMTA4NTI3ZDQxNjBfNTM_c84a73f4-8efc-4228-9212-5eb043016390">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;460.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;478.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,237.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,185.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(723.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(694.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;514.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMS0xLTEtMS0w_038137da-0ee0-4b57-85ea-74be43792cc7"
      unitRef="usd">483100000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMS0zLTEtMS0w_32e3eb79-1719-4f02-a549-be522c859178"
      unitRef="usd">460700000</holx:ManufacturingEquipmentAndSoftware>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMi0xLTEtMS0w_068e183f-9ba3-4453-a089-849b389a85e1"
      unitRef="usd">478300000</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMi0zLTEtMS0w_379e0151-8479-49c5-84cc-9ab5e38a1016"
      unitRef="usd">456800000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMy0xLTEtMS0w_447522c1-8cf2-4e24-af80-0fec0a5c9aa5"
      unitRef="usd">173700000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfMy0zLTEtMS0w_9da85f3a-e132-4d22-9f6a-443d3b35b176"
      unitRef="usd">167300000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNC0xLTEtMS0w_0007d041-3a1f-4d03-a891-764dc349c44a"
      unitRef="usd">45200000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNC0zLTEtMS0w_57e6355c-cf0f-4902-9bb3-af96220badfe"
      unitRef="usd">44300000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNS0xLTEtMS0w_114d28c1-bc49-4dab-9deb-031abb31693a"
      unitRef="usd">40800000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNS0zLTEtMS0w_8fcbce06-27ac-4aa1-9011-640bc98b9fb1"
      unitRef="usd">40700000</us-gaap:Land>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNi0xLTEtMS0w_757f4243-0d29-41c1-bdab-abae6a358bb8"
      unitRef="usd">16600000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNi0zLTEtMS0w_d7e1e795-0e80-45fb-a940-a8caf9e586b4"
      unitRef="usd">16100000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNy0xLTEtMS0w_851ddeac-fa58-4d8a-a13f-ca39265cd4b9"
      unitRef="usd">1237700000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfNy0zLTEtMS0w_ec8cd101-70c2-432a-a82d-0283cbbaaed3"
      unitRef="usd">1185900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOC0xLTEtMS0w_e587eb8c-1b4b-4686-827a-89f61f1e1350"
      unitRef="usd">723200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOC0zLTEtMS0w_77946221-b8af-4a0b-8a0f-13fce2d5d8b4"
      unitRef="usd">694400000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOS0xLTEtMS0w_74b78f39-7dfc-47ec-a19a-3260d86277b9"
      unitRef="usd">514500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83My9mcmFnOjQ2OGRkNWMwZDM2ZjQ2ZTA5YWNkMTEwODUyN2Q0MTYwL3RhYmxlOjgwMDBmNWU4Zjk3MzQ5ZmFiOTMwOTllNTk4MmJmMzkyL3RhYmxlcmFuZ2U6ODAwMGY1ZThmOTczNDlmYWI5MzA5OWU1OTgyYmYzOTJfOS0zLTEtMS0w_780a6456-ecbe-46eb-9150-c11e0cd90798"
      unitRef="usd">491500000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAyNw_fa12ad44-71b4-4355-a39d-9afba34e34a5">Business Segments and Geographic InformationDuring the first fiscal quarter of 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first fiscal quarter of 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019. Segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,719.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of world&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTI4_5c926c5b-f492-4623-9792-a67e5c6acdcf"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i10c0a8b3f4be439a89b84dd347cf9122_D20190929-20200328"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTI4_908d00c6-6375-42d9-a0e3-d3d19ab0066f"
      unitRef="segment">5</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_320138f3-01e0-4e64-b24c-b84be4e252da"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_4c15c0ac-dd27-4360-bb5c-424409574257"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5132f5a64161477d9659bcfb23dd2d2d_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_7c86c09a-8e31-461f-abb5-50b9feb68e66"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i964f3515c8f44fc89d36c781fe3b66d9_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMTIwMA_e078eb44-bc96-41b8-ac8f-416bd7a9fc37"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAxNA_db51ee79-7f88-4f98-9320-17233ee41d84">egment information is as follows:&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,128.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;311.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;332.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,609.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;784.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;86.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(51.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;885.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;124.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medical Aesthetics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,177.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,203.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,200.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,418.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,438.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,719.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,355.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,195.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMy0xLTEtMS0w_718577ef-8674-4b83-9a68-95fb93b1875f"
      unitRef="usd">1128200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMy0zLTEtMS0w_6154be60-69c3-4c47-9185-84bd40dec8fc"
      unitRef="usd">311500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNC0xLTEtMS0w_a91715d1-906c-4f4b-b645-d8bcb48c2db3"
      unitRef="usd">332700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNC0zLTEtMS0w_2b40cb6c-f23e-48ab-8c52-98398daac0fb"
      unitRef="usd">331100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNS0xLTEtMS0w_cda94c9f-5bc4-4204-8090-e5be6026ca19"
      unitRef="usd">124000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNS0zLTEtMS0w_798f59c9-6a5c-4f9c-9c1d-e7a53c983d70"
      unitRef="usd">119100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNy0xLTEtMS0w_e08210a4-a4b5-4d5f-9f99-4d9266e0e6d9"
      unitRef="usd">24900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfNy0zLTEtMS0w_a934cf22-76cf-476a-a291-f1d95dab0a45"
      unitRef="usd">23500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0xLTEtMS0xNDk1_7ff305e3-6e8f-4cc9-9e13-0511f2f3f47f"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0zLTEtMS0xNDk1_bdfc4002-657c-4bf7-90a9-f4e444907ea0"
      unitRef="usd">65300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0xLTEtMS0w_50fbd1f0-3937-420d-95d8-f54516b30665"
      unitRef="usd">1609800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfOC0zLTEtMS0w_44eaec13-b176-4778-8662-7111b6cf6dcc"
      unitRef="usd">850500000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTAtMS0xLTEtMA_b6b82008-46af-4d3d-9f51-c9f1cf2a7614"
      unitRef="usd">784500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTAtMy0xLTEtMA_6200a856-05a7-41ac-8774-1450ad53f3b0"
      unitRef="usd">49500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTEtMS0xLTEtMA_5a443f25-4c17-4da2-9e46-7e4e0c550b3e"
      unitRef="usd">86300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTEtMy0xLTEtMA_a97a8cea-82c9-41f7-9341-a186e9574392"
      unitRef="usd">93900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTItMS0xLTEtMA_4a1cdb6d-7d54-41af-9b2e-592f5f2b4dd6"
      unitRef="usd">13700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTItMy0xLTEtMA_1d5b360c-ee49-4561-bb23-cebf601da95b"
      unitRef="usd">31500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTQtMS0xLTEtMA_f04a2995-4e9b-4a48-9ca8-067ccfa58b87"
      unitRef="usd">1000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTQtMy0xLTEtMA_887518be-aa52-437b-b1f5-f1f8a217c18e"
      unitRef="usd">900000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMS0xLTEtMTUwNQ_b2084beb-ce4d-4e40-ab1e-b5933a7fb896"
      unitRef="usd">0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMy0xLTEtMTUwNQ_448b4981-341a-4670-8c77-4bc7a6cc8122"
      unitRef="usd">-51000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMS0xLTEtMA_fdfef846-a073-4b35-8827-031aa0db1d09"
      unitRef="usd">885500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTUtMy0xLTEtMA_ca371c1c-0a1e-4d4b-8447-847c42011cb9"
      unitRef="usd">124800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTctMS0xLTEtMA_43c4b37a-7a00-44d6-b8a5-235e3d3a8dae"
      unitRef="usd">56300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTctMy0xLTEtMA_2c42e4e9-cbe2-477e-8bbb-9214d837594a"
      unitRef="usd">59100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTgtMS0xLTEtMA_64ebeec9-8dec-4fa6-8fad-0e47cb32fd46"
      unitRef="usd">13100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTgtMy0xLTEtMA_45689ba2-6c7b-44cc-aff1-b143767774a6"
      unitRef="usd">10000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTktMS0xLTEtMA_feb38206-360d-4fcf-9925-25e0a01278a9"
      unitRef="usd">23200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMTktMy0xLTEtMA_e147178d-e443-471c-8ffb-de95ff0abec5"
      unitRef="usd">21000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjEtMS0xLTEtMA_d580de23-7d6b-4fcf-981e-061dc52b1e62"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjEtMy0xLTEtMA_8b1a4962-87bb-404b-bd53-657ca2159731"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMS0xLTEtMTUxMw_8ab394c1-667d-4a27-9870-44b2163c334e"
      unitRef="usd">0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMy0xLTEtMTUxMw_511b0655-d636-4e55-8714-6bc7f193de5b"
      unitRef="usd">4100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMS0xLTEtMA_83693883-49c9-4be0-93a7-1ea1c3d4c222"
      unitRef="usd">92800000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjItMy0xLTEtMA_93be640c-8727-4b5a-bc8f-c27601ef68c9"
      unitRef="usd">94400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="idef65d9f9af54b9cb869f84800b92f0b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjQtMS0xLTEtMA_39fa0c2b-89e7-4abe-bb1c-9a6a91238667"
      unitRef="usd">38300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2f387b4b787a4b4c876253960d08d1bf_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjQtMy0xLTEtMA_b191bcdb-b873-4121-995d-d47e8571a9b1"
      unitRef="usd">18100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="id0c3935591854901bf7fb49b08f9ef41_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjUtMS0xLTEtMA_9a5fa893-2187-4665-bc0b-8228df1cee38"
      unitRef="usd">2900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia1f95a3ba8874c0ab2b9992bc1f4d46a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjUtMy0xLTEtMA_87751700-3810-47b4-b08a-2ffb0adddd16"
      unitRef="usd">6400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i9002d1e4a0834d64b3a0fab31fa04bb2_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjYtMS0xLTEtMA_d37945fd-0d1e-4566-a41d-c22098c3afb3"
      unitRef="usd">3300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i27dad0ec6dc2491985b024893b9bdb76_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjYtMy0xLTEtMA_7b24d16c-f280-405a-9046-0972d52e3e0d"
      unitRef="usd">5300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="idcffe5092e5e450db7039ae724c4f0ec_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjgtMS0xLTEtMA_2c25fbf7-303b-4003-bc80-d1aff3a748a8"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i3ebc5a011ab243ec9d557f33ce3ce340_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjgtMy0xLTEtMA_c2c03bd1-08f2-403d-bfb3-1baaf1518fbd"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if1a3cd78896644659e948a7690e47e54_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMS0xLTEtMTUyMw_2111e841-382e-44b0-b823-88b6233041ab"
      unitRef="usd">0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iae70212752be41b28bd54fda1cba672b_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMy0xLTEtMTUyMw_50e95a0b-62fd-4b9e-9707-0240c1309da9"
      unitRef="usd">1400000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2cca350406704671a994c46fd4de1acd_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMS0xLTEtMA_70c6fb98-8a4f-4ea4-b10b-dc6f351a5b38"
      unitRef="usd">300000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i189fd242f489432a9c8db82a5c7ffe1a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMjktMy0xLTEtMA_b57ea9d8-d18c-4839-9ba8-c9dba349490e"
      unitRef="usd">200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMzAtMS0xLTEtMA_bd905d62-3d70-41a2-b512-341dd6a1615c"
      unitRef="usd">44800000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjg4NzE3OTU4YTc1NzQ1MGNiN2E0OGNmNWRiZmFiMjMyL3RhYmxlcmFuZ2U6ODg3MTc5NThhNzU3NDUwY2I3YTQ4Y2Y1ZGJmYWIyMzJfMzAtMy0xLTEtMA_f715ce58-0a1a-4361-8577-774c387ac3a0"
      unitRef="usd">31500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="i2bd66551f9c242be97d7f7e5bf36f159_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMi0xLTEtMS0w_472cde2f-5897-4a8e-a0bb-265495ef5f24"
      unitRef="usd">2177800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i53fdb57bb16f4ecd921dea40ee6810c9_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMi0zLTEtMS0w_d7f8314d-a6d9-458f-81a4-a856dff93d46"
      unitRef="usd">2161400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="idea9543291624e5ababf4c314fce32dd_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMy0xLTEtMS0w_e593836e-5ca6-43ce-ac4d-5ca4b2336126"
      unitRef="usd">1203400000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ida8674e08ddb40be8abf86e02713868e_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfMy0zLTEtMS0w_113b9b58-4412-41de-b9f2-36b037f5ec7f"
      unitRef="usd">1200900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0ce3ba4253a94d52bc59d8eee2d9a4bf_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNC0xLTEtMS0w_f329972c-ea2e-4a92-ba12-2c995fd5eb37"
      unitRef="usd">1418500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9b99c5a4675c4355b2ada4de33915985_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNC0zLTEtMS0w_22aedefd-fad5-4449-884e-d9655951c394"
      unitRef="usd">1438700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i95f6c5d4cda44d798ae43baeb9d4c057_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNi0xLTEtMS0w_8ea604a1-63fb-4f5d-9281-f8e1fa759b6b"
      unitRef="usd">31300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i4f800d332c6b407198afce370a678a7d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNi0zLTEtMS0w_dbc46953-3b6d-4e6c-b332-e8e9855b527a"
      unitRef="usd">38900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i0a4363dfa5c645a0825be13c07abee4c_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNy0xLTEtMS0w_1f82da96-faec-4450-a841-ed3e00e6242f"
      unitRef="usd">2719700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i58367c7ce8c54c989fc82c51b7e6dbcf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfNy0zLTEtMS0w_96ceeb01-f6c9-4daa-bd33-3c70bbdc34c7"
      unitRef="usd">2355900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfOC0xLTEtMS0w_d35127b9-c694-42fe-b7a3-d7138a0ece04"
      unitRef="usd">7550700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOjM5ODNiNmE4MDU2ZDQ1ZTFhODhjZDk5ZDI5NWExNzIwL3RhYmxlcmFuZ2U6Mzk4M2I2YTgwNTZkNDVlMWE4OGNkOTlkMjk1YTE3MjBfOC0zLTEtMS0w_47af6666-6d07-4831-8208-c0948a39ada4"
      unitRef="usd">7195800000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RleHRyZWdpb246M2Y5ODUzOTEzYmMxNDIzZWExMDE0YTVjNTE5OTBmMjdfMjAyNQ_140fe03b-4adc-416d-bd3e-fecabce5d343">&lt;div style="margin-top:12pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.611%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 26,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 28,&lt;br/&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="i504b801807f54f45b6f8e3c4f8e8ab7f_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMi0xLTEtMS0w_71ab76f5-b5c5-482e-91fc-7815a8e59465"
      unitRef="number">0.707</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i0f9ff6e659fb41099b5289ce86b3a475_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMi0zLTEtMS0w_8c840ce0-8a4c-4c7f-90f2-e0a69958411a"
      unitRef="number">0.744</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i7b1f176304764c78b5167ddff1154e94_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMy0xLTEtMS0w_3116b18e-ed78-42d9-916c-680d89b1f60b"
      unitRef="number">0.210</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i735a514a841c46dea02aa695ce0c0b4c_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfMy0zLTEtMS0w_07629c50-a29a-4d2d-8b35-18a5becc9bf5"
      unitRef="number">0.129</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i06a19a89375c4d86999c1a611e362b7a_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNC0xLTEtMS0w_1f2fb654-ed0c-49b3-b388-57ff920b0419"
      unitRef="number">0.055</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="iba77fd578ab5427199523a3fa6c4a99c_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNC0zLTEtMS0w_11941ee4-85eb-465f-8198-bf5e898264f3"
      unitRef="number">0.083</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i2b1fb47303fa4a959860825ff50f60af_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNS0xLTEtMS0w_0b18dc7d-e79e-4172-af19-709a867bebda"
      unitRef="number">0.028</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="iaf46dd81205b47668902c1445ae9f97f_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNS0zLTEtMS0w_8e7fccad-4d2d-41ee-8bd0-8397230e91d1"
      unitRef="number">0.044</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNi0xLTEtMS0w_4476e67d-aa58-48ba-a0cd-712ce1139de4"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83Ni9mcmFnOjNmOTg1MzkxM2JjMTQyM2VhMTAxNGE1YzUxOTkwZjI3L3RhYmxlOmIwZGMxZGFlZjc2ZDQxNjE4NTFjODA0N2Q1NjNhMzE0L3RhYmxlcmFuZ2U6YjBkYzFkYWVmNzZkNDE2MTg1MWM4MDQ3ZDU2M2EzMTRfNi0zLTEtMS0w_6c70b0fd-4cee-4e7e-9fbb-16579e7e0d57"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNTEyNw_2a935b1b-ee70-49c9-9ccc-a321e514035e">Income Taxes&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rate for the three months ended December 26, 2020 was a provision of 21.5% compared to a net benefit of 296.1% for the corresponding period in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended December 26, 2020 differed from the U.S. statutory tax rate primarily due to state income taxes, the global intangible low-taxed income inclusion, and unbenefited foreign losses, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended December 28, 2019 differed from the U.S. statutory tax rate primarily due to a $312.2&#160;million discrete tax benefit related to the Medical Aesthetics business outside basis difference, partially offset by an increase in the Medical Aesthetics business valuation allowance. The outside basis difference is the difference between the carrying amount of an entity's investment for financial reporting purposes and the underlying tax basis in that investment. An outside tax-over-book basis difference for an investment in a subsidiary results in the recognition of a deferred tax asset only when it becomes apparent that the reversal of the temporary difference will occur in the foreseeable future. As the Medical Aesthetics business met the assets held for sale criteria during the three months ended December 28, 2019, the requirement for recognition of the deferred tax asset for the outside basis difference was also met. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Income Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to tax examinations for value added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNjEw_f8aeb6bf-7e6b-4818-a608-4331c1fbabca"
      unitRef="number">0.215</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfNjk1_1c4a7ce0-33bc-41cb-a4b5-f457a8880049"
      unitRef="number">296.1</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ic82c48e220f04e80a509c6a97393b47c_I20191228"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV83OS9mcmFnOjVlZTJkZWE2ZTg5NDQzNmE4MjgxOTE0YWZjNDQ0ZDU4L3RleHRyZWdpb246NWVlMmRlYTZlODk0NDM2YTgyODE5MTRhZmM0NDRkNThfMTA5OTUxMTY0Mjc2NQ_9ca1a8ce-419a-4f6f-82da-f7a37997e5b1"
      unitRef="usd">312200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTcxMw_ac2252c7-726c-40cf-912c-e89e8fb1654f">Intangible Assets&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,969.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,866.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,643.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,943.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,699.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;26, 2020 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTcyOA_a3d477d5-0777-4248-9d31-7a0a89d6b02d">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,056.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,969.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,054.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,907.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;549.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;477.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;245.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;181.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-competition agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,866.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,643.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,852.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,569.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,943.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,699.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,931.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,623.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy0xLTEtMS0w_ba12c12d-8b7d-4cd5-a4e6-4a7ae0a18770"
      unitRef="usd">4056100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4b4734c6630945d0ba5cf90b8f66ea3b_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy0zLTEtMS0w_b6dc9dd5-9b22-46d8-9c9a-018dedcdaf9d"
      unitRef="usd">2969400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9e60b8115b744ab191b4024f191eb8bf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy01LTEtMS0w_bcf50ccf-8e0e-4919-9ff9-3b57640498d7"
      unitRef="usd">4054000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9e60b8115b744ab191b4024f191eb8bf_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMy03LTEtMS0w_978e3768-4e24-4a4b-a24f-66ce336a3d8a"
      unitRef="usd">2907200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i243ea054fba6480fbcab7af21d6a4fce_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS0xLTEtMS0w_5d160eae-644b-4dbb-932e-05924190e8a1"
      unitRef="usd">560500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i243ea054fba6480fbcab7af21d6a4fce_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS0zLTEtMS0w_4cbd7e1f-4c4b-4060-bf07-3706748854de"
      unitRef="usd">486700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS01LTEtMS0w_f216794a-76cd-42fc-aa48-9d4ef959605a"
      unitRef="usd">549100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7e986e633b1f48ef821e7fdcc4c3f4cb_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNS03LTEtMS0w_b62385e9-26d6-4b4e-a2a8-00eef85b5ef9"
      unitRef="usd">477800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="iafa5b970ae8547d5869dbb3f0236c428_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi0xLTEtMS0w_5f19c8f2-4247-4ea0-a949-9d800fa6680d"
      unitRef="usd">245700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="iafa5b970ae8547d5869dbb3f0236c428_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi0zLTEtMS0w_4a8c1bf5-3636-41ab-afe2-0695acd2bd04"
      unitRef="usd">183800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic2252adf156645a6b718b3df114b1fad_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi01LTEtMS0w_5e587aba-1157-408f-998e-e957ef612213"
      unitRef="usd">245500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic2252adf156645a6b718b3df114b1fad_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfNi03LTEtMS0w_cde5c7d3-300c-483f-bd1b-1affee9922ac"
      unitRef="usd">181200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC0xLTEtMS0w_a2d5faf1-8d7f-426f-b9e8-5ece49ad734d"
      unitRef="usd">1600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic726ebf357c14fc3bc4f34e2bb5c37c7_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC0zLTEtMS0w_fbd2ff6a-2e04-4eee-8507-91bd6da26ced"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie951bc855db2428a86d3e005063b41ef_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC01LTEtMS0w_9bb71200-0d64-4d6d-a483-9ba850e25803"
      unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie951bc855db2428a86d3e005063b41ef_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOC03LTEtMS0w_8eaa7ea5-88ef-4a04-a937-c5cd461d4eb5"
      unitRef="usd">1300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i4e3d41a755af40568a3e504182462ce6_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS0xLTEtMS0w_684c96d7-49a6-4351-85fc-1ba1c34276a5"
      unitRef="usd">2500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i4e3d41a755af40568a3e504182462ce6_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS0zLTEtMS0w_6aad55ad-ba69-45b8-8228-6490b9f09561"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6c20b78ad72e4fe8a5420980636498f0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS01LTEtMS0w_039930ff-0e0a-42f5-bb89-30376feff0b7"
      unitRef="usd">2400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6c20b78ad72e4fe8a5420980636498f0_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfOS03LTEtMS0w_491fe4fd-2d0f-4a48-ba71-5b0836580191"
      unitRef="usd">2300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i663bf06f259e40619f00b794ee8f3df4_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtMS0xLTEtMA_9ce11d78-83d8-4124-824a-0beb54837aed"
      unitRef="usd">4866400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i663bf06f259e40619f00b794ee8f3df4_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtMy0xLTEtMA_db89c94a-4cd3-4666-b173-6b5d0e9cc062"
      unitRef="usd">3643800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtNS0xLTEtMA_dc75acef-a578-4550-acd4-30f949e307fe"
      unitRef="usd">4852500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2c9d10aa6c3744b2ba7572a9459fca82_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTAtNy0xLTEtMA_636820eb-5b78-43c0-b424-b84c286b9284"
      unitRef="usd">3569800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="if7f4ea0fd45f430abe0bc8838c398d85_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItMS0xLTEtMA_0826f6dc-d888-4e8b-8170-1f9e1b2106f5"
      unitRef="usd">51900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="if7f4ea0fd45f430abe0bc8838c398d85_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItMy0xLTEtMA_d1d5317e-1d46-47e8-ae73-33a6d830810a"
      unitRef="usd">43800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib64c67176ca34a27bd5311e672ebe881_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItNS0xLTEtMA_d5b5902b-0a7b-4d8a-bb4f-0dc5ee11b800"
      unitRef="usd">51800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib64c67176ca34a27bd5311e672ebe881_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTItNy0xLTEtMA_6328e1fc-35d1-476b-b162-d4acb101fe06"
      unitRef="usd">43200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8aeb602620b040dbb06bd27522eabae8_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtMS0xLTEtMA_a4c1e81a-5bdf-4348-bea0-651cb19e6a46"
      unitRef="usd">25600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8aeb602620b040dbb06bd27522eabae8_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtMy0xLTEtMA_ad804e70-77b1-48a4-9bcb-8b7febe6faaa"
      unitRef="usd">11500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib5e39d5d745b47fd991512768cc51329_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtNS0xLTEtMA_515f14cd-ab3d-4bcf-ae00-75536bd949a9"
      unitRef="usd">26800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib5e39d5d745b47fd991512768cc51329_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTMtNy0xLTEtMA_aa0a6bcc-f708-4712-9da7-1bc56d4ca2ba"
      unitRef="usd">10600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtMS0xLTEtMA_14e2a03a-ca40-4155-afd7-91875a8044c4"
      unitRef="usd">4943900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtMy0xLTEtMA_a01cc3fc-adf1-422a-a633-b29a07adc773"
      unitRef="usd">3699100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtNS0xLTEtMA_c12f33c8-a1e3-4594-8d90-c43c5b986f39"
      unitRef="usd">4931100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOmI1MDk2NWM3Y2M0MDRlZmQ4NWY1NmUxYjc3ZjdlODU5L3RhYmxlcmFuZ2U6YjUwOTY1YzdjYzQwNGVmZDg1ZjU2ZTFiNzdmN2U4NTlfMTQtNy0xLTEtMA_365df42d-82ec-435c-b96a-93448025852b"
      unitRef="usd">3623600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RleHRyZWdpb246MmVkYTk0Y2MxYzQ2NGI4ODk0NzE5ZjdlYWJjOTFlZWJfNTczMQ_3df288c3-2916-4c6b-90af-d1959fa0a81e">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;26, 2020 for each of the five succeeding fiscal years is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:14pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.034%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.766%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;213.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;274.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMC0xLTEtMS0w_44541d76-8ea3-4000-88d2-84ceac88306a"
      unitRef="usd">213300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMS0xLTEtMS0w_b5e4af39-bfca-4a4a-b499-ac07fd8be886"
      unitRef="usd">274300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMi0xLTEtMS0w_9c038c9f-2043-4a71-a78b-8705cdea881a"
      unitRef="usd">178000000.0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfMy0xLTEtMS0w_f515b770-d526-4665-ad5f-c81cec086989"
      unitRef="usd">166600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84Mi9mcmFnOjJlZGE5NGNjMWM0NjRiODg5NDcxOWY3ZWFiYzkxZWViL3RhYmxlOjhjZjg5Yjg1NGZiZjQyMDU4NzdjMmE4ZmMwNDA1YTZhL3RhYmxlcmFuZ2U6OGNmODliODU0ZmJmNDIwNTg3N2MyYThmYzA0MDVhNmFfNC0xLTEtMS0w_a26d7a7c-56aa-42ef-ad89-de99dbf3f4ed"
      unitRef="usd">153200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RleHRyZWdpb246OWFjNDAwZDcxZDE5NGM2Y2JiZTVkNjRkMTg4YjRmZmVfODE_695609fd-7d87-4e5a-ad7d-76f27a5716bd">Product Warranties&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RleHRyZWdpb246OWFjNDAwZDcxZDE5NGM2Y2JiZTVkNjRkMTg4YjRmZmVfNzg_631a10e8-b28f-4032-a823-439780c8fbce">&lt;div style="margin-top:6pt;text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:23pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.888%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:34.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.248%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.951%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.240%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Acquired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Three Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i2b4dfc4a55634d5980988f0884ae4448_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0xLTEtMS0w_dbb291e2-9ccd-4e77-88cf-b0f6651394d7"
      unitRef="usd">9900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0zLTEtMS0w_d98ed542-335f-4b87-b09c-a03d21680063"
      unitRef="usd">3300000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi01LTEtMS0w_74c35ae0-6281-4f0b-9d25-441221edab7d"
      unitRef="usd">0</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi05LTEtMS0w_9f528230-0b0c-4ad5-83d7-b007c9cdc1d2"
      unitRef="usd">3700000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i573838e4ead64367a1cf3a3e4674ffd2_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMi0xMS0xLTEtMA_05b2a825-1ed0-4d3b-a9a4-010481b205f9"
      unitRef="usd">9500000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="if86ea7db4fd24e63b6e2c24f3290f064_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0xLTEtMS0w_c0673bae-a891-4703-a676-743484d3a9b6"
      unitRef="usd">13900000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0zLTEtMS0w_e69eb3f2-3545-4918-9332-625f607b70bb"
      unitRef="usd">3800000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy01LTEtMS0w_d229d4c3-c581-4c46-aed8-dab81b01378f"
      unitRef="usd">500000</us-gaap:ProductWarrantyAccrualAdditionsFromBusinessAcquisition>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy05LTEtMS0w_69936296-53e2-41bf-a2c2-c8ca26efbfc5"
      unitRef="usd">4100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="ia87ad826395149329bd9e8ac7b691cb4_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84NS9mcmFnOjlhYzQwMGQ3MWQxOTRjNmNiYmU1ZDY0ZDE4OGI0ZmZlL3RhYmxlOjdiNjM1OTc0OTgwODQzMmE5OGFhZmUwYjBkMTUzY2JlL3RhYmxlcmFuZ2U6N2I2MzU5NzQ5ODA4NDMyYTk4YWFmZTBiMGQxNTNjYmVfMy0xMS0xLTEtMA_0c04741b-18f0-4edb-86c4-877b7fc6e44b"
      unitRef="usd">14100000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RleHRyZWdpb246YjY3YmNhYWI4Y2RhNDc5MDhjMTJkZjQ0OGQzNTdjOTZfMTkz_fbddcbe6-b1a5-47fa-a895-f7a26938eb8e">Accumulated Other Comprehensive Income (Loss)&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RleHRyZWdpb246YjY3YmNhYWI4Y2RhNDc5MDhjMTJkZjQ0OGQzNTdjOTZfMTkx_58e969b9-a6dd-4ac2-b15c-a99738770f7f">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 26, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(22.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(24.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(49.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;17.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(5.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(23.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(30.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.489%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.192%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.195%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 28, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Caps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(41.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(42.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amounts reclassified to statement of income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(33.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(28.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="i47fc0ea3fd504f739a98ccb1f8602c4d_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi0xLTEtMS0w_9d8d422e-73b6-4113-a345-a8737d260e79"
      unitRef="usd">-22900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i012977a16707452184c540c1c42de324_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi0zLTEtMS0w_ce41e250-ee19-4fec-ad73-7a523d3384dd"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5ca4657cf4aa4a1883690d1eebc48675_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi01LTEtMS0w_c4387037-8076-4f0d-9ab4-ee706a05594a"
      unitRef="usd">-900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i8d9e66846015431a805ecdc7a2b07991_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi03LTEtMS0w_109322a8-5783-4687-be9e-dd65d40b0731"
      unitRef="usd">-24100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a34844d9d004ca59421077b20e85919_I20200926"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMi05LTEtMS0w_4bdf0807-fb64-48b1-875a-36238406dd24"
      unitRef="usd">-49700000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy0xLTEtMS0w_e073865c-019e-49e5-873b-11eb0a778dd3"
      unitRef="usd">17800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy0zLTEtMS0w_b944916a-d589-4951-8036-499110404cf1"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy01LTEtMS0w_454225d2-55f1-4c33-a1e9-5b476b7c1e80"
      unitRef="usd">-200000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i691aa4e01085425ea916509572c8429b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy03LTEtMS0w_406ac204-1cc6-4b22-8e63-863b26a3e485"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfMy05LTEtMS0w_1eabfbf5-b08e-44f5-8466-a8ccced46a4e"
      unitRef="usd">18500000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i95d5452a442b4d0a8e1ca6ee93d1c6e4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC0xLTEtMS0w_07e066f0-2b39-4654-8e87-422e6ab8332d"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i08bc9c3f90e548e4b4717ed8cfaf4f01_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC0zLTEtMS0w_9f29ee7c-7031-4e76-9aa5-722b487a33de"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ib42c6f61d96b46eabeefd6a9a7b472d4_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC01LTEtMS0w_00d5ce32-9aeb-4d09-850e-8188400faba9"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i691aa4e01085425ea916509572c8429b_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC03LTEtMS0w_7771f4e3-3bfe-48bb-9384-f04defc191cb"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="if770fda10e1f4568a769511e2cb46775_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNC05LTEtMS0w_bcbc6252-dabb-451e-b226-aff55ba0ce55"
      unitRef="usd">500000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i8f3b88a636814103b52b8b03edd8eaad_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi0xLTEtMS0w_a11008c0-f543-4252-9927-358ab6fef7bc"
      unitRef="usd">-5100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d6e7aa54b314ef6b6b0475e6c1109a8_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi0zLTEtMS0w_8e6c117d-5254-4c9c-bedf-fe5cbeb67f30"
      unitRef="usd">-1800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6d75b63e30b04cf3a05528421174cf0f_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi01LTEtMS0w_504f4ad7-7b1f-4c6b-b1c2-27153e69f528"
      unitRef="usd">-600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3e77d8b4a000446c87e498c3fb63a20c_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi03LTEtMS0w_49cdc022-9fa6-49ba-bb72-a41a194433ea"
      unitRef="usd">-23200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ice8e1c44566e46d7a9428b4c849cf075_I20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjJiYzQ2YTE4YjUyNzRkYWRhZjc0NzhhMTQyOTVmODhlL3RhYmxlcmFuZ2U6MmJjNDZhMThiNTI3NGRhZGFmNzQ3OGExNDI5NWY4OGVfNi05LTEtMS0w_b6895bdf-9972-411e-9a66-8198feab7ff5"
      unitRef="usd">-30700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibcaee226383e4970803638e86e611e5f_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi0xLTEtMS0w_7cd615d0-041c-4f33-8ff8-67d38c994f62"
      unitRef="usd">-41400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3896841cd53547aa9f241c9961480908_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi01LTEtMS0w_2fae8177-0fef-4d4d-b4c4-f1ab05025244"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i63616236f1194463b9ef82bc0e35b837_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi03LTEtMS0w_f87aefc0-d0a5-476f-ad0c-08ad2c3ff60e"
      unitRef="usd">-2700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i18a05642170e4a2eaba83cc4b9f1db63_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi05LTEtMS0xNDEz_91803bff-3290-4e6a-84f0-57c573795fe1"
      unitRef="usd">3500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5aebec3fb9bb4e4488a724c4d7743031_I20190928"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMi05LTEtMS0w_32376a8b-1278-4d8f-ab1b-f99047300db4"
      unitRef="usd">-42300000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy0xLTEtMS0w_51136c26-566c-40a5-8303-55eb7d3e4aad"
      unitRef="usd">8300000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy01LTEtMS0w_4ef6c77e-ce98-4a73-9b07-37965d0279ec"
      unitRef="usd">0</us-gaap:OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax
      contextRef="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy03LTEtMS0w_86b93f62-a1e9-471a-9d0f-b3a499e66d41"
      unitRef="usd">-300000</us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
      contextRef="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy05LTEtMS0xNDEz_e7b44bcc-ba85-4150-b3ca-81e99e33b60d"
      unitRef="usd">4300000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax
      contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfMy05LTEtMS0w_e12fbe71-f794-4698-96d2-8a3b7ac4723e"
      unitRef="usd">12300000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="ic43a6ad9eedd49ce8a044789054a1809_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC0xLTEtMS0w_e2a90992-c50c-4ab3-98d6-110b5631c3aa"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i54afe1ceaf2243dea79f1de89a0e8413_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC01LTEtMS0w_256d8c9e-adf8-46f9-8089-853f52b3f959"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="id3b61d840c4e4f9a85f176333669d1a7_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC03LTEtMS0w_0de3ee58-b675-43ef-8c6a-d02f6028eaf5"
      unitRef="usd">1300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i7361b24ef09340f78be8c8e6dd51cc2a_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC05LTEtMS0xNDEz_97fc8e1c-c8d4-432c-9b1e-e433d0593a11"
      unitRef="usd">0</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
      contextRef="i8e3c366d73c74821b14d46635822aff1_D20190929-20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNC05LTEtMS0w_527350ff-ee5e-42b9-a0c6-a6c2dd351350"
      unitRef="usd">-1300000</us-gaap:ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i0b08910f86f346c9b1270b470577d0b7_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS0xLTEtMS0w_c7a5bd14-1c39-40f9-8855-c39e26755ad0"
      unitRef="usd">-33100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5265c14bdf944ebeb3a15533c9c6b571_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS01LTEtMS0w_662e6169-f1a8-41a6-8d1e-e695a63a6cc2"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i415e1540a94545748e7bb75e5b9e6db7_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS03LTEtMS0w_8b845232-f959-42f9-9231-8c73b241f3fc"
      unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if85ce9153c7c4628b53a745f295945de_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS04NTYz_5ddd027d-a4ec-4499-a482-8b2b715f3b32"
      unitRef="usd">7800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if85ce9153c7c4628b53a745f295945de_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS04NTYz_d0e503c7-91dc-4c14-be98-ca05270883d1"
      unitRef="usd">7800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1fe0d76b1bd14a6a9eca3b46e2d1ae6a_I20191228"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV84OC9mcmFnOmI2N2JjYWFiOGNkYTQ3OTA4YzEyZGY0NDhkMzU3Yzk2L3RhYmxlOjljYmJmZGU2YjNmMDRiODA4NzIzZTMzMWQ1MTBjMGQ3L3RhYmxlcmFuZ2U6OWNiYmZkZTZiM2YwNGI4MDg3MjNlMzMxZDUxMGMwZDdfNS05LTEtMS0w_2fd9ad69-1cf0-4cad-97e5-41b9c92c9f1f"
      unitRef="usd">-28700000</us-gaap:StockholdersEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i570b9aef162a4a48b5ccb34ec6b061f8_I20191211"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzNTI1NA_4c1e78d3-4bc3-4b98-8d6d-eca54427617c"
      unitRef="usd">500000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="i05539a83a04849449de905f6a9d13244_D20200927-20201226"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzMDUxOQ_3bd83486-c20a-4cea-ba9f-ce26e06875a9"
      unitRef="shares">1500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:ProceedsFromRepurchaseOfEquity
      contextRef="i05539a83a04849449de905f6a9d13244_D20200927-20201226"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzMDY2MQ_1c390dce-23c2-41d4-b513-6f5c5b6a66a3"
      unitRef="usd">101300000</us-gaap:ProceedsFromRepurchaseOfEquity>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ic5ace0144f6f4565a88544db9fa33ffb_I20191211"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85NC9mcmFnOmI4NzY3ZjZiODVmNjQ0Mzg5MzA4YzU5OGYxNjQwMTA0L3RleHRyZWdpb246Yjg3NjdmNmI4NWY2NDQzODkzMDhjNTk4ZjE2NDAxMDRfMTA5OTUxMTYzNTI3MA_4a607051-6101-457a-88ec-faf4cbae352a"
      unitRef="usd">1000000000.0</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85Ny9mcmFnOmNlYjZlYzVjMzIwMjQ0YTlhNGMwNTBjMjE1ZTUwN2Q2L3RleHRyZWdpb246Y2ViNmVjNWMzMjAyNDRhOWE0YzA1MGMyMTVlNTA3ZDZfNDA4NQ_9a5e3fbb-5c37-496b-b786-0d87fd32cb25">New Accounting Pronouncements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 1 for Recently Adopted Accounting Pronouncements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-01, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2020, the FASB issued ASU No. 2020-04, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reference Rate Reform (Topic 848)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to &lt;/span&gt;&lt;/div&gt;only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted
      contextRef="ic03262a8c15c400d913e0e82e531001c_D20200927-20201226"
      id="id3VybDovL2RvY3MudjEvZG9jOmYwNDJhMDllNWVlZTQzMWE5M2ZkMTAwYmE1NGRmOGU5L3NlYzpmMDQyYTA5ZTVlZWU0MzFhOTNmZDEwMGJhNTRkZjhlOV85Ny9mcmFnOmNlYjZlYzVjMzIwMjQ0YTlhNGMwNTBjMjE1ZTUwN2Q2L3RleHRyZWdpb246Y2ViNmVjNWMzMjAyNDRhOWE0YzA1MGMyMTVlNTA3ZDZfNDA4Ng_1ba05d17-bf63-47f5-973e-fdeb757f9879">New Accounting PronouncementsSee Note 1 for Recently Adopted Accounting Pronouncements.</us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779325720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 26,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">257,661,792<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699161896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProductRevenue', window );">Product</a></td>
<td class="nump">$ 1,455,400,000<span></span>
</td>
<td class="nump">$ 699,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ServiceRevenue', window );">Service and other</a></td>
<td class="nump">154,400,000<span></span>
</td>
<td class="nump">151,200,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,609,800,000<span></span>
</td>
<td class="nump">850,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Product</a></td>
<td class="nump">284,500,000<span></span>
</td>
<td class="nump">237,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmortizationCostofGoodsSold', window );">Amortization, Cost of Goods Sold</a></td>
<td class="nump">61,600,000<span></span>
</td>
<td class="nump">63,600,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Costofservice', window );">Service and other</a></td>
<td class="nump">83,300,000<span></span>
</td>
<td class="nump">89,800,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,180,400,000<span></span>
</td>
<td class="nump">433,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">59,300,000<span></span>
</td>
<td class="nump">61,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">128,000,000.0<span></span>
</td>
<td class="nump">144,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">91,500,000<span></span>
</td>
<td class="nump">87,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">10,100,000<span></span>
</td>
<td class="nump">9,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets and equipment</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration fair value adjustments</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring and divestiture charges</a></td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">900,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">294,900,000<span></span>
</td>
<td class="nump">309,000,000.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">885,500,000<span></span>
</td>
<td class="nump">124,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(28,100,000)<span></span>
</td>
<td class="num">(32,800,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="num">(21,600,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(3,800,000)<span></span>
</td>
<td class="nump">3,300,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments', window );">Income before income taxes</a></td>
<td class="nump">832,400,000<span></span>
</td>
<td class="nump">97,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision (benefit) for income taxes</a></td>
<td class="nump">179,000,000.0<span></span>
</td>
<td class="num">(288,400,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">653,400,000<span></span>
</td>
<td class="nump">385,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,000,000.0)<span></span>
</td>
<td class="num">(300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income attributable to Hologic</a></td>
<td class="nump">$ 654,400,000<span></span>
</td>
<td class="nump">$ 386,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share attributable to Hologic:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 2.53<span></span>
</td>
<td class="nump">$ 1.44<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 2.50<span></span>
</td>
<td class="nump">$ 1.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">258,605<span></span>
</td>
<td class="nump">267,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">261,785<span></span>
</td>
<td class="nump">269,721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortization, Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Costofservice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of service</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Costofservice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Product Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Service Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120380238&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(h)(1)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365698818824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 653.4<span></span>
</td>
<td class="nump">$ 385.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">17.8<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(0.2) for the three months ended December 26, 2020 and $1.7 for the three months ended December 28,2019.</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax', window );">Loss reclassified from accumulated other comprehensive loss to the statements of income</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income</a></td>
<td class="nump">19.0<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">672.4<span></span>
</td>
<td class="nump">399.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest', window );">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ComprehensiveIncome', window );">Comprehensive Income</a></td>
<td class="nump">$ 673.4<span></span>
</td>
<td class="nump">$ 399.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph c<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=d3e41638-113959<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724391-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e689-108580<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695433816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax', window );">Change in value of hedged interest rate swap and interest rate cap, tax</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699162248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash less assets held for sale</a></td>
<td class="nump">$ 868.7<span></span>
</td>
<td class="nump">$ 701.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves of $39.4 and $31.6, respectively</a></td>
<td class="nump">1,216.1<span></span>
</td>
<td class="nump">1,028.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">420.2<span></span>
</td>
<td class="nump">395.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrepaidIncomeTaxesCurrent', window );">Prepaid Income Taxes-Current</a></td>
<td class="nump">29.9<span></span>
</td>
<td class="nump">38.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">61.4<span></span>
</td>
<td class="nump">58.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">2,596.3<span></span>
</td>
<td class="nump">2,222.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">514.5<span></span>
</td>
<td class="nump">491.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,244.8<span></span>
</td>
<td class="nump">1,307.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,663.3<span></span>
</td>
<td class="nump">2,657.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">531.8<span></span>
</td>
<td class="nump">516.6<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">7,550.7<span></span>
</td>
<td class="nump">7,195.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">324.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">184.3<span></span>
</td>
<td class="nump">178.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">611.9<span></span>
</td>
<td class="nump">547.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">182.9<span></span>
</td>
<td class="nump">186.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsCurrent', window );">Current portion of capital lease obligations</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">1,056.0<span></span>
</td>
<td class="nump">1,239.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,689.5<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalLeaseObligationsNoncurrent', window );">Finance lease obligation - long term</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">17.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">189.4<span></span>
</td>
<td class="nump">201.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">317.5<span></span>
</td>
<td class="nump">303.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211;750,000 shares authorized; 296,533 and 295,107 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">5,895.3<span></span>
</td>
<td class="nump">5,904.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(918.8)<span></span>
</td>
<td class="num">(1,573.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 39,078 and 37,609 shares, respectively</a></td>
<td class="num">(1,680.9)<span></span>
</td>
<td class="num">(1,579.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(30.7)<span></span>
</td>
<td class="num">(49.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total Hologic's stockholders&#8217; equity</a></td>
<td class="nump">3,267.9<span></span>
</td>
<td class="nump">2,705.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Stockholders' Equity Attributable to Noncontrolling Interest</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">3,269.0<span></span>
</td>
<td class="nump">2,707.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 7,550.7<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrepaidIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income Taxes-Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrepaidIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of capital lease obligation due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalLeaseObligationsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121616839&amp;loc=d3e45280-112737<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 840<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121569800&amp;loc=d3e45023-112735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalLeaseObligationsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699174712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Accounts receivable, reserves</a></td>
<td class="nump">$ 39.4<span></span>
</td>
<td class="nump">$ 31.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000,000<span></span>
</td>
<td class="nump">1,623,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000,000<span></span>
</td>
<td class="nump">750,000,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">296,533,000,000<span></span>
</td>
<td class="nump">295,107,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">39,078,000,000<span></span>
</td>
<td class="nump">37,609,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365687155864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th">
<div>Share Repurchase Program </div>
<div>Treasury Stock</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling Interest, Increase from Business Combination</a></td>
<td class="nump">8,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">292,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 28, 2019</a></td>
<td class="nump">2,115,700,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">$ 5,769,800,000<span></span>
</td>
<td class="num">$ (2,688,700,000)<span></span>
</td>
<td class="num">$ (42,300,000)<span></span>
</td>
<td class="num">$ (926,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance (Accounting Standards Update 2018-01 [Member]) at Sep. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">385,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">3,279<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(80,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (80,900,000)<span></span>
</td>
<td class="nump">$ 164,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (41,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,462<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 28, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,749,800,000<span></span>
</td>
<td class="num">(2,302,300,000)<span></span>
</td>
<td class="num">(28,700,000)<span></span>
</td>
<td class="num">$ (1,170,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">386,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="num">(205,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">6,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,257,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">94,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,851<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (267,600,000)<span></span>
</td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment', window );">Accelerated share repurchase agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 28, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,827,600,000<span></span>
</td>
<td class="num">(2,206,000,000.0)<span></span>
</td>
<td class="num">(58,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">96,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Acceleratedsharerepurchaseagreement', window );">Accelerated share repurchase agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,091,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(200,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">136,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,684<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 27, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,861,700,000<span></span>
</td>
<td class="num">(2,068,100,000)<span></span>
</td>
<td class="num">(61,900,000)<span></span>
</td>
<td class="num">$ (1,479,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">137,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="num">(100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,258,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">493,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100,100,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">295,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 26, 2020</a></td>
<td class="nump">2,705,200,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
<td class="nump">5,904,800,000<span></span>
</td>
<td class="num">(1,573,200,000)<span></span>
</td>
<td class="num">(49,700,000)<span></span>
</td>
<td class="num">$ (1,579,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">494,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">2,707,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">490<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ChangeInParValue', window );">Change in par value</a></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(46,400,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46,500,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">653,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (101,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 26, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">296,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 26, 2020</a></td>
<td class="nump">3,267,900,000<span></span>
</td>
<td class="nump">$ 3,000,000.0<span></span>
</td>
<td class="nump">$ 5,895,300,000<span></span>
</td>
<td class="num">$ (918,800,000)<span></span>
</td>
<td class="num">$ (30,700,000)<span></span>
</td>
<td class="num">$ (1,680,900,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable', window );">Net loss attributable to noncontrolling interest</a></td>
<td class="num">(1,000,000.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">654,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount', window );">Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount</a></td>
<td class="nump">1,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 3,269,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Acceleratedsharerepurchaseagreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accelerated share repurchase agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Acceleratedsharerepurchaseagreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ChangeInParValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Change in par value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ChangeInParValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchaseProgramAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchaseProgramAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (12)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph (16)(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3A<br> -Subparagraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=SL6540498-122764<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21914-107793<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22644-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121646688&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568740-111683<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=115929471&amp;loc=d3e21711-107793<br><br>Reference 15: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4568447-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsForNewAccountingPronouncementsAxis=us-gaap_AccountingStandardsUpdate201801Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695035560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 653,400,000<span></span>
</td>
<td class="nump">$ 385,800,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">21,100,000<span></span>
</td>
<td class="nump">21,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangibles</a></td>
<td class="nump">71,700,000<span></span>
</td>
<td class="nump">72,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">18,600,000<span></span>
</td>
<td class="nump">18,100,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(12,000,000.0)<span></span>
</td>
<td class="num">(327,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">29,500,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(175,500,000)<span></span>
</td>
<td class="nump">17,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(21,200,000)<span></span>
</td>
<td class="num">(14,900,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">8,900,000<span></span>
</td>
<td class="nump">1,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(18,300,000)<span></span>
</td>
<td class="num">(2,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">4,600,000<span></span>
</td>
<td class="num">(55,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">58,100,000<span></span>
</td>
<td class="num">(22,600,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="num">(10,500,000)<span></span>
</td>
<td class="num">(10,300,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">650,000,000.0<span></span>
</td>
<td class="nump">113,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="num">(4,900,000)<span></span>
</td>
<td class="num">(11,800,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Capital expenditures</a></td>
<td class="num">(32,400,000)<span></span>
</td>
<td class="num">(11,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(12,400,000)<span></span>
</td>
<td class="num">(20,100,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Purchaseofinsurancecontracts', window );">Purchase of insurance contracts</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,400,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other activity</a></td>
<td class="num">(200,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(49,900,000)<span></span>
</td>
<td class="num">(45,700,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(18,800,000)<span></span>
</td>
<td class="num">(9,400,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ProceedsFromSeniorNotes', window );">Proceeds from Notes Payable</a></td>
<td class="nump">950,000,000.0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_RepaymentOfSeniorNotes', window );">Repayments of Senior Debt</a></td>
<td class="num">(970,800,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLinesOfCredit', window );">Repayment under revolving credit line</a></td>
<td class="num">(250,000,000.0)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization', window );">Proceeds from accounts receivable securitization agreement</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">16,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Payments to Noncontrolling Interests</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,400,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of deferred acquisition consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(16,600,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDebtIssuanceCosts', window );">Payment of debt issuance costs</a></td>
<td class="num">(13,700,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(101,300,000)<span></span>
</td>
<td class="num">(285,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">23,300,000<span></span>
</td>
<td class="nump">18,700,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(46,400,000)<span></span>
</td>
<td class="num">(10,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(500,000)<span></span>
</td>
<td class="num">(400,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(428,200,000)<span></span>
</td>
<td class="num">(289,900,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="num">(4,200,000)<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash and cash equivalents</a></td>
<td class="nump">167,700,000<span></span>
</td>
<td class="num">(220,300,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">701,000,000.0<span></span>
</td>
<td class="nump">601,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 868,700,000<span></span>
</td>
<td class="nump">$ 381,500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsFromSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsFromSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseofinsurancecontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of insurance contracts</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseofinsurancecontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_RepaymentOfSeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment of Senior Notes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_RepaymentOfSeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDebtIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDebtIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds from (repayments of) securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermCapitalLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermCapitalLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690963944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BasisofPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;26, 2020 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;17, 2020. In the opinion of management, the financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;26, 2020 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;25, 2021. </span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The purpose of ASU 2016-13 is to replace the current incurred loss impairment methodology for financial assets measured at amortized cost with a methodology that reflects expected credit losses over the lifetime of the financial asset. As a result, credit losses are recorded when financial assets are established if credit losses are expected over the asset's contractual life. The measurement of expected credit losses is based upon historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The Company adopted the standard during the first quarter of fiscal 2021. The adoption of ASU 2016-13 did not have a material effect on the Company's consolidated financial statements. See Note 5 for additional information.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2019, the FASB issued ASU No. 2019-08, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Compensation - Stock Compensation (Topic 718) and Revenue from Contracts with Customers (Topic 606)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The guidance identifies, evaluates, and improves areas of GAAP for which cost and complexity can be reduced while maintaining or improving the usefulness of the information provided. The amendments in that Update expanded the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. The Company adopted the standard in the first quarter of fiscal 2021. The adoption of ASU 2019-08 did not have a material effect on the Company's financial statements.</span></div><div style="margin-top:8pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;26, 2020. </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were two unrecognized subsequent events related to the acquisitions of Somatex Medical Technologies GmbH ("Somatex") and Biotheranostics, Inc. ("Biotheranostics"). On December 30, 2020, the Company completed the acquisition of Somatex for a purchase price of approximately $64.0&#160;million. Somatex, located in Germany, is a manufacturer of biopsy site markers, including the Tumark product line of tissue markers, which were distributed by the Company in the U.S. prior to the acquisition. On January 5, 2021, the Company announced that it had entered into an agreement to acquire Biotheranostics for a purchase price of approximately $230.0&#160;million. The closing is subject to certain regulatory approvals. Biotheranostics, located in San Diego, California, manufactures molecular diagnostic tests for breast and metastatic cancers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasisofPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasisofPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691009544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are immaterial. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 2% and 3% of the Company&#8217;s consolidated revenue for the three months ended December&#160;26, 2020 and December 28, 2019, respectively.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating or sales-type lease as well as performance obligations for reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Sales-type leases are immaterial. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented approximately 2% and 3% of the Company&#8217;s consolidated revenue for the three months ended December&#160;26, 2020 and December 28, 2019, respectively.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690975752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">Fair Value Measurements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of interest rate caps, an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative instruments. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;26, 2020:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 26, 2020 and December 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.795%"><tr><td style="width:1.0%"/><td style="width:7.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets and goodwill. There were no such remeasurements to equity investments in the three months ended December&#160;26, 2020 and December&#160;28, 2019. During the first quarter of fiscal 2020, the Company's Medical Aesthetics division met the criteria to be classified as assets-held-for sale, and the Company recorded a $30.2 million loss to record the asset group at its fair value less costs to sell. This is a level 1 measurement. See Note 7 for additional information. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, cost-method equity investments, interest rate caps, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate caps, interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by GAAP, which approximates fair value. The Company believes the carrying amounts of its cost-method equity investments approximate fair value.</span></div>Amounts outstanding under the Company&#8217;s 2018 Credit Agreement (as defined below) of $1.4 billion aggregate principal as of December&#160;26, 2020 are subject to variable interest rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 2028 Senior Notes and 2029 Senior Notes had fair values of $427.0 million and $974.0 million, respectively, as of December&#160;26, 2020 based on their trading prices, representing Level 1 measurements. Refer to Note 8 for the carrying amounts of the various components of the Company&#8217;s debt.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI http://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692499944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NXC Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed the acquisition of assets from NXC Imaging, for a purchase price of $4.9&#160;million. NXC Imaging was a long-standing distributor of the Company's Breast and Skeletal products in the U.S. Based on the Company's preliminary valuation, the majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Acessa Health</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 23, 2020, the Company completed the acquisition of Acessa Health, Inc. ("Acessa") for a purchase price of </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$161.3&#160;million, which included a hold-back of $3.0&#160;million that was paid in January 2021, and contingent consideration, which the Company estimated the fair value to be $81.8&#160;million as of the measurement date. Acessa, located in Austin, Texas, manufactures and markets its ProVu system, a laparoscopic radio frequency ablation system for use in treatment of uterine fibroids. Acessa's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. Each quarter the Company will be required to remeasure the fair value of the liability as assumptions change and such adjustments will be recorded in operating expenses. This fair value measurement was based on significant inputs not observable </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or benefits, respectively. In the first quarter of fiscal 2021, the Company remeasured the contingent consideration liability and recorded a charge of $4.6&#160;million to record the liability at fair value as of December 26, 2020.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the preliminary purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Acessa's business. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities, primarily taxes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the preliminary purchase price allocation, the Company determined the identifiable intangible assets are developed technology and trade names. The preliminary fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 18.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life of developed technology and trade names is 10 years. The preliminary calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the preliminary amount of goodwill were based on synergistic benefits of Acessa's products being complementary to the GYN Surgical portfolio of products and utilizing the GYN Surgical's sales force to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Health Beacons</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, the Company completed the acquisition of Health Beacons, Inc. ("Health Beacons"), for a purchase price of $19.7&#160;million, which included hold-backs of $2.3&#160;million that are payable up to eighteen months from the date of acquisition. Health Beacons manufactures the LOCalizer product. Based on the Company's preliminary valuation, it allocated $10.7&#160;million of the purchase price to the preliminary value of developed technology and $6.2&#160;million to goodwill. The remaining $2.8&#160;million of the purchase price was allocated to acquired tangible assets and liabilities. The allocation of the purchase price is preliminary as the Company continues to gather information supporting the acquired assets and liabilities. Health Beacons' results of operations are reported in the Company's Breast Health reportable segment from the date of acquisition. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Alpha Imaging</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2019, the Company completed the acquisition of assets from Alpha Imaging, LLC ("Alpha Imaging"), for a purchase price of $18.0&#160;million, which included a hold-back of $1.0&#160;million and contingent consideration which the Company has estimated at $0.9&#160;million. The contingent consideration is payable upon shipment of backlog orders entered into by Alpha Imaging prior to the acquisition. Alpha Imaging was a long-standing distributor of the Company's Breast and Skeletal </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">products in the U.S. The majority of the purchase price was allocated to a customer relationships intangible asset with a useful life of 5 years.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SuperSonic Imagine</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 1, 2019, the Company purchased 46% of the outstanding shares of SuperSonic Imagine ("SSI") for $18.2 million. SSI is a public company located in Aix-en-Provence, France that manufactures and markets ultrasound medical imaging equipment. In September 2019, the Company launched a cash tender offer to acquire the remaining outstanding shares for a price of&#160;&#8364;1.50 per share in cash. The Company determined that SSI was a Variable Interest Entity (&#8220;VIE&#8221;) but it was not the primary beneficiary as it was not a party to the initial design of the entity nor did it have control over SSI's operations until November 21, 2019 when the Company's ownership of SSI's voting stock exceeded 50%. Accordingly, the Company initially accounted for this investment under the equity method of accounting.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 21, 2019, the Company acquired an additional 7.6 million shares of SSI for $12.6 million. As a result, the Company's ownership interest increased to approximately 78% of the outstanding common shares of SSI at November 21, 2019, and it now controlled SSI's voting interest and operations. The Company performed purchase accounting as of November 21, 2019 and beginning on that date the financial results of SSI are included within the Company's consolidated financial statements, specifically the Breast Health reportable segment. The Company remeasured the initial investment of 46% of the outstanding shares of SSI to its fair value at the acquisition date, resulting in a gain of $3.2 million recorded in the first quarter of fiscal 2020. The total accounting purchase price was $69.3 million, which consisted of $17.9 million for the equity method investment in SSI, $12.6 million for shares acquired on November 21, 2019, $30.2 million for loans the Company provided to SSI prior to the acquisition to pay-off pre-existing loans and fund operations that are considered forgiven, and $8.6 million representing the fair value of the noncontrolling interest as of November 21, 2019. The Company purchased an additional 1.1 million outstanding shares in fiscal 2020 for $1.8 million, and as of December 26, 2020, the Company owned approximately 81% of the outstanding shares of SSI.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of SSI's business. As part of the purchase price allocation, the Company determined the identifiable intangible assets were developed technology, customer relationships, and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 12.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rates applied were benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. The weighted average life for the developed technology is 9 years, customer relationships is 9 years and trade names is 8.6 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. The factors contributing to the recognition of the </span></div>amount of goodwill were based on synergistic benefits of SSI's products being complementary to Breast Health's 3D mammography systems and using the Company's existing U.S. sales force as SSI's presence in the U.S. is limited. None of the goodwill is expected to be deductible for income tax purposes.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690990392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Trade Receivables and Allowance for Credit Losses</a></td>
<td class="text">Trade Receivables and Allowance for Credit Losses<div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Effective September 27, 2020, the Company adopted Topic 326, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns as a result of the pandemic. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses as of December 26, 2020, compared to December 28, 2019:</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"/><td style="width:25.839%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.662%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.809%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.812%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Reclassified as Assets held for sale</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-<br/>offs and<br/>Payments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 28, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690992104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock', window );">Dispositions</a></td>
<td class="text">Disposition<div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sale of Medical Aesthetics</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2019, the Company entered into a definitive agreement to sell its Medical Aesthetics business to Clayton Dubilier &amp; Rice ("CD&amp;R") for a sales price of&#160;$205.0 million&#160;in cash, less certain adjustments. The sale was completed on December 30, 2019, and the Company received cash proceeds of $153.4 million in the second quarter of fiscal 2020. The sale price was subject to adjustment pursuant to the terms of the definitive agreement, and the parties agreed to a final sales price of $150.0&#160;million in the fourth quarter of fiscal 2020. The Company agreed to provide certain transition services for three to fifteen months, depending on the nature of the service. The Company also agreed to indemnify CD&amp;R for certain legal and tax matters that existed as of the date of disposition. In connection with its accounting for the sale, the Company recorded indemnification liabilities of $10.9&#160;million within accrued expenses associated with its obligations under the sale agreement.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of this transaction, the Medical Aesthetics asset group was designated as assets held-for-sale in the first quarter of fiscal 2020. Pursuant to ASC 360, asset groups under this designation are required to be recorded at fair value less costs to sell. The Company determined that this disposal did not qualify as a discontinued operation as the sale of the Medical Aesthetics business was deemed to not be a strategic shift having or will have a major effect on the Company's operations and financial results. Based on the terms in the agreement of the sales price and formula for net working capital and related adjustments, its estimate of the fair value for transition services and the amount that must be carved out of the sale proceeds, and liabilities the Company will retain or for which it has agreed to indemnify CD&amp;R, the Company recorded an impairment charge of $30.2 million in the first quarter of fiscal 2020. The impairment charge was allocated to Medical Aesthetics long-lived assets, of which $25.8 million was allocated to cost of product revenues and $4.4 million to operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2020, this business incurred a loss from operations of $46.5&#160;million, which excludes corporate allocations. The operating expenses include only those that were incurred directly by and were retained by the disposed business. The Company will continue to incur expenses related to this business under the indemnification provisions primarily related to legal and tax matters that existed as of the date of disposition. These expenses were not significant in the first quarter of fiscal 2021.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690951560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 29, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Arrangements<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2018 Amended and Restated Credit Agreement</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 17, 2018, the Company and certain of its subsidiaries refinanced its term loan and revolving credit facility by entering into an Amended and Restated Credit and Guaranty Agreement as of December 17, 2018 (the "2018 Credit Agreement") with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders. The 2018 Credit Agreement amended and restated the Company's prior credit and guaranty agreement dated as of October 3, 2017 (the "2017 Credit Agreement"). As of December 26, 2020, the principal amount outstanding of the term loan under the 2018 Credit Agreement (the "Term Loan") was $1.4&#160;billion. The Term Loan bears interest at an annual rate equal to the Eurocurrency Rate (i.e., the LIBOR rate) plus an Applicable Rate, which was 1.00% as of December 26, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also has a $1.5&#160;billion revolving credit facility (the "Revolver") under the 2018 Credit Agreement. The borrowings of the Revolver bear interest at a rate equal to the LIBOR Daily Floating Rate plus an Applicable Rate, which was 1.00% as of December 26, 2020. In response to the market uncertainties created by the COVID-19 pandemic in March 2020, the Company borrowed $750.0 million under the Revolver, $250.0 million of which was used to pay off amounts outstanding under the asset securitization agreement, in order to have sufficient cash on hand. During the first quarter of fiscal 2021, the Company paid off the remaining outstanding balance of $250.0&#160;million. As of December 26, 2020, the full amount of the Revolver ($1.5 billion) was available to borrow by the Company.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.591%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2018 Credit Agreement. As of December 26, 2020, the Company was in compliance with these covenants.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 28, 2020, the Company completed a private placement of $950&#160;million aggregate principal amount of its 3.250% Senior Notes due 2029 (the "2029 Senior Notes") at an offering price of 100% of the aggregate principal amount of the 2029 Senior Notes. The Company used the net proceeds of the 2029 Senior Notes offering in September 2020 and cash on hand to redeem in full its 4.375% Senior Notes due 2025 (the 2025 Senior Notes") in the aggregate principal amount of $950.0&#160;million on October 15, 2020 at an aggregate redemption price of $970.8&#160;million, including a premium payment $20.8&#160;million.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2025 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the redemption, the total aggregate principal balance of 2025 Senior Notes was $950.0 million. As the Company planned to use the proceeds from the 2029 Senior Notes offering to redeem the 2025 Senior Notes, the Company evaluated the accounting for this transaction under ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to determine modification versus extinguishment accounting on a creditor-by-creditor basis. Certain 2025 Senior Note holders either did not participate in this refinancing transaction or reduced their holdings and these transactions were accounted for as extinguishments. As a result, the Company recorded a debt extinguishment loss in the first quarter of fiscal 2021 of $21.6&#160;million. For the remaining 2025 Senior Notes holders who participated in the refinancing, these transactions were accounted for as modifications because on a creditor-by-creditor basis the present value of the cash flows between the debt instruments before and after the transaction was less than 10%. The Company recorded a portion of the transaction expenses of $5.8&#160;million to interest expense pursuant to ASC 470, subtopic 50-40. The remaining debt issuance costs of $7.9&#160;million and debt discount of $6.4&#160;million related to the modified debt will be amortized over the term of the 2029 Senior Notes using the effective interest method.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690997688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses or any reliance on collateral findings regarding invalidity from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review proceedings. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the USPTO for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '348 patent. On September 12, 2016, the PTAB declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018 the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, Hologic filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208. Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. The original trial date of July 20, 2020 was vacated. On October 21, 2020, the trial court scheduled a 10-day trial beginning on August 9, 2021. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As described in Note 7, the Company has agreed to indemnify CD&amp;R for certain legal matters related to the Medical Aesthetics business that existed at the date of disposition. The Company currently has $8.5&#160;million accrued for such matters as of December&#160;26, 2020. While the Company believes the estimated amounts accrued are reasonable, certain matters are still ongoing and additional accruals could be recorded in the future. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695680600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income Per Share<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692480632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"/><td style="width:63.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.336%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase 0.6 million and 0.8 million shares of the Company's common stock during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average exercise prices of $68.35 and $45.67, respectively. There were 4.6 million options outstanding at December&#160;26, 2020 with a weighted-average exercise price of $44.13.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"/><td style="width:63.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.336%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.5 million and 0.7 million restricted stock units (RSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, with weighted-average grant date fair values of $68.35 and $45.64 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units (PSUs) during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $68.35 and $45.65 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years provided the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of PSUs based on a one-year free cash flow measure (FCF) to its senior management team, which had a grant date fair value of $68.35 and $45.65 per unit during the three months ended December 26, 2020 and December 28, 2019, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the one-year measurement period, but the FCF PSUs vest at the end of the three year </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">service period. The Company is recognizing compensation expense for PSUs and FCF PSUs ratably over the required service period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards (MSUs) to its senior management team during the three months ended December&#160;26, 2020 and December&#160;28, 2019, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of three years based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $82.31 and $43.78 per share using the Monte Carlo simulation model. These awards cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;26, 2020, there was 3.1 million in aggregate RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="margin-bottom:18pt;margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;26, 2020, there was $26.0 million and $83.2 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.7 and 2.3 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692487304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text">Other Balance Sheet Information<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692243752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic InformationDuring the first fiscal quarter of 2021, the Company had four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. During the first fiscal quarter of 2020, the Company had five reportable segments that included Medical Aesthetics. The Company completed the sale of its Medical Aesthetics business on December 30, 2019. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, intangible asset and goodwill impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items.<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019. Segment information is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;26, 2020 and December&#160;28, 2019.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from France, the United Kingdom and Germany. The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of world&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365693043160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 740), each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three months ended December 26, 2020 was a provision of 21.5% compared to a net benefit of 296.1% for the corresponding period in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 26, 2020 differed from the U.S. statutory tax rate primarily due to state income taxes, the global intangible low-taxed income inclusion, and unbenefited foreign losses, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 28, 2019 differed from the U.S. statutory tax rate primarily due to a $312.2&#160;million discrete tax benefit related to the Medical Aesthetics business outside basis difference, partially offset by an increase in the Medical Aesthetics business valuation allowance. The outside basis difference is the difference between the carrying amount of an entity's investment for financial reporting purposes and the underlying tax basis in that investment. An outside tax-over-book basis difference for an investment in a subsidiary results in the recognition of a deferred tax asset only when it becomes apparent that the reversal of the temporary difference will occur in the foreseeable future. As the Medical Aesthetics business met the assets held for sale criteria during the three months ended December 28, 2019, the requirement for recognition of the deferred tax asset for the outside basis difference was also met. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to tax examinations for value added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates pursuant to ASC 450. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. While the Company believes estimated losses previously recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692470584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 28, 2019</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,056.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,866.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,643.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,943.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,699.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;26, 2020 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692229672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.888%"><tr><td style="width:1.0%"/><td style="width:34.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.951%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 26, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 28, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI http://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690861672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Income (Loss)<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:49.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.195%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:49.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.195%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI http://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692755672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting PronouncementsSee Note 1 for Recently Adopted Accounting Pronouncements.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691038184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>New Accounting Pronouncements (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">New Accounting Pronouncements</a></td>
<td class="text">New Accounting Pronouncements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 for Recently Adopted Accounting Pronouncements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740) Simplifying the Accounting for Income Taxes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board issued this Update as part of its initiative to reduce complexity in accounting standards (the Simplification Initiative). For public business entities, the amendments in this Update are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020 and is applicable to the Company in fiscal 2022. The Company is currently evaluating the impact of the adoption of ASU 2019-12 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-01, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investments - Equity Securities (Topic 321), Investments - Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update to clarify certain interactions between the guidance to account for certain equity securities under Topic 321, the guidance to account for investments under the equity method of accounting in Topic 323, and the guidance in Topic 815. This update could change how an entity accounts for an equity security under the measurement alternative or a forward contract or purchased option to purchase securities that, upon settlement of the forward contract or exercise of the purchased option, would be accounted for under the equity method of accounting or the fair value option in accordance with Topic 825, Financial Instruments. For entities that have adopted the amendments in Update 2020-01, the updated guidance is effective for annual periods beginning after December 15, 2020, and is applicable to the Company in fiscal 2022. Early adoption is permitted. The Company is currently evaluating the impact of the adoption of ASU 2020-01 on its consolidated financial position and results of operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reference Rate Reform (Topic 848)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board issued this Update as optional guidance for a limited period of time to ease the potential burden in accounting for or recognizing the effects of reference rate reform on financial reporting. This update will provide optional expedients and exceptions for applying GAAP to </span></div>only contracts, hedging relationships, and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. For entities that have adopted the amendments in Update 2020-04, the updated guidance is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of the adoption of ASU 2020-04 on its consolidated financial position and results of operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690975192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">675.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">995.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">763.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">472.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">231.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">217.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 29, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">632.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,263.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">192.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">232.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365693009432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;26, 2020:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:17pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:95.029%"><tr><td style="width:1.0%"/><td style="width:37.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.130%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.569%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.288%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="margin-top:9pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 26, 2020 and December 28, 2019 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:18pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:84.795%"><tr><td style="width:1.0%"/><td style="width:7.348%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:52.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.520%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.523%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments/Accruals</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692521752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Acessa's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of August 23, 2020, as set forth below.</span></div><div style="text-align:center;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:63.596%"><tr><td style="width:1.0%"/><td style="width:7.865%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:71.543%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.292%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">127.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">161.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to SSI's tangible and identifiable intangible assets and liabilities based on the estimated fair values of those assets as of November 21, 2019, as set forth below.</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:58.333%"><tr><td style="width:1.0%"/><td style="width:78.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.951%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short and long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690787016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">The following is a rollforward of the allowance for credit losses as of December 26, 2020, compared to December 28, 2019:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365698810360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"/><td style="width:73.386%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.216%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.365%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolver</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">324.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,361.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,379.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">939.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">932.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,689.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,713.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,764.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,038.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the Credit Agreements were as follows:&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.590%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.591%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.04&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Schedule Of Interest Expense Under Convertible Notes</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has 2029 Senior Notes outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February&#160;15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year, commencing on February&#160;15, 2021.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. The Company may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. The Company also has the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if the Company undergoes a change of control coupled with a decline in ratings, as provided in the indenture, the Company will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company evaluated the 2029 Senior Notes for derivatives pursuant to ASC 815 and did not identify any embedded derivatives that require bifurcation. All features were deemed to be clearly and closely related to the host instrument.</span></div><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes, 2028 Senior Notes and 2025 Senior Notes was as follows:</span></div><div style="margin-bottom:5pt;margin-top:17pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.449%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Expense</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692410776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.227%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.712%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized (loss) gain recognized in income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.6)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;26, 2020: </span></div><div style="margin-bottom:5pt;margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate caps and interest rate swap for the following reporting periods:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.905%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate cap agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock', window );">Schedule of Adjustment to Fair Value within the Consolidated Statements of Income</a></td>
<td class="text"><div style="margin-top:18pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the adjustment to fair value (realized and unrealized) recorded within the Consolidated Statements of Income for derivative instruments for which the Company did not elect hedge accounting:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:81.432%"><tr><td style="width:1.0%"/><td style="width:58.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.289%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.700%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives not classified as hedging instruments</span></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of Loss Recognized in Income</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18.7)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691088088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">258,605&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267,893&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,785&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">269,721&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">340&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,290&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock Units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690723672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Operations:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"/><td style="width:63.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.336%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:72.953%"><tr><td style="width:1.0%"/><td style="width:63.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.334%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.336%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691008424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">207.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">420.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">478.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,237.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,185.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(723.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(694.4)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">514.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690960776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">egment information is as follows:<div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,128.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">311.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">331.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,609.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">784.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">885.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medical Aesthetics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 26,<br/>2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,177.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,203.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,200.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,418.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,438.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,719.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,355.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,195.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="margin-top:12pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:90.058%"><tr><td style="width:1.0%"/><td style="width:69.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.025%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 26,<br/>2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 28,<br/>2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.8&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691008424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 26, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 26, 2020</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,056.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,969.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,054.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,907.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">549.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">477.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">245.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-competition agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business licenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,866.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,643.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,852.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,569.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,943.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,699.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,931.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,623.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;26, 2020 for each of the five succeeding fiscal years is as follows:</span></div><div style="margin-bottom:14pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.766%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">213.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">274.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365780023128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:23pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:88.888%"><tr><td style="width:1.0%"/><td style="width:34.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.248%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.951%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.235%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.622%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.240%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Acquired</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 26, 2020</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.7)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 28, 2019</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692225928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 26, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:49.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.195%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 26, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(22.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(24.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(49.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(5.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.6)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(23.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(30.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.122%"><tr><td style="width:1.0%"/><td style="width:49.489%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.192%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.195%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended December 28, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Caps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(2.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amounts reclassified to statement of income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(33.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(28.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690708024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Presentation Details (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Jan. 05, 2021</div></th>
<th class="th"><div>Dec. 30, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember', window );">Somatex [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BiothernosticsMember', window );">Biothernostics [Member] | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 230,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SomatexMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SomatexMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BiothernosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BiothernosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779955480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,609,800,000<span></span>
</td>
<td class="nump">$ 850,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">50,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,137,800,000<span></span>
</td>
<td class="nump">632,700,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">472,000,000.0<span></span>
</td>
<td class="nump">217,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,128,200,000<span></span>
</td>
<td class="nump">311,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">763,500,000<span></span>
</td>
<td class="nump">231,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">364,700,000<span></span>
</td>
<td class="nump">79,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">124,800,000<span></span>
</td>
<td class="nump">121,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">80,100,000<span></span>
</td>
<td class="nump">77,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">44,700,000<span></span>
</td>
<td class="nump">43,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">995,300,000<span></span>
</td>
<td class="nump">178,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">675,300,000<span></span>
</td>
<td class="nump">142,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">320,000,000.0<span></span>
</td>
<td class="nump">36,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">12,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">8,100,000<span></span>
</td>
<td class="nump">12,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">332,700,000<span></span>
</td>
<td class="nump">331,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">258,200,000<span></span>
</td>
<td class="nump">256,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">74,500,000<span></span>
</td>
<td class="nump">74,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">267,700,000<span></span>
</td>
<td class="nump">274,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">203,000,000.0<span></span>
</td>
<td class="nump">209,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">64,700,000<span></span>
</td>
<td class="nump">65,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">65,000,000.0<span></span>
</td>
<td class="nump">56,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">55,200,000<span></span>
</td>
<td class="nump">47,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">9,800,000<span></span>
</td>
<td class="nump">9,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">124,000,000.0<span></span>
</td>
<td class="nump">119,100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">101,000,000.0<span></span>
</td>
<td class="nump">98,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">23,000,000.0<span></span>
</td>
<td class="nump">20,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">65,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">24,900,000<span></span>
</td>
<td class="nump">23,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">15,100,000<span></span>
</td>
<td class="nump">14,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 9,800,000<span></span>
</td>
<td class="nump">$ 8,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779801352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,609.8<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,137.8<span></span>
</td>
<td class="nump">632.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">338.2<span></span>
</td>
<td class="nump">109.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">88.3<span></span>
</td>
<td class="nump">70.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_RestofWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 45.5<span></span>
</td>
<td class="nump">$ 38.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695729352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,609,800,000<span></span>
</td>
<td class="nump">$ 850,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">50,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Disposables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,263,400,000<span></span>
</td>
<td class="nump">466,400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">192,000,000.0<span></span>
</td>
<td class="nump">232,900,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">137,100,000<span></span>
</td>
<td class="nump">145,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 17,300,000<span></span>
</td>
<td class="nump">$ 6,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365691095432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 702.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695390552">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">31.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">30.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2020-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2021-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365690993768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total (percentage)</a></td>
<td class="nump">0.02<span></span>
</td>
<td class="nump">3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365693146232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">123.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">6.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ContingentConsiderationTypeDomain', window );">Contingent Consideration Type</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">86.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Contingent Consideration Type</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">36.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">6.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Contingent Consideration Type</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">30.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">86.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Forward foreign currency contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Contingent Consideration Type</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">86.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ContingentConsiderationTypeDomain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ContingentConsiderationTypeDomain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365780050888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Jun. 27, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">1,400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">427.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="nump">$ 974.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699062152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments/Accruals</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 86.4<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365686635336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 28, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Aug. 23, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Feb. 03, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 21, 2019 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Nov. 30, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th">
<div>Sep. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Nov. 20, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,663.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain', window );">Equity interest in acquiree, remeasurement gain</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment', window );">Consideration related to equity method investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares', window );">Consideration related to newly acquired shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment', window );">Consideration, portion related to loan repayment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest', window );">Business Combination, Consideration related to fair value of noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_FairValueAssumptionDiscountRate', window );">Discount rate percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,244.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,307.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember', window );">NXC Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AnnualIncrementalRevenueGrowthPeriod', window );">Annual Incremental Revenue Growth Period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health | Contingent Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">$ 18.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage', window );">Equity interest in acquiree, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">81.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 34.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired', window );">Percentage of outstanding shares acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare', window );">Cash tender offer price (per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationSharesAcquired', window );">Shares acquired | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">9 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years 7 months 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember', window );">Health Beacons</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Remainder of purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Purchase price withheld</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_Holdback', window );">Holdback</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember', window );">Alpha Imaging | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AnnualIncrementalRevenueGrowthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Annual Incremental Revenue Growth Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AnnualIncrementalRevenueGrowthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessAcquisitionCashTenderOfferPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Acquisition, Cash Tender Offer Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessAcquisitionCashTenderOfferPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Ownership Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Shares Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_FairValueAssumptionDiscountRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value Assumption, Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_FairValueAssumptionDiscountRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Holdback">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Holdback</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Holdback</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of voting equity interests acquired at the acquisition date in the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116859824&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=79982066&amp;loc=d3e1392-128463<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_NXCImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationByTypeAxis=holx_ContingentHoldbackMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_HealthBeaconsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AlphaImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365693882280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Nov. 21, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 2,663.3<span></span>
</td>
<td class="nump">$ 2,657.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember', window );">SuperSonic Imagine</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue', window );">Deferred revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt', window );">Short and long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities', window );">Other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 161.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of property, plant, and equipment recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI http://asc.fasb.org/extlink&amp;oid=121600890&amp;loc=d3e2207-128464<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121647850&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_SuperSonicImagineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695780136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 31.6<span></span>
</td>
<td class="nump">$ 17.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit Loss</a></td>
<td class="nump">9.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AccountsReceivableAllowanceForCreditLossTransfers', window );">Reclassified as Assets held for sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(5.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write- offs and Payments</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 39.4<span></span>
</td>
<td class="nump">$ 11.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccountsReceivableAllowanceForCreditLossTransfers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Transfers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccountsReceivableAllowanceForCreditLossTransfers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779372712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Disposition (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 20, 2019</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss', window );">Disposal Group, Including Discontinued Operation, Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember', window );">Disposal Group, Disposed of by Sale, Not Discontinued Operations | Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration', window );">Disposal Group, Including Discontinued Operation, Consideration</a></td>
<td class="nump">$ 205,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfBusinesses', window );">Proceeds from Divestiture of Businesses</a></td>
<td class="nump">$ 153,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_IndemnificationLiabily', window );">Indemnification liabily</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup', window );">Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">150.0&#160;million<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,800,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember', window );">Operating Expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Intangible asset and equipment impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,400,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_IndemnificationLiabily">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indemnification liabily</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_IndemnificationLiabily</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Identification of the segment that the disposal group, including discontinued operation is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfBusinesses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfBusinesses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365813722312">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 74.9<span></span>
</td>
<td class="nump">$ 324.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,689.5<span></span>
</td>
<td class="nump">2,713.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">2,764.4<span></span>
</td>
<td class="nump">3,038.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">74.9<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,361.8<span></span>
</td>
<td class="nump">1,379.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">250.0<span></span>
</td>
<td class="nump">$ 750.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember', window );">2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">939.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">394.8<span></span>
</td>
<td class="nump">394.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 932.9<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365698304664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 15, 2020</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 17, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,764,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,038,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">324,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember', window );">Amended Term Loan | Percentage Added to Eurodollar Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember', window );">Accounts Receivable Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (21,600,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest Expense, Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt Instrument, Unamortized Discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtRedemptionPremiumPaid', window );">Premium payment</a></td>
<td class="nump">20,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExtinguishmentOfDebtAmount', window );">Extinguishment of Debt, Amount</a></td>
<td class="nump">$ 970,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue', window );">Debt Instrument, Offering Price, Percent Of Face Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">103.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.813%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Four</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes | Debt Instrument, Redemption, Period Five</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Debt Instrument, Redemption Price, Percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving Credit Facility [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfDebt', window );">Repayments of Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Long-term Debt, Current Maturities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount', window );">Debt Instrument, Unused Borrowing Capacity, Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtInstrumentOfferingPricePercentOfFaceValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Offering Price, Percent Of Face Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtInstrumentOfferingPricePercentOfFaceValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DebtRedemptionPremiumPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Redemption, Premium Paid</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DebtRedemptionPremiumPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph e<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExtinguishmentOfDebtAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of debt extinguished.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExtinguishmentOfDebtAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117329964&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_AmendedTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_PercentageAddedtoEurodollarRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AccountsReceivableSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPeriodAxis=us-gaap_DebtInstrumentRedemptionPeriodFiveMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692905416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">$ 13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">1.23%<span></span>
</td>
<td class="nump">3.11%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">1.15%<span></span>
</td>
<td class="nump">3.04%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695672680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 15.1<span></span>
</td>
<td class="nump">$ 15.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 4.8<span></span>
</td>
<td class="nump">4.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2025 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 2.3<span></span>
</td>
<td class="nump">10.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2025SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365698745800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 28, 2019</div></th>
<th class="th"><div>Sep. 29, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_InterestRateCapAgreementsAggregatePremiumPayable', window );">Interest Rate Cap Agreements Aggregate Premium Payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_NotionalAmount', window );">Notional Amount</a></td>
<td class="nump">299.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">$ 4.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="num">$ (4.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign Exchange Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 245.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_InterestRateCapAgreementsAggregatePremiumPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest rate cap agreements aggregate premium payable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_InterestRateCapAgreementsAggregatePremiumPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Notional Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695131784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="num">$ (4.1)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized Gain (Loss) on Derivatives</a></td>
<td class="num">(14.6)<span></span>
</td>
<td class="num">(3.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized Gain (Loss) on Derivatives</a></td>
<td class="num">(6.6)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Derivative, Gain (Loss) on Derivative, Net</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Unrealized Gain (Loss) on Derivatives</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">$ (1.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives not designated as hedging instruments | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Derivatives not designated as hedging instruments | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365693164600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative Liability</a></td>
<td class="nump">$ 30.7<span></span>
</td>
<td class="nump">$ 31.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">30.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">11.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Interest Rate Swap | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">11.1<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">6.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Foreign currency option contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative Asset, Fair Value, Gross Asset</a></td>
<td class="nump">$ 0.8<span></span>
</td>
<td class="nump">$ 10.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695505640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (0.7)<span></span>
</td>
<td class="num">$ (4.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(0.2) for the three months ended December 26, 2020 and $1.7 for the three months ended December 28,2019.</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of gain (loss) recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember', window );">Interest rate cap agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(0.2) for the three months ended December 26, 2020 and $1.7 for the three months ended December 28,2019.</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="num">$ (0.3)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365789580296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedges, gain (loss)</a></td>
<td class="num">$ (18.7)<span></span>
</td>
<td class="num">$ (3.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings', window );">Forward foreign currency contracts</a></td>
<td class="num">(9.5)<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Derivative instruments not designated as hedges, gain (loss)</a></td>
<td class="num">$ (9.2)<span></span>
</td>
<td class="num">$ (1.7)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779559912">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Detail)<br></strong></div></th>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>petition</div>
</th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MinervaMember', window );">Minerva</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,800,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Petitions filed | petition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_LegalAccrual', window );">Legal Accrual</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LegalAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Legal Accrual</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LegalAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MinervaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MinervaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779384120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">258,605<span></span>
</td>
<td class="nump">267,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units</a></td>
<td class="nump">3,180<span></span>
</td>
<td class="nump">1,828<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">261,785<span></span>
</td>
<td class="nump">269,721<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">340<span></span>
</td>
<td class="nump">1,290<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695752600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 18.6<span></span>
</td>
<td class="nump">$ 18.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.2<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">2.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 11.2<span></span>
</td>
<td class="nump">$ 10.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779916056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices</a></td>
<td class="nump">$ 68.35<span></span>
</td>
<td class="nump">$ 45.67<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock option outstanding</a></td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding</a></td>
<td class="nump">$ 44.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 26.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.35<span></span>
</td>
<td class="nump">$ 45.64<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 83.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.35<span></span>
</td>
<td class="nump">$ 45.65<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 82.31<span></span>
</td>
<td class="nump">$ 43.78<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values</a></td>
<td class="nump">$ 68.35<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember', window );">RSU, PSU, MSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</a></td>
<td class="nump">3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365694668248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.40%<span></span>
</td>
<td class="nump">1.70%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">33.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 19.86<span></span>
</td>
<td class="nump">$ 13.83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365695641096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 152.6<span></span>
</td>
<td class="nump">$ 152.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">60.1<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">207.5<span></span>
</td>
<td class="nump">196.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 420.2<span></span>
</td>
<td class="nump">$ 395.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365779679656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 483.1<span></span>
</td>
<td class="nump">$ 460.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">478.3<span></span>
</td>
<td class="nump">456.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">173.7<span></span>
</td>
<td class="nump">167.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">45.2<span></span>
</td>
<td class="nump">44.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">40.8<span></span>
</td>
<td class="nump">40.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">16.6<span></span>
</td>
<td class="nump">16.1<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,237.7<span></span>
</td>
<td class="nump">1,185.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(723.2)<span></span>
</td>
<td class="num">(694.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">$ 514.5<span></span>
</td>
<td class="nump">$ 491.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6812-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365786226584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 27, 2020 </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 28, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Mar. 28, 2020 </div>
<div>Segment</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,609,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365687059656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,609.8<span></span>
</td>
<td class="nump">$ 850.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">885.5<span></span>
</td>
<td class="nump">124.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">92.8<span></span>
</td>
<td class="nump">94.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">7,550.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,195.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">1,128.2<span></span>
</td>
<td class="nump">311.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">784.5<span></span>
</td>
<td class="nump">49.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">56.3<span></span>
</td>
<td class="nump">59.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">38.3<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,177.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,161.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">332.7<span></span>
</td>
<td class="nump">331.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">86.3<span></span>
</td>
<td class="nump">93.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">13.1<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,203.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,200.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">65.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(51.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">124.0<span></span>
</td>
<td class="nump">119.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">13.7<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">23.2<span></span>
</td>
<td class="nump">21.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">5.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,418.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,438.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">24.9<span></span>
</td>
<td class="nump">23.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">31.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 2,719.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,355.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699017704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">70.70%<span></span>
</td>
<td class="nump">74.40%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">12.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">5.50%<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">2.80%<span></span>
</td>
<td class="nump">4.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692402072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="nump">21.50%<span></span>
</td>
<td class="nump">29610.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember', window );">Medical Aesthetics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized Tax Benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 312,200,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_MedicalAestheticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699288872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Sep. 26, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 4,943.9<span></span>
</td>
<td class="nump">$ 4,931.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,699.1<span></span>
</td>
<td class="nump">3,623.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,056.1<span></span>
</td>
<td class="nump">4,054.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2,969.4<span></span>
</td>
<td class="nump">2,907.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">560.5<span></span>
</td>
<td class="nump">549.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">486.7<span></span>
</td>
<td class="nump">477.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">245.7<span></span>
</td>
<td class="nump">245.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">183.8<span></span>
</td>
<td class="nump">181.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-competition agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember', window );">Business licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Total acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,866.4<span></span>
</td>
<td class="nump">4,852.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,643.8<span></span>
</td>
<td class="nump">3,569.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">51.9<span></span>
</td>
<td class="nump">51.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software embedded in products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">25.6<span></span>
</td>
<td class="nump">26.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 11.5<span></span>
</td>
<td class="nump">$ 10.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_BusinessLicensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365692458584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 26, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2021</a></td>
<td class="nump">$ 213.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2022</a></td>
<td class="nump">274.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2023</a></td>
<td class="nump">178.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2024</a></td>
<td class="nump">166.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2025</a></td>
<td class="nump">$ 153.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365699008680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 9.9<span></span>
</td>
<td class="nump">$ 13.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">3.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition', window );">Standard and Extended Product Warranty Accrual, Additions from Business Acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at End&#160;of&#160;Period</a></td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="nump">$ 14.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from a business acquisition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365816528008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 28, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 2,705.2<span></span>
</td>
<td class="nump">$ 2,115.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">17.8<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">4.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">3,267.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(22.9)<span></span>
</td>
<td class="num">(41.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">17.8<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(33.1)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(1.8)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(49.7)<span></span>
</td>
<td class="num">(42.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">18.5<span></span>
</td>
<td class="nump">12.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(30.7)<span></span>
</td>
<td class="num">(28.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember', window );">Interest rate caps - derivative | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.9)<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="num">(0.5)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(1.7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(24.1)<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">4.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax', window );">Amounts reclassified to statement of income</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (23.2)<span></span>
</td>
<td class="nump">$ 7.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (i-k)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121558989&amp;loc=d3e80720-113993<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17B<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL34724394-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121640130&amp;loc=d3e1436-108581<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateCapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140365698684232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase Share repurchase (Details) - USD ($)<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 26, 2020</div></th>
<th class="th"><div>Dec. 11, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member', window );">December 11, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromRepurchaseOfEquity', window );">Repurchase of equity</a></td>
<td class="nump">$ 101,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharerepurchaseplanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for share repurchase plan [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharerepurchaseplanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepurchaseOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net cash inflow or outflow resulting from the entity's share transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepurchaseOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcceleratedShareRepurchasesDateAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>91
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M)2)SZ'/F<:D?@/MK(=3Q1+^@V$@=_PM02P,$%     @ 8($[4G+@E)-*!@
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M18L+8AK3)*1DU"D996\ &PYW=P:VI25'29F_>E%,WXZ&"@AULDC#LKB#'%<
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M#,965<-5M3!RZ^:3E30X[;C7 @=24%8 OZ^E-!\+ZZ 9<1?_ 5!+ P04
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M=AB*YT1-P@.KL/\B4N<96V=YIJ' NW"-!V!@-S&>)MX+V723@+Q<E-N%YK*
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M(0(.L382%/_6, 7.C1)R_&Y$K3:F<=P>OZG?5\EC,@NJ8"KX#Y;H=&P-+)+
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M(^M#03W1HJCVU870N$M7PQ0/4B"- =Y?"J'?)F:K;H]FD[]02P,$%     @
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M"2$*S=[4PY/&AQ<SU(./XN"KL_4R=]5)4CGJ76VJINRJ\BB[7]VD774#5E8
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M^A?_[#:1 %;2L(@4GASBYV\2"6"3R&#5NO"D$#]""@&4,$RB,>A1(9YDDT@
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M6(:!"XBN;R'T 5HJE(><JL;I:)4A2Z]LB>)',56$N&]TK@S!:YN;MD!0%F@
M>!6U+8'8!V4PG))='X28P8[V%%_)3J:$S1%<9G2I>.,%H$7:O[3%.8ZR!3@2
M*%1H%*B, *?P6X4$]B0[%A7:[&_:RZPJHJ>](/"4$K?500+M*IU78HM;95H5
M*0>4O ([>Y; J>V(\YI0ZW7DN6NMR&Q:W[C K.[_I;8CHFE^D;=69@KKGK'
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MH[YR>)KW7G)5D?'*&N&H.)F<';P[/^3]<<.?BG9^]%MP)AMK/_/#^_QDLF!
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M?J7;QA:*;3"KVP_8B!X/[8P1_6^$HB.$L(N/$<)$X4GIK&I0:_1&YL'XI71
M8)(C>K<'E>$*1IC)!IP $DPJX#Q<27>;2$-'4(*RO@/#-.(RC!=]W!IQ:*QL
M<R$_B:H1'D\,?(PT*TK.L-T()GV2NNG60WNM"&4)OTPM2>1_0A.8M"'Y.;@:
M^,OE$C+''FBCGV;"E925PA82J7%-5I( !>V%+A2;%\Y![T7--?]7J ^@0>>=
M'!Z9!B*%,?E:514I>*EL8+HU@.VBG>A4%I.!( O;@W6H(PL)_M@HI_@%EB%(
MWC:9#X4P1$*T,Y7*Q18G1Z917I@@=\8J+"_:.=NQ$"J$ 56CY5./ID&PUNC&
M-<BC\K)&\E_G(*V62FP]:TEQ^(YEAODH%V*J-'+BC55L[# ^&-I$IV6RLIPV
M?S^D525T&S\)QU>,VR^695-5]R2JRF2A2G*)SIJI7N@XU5^HGCY8B1QCN<,;
M% A NYBH(XX+]L\"$&:[L0"&2*_Y1YN01?OT05GFNWWK2RLEU:W"2U;XW>;8
M:'3P?C<ZWVR9C?"JG421"KR6!N%80U_>!?C]!M*'[Z&^,RPN&Y8]<:(G% _C
M9#Y*<)?&\6C:5RM*TV0TPV\\BOO"%2>3440Q^,:' D9XM: D!=@1O?C'=_,D
M3I[3Z724!O.GT6(TQ]U\&F'%ZW8S+ZVI-UL<Q79(>C:?8.X3FBP>,)Z? G>1
M@D&?;\I^L(.';&/X$6'Z(UR_GV+2#\QQ/@UVV?LYHKQ7DIS,?=4XI#P]#?Y.
M.6!]QJ 64QR!1H\Q IA0PNP.&4=XP7^/,)X \@DMDA#9Q60TH6NQ4HP1MDX>
ME.-!6--YFY/Y XX) G0*E![#%+,YBX?\-B0BP#S",696VYT6 2@*=3B9!-8A
M6;VJOI4KOWLZ(EJ'_B3#>#8+8+@[97L'D1\F48I1OD8/*F8X02"F?$5<9@^\
M!+^4([;8<R(9SK C9KBFTRG>H%*'4]3U+-S%BRG(O#MHVM"3]F-6VJY16[G3
MJ@*$N>?CA4:1G+#F[MH!)GQK]=FGUVY ;M&Z_1H)^L-6:O$G^D.Q^YX2'%CX
MPI2ZV7=\K F="-)^T](DD!:L9FUS;U;<JSKO*4@]MLZ(?@OJ''QFI/=:,>ZM
M9S)#CAB^.0JD/3.-]A9M(@MW,@]M"[M0?CU@/5=#3<Z>N_"U$_Q]V7"O8K^X
M<^0&!PQT++2D7%HTW[R5J%?H[YD<[K/\!=0PO?O@A(#K^Z^8NG1*/'TK,A1S
M]C6#UR6&AW39\)=XI40P\[, <&N$T9/H^8ULVS/.?54>QN+G '*JT%U#:3\&
M'71!BQR(_^2/*;I$'E#] 95]>J/R''%^B4VSS2&2=[]-_3WW)4$HE P%B[,J
M6_6]CM.VS?^[??623S/>3"<T8TD[V20IJ.0)5!E;[J0?3M;K$V)=.Z%-4/[@
MH!!KXPFU.'$4M0CM]=CQ9KQWD$20BG!<=FT%MF?*[>CV1'[9'D1WT]OC_!M\
MFRGMJ))++(5#. #;]HC</GBS"L?2.^.Q,\)M*07J@"?@_=)@GW4/;&#[?XJ+
M_P)02P,$%     @ 8($[4M&=QA)M!@  L@\  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C$N>&ULI5?;<MLV$/T5C-KT,F-+LFPG3FI[QG;::1[<\<1)\]#I
M T0N120@H "@9/U]SRXHFDIB)].\2"2(W3U[]@:<KGWX$&NBI.X:Z^+9J$YI
M^6(RB45-C8YCOR2'+Y4/C4YX#8M)7 ;2I0@U=C*;3I].&FW<Z/Q4UF["^:EO
MDS6.;H**;=/HL+DDZ]=GHX/1=N&U6=2)%R;GITN]H%M*;Y<W 6^37DMI&G+1
M>*<"56>CBX,7ET>\7S;\;6@=!\^*/9E[_X%?7I5GHRD#(DM%8@T:?RNZ(FM9
M$6!\['2.>I,L.'S>:O]#?(<O<QWIRMMWIDSUV>ADI$JJ=&O3:[_^DSI_CEE?
MX6V47[7.>P\/1ZIH8_)-)PP$C7'Y7]]U/ P$3J8/",PZ@9G@SH8$Y4N=]/EI
M\&L5>#>T\8.X*M( 9QP'Y38%?#602^>O7.$;4F_T'<7328)&7I\4G?1EEIX]
M('VHKKU+=52_NY+*7?D)D/1P9ELXE[-'%;ZD8JQF3_?4;#J;/J+OL'?O4/0=
M?M4]]=+$POK8!E+_7,QC"DB(?Q\Q<=2;.!(31_^3P6^75J\X2PL?2NT*0B*D
M6EW<7JEG1],]M;/QEV[YUSU%NJB5<8F":=02O[Y4)JK"HVY*"E3*QT705B6O
M4DU*.]?B+>_=PVNI$OBA.Q1Z)!9N2#-/I6JC<0OL4!2300E@J9.FJB(I*)$-
M^#16%]CGDDD;UA'H8VM8!ZP&8J< 1%P8&A/T'UL=@%^JJU0H59/BPW8&6-"3
MQ*.JM595B"\$-J2#^-1"?:IURD) L0Q^!4I$ZAX*V.3F@%H+ >A%?C_Y_9*E
M@,A$4%2^1R5V!DO8"91$6,\M\*P@%[,M7T"/*MO O#&TW<B,U1NL7?EFJ=WF
MIQ].9@?/?HM?\G'K6:H#D6IRD1$7F4*)4#,'7=LR46L-NK)[TBM]I68'X^,G
M2 (8ZF*@E4.+GY.CRB39\OSI^.!);PD1"A27WI4,?9M(3KXM\1*$F>S ]P(N
M#10PKBKX1L3>CF_'*B:=VN3#YEXM+&-6&+L!IQ)$WD,[X=L3!0OKYX@^Z-9N
M83@L&#?[O*'/._S9E@G*.=^ZCHP<5[1O!YD862-82T9;F/55%9FW38XF^"R$
MO1XT/&SS@&$*MHI0>:"G'.+)*#JTY%&1R]H4Z.EWK*_#"(H=Q&#.MR$GC].L
M';[%=HZ2-J"#(:XA7"M$5V4GNT2/[#=Q++1[C-G,044 "M7\G)GE[TCO$B7X
M?;$^X5@?//^>6&OUX^'!;#P#1]8RP\/2ZU,YD)5FT'6W:V#G/G"!-E%3,D54
M<VYC%%'H;>*FF,MZBPRM]LL!!X&("DXZW!3=5Y6OM&UU/FE8Q(!;>&;P(:O<
M)5GI8&5.:4V4;14ZA(VTW\:W3I).;QOLSQ&(5@#1<,N2Q#,.%N$"^%AZ.,-%
MW(:E1S[G%@^5+6(4K"@5!@60N(;LN5<HG7R+&AOW_8K"/I^L/O>!;0M1/1K#
MW;3/U0WP1)R0XI9"G@4+9U+7J#0?H2A(DP(D'9E\[Q"(=4T\"< )5P:<6'(O
M@P%!FU4!5X3+73TF:N ZVQP 7"-WNK;<(> :C432NZLV8=#!X?C5^#:4K0K$
MJ&JR>1X  ((5#/=Y/6S]WU(>>YTC,BO[8'["D23)YRQMR_#!_)*Y8*-GZ&/U
MEW?[@^/0M4Y '(<#B1,2@7N/>I=JDCFM<>B4M(YBD+,<')3P9D]<C_LRMKF$
M-L%;FQN+!["@'$P.ACXH:M!5+I1KA83L&I\"AE:XI7FW\$PC(K9"2_!M5.]!
M;$1T9-/.'(7N#\B/@D+")>13HZ@ DQ5WX=]1Q(NYD_)0Q-23%HK"B:UVP@*?
MM(Z.IV,^G+&XX[N Q;C$'F(7M@F20]EA0H'>&V9"<![KID\<=BP^Z3P(&#:0
M8W-D5XV60F[!-.=RZLCA1(BQD?,'.M:""]7Q*_?T-M4>:8EI,58WGWNT@U?5
M.G;'- #C,<B(V0PR"1KR890/"%UR1(;;![#'/%;O:F-I1_6<K$&EQL'!+<]9
M='Q:<7#MYMXVAY][+D8>"G2O#ZMN2SD6XC/4<$UW.<+L(A]--R7!55C0@+Q>
M\[;\<\E_Z>0_&=RC&H(:OBV**I?RE:I?[2^D%_D>=K\]WV:O@<(@AI8JB$['
MSXY'*N0;8GY)?BFWLKE/N./)8XU+-07>@.^5]VG[P@;Z:_KY?U!+ P04
M" !@@3M2!N64 ;H#   O"   &0   'AL+W=O<FMS:&5E=',O<VAE970R,BYX
M;6RM5M]SVS8,_E=PNMWM)=5OR7+.]IV3K%T?NLLEW?:PVP--P1:O$JF25)ST
MKQ](V8K;QG[:@V+P(_ !($ BB[W27TR#:.&Y:Z59!HVU_744&=Y@QTRH>I2T
MLU6Z8Y:6>A>97B.KO5'71FD<EU''A Q6"X_=Z]5"#;85$N\UF*'KF'ZYP5;M
MET$2'($'L6NL Z+5HF<[?$3[9W^O:15-++7H4!JA)&C<+H-U<GV3.WVO\)?
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M3?\"4+L#M+]6RAXF+D#_OV+Z$U!+ P04    " !@@3M2*#NYEOL!  "P!
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M]#4%BQF1UQD3P*J"=SKLL8^V;VWYH$P.8#@G7C1>Z4S%^7#58AT-"!U/5;U
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M7./CB)T(8']I07"S$ /MY];%7U!+ P04    " !@@3M2:Y':OK($  ##"@
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MDT8 SS="Z&EA'.S?K8O_ %!+ P04    " !@@3M21PX/J=$#   E"0  &0
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M<FMS:&5E=',O<VAE970S,2YX;6R]6-N.VS80_17"37H!'-F2?-WL+K"[2=
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M=(BQY;6J_/"F"%>9N?%T,0JO&=U$T;( S2^,\8\?O$!]MSW[!U!+ P04
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MWQC^0DFHA#]E.344=Z5V-P,,!N1D$(?OR=-@'%YUPP#.D&#4DV!TE@3?_>6
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ME*5GR$\K>O=1.P$Z+Y2RAX5ST/^3F/T$4$L#!!0    ( &"!.U+:+@.'/0,
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M1U1H(82CK@J)MPYNI)08VBGPD.(\[%V&OARBP#FJ1BX#((_BXR^T#-H=PKR
M(4_DX>VAZY  E P'9;<,5WEEX3=I7 3]!C8,<,?(N)HSP!W#QV28YKNF;26U
MYLPGNB>T&C6BJK>,*8[)'JH? 2 &[&/1R%4 UC%\Z(96P?610KY0!3>41)1@
M50!&,IR1_:K0ES\,T,=&=J<,4,>&^U/FNDZV<U!.%3RA(L** (1D."&[8I^G
M>5Y=\?/"F"S)EMC<#" N&MFQ1D"Y:+ACC5P;JKPW74\@.72VW?P C5%ON^J*
M?01Q(B!=-/8<7&L2[AMFX5R3^H+X'N>+BP]$C(XQLZ[X?4$3 >"BD>UM!$R+
MAMO;R/6LCNQ82#<E8%^$L^^\,'%I@_<F3NT*.TE@532R@>4 +3[<P'*/@76F
M"[>Z>D,)=OOD #N.PZZC[Q'PX( K/K)QY< I/MRX<M>-4NZ?#/.&"G0.'_C&
M<;X=ZMV7%[SUF&!D?\H!37RX/^4>UQEY9\.\D=AD& >@<1QHAVKOMB_7\1(?
MF'  %!_9AW(@%Q_N0[GK+JF0?IQX0N7A%$[W"1 03^#$PP4_@B\"""9&-J4"
M4":&FU+A.DT:,N] W!NJL9&X  0*'(%?+4!?X A FAC9CPI@FQCN1X7'C_IG
M8GR1')6_]0@4)Z(7[U7.6[F?JW&;IYMZ#_H# ,B)D9VH -B)X4Y4>)Y_<O_U
M[T9RP3#] 9$"1^21^A\!) D,E"-;50GLD\.MJG0=*.?>\8XG,I+8\%(",25.
MS./KT9=/$I H1W:O$E HA[M7Z9I2_PH27R#%J@'XE#@^?_WSM^!V4RR3.2XM
MX$Z.[$UE:S'(<&\J7>-):.1ECR^4:/1B!SI*G(YM>8\A"]!-CFQ=%4!,#;>N
MRO6C)#Q\L+=;$^.&:H4--16P3^'L.U"[+S<4L$N-;%P5($H--Z[*XT;]XTI?
M9(C=5Q6 3>%@NS*+1N=WIK0K\Y4'2@J I$;VJ@I0I89[5>4Z4$=;-T0</NSH
M9@9D4SC97&V/@(=J+7(;V:@JX)0:;%1GRG6?+,168VA@EL:9Y16R+Q<T@$>/
M;#@U($@/-IPS[;I(%F$N1@..-(ZCV\\F-?6#^Z].NVH@B![9)6J@BA[N$K7K
M_6BD?33U1:+/ZS6P2.,L.M#WB)^[!JKHD5VA!K+HX:Y0>Q;0<N]#&U_D866Z
M";;6S^(\<O7NOZ2VO:9V[$6U86M5;?@-RVIW;45GU.73W!>IO%.OT]8;$&M3
M+)L70\I@GF\RNWVW8+]W__;)N^:5BX/]Y_5;*<V;%=#-]I66J[@:S%4>,#5W
M59?AF]K,%-N71+8;-K]OWK/XE%N;KYN/*Q,O3%$'5-_?Y;E]WJ@/L']7Y^Q_
M4$L#!!0    ( &"!.U)6M6(M_ (  %P*   9    >&PO=V]R:W-H965T<R]S
M:&5E=#0R+GAM;+5676^;,!3]*Q;:0RNM@"$04B61FJ3;*JU2U*CKP[0'%VZ(
M5<"9[33=OY]M""%?;(J4EX#-/>>>>TPNM[]F_$TL "3ZR+-"#*R%E,M;QQ'Q
M G(B;+:$0CV9,YX3J98\=<22 TD,*,\<SW5#)R>TL(9]LS?EPSY;R8P6,.5(
MK/*<\#\CR-AZ8&%KL_%$TX74&\ZPOR0IS$ ^+Z=<K9R:):$Y%(*R G&8#ZP[
M?#O&H0:8B!\4UJ)QCW0IKXR]Z<5#,K!<K0@RB*6F(.KR#F/(,LVD=/RN2*TZ
MIP8V[S?L7TSQJIA7(F#,LA>:R,7 BBR4P)RL,OG$UM^@*BC0?#'+A/E%ZS(V
M#"P4KX1D>056"G):E%?R41G1 .!3 *\">/N S@F 7P%\4VBIS)0U(9(,^YRM
M$=?1BDW?&&\,6E5#"WV,,\G54ZIP<O@$[U"L -V@K\!23I8+&I,,;;:O)B )
MS<2U"GB>3=#5IVOT"=$"/=(L4\<@^HY4*C27$U<91V5&[T1&'SVR0BX$NB\2
M2';QCE)?E^!M2AAYK803B&WDA9^1YWKN$3WC_X%'&HY[+7+\VE'?\/FG^*@@
M:<HA)>8]9?/:S)_?52AZD)"+7RV).G6BCDG4:3^ZHT=0(B.#U/_D]R$.W9X=
M]9WWIC.'85'@VD$=M:,KJ'4%K;J>"RHA03-)Y+ZX';ZPY@LO:VBW3M0]V] 2
MV6L:BOWN@:&'8:'OV=WCAD:UKJA5U_V*J[;=4F"O)NI=UDGL;MN*>[:7%;3I
MDN]'MK?GY9$PK-[ASG$S<:/CX59I=X*2FRF)Z9S&;;5Z6T+OPK9N>POVS[?5
M/_ KBFQ_W]7#J*[;\'Y7V+87X7\U(R%UY2^,9VU-'6^[" XN[.JVP>#P?%?#
M@Q[9"1HMLG+U,&KGC2Z%.8WO= X\->.+0#%;%;+\WM6[]8AT9P:#O?V1'IW,
M]W]+4\Y=CX2GM! H@[FB=.VN,IF7HTRYD&QIIH%7)M5L86X7:OP#K@/4\SEC
M<K/0">J!<O@74$L#!!0    ( &"!.U)AUP5!+P,  "H+   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0S+GAM;+56WV^;,!#^5RRTAU;*"H8 295$:I)-J]1J
M5;-N#],>''(!JX"I[23M_OK9AI!?%$V5DH=@F_ONOOL.CAML&'\6"8!$KUF:
MBZ&52%E<V[:($LB(N&(%Y.K.DO&,2+7EL2T*#F1A0%EJNXX3V!FAN34:F+,'
M/AJPE4QI#@\<B566$?XVAI1MAA:VM@>/-$ZD/K!'@X+$, /Y5#QPM;-K+PN:
M02XHRQ&'Y="ZP=<3'&J L?A)82/VUDBG,F?L66]N%T/+T8P@A4AJ%T1=UC"!
M--6>%(^7RJE5Q]3 _?76^U>3O$IF3@1,6/J++F0RM'H66L"2K%+YR#;?H$K(
MU_XBE@KSCS:EK=^U4+02DF456#'(:%Y>R6LEQ!Y ^6D&N!7 /0:\%\&K )Y)
MM&1FTIH2248#SC:(:VOE32^,-@:MLJ&Y+N-,<G67*IP</<(:\A6@SVB[FK^A
M'V\%H(LI2$)3<:GN/<VFZ.+3Y<"6*J0&VE'E?ERZ=]]Q[Z%[ELM$H"_Y A:'
M>%M1K?FZ6[YCM]7A%*(KY 8=Y#JNT\!G\C_PGH;C?@L=KY;/,_Z\]_Q10>*8
M0TS,0\F6M8R_[Y0INI60B3\M@;IUH*X)U&VODV@J08D,#%*_MNL1#IQ^S]&_
M@;W>5^?4M.<[_J'E 3^_YN>W\INH,G/U3JK'5R9H8AY<X!UT1\F<IE2^=6IE
M'B%B<4[_'C\/93)E&'^/H>^$+02#FF#02E!5JF""S--C#0^\A;6W\+QU[]6!
M>A^N>^]$*NP&7K>I[J>FW2#HMLC:K_GUV^M."BI)BN!E10O5WF4'12PK6*Z6
M I%\@01;R@WAT"(&=G;=RCFO[GBO,>(/*U]!#Z3ONTZ3\@VFKN?V6Z3'[HZB
MVTIQ!GQ-HU9E=XT,G[F3X5TKPQ_O917T0%DOQ(W*-IAV?:=-V5TWP^WM[+M,
M@+<ENVL[.#BSKKN>A,./ZQJ>?B1"KU'64\O ;1+5WILZ5*^/S3 FU.N_RF7Y
M0:]/ZX'OQHPY1^=C/0B::6;GIIPB[PF/:2Y0"DOETKD*5=5X.9B5&\D*,]O,
MF50?'+-,U# +7!NH^TO&Y':C ]3C\>@?4$L#!!0    ( &"!.U+2^J<E_0$
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M'E==WADRNE6+?79*_<I?S00/@">!&RBWL1%*:(,>N!'H<<T7KF$". +6MOX
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M8@?42DNE$ +!0K<4:U!/0*/03:..ZNF\:3TQP!)KKM?VRD W&H$!\UA;X<8
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M<FMS:&5E=',O<VAE970T.2YX;6R-5=MNXC 0_14KZD,K[28AW$(%2%RVVGU
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M!@9%P>E0%!@4!?_>L^";2JM>N&!;Y Q@ A@P_5O-FTJIGC^.]1FKP5$ ETY
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MC,2J#('USY$\$L;*2#J/'TW02>M9"OO';]%_J3JO.[/%DCQR]A?=J>1N,I^
M'=GC@JFO_/2)-!V:EO%BSF3U'YR:MMX$Q(54/&W$.H.49O4O?FD&HB> @4&
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M+&XESMQ&2\HRR!43.9&P'CO7_JN%'QN E?C$8*^.QL28LA+BBYG<I&/',XR
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M,=-1-?*TT6?OXBU++3>%%M2A94:6+D#1*X!\Y+? I_WP.<EZX;-^^ <L71#
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MVZ]GMA>*K[)O,69<*9YD/Y>,SIDP#?3S!=<S/[\PGW?LOF$Z_1]02P,$%
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M#/3YC.NK6"R,@W*$'_X#4$L#!!0    ( &"!.U(P;K&2N0,  *$,   9
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;,5768_;-A#^*X21 !L@L2Z?"]N
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MU&A0,O)RBP/,@QSSH!7SHP %COC?0,51R(T;(@WKE^'B7F=0P9M:]<M6W6;
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M@C (@P/JM^WJ,Y8=4_<Q,E5XPBH\86ZO^]OP;#E.90*?6;+@<@$W+A&YY1C
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MM!/ ];E2]G7B+FO5Y7SR"U!+ P04    " !@@3M2=2$M/EH#  "G"@  &0
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M9$.OYY$$YG3)S;U<7T.94-OZBR77[I^L2]O (_%2&YF78&20,U$\Z6M9B!H
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ML[,^MMW8M91W-T4KOZ4JQ2H0#G-T&32Z>#95T1V+B9$+UV">I<%VY889?E&
ML@:X/Y?2;"8V0/6-,OH'4$L#!!0    ( &"!.U+,M*=$;@(  *X&   9
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M"BA[ /?W4IK+Q+:@]A65_@%02P,$%     @ 8($[4BWF-IY6 P  4 H  !D
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MJ:469QTQQW7,\8=ZLSOF$:O$.FY3:/R^P?K[_?7>Q@_&7KLXOK>[ [S.]!]
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M=D:S.\)R!P<A-RH&T.0Y3;@:.K'6VUO756$,*54-L06.3U9"IE3C5JY=M95
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MC8OQJ:ZJ11'\2U.4Y <B-E0[8AAK2M_MZ\LNBC)7=!3/;:58<:7KCFTF^LL
MA5F@YV/.U;%C-JB^-<9_ %!+ P04    " !@@3M2T?*_4'@"  !9!@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970V."YX;6R-54UOHS 0_2L6ZJ&5-D @T*8B
M2$VB:GNH-DK4[6&U!P<FP:JQ6=L)W7^_MJ&(-B3:2_#'>S-OGNU)4G/Q)@L
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MZ5/6-@_ZC0;"&.CO.\[50\>\ H97W^H'4$L#!!0    ( &"!.U+OZ#5(R@(
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MK<;(/?=)O,L9%\F:._8D]!2UO1^/ -A)$O [(= $Z&T9B,(Q&BP @QV&UB4
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M0?=,%6AZ7= [O0)V:.@.6BI@Q[7V'F]O("F K\R<)E#,2BJKN[RVUK/@E9F
M/MBG>D8T@TY#4PV8]YBO"!4HAU11JNZI"L*KF:W:2+8V8\^2235$F66FYES@
M^H!ZGS(F=QOMH)Z<)_\ 4$L#!!0    ( &"!.U)C(.NGA0(  '@&   9
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MV$%9 SR?2VFV"WM!]5=A\!=02P,$%     @ 8($[4N+DY7(J!0  MQD  !D
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M\26?S7]ZOOX-4$L! A0#%     @ 8($[4@=!36*!    L0   !
M     ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4    " !@@3M2D\HT
M3.X    K @  $0              @ &O    9&]C4')O<',O8V]R92YX;6Q0
M2P$"% ,4    " !@@3M2F5R<(Q &  "<)P  $P              @ ', 0
M>&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    ( &"!.U)X^,N0, 4  %05
M   8              " @0T(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q0
M2P$"% ,4    " !@@3M2<N"4DTH&  "@&@  &               @(%S#0
M>&PO=V]R:W-H965T<R]S:&5E=#(N>&UL4$L! A0#%     @ 8($[4LXE1ZBW
M P  [@H  !@              ("!\Q,  'AL+W=O<FMS:&5E=',O<VAE970S
M+GAM;%!+ 0(4 Q0    ( &"!.U+#<'X=9P(  &@%   8              "
M@> 7  !X;"]W;W)K<VAE971S+W-H965T-"YX;6Q02P$"% ,4    " !@@3M2
MUJVZBLD&   [&P  &               @(%]&@  >&PO=V]R:W-H965T<R]S
M:&5E=#4N>&UL4$L! A0#%     @ 8($[4D$S<I(! P  I@D  !@
M     ("!?"$  'AL+W=O<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    (
M &"!.U**.L($_ H  .=%   8              " @;,D  !X;"]W;W)K<VAE
M971S+W-H965T-RYX;6Q02P$"% ,4    " !@@3M2GUS2X@0(  "/(@  &
M            @('E+P  >&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#
M%     @ 8($[4NVYB<M["0  M1<  !@              ("!'S@  'AL+W=O
M<FMS:&5E=',O<VAE970Y+GAM;%!+ 0(4 Q0    ( &"!.U+[%6<$Z@,  /T,
M   9              " @=!!  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL
M4$L! A0#%     @ 8($[4A!"()Z[!@  =1(  !D              ("!\44
M 'AL+W=O<FMS:&5E=',O<VAE970Q,2YX;6Q02P$"% ,4    " !@@3M2IJM.
M'V@-  "U*P  &0              @('C3   >&PO=V]R:W-H965T<R]S:&5E
M=#$R+GAM;%!+ 0(4 Q0    ( &"!.U+8;L%^3P4  (8,   9
M  " @8):  !X;"]W;W)K<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @
M8($[4H^."\/]!0  S0X  !D              ("!"&   'AL+W=O<FMS:&5E
M=',O<VAE970Q-"YX;6Q02P$"% ,4    " !@@3M2.)K7!:X+  #.(0  &0
M            @($\9@  >&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4
M Q0    ( &"!.U*X@<8S<0L  /@?   9              " @2%R  !X;"]W
M;W)K<VAE971S+W-H965T,38N>&UL4$L! A0#%     @ 8($[4HFX ?79 @
M5P8  !D              ("!R7T  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX
M;6Q02P$"% ,4    " !@@3M2'TYO>MX&  "-%   &0              @('9
M@   >&PO=V]R:W-H965T<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( &"!.U)J
M9!(-&0,  '8&   9              " @>Z'  !X;"]W;W)K<VAE971S+W-H
M965T,3DN>&UL4$L! A0#%     @ 8($[4NGIH_Z@!@  LQ   !D
M     ("!/HL  'AL+W=O<FMS:&5E=',O<VAE970R,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &"!.U(H.[F6^P$  + $   9              "
M@:RB  !X;"]W;W)K<VAE971S+W-H965T,C4N>&UL4$L! A0#%     @ 8($[
M4ED9 ')3!0  >@T  !D              ("!WJ0  'AL+W=O<FMS:&5E=',O
M<VAE970R-BYX;6Q02P$"% ,4    " !@@3M2:Y':OK($  ##"@  &0
M        @(%HJ@  >&PO=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0
M   ( &"!.U)'#@^IT0,  "4)   9              " @5&O  !X;"]W;W)K
M<VAE971S+W-H965T,C@N>&UL4$L! A0#%     @ 8($[4E/@*:C# P  L@@
M !D              ("!6;,  'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q0
M2P$"% ,4    " !@@3M2<4$:5DT"   %!0  &0              @(%3MP
M>&PO=V]R:W-H965T<R]S:&5E=#,P+GAM;%!+ 0(4 Q0    ( &"!.U)37E:
MS08   <2   9              " @=>Y  !X;"]W;W)K<VAE971S+W-H965T
M,S$N>&UL4$L! A0#%     @ 8($[4J"ZO= !!0  YPX  !D
M ("!V\   'AL+W=O<FMS:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !@
M@3M2/G&K9^D"  !A!@  &0              @($3Q@  >&PO=V]R:W-H965T
M<R]S:&5E=#,S+GAM;%!+ 0(4 Q0    ( &"!.U(Y#)@\I ,  %4(   9
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M970S."YX;6Q02P$"% ,4    " !@@3M2I:!2B3\#  !+"   &0
M    @(&;VP  >&PO=V]R:W-H965T<R]S:&5E=#,Y+GAM;%!+ 0(4 Q0    (
M &"!.U(#;TOR40(  #$&   9              " @1'?  !X;"]W;W)K<VAE
M971S+W-H965T-# N>&UL4$L! A0#%     @ 8($[4I;8%V%S!P  MS,  !D
M             ("!F>$  'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6Q02P$"
M% ,4    " !@@3M25K5B+?P"  !<"@  &0              @(%#Z0  >&PO
M=V]R:W-H965T<R]S:&5E=#0R+GAM;%!+ 0(4 Q0    ( &"!.U)AUP5!+P,
M "H+   9              " @7;L  !X;"]W;W)K<VAE971S+W-H965T-#,N
M>&UL4$L! A0#%     @ 8($[4M+ZIR7] 0  ^ ,  !D              ("!
MW.\  'AL+W=O<FMS:&5E=',O<VAE970T-"YX;6Q02P$"% ,4    " !@@3M2
MN$W7>.L"  #K#P  &0              @($0\@  >&PO=V]R:W-H965T<R]S
M:&5E=#0U+GAM;%!+ 0(4 Q0    ( &"!.U*%B[Q6- (  !(%   9
M      " @3+U  !X;"]W;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%
M  @ 8($[4L"/]@)T!0  %2,  !D              ("!G?<  'AL+W=O<FMS
M:&5E=',O<VAE970T-RYX;6Q02P$"% ,4    " !@@3M2^H8JMEP#  #]"P
M&0              @(%(_0  >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+
M 0(4 Q0    ( &"!.U+@AE^DUP(  + '   9              " @=L  0!X
M;"]W;W)K<VAE971S+W-H965T-#DN>&UL4$L! A0#%     @ 8($[4J<D&:/.
M!P  E"D  !D              ("!Z0,! 'AL+W=O<FMS:&5E=',O<VAE970U
M,"YX;6Q02P$"% ,4    " !@@3M2T8GC!Y $  !U$@  &0
M@('N"P$ >&PO=V]R:W-H965T<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( &"!
M.U*K88OQ[0(  .<'   9              " @;40 0!X;"]W;W)K<VAE971S
M+W-H965T-3(N>&UL4$L! A0#%     @ 8($[4ASK3A2@ P  R@T  !D
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M=#4W+GAM;%!+ 0(4 Q0    ( &"!.U(P;K&2N0,  *$,   9
M  " @<<H 0!X;"]W;W)K<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @
M8($[4K8I_>(I!   L1(  !D              ("!MRP! 'AL+W=O<FMS:&5E
M=',O<VAE970U.2YX;6Q02P$"% ,4    " !@@3M27;'NH)L#  "H#P  &0
M            @($7,0$ >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4
M Q0    ( &"!.U)U(2T^6@,  *<*   9              " @>DT 0!X;"]W
M;W)K<VAE971S+W-H965T-C$N>&UL4$L! A0#%     @ 8($[4O@Q56CE @
MKP@  !D              ("!>C@! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX
M;6Q02P$"% ,4    " !@@3M2S+2G1&X"  "N!@  &0              @(&6
M.P$ >&PO=V]R:W-H965T<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( &"!.U(M
MYC:>5@,  % *   9              " @3L^ 0!X;"]W;W)K<VAE971S+W-H
M965T-C0N>&UL4$L! A0#%     @ 8($[4IA"+70X P  _ L  !D
M     ("!R$$! 'AL+W=O<FMS:&5E=',O<VAE970V-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( &"!.U+OZ#5(R@(  %\(   9              "
M@3M4 0!X;"]W;W)K<VAE971S+W-H965T-S N>&UL4$L! A0#%     @ 8($[
M4L[.-WK!!0  U1T  !D              ("!/%<! 'AL+W=O<FMS:&5E=',O
M<VAE970W,2YX;6Q02P$"% ,4    " !@@3M2;WBK"^@"  !%"P  &0
M        @($T70$ >&PO=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0
M   ( &"!.U)C(.NGA0(  '@&   9              " @5-@ 0!X;"]W;W)K
M<VAE971S+W-H965T-S,N>&UL4$L! A0#%     @ 8($[4KQUPIB6!   )!8
M !D              ("!#V,! 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q0
M2P$"% ,4    " !@@3M2?7@:%64"  #L!0  &0              @('<9P$
M>&PO=V]R:W-H965T<R]S:&5E=#<U+GAM;%!+ 0(4 Q0    ( &"!.U)%O/J@
M @,  #8(   9              " @7AJ 0!X;"]W;W)K<VAE971S+W-H965T
M-S8N>&UL4$L! A0#%     @ 8($[4N+DY7(J!0  MQD  !D
M ("!L6T! 'AL+W=O<FMS:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " !@
M@3M2P*AX>+<"  !U"   &0              @($2<P$ >&PO=V]R:W-H965T
M<R]S:&5E=#<X+GAM;%!+ 0(4 Q0    ( &"!.U++W7(U4@(  #P,   -
M          "  0!V 0!X;"]S='EL97,N>&UL4$L! A0#%     @ 8($[4I>*
MNQS     $P(   L              ( !?7@! %]R96QS+RYR96QS4$L! A0#
M%     @ 8($[4N29-2?I!0  H3,   \              ( !9GD! 'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( &"!.U)Z! -=7 (  "$N   :
M      "  7Q_ 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( &"!.U(N* K8%0(  /PL   3              "  1"" 0!;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@    !6 %8 D1<  %:$ 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>356</ContextCount>
  <ElementCount>409</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>107</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1007008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2110103 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2117105 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - Disposition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Disposition</Role>
      <ShortName>Disposition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2126108 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2139110 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2141111 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2144112 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2149113 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2153114 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2158115 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2160116 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2164117 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2167118 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2171119 - Disclosure - New Accounting Pronouncements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncements</Role>
      <ShortName>New Accounting Pronouncements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2272201 - Disclosure - New Accounting Pronouncements (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NewAccountingPronouncementsPolicies</Role>
      <ShortName>New Accounting Pronouncements (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NewAccountingPronouncements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2304301 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2313302 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2318303 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2342307 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2350309 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2354310 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2361311 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2365312 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2368313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Basis of Presentation Details (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentationDetailsDetails</Role>
      <ShortName>Basis of Presentation Details (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2405402 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2406403 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2407404 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2408405 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2411407 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails</Role>
      <ShortName>Fair Value Measurements - Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2425414 - Disclosure - Disposition (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DispositionDetails</Role>
      <ShortName>Disposition (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Disposition</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2434419 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails</Role>
      <ShortName>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2437422 - Disclosure - Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2438423 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails</Role>
      <ShortName>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - Commitments and Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesDetail</Role>
      <ShortName>Commitments and Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2443425 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2446426 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2447427 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2448428 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2451429 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2452430 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2455431 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2456432 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2457433 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2459434 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>2463436 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>2466437 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>2469438 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="holx-20201226.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>2470439 - Disclosure - Share Repurchase Share repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails</Role>
      <ShortName>Share Repurchase Share repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="holx-20201226.htm">holx-20201226.htm</File>
    <File>ex101verstreken-ukcontract.htm</File>
    <File>holx-20201226.xsd</File>
    <File>holx-20201226_cal.xml</File>
    <File>holx-20201226_def.xml</File>
    <File>holx-20201226_lab.xml</File>
    <File>holx-20201226_pre.xml</File>
    <File>holx_q1-2021xex311.htm</File>
    <File>holx_q1-2021xex312.htm</File>
    <File>holx_q1-2021xex321.htm</File>
    <File>holx_q1-2021xex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>97
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20201226.htm": {
   "axisCustom": 0,
   "axisStandard": 27,
   "contextCount": 356,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20201226_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20201226_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20201226.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20201226_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20201226_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20201226.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 576,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 5,
    "http://xbrl.sec.gov/dei/2020-01-31": 5,
    "total": 10
   },
   "keyCustom": 51,
   "keyStandard": 358,
   "memberCustom": 46,
   "memberStandard": 51,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20201226",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110103 - Disclosure - Leases",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Fair Value Measurements",
     "role": "http://www.hologic.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2117105 - Disclosure - Business Combinations",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Trade Receivables and Allowance for Credit Losses",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses",
     "shortName": "Trade Receivables and Allowance for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - Disposition",
     "role": "http://www.hologic.com/role/Disposition",
     "shortName": "Disposition",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2126108 - Disclosure - Borrowings and Credit Arrangements",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ifd16ca2b243144f3b7321f3f02ebd774_D20190331-20190629",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139110 - Disclosure - Commitments and Contingencies",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141111 - Disclosure - Net Income (Loss) Per Share",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144112 - Disclosure - Stock-Based Compensation",
     "role": "http://www.hologic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149113 - Disclosure - Other Balance Sheet Information",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformation",
     "shortName": "Other Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Consolidated Statements of Income",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2153114 - Disclosure - Business Segments and Geographic Information",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2158115 - Disclosure - Income Taxes",
     "role": "http://www.hologic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2160116 - Disclosure - Intangible Assets and Goodwill",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i941434869d224c1a85b4cd87caa2db6e_D20190630-20190928",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164117 - Disclosure - Product Warranties",
     "role": "http://www.hologic.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2167118 - Disclosure - Accumulated Other Comprehensive Loss",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2171119 - Disclosure - New Accounting Pronouncements",
     "role": "http://www.hologic.com/role/NewAccountingPronouncements",
     "shortName": "New Accounting Pronouncements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DescriptionOfNewAccountingPronouncementsNotYetAdopted",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2272201 - Disclosure - New Accounting Pronouncements (Policies)",
     "role": "http://www.hologic.com/role/NewAccountingPronouncementsPolicies",
     "shortName": "New Accounting Pronouncements (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2304301 - Disclosure - Revenue (Tables)",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313302 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2318303 - Disclosure - Business Combinations (Tables)",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Statements of Comprehensive Loss",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322304 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2327305 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Derivatives (Tables)",
     "role": "http://www.hologic.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342307 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://www.hologic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350309 - Disclosure - Other Balance Sheet Information (Tables)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationTables",
     "shortName": "Other Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2354310 - Disclosure - Business Segments and Geographic Information (Tables)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2361311 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2365312 - Disclosure - Product Warranties (Tables)",
     "role": "http://www.hologic.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2368313 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i9a899c4bae794d06842003a1fa6af944_D20191121-20191121",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Basis of Presentation Details (Details)",
     "role": "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
     "shortName": "Basis of Presentation Details (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ie2315ca24bb44334b2ede0aa904f5731_D20201230-20201230",
      "decimals": "5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2405402 - Disclosure - Revenue - Business Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i804f2e6f9b9c4c2dac795221463c7352_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406403 - Disclosure - Revenue - Geographical Revenue (Details)",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i7b1f176304764c78b5167ddff1154e94_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407404 - Disclosure - Revenue - Revenue by Type (Details)",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ib9475dc3a7d5487fbeab85f649c54044_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408405 - Disclosure - Revenue - Narrative (Details)",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ife84c0d8763b4705a470b753572dd9ad_I20201226",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409406 - Disclosure - Revenue - Remaining Performance Obligation (Details)",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
     "shortName": "Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ife84c0d8763b4705a470b753572dd9ad_I20201226",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411407 - Disclosure - Leases - Additional Lease Information (Details)",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i241d11756be14078a3555bf86956ce71_I20201226",
      "decimals": "-8",
      "lang": "en-US",
      "name": "holx:PrincipalAmountOfBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416410 - Disclosure - Fair Value Measurements - Roll Forward (Details)",
     "role": "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails",
     "shortName": "Fair Value Measurements - Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Consolidated Balance Sheets",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i9a899c4bae794d06842003a1fa6af944_D20191121-20191121",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Business Combination - Narrative (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i9a899c4bae794d06842003a1fa6af944_D20191121-20191121",
      "decimals": "2",
      "lang": "en-US",
      "name": "holx:BusinessCombinationOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i0abfc60aa15d4a8bade3170d8c3c2954_I20191121",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423413 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "if86ea7db4fd24e63b6e2c24f3290f064_I20190928",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425414 - Disclosure - Disposition (Details)",
     "role": "http://www.hologic.com/role/DispositionDetails",
     "shortName": "Disposition (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "if971c19f3f994df5b3e6a7fa6ae64849_D20190929-20191228",
      "decimals": "5",
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428415 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i6b85682ab2d3455ca69df8563e60aa95_I20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:LongTermDebtObligationsWithoutConvertibleNotes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429416 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i9a8984669d744df49521703334b03d7e_D20200928-20200928",
      "decimals": "3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentRedemptionPricePercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430417 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i0a51b5cca5d945e59b45ad98742b88f1_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431418 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i946944c5847f4222b4d01aab1a2fa089_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "icb558ac27372440189b269e14d6cb9e9_D20180930-20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434419 - Disclosure - Derivatives - Additional Information (Details)",
     "role": "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
     "shortName": "Derivatives - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "icb558ac27372440189b269e14d6cb9e9_D20180930-20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:InterestRateCapAgreementsAggregatePremiumPayable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435420 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "role": "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
     "shortName": "Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i1ec2e88d3f1a4a7aa83e8c5c06664ef6_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436421 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "role": "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437422 - Disclosure - Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)",
     "role": "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails",
     "shortName": "Derivatives - Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i3be9e57ba38f4e4eab5fb7b166680c7c_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438423 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)",
     "role": "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
     "shortName": "Derivatives - Gain (Loss) on Fair Value Hedges Recognized in Earnings (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ifa0e515bd1224c0d899e4fcd02858289_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - Commitments and Contingencies (Detail)",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
     "shortName": "Commitments and Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ifa0e515bd1224c0d899e4fcd02858289_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443425 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446426 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "iafdc57909e694817a52781dc7898179f_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447427 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i77f1735bfb9347b4ac779750bab1e71b_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448428 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "role": "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451429 - Disclosure - Other Balance Sheet Information - Inventories (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail",
     "shortName": "Other Balance Sheet Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452430 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail",
     "shortName": "Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "if86ea7db4fd24e63b6e2c24f3290f064_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Consolidated Statements of Stockholders' Equity",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "if86ea7db4fd24e63b6e2c24f3290f064_I20190928",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455431 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ia6a843dc84ba4d40b6a85a47c09a1e90_D20200329-20200627",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456432 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457433 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459434 - Disclosure - Income Taxes (Details)",
     "role": "http://www.hologic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463436 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i573838e4ead64367a1cf3a3e4674ffd2_I20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2466437 - Disclosure - Product Warranties - Product Warranty Activity (Detail)",
     "role": "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail",
     "shortName": "Product Warranties - Product Warranty Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i2b4dfc4a55634d5980988f0884ae4448_I20200926",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2469438 - Disclosure - Accumulated Other Comprehensive Income (Detail)",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
     "shortName": "Accumulated Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i47fc0ea3fd504f739a98ccb1f8602c4d_I20200926",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i570b9aef162a4a48b5ccb34ec6b061f8_I20191211",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2470439 - Disclosure - Share Repurchase Share repurchase (Details)",
     "role": "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails",
     "shortName": "Share Repurchase Share repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i570b9aef162a4a48b5ccb34ec6b061f8_I20191211",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchaseProgramAuthorizedAmount1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1007008 - Statement - Consolidated Statements of Cash Flows",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "ic03262a8c15c400d913e0e82e531001c_D20200927-20201226",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i8659049ec61c4559b26d2dde9021937c_D20200628-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Basis of Presentation",
     "role": "http://www.hologic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20201226.htm",
      "contextRef": "i8659049ec61c4559b26d2dde9021937c_D20200628-20200926",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 107,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r569"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r570"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r572"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r571"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r568"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2025SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2025 Senior Notes [Member]",
        "label": "2025 Senior Notes [Member]",
        "terseLabel": "2025 Senior Notes"
       }
      }
     },
     "localname": "A2025SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Acceleratedsharerepurchaseagreement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accelerated share repurchase agreement",
        "label": "Accelerated share repurchase agreement",
        "negatedTerseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "Acceleratedsharerepurchaseagreement",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableAllowanceForCreditLossTransfers": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "label": "Accounts Receivable, Allowance for Credit Loss, Transfers",
        "negatedTerseLabel": "Reclassified as Assets held for sale"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTransfers",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AccountsReceivableSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable Securitization [Member]",
        "label": "Accounts Receivable Securitization [Member]",
        "terseLabel": "Accounts Receivable Securitization"
       }
      }
     },
     "localname": "AccountsReceivableSecuritizationMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccumulatedOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Abstract]",
        "label": "Accumulated Other Comprehensive Income [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.hologic.com/20201226",
     "xbrltype": "stringItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Total acquired intangible assets"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AlphaImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Alpha Imaging [Member]",
        "label": "Alpha Imaging [Member]",
        "terseLabel": "Alpha Imaging"
       }
      }
     },
     "localname": "AlphaImagingMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmendedTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Term Loan [Member]",
        "label": "Amended Term Loan [Member]",
        "terseLabel": "Amended Term Loan"
       }
      }
     },
     "localname": "AmendedTermLoanMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Cost of Goods Sold",
        "label": "Amortization, Cost of Goods Sold",
        "terseLabel": "Amortization, Cost of Goods Sold"
       }
      }
     },
     "localname": "AmortizationCostofGoodsSold",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountAssessedInDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount assessed in damages.",
        "label": "Amount Assessed In Damages",
        "terseLabel": "Assessed damages"
       }
      }
     },
     "localname": "AmountAssessedInDamages",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AnnualIncrementalRevenueGrowthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Incremental Revenue Growth Period",
        "label": "Annual Incremental Revenue Growth Period",
        "terseLabel": "Annual Incremental Revenue Growth Period"
       }
      }
     },
     "localname": "AnnualIncrementalRevenueGrowthPeriod",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_AssetsofBusinessHeldforSaleAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets of Business Held-for-Sale [Abstract]",
        "label": "Assets of Business Held-for-Sale [Abstract]",
        "terseLabel": "Assets of Business Held-for-Sale [Abstract]"
       }
      }
     },
     "localname": "AssetsofBusinessHeldforSaleAbstract",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_BasisofPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation [Abstract]",
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationAbstract",
     "nsuri": "http://www.hologic.com/20201226",
     "xbrltype": "stringItemType"
    },
    "holx_BiothernosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Biothernostics",
        "label": "Biothernostics [Member]",
        "terseLabel": "Biothernostics [Member]"
       }
      }
     },
     "localname": "BiothernosticsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "terseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessAcquisitionCashTenderOfferPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisition, Cash Tender Offer Price Per Share",
        "label": "Business Acquisition, Cash Tender Offer Price Per Share",
        "terseLabel": "Cash tender offer price (per share)"
       }
      }
     },
     "localname": "BusinessAcquisitionCashTenderOfferPricePerShare",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Equity Method Investment",
        "terseLabel": "Consideration related to equity method investment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToEquityMethodInvestment",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Fair Value Of Noncontrolling Interest",
        "terseLabel": "Business Combination, Consideration related to fair value of noncontrolling interest"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToFairValueOfNoncontrollingInterest",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Loan Repayment",
        "terseLabel": "Consideration, portion related to loan repayment"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToLoanRepayment",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "label": "Business Combination, Consideration Transferred, Portion Allocable To Newly Acquired Shares",
        "terseLabel": "Consideration related to newly acquired shares"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferredPortionAllocableToNewlyAcquiredShares",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationOwnershipPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Ownership Percentage",
        "label": "Business Combination, Ownership Percentage",
        "terseLabel": "Ownership percentage"
       }
      }
     },
     "localname": "BusinessCombinationOwnershipPercentage",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Debt",
        "negatedTerseLabel": "Short and long-term debt"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDebt",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 13.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Intangible assets, fair value (percentage)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Liabilities",
        "negatedTerseLabel": "Other liabilities"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherLiabilities",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationSharesAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Shares Acquired",
        "label": "Business Combination, Shares Acquired",
        "terseLabel": "Shares acquired"
       }
      }
     },
     "localname": "BusinessCombinationSharesAcquired",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "holx_BusinessLicensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business licenses.",
        "label": "Business Licenses [Member]",
        "terseLabel": "Business licenses"
       }
      }
     },
     "localname": "BusinessLicensesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software embedded in products"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ChangeInParValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Change in par value",
        "label": "Change in par value",
        "terseLabel": "Change in par value"
       }
      }
     },
     "localname": "ChangeInParValue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ComprehensiveIncome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Comprehensive Income",
        "label": "Comprehensive Income",
        "totalLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Disposables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentHoldbackMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Holdback",
        "label": "Contingent Holdback [Member]",
        "terseLabel": "Contingent Holdback"
       }
      }
     },
     "localname": "ContingentHoldbackMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of impairment loss recognized in cost of product sales in the period resulting from the write-down of the carrying amount of an intangible asset to fair value.",
        "label": "Cost Of Goods Sold Impairment Of Intangible Assets and equipment",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "CostOfGoodsSoldImpairmentOfIntangibleAssetsandequipment",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Costofservice": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of service",
        "label": "Cost of service",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "Costofservice",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement",
        "verboseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DebtInstrumentOfferingPricePercentOfFaceValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Offering Price, Percent Of Face Value",
        "label": "Debt Instrument, Offering Price, Percent Of Face Value",
        "terseLabel": "Debt Instrument, Offering Price, Percent Of Face Value"
       }
      }
     },
     "localname": "DebtInstrumentOfferingPricePercentOfFaceValue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_DebtRedemptionPremiumPaid": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Redemption, Premium Paid",
        "label": "Debt Redemption, Premium Paid",
        "terseLabel": "Premium payment"
       }
      }
     },
     "localname": "DebtRedemptionPremiumPaid",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_December112019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2019",
        "label": "December 11, 2019 [Member]",
        "terseLabel": "December 11, 2019"
       }
      }
     },
     "localname": "December112019Member",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_December112020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2020",
        "label": "December 11, 2020 [Member]",
        "terseLabel": "December 11, 2020"
       }
      }
     },
     "localname": "December112020Member",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DetailsOfCertainBalanceSheetAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of certain balance sheet accounts.",
        "label": "Details Of Certain Balance Sheet Accounts [Text Block]",
        "terseLabel": "Other Balance Sheet Information"
       }
      }
     },
     "localname": "DetailsOfCertainBalanceSheetAccountsTextBlock",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment under customer usage agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_FairValueAssumptionDiscountRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value Assumption, Discount Rate",
        "label": "Fair Value Assumption, Discount Rate",
        "terseLabel": "Discount rate percentage"
       }
      }
     },
     "localname": "FairValueAssumptionDiscountRate",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "GYN Surgical"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_HealthBeaconsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Health Beacons [Member]",
        "label": "Health Beacons [Member]",
        "terseLabel": "Health Beacons"
       }
      }
     },
     "localname": "HealthBeaconsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Holdback": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Holdback",
        "label": "Holdback",
        "terseLabel": "Holdback"
       }
      }
     },
     "localname": "Holdback",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_IndemnificationLiabily": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indemnification liabily",
        "label": "Indemnification liabily",
        "terseLabel": "Indemnification liabily"
       }
      }
     },
     "localname": "IndemnificationLiabily",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InterestRateCapAgreementsAggregatePremiumPayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate cap agreements aggregate premium payable.",
        "label": "Interest Rate Cap Agreements Aggregate Premium Payable",
        "verboseLabel": "Interest Rate Cap Agreements Aggregate Premium Payable"
       }
      }
     },
     "localname": "InterestRateCapAgreementsAggregatePremiumPayable",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total (percentage)"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LegalAccrual": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Legal Accrual",
        "label": "Legal Accrual",
        "terseLabel": "Legal Accrual"
       }
      }
     },
     "localname": "LegalAccrual",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Awards [Member]",
        "label": "Market Based Awards [Member]",
        "terseLabel": "Market Based Awards"
       }
      }
     },
     "localname": "MarketBasedAwardsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MedicalAestheticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medical Aesthetic",
        "label": "Medical Aesthetics [Member]",
        "terseLabel": "Medical Aesthetics",
        "verboseLabel": "Medical Aesthetics"
       }
      }
     },
     "localname": "MedicalAestheticsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinervaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minerva [Member]",
        "label": "Minerva [Member]",
        "terseLabel": "Minerva"
       }
      }
     },
     "localname": "MinervaMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_NXCImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NXC Imaging",
        "label": "NXC Imaging [Member]",
        "terseLabel": "NXC Imaging"
       }
      }
     },
     "localname": "NXCImagingMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Netincome": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income attributable to Hologic",
        "label": "Net income",
        "terseLabel": "Net income",
        "totalLabel": "Net income attributable to Hologic"
       }
      }
     },
     "localname": "Netincome",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotionalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notional Amount",
        "label": "Notional Amount",
        "terseLabel": "Notional Amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PercentageAddedtoEurodollarRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage Added to Eurodollar Rate [Member]",
        "label": "Percentage Added to Eurodollar Rate [Member]",
        "terseLabel": "Percentage Added to Eurodollar Rate"
       }
      }
     },
     "localname": "PercentageAddedtoEurodollarRateMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrepaidIncomeTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Income Taxes-Current",
        "label": "Prepaid Income Taxes-Current",
        "terseLabel": "Prepaid Income Taxes-Current"
       }
      }
     },
     "localname": "PrepaidIncomeTaxesCurrent",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "verboseLabel": "Borrowed principal"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsFromSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Senior Notes",
        "label": "Proceeds From Senior Notes",
        "terseLabel": "Proceeds from Notes Payable"
       }
      }
     },
     "localname": "ProceedsFromSeniorNotes",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Revenue",
        "label": "Product Revenue",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseofinsurancecontracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of insurance contracts",
        "label": "Purchase of insurance contracts",
        "terseLabel": "Purchase of insurance contracts"
       }
      }
     },
     "localname": "Purchaseofinsurancecontracts",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RSUPSUMSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSU, PSU, MSU [Member]",
        "label": "RSU, PSU, MSU [Member]",
        "terseLabel": "RSU, PSU, MSU"
       }
      }
     },
     "localname": "RSUPSUMSUMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RepaymentOfSeniorNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment of Senior Notes",
        "label": "Repayment of Senior Notes",
        "negatedTerseLabel": "Repayments of Senior Debt"
       }
      }
     },
     "localname": "RepaymentOfSeniorNotes",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Schedule Of Interest Expense Under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ServiceRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "ServiceRevenue",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ShareRepurchaseProgramMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Repurchase Program [Member]",
        "label": "Share Repurchase Program [Member]",
        "terseLabel": "Share Repurchase Program"
       }
      }
     },
     "localname": "ShareRepurchaseProgramMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that must lapse in order for the restricted stock units to vest.",
        "label": "Shared Based Compensation Arrangement Restricted Stock Vesting Period",
        "verboseLabel": "Performance stock units vesting period"
       }
      }
     },
     "localname": "SharedBasedCompensationArrangementRestrictedStockVestingPeriod",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharerepurchaseplanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for share repurchase plan [Table]",
        "label": "share repurchase plan [Line Items]",
        "terseLabel": "share repurchase plan [Line Items]"
       }
      }
     },
     "localname": "SharerepurchaseplanLineItems",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharerepurchaseplanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "share repurchase plan [Table]",
        "label": "share repurchase plan [Table]",
        "terseLabel": "share repurchase plan [Table]"
       }
      }
     },
     "localname": "SharerepurchaseplanTable",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SomatexMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Somatex",
        "label": "Somatex [Member]",
        "terseLabel": "Somatex [Member]"
       }
      }
     },
     "localname": "SomatexMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SuperSonicImagineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "SuperSonic Imagine [Member]",
        "label": "SuperSonic Imagine [Member]",
        "terseLabel": "SuperSonic Imagine"
       }
      }
     },
     "localname": "SuperSonicImagineMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20201226",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r168",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r168",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r194",
      "r303",
      "r305",
      "r504",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r194",
      "r303",
      "r305",
      "r504",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r195",
      "r196",
      "r303",
      "r306",
      "r543",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r195",
      "r196",
      "r303",
      "r306",
      "r543",
      "r556",
      "r557",
      "r558",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchaseProgramAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount needed to adjust previously recorded stockholders' equity balances to the actual aggregate amounts paid, whether in cash or other consideration, to acquire all of the shares purchased under an Accelerated Share Repurchase arrangement.",
        "label": "Accelerated Share Repurchase Program, Adjustment",
        "terseLabel": "Accelerated share repurchase agreement"
       }
      }
     },
     "localname": "AcceleratedShareRepurchaseProgramAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateAxis": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date of execution of accelerated share repurchases.",
        "label": "Accelerated Share Repurchases, Date [Axis]",
        "terseLabel": "Accelerated Share Repurchases, Date [Axis]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AcceleratedShareRepurchasesDateDomain": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date upon which the accelerated share repurchase agreement was executed.",
        "label": "Accelerated Share Repurchases, Date [Domain]",
        "terseLabel": "Accelerated Share Repurchases, Date [Domain]"
       }
      }
     },
     "localname": "AcceleratedShareRepurchasesDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdate201801Member": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounting Standards Update 2018-01 Leases (Topic 842): Land Easement Practical Expedient for Transition to Topic 842.",
        "label": "Accounting Standards Update 2018-01 [Member]",
        "terseLabel": "Accounting Standards Update 2018-01 [Member]"
       }
      }
     },
     "localname": "AccountingStandardsUpdate201801Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r18",
      "r33",
      "r200",
      "r201"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves of $39.4 and $31.6, respectively"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r75",
      "r81",
      "r84",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r50",
      "r249"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less \u2013 accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r81",
      "r91",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r36",
      "r78",
      "r80",
      "r81",
      "r530",
      "r551",
      "r555"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r77",
      "r81",
      "r84",
      "r130",
      "r131",
      "r132",
      "r407",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r71",
      "r81",
      "r84",
      "r407",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r34",
      "r350"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r347",
      "r348",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r121",
      "r240"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of acquired intangibles"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r366",
      "r367",
      "r368",
      "r369",
      "r506",
      "r507",
      "r508",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r322",
      "r324",
      "r352",
      "r353"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r40",
      "r202",
      "r214"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period",
        "terseLabel": "Accounts receivable, reserves"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write- offs and Payments"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r121",
      "r233",
      "r240"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r121",
      "r245"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Intangible asset and equipment impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r124",
      "r176",
      "r183",
      "r190",
      "r207",
      "r403",
      "r408",
      "r453",
      "r511",
      "r528"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r20",
      "r22",
      "r66",
      "r124",
      "r207",
      "r403",
      "r408",
      "r453"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r325",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r419",
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r24",
      "r248"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r320",
      "r321",
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.",
        "label": "Business Acquisition, Percentage of Voting Interests Acquired",
        "terseLabel": "Percentage of outstanding shares acquired"
       }
      }
     },
     "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r392",
      "r393",
      "r395"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r120",
      "r397"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration fair value adjustments"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r120",
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r391",
      "r394",
      "r396"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Purchase price withheld"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 14.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "verboseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r385"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "terseLabel": "Remainder of purchase price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": {
     "auth_ref": [
      "r384",
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment",
        "terseLabel": "Property, plant and equipment"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r385"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of equity in the acquiree held by the acquirer immediately before the acquisition date in a business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage",
        "terseLabel": "Equity interest in acquiree, Percentage"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain": {
     "auth_ref": [
      "r381"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In a business combination achieved in stages, this element represents the amount of gain recognized by the entity as a result of remeasuring to fair value the equity interest in the acquiree it held before the business combination.",
        "label": "Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain",
        "terseLabel": "Equity interest in acquiree, remeasurement gain"
       }
      }
     },
     "localname": "BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CapitalLeaseObligationsCurrent": {
     "auth_ref": [
      "r28",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer.",
        "label": "Capital Lease Obligations, Current",
        "terseLabel": "Current portion of capital lease obligations"
       }
      }
     },
     "localname": "CapitalLeaseObligationsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalLeaseObligationsNoncurrent": {
     "auth_ref": [
      "r59",
      "r468",
      "r469"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount equal to the present value (the principal) at the beginning of the lease term of minimum lease payments during the lease term (excluding that portion of the payments representing executory costs such as insurance, maintenance, and taxes to be paid by the lessor, together with any profit thereon) net of payments or other amounts applied to the principal, through the balance sheet date and due to be paid more than one year (or one operating cycle, if longer) after the balance sheet date.",
        "label": "Capital Lease Obligations, Noncurrent",
        "terseLabel": "Finance lease obligation - long term"
       }
      }
     },
     "localname": "CapitalLeaseObligationsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r16",
      "r48",
      "r123"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash less assets held for sale"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r118",
      "r454"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r424"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Interest rate swap at fair value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r130",
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r32"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013750,000 shares authorized; 296,533 and 295,107 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r87",
      "r89",
      "r90",
      "r96",
      "r520",
      "r538"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r95",
      "r108",
      "r519",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationByTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of contingent consideration.",
        "label": "Contingent Consideration by Type [Axis]",
        "terseLabel": "Contingent Consideration by Type [Axis]"
       }
      }
     },
     "localname": "ContingentConsiderationByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContingentConsiderationTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of contingent payment arrangement.",
        "label": "Contingent Consideration Type [Domain]",
        "terseLabel": "Contingent Consideration Type"
       }
      }
     },
     "localname": "ContingentConsiderationTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r103",
      "r504"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r286"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r28",
      "r29",
      "r30",
      "r512",
      "r513",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Basis spread on variable rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r465",
      "r467"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r57"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodAxis": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about timing of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period [Axis]",
        "terseLabel": "Debt Instrument, Redemption, Period [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodDomain": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period as defined under terms of the debt agreement for debt redemption features.",
        "label": "Debt Instrument, Redemption, Period [Domain]",
        "terseLabel": "Debt Instrument, Redemption, Period [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFiveMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period five representing fifth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Five [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Five"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFiveMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodFourMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period four representing fourth most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Four [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Four"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodFourMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodOneMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period one representing most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period One [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period One"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodOneMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodThreeMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period three representing third most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Three [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Three"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodThreeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPeriodTwoMember": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period two representing second most current period of debt redemption features under terms of the debt agreement.",
        "label": "Debt Instrument, Redemption, Period Two [Member]",
        "terseLabel": "Debt Instrument, Redemption, Period Two"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPeriodTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "auth_ref": [
      "r525"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "terseLabel": "Debt Instrument, Redemption Price, Percentage"
       }
      }
     },
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r59",
      "r126",
      "r292",
      "r293",
      "r294",
      "r295",
      "r464",
      "r465",
      "r467",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r464",
      "r467"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt Instrument, Unamortized Discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": {
     "auth_ref": [
      "r58"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.",
        "label": "Debt Instrument, Unused Borrowing Capacity, Amount",
        "terseLabel": "Debt Instrument, Unused Borrowing Capacity, Amount"
       }
      }
     },
     "localname": "DebtInstrumentUnusedBorrowingCapacityAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r51",
      "r466"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r121",
      "r125",
      "r365",
      "r372",
      "r373",
      "r374"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r357",
      "r358"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r121",
      "r247"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r67",
      "r70",
      "r423",
      "r486"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Fair Value, Gross Asset",
        "terseLabel": "Derivative Asset, Fair Value, Gross Asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Derivative, Gain (Loss) on Derivative, Net"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r420",
      "r424",
      "r431",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r416",
      "r420",
      "r431",
      "r436",
      "r437",
      "r440",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r430",
      "r432"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Derivative instruments not designated as hedges, gain (loss)"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r68",
      "r69",
      "r450"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative Liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r413",
      "r415"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r412",
      "r414",
      "r415",
      "r416",
      "r418",
      "r426",
      "r431",
      "r438",
      "r439",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DescriptionOfNewAccountingPronouncementsNotYetAdopted": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a new accounting pronouncement that has been issued but not yet adopted.",
        "label": "Description of New Accounting Pronouncements Not yet Adopted [Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "DescriptionOfNewAccountingPronouncementsNotYetAdopted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r303",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]",
        "terseLabel": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r246",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Consideration",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Consideration"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": {
     "auth_ref": [
      "r8"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.",
        "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup": {
     "auth_ref": [
      "r1",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the segment that the disposal group, including discontinued operation is reported.",
        "label": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group",
        "terseLabel": "Disposal Group, Including Discontinued Operation, Segment that Includes Disposal Group"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationSegmentThatIncludesDisposalGroup",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share attributable to Hologic:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r97",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r146",
      "r148",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r521",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r97",
      "r137",
      "r138",
      "r139",
      "r140",
      "r141",
      "r148",
      "r153",
      "r154",
      "r155",
      "r159",
      "r160",
      "r521",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r156",
      "r157",
      "r158",
      "r161"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.",
        "label": "Effect of Exchange Rate on Cash and Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r340"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r134",
      "r142",
      "r144",
      "r162",
      "r211",
      "r291",
      "r296",
      "r347",
      "r348",
      "r349",
      "r368",
      "r369",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ExtinguishmentOfDebtAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of debt extinguished.",
        "label": "Extinguishment of Debt, Amount",
        "terseLabel": "Extinguishment of Debt, Amount"
       }
      }
     },
     "localname": "ExtinguishmentOfDebtAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r444",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r445",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r312",
      "r313",
      "r318",
      "r319",
      "r445",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r312",
      "r313",
      "r318",
      "r319",
      "r445",
      "r477"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r445",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r447"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r448"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Payments/Accruals"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r446"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r312",
      "r313",
      "r314",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r476",
      "r477",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r419",
      "r426",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r205",
      "r206",
      "r215",
      "r218",
      "r219",
      "r220",
      "r221",
      "r222",
      "r223",
      "r224",
      "r225",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]",
        "verboseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r239"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of Fiscal 2021"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r241"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r234",
      "r236",
      "r239",
      "r242",
      "r505",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r239",
      "r509"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r312",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency option contracts",
        "verboseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r248"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnFairValueHedgesRecognizedInEarnings": {
     "auth_ref": [
      "r427"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total amount of gain (loss) derived from fair value hedges recognized in earnings in the period.",
        "label": "Gain (Loss) on Fair Value Hedges Recognized in Earnings",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "GainLossOnFairValueHedgesRecognizedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinEarningsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r121",
      "r284",
      "r285"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment loss"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r229",
      "r230",
      "r510"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r101",
      "r124",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r207",
      "r453"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r416",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r121",
      "r243"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets and equipment"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r128",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.",
        "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r0",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r9",
      "r11",
      "r12",
      "r13",
      "r253",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r361",
      "r363",
      "r364",
      "r370",
      "r375",
      "r377",
      "r378",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r125",
      "r143",
      "r144",
      "r174",
      "r359",
      "r371",
      "r376",
      "r540"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision (benefit) for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other activity"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r149",
      "r150",
      "r151",
      "r155"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and issuance of stock units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r232",
      "r237"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r92",
      "r170",
      "r463",
      "r466",
      "r523"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r522"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r106",
      "r283"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest Expense, Debt"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateCapMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract in which the cap writer, in return for a premium, agrees to limit, or cap, the cap holder's risk associated with an increase in interest rates. If rates go above a specified interest-rate-level (the strike price or the cap rate), the cap holder is entitled to receive cash payments equal to the excess of the market rate over the strike price multiplied by the notional principal amount.",
        "label": "Interest Rate Cap [Member]",
        "terseLabel": "Interest rate caps - derivative",
        "verboseLabel": "Interest rate cap agreements"
       }
      }
     },
     "localname": "InterestRateCapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r433"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest Rate Swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r168",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r192"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r42",
      "r226"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r17",
      "r65"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r44",
      "r226"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r43",
      "r226"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r105",
      "r169"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r444"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r23",
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r24",
      "r248"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r471"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r39",
      "r124",
      "r207",
      "r453",
      "r515",
      "r533"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r56",
      "r124",
      "r207",
      "r404",
      "r408",
      "r409",
      "r453"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r53"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r53",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Trade Receivables and Allowance for Credit Losses"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r30",
      "r282",
      "r513",
      "r529"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "terseLabel": "Long-term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r59",
      "r281"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r263",
      "r264",
      "r265",
      "r267",
      "r268",
      "r269",
      "r270",
      "r272",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r266"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Petitions filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MergersAcquisitionsAndDispositionsDisclosuresTextBlock": {
     "auth_ref": [
      "r14",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for business combinations, including leverage buyout transactions (as applicable), and divestitures.  This may include a description of a business combination or divestiture (or series of individually immaterial business combinations or divestitures) completed during the period, including background, timing, and assets and liabilities recognized and reclassified or sold. This element does not include fixed asset sales and plant closings.",
        "label": "Mergers, Acquisitions and Dispositions Disclosures [Text Block]",
        "terseLabel": "Dispositions"
       }
      }
     },
     "localname": "MergersAcquisitionsAndDispositionsDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/Disposition"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r64",
      "r124",
      "r207",
      "r453",
      "r514",
      "r532"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r118",
      "r119",
      "r122"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r13",
      "r85",
      "r88",
      "r94",
      "r122",
      "r124",
      "r133",
      "r137",
      "r138",
      "r139",
      "r140",
      "r143",
      "r144",
      "r152",
      "r176",
      "r182",
      "r186",
      "r189",
      "r192",
      "r207",
      "r453",
      "r518",
      "r536"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "holx_Netincome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "New Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NewAccountingPronouncementsPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-competition agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable": {
     "auth_ref": [
      "r102"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "holx_Netincome",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) attributable to other redeemable noncontrolling equity holder.",
        "label": "Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Redeemable",
        "terseLabel": "Net loss attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r297",
      "r386",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling Interest, Increase from Business Combination"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenseMember": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing expenses associated with normal operations.",
        "label": "Operating Expense [Member]",
        "terseLabel": "Operating Expense"
       }
      }
     },
     "localname": "OperatingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r176",
      "r182",
      "r186",
      "r189",
      "r192"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r15",
      "r411"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r76",
      "r78",
      "r401",
      "r406"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan, attributable to parent.",
        "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent",
        "negatedLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r401",
      "r402",
      "r406"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "auth_ref": [
      "r73",
      "r74",
      "r78"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax",
        "totalLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r422",
      "r428",
      "r441"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "negatedTerseLabel": "Amount of gain (loss) recognized in other comprehensive income, net of taxes:",
        "terseLabel": "Amount of gain (loss) recognized in other comprehensive income, net of taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax": {
     "auth_ref": [
      "r72",
      "r79"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of tax expense (benefit), after reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Tax",
        "terseLabel": "Change in value of hedged interest rate swap and interest rate cap, tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r86",
      "r89",
      "r91",
      "r95",
      "r291",
      "r455",
      "r460",
      "r461",
      "r519",
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income activity"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r86",
      "r89",
      "r401",
      "r402",
      "r406"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "holx_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to noncontrolling interests.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r86",
      "r89",
      "r401",
      "r402",
      "r406"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax": {
     "auth_ref": [
      "r78",
      "r82",
      "r83",
      "r417"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustment from accumulated other comprehensive income of accumulated gain (loss) realized from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax",
        "negatedTerseLabel": "Loss reclassified from accumulated other comprehensive loss to the statements of income"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax": {
     "auth_ref": [
      "r72",
      "r78",
      "r443"
     ],
     "calculation": {
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).",
        "label": "Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax",
        "terseLabel": "Changes in value of hedged interest rate swaps and interest rate caps, net of tax of $(0.2) for the three months ended December 26, 2020 and $1.7 for the three months ended December 28,2019.",
        "verboseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/DerivativesScheduleofCashFlowHedgesIncludedinAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r122"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r116"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r113"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDebtIssuanceCosts": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.",
        "label": "Payments of Debt Issuance Costs",
        "negatedLabel": "Payment of debt issuance costs"
       }
      }
     },
     "localname": "PaymentsOfDebtIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r110"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r111"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r117"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Payments to Noncontrolling Interests"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r31"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r31"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r19",
      "r21",
      "r227",
      "r228"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfBusinesses": {
     "auth_ref": [
      "r109"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.",
        "label": "Proceeds from Divestiture of Businesses",
        "terseLabel": "Proceeds from Divestiture of Businesses"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfBusinesses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DispositionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r112",
      "r342"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfAccountsReceivableSecuritization": {
     "auth_ref": [
      "r129"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds from (repayments of) securitizations of receivables treated as collateralized borrowings, which are classified as financing transactions.",
        "label": "Proceeds from (Repayments of) Accounts Receivable Securitization",
        "terseLabel": "Proceeds from accounts receivable securitization agreement"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfAccountsReceivableSecuritization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepurchaseOfEquity": {
     "auth_ref": [
      "r129"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash inflow or outflow resulting from the entity's share transaction.",
        "label": "Proceeds from (Repurchase of) Equity",
        "terseLabel": "Repurchase of equity"
       }
      }
     },
     "localname": "ProceedsFromRepurchaseOfEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r277",
      "r278",
      "r516"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at End\u00a0of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualAdditionsFromBusinessAcquisition": {
     "auth_ref": [
      "r276"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from a business acquisition.",
        "label": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition",
        "terseLabel": "Standard and Extended Product Warranty Accrual, Additions from Business Acquisition"
       }
      }
     },
     "localname": "ProductWarrantyAccrualAdditionsFromBusinessAcquisition",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r274"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r275"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r280"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r49",
      "r248"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r26",
      "r27",
      "r250",
      "r534"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r26",
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r99",
      "r216"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax": {
     "auth_ref": [
      "r81",
      "r84",
      "r91",
      "r455",
      "r459",
      "r461"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss).",
        "label": "Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax",
        "negatedTerseLabel": "Amounts reclassified to statement of income"
       }
      }
     },
     "localname": "ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RedeemableNoncontrollingInterestEquityOtherCarryingAmount": {
     "auth_ref": [
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncontrolling interests which are redeemable by the parent entity, classified as other equity.",
        "label": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount",
        "terseLabel": "Redeemable Noncontrolling Interest, Equity, Other, Carrying Amount"
       }
      }
     },
     "localname": "RedeemableNoncontrollingInterestEquityOtherCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfDebt": {
     "auth_ref": [
      "r114"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.",
        "label": "Repayments of Debt",
        "terseLabel": "Repayments of Debt"
       }
      }
     },
     "localname": "RepaymentsOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLinesOfCredit": {
     "auth_ref": [
      "r114",
      "r127"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for payment of an obligation from a lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Repayments of Lines of Credit",
        "negatedLabel": "Repayment under revolving credit line"
       }
      }
     },
     "localname": "RepaymentsOfLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermCapitalLeaseObligations": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the obligation for a lease meeting the criteria for capitalization (with maturities exceeding one year or beyond the operating cycle of the entity, if longer).",
        "label": "Repayments of Long-term Capital Lease Obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "RepaymentsOfLongTermCapitalLeaseObligations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r114"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r355",
      "r566"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 7.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r121",
      "r255",
      "r257",
      "r258"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring and divestiture charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r35",
      "r296",
      "r350",
      "r531",
      "r550",
      "r555"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r134",
      "r142",
      "r144",
      "r211",
      "r347",
      "r348",
      "r349",
      "r368",
      "r369",
      "r546",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r301"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in CCYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r93",
      "r124",
      "r167",
      "r168",
      "r181",
      "r187",
      "r188",
      "r194",
      "r195",
      "r198",
      "r207",
      "r453",
      "r524"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving Credit Facility [Member]"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r81",
      "r460",
      "r461"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Changes in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r382",
      "r383"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Assets at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r420",
      "r431",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r444",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r450",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r234",
      "r238",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r234",
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r25",
      "r45",
      "r46",
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r53",
      "r126"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": {
     "auth_ref": [
      "r430",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative instrument not designated or qualifying as hedging instrument.",
        "label": "Derivatives Not Designated as Hedging Instruments [Table Text Block]",
        "terseLabel": "Schedule of Adjustment to Fair Value within the Consolidated Statements of Income"
       }
      }
     },
     "localname": "ScheduleOfOtherDerivativesNotDesignatedAsHedgingInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r387"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r100",
      "r195"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r176",
      "r179",
      "r185",
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r325",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Utilized to Value Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r163",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r198",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r165",
      "r166",
      "r176",
      "r180",
      "r186",
      "r190",
      "r191",
      "r192",
      "r193",
      "r194",
      "r197",
      "r198",
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r517",
      "r535"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units (RSUs), weighted average grant date fair values"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r331"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r328",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based compensation, stock option outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of options outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r323",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise prices"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r335",
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r1",
      "r163",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r177",
      "r178",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r187",
      "r188",
      "r189",
      "r190",
      "r192",
      "r198",
      "r231",
      "r252",
      "r256",
      "r259",
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
      "http://www.hologic.com/role/IncomeTaxesDetails",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r62",
      "r130",
      "r131",
      "r132",
      "r134",
      "r142",
      "r144",
      "r162",
      "r211",
      "r291",
      "r296",
      "r347",
      "r348",
      "r349",
      "r368",
      "r369",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r546",
      "r547",
      "r548"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r130",
      "r131",
      "r132",
      "r162",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r31",
      "r32",
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r31",
      "r32",
      "r291",
      "r296",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r31",
      "r32",
      "r291",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r62",
      "r291",
      "r296"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r31",
      "r32",
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r32",
      "r37",
      "r38",
      "r124",
      "r203",
      "r207",
      "r453"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total Hologic's stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r124",
      "r130",
      "r131",
      "r132",
      "r134",
      "r142",
      "r207",
      "r211",
      "r296",
      "r347",
      "r348",
      "r349",
      "r368",
      "r369",
      "r399",
      "r400",
      "r410",
      "r453",
      "r455",
      "r456",
      "r461",
      "r547",
      "r548"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r462",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r462",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r462",
      "r472"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentationDetailsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r205",
      "r206",
      "r473",
      "r474",
      "r475",
      "r476",
      "r477",
      "r478",
      "r479",
      "r480",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r61",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r61",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r32",
      "r291",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r61",
      "r299",
      "r300"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 39,078 and 37,609 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r291",
      "r296",
      "r299"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r136",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r366",
      "r367",
      "r368",
      "r369",
      "r506",
      "r507",
      "r508",
      "r544",
      "r545",
      "r546",
      "r547",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r121"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Unrealized Gain (Loss) on Derivatives"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r356",
      "r362"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "terseLabel": "Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r147",
      "r155"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r146",
      "r155"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.19)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "http://asc.fasb.org/topic&trid=2134417"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3179-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(h)(1)(i))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1448-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1505-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1707-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1757-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1500-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e4984-109258"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6812-107765"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2443-110228"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12565-110249"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "http://asc.fasb.org/topic&trid=2155896"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12317-112629"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=117329964&loc=d3e12355-112629"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(12)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(16)(c)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "14",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "15",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=SL6540498-122764"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405686&loc=d3e22802-112653"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130556-203045"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121600890&loc=d3e2207-128464"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121647850&loc=d3e4845-128472"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579240-113959"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5579245-113959"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5580258-113959"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41620-113959"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "c",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41638-113959"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624171-113959"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL109998890-113959"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624177-113959"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624181-113959"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41641-113959"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=d3e41678-113959"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121582272&loc=SL5629052-113961"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121558989&loc=d3e80720-113993"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "http://asc.fasb.org/topic&trid=2155941"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13476-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121569800&loc=d3e45023-112735"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "840",
   "URI": "http://asc.fasb.org/extlink&oid=121616839&loc=d3e45280-112737"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121329987&loc=SL77916155-209984"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "e",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r567": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r568": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r569": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r570": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r571": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r572": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i-k)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e640-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e689-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724391-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121640130&loc=d3e1436-108581"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>98
<FILENAME>0000859737-21-000006-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-21-000006-xbrl.zip
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M/B>9&.LH$ETE%,]B**05OYHD&XEKHZP.:9MHH<J/)2.QJL#[AG*"MTE["_?
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M;P1+7P=ZA./O]IK&S%YS,TA,N@6(<PC $]T-^DZ)ZP@,B(V;3NMZDY4&SA.
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MN"DJ-A=A6JURDMF#-P/1)(F%$65C0G[10P 3? 6---)+:+/'WXE$ D.(C P
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M,,,FBQV3SE,C8'!.82S(KD?,XT%L+C,+IQJ4(3HS"+MYL2-<A>Z N. GP<^
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M/>RU*.HWP0 D@[Q3!00#JP4UZQWN46G)@.D5 68F,)#@Y"29D6OS3@UT$#U
M%;Y4(3IO?6B*^LW-Q_:]ANZZBP^[$0&SG>N>$G4+X(S$H$$8"(4! 39,/R F
M%(D"Y#D_F*<U[A+*L2"/B;53(7W8Y:<BJ)Z:QRXZV/B[*E8] !-E/87 RO&G
M"@T-+7W(#&W9S!YWO)T[^"?9!8[>Y_.#Q!F@QFZ2W/Y]Q;1UV;BZ:(KK]E6G
MV4#&[YKV_BM^FIQ=Y0)]L.&9A#+FDL6,SH^_(4<+\>JU25+%1!SK%.%"IB;!
M=Q!JONBEN6AO6HW?Q'7],SGHO+_6?RE@!\2LL8=G=N[N5A=GR4T#6;[L[^6A
MJ>U4=^^EC7C5>Z.#6W$MRZ$<Q)UH1T63N5RTJ<LY%69A&LU?T'WK/J.K-D[R
M&<4I(*^2[%J%NR1L7J"1 @PBL2J2F')(D9_:KB/](ON?.1Y^S\(]K<#KWVX/
M6_=Y7#4C'.;Q<'\)S3-2?6TY%EB96G:PS)2Y4^R>X$H=+C +ME>8>SU@DIBG
M:$K>58M+%JT_F%/U)5 CEZ8::!-D0_1I!6H1<>>Y3>RJ">!3*E>:::<1^7$F
M4W/J"+E^%0<RLR637/5A=.D'O XAJ@G)T3 A_ D*O;20R6E5GDY:Z9QR FJ!
M:6?XL #3&)DQ8%5:K/VQ-&"HKYH+\H Y:X#0=8U>,FN'#Y*4KZ3D/VE?<M]U
MK5;!XCOSX;8G[<XN"LH;V.#[RCZ<F+%BPL[C%-63*B7OM'<&;NAX[(YP<[]V
M=_$DW,U5+V.G'_F^G3GLUKU7[[R2*0K'_I*79CQ<-$];C?JY:#>14[[<5[9&
M?HWE$ZN-*GDQX$NB"_83,50AVI>P4TOO)69];132M2WNXM#L""U'A'":'!'6
M84*ZTN\H&T;U0:]'B!71MYNQ)V33>:U+K6#WZKGO[L)UH>V>R&DFAX<S.1R-
MQ)8"%=W$Q&J&5T:[4!<12#_F:!5BT)P_1ERF@D')AB]EC:#/&YWGL:<O3.6T
M2(R 6A#TOR#A3T1%.D.7+A8ONFZV;ZXN06H;K7;CX\5-!_UT:RN[]R 7F@@7
M1"\S^CRP0&HY8Y4P-"1Q)7_M-#;9*-+-!DQ?*6CHFVA-6B)-3T7PN_=Y>9^G
M/CMMW31:U^>MRWK[,[K&&LW3C^VU)2N=3J--K^%.M0WT""['6/RU]PG,&).%
M2]4+$+';L#J(Z"6XM2TU-\4"7CJ)A7\2?(B3> LK)Z"H8 R6K-Q$60I=$>MQ
MA@S%E\YX=5^8=/W:;F%%CT9S_47KLU?YLM@CU9<1:1$I^D8KYO2PP<%\UKFB
M2<2.=6+$CGL=L\(ID8>,U):<5#V?K4%F]Y1HC@?)/1PAZ%02W3'70%O+I3J\
MO@([QV)0 >"=$UM ;BH/W,Y)-P4?>BZ6X#I%L8H7)HOBT]G5.6R'K8NFJ%^>
MBGJG@[[>!X0!V+#>K^X^A*] ESVUFU><+J[BA3B&TS6Z6%$!C?F0F2 @<;T,
M98_TE"8S/X6/R/N9")^[#Y\ ]4<DQ893>.>4+^5[4-B46.)69#[HWT7#0<'
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M<[S?X?L\?+-UMO7F=WGX=//\-Z_X6J9WN-_G8W__</CT=[/5W>YN[2=QV#V
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M^*H.="L*@:U "4R.('3)3 -Y\%TVH,AD=':!B0"4G(_:2]8[5JF8I8XK&BP
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M/"?,RP?HO/)=<P#71E%DR36U94&6&$I$X827RBCA0YP#N(T8-]0Y90*;<K9
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M520'$T@BK4Q54WR<&9NJ)$"@!I$("I#4(==5+88P@0,R::5Q%IXX\]$X(,&
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M%YQ#:9U@ 5/20S(@DDR@,FD%RXC7!A4.O/*OU.,7H]J#9=@XW$Q"L,:E HB
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M+/Z",5(N*F.8"M2A6D@SCYO/[M+)Z2 =XY"&U;^Y4K$IC<\B97VFVP=(RBD
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MSSD.H;C1;?[QPW^^\8"79-0ND(P^V=G=6ON%#7FOW]OF,&W03FOG]GZ72O7
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M)(35%ZF+/\( 2%T04J>:AF!C4W >4245XB'3IE4R(I6,Q8H$07F>ARF<[X3
MSL]URZ3T_R-+=OGM897+N.^AH,]-:/!"70HEO0Z81J2US8*%YI]<2A)1*F@D
MWE//=*9!?0D/_J,^V^>0Y')S=-Z!6@%TW@J=4Y'BM/8AN(BHMQIQZRRR6EH4
M31 >FZ X$6N;C%X2=ZD1.E= H"QA8&4[NB).2A3TM#T\J@I0=/K#QW:,[YZ%
MRA4G>9[;=F]8PM!QN-?;N>"4O50\!2PY%TM>J!V14@Q"88ZLIQCQ9+*:22$A
M+ZEC&)=+<6W6,.228WC79TD(N*QTP.4ZM6$ Q L'\53J*&H""Y&A1'$JE44Y
MTE0XA)6C1%*/A24+*P #,9F5C,GLC8[B8+*1U/AM$ICYQWJC%Q];8:UZJ)[*
M'ZU^KW]Q.QX6AC=ARP^SDB<*@QDF&EG"'>(X,62MXBBJ[,B J2/5PK#>ZT*(
MVM1GBPF@NEBHSA02=1$+9BB*F 7$HS7()LN1T]K(:)S3T1>HUO\RRA40-4L8
MQYED$+N8ERCQ7-R,[)<;GJ^>YQKGU>3..]B..D\R?#;H=\?E5DYS_^U]R_?^
MHW+>V&Z_N*[9[O4'[='9>:Q\JQ<N?LK.?T_SR\TX.NJ'Z?8_9#'.1\07BC5Q
MIY7#42*60K75A9&CV"&MF=1*2^*U6]O4C"XL.^?:(%NB2-(C)HX[V"D#XJ@M
M<4P5G!$6XT0H(MCA0AP4::SRLLLD96T>"%;HM4VCEITW5D#?+6'0ZN6@_ZD]
M+-3SFXN]F-JC?Y1H].V5WJ-8"-^1F,M<.UGZ_C'V"?#G//SY=>OBR3!EI$@&
MD>08XIGDD,,TKX6)9UHQQB7G:YM$+>!\+<2L:AQHOKM"F0#:!8%V*GH\%U01
M+9 F)3^:N8B,EQ)Y8W Y]"5T9"4Q4%^B>FH48UX!3;/,)<9;\:J#77>[SJQ=
M1_S][IZ_WA/$0VJY//K@ / -)X.=607G@N$Z<H*"\ EQBUVY#"UK.1JMBIY(
M3=S:IA1LV9? <X?.@,: QNXZ3 @T=BL:FRGT1)SGP4:D"/.(.\*1(UHAS2Q1
MTA,<@US;9%K<OHX!1/(>7R2OB-V28=^PH]&@[4Y'MESS..HW<D<4AACT.YU2
M+KL]B=TOJ H4RT,G]$_+=RWQ/DP],M9:%SQUOLFRV[M P>>Y,I=8#E_'$&.W
M.!Z(>BZBOE!^FW-N@M(4"28(XB82I+WPR$=CG8\,"UPBAI?$"^<./5P?2$L4
M2'S4['!W849@AP=DAYE3D=A9%ZL-6&*SC(L6V21"7I=&Y4WTG-M0BJS\F%&W
M-.RP @)N"5/MIM'*'R3<OW,3/K0]1#%A^7]?4<RC?N=+6?N/1R1,&'--&!<J
MMP?'A0HF3Q,R1,2EK+*O,0K8IY+:DVS9RY)B 9<10_@2^&NY^6MAX4O@K]OQ
MUTS]U4Q2,L\HB 2!45X<,^28UDAK2A*/6(>J0+V6"ZM6!G'+1Q:WG,C>DSC(
MC]GM9HH8'MG!E3KXR96QRVOTS?4655?&/Q810[G/5J[ H%[F%)0_['#^==LC
MD#8KHEY>QL&;PE2+7871[T-_.W;0R[TU//^Z:E1]TS08-,TU-,V%2LG..9]=
M(LLBC"/N<%Z3"4J0DI;9J*VF.)7ZJ^+6YV+K5[D'V&?%V>>6:RA@G[MAG^F*
MBGLEO JLE'LN==H=1]JEA$14RN49@C-9;3#R^A=J7P%Y^9,L\-K+R^UVYW04
MP]UM+*W:!#!_!ZS<]'#7XG0R)F&"F&N"N% 7VR?)4I $4:$UXBIJ9"7'R&9O
MQ&BLLGHL3Q=U9&UI\E" V8#9'DSX K/=D-FFTM=B25/ #!$1"[/E2<898Q$/
MQ'.K\[\QKJ3OH@I200[-8\JA>5?](X:&S:VR'V*C=]IU<=#HI_&.PK#1/QT-
M1[97/=&-MA%^W*-:]#;"=>OEW&<K5V X+_,Z[])MA'ER<I<PZ_9* 3!&\H(3
MG]C%*MR9-T)_-'G]>UUPSC);8Y)I51RSERJ-,-R;$LS%0!D#M7 -M7"AT"R+
M6G#I*')42L2MM4CK9%&(5'A+H]*QK(.$7I=X4?<ZUVBQ P!?8&80 +PV )^)
MA"OG$L<"E4Q(Q#6QR.@84:#:8<5BB,1D@$NUK@V4J(5<BYL$PZ_%HA?U\O@Q
M+I/,*W>V:>E4UL3+/W QT/!<-'RA.*UQ,:2D.5(!$\2)X*7<$D%)*)\DUMY*
M4FB8K"M]:YVU>*@M7P%;()CZJCP@F$41S%3G,>YQGB(<$I*5(K9!(B.H1Y8J
MF8@+ 0M5",:L*[K@+/+Z$4Q-9>(_JS3K_'=H?]K\5_[C_!TSS^QC.4P\89+-
M?[G!/S>_N>6Z;[M' J*%@-[$V+#>][OYN\]*!8Q>?Q2'&U>V>_)F3C>4R%]P
MTA^VRRA\,H@=.VI_BK]_;H?1T3F[S;QQ,M+P]"W6#?N%3*Y\2UWZB%WLC=D_
M2VLKNDN84XM-%#%&SH@U+(7\1,Z*3-0ZFO=EJ39YT]'@_ E.,K,B-XCV([(I
M/^ 3V_ELSX9K_[S0#]UV#WW7[]]WV94=D])".D9=TC%CN.?IHS^NB/XDLTP<
M%*O<)EN;MC2.!F7R_-NO791)=K\Z3-%/C5+QO11G_]<_[>9E[G_087I9#ZQM
M-OZ]]V+O^>[3]<9NZ^G5".[:P8<\H*KS0_2B/GK0YC_=:[W9>[&[O;6_L]UX
MLY__:NZT]M\T]IXUGNXU7[[>^?=.Z\WN7SOEZ?::.S5BULN?Y[>W/7L:VEDL
M_:,.;:T^\4E[E+_-7X/S?MOM-?(7=<I-!U>W?S*6)MQ>B&EF=(DK!M?XP-*W
M::&2&?E!._9D&)^<__#[^4S<[E6-J][TO9[(WS)A0F,V%%:%#"?QG,G'3WAR
MH^+)[[31^#4I-_)B_,J7\0;Y/_60(7-97OOQ"=_0^MJ//\=K@K$;O?.7C;W>
MQ_XBME>+;7M]K27BY?K^3H>7N4X_C?'\,#WU ^-6/;6?9_K8:&:[HV%C)PN
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M_'OM6I>)+^IS'N/EWGP1EWM3NK8)EWL_0%L>S>7>U[O;^ZK6_@+W=7G("U>
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M)[8=S@\7C^R7&\[YCV+9<=LYOSHA->GR\=FH_=+AL*J8GVCVGL[._C:Z%$U
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M5J!(;IP@DB*FB48\.(H,#1I1F[2Q1"C/4UZ;$KZPQ6EMY E4TZ]7S D OCB
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M DS $BP!)F )E@ 3L 1+@ E8@F4=+ $F8 F6 !.P!$N "5B")< $+,&R#I8
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M1">Y(LX2C:CW"G$A"3(Q.N0-=4(X[$5D6>"M2ZTWU ]$]X]EYSC0=T" "R!
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M:,/(Y?5LX3Q872'^H%?3S0(8H#D_-*>!8):QF0S12&*F"S0%<B)1E*+6+K&
MDU!EV2%N7RD$BDW/C[)J=JI24 ?Q*/:&[4_Q/#)<G/"I/3J#G%38O 0O@9?
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M+(IDN3Q9MIK..4=Y])YDIS*1G EB->,$K+ J*>N5I763@"MS10!M30GS+]*
M4W=TVO-G]4[@SSD6K\0KG^Z5:"9X)5YY5S-Y.B5E7GV&8>Q.2\HTG4T[@].Z
MS(\>NHY,2S"(,I%I,"EZ\-EL0SG# &H#K"+3I$K61NYI]#2E#-0E-3TP5Y1X
M/3#'*167]Z.NT-W3/:>7DV%5V^4N!M/2VZ/FS8,I[O,' K>FEM/8KS^WCYF
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M<^XV!E"L,<&P,SZ&18AY^O[IO$W?:<_W'SKY__'1WCJG][^:(=U<-&_'^*;
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M')3!AAOAK#=>20<6,#R+<#,;I9O7:.IU.KWSPB3-HSX8NP^G1,%/0ZH?;YJ
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M*K0'3 T164PE<BPH1E4(EM"5=2'FME?1Y+C-6:PP5U%BR3T-G!/.-1 5$HC
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M#R2?)."B3YQC)JA(*<9FIVIQ %<S<$54,OF$F L*N*OR")1- GLWD11E8MZ
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MZ6D',#$SJK(#^1(8$]L?EE 5LK1!7S.LC>U$F.O"Q(7^72NPE8QPNJ9RL28
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MT7AI@LM!'T%N-<_KE_^^!OQJ9TP2.EU]8/'<^5J[]6H(^VTF8;A<;S=+R/2
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M!^S",4\MU?CK;J@I\I$>W^F.%76AIXLE^H+9*]X^!_8* LLT19(Y@;AV^6P
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M7U%P8LZ9CJ X=;]T1SB"-NY^F*<1;1MWO_87HJX@6T@\$FH,O_[-JKVW;DB
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M@?<FY(Y37]@ZZ8?8'7_K>4V.W[(5.S[8^+"X"V]/,Q]-=9=7WM70_M]FK><
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M2F]I;I:^C+?(TM>NNRS16T8L_^CT9;]5E/PI4.KGGJZU',L+D6/!UB4OL;4
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M#T4I\.V;+%(30:S"FAH.5W,L8,:-,<%2[+&[W2;+NDCX Y;SQ<QR-DQ9)X)
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MMD]BKY+8#*UW<7A6!(0:V9)&L_0F881'<??7WNM^KS5FNR=JLY7O?59L-$]
M(]<-II9558<C-^R$CAUTBDA3I?>:V<^SZ&W>/>KVX4XJ8=9,Y5CD6JNI2]9G
M;=0B&U4\7GZMT\NR][UKYSS_[?>1'=@>?'C\ &JQIBNWT/IWOH6-\N/\0]OX
MJ1)Q_M7VON0/;Y>H8#=;[:WMK2S=E&_#VU,8Z5E1X-T.X-,Z12@7_#]<""ZR
MV7J?Q3E:?\",MOZ(18\J#_&/_WW=VAT.1W&P.3MS,)Y!JUO>6*M@+1Q<RT[-
MP:"9@UFYW=-!;O?QDWDY:N9E(J8;[$3*:M^?]?/DL#(W:C(W:L'<;+6V9Z>4
MRLVQ8EV6NNWT?.<T:VA5^KC]T1D,LE:)3V-]W\H$)CI=BV^V&LGXY'A^,C#D
M583N'O!(];16U&X/'O\HC_E#;S2,82QG]+JVD^TR&V.H:IXF5+V[FL_.GMC?
MV<;MSQ]P^_)(M+</K<H,I8Z@?#HV-^\D9*,,*! ?K?$D'_D"Y+$T57>5F%VU
M5L8FTG+1#K)&'1@9K(XLOEU<#42V;JM(W,6LG5U)QL76F]&@7Q74_47K77[Y
MWYVMN%79\A^[O^Z_*Q_ZJ77:'0V+"SH]A2!1XFI^>R.EE\URJ56"]<!"F4^2
M%'5$>Z^<S1W/</L$2V4!C"<?'&8+U:(F%KK;_NUZ._S5#CO#]Z> QL)^[R]P
MQ7G,><AD;(2(OC KW-_Y<'[(I59!TX1@3C,!5L3(>2E1-%(SY[+,;;$[?)71
M\5_SX:3Q?2])O'1:H!%,L5]IDZ^F/NH#8]%JI13E6"2+;4PD9>5G^*&B)R::
M4*+N7B" <>^G*J#\5F.*/?NU<S(ZN>*;UUZY>.4OY_O;AR$R(^$1("491IS!
M.M'*>N2UP$8QQ16A>74LV_&OO?(UP*Z*Z0V'-X3T&T! Y>"GI-!J%-%<H7C\
M68>_P-%7OGS'9KG/WP![%$G3XO!OX=FS,UB^]EN[^7:'I_W>,#9?!_C^2SR#
M6ZOQW5E&PC 3!775XJ>O]__:W4'$M& IA7C2\1E;[MD!?.D$3S4KK;K_N)I:
M=F*Y#H<A$>.2Z^@TMX$8HSF%E$YB7Q?B&"/W4HA[)M1F=UY.>Y_?B/;187(J
M2LLYBIX)Q'D(R&@G$,R]T)*[#'LV7JF%G,%CC>S)HFCL?'.E1T^EC#B07(1-
M>=_*$>^X"N!S&5.I$GB^!EX@N8(-O(NG]J)H=%:ZE2_8 ':_[K\]3  JHK,$
M:<8!V4;GD.9&(6,U$]1JF'ZRC#1Z; #@:B8.**<4V;7 /,,+J<ZMAC/)U<1B
M;!:N;PTC -O.6>>R*NF,4[_-[&9*A35?\=A"QCH<I=3QG9QQ>3L\;L';C^&J
M6ZV=4<F_;](JGG55I[83RBCS'P?Q!-Q?2?ZFQNILM]"ZK:A:+KP/B@<()<1P
M0 N.*2EMU,IXE@37:Z-^$*-^^[5]?DB)P!I'A["T#G$ ;F#>GB-/0W T,JZ#
MO9X)_:1)V*XM(*11=U([F(OT_U[%6.ZH@;&*C:PS_]N8SX>,*V'92FE8 G<8
M+.)))01/(Z)$( ?0)D0MPV)<V:HA957[L?\ A"L@#9Q7!8K&>*KR/ZOD8LMR
MJD7)V?=2?EZ0N0!X?+DRT-L"S,>II+UP%A$M;(6I= @><2,8D]$%&]1U,M"/
M-YW>;1*7^/4T0@8!>4=Y.5=GP>?9HSC);7):,ZSJQMG@9_Z>$Y_\Q]@K$M&G
M,)I^F (%\VG5$+YGD+%"K20]_/D;M9RO2M1N/(RZ,RPIR,?P7>2=)=UB8OG+
M=U9,EEO"W.VRU[]FI'F8P=YZ0,^!->[&$Y3F:<HN'QS#6F[MP?N.AZTW>5?H
M%@3)/W:F5Q09?A*/X0J0_8ZJSL]Q%G79AC0/;LN/@K_R"1X%G4<L:R6@M9#&
M3;FX%<0)[RVDX5Q$81P7-ABM.,T4#N2FPLT518W&!M]4)CA.NI_)&?S/GK8I
M7)-^@NL?G>]]SJ]_$!\_']'VY1&'I*D+W_OYX^6G+_/-H.W+CPS&>/GIY$W>
MV[DHB=1!MP/79_L[1Y=MN)\]VO[</GDW*ZQM>,")!8D8-Y!8.9WIC7,5FT;J
ME#8Z<K/Q2C[\6<_OW1R_U@5:N[/5W!G!5%HF@L3)<6:3U2)BZ[ TGCMO:'9G
MQ( [,RC_ .Y,K]W9=W%G$\IV;*75,@D4@\L%1Z:0<\DB8X((2A)%3"XXLGNC
M)/M!_NP98. G>!;U[VMK=&N2M6L:W[X1"RYH?%O4Z]-XU-S*4>UB_EDJHD^^
M^>W[>M1II7(G=/+<)\2QYXA[:I&U1H&#%3IHY2E$PKR%0]GCX&;Z$4OA7P\J
M4;9V']^,O=;NX_NZCPD@,RH&YCSX"Y<(XMI39+PU"+R'BP8#A'( R-@6(6OW
M\1A@W+KHN;#HV>RUSNRSKOGWKSOIP$D@1 GI(N%8:?#>0KBDI1'21T46-^+<
MP5%OGU5.^DUO[:=7\M/M:?'"E+P+RI%,X:T0#UGKS'B/3%"4 ,I+*O@,\\A]
M%0*?J9]>T_]_B]/0RFI#P P)M9Q1HDW0UGN=+//*RT+J>R_H;NTT[NXTID2Y
M%8 Z(RG"."L %&U$'PW23$65A&78I0SN\#<3[SQOI_%(P=WU=!GS?79-4QW=
M$M=V5#Z)_KSE)[&SO[*=WK!U=MYO56?<.[8+?_XGPL]GPU]:MG56T2;'NDI8
MZ!Q*_Q[<R+ADF#\Q>7FS!59Z/.G_MX/8.HEV.!J,#VSG?KZN'>93W/D\0"M:
M>%_=CU]WZ)=34\/JK'7=,@BO^E&W8LW+EQC$?MHLEP_YB'X^G]]KI=&@G$0/
M$>ZMF_]RS<&L:QNYF^, N6L7+N/AUVZG=/V7T_5G97CCR5K>M5NO=)13@I\5
M78DMX3%;W8JD$PM%/.ZWP_FQS,Q-A!3OX^G9=*_0O,454XNE.I_Y"/ZI3OE9
M7RW;%<^<$,*%"B33A6KN0]!<1\R3ES9$PF@<DUGI.Q\CJ![MLY 0N/LQ@8,]
MUM[9X_L''R[;EWL7@%P.F70,:X(1A=P0<9$"LCP7D!1+FO# ->,;KXRXX<!)
MRQZ!RSHJ5G"%G:(B+%FQ!'DGD[CQQ/XT*GU?>#T F>9&/0@-3QZ:WI=A7.X=
M[!Y2EJL)+B$9J4!<!H:,)@9)SJDGTI!@?$:;=(%I_&M&#JD51CFZ43,F/9G3
M2]KXJ::0Z*=4D=& #54GU[ZST11!DEF+V:_']&<>4FTL^PFRG/B7[8[61C,Q
MFL_;AU(H[F6461TH\XTPB1RS 4FJK()'(H+*#0$+:1]JS'6](ZF TIS]5*?7
MF\A4G>.$/_3B&5RC#[E,&"[][,3F.C-!#^RD!G23LYKY.!3@,T!F%8KK=N_@
MV'!4WBO(NI7B7"EAC8-DBQM#M(*$7-VZ4K=V;'>QT8^'RG <A% H29J/RCF)
MK(Y@H]9*;KE5/H%CXUO@_V[IV$3EV*YHSH-?J[']]4:]"E2R04IEP9^%*'@2
MS"JF.0/KB9H'HVK>3X*)N*<3E]G3S1VO?&FX:8["@[:W#QW'+L)_4=0X(DXX
M.#H;/7)12.%8XB++*)F;3^IFW])P@Q&Q63N>BE!I;#39Z9R<%M,81\:5CNEB
M3P,UCM+DN(A,>V.LQ<8FEH*2O&H'R4:#%EK/*F05;[YFVH]19WA<1<]L36O[
MF;4?@-U6!RQ%0,EGV.VY15HZC*S*U(X>'E 08#\*+V6$K>TG,PWX[JB<^,^9
M6#SIC$Y:];'Z1V<D8WSU;FS1?U9#_M-VPMI *@/A>T>'-K @J*6(&\T1#S[S
M6_" 3/1@)Y9*K%UFR;S)/NY^4ONI5!97)A:=B](ON="S>W(20P="3/>B9K2L
MN94F$:<J^U0UUD4P9HIFY,K4KLPD>3=PO$8WWX21+[^PO?-#F\D2$\!B'YT!
M6 QNWF)'D'?8"2,5<]PN0S2M:=J1&9H:L(U>1:LSRH7R0EY:9V1IT#^Y*2>;
M)%P+ ?9L23+^ PGYF*K5>I\?:[Y*RG9]W(&A#6"MC*TPG]K??O^ZQ17>;#6+
M]W$XJ6RD#SRB:[]_,\]\B'EC(W/KGO1#)W5\17+T3QP,1\-6G,%YT].=JX$U
M(UU_@-P%:GX&7S'L0+;^NN;CG7^>+8 'F9JW%3O5_D@GM'I]2.)MWF $;W,6
MJX2J,V$\+E8R]5CA4O!M(U]906=0KEDH[6I&AVR&D_<W# W5Z.%#V5;L_-T-
MBV';S$ WZI[-6MT@,X@7LN!*-FEN7KK]X;#) J^C=UH5TM/@HW(&"Y8LY+.P
M.CWQ29)@A*/.X5N<]KNUR_P][\#] 3<2A_N]1?C^Y?K.N?K"_LZ;0Z(UA43<
M(X5%;N$V!FD2./(0P3!142IL (:0I8=BQL[TM_Y@CM_K:H1MELSY<7]ZG83&
MYJ;6R>;MS7]ZP0];+GJ;W?<-"[MV[_ 58/?9%\>FZE:*:"D3H,"USLYCK,96
MUDMG'(OSB_#]L=J[S>(&%?286MT93W3C,'\5.$6"_S5;^IM:BZ?]P5E-\39_
MD?I(]? Q+[FYPVKK13:]R X^'H;$*>6* $8)#'&5/(*L"'(D[(4B7@5&Y,8K
M<5-VE,-<9^ZH?>MT! '.@@W#BV-\,!RYL_YIQ[<$1AQ79C=9EY4E#_/'?-YP
M'YZM;%UWA+ZKD:@#K((E^UNE%? Z#[,=UX95&Q:&>SB4-(4DK$(V<H&X#A*Y
M2#E2W#IJN6;@@3=>J:62E>/]4/!AQ2H"Q/B[%'J_BSW,4NO9D^PT+V/8J<>\
MMHS&,CZ_/301PC@8!Y)*>,0)6(;1.B(NJ U2!8CM+I_=7]9]=S)F;>Y624K-
M8EQ";:RMY1S>!&&P-7X4K=RW-%%T6+J--1HV)*(1DB=?1#+&GNTDGAWWP[H4
M=+44I.]:"OI!!9O*E*[^.R<XM-;6FM/6TFMMK<<QEN^HK;6:5M;C+=).9SC'
M*VN@:&^D\\08)7/K#M;)6"XTP!M+!/9LW6_P@+BAO?/AD%JBP0(9,DX9!##2
M@'>QF?C'&QJ")XR$W&\@Z6W[#2;*6G/Q:^.G&0;P:YH/[D@.'AA30D7GL='<
M1:^EYQ9^L<X'Y@E>U^<?8G-P%^]O'U)FDH]2()P\9+R>>62,)@@'KP/G\-?
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M/79#^L@A]2*>AD!\1 H[BKCU AEG.*+"&"\4M;0H&]T ;\X6>);)_D+&*5?
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MOZ)@GW/V3 3%JOMEU@DB&&/[>-XE,;;Q.. +45<0%A);$L;PZ]^L;DE(($"
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M]#Q4%18\ZE9!VIN#-$; !]!>)AHBI](8'1S3C@&^1:V%KJCA*T+:&#5,'/O
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M"E056E9HN:AH.2_26*'E_-!RC AJ;"47$D7O(KABT2%#!$:>D(A],%B97)G
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M2\NHKI9V[DMKL X8>XDD4P)Q&@RR.#(46  GUX%&25C:U/P9;]"U&R], QH
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M5MSHL3\Q5W^!V:_0Q6I2>1BE1%_@ W5U-97H8\?%?H/*U?]U_7^N9T/I!C6
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M_LUWX.JN;;^>L/[&<-AO.9#&8:?W%C8=9O>ZHHA6'/QQ^FY*G1M G#LPO#^
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M!.4+III"58DJXWJMI8RZ8RZO)7&NZ03W# ;YB0 'PY9MPVM[*0TR()S6\A>
MPE>P,!TTS'!4(T->@LF#)J6TYL93CV(\VED]LT[K>W[>>(Q 7EVX#5[7&_5K
M<5_7T8*Y#48.E+"6S46G5ALG</-!5<2KGN18-1GD>9\K:7;URM9KD"(,%!Z=
M/]<KFW\'A22 TG0'.O^I"?+L27U<J.\NI&X;_^\6575SXP6N(Z4X81XUM@(;
M+ZU1S##'5=4VY;+ N4U1W<_=K'GO=V$% PBB/VKN69XJNP\M>&#,8GOG\_>M
MG5V\=>AI\\-7XRT![2^'F.0<BB03RIU24%*6*6-4%([D+FATC5[C]P0R;N>=
MGK<+INI(54:VUE.JFGG IME(V0 ;YB .6W[0<-G&B@.P0D;#;+'5-L>$"JL*
M@E=AFZWJ].7*BG$B[W[T\&^V/78=V%S"+%O:=5' Z]Z:3;C\T+EO7!R>Q%B_
MR]M^_[2R#3NYJE[&0SNQ_OXG5R[\!H/H9'NJPMA<K]"WJI)JQSV83);5H_YQ
M#Z![6D^PKHI:/;1:P6I U=0 *&</K,S,R:CA0M3[5GF1>T>7YY#?72W4=#2M
M;.I-8?D4QC,8M8?3*I9C=AF.30D+? ?/JA1-&)+--:K!6H2-.#F(V4R%-<E"
M "9QG/51>$$UVOI1,*X!3'DL>H:QD_M(P3OG!G@"M#.V&:=U-'.MTE@9EFDT
M!"L<)CSXZ?YV8OW6:HB#QD%LU\9J+B0)TJ&5C5![PYJF4RA<'4^D,N2GFWEA
MC2HBN;Q*$\B]EKXJRZT]Z.6A/YK<NC\Q=4O/4K/713/O4F/+#F''!K^\*G3M
MF0CS2;E9H!W@VD,0[!645AXDF\N@5I9416T9XH ! I#R:EU %54.I8R?I_U>
MNUTK4+VJ?BS .)IS1P%_=$![VFC4)N*8KK-_:OXM677K=?=[F8> 7;^![.^-
M!HU#X*H!L&9UT;EZKO#L(U@/'_M#"S=<>.FD</@4?<X]*']9:XS9JIU4VP74
M'(QLMUJ%[ /D J\UWM>W=[-:T,Z%;_N#JHKE!!UJ/AZ/"=!Y]N*\(*"3C+7L
MP;RXRCZX:P<,[P" <3&7\&VW8W<_+W.-I>/%R2@P&'0JSUBNMIE1NIO_S+KK
M:'C0 TQJY4J[?UV>T;GQ-@[L8.Q A(%E=7_LP=\'&&GEXIS989R-P#%Q#/)P
MIQLX'?-:X\M!JQW//=K%=@M@>C#G4JSMB5QF]UO>W/;I[-UY^[/ !=4>T'EU
MNJUV%"J'93^7S:P ?4PC>77S,>78&LCECO?CW.)-GSS!_AKO+Y3TON'AVEUQ
MX$46PI?7%\*_^5FDIM.SR%(]_^E7SU_.\V3YX_-DPPEG7$L3*.4>+!KAN ]:
M>6MI<#*.O9B2831V9^K+Y\D3QT?=BV7ICI7YUC2HYL_VWKLWHOFN>;CU!<R[
MPX^M[<UL-OKOVU]VV=Z7MZW=LZ/O>U_^;EVJC]WY^VAWYPCOTJWONV<?://=
M>UZ9C6=OQ-YA:.]^^?-P>^<MC.7/U-SQW[=.OEI/J:!>(46E1QS[A, J]RAJ
M$W5R1 J>+AXK:V8CY5@)02SW)IKDK ^!"9&P=.F*8^6IUZE>_1^?+5_=X>%G
M[WRXRNQO6[DPXK^S0^TB655\^((IZG1[XZME@2L5!,)**<0IU\@$1I"RV&H3
MI,,TW+#BNESJ@NMS9#VV3*MSZ>HL=6P[3AM'7*ZJ_H P? \%U\6E>NOW5%V]
M"LJK]87;EE?G8DU3L_B*Y61-DE][[(]_$^SZEY;!+N-@*;_18\>))1>,D<R6
M*Y>"%?N]DQ\EM2U-=?"K"CS_2+/>!,#OMX[SU\^MGOS&(,/]I6/%160V/ND5
M^12/AS]8DJNY@IJKN.*\3'D&E=#?]7N#0>6S>#T^;*C^^#N[^4II^5\A.>]'
MG5'EX*M6<J.3CV+.[ \!YQ:<^!S7K!#A8Q'ABZB-YL<QLJV+=M*KNR2S+8SJ
M?CE;K@QRJ0=Y:]Y*U?^N3+K*D1%BR?EL,WZ+[=YQ#+4!/XS^H NOWC^]<<[:
M%0OPW/J?7S7%Y4ZHNT6L%<]U?KB7DF'#1<A' SX9['22,EKFZ@[F%Z.[;]7!
M_ <^STJ+6):HJU]U>DYR4\G6YA%M?MEBNW0+;VU^;.]U/O#FEUW2['S^OGOH
M679Z;F_FL5W,3?U\LKVS2W;/PN'NV8>3YKN_87S[9._P,]W;>=MJGH5.DW[F
MS9WV^?+5SA+J257=5N4$U2"0Y5$B;I6-V!*M%%Y9YZM87!4L?,OLU!] W6V[
MD_\BNEZ4!064"BC= RC-:>+S2GB!J=O!U"R%WLG@30!P,HY2Q&70R'AC$28Z
MQ."#32:LK--5(\W=&YH4F"HP]4 P9:($3")$.,6Y=<00QS'E"3Y$IUVJ80J;
MHCLM#2B1&2CY)+#W">F((^*&&&12,H@YH23'W.B@:MV)W[VR1P&E DHO I2*
M[K00F&)3F#)*1Z:D1CQ2#H8==\C";B(I?61,6A:TK70GK*Y-Q'D,F/J))VWY
MROD\E2L7Y/Y_,B[*UZ,!O#SVZQ#\'+!^T#J^4TOAYU10[C+^4\ZB!:4E.2NY
MQLEYZY1-E 1I>?+Q>MNY:)[W!NGG*GB+ * <;422 YKSX!PRC$:$A:&<&!RU
M)2OK0N)EZ9I2&I<\448MVMA"6'?FR>+>!15)0MQGUL42(Y>P0DQAJ;C6@@<0
MU%S+A37]+JR[A*RKHM$R2L8<25S'I"F)*@7ON6<):.1Z&ZO(V/MDU)EW!V!4
M*L,M4M('Q&GRR-HJFX#'9(216(#9)+BY^[E88=07S:A%QBZ$==G<:1%E6D2#
MJ P2<<<CLM1JA#$0K!9.  .#C%7JMBUN[I5U7UKDT$[?AEAQR:_9XC=U,S]I
M^+')"F<4MA$T0Q5$3D-UCB5,F?2<ZF*+/P;8S+>?$(D8KQ/-N88*<3#(D#7<
M@)Z@,4Y6YD;P*^N4B[LK],MW!E08]0$9M>@)"V'=.5L\IV2[)!"3#/0$8AVR
M*5*$I1'6!^H"SIUC-+N[GE!8=WE9MZI!8$,B0DHNK'2*:,?@;\)!Z;>AV.*/
MPZ@S6UQ$H95U%A$B0,9BG9 Q.J)HA(I) JH25LO8._N["Z.^:$8M,G8AK#NS
MQ7V(PJO $,/8(ZY90BX0AXA-*49C*+4^RUA28@]>PI4O+?8@%Y_,%?7CL*[J
M:??[L:KW6>(/KH=Y165TB0GE"4^>.<\3XY$Z)SQ37A6?QR. ^O;K.9^'I4$D
MFPC2027$J010-U$C$7WDQ@;%> !07Y-+Y%XM)R-/CTV+-K80QIUY/)(+-"5I
M$8V8(QYSDW"!%3+$!1DLE3Y6C%O"AIXQXX+53)S70@1'.=56R\ BQ@)+YCB)
M/XCO+O+U/METYN\P#DQ;V *$@P0V!=9$%DPG9)P%=HU4:,P*FQ8V+=Z.I6#<
MF;=#1VM5M )I'4$QMB!DK6$*>>$#ER3PZ$1F7+9$C/O2X@[^F#3V:+=\;I19
MH@^NSZ*/+'!BE1 V<2RDMBP*S(FF7%(?9;'$'P-PYC,!I.;>R* 0F-T2<2;
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M+.*H:10,YDG\E0+G/.O"4#>\S^R9E9!^KPL??56[8O!7K]WRI_6_._#./]I
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MJZ C!VO><*,!#'( IA$\)=?OK&D"I%HW5"R4WW)NC/UXR8RJ7$5C0PH& ;>
M7MOJ-(XK?\N@4F:KQ_0&\<+E,U>:3=GU-%.;Q=AO53VP<H[!>/-105Z,>447
MGCSS5M%:S9[^-FCX.K$4X")^L^W1S*D&"P3:_D2YMQE+QLI^YH(Q!S0R2E7.
MC&YU1E6IZ@E4]JYOP1N/>X-6=5<>):C5H_:PTLU[QV/WQN"R4GU3G*!KXEE
MSI\6L+=_.F>B7(TX%"-,E@]QOL6ZG.V@@1JUYZ<QJW8[ 2%&R6^KC2LOWHI
M]Z$BD#][P!F-O^'W47_^7O9;S3=SE;"KO_\5PWZFUO&%FHC?'A.\UGZ,7L"6
MOFWAR:<-'_M#"WQ9 4%M4@^ U8<G,78K"M@? 2N!E,XWC3&LPI+)C;%>N\%L
MH6M[=;K:JS]\3&MN(R:&;IP\M%-O"'#I''K".Z>[46_&N>=/?X8]R,L LQ[5
MLX8GM$,#[.ON?FP<],!6[]98>CIY_*!V?EZ<U.G<R#K1#H DJFJ&M@UKUJUA
MOW*:PMTG><FS&M.O$"NC]\2D'Z,6+,#4>S6W:L,#.UR%H68'11P.V]."B973
M_XH'Q^^Q[UN#Z1G#Q1>M-DZJ";LXF5[&0[CQ9LO<JR])MM5O9#2.D_&/95F_
M7N[*^S%>< J"X.T4<-]W!Z#;U\I=)<<F<JN::N/ ?AM#>0Q7"+(QI4ZQ)E]1
M[V.8V^N+?D+;!0!K3Z793T76ZNUEUAO;!P$UE4%P[W'V# UA8(L3:-6DBT![
M4('&ETV@?8PIYK9.L?$QL\+'7.VY,Y4P7"^SA ']N*9I(-0IN]8G2^T6< M<
M7C-IQ0,PL,QV,4-B!65@00)8P+UNU <RNJ _Y^? __6C[^UW6V?GCUXK'NA/
MEZZ?1].OEZ[7G6.??CS.'6NZ^^>%Q$FK#:S5[WUKA3B;0OQ^'$.KPJ;,;?&[
MC\>UJ*SF!.!1V3/O-C;^RA,YSRP_#(P9+RJG:PI8[O<)4[_JQW8E6'X_:87A
MP23\?>[&<< 6GMUB'<#$:'C]+=<%X3PT[5!]88'F_CWHSW)%]B-R_6B/4(7>
MKVS[Q)X.5OYY/FJFU447UO#B]*^=9$KWYJVN,3  A=98_*H2NODJ&)-=FK$T
M#OK9H?I?/S\;4"OK.Y5X!.YZG7VQE5_.KE^UDX][>' ;A];/W76]+DCOB=H%
M5O#!6-&O^1,0X*!U/+:E>U4CQ>&L!]]8TYF!T;_?_[']L5(5N_7%%W JPXP?
MUD6S06T+H'=,O(OPM[>C6MN[$MWNJF/Q&^M8 )#3U]@*;NMH%3(+FNGW1OL'
M,W6+U0=K"[3XJQ$O0D&ZL=/Q10*UN1ZH;WZL"'^L%'@O\'Z?9\/OA['3H(_K
M,*XC$2[_^S"#NGI=MFP7^"PC?E4H4OT^:&R"5!D-!A-@W #]]G30JI!Q9KP#
M#809>'Z<@>?V%#QO$L@LKXQC?B0:>;WQ>>?]=G/CXV[CT\[&SINM-\V=7Y_$
MLEBYG_)QR5A.3AMM5#(QN^?J:)7*,JL-GFH_0\^/)EH P,9Q1HZL8IS.J1:@
MGL1L=O6GWB?4[O6.QN<7D]=,SPLJS]@DT/93'1I3DS]5&Y/QS7EC-VKI3@QC
MU9#.WT+>7''+F^]CW]WL7E!:0 .IM!H8?W6:LC)_V<IOE<HQ.+<TK>ZW7AN4
MF:-N[Z2F[U&W_MQO#8Y F<N'DI5SLU9QIJI=LG4P6QVDUK&@&-8JV:BR1_-_
M@!Z //JG4VZ#6T:5M5EQT&JV>JLXLKS$69GR!ZWX;3RP6NOKV'PD UK6*2B
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ME YSI<[Q2/6PMO]^\_'O]V^^W$3-%4NM+'VIFUW8R;E8[*^>"^(Y5[LCTP?
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M%OA)S%'2Z4SK3J0U<8H$-^&47W*R#ZA>,O=/,!M"&O_EU5OX1=NP_C04LP6
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MMYZ!X+-4$K YL\#44S[P\XRXH]#G6'\PX4(8XDN1M;0I[)5 1[&.!L1]((&
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MW+-4=46AQB,Z/+U44_C.!J.5+H!89WK5CCQPO>L@O;/D=15S#!BVM$E$.0$
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M53.7ENJR,A77DEKLP!2@SJ2IQR29EI:)4W"+H5$@)A' '_BFX1)W2,+A28
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M$PW6*$5'[:,:G2A=K12UE"%3*]_+%BN(#S!S;:4)X$9;!E6A^#K 4;0M;"2
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MBV3F8I-<;)*+37*Q22XVJ0$NYT9XEEULDHM-<E?G+C:IN9ATL4DN-LF=RD[
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M#BL>V? P% I:&4\2,9\&OC<+ON!\"D:@D@@>@]=QC%HFDXBBWV!M:3Y,@U$
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M%FZAECXEO;[8\LHQ'ZHYU(RGP*JFH7/-'XL>=0V9,EF J(1WP^YBY1BBB2F
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MB'HF'_8A$040W-U;EAN=%]G-.#R@?8 IX0^4W;!*S+Y$U&(\E9B8#NQ!E&:
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M$NUIHU'>@#H&:U<O6.ZT;1<KJ*E'<-QMGZQ5C^#XN-W;N!X!)GDO V.]?KE
M0VF\)B]^(C49VS#0?!5\J1)=2R?CBQFFT?_%^?*Z$3JEA0=1)J))@ ):P(/8
ML;T@\#,?]E244L49KYB&S_5&7H)J:XJK6% 1?P#2?,I53S,YGP.&#O(Y?4,S
M)D0=P"Y9G"SPF;$($N]:A%QA99XG\!ILV.Y3G_A -TFO!6R]'/5FB[3GK-I
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MMPL8DL\TX+8-LB4#ND@*ITT]NZD;1E L>*MJ7#0KY43I7;9+4=1R,!(;7N[
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M !,QBU52B0*"%3.UE#AA7>0/&8:I]QY.E)C".EK>KT(IPF=I&JO\@Q:^)4N
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M8(LOGKZJ1AK4U]03E3:M+XQ5+RH32:AMI[+)5&A);6HJ1O&/5-$J3ZJ1YR:
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MB"O3'BJ5\(]"V!_@D\-_'/&/#^G1!C:I@T4.JF.^#M +/CG"0L QB=;I6NY
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MFF+*;[B[D#,:B3<,N("<(*K->"$HW")+K1/JC9)GUX,K]JR8%<R"L?^*VBQ
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MAK&_3?]<YU=#9L&,0P59),L(A1T \7?N;0IA:JA.NMU3?:@.?2GCVT8^LW\
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MI$#DRN^W5%I==;^G*TW9.TS3DOG-'&#@0R(\?&:DQ+>R8]P@PO^#W #?0W-
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M/%<)<3?:O\?@#I7'O4V7E=+N7)24W7M_%L-R&M^DYV=YM#:SJV).^:Z0R^?
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M<\3#I(UI:>)@9-R.[XIJI.!BPYJNW^?M'Z]G;]NYC]T-PKP&_H2T2%J?+R6
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M' L!):VI"XIK$ZH$ W>3-*8[ORK"I)!.RF$$HO&)Y%2[7&B71NT1)X$A V\
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M\%\OW[_YX>=QNKK T>R'5Q,,,\P__#Z<G?WPSXS3?_U0)N.+'_XYGOQK^#D
M_,?\'[T:7WZ9##^=S7X03/#5/YW\.7DEA18)4DH9%,L1G!8.6) LT:^\MN[_
M?/ISX";PP@1HQA2HD#@$@PJR9C86%F)D<?[0\^'H7W^N_XEABC_0XD;3^6__
M\N/9;';YYY]^^OWWW__T1YR<_VD\^?238$S^M/S;/U[_]3_6_O[O<OZWN??^
MI_F?WOS5Z;#K+])C^4__];<W'](97@08CJ:S,$I?7T"OS[.;?W@;C?YI\8?T
M5Z?#/T_G__[-.(797#T/+N&'C7^C_@Z6?PWJCX +D/Q/?TSSC__Q;S_\L)!<
MF*3)^!S?8_GA^I=_?_]Z'>EP-/LI#R]^NOX[/X7S<T(\?\+LRR7^Y<?I\.+R
M')<_.YM@V8A^N>0*2E<X_[L^[:>#,9T1D$FZB@CT4QQ5@O>(L>OIAV.^>19D
M+.'J?-8CXO5G]XIW?!&&?0IX[=$]H)T_""[P(N*D3ZAWGGL+YQ+D*L+ZR+/Q
M^?C3,/TIC2]^FJ-[-:9M^%WXA%L@&Y__0:\7C MAYA"^_N-;KR<]#T?#NG6\
MH=]>/Z&^:R\@^,<,1QGSCS\,\U]^'*)AR6KOC/"H=+)!1V>2<3)S&74T@TY(
M.TID-!V?#W,]9S[,Z+_UX)F.RVLZH"[V%-.]3^Q#=MM#7A$H<TY%;6T(S"CN
MO$,F?.*)R1+HQW&P/?A>I/QJ?'$YP;/Z$7[&-^/IM$^!KS^\G>P?6,B*&D0J
MFOX?61NF*.^-E\PRM(7L$R*[PXUJN'=);33R+DSH3\YP-DQAFP-X?_7<?=,1
M=77/$E<4QRWS0B>9HS *R50S@2G.A/0B:8-L>\5M7.S>6GP9SJL!^.$,<7;P
M=W3W8?WJXAZ@*^*.*FEO@V>8N J8G!712&F"D%%&)@9;0>Y'HKU^!_<\N:&L
MM^=YLL8J&P4&:51$Y45DJG@K6$[><+E9\/WS^O9G]&$V3O^BOYW)F?SEOZ^&
MLR]][D@=3V^W"SVTE!6-R*Q<3%DQ%Y+"R)SG+ ?%(SK.M=B\\W2\IZYIN:KS
M<;KSVO/J"(YO+-?S$/%\_M/!U10^A7 YN'DXB0%?TR^G X.<OLH8H0290)5@
MP2?EP!DE1!;T_>;0:??.;=X2IG%N^%Z_X:>JK)_P?#9=_F2N/F#\VI?\WYNA
M+!2V_^+>8T9RA^,Y_C8FDV<T(QW2W_WT>C3#"4YG"PF^)8)/7H7)Y O]T8N+
M\=5H-K"1-BIN!607&2@N$7Q6&73 F$7(60G70@9[([XKJJ_L?C%9"NW:I]G3
MZ:F1FEZ9,QL_AJX6S*&5_OC#>$(?T5]^9(>2K!LNF=@3#%/\E>3V\FI*(II.
MR6R(P]$\,C-0=;DZ&"#+W8!B2%)"&R!S,N"%CM)'V8)@>Z%]]N1JKZ-U8O%#
MB;6$]S,N_O?U:'WW?T\K^G4\^3U,\B ;X7)R :3/!<C"8A"+BL!=RAB(#L:7
M%I3:$>>S)U-+O:S32!Q*HP]G9,1-7T^G5Y@'TKN843/P-A&6XA(XI2/$(!09
MX2:*PIJ<[;= ')\ 334V[DG<#7:0]54.3!'6%(L@A2?B:V8A>E- 9Q1&R&2D
M3VV,NVYK_&1I<)CH6^P#%=&"ES]?3>@8?(>3X3@O^#K_P[>75?[37_[ 21I.
M*WTQ:8?1@TM$6I6CA"A%!NXU(PEP]*P=67:"^@V0J9WJULDF&Y'M'^'\"KL!
M>RE54"J 5W6K%(F#$])#8#DQM#(X98_(M<U(OTFJ]:2X=::I?9E6 T&#5V=A
M](GD\2Y,Y@@'.K'(LY1@/0^@K#'@L21@P05KDQ18\D,!I<XGGZ;6#Q?BND;U
MX5&;Z6PR3//(%RWXMD'U&\[>EL4/:-D?PQ__',[.JD2(J-,!6L9T<@6"*8X.
MV.(AHI' ?$@&4XXY-PK:[ ?X-#EU5#6NT\_T3+_%SK<*?A5S"-G0J5H@SH];
M*32A=X;(@FA-2);VP2-0;RNPWQ3M^E??.N5L4]/\EXO+\_$77)R^[ZXFZ8PD
M^.X\C*:#$A@=KTR0:1>1Y%0]"D;>IN0%74HQJ=(DB+@GWM,FWC&4N,X]U])2
MWXAZP W3SDL!R4<#RB@)GGP*,A$\RS8426([MK6^$>TWR;L>%;C..G\HZU[D
M_W<UG<TO-3^.7^0\UT<X?Q>&^?7H5;@<SL+Y_,NIR:>YYEO@:#J/RK]'DMYT
M.,,/./D\3+A8[7M,XT\+K2YLV."],Y)G4!@$&1&8P*=JS7JC<XI:AS9QKM8+
M.VTN/RE:= 1D#[\LQ-DB^:YF#0TTD[I@\L"]UZ!*DN BF;N,.\.*=<EIT^02
M\#:*TV;4_@+O4/_! ?G%]?7M[+&OX):&Z2 %VHY%H.5F8T%QHF?T@4/,S!2"
MS!SR%JS8!MQIDZ5W]71PZ. X_L<JAJO)EUM>]8M$8IA@'MA@N5=D2]:M#!13
M"%%D#MP(S4+*2:C8@CKW8#IMQO2EC ZB'!R#OX-M?OPMH2TC?7_#V=DX#XR6
M3FA50'@Z#Y6P&GP1'+++*).)*FK1G#7W /R&*-27FCKXM'>D_<8X2PG/<3)/
M2:Q,?X^72X]B,OXT"1=?K;>!S#K$) )8[6B3+,*14UM(/H(.66.R]%8W,;^W
MQWC:K&JEK YB'1SPOYLR08M6B3$096ZF6ZP6>@*KF+0<LT#OCYNATDO>A67)
M8G8"/*M![:0E'0;<D"ZY<EP(EGB[4-T]>1?]Y3O>L;3GEE3WWYQ^S?0<,*(Q
M5UQ!+H48KBR94=H@:**<L\FQ)(^:!;G'&DY[&WDL97=L,WM'.N>7G 1X. <\
M0"%2,BH!?8.TP1 BVNV4@2Q1Q9 ]_=&JM=-]17SSR-.DP %BZ]#>WA'#.8Q;
MI]FT[M.3F],L?)K@/+=SX$W)C@D%A;E(YE%.9![5K' 50LG,>3K<MM+K%B\[
M88WW+>J.3+:#HVCOPI?K&.'?AJ/QA)8^/[VOA3'0):>(.H'@F>!9&2 8S6FC
MD<@CQR+7DD!Z.57NAW6:G&F@D@[&-,B$)>&<7]7;WW?CR5P-L]ED&*]F]:CZ
M..X^S0991K+?#/GP5@A0T9,+AM( $Y:\>N>M4$U"<_W ?_:9]X^@Q2:YD=="
M^3@WBRRS18F0@9ND03DAP9-?3U106=ML3$E-8G9W8?3(C5NM78[ B+UEV95O
M_\.B4<>?T_EXBODO/\XF5_CUAT0E_&/VR_G\A7_Y<8J?UFV!/;W?=??\C^%T
MX%THQ:=$VV2]HW*!TW*\ LZ\XQB=S+&=+]P)J4>:W--MYQ[:[*'GK@*-P^7=
MHERC$]G/\ZUV*VR#E1Y [3GQ\ZU.._T<+)OZ&75PHB=%;L6/ [1P;*:0)V:\
MTP&BT'2\"6;!2>- >V]3M 4U-@GG'Y\A=SI(/0V"["+\'HDQ=]VZ@?UM;J,-
MD!L5"S=UHV1D@3L/KF@/Y-.S+%7Q.FZ7&7_?6Q[!PNQ-&>,6DFQ0;WYS%"XL
MX'I=/1Y5UVM.[.CHZ,MD/5D=JFN>:DYKKG>0ROMDE6.ANVE97]9D%ZI3L!IZ
MDWJ#TKX53-?LWP942XNA$]4CF0K]:6_<2O0-S(1N<#G0FW-4D$5 ^@RL@UAT
MW1I5$MSR8-OT"3@B'QXR#(Y,AUTDWH &!.=BO(C]71]A03DG QUAB6<%BF<)
M3BL)08K:QLX;$9MDQZXA.;[!T(.&QGV*MX&%L"%Q=@F.^9 YTBE8(IV"0F@Z
M!9V"A&3U>J0343=)W;\7U2GPH#^Q-]@#WN.,UH?YES 9U9*GI2VKA8M.9&">
MK"$R:P,$5^.A1IN(TFD=FP2TN^&< @MZ$'0#"_%%2E<75^?U5F]3DNLU4&Z5
M-"$(,%J3=Z-RJ<6_9"FGPB0=@-&I)D6T6R,\!9*T44>#NXH[R8G+G2PP7KC-
M8*LOI1@S$$(.H(U)Y&$)K7B3'D(=6$Z!"X>*N,>>"E]/LILRG%_'D]_P=^)K
M;;57[]DFXQ'],BT:4BYB:5+';%3UHZ,@L,E#U*%F/#M&/C:=>[R)/[$3RA,(
M0;332HN-@_[>V_(BC^?M0JYIO0VFEA&)+E"/$Y!HJ,O5[:4O130P2CNQ)41?
M$E. ,B907@MPSA<09#X%VO<4F<O/FQP/1"<>F1N[R+\!)[XNEK;.40Z3//W[
M9>V#+!AWC"_-Z8A1"&, A:P]0A#!&4:K)O1:I6 #;W+'M16ZXULEARMRW4#M
M60L;XQS__M.*F-[0;_N>@Q"F9[^>CW_O=R+%S4,;3C?H!KXZR,!PIYE S"DK
MHU*4+$9A#2G'6>73YD$&74O82>(OPW1(#WHWP2D]<M$M> \9=SWF<*D^"&YU
MH(I)17N=T*2H./<AQ.RJ,)U,68@X> #FH9+[N<8.SJ?7_].3'%<>VD2J]P%?
MD7%&GI-PRNB0%-'61]HE9"V_EYIQ:[IDO/+XWCO><QF<(5<-0IURIH0E)UN9
MNJ,I;:65HF";/*O>.]YWM+&NWSY)?3+_S<=)&$T+3B:8^4")R+07"%QCJ"/R
MD$R'N0"D04WF1&J37K8+R">1L[H+/U9/TF8::9E:L'!614J.3$@-6J=J0-20
M-0L,D,7$G RAZ$8M.9](9NHA>C] ED\E,W5)W7D]\G0A].IRA.BSK*KS4D8R
M]JR&@&B@H,T>,20IF^28;,#S1$([.VEXPR9QB*0;^&)=L!:UZ7@=^-P&8,N(
MSH,('R>\TXL^M^#(X<IX%-8HEX/V)D%F=,(I8\EO+$5 <C:BLMIB;'+']$AL
M>2#>\SADV44'O2>J$@0ZL*ZC",8JVAY3 >TEUCXI%H)"#X;;K&PID:G5A(0-
MF:FW'WM\P[%GF8][$5B/5N(<R<OAN%Y8CL;3V3 M+[?KB"6;M .M:E<U;A/$
MZ&I'2UD,<9AEM9I.U*W!KJ>?E"(/%E^+8H*K.,7_OJKI<)^K-4/_;+[_*(9>
MBU*SF)RIL!P$7<BJT3S;( (CG[V)^=^-YP3,O#XDW6(RR#JL)<^W -:TZ&@3
MLD=*(^Y#?P]SX@#A'V=[N ;(O(A))=JRK": F&UM@B? 9TO_DS*3IDVAT7%9
M\5 R\5%)L8O,VY/AY@!+7&;+09B:[\ID@5!<)$LU.ZNB0EP[_UL0X=%JD/K1
MUOT<V$/41[ER>X^$[FHE"K'=9<7RGQY^)=$)8N7BH12,@6MK<[#*HP]>YBQ,
MLH5A83D-.N#L(XFYF;#7Y<W=!_0FE2Y J[*1D4P7HF922AE%QB=33GAN4# 7
M9!YLA+:/A);V]?5O#[CNNO^!O4EP&\ K$K4R(B^96_+1%'?16R2_G3NNN=/&
MQL']CSYLE_YY. V?/DWPT_R&X6VY?OC7P#:+A4!9!5H6#DHY!T[5GGN."?JC
MHOQ:#ZQ>-NR'@!V>Y3Y_WG10B+D949*+[%)-MU802R(_.4H6,$9RN1KEM2\
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M!](-+WAD([:5=L8]BW:CR=KKJ,WQ9#+^G611"[\6Q5XO)I,P^C3_TO:;H?G
M(WL8CKD+Z-5Z+B6=$\5K28Y)*C*6PE!XR4@-2I@TV %^GY+>O[)TNP<WE_H6
M%:0V(3J5:2NE;9:;Y)-P2J$C%01NDWA(]@=6C3[P]%?CB\LP^C+]^M<6!6H-
M=++Q5<VUM-TB5XOZDF,A%9:TH.,QN\B19Q12)Z>L*_(AO6U\Z8$F%\;9Z]%T
M-KF:W^3<I#X5)X-6PI*3)>@<9P$7#>Q1),^C*K&T:<*T <^AEN6;\>C31YQ<
MU,=?#X\8:#)(6,X</ ^&EDA6BO>Y@-6TCX7D;4A-IJ5U8'F$T[P'O:_:;X<*
MN>]F(+?QO(WGPT\+V^2?P]G9^&KV:CSZC)-9'1+^VWA6"PE$06>X@Z*2([O"
M(<3(YNLO2LOHW99MN'=[[_/6?6M!-_ R;Z/].DUL8)))*I0,AD4$98.#F*2
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M6^M*:XR>.AUS,5]>?IM*5/W5*K)URW",)4JCF5HU>":;O+;=,<0&1&=UMJ9
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MI<#VXX>M!UT.6A/?LIN)]I%7BX@)+Z*808\35;.?4)@PSX,>I0$F+$D2891
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M7[;)+,B/.2&D#FV)(%(M$).(<N@E81@1CU'D&U7=U1IU;MRX)73S18(ML:^
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MP"1?O):.W?>N=_'K=Q:Y:<+&MO[PMJVVT :8+,+8=[S00]!G@0]1+.T+@E@
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M"3H^A9%1A\F+L9JL;^0 S$S;0/:"<::YX_%[IVS9V"O]7B/&_FO-4["NY2O
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M44D.TNQ/8"T\N#X/LS'WFB-FDU -1I^4)<U1V:>^ 4\PK_;]3A)H]7(C>;'
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M#36!+:&OFJ)4@PHU:,"OMYY8!G7D9< "GN9%%/01LEH,06/8:8L:Z.-P4)S
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MRED$42Q2R 2)8(IX'B=*9BRE+@TO.V0Y,<P(W2[?GXE>=&XN?A%8.P()!-?
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M0V1;U7V:/[A [)"X/Q#4(R7PAX3<+97? [?.E'Z7YXV7VN]AY4&*O\_]'O/
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M-Q6Q665?4TD<;(R%/EWFQQE^.XZ=Z* .S-0'%<[K38R=Z?L]YIL1KRUJ0N/
M0:^%YE$5,C=ZN;HT?;ZU#0OSI"'Z/(T^7N'[U(^C_AOTJA]U7,[WJQ]7!=_3
M)+Z@96F*1U2*&4FWG+\\O2Q,:/&7S:-<GREOWW0RK0.TMWT8L%0HCY($QCR7
M>IK+,&2B() 7DD>89PJIPB-T.J2.5LPW?GAUO<8J39N=QE2];MZL0&G*<U>)
M!MJ%]6F;$71\;0^J1AZNL4ZQ#LVJYZH]PT!E&3C7P&/7=;DV;[^31\B#KO#
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M)+T?H&ZAZM;X=,:O7W_*>$'MUA8=1+K;W^5!MM]>GN7ZVVHYYW=/5+._;(H
MTBC!2C **4TI1*20D#"20%3$2DBDLHQ:16MV"9D<L6[5!(V>#M1P"4@+1@T
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MI107D+-,0"21@(PC!6424RX2)H7;(::EW*FM.?;5K@B [NGN&I!LA[S=>F0
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M1'$6X5A"[3M(<QZ6FZ0Y"@LD$Y84F:*<NIS\VXN>VJ&_:;G)M>K@Q>QCSI=
MM3H#NE7:C54<QL&.989!=V#6,< :K4&KMMDS_NFW&N6?P59Y<'L=9F<N<D<L
M)#<Y2!^5J]Q1.>8NCR?X<=E7^5SOWY9?U.?5\L'LTAK7:D9E+),L*S3V!8:(
M:*>'2()@*E*<1@G%!6>SI7PP4?1VW'5)E-6W1.IO:5_@<)_45E,3(K/0JD+M
M9ST!H95U8ZB+Z-KQ42_$QF&?G8H&J\];K#YT8>5,,]> "$DJ%V6-2B'7+#XF
MC*O7^]+##[E\D5^EB5K5O',OUVJU?M(D)+^PQ?RAKBR:FA1;SG*H]&H((HD%
MI)Q)F$O&\JQ@BBBG?1(KJ5-;)C5*FZ. 1FVPIS?8*7YSK4![CY&PY97 ^ Y.
M,J&@]6 >!ZC"TI"-X)$YR0&+4X)RN=F/K7Y;KB5?/2SG_R/%=_KG.[F4:KXI
M9WK%I62N%,R+F$)44 P)27.(4"*S""--7;D+/UV0,S5&VE<3:#U!JZ@;\UQ"
MU8YK F U,+NXP^3,(E= ",D;ET2-RA17[#WFAFN7^['!.[HP[/+M4<K-9S-$
M)H;%=/I.449CP2(8"YQ!9(HPXY2: YZ$,!J1-$N<Z."2H*GQ0:,GJ!0%K:9>
M_=0O8FM'"B$0&Y@5_,!R9H9K2(2DAHNR1N6&:Q8?D\/5ZSV/>C8K_H^[LGR1
MXL/+NG9(YBM11:]]?'I>K%ZEK*ZY;RHCW6LU9E@D$6>9@HP(!%&*"DAHE,!"
MY#SE49%(YM1UQTN+J?'*^R9MR^@)YI4QX&6IAP)L'B60C1G-W[=UP)[U,QQ/
MD;R&S/* :>B!&/KLJ0*W-@#4%FP+]#3=?5HS0'UM:PBX[QH(]].I/D &/;CR
M4F3<,ZT^6)T<=_5ZF!^)UE]^]=2Z+68:H013I&"1)9H?%4L@%IF &488ISC)
M6%:X\..Q@"E3WPWXU^@O4;QKH0G^[5]P$L?_4631311%;5XK?=D\KM;&U_T/
MD)#\)DO3ZL@X(=E-'!7M9361W@#]LPF@GO^0"\>*DR>C8T>%?3 ?F.4:N+_5
M<+==RRJ@PC'8)?M#DM.)C%%YYY*%QY1R\3K/BM>KE?ACOC!5;(]KKIR)$\L)
M0B1%& H5$8@$81!GN8)QEA=Q%,=82:<R]D[2I\8SK?(549R40PH1K><V.'9,
M,ACD ]-,4+3=BV;[H!:T>+:3 N,6T?;!YJ28MM=#_#CO;LE73]KOHILZ<6IO
M,5L5\Q9SLYZEBYW@\MWK0=>RLKMM65EMNR I,J10"DE44.UWJ2I264*5(ID3
MCK*".[4)&$?MJ;'L8>- \*N^U&MW;*1!MR/AZ0WEP.SM,8K.'#TNJ"')?23-
M1YT5QAV-X^ED9.F>K<0OUSO\/%_*.ZU[.8M-"AK1LXC(.3$'(P32+,)0YCC5
MOGB.<[ND-!>A4YL#N@N/@M^-XJ#2W'%2L!H!.TH/C>O A!P"4O=.XPX8!6TY
M;B-WW-[C#DB<-"%WN=>_5^XG37MT\5^2KC_IWY2SG N2$"5@GJ011#3'D&&1
MPHS%&,?Z/Q&RZIO9(6-JO+-M!EOK"8RBH-+4O5GN,9S=K!((I*&].G=\O+KE
M7D @0+?<XR>/WBWW@FGGNN5>NC2X\W&FS+*1^OV/U2P6 BL3IA')/(8H+PI(
M>2:@)#Q)3$UD)IUJ>'AI,36::-Y^_9JEP=R/CC'H[8^$0?8M'92]:DK[QMS4
M#*0-&<5GN8[C2$Y,AR)3\6JN8^7@YE@\S+.%^%Z4_ON7]5JS[HRBC-$D5Y B
M*2$BBD-<B SB.,EBE4>Q2&*WXG=GI+A\>.-4K6L4 Z8QNPFRZIEU<PY9@E"<
M<IK"E)-">Y19:CJQ"\A2%264)XQF3I-)3UQ':;M^D(QS UJ4_T8W+VN/=,MS
ML-K-#SW!&IC]>^#DWEO],A)!&ZF?$3-NU_3+=IZT2.^XM%^+I2_JEG.3#E+^
MNMK(\O.*+LO;I=@F47Z57,Y_'#;@83A2N:99*#3;0I202/.$Z:@4QTG*N)(%
M=POP\]=E:GRRWYZG->8&5.;<@,J@ZKQTEW"\L\FOHY+/^-D1TO]7W=OVN(UK
MV<+?[Z\@,,!,-U"<*XFD1-X!+E!))WT"Y"1YDNISGD%_,/A:\4S%KK%=Z<[Y
M]9?4BRV7;9F4*)7.O*0K%5G<>]%:VB3W7GNB61F9N 9,R"0]D@:@.T9+I#[F
MO$@'I &X76IX-.26?=7N:C+_K,NP;G7O3DB>M@NE6,%=)3G5!;/+>FK)E>4*
M$ANB*6X4+X3WWE[70'.CSUK[K8DN]M:"RMQ02;P+Z%[?ZHN%V<CDUA>N'KIY
MW5@,UM"[</N)]?2ZG3S5UKMR?<^-P$8?^*^:NX-0M]7X]^7NZV^KM=CJ34E
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M_K[>/#3MLIP,46'7+Q 1UT!4N\1593)HD$993DS!<J_-CO.WGR-3N!W"TL2
M@[=3W#S.1@>A,0$%[(&X_LC[(!)PBC@(F8D.  ,1"CNTNPA YWG;Z:>F.RJ[
M:/'1*=?EJZ(52OJ<FOVZ7JL_E@\/M^=.SS[HW0(56"O!%"P$5A GLH 4YQDL
M*$N9X)G@B(6DZX]D9Q!]3I#E_^F@@;L,U:08:RK]0K,93-#(C#XH8>$&-)[>
M7,Y=L/Z.6O\9<T)&+A6-8NI+5Y7&Q-NC #7J<).^3LY:T_K-(N=<92:1D)C,
MO4X2!2DK"I?W:# M,BR,&EBB'\/.^47CW_BR5HT&>WWUQ\G>+5?G==1W2\S9
MFO.[Y?(+I?7+%W^Q^,[&#%XL5TW]9WBQ^.(=Z<7B/5Q/$02]TAO^4/:T_+9<
M+9U*S&[Y7;_Y\U&OMGK!=<:$=@IV*L,0%_8GQG,)LSQGB'"II P2K;HRWMR(
MOC:W9 )^9'"@P,$5F/WX.B)X(_-N&[=C6T%M;$2] C]4HBH47!ER6DT"/_]/
M5 @\/]9CL_:=#8V^K2R=R9+F*K;ZL=!"(262!.8JMX2"T@QRE2-(.26,:J)Q
MXG74TS'&W/CCF96USH"GB$ 7EAZ[N,,1&IDD1@,G8$-W.$@3[>J&@A6VK=L-
M0^?>[H6/3K?!VVW[T2[OE4M[9M[8:&XEE_SA(()=)GL@(DA!)(7:%);NJ)'0
M_H)#EBN!L]3DF@>=;%\89VZ4MS?S2)B]3T[-!5Q-SB@J%(>2Z,2&I,1 GMNX
M5!;:9(9J*1D.:Z0; =EI.NF.CJU?'!H!KY%?+7V "L]$ZH8A:NK1A:&FS37J
M]O<DN>C*Y;T"2\M@U=J9/]2GMU)FAK@J!VYL+(DE=1F-)(6<<H88HH0:KXZY
MEP:8&[\>F1@4*YUBYQ5%#D)D]!"R95V?;(!SJ 2%CX/0F2QV#$(I-'2\",&5
MN/'T<U,&C1>M?A8Q7KZN7[AX9S_VT=RJ]:.[:?V5$X5,"18YE(EQO=:XL#&-
M8= PEF#-I"8JJ.WWN4'F1F3.1G=^TE@)?O]E[8Y5 D.9LWCZQ3%#41J9W.H^
M6TXX[,N.KQ3?J"WX[5'QG;Z.57 TTP5&S%#F[#B3QC%=GCX/8CJO[5F[;J=4
M+1^>W&;;%RV?-N4^_IL_Y<.3TNJM-=>5D#Y5+X6/IA$";5H_WGYS7XH%RQ*3
M24ZA7?\HB'5!(=6$PMP4U*Z!4I&QH(WY*%;-C6+^KI?W7W?:QH9V?<;O->#6
M2]BX677XW8*?EJOZ1\]NOW%GTH^K)I^?L<FMY0\X. 0:CX![;D'+)_>J:+PZ
M-*R] 95G$<OF8P(=M9@^BF'3EMC'Q/*D\#[JS?O**Z_LZ^'U1JOE[BV7[DSV
MQ_N]GIYFBA:$%3#-TM1&=;*PBU1I+%$G.E-YDJ4X*+NF<[2Y<:\SK&PX4YH+
M&GN'*!=V@NU'H]$@')D>!Z'70U39 Y6XBLI= TXLI^SA^ZF6LL^'^G%*J2+R
MP1K/MU\K78 F2\ N$C.E;+A',UQ G"(#6:XS*!3")C%I(C3JT9'[XH!>S\/T
M;;@K/1VN_NMINRN%9\LT@]5Z!9T'8.GF((Q9+D/NQRK#$)R&42K4:B/W^D.U
MG9<#WV NN8I%3!ZY/-BD''+5Y^?\<?T#_;BC4G)W<<]Z99^,:I-@(0J!$IE(
MR)7KHZUR#:E(,4P$D9E=.IK"X) XY.PH<XL_ZC:;>RM[;B^=1]2/%@;C-#(E
MA$,4S :=$,1D@O,#3<H"G;X^9X#NBWMV))5?M7IZ<)&)Y96W#^L_JKXREF'*
M-=&[E:=8V9W+0SV(8"&>:BUMH(%40B'.M(8,92E,>);(+*-%+H(R&4:R<VX,
MU+CIXOC?5AO-'\J4\U*:_+B)T^W'U^\">YR.--5^Q#:#"1R9&MMSYWP$SLFF
M U?C9CEU(4*/X/?283"*XMK(DQ*U,>M(ID[;P'5<O$\:O8X\W(#%ZH6!;K_S
MY8,;[.UZ\X4_M#;I;O=KM[T@K,29213*H9*N#YE$'(J<%[!(,R0X(8B$[97%
M,FQN+Y6/9^1ZES7'/)0<([1KRP@V6C[P[7:?[-AG21QC8@-6T!-/U]@+[M?O
M;L O6NQ:QQLW8.\,M+,$G3LWH-7R\09P8[]&X.!9N;D151@X-M;1%_0Q;)M^
M_1\1T;/;!3'O'^^THTR0T=O=9_O:N=U]TIOE6KU9J47!<N941B'BF;!K!I5#
MIBR?(\EIEE-#C0K2(@X8>VZ4W9@)-BYS@^^ MD^T*QPN#1Y^!G)I"OJ?B$0
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MYCI#E3U34ZDHSI,$9B9%$&?V#RKMH\RD(8@R)(LD#WIVSPPRNR?8V@B=D:7
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M#;&VA">2C$*>::$SA*A.O32M0@>>&\&UG\L._<A0.9C@^?"(^T9">4+B>TF
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MYKQ((,Y3"H74""HF4*%)AE015,OG-^S<EAKG\DT#WTV>>/N]4^*C./*[X!R
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M5<;O]O=$%__*Y6&$H/1RX?IV/'SZNE[54L@+I!#6:<Y@RA,"L2(I9(0C:.E
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MU*L@92P#Y\9)QY*"&UUE>[ECAM)\\*VTOU;>^-:EI#7-_'83W!QF;61>/)\
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MYAWIB'H]*4Y,%&@-RTB)*Q=35@9K7$K&Q"J5E8]2U5J7UQ-![E"YM(RUCS-
M!RQ]\=]P45Q(I:5',P6@#!5SBMAB7S@7D^>6>V9.!+;;9+76Q/5$:#M8,L\
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M,!]1JIDP29.02P-AZ1-Q&BTEQT-&:TEH3>^7"&SOVW X#4W>*/>-P5/*J0%
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M<6TP;W;V9SA;)K\LPT II.#0?B5.E$FD:-VB%:V!0$:G+*<$-M9U6;=1-2S
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M6QF(5ZZ,G2ZKYX$2XTT")BCZ0EM2UD]TW.Z]C"8=U@/@=<AA7$?6#2#]AW$
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M526U> <]C>BN:BY!#U)H $Q?9GXZQS??M&I9)HMN6=V\-%^9;__5>H/&1)6
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M&]\<AV+@&>^&QVU+ECCW)9\(5YM+]1TG3F?4"RD[(9D00*N40P[G5:C_8_9
M?Y(_TJMX,TW5 C2;),E7W4483]>%-@=$8[8^IX_0RX\)["G.LNU%-X/^M LV
MN7)]6L;OL<!(H,&2"%)+D:1UHLHUSF-$'=VMY^&SMTT>9 *, ,@D<09EZ9FX
MTAA$..ZM#E%!'8=Q/_(&[LC2%V8>=/+I7S:-1HBWL?#PH9"//*V6,JHX$O)1
M>(4$2OC28Y-&3R0X2JQWD3@O#+KQ.0.MDKI;4R7=)":4H_AL.OXG.F )1;4N
MV5W.#(S_?35&[-Z='8B_N[J =&]4H/=>V%3&PXM06AE937RDD;"8DZ0^,EJ'
M1SVOHV$E]Q04[J[^.KVTGX\V_-7/2NWZ5SCBKFR?QU;2CX^3?PI%J4#*J&PF
MVBE))+H*Q%%*23):4>TXDZK*'=EI%.7F+<N-,E^6%<]??K_UMU46EV$:0LE3
M$*(D"/O@T5VACFB?P;HL(@]5&JH\E="&5=U3<+1;U5605P/1E2VK6I8\!*ZE
M,CRBT5NR910/Q,6(0'$NLTRC3'5:3.R@IY4"UQH@V.%!'".11H&U,@DVB=-&
MBIB4" 2,*_7G4I8>@T"T"59E[APU55WSG92UH<J.DO\>F#I<&$/G5/[ZGZ_>
M7?BS\?1LG3*/&RH -898)17:LM&A@I><1*MH4DQGP_<K/+C_Y/:0<(34NKY8
M.+3\7T1DBO\;^,GB?%-&I7CTEE'"*"#YI0EN4-20;*@56NM$^7U3<4?IR8-G
M#YNG4!$#1[)Q:!1\OKJ$V>=N.HXK),.FNCM2L%Z5FRW/B8Q"DR!M),:)$N&/
M-J7]2N-WO&#8V_B*>.B#H4.#8H7FE^ C&F9K^HUV(E@A"<MH^4LN. DL4>+P
MP$PB@>"PW^FPY>'#WCY7!,.QC!P:""\FE^?^[A'GC+-22$=H1E]0@J D""A=
M^CVCKO0/$?=G8^PX(QX\>]@+V)IGQ'%L;, /V=%/\N7W,FEF:5A++T)T,9!,
M2SF1!8>'GF8$F>8EI88Q6V5FR@\I:Z6SQ@F<WGZEU"[L;HVY F>S#FI9] ]E
M3T:""S$$LLS(16 Z5;GBZ&=0636GIV<D/'GZV%/$,O0A=[.:OW63%'S\QZ:&
M7'(%*0%1C)8R25<&KD9/6$!5STWRWN[9F6/'&YK$R*%2[/IF:0/ZY^UX.E[
M^_'7D@B[\-.S,:KHU<W<R^^_^/_J9LN.RLL-A6:;XD)XM XL&O@^*6*E-T2
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MWE\%4@ZK>_3+\FV?5YD)Z3UP7DA0B=#K3.2@E0PQ"%>"ZOZ^>')W'??RZN6
M#(.,G\SS>'?]">?UF>#Z;7KAD)%CQQWDXFO_(%<@U":CS 46=/!,B,W(27='
M9>O..FX_ULLQ.1X1/]V=<FMJKO]!6CZ27+P/WY9!$694X,4&\+$&13S7X$M!
MB(74BDP*N6R:+CO)+CONK-;+X1D6*?\&!^F7VVW=5L9?E&B++SQ#9,*2[:I\
M?45!C,(LDE>&9WZJFH]VN^RXS5R_!^D8I(R=G!JRG/X7C-<77*4Z"EY##%R
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MO)>8GDD<[L.SL<7]>-+D!R1GCXR^?RW%<9<+#<9&93E8%B0H:;&647!(T?+
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MD<Y]>-_#;;HQ[6\9D4GH2_#1@<R(M:T;@DL)(47A7<U]DTW0!#];B.G/*3A
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MV6*R-(\K0?3?#:;IPH53)+GD'(+BY*6Y),A5%TI'JU(N8;/EQ< G:L3=C]T
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M5OMY%G4.B*B#I= !H)ZH=DZH$J^,B<0-VD6QX!(:R)GG(A1WWO96:7Z"C-W
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MTL?M5< V)N>0%#8KM6$%<[+VLZY%P9850:Y4,$U2GH?77X]3/#L4@@[C?!<
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MIG142;'\01NXJ+/*?? *;-$2E/0:? H>I&:<,TGL;=.FMOG.SKJ1Q3YH'RP
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M0RB3.DF2OXS5[81_ T@M[>C4^_GLTSQ\65<E8@XNQFKN:BY8&5D-7]8@T<M
M:]3>-YFE^SA)/=Y0[$;>N[M--\P?+(RVI1#66^4#5NZ0?JE0[X-KGT&F&+/4
M*&R;;B5/$=5S.7!'@C\(3R=(H>^Y\"\PK>M;.*==Q6]K7;0QS'M$XHRB!6"(
MY,V32T8,$:Q8*V,Z;&=ZZ.E#Q,,I@IMUR<4!&!;R_G&"\^K][S!I\8)^N5:9
M+*T+6@6H+<2(2X:!DQB!O/VD/-<,V]QP/H"V?DZKV^U878MC^ C;*B&R* K6
M[)=DCAQ%6IECIM:@"(6>\<QLDU/B@ZCKO3*H6TP<A[D3!#3([8U)"C9$0C"I
MUE_X8L#'', '+XUPQFN[.T_E6K:W!A)\=I\[AIU#PH-@VP58'C%*+BD@=37]
M+AD$9P2QHU!8:K@+:;=ES/-XN'UZ[U54E\+#2>SL&P\/;-WWZ<U0A."%!V"Z
M-M@MA.E@O "I?+WLXIE-N\FG@Q,T;_JM9^[>;^F6G0/P5M8)ZOW(<;7\/)O7
M ^Z;+[/5=,E'FE0D2V&(19J#4JC RQ@A*5O5*9A&YUD'TC>L3,Z):'CH[*!C
MT0P/<?GG,HDU+Q<C'VQBT=0:(5YO/@723)<"")NM#HDSI=K5R#])VK#BKR8X
M.U<@ X 8J4I"S.O!!O<+>U?N3N!LS748X)(+4#(6\*9VM4QU:EP.KIA6DP">
M(&M86V0WT.I0$ -M;?P6OY/W60UQU9GY;$K_3+@9[7#"X>=3C^OBR/-@<CLZ
MZ/SI9;/).(U_&E_&L;!2"B,MJ=-%T-"VY9,&C(ZVKY"RQB8ED8^3=*[9>8&+
M-!]_K4)Y5Y[@]-O9\D]<WN395PI81H14I#"3@?%6@XHQ0\0@*T>L4D%+XYK,
M/3V)VM[C_B[0M&NEVLOM^HS7+8,[-F)WCVULS!XFO[U1,R5E5Q,"426"H949
M0L8(+H>2$HJ2>)/ZUG9&[3DF_]A\WK?L+@P-SZY <?6VEY86?-2!MO<2<RP6
M11M[=BRA@S5EQV!HUY0UE59[*[;]HGY$<A3_^I?_ U!+ P04    " !@@3M2
M.=5T+0@(   <)@  %@   &AO;'A?<3$M,C R,7AE>#,Q,2YH=&WM6FUO&S<2
M_GZ_@E5PJ0/HW7)LRXX!1U80'Q([M56D_72@EK-:PMSEEN1*5G_]S9"K%UM2
MHZ!)JPH7(&OM<C@<SCQ\9LC=\Q^N;GN#7S_U6>)2Q3[]_/;#=8]5:HW&Y\->
MHW$UN&+O!Q\_L$Z]V6(#PS,KG=095XU&_Z;"*HES>;?1F$PF]<EA79M18W#7
M(%6=AM+:0ETX4;DXIR=X!2XN_G7^0ZW&KG14I) Y%AG@#@0KK,Q&[+, ^\!J
MM5*JI_.ID:/$L7:SW6*?M7F08Q[:G70*+F9ZSAOA_KSA!SD?:C&].!=RS*1X
M4Y'QZZ/HJ!.UAB(^[8B8GT2=CH"3^ 1.AB#XZ_^VT,@&BH<^UDT5O*FD,JLE
M0.-W.^WZ\5'NSB92N*3;:C;_7?&B%^>QSAR.9[!_^!G4K"AS\.AJ7,E1UO53
MJH2NL^9(*VVZ+YK^WQFUU&*>2C7M_CB0*5AV Q-VIU.>_5BU&(::!2/C(&CE
M[X VH7G^=A),/D8]2F8PFT*K34;W'Q,YE(X=MNJMIQ8O3YR;$<[=Z1Q[H=HE
MVR-T-IB_Q?A@AH!(&TX@[!:9 $-2E8M>_VYP_>ZZ=SFXOKU!&-_=_WQY,V"#
M6W;?[_EGA\TVNWW'!N_[[/[R[NWE3?^^=OO+A_ZO[+(WH)9VL]G>UB/???Z=
MM<&[KK)[!WD"&?M49Q]Y]%$JQ;,JB\ X&4^92[A[^>+HY&SKT.9<"%QY-04Q
MCG(R"[9$UV:N6Z,G?]-D6_79)/[ZT9^YI5D_(C=<LX2/@1D82Y@@9[E$6O9;
MP0VN"#7%Y[DVCNF,O=,F9:UF[2>F8_8>+1[)J,JNLZB.P3G=A^"T=RXX;[G%
MD*#STRE[R/1$@1A!-<2HC(S0:$*F,>G@"%QFC&=35F3.%( SP#3D,Q*&C+,4
M[XSDBL4\PD>&Z11)T^D@MR*00036<C,ED90_ (Z[I-/B,X'&X)#*IS,<@P0B
M:3!]H5B&W9FG,S9)9)0P6]!ET7\"!DHE-(%46H5YCE+F1+H$)VASB+R!I#='
MT[3 :8ZQFV##Z;(;]@6"A_\<" *+989!)KPL@EI%_*$X-INE=IG%R!X^P>'O
M2!4"=2)PEB)81=!)8IP<XTZ0)2@KM<!D"0?[;&B$O?#E6Y4D"H4""$2-:/'#
M66]/Q&W"8J4G=H92 R-I'=9^CG%Z&.Q&*ZM+8+,S8U:LW1>\=78.;X,GP7GY
MXJ3=.CZS):+*DH H0L>QQ%L?MFO&#7B 8,#E4 $%D@&B<JBD34B<Q%*D1Z)(
MNA?21DK; OL1<1JM E)RHR,0^-BR P2& $1:B'[_,4IX-@)VB9QT5RB4:!WR
M6NOH %[YKJTC$>["K:2:,@L()?V,B&L)N %(9,O6 \5/!HIQ()KG<SBC!*7T
M?2F9#OBK7<'HZ_IIB_QP!1:W#1@MG]&^#*4J)=N(%W;[+I3UAH"P*$<*>507
M!A4@.8VE]92'4I!Y/50E+\ARF7 -*.YQ5B;2!5:J)1E3HT3B1%NL5E+XS:LM
MAE8*R8VD"<B0[GT*R$A382D%^V5I?;[V!(F[8S0(MZV^4XY5I(P*Q8G7<5K>
MB$4JQQZA,%BN9_#7$$@0J1?[@]@7JCT8[A".#SNK.-Z:L%;@O#W5;8UJ7 EC
M*0BLW.J,$Z=SBT"GJI(0S(V8H0GQ+?E0*NFFE-W7#4MKRP//8RHLBR>B2U6I
M3QV/Y83RPN2(:>NKD0@WZ<(;X.O3$6189"B$-K9 3FN&1+#V#O#%M25S9.^]
M 7"T0P .1-P?<U5XMJ+H0AQC@2C'&!>[IM";UQ);L&^X75_[>;QB1V1.&RK,
MH2[<9@NVR0]\+@U4/L=?WO&PX:PP]TL0@B?0'@\W&F ?("=V"'(E9X9HKJ*"
M]MUEX>9;UD+O*YB2\KF.HL)0[)>2YQJMJ;8.G],Q)NJR$2HJ3W#8P88N,8(8
M.>R9=&DX;I? 'QG0:4)6S.UZ%:Q*N)U7&L1^'O0@?%KP_B@I>\J4? !5GA\\
MDZ_^:1?M$]"/]F0?YL\2Q6R)5!<D19RY#-,%7Q'0OJ+T6"EBYZ9Q+&2=-G:>
M[?T#5)FFTCF /\@(0XWU!+4+B?9Y)0<(9B1@2P2/?ZF<GJU ^*V0:+Y?;446
M^6.&5__?;GVW+'^IL$##@E$BTFB'2WOE2 )"H\S4\VW/!/@#I=Y0L/GDZTM-
M?]@Y.Q+Z*L"5.Y1POK"&U[C CA;FM+81G&6!BET,O>S!M>'SO\7D;XL4\8%.
M\I,IT\G:P[-]HKP=W ]=8@J/#=)&%<,.GND0./YLND18-61 F8VU&@.EP8R/
MRB-V4Y(CI+G24\#62:(#(_(G^$6\?9,:H;[C;_:NT&F>%ME_.%819OKR1>MU
M\ZQ]7 VOOE?,_]9FMK<R,UCU)5\.M7,Z[=+[\B7O^E1Y[OS^M)0?XN(&4T/K
M%<\M=&<_SC MYHI/NS+S-OA.9V/*I%B"E6^B46?Y.O[TM'[</*8W\L[@?S%3
M7[ZLK_N7]0TG5MLZ)_73YN;F9KVUL>T;J6UXDX/9.'V;\^Q-Y; RZU"NO6X[
M?V2M=6_BUWCEKX=P,V"C@TO27P-,5J_K7EYODMUTG8.O].P?.*W)?$[<RM$E
M%#T-Y.@[.MMC,Z?M9!16/I'P45CGXN_DLG^05WH)EU@79%7VR6"50PG=%Q"]
M1$+,^H\0%704P6Y#A?ZG'-;P;+6&'9]]2I3K\"U5-QPZCV'EXZ(%-CV?-A==
M^! !6KC-739]L;/Q2Z7R&KZ;\E]P7?P/4$L#!!0    ( &"!.U)G*; <[@<
M -<E   6    :&]L>%]Q,2TR,#(Q>&5X,S$R+FAT;>U:;6\;-Q+^?K^"57"I
M ^A=\IOL&'!L!?$UM7N.BEP_':@E5R),+;<D5[+NU_<9<O422VX4-$U=XP)D
MK5T.A\.9A\\,N7OZW>7-Q>"7G_IL[">:_?3SF_=7%ZQ2:S0^=BX:C<O!)7LW
M^/$]Z]:;+3:P/'/**Y-QW6CTKRNL,O8^[S4:L]FL/NO4C1TU!K<-4M5M:&.<
MK LO*F>G] 17R<79/TZ_J]78I4F*B<P\2ZSD7@I6.)6-V$<AW1VKU4JI"Y//
MK1J-/6LWVRWVT=@[->6QW2NOY=E"SVDCWI\VPB"G0R/F9Z="39D2KRLJ%4>B
M>=#I=#O'!UU^)(X.>+-SW.VVCH_;K40F_VW!R ;$8Q_GYUJ^KDQ45AM+&K_7
M;=</]W-_,E/"CWNM9O.?E2!Z=IJ:S&,\B_[Q9U2SH<S+>U_C6HVR7IA2)79=
M-"=&&]M[T0S_3JBEEO*)TO/>]P,UD8Y=RQF[-1.>?5]U"$/-2:O2*.C4_R1L
M@GGA=A9-/H0>K3*YF$*K34;W[\=JJ#SKM.KM3RU>GSBW(\S=FQR]H';-]@3.
MEO8O,3Z:(61B+"<0]HI,2$M2E;.+_NW@ZNW5Q?G@ZN8:,+[]\//Y]8 -;MB'
M_D5XUFFVV<U;-GC79Q_.;]^<7_<_U&[^\[[_"SN_&%!+N]G<V2-_^OR[6X-W
M564_<*NES-B/=78SE-:;K,H2_%7IG/DQ]R]?[!^=[!S8G N!=5?3,L481XM0
M*S@V\[T:/?F+IMJJ+R;Q[4=_X)9F?9_<<,7&?"J9E5,E9V L/U:._5IPB_6@
MYWB>&^N9R=A;8R>LU:S]FYF4O8/%(Y54V566U!&<X^<0G/:3"\X;[A 2.'\R
M9W>9F6DI1K(:8U1&1AB8D!FD'(S 5<9X-F=%YFTA,0,DH9"/$#+.)KBSBFN6
M\@2/+#,34*8W46Y#().)=([;.8E,^)W$N&LZ'9X)&(,A=4AF&(,$$F61O""6
MH3L+9,9F8Y6,F2OHLNH_DU:62F@"$^4TLAPES)GR8TS0Y3()!I+>'*89@6E.
MT4VPX7S=#<\%@IV_#P0E2U6&(!->5D&M G\01[-=:U=9"O8(Z0V_$UT(Z 1P
MUB)8!>@4,4Z.N!-D"<I:KS!9PL$]&!JP%Z%XJY)$H2$ (!J@)0SG@CT)=V.6
M:C-S"Y1:.5+.H_+SC-/#:#>LK*Z!S2V,V;#VN>"M^^3P-O@D."]?'+5;AR>N
M1%19$A!%F#15N UANV+<R@ 0!%P-M:1 ,@E4#K5R8Q(GL0GHD2B2[H5RB3:N
M0#\B3FMT1$IN32(%'CNV!V (":3%Z/?ODS'/1I*=@Y-N"PV)5H?76OM[\E7H
MVMH7\2[>*JHHLXA0TL^(N-: &X%$MNP\4/K)0"D&HGD^A#,D**4_EY)IC[]Z
M*A@]J!^WR ^7TF'3@&B%C/9Y*%4IV2:\<+MWH:PWE(!%.5+,HZ:P4 !RFBH7
M* ]2,@MZJ$I>D>4ZX5JI><!9F4A76*F69$R-"L0)6YS12H2MJRN&3@G%K:()
MJ)CN0PK(2%/A* 6'9>E"O@X$B;TQ#,*F-73*446JI-"<>!W3"D:L4CEZQ,)@
MO9[!KZ$D05 O^DOQ7*AV;_B$<-SI;N)X9\+:@//N5+<SJK$2IDH06+DS&2=.
MYPY IZJ2$,RM6* )^%9\J+3R<\KNVX:EM16 %S 5E\4GHFM5:4@=]^6$\L+F
MP+0+U4B"+;H(!H3Z="0S%!D:T$:+S&G-D AJ[PA?K"V5@[V?#8"3)P3@2,3]
M*==%8"N*KDQ3%(AJBKBX+87>LI;8@7WC[?;:+^ 5'<&<+E:80U/XQRW8)3_P
MI;2D\CG]_(Z'#1>%>5B",GH"]@2XT0#/ 7+B"4&NY,P8S4U4T+Z[+-Q"RU;H
M?0%34CXW25)8BOU:\MRB=6*<QW,ZQ(0NET!1>8+#]A[ID@+$X+ 'TJ7AV"[)
M<&1 IPE9L;3K5;1JS-VRTB#V"Z"7(J2%X(^2LN=,JSNIR_.#!_+5/^RBYP3T
M_6>R#PMGB6*Q1*HKDB+.7(?IBJ\(:%]0>FP4L4O3. I9;ZQ;9OOP "HG$^6]
ME+^3$88&]02U"P7[@I(]@!D$[(C@\9?*Z<4*E+\6"N:'U59D23AF>/7_[=:?
MEN7/-0HT%(P*2*,=+NV5$R4!C3)3+[<],\GO*/7&@BTDWU!JAL/.Q9'0%P&N
MW*'$\X4MO,8%.CJYI+5'P5D6J.ABZ54/UD;(_P[)WQ43X -."I,IT\G6P[/G
M1'E/<#]TCA2>6M!&%6&7@>D G' V72*L&C.@RJ9&3R6EP8R/RB-V6Y*CG.3:
MS"5:9V,3&9%_@E_@[:O4"/4G_E[O$DX+M,C^Q5%%V/G+%ZV#YDG[L!I??&^8
M_[7-;.]D9K3J<[X<&N_-I$=OR]>\&U+EJ0_[TU)^B,4M;0W6:YX[V5O\.$%:
MS#6?]U06; B=3J:425&"E>^AH;-\&7]\7#]L'M+[>&_Q7RS4EZ_JZ^%5?<.+
MS;;N4?VX^7ASL]YZM.TKJ6T$DZ/9F+[+>?:ZTJDL.I1KK]?.[UEKVWOXAUZ)
MOO_V*&Y&>'2Q*L,U(F7SNOGV>HFFTE6_XX4F"TEN)\^5V KK.H<GZ+".+5SP
M5-VZ\=%#<.LW\]G?RRT78R53]G9)]C>QO/Y#OFD$JME";0^^ LI-_ RJ%T^,
MIW+CNZ 5#@,9-E==^!!@+/SC71[[V.;1CXS*:_SD*7Q\=?8;4$L#!!0    (
M &"!.U*7'^&1504  (L3   6    :&]L>%]Q,2TR,#(Q>&5X,S(Q+FAT;=U8
MZW/:.!#_?G_%'IE+Z0Q^0G@W,\0XP3<$*'8N[:<;80O0U-BN+$*XO_Y6,K1)
M"==VKH_<\4&#K-W5/G[:7:G[:W_L!&\G+BS%*H;)S<70<Z"D&<9MU3&,?M"'
M07 ]A)IN6A!PDN1,L#0AL6&XHQ*4ED)D;</8;#;ZIJJG?&$$4T.*JAEQFN94
MCT14.N_*+SA2$IW_TOU5TZ"?ANL5302$G!)!(UCG+%G ;43S=Z!I.RHGS;:<
M+98";-.VX#;E[]@=*=8%$S$]W\OI&L6\:ZA-NK,TVIYW(W8'+'I58J16CZC5
M:IW-:%2;STB36I;5K%-KWC0;U6;K3PN5-)"\X,G%-J:O2BN6:$LJ]V_7;+UQ
MEHG.AD5BV;9,\[>2(CWOSM-$X'X<^8N_A9@#88+>"XW$;)&TE4FE@G6_'*9Q
MRMLGIOIUY(HV)RL6;]LO K:B.8SH!J;IBB0O*CF&0<LI9_.",&=_4=0)U5/3
M3:%R ^7$+*%[$RQ;*NW>+]F,":C:NO58XX>&$[Y VT6:(1>*?:![B,ZF_"<I
M[U NV)R%1&+PJ/;/1=O)FN=K@ON*%'P:2IU/3ZRZV6F9=4CG()84?,)G)*&Y
M-KZ/Z19ZH9 KMFG:S]Z\LK^>Y859.93)R\(VDD10GNTF:,HCPZWJF5D!9TDR
M5!OJ56EK(,\M6,T*W"1,9@)?8$+(\>Q'].77(90E$3JD;=?46?WN;JD]Z1:O
M@A;0;$D3F.AP3<)K%L<DD68S.@?WGH9KP>XHC.>(9'0#^F" NBU86 $O"?4*
M$.C3F&P(IQ"F/$NYPCN4)6!.3YJV;7:<=)619*MF5N=E!:(4EI33V19"=4BV
M%<C^%?Z@G'__^%90"2).3\Z:G2\.=4:B"&N%%M.YC(%^]DGX-:OYTX)?MCY
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M]U[K;)[E)9.Z[CK]"U!+ 0(4 Q0    ( &"!.U(AE7K2Q!\  )^Z   >
M          "  0    !E>#$P,79E<G-T<F5K96XM=6MC;VYT<F%C="YH=&U0
M2P$"% ,4    " !@@3M2ELW$2VFA @!,C2$ $0              @ $ (
M:&]L>"TR,#(P,3(R-BYH=&U02P$"% ,4    " !@@3M2N7H7$.45   $^P
M$0              @ &8P0( :&]L>"TR,#(P,3(R-BYX<V102P$"% ,4
M" !@@3M2#4I2]V0I  "]M@$ %0              @ &LUP( :&]L>"TR,#(P
M,3(R-E]C86PN>&UL4$L! A0#%     @ 8($[4I.FM*PE=@  O @% !4
M         ( !0P$# &AO;'@M,C R,#$R,C9?9&5F+GAM;%!+ 0(4 Q0    (
M &"!.U*@9O%S) \! -,X"P 5              "  9MW P!H;VQX+3(P,C Q
M,C(V7VQA8BYX;6Q02P$"% ,4    " !@@3M2:$68=RNL  "FN0< %0
M        @ 'RA@0 :&]L>"TR,#(P,3(R-E]P<F4N>&UL4$L! A0#%     @
M8($[4CG5="T("   '"8  !8              ( !4#,% &AO;'A?<3$M,C R
M,7AE>#,Q,2YH=&U02P$"% ,4    " !@@3M29RFP'.X'  #7)0  %@
M        @ &,.P4 :&]L>%]Q,2TR,#(Q>&5X,S$R+FAT;5!+ 0(4 Q0    (
M &"!.U*7'^&1504  (L3   6              "  :Y#!0!H;VQX7W$Q+3(P
M,C%X97@S,C$N:'1M4$L! A0#%     @ 8($[4NJ(SDP_!0  21,  !8
M         ( !-TD% &AO;'A?<3$M,C R,7AE>#,R,BYH=&U02P4&      L
,"P#F @  JDX%

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
